Citrus Sinensis ID: 015395

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------
Protein Sequence
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEEccccccHHHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccHHHHHHccccccccccccccccccccccccHHHHccc
Secondary Structure Prediction (SSPRO)
ccEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccHHEEccccccEEEEEEEEccccccHHHHHccccccccHHHHHHHEHHHHHccccccccccccccccHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHccccHHHcccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MAVTGSVIERQAlllpleeesptgynKIHVHigkdnricypgngsgggsgdQVAAVVPevshlgwghwYTLRELevstngfsddkvigeGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNgnleqwlhgdvgpcspltwEIRMNIILGTAKGLSylheglepkvvhrdikssnilidkhwnpkvsdfglakllgsessyITTRVmgtfgyvapeyastgmlnersdvySFGILIMEVIsgripvdysrppeeVNLIEWLKKMVtnrnpegvldpklpekptsRLLKRILLVALRcvdpnaqkrpkmghvvhmleaqespskedryraspkneliekqvtesgdnstnetgvhtneTRWQHQEFQKEKH
Flexible Loop (DISEMBL)
mavtgsvierqalllpleeesptgYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNnrgqaerefkveveaigrvrhknLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSnilidkhwnpkvSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISgripvdysrPPEEVNLIEWLKKMVTnrnpegvldpklpekptSRLLKRILLVALRCVDpnaqkrpkmghvvhmleaqespskedryraspkneliekqvtesgdnstnetgvhtnetrwqhqefqkekh
Low Complexity Region (SEG)
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPgngsgggsgDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKvigeggygivyyglleDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH
Disordered region (IsUnstruct)
***********ALLLPL*****TGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN*****************RLLKRILLVALRCVD***********************************************************************
Disordered Region (DISOPRED)
******************************************************************HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN*GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA*****************************************************
Disordered Region (DISEMBL)
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ************PKNELIEK****************TNETR***********
Disordered Region (DISPRO)
***********************************************************VSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA*****************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	407	2.2.26 [Sep-21-2011]
Q3EDL4	472	Probable serine/threonine	no	no	0.911	0.786	0.663	1e-148
Q6NKZ9	437	Probable receptor-like se	no	no	0.727	0.677	0.724	1e-133
Q9SJG2	494	Probable receptor-like pr	no	no	0.884	0.728	0.614	1e-125
Q8LEB6	484	Probable receptor-like pr	no	no	0.818	0.688	0.634	1e-124
Q9LRP3	467	Probable receptor-like pr	no	no	0.813	0.708	0.619	1e-123
Q9LV48	652	Proline-rich receptor-lik	no	no	0.707	0.441	0.472	3e-75
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.727	0.411	0.458	2e-74
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.754	0.432	0.458	5e-74
Q9LK03	717	Proline-rich receptor-lik	no	no	0.724	0.411	0.457	1e-73
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.710	0.563	0.461	1e-73

>sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2

 Score =  525 bits (1351), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 260/392 (66%), Positives = 305/392 (77%), Gaps = 21/392 (5%)

Query: 27  KIHVHIGK-DNRICYP-----GNGSGGGSGDQVAAVV------PEVSHLGWGHWYTLREL 74
           +I V IGK ++R+ +      G   G  S  + A+        PEVSHLGWG WYTLREL
Sbjct: 88  EIQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHLGWGRWYTLREL 147

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E +TNG  ++ VIGEGGYGIVY G+L D +KVAVKNLLNNRGQAE+EFKVEVE IGRVRH
Sbjct: 148 EAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH 207

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           KNLVRLLGYC EGA+RMLVY++V+NGNLEQW+HGDVG  SPLTW+IRMNIILG AKGL+Y
Sbjct: 208 KNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAY 267

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LHEGLEPKVVHRDIKSSNIL+D+ WN KVSDFGLAKLLGSESSY+TTRVMGTFGYVAPEY
Sbjct: 268 LHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEY 327

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
           A TGMLNE+SD+YSFGILIME+I+GR PVDYSRP  E NL++WLK MV NR  E V+DPK
Sbjct: 328 ACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPK 387

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDR--YRASPKNEL 372
           +PE P+S+ LKR+LLVALRCVDP+A KRPKMGH++HMLEA++   +++R   R     E 
Sbjct: 388 IPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRDHGSRER 447

Query: 373 IEKQVTESGDNSTNETGVHTNETRWQHQEFQK 404
            E  V  +G  S      H       HQ+ Q+
Sbjct: 448 QETAVVAAGSESGESGSRH-------HQQKQR 472

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1

 Score =  475 bits (1222), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 216/298 (72%), Positives = 256/298 (85%), Gaps = 2/298 (0%)

Query: 63  LGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF 122
           +GWG WY+L++LE++T GFSDD +IGEGGYG+VY     D S  AVKNLLNN+GQAE+EF
Sbjct: 127 MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEF 186

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           KVEVEAIG+VRHKNLV L+GYCA+ A   RMLVYEY++NGNLEQWLHGDVGP SPLTW+I
Sbjct: 187 KVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDI 246

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
           RM I +GTAKGL+YLHEGLEPKVVHRD+KSSNIL+DK WN KVSDFGLAKLLGSE+SY+T
Sbjct: 247 RMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVT 306

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
           TRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+GR PVDYSRPP E+NL++W K 
Sbjct: 307 TRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKG 366

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP 358
           MV +R  E V+DPK+   P  R LKR LLV LRC+D ++ KRPKMG ++HMLEA++ P
Sbjct: 367 MVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFP 424

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1

 Score =  449 bits (1156), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 223/363 (61%), Positives = 271/363 (74%), Gaps = 3/363 (0%)

Query: 31  HIGKDNRICYPGNGSGGGSGDQVAAV-VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGE 89
           H G++      G   GGG       V +PE+SHLGWGHW+TLR+LE++TN F+   V+GE
Sbjct: 132 HSGEEGGFGSAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGE 191

Query: 90  GGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH 149
           GGYG+VY G L + ++VAVK LLNN GQAE+EF+VEVEAIG VRHKNLVRLLGYC EG H
Sbjct: 192 GGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 251

Query: 150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           RMLVYEYVN+GNLEQWLHG +     LTWE RM II GTA+ L+YLHE +EPKVVHRDIK
Sbjct: 252 RMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIK 311

Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           +SNILID  +N K+SDFGLAKLL S  S+ITTRVMGTFGYVAPEYA+TG+LNE+SD+YSF
Sbjct: 312 ASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSF 371

Query: 270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
           G+L++E I+GR PVDY RP  EVNL+EWLK MV  R  E V+DP+L  +P+   LKR LL
Sbjct: 372 GVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALL 431

Query: 330 VALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNETG 389
           V+LRCVDP A+KRP+M  V  MLE+ E P  ++R     K   +E  + E+ D S   +G
Sbjct: 432 VSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSKTAGME--IVETKDESLGPSG 489

Query: 390 VHT 392
             T
Sbjct: 490 SET 492

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1

 Score =  446 bits (1147), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 215/339 (63%), Positives = 264/339 (77%), Gaps = 6/339 (1%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           +PE SHLGWGHW+TLR+L+++TN FS D +IG+GGYG+VY G L + + VAVK LLNN G
Sbjct: 142 LPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLG 201

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           QA+++F+VEVEAIG VRHKNLVRLLGYC EG  RMLVYEYVNNGNLEQWL GD      L
Sbjct: 202 QADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYL 261

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           TWE R+ I++GTAK L+YLHE +EPKVVHRDIKSSNILID  +N K+SDFGLAKLLG++ 
Sbjct: 262 TWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADK 321

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
           S+ITTRVMGTFGYVAPEYA++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV+L+E
Sbjct: 322 SFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVE 381

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
           WLK MV  R  E V+DP L  KP++  LKR LL ALRCVDP ++KRP+M  V  MLE++E
Sbjct: 382 WLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEE 441

Query: 357 SP-SKEDRYRASPKNELIEKQVTESGDNSTNETGVHTNE 394
            P ++EDR R   +N       T   D   N T    +E
Sbjct: 442 YPIAREDRRRRRSQN-----GTTRDSDPPRNSTDTDKSE 475

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1

 Score =  443 bits (1140), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 205/331 (61%), Positives = 265/331 (80%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           +PEVSH+GWGHW+TLR+L+++TN FS + +IG+GGYG+VY+G L + + VAVK LLNN G
Sbjct: 130 LPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPG 189

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           QA+++F+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+NNGNLEQWLHGD+     L
Sbjct: 190 QADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHL 249

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           TWE R+ +++GTAK L+YLHE +EPKVVHRDIKSSNIL+D +++ K+SDFGLAKLLG++S
Sbjct: 250 TWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADS 309

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
           +Y++TRVMGTFGYVAPEYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EEV+++E
Sbjct: 310 NYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVE 369

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
           WLK MV  +  E V+D +L  KPT+  LKR LL ALRCVDP+A KRPKM  V  MLE+ E
Sbjct: 370 WLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDE 429

Query: 357 SPSKEDRYRASPKNELIEKQVTESGDNSTNE 387
            P      R   +N+  E     +  N  N+
Sbjct: 430 YPVMPREERRRRRNQNAETHRESTDTNKDND 460

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  282 bits (722), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/296 (47%), Positives = 201/296 (67%), Gaps = 8/296 (2%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA 128
           +T  EL  +TNGFS+  ++G+GG+G V+ G+L    +VAVK L    GQ EREF+ EVE 
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           I RV H++LV L+GYC  G  R+LVYE+V N NLE  LHG   P   + W  R+ I LG+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT--MEWSTRLKIALGS 385

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           AKGLSYLHE   PK++HRDIK+SNILID  +  KV+DFGLAK+    +++++TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--- 305
           Y+APEYA++G L E+SDV+SFG++++E+I+GR PVD +    + +L++W + ++ NR   
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL-NRASE 504

Query: 306 --NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             + EG+ D K+  +     + R++  A  CV  +A++RP+M  +V  LE   S S
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLS 560

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  279 bits (714), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 139/303 (45%), Positives = 200/303 (66%), Gaps = 7/303 (2%)

Query: 57  VPEVSHLGWGHW-YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR 115
            P+ + LG G   ++  EL   T GF+   ++GEGG+G VY G L+D   VAVK L    
Sbjct: 346 TPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGS 405

Query: 116 GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
           GQ +REFK EVE I RV H++LV L+GYC    HR+L+YEYV+N  LE  LHG   P   
Sbjct: 406 GQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV-- 463

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           L W  R+ I +G+AKGL+YLHE   PK++HRDIKS+NIL+D  +  +V+DFGLA+L  + 
Sbjct: 464 LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTT 523

Query: 236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            ++++TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+++GR PVD ++P  E +L+
Sbjct: 524 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583

Query: 296 EW----LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           EW    L K +   +   ++D +L ++     + R++  A  CV  +  KRP+M  VV  
Sbjct: 584 EWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRA 643

Query: 352 LEA 354
           L+ 
Sbjct: 644 LDC 646

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  278 bits (712), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 144/314 (45%), Positives = 201/314 (64%), Gaps = 7/314 (2%)

Query: 47  GGSGDQVAAVVPEVSHLGWGHW-YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK 105
           GG G   +   P+ + +G G   +T  EL   T GFS   ++GEGG+G VY G L D   
Sbjct: 318 GGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKL 377

Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L    GQ +REFK EVE I RV H++LV L+GYC   + R+L+YEYV N  LE  
Sbjct: 378 VAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHH 437

Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD 225
           LHG   P   L W  R+ I +G+AKGL+YLHE   PK++HRDIKS+NIL+D  +  +V+D
Sbjct: 438 LHGKGRPV--LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVAD 495

Query: 226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY 285
           FGLAKL  S  ++++TRVMGTFGY+APEYA +G L +RSDV+SFG++++E+I+GR PVD 
Sbjct: 496 FGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555

Query: 286 SRPPEEVNLIEW----LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
            +P  E +L+EW    L K +   +   ++D +L +      + R++  A  CV  +  K
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615

Query: 342 RPKMGHVVHMLEAQ 355
           RP+M  VV  L+++
Sbjct: 616 RPRMVQVVRALDSE 629

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  277 bits (709), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 139/304 (45%), Positives = 199/304 (65%), Gaps = 9/304 (2%)

Query: 63  LGWGHW---YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE 119
           LG G +   +   EL  +TNGFS+  ++G+GG+G V+ G+L +  +VAVK L     Q E
Sbjct: 333 LGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGE 392

Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           REF+ EV  I RV H++LV L+GYC   A R+LVYE+V N  LE  LHG   P   + W 
Sbjct: 393 REFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPT--MEWS 450

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
            R+ I +G+AKGLSYLHE   PK++HRDIK+SNILID  +  KV+DFGLAK+    ++++
Sbjct: 451 SRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHV 510

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           +TRVMGTFGY+APEYAS+G L E+SDV+SFG++++E+I+GR P+D +    + +L++W +
Sbjct: 511 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWAR 570

Query: 300 KMVTN----RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
            ++       N E V+D KL  +     + R++  A  CV   A +RP+M  V  +LE  
Sbjct: 571 PLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGN 630

Query: 356 ESPS 359
            SPS
Sbjct: 631 ISPS 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  277 bits (708), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 136/295 (46%), Positives = 199/295 (67%), Gaps = 6/295 (2%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA 128
           +T  EL  +TN FS+  ++GEGG+G VY G+L + ++VAVK L     Q E+EF+ EV  
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           I ++ H+NLV L+GYC  GA R+LVYE+V N  LE  LHG   P   + W +R+ I + +
Sbjct: 231 ISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPT--MEWSLRLKIAVSS 288

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           +KGLSYLHE   PK++HRDIK++NILID  +  KV+DFGLAK+    +++++TRVMGTFG
Sbjct: 289 SKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFG 348

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN---- 304
           Y+APEYA++G L E+SDVYSFG++++E+I+GR PVD +    + +L++W + ++      
Sbjct: 349 YLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEE 408

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
            N EG+ D KL  +     + R++  A  CV   A++RP+M  VV +LE   SPS
Sbjct: 409 SNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISPS 463

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
359480850	516	PREDICTED: probable serine/threonine-pro	0.982	0.775	0.777	0.0
296082408	434	unnamed protein product [Vitis vinifera]	0.864	0.811	0.831	1e-178
225458659	519	PREDICTED: probable serine/threonine-pro	0.953	0.747	0.761	1e-175
449450231	842	PREDICTED: uncharacterized protein LOC10	0.968	0.467	0.742	1e-174
307135852	842	serine/threonine-protein kinase [Cucumis	0.968	0.467	0.742	1e-174
255565232	509	BRASSINOSTEROID INSENSITIVE 1-associated	0.950	0.760	0.770	1e-174
255538254	528	Serine/threonine-protein kinase PBS1, pu	0.977	0.753	0.734	1e-173
449482676	521	PREDICTED: probable serine/threonine-pro	0.968	0.756	0.742	1e-172
356496904	503	PREDICTED: probable serine/threonine-pro	0.938	0.759	0.760	1e-172
357482863	492	BRASSINOSTEROID INSENSITIVE 1-associated	0.945	0.782	0.749	1e-171

>gi|359480850|ref|XP_002282732.2| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera]

 Score =  664 bits (1713), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/418 (77%), Positives = 361/418 (86%), Gaps = 18/418 (4%)

Query: 8   IERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSG--DQVAAVVPEVSHLGW 65
           IE QALLLP  EESP G ++IH+ +GKD+RI YP     G +   +Q + V PEVSHLGW
Sbjct: 99  IEGQALLLPPGEESPGGVHRIHIELGKDHRISYPERVVSGEARAVEQASIVAPEVSHLGW 158

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR-------GQA 118
           GHWYTLRELE STN F+DD VIGEGGYGIVY+G+LEDN++VAVKNLLNNR       GQA
Sbjct: 159 GHWYTLRELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNRCFLATTMGQA 218

Query: 119 EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW 178
           E+EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP SPLTW
Sbjct: 219 EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSPLTW 278

Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           EIRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY
Sbjct: 279 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSEHSY 338

Query: 239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           +TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME+ISGR PVDYSRPPEEVNL++WL
Sbjct: 339 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEVNLVDWL 398

Query: 299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP 358
           K+MVT+RNPEGVLDPK+PEKPTSR LKR LLVALRCVDPN+QKRPKMGHV+HMLEA+ESP
Sbjct: 399 KRMVTSRNPEGVLDPKIPEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAEESP 458

Query: 359 SKEDR---------YRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH 407
            ++DR         +R SP+N L+EK+VTESGD+S  E+G H N  RW+ +E Q EK 
Sbjct: 459 FRDDRRAGRDSVRAHRDSPRNGLMEKRVTESGDSSGYESGAHANRQRWRQEESQAEKQ 516

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296082408|emb|CBI21413.3| unnamed protein product [Vitis vinifera]

 Score =  630 bits (1626), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 300/361 (83%), Positives = 329/361 (91%), Gaps = 9/361 (2%)

Query: 56  VVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR 115
           + PEVSHLGWGHWYTLRELE STN F+DD VIGEGGYGIVY+G+LEDN++VAVKNLLNNR
Sbjct: 74  IAPEVSHLGWGHWYTLRELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNR 133

Query: 116 GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
           GQAE+EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP SP
Sbjct: 134 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSP 193

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LTWEIRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE
Sbjct: 194 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSE 253

Query: 236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            SY+TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME+ISGR PVDYSRPPEEVNL+
Sbjct: 254 HSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEVNLV 313

Query: 296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
           +WLK+MVT+RNPEGVLDPK+PEKPTSR LKR LLVALRCVDPN+QKRPKMGHV+HMLEA+
Sbjct: 314 DWLKRMVTSRNPEGVLDPKIPEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAE 373

Query: 356 ESPSKEDR---------YRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEK 406
           ESP ++DR         +R SP+N L+EK+VTESGD+S  E+G H N  RW+ +E Q EK
Sbjct: 374 ESPFRDDRRAGRDSVRAHRDSPRNGLMEKRVTESGDSSGYESGAHANRQRWRQEESQAEK 433

Query: 407 H 407
            
Sbjct: 434 Q 434

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225458659|ref|XP_002282863.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera]

 Score =  621 bits (1602), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 309/406 (76%), Positives = 342/406 (84%), Gaps = 18/406 (4%)

Query: 14  LLPLEEESPTGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHLGWG 66
           LL   EESP G  +IH+ IGKD+RI YP  G G         SGDQV   VPEVSHLGWG
Sbjct: 108 LLQPGEESPVGLQRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQVTIAVPEVSHLGWG 167

Query: 67  HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEV 126
           HWYTLRELE+STNGF+D+ VIGEGGYGIVY G+LEDN++VAVKNLLNNRGQAE+EFKVEV
Sbjct: 168 HWYTLRELELSTNGFADENVIGEGGYGIVYRGVLEDNTQVAVKNLLNNRGQAEKEFKVEV 227

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV+NGNLEQWLHGDVGP SPLTW+IRMNII+
Sbjct: 228 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPHSPLTWDIRMNIII 287

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
           GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRVMGT
Sbjct: 288 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRVMGT 347

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           FGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGR PVDYSRPP EVNL+EWLK MVTNRN
Sbjct: 348 FGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNLVEWLKAMVTNRN 407

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK--EDR- 363
            EGVLDPK+PEKP+SR LKR LLVALRCVDPNAQKRPKMGHV+HMLEA + P +  +DR 
Sbjct: 408 AEGVLDPKIPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEADDFPFRDFQDRR 467

Query: 364 --------YRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQE 401
                    R   K+  +EK++ ESGD+S  E+G   N + W+  E
Sbjct: 468 AGREHGRAQRDGMKDRFLEKRMIESGDSSGYESGAQNNRSLWKKPE 513

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450231|ref|XP_004142867.1| PREDICTED: uncharacterized protein LOC101203008 [Cucumis sativus]

 Score =  618 bits (1593), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 305/411 (74%), Positives = 348/411 (84%), Gaps = 17/411 (4%)

Query: 12  ALLLPLEEESP-TGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHL 63
           A LL  EE SP +G ++IH+ IGKD+RI YP  G G         SGDQ    VPEVSHL
Sbjct: 425 ATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHL 484

Query: 64  GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GWGHWYTLRELE STN F+D+ VIGEGGYGIVY G+LEDN+ VA+KNLLNNRGQAE+EFK
Sbjct: 485 GWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFK 544

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           VEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEY++NGNLEQWLHG+VGPCSPLTW+IRMN
Sbjct: 545 VEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMN 604

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II+GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRV
Sbjct: 605 IIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRV 664

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           MGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGR PVDYSRP  EVNL+EWLK MV+
Sbjct: 665 MGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMVS 724

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDR 363
           NRN EGVLDPKLPEKP++R LKR LLVALRCVDPN QKRPKMGHV+HMLEA E P ++DR
Sbjct: 725 NRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDR 784

Query: 364 Y------RASPKNELIEKQVTESGDNSTNETGVHTNETR--WQHQEFQKEK 406
                  R+  K +L+E+ V+ESG++S  E+G  T  +R  W+ QE ++++
Sbjct: 785 RVGREPGRSLLKEKLMERLVSESGESSGYESGA-TQASRHLWRKQELEEQQ 834

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|307135852|gb|ADN33721.1| serine/threonine-protein kinase [Cucumis melo subsp. melo]

 Score =  617 bits (1591), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 305/411 (74%), Positives = 348/411 (84%), Gaps = 17/411 (4%)

Query: 12  ALLLPLEEESP-TGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHL 63
           A LL  EE SP +G ++IH+ IGKD+RI YP  G G         SGDQ    VPEVSHL
Sbjct: 425 ATLLETEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHL 484

Query: 64  GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GWGHWYTLRELE STN F+D+ VIGEGGYGIVY G+LEDN+ VA+KNLLNNRGQAE+EFK
Sbjct: 485 GWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFK 544

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           VEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEY++NGNLEQWLHG+VGPCSPLTW+IRMN
Sbjct: 545 VEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMN 604

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II+GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRV
Sbjct: 605 IIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRV 664

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           MGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGR PVDYSRP  EVNL+EWLK MV+
Sbjct: 665 MGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMVS 724

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDR 363
           NRN EGVLDPKLPEKP++R LKR LLVALRCVDPN QKRPKMGHV+HMLEA E P ++DR
Sbjct: 725 NRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDR 784

Query: 364 Y------RASPKNELIEKQVTESGDNSTNETGVHTNETR--WQHQEFQKEK 406
                  R+  K +L+E+ V+ESG++S  E+G  T  +R  W+ QE ++++
Sbjct: 785 RVGREPGRSLLKEKLMERLVSESGESSGYESGA-TQASRHLWRKQELEEQQ 834

Source: Cucumis melo subsp. melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565232|ref|XP_002523608.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223537170|gb|EEF38803.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  617 bits (1591), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 313/406 (77%), Positives = 343/406 (84%), Gaps = 19/406 (4%)

Query: 9   ERQALLL-PLEEESPTGYN----KIHVHIGKDNRICYP---GNGSGGGSGDQVAAVV-PE 59
           ERQALLL P EEESP GY+     I + IGK + I YP   G    GG GDQ+A VV P+
Sbjct: 100 ERQALLLMPPEEESPMGYHHGTGNIQIEIGKGHLISYPVSSGEAPRGG-GDQLAMVVGPD 158

Query: 60  VSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE 119
           VSHLGWGHWYTLRELE STNGF+D+ VIG+GGYGIVYYG+L DN++VAVKNLLNNRGQAE
Sbjct: 159 VSHLGWGHWYTLRELEASTNGFADENVIGQGGYGIVYYGVLVDNTQVAVKNLLNNRGQAE 218

Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           +EFKVEVEAIGRVRHKNLVRLLGYCAEG+HRMLVYEYVNNGNLEQWLHGDVG CSPLTWE
Sbjct: 219 KEFKVEVEAIGRVRHKNLVRLLGYCAEGSHRMLVYEYVNNGNLEQWLHGDVGSCSPLTWE 278

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
           IRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WN KVSDFGLAKLL  ESSYI
Sbjct: 279 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKLWNAKVSDFGLAKLLYPESSYI 338

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           TTRVMGTFGYVAPEYASTGM+NERSDV+ FGILIME+ISGR PVDYSRPP+EVNL+EWLK
Sbjct: 339 TTRVMGTFGYVAPEYASTGMVNERSDVFGFGILIMEIISGRNPVDYSRPPDEVNLVEWLK 398

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
           +MVTNRNPEGVLDPKLPE+P+SR LKR+LLVALRCVDPNAQKRPKMGHVVHMLEA E P 
Sbjct: 399 RMVTNRNPEGVLDPKLPERPSSRALKRVLLVALRCVDPNAQKRPKMGHVVHMLEADEFPF 458

Query: 360 KEDRYRASP---------KNELIEKQVTESGDNSTNETGVHTNETR 396
           ++DR              K+ L+E  +TESGD S  + G     TR
Sbjct: 459 RDDRRGGKDPRGTQCDNNKDALMENSMTESGDRSGVQDGDVIKNTR 504

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255538254|ref|XP_002510192.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223550893|gb|EEF52379.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  613 bits (1582), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 313/426 (73%), Positives = 351/426 (82%), Gaps = 28/426 (6%)

Query: 7   VIERQALLLPLEEESPTG-YNKIHVHIGKDNRICYP----GNGSGGG-------SGDQV- 53
           V E + +LL  EE SP G  N+IH+ IGKD+RI YP    G+G+G G       SGDQ  
Sbjct: 104 VPESEPVLLE-EENSPVGGRNRIHIEIGKDHRISYPERAGGSGNGSGETRSSPRSGDQAG 162

Query: 54  -AAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL 112
            A VVPEVSHLGWGHWYTLRELEVSTN F+D+ VIGEGGYGIVY G+L+DN+ VAVK  L
Sbjct: 163 GAIVVPEVSHLGWGHWYTLRELEVSTNCFADENVIGEGGYGIVYRGILDDNTNVAVKICL 222

Query: 113 NNR-------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
                     GQAE+EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV+NGNLEQW
Sbjct: 223 TTACTFWWCMGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQW 282

Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD 225
           LHGDVGPCSPLTWEIRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+D+ WN KVSD
Sbjct: 283 LHGDVGPCSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSD 342

Query: 226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY 285
           FGLAKLLGSE SY+TTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGR PVDY
Sbjct: 343 FGLAKLLGSERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDY 402

Query: 286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
           SRPP EVNL+EWLK MVTNRN EGVLDP+LPEKP+SR LKR LLVALRCVDPNAQKRPKM
Sbjct: 403 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLPEKPSSRALKRALLVALRCVDPNAQKRPKM 462

Query: 346 GHVVHMLEAQESPSKEDR------YRASPKNELIEKQVTESGDNSTNETGVHTNETRWQH 399
           GHV+HMLEA E P ++DR       R++ +    +K+V+ESGD+S  E+G  TN T W+ 
Sbjct: 463 GHVIHMLEADEFPFRDDRRTGREHVRSNREGMKTDKRVSESGDSSGYESGAQTNRTLWRK 522

Query: 400 QEFQKE 405
           QE +++
Sbjct: 523 QEGEEQ 528

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449482676|ref|XP_004156368.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus]

 Score =  612 bits (1578), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 305/411 (74%), Positives = 348/411 (84%), Gaps = 17/411 (4%)

Query: 12  ALLLPLEEESP-TGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHL 63
           A LL  EE SP +G ++IH+ IGKD+RI YP  G G         SGDQ    VPEVSHL
Sbjct: 104 ATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHL 163

Query: 64  GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GWGHWYTLRELE STN F+D+ VIGEGGYGIVY G+LEDN+ VA+KNLLNNRGQAE+EFK
Sbjct: 164 GWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFK 223

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           VEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEY++NGNLEQWLHG+VGPCSPLTW+IRMN
Sbjct: 224 VEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMN 283

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II+GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRV
Sbjct: 284 IIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRV 343

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           MGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGR PVDYSRP  EVNL+EWLK MV+
Sbjct: 344 MGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMVS 403

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDR 363
           NRN EGVLDPKLPEKP++R LKR LLVALRCVDPN QKRPKMGHV+HMLEA E P ++DR
Sbjct: 404 NRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDR 463

Query: 364 Y------RASPKNELIEKQVTESGDNSTNETGVHTNETR--WQHQEFQKEK 406
                  R+  K +L+E+ V+ESG++S  E+G  T  +R  W+ QE ++++
Sbjct: 464 RVGREPGRSLLKEKLMERLVSESGESSGYESGA-TQASRHLWRKQELEEQQ 513

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496904|ref|XP_003517305.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max]

 Score =  609 bits (1571), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 305/401 (76%), Positives = 336/401 (83%), Gaps = 19/401 (4%)

Query: 18  EEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGD-------QVAAVVPEVSHLGWGHWYT 70
           EE +P GY++I   IGK++RI YP       S +       QV  V+PEVSHLGWGHWYT
Sbjct: 100 EETTPLGYHRIQFEIGKNHRISYPERPLVRSSSNDPSSCEVQVPTVIPEVSHLGWGHWYT 159

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
           LRELE STN F+ + VIGEGGYGIVY+G+L DN+ VA+KNLLNNRGQAE+EFKVEVEAIG
Sbjct: 160 LRELEDSTNAFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAIG 219

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           RVRHKNLVRLLGYCAEGAHRMLVYEYV+NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK
Sbjct: 220 RVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 279

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL+YLHEGLEPKVVHRDIKSSNIL+ K WN KVSDFGLAKLLGS++SYITTRVMGTFGYV
Sbjct: 280 GLTYLHEGLEPKVVHRDIKSSNILLSKQWNAKVSDFGLAKLLGSDNSYITTRVMGTFGYV 339

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APEYASTGMLNERSDVYSFGILIME+I+GR PVDYSRPPEEVNL++WLKKMV+NRNPEGV
Sbjct: 340 APEYASTGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEVNLVDWLKKMVSNRNPEGV 399

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRA---- 366
           LDPKLPEKPTSR LKR LLVALRC DPNAQKRPKMGHV+HMLEA++SP KEDR RA    
Sbjct: 400 LDPKLPEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEDR-RAKRDA 458

Query: 367 --SPKNEL-----IEKQVTESGDNSTNETGVHTNETRWQHQ 400
             SP + +      E  V+ S D+   E GV  NETR   Q
Sbjct: 459 GHSPNDRVGDGLKEEVTVSVSVDDGKLENGVCANETRSNLQ 499

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357482863|ref|XP_003611718.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase [Medicago truncatula] gi|355513053|gb|AES94676.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase [Medicago truncatula]

 Score =  607 bits (1565), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 302/403 (74%), Positives = 334/403 (82%), Gaps = 18/403 (4%)

Query: 16  PLEEESPTGYNKIHVHIGKDNRICYP-GNGSGGGSG-------DQVAAVVPEVSHLGWGH 67
           P EE +P  Y +I   IGK++RI YP   GS   SG       DQV AV+P+VSHLGWGH
Sbjct: 86  PEEETAPLSYKRIQFEIGKNHRISYPEQRGSVEHSGERESRPLDQVNAVIPQVSHLGWGH 145

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           WYTLRELE +TN FS D VIGEGGYGIVY+G+L+DN+ +A+KNLLNNRGQAEREFKVEVE
Sbjct: 146 WYTLRELEDATNEFSPDNVIGEGGYGIVYHGILKDNTNIAIKNLLNNRGQAEREFKVEVE 205

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
           AIGRVRHKNLVRLLGYCAEGAHRMLVYE+V+NGNLEQWLHGDVGPCSPLTWEIRMNIILG
Sbjct: 206 AIGRVRHKNLVRLLGYCAEGAHRMLVYEFVDNGNLEQWLHGDVGPCSPLTWEIRMNIILG 265

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           TAKGL+YLHEGLEPKVVHRDIKSSNIL+ K WN KVSDFGLAKLL  ESSYITTRVMGTF
Sbjct: 266 TAKGLTYLHEGLEPKVVHRDIKSSNILLSKQWNSKVSDFGLAKLLSPESSYITTRVMGTF 325

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           GYVAPEYASTGMLNERSDVYSFGILIMEVI+GR PV+YSRP EEVNL+EWLKKMV+NRNP
Sbjct: 326 GYVAPEYASTGMLNERSDVYSFGILIMEVITGRNPVEYSRPAEEVNLVEWLKKMVSNRNP 385

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDR---- 363
           EGVLDPKLPEKPTSR LKR LLVALRC DPNAQKRPKMGHV+HMLEA++SP KE+R    
Sbjct: 386 EGVLDPKLPEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEERRVRR 445

Query: 364 ---YRASPKNELIEKQVTESG---DNSTNETGVHTNETRWQHQ 400
                +SP   + ++   E+    D+   E    TNET   H+
Sbjct: 446 DPGVGSSPTTSIEDRSKEEAAVSIDDGMLENEKCTNETSSNHE 488

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
TAIR|locus:2132353	492	AT4G02630 [Arabidopsis thalian	0.948	0.784	0.660	1.1e-137
TAIR|locus:2025396	472	AT1G01540 [Arabidopsis thalian	0.813	0.701	0.703	1.8e-126
TAIR|locus:2139559	437	AT4G34500 [Arabidopsis thalian	0.737	0.686	0.685	8.2e-115
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.835	0.664	0.607	7.8e-110
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.820	0.676	0.610	3e-108
TAIR|locus:2146203	484	AT5G18500 [Arabidopsis thalian	0.823	0.692	0.601	6.3e-108
TAIR|locus:2093591	467	GPK1 "glyoxysomal protein kina	0.803	0.700	0.596	7.2e-107
TAIR|locus:2027559	492	AT1G56720 [Arabidopsis thalian	0.800	0.662	0.609	4e-106
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.859	0.751	0.560	2.2e-105
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.710	0.446	0.447	9.7e-64

TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)]

 Score = 1348 (479.6 bits), Expect = 1.1e-137, P = 1.1e-137
 Identities = 266/403 (66%), Positives = 308/403 (76%)

Query:    16 PLEEESPTGYNKIHVHIGKDNRICYPX------XXXXXXXXDQVAAVV--PEVSHLGWGH 67
             P + +     NKIH+ IGKD+RI YP               DQ   ++  PEVSHLGWGH
Sbjct:    89 PHQNQQREDDNKIHIEIGKDHRIAYPERGGWTGSGSGSGSGDQGLLMLSGPEVSHLGWGH 148

Query:    68 WYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVE 127
             WYTLRELEVSTNGF+D+                 D S VA+KNLLNNRGQAE+EFKVEVE
Sbjct:   149 WYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVE 208

Query:   128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIIL 186
             AIGRVRHKNLVRLLGYC EGAHRMLVYEYV+NGNLEQW+HG  +G  SPLTWEIRMNI+L
Sbjct:   209 AIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVL 268

Query:   187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             GTAKGL YLHEGLEPKVVHRDIKSSNIL+DK WN KVSDFGLAKLLGSE SY+TTRVMGT
Sbjct:   269 GTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGT 328

Query:   247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
             FGYVAPEYASTGMLNERSDVYSFG+L+ME+ISGR PVDYSR P EVNL+EWLK++VTNR+
Sbjct:   329 FGYVAPEYASTGMLNERSDVYSFGVLVMEIISGRSPVDYSRAPGEVNLVEWLKRLVTNRD 388

Query:   307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRA 366
              EGVLDP++ +KP+ R LKR LLVALRCVDPNAQKRPKMGH++HMLEA++  SK+DR  +
Sbjct:   389 AEGVLDPRMVDKPSLRSLKRTLLVALRCVDPNAQKRPKMGHIIHMLEAEDLVSKDDRRNS 448

Query:   367 SPKNELIEK--------QVTESGDNSTNETGVHTNETRWQHQE 401
                   IE+         V ES D S N   ++ ++   ++++
Sbjct:   449 GGGGGGIEQGRSPRRKTNVNESEDESGNSVLINNDQLALENKQ 491

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0042546 "cell wall biogenesis" evidence=RCA

TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1242 (442.3 bits), Expect = 1.8e-126, P = 1.8e-126
 Identities = 235/334 (70%), Positives = 271/334 (81%)

Query:    58 PEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQ 117
             PEVSHLGWG WYTLRELE +TNG  ++                 D +KVAVKNLLNNRGQ
Sbjct:   131 PEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQ 190

Query:   118 AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
             AE+EFKVEVE IGRVRHKNLVRLLGYC EGA+RMLVY++V+NGNLEQW+HGDVG  SPLT
Sbjct:   191 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLT 250

Query:   178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
             W+IRMNIILG AKGL+YLHEGLEPKVVHRDIKSSNIL+D+ WN KVSDFGLAKLLGSESS
Sbjct:   251 WDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESS 310

Query:   238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW 297
             Y+TTRVMGTFGYVAPEYA TGMLNE+SD+YSFGILIME+I+GR PVDYSRP  E NL++W
Sbjct:   311 YVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDW 370

Query:   298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES 357
             LK MV NR  E V+DPK+PE P+S+ LKR+LLVALRCVDP+A KRPKMGH++HMLEA++ 
Sbjct:   371 LKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDL 430

Query:   358 PSKEDRY--RASPKNELIEKQVTESGDNSTNETG 389
               +++R   R     E  E  V  +G  S  E+G
Sbjct:   431 LYRDERRTTRDHGSRERQETAVVAAGSES-GESG 463

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1132 (403.5 bits), Expect = 8.2e-115, P = 8.2e-115
 Identities = 207/302 (68%), Positives = 247/302 (81%)

Query:    63 LGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREF 122
             +GWG WY+L++LE++T GFSDD                 D S  AVKNLLNN+GQAE+EF
Sbjct:   127 MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEF 186

Query:   123 KVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
             KVEVEAIG+VRHKNLV L+GYCA+ A   RMLVYEY++NGNLEQWLHGDVGP SPLTW+I
Sbjct:   187 KVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDI 246

Query:   181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
             RM I +GTAKGL+YLHEGLEPKVVHRD+KSSNIL+DK WN KVSDFGLAKLLGSE+SY+T
Sbjct:   247 RMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVT 306

Query:   241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
             TRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+GR PVDYSRPP E+NL++W K 
Sbjct:   307 TRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKG 366

Query:   301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK 360
             MV +R  E V+DPK+   P  R LKR LLV LRC+D ++ KRPKMG ++HMLEA++ P +
Sbjct:   367 MVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFR 426

Query:   361 ED 362
              +
Sbjct:   427 PE 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1085 (387.0 bits), Expect = 7.8e-110, P = 7.8e-110
 Identities = 207/341 (60%), Positives = 255/341 (74%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE+SHLGWGHW+TLR+L+++TN F+ +                 + + VAVK LLNN G
Sbjct:   166 LPEISHLGWGHWFTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLG 225

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QAE+EF+VEVEAIG VRHKNLVRLLGYC EG +RMLVYEYVN+GNLEQWLHG +G  S L
Sbjct:   226 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTL 285

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE RM I++GTA+ L+YLHE +EPKVVHRDIK+SNILID  +N K+SDFGLAKLL S  
Sbjct:   286 TWEARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGE 345

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S+ITTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR PVDY RP  EVNL+E
Sbjct:   346 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVE 405

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+D ++   P +R LKR LLVALRCVDP AQKRPKM  VV MLE+ E
Sbjct:   406 WLKMMVGTRRAEEVVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDE 465

Query:   357 SPSKEDRYRASPKNELIE-KQVTESGDNSTNETGVHTNETR 396
              P +E+R     +   +E  + TE   +++   G   N T+
Sbjct:   466 HPFREERRNRKSRTASMEIVETTEESADTSKGPGHSENTTK 506

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 205/336 (61%), Positives = 249/336 (74%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE+SHLGWGHW+TLR+LE++TN F+                   + ++VAVK LLNN G
Sbjct:   159 LPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLG 218

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QAE+EF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEYVN+GNLEQWLHG +     L
Sbjct:   219 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNL 278

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE RM II GTA+ L+YLHE +EPKVVHRDIK+SNILID  +N K+SDFGLAKLL S  
Sbjct:   279 TWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGE 338

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S+ITTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR PVDY RP  EVNL+E
Sbjct:   339 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVE 398

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+DP+L  +P+   LKR LLV+LRCVDP A+KRP+M  V  MLE+ E
Sbjct:   399 WLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDE 458

Query:   357 SPSKEDRYRASPKNELIEKQVTESGDNSTNETGVHT 392
              P  ++R     K   +E  + E+ D S   +G  T
Sbjct:   459 HPFHKERRNKRSKTAGME--IVETKDESLGPSGSET 492

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
 Identities = 202/336 (60%), Positives = 250/336 (74%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE SHLGWGHW+TLR+L+++TN FS D                 + + VAVK LLNN G
Sbjct:   142 LPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLG 201

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QA+++F+VEVEAIG VRHKNLVRLLGYC EG  RMLVYEYVNNGNLEQWL GD      L
Sbjct:   202 QADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYL 261

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE R+ I++GTAK L+YLHE +EPKVVHRDIKSSNILID  +N K+SDFGLAKLLG++ 
Sbjct:   262 TWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADK 321

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S+ITTRVMGTFGYVAPEYA++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV+L+E
Sbjct:   322 SFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVE 381

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+DP L  KP++  LKR LL ALRCVDP ++KRP+M  V  MLE++E
Sbjct:   382 WLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEE 441

Query:   357 SP-SKEDRYRASPKNELIEKQVTESGDNSTNETGVH 391
              P ++EDR R   +N              T+++  H
Sbjct:   442 YPIAREDRRRRRSQNGTTRDSDPPRNSTDTDKSEYH 477

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
 Identities = 197/330 (59%), Positives = 256/330 (77%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PEVSH+GWGHW+TLR+L+++TN FS +                 + + VAVK LLNN G
Sbjct:   130 LPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPG 189

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QA+++F+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+NNGNLEQWLHGD+     L
Sbjct:   190 QADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHL 249

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE R+ +++GTAK L+YLHE +EPKVVHRDIKSSNIL+D +++ K+SDFGLAKLLG++S
Sbjct:   250 TWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADS 309

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             +Y++TRVMGTFGYVAPEYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EEV+++E
Sbjct:   310 NYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVE 369

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  +  E V+D +L  KPT+  LKR LL ALRCVDP+A KRPKM  V  MLE+ E
Sbjct:   370 WLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDE 429

Query:   357 SP--SKEDRYRASPKNELIEKQVTESG-DN 383
              P   +E+R R   +N    ++ T++  DN
Sbjct:   430 YPVMPREERRRRRNQNAETHRESTDTNKDN 459

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=RCA

GO:0043161 "proteasomal ubiquitin-dependent protein catabolic process" evidence=RCA

GO:0043248 "proteasome assembly" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0051788 "response to misfolded protein" evidence=RCA

TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)]

 Score = 1050 (374.7 bits), Expect = 4.0e-106, P = 4.0e-106
 Identities = 201/330 (60%), Positives = 248/330 (75%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE SHLGWGHW+TLR+LE +TN FS +                 + + VAVK +LN  G
Sbjct:   156 LPE-SHLGWGHWFTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLG 214

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QAE+EF+VEV+AIG VRHKNLVRLLGYC EG HR+LVYEYVNNGNLEQWLHG +     L
Sbjct:   215 QAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYL 274

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE RM +++GT+K L+YLHE +EPKVVHRDIKSSNILI+  +N KVSDFGLAKLLG+  
Sbjct:   275 TWEARMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGK 334

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S++TTRVMGTFGYVAPEYA++G+LNE+SDVYSFG++++E I+GR PVDY RP  EVNL++
Sbjct:   335 SHVTTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVD 394

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+DP +  KP +R LKR LL ALRCVDP++ KRPKM  VV MLE++E
Sbjct:   395 WLKMMVGTRRSEEVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 454

Query:   357 SP-SKEDRYRASPKNELIEKQVTESGDNST 385
              P  +EDR R+  +   +E  +    D ST
Sbjct:   455 YPIPREDRRRSRTREGSME--INSDTDMST 482

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
 Identities = 200/357 (56%), Positives = 256/357 (71%)

Query:    13 LLLPLEEESPTGYNKIHVHIGKDNRICYPXXXXXXXX-----XDQVAAVVPEVSHLGWGH 67
             L L +E+    G +      GK+  +C                    + +PE SHLGWGH
Sbjct:    85 LNLEMEKNRENGLSSSRSGSGKEGYLCVANRSTSSLYEMATPSPSPLSGLPE-SHLGWGH 143

Query:    68 WYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVE 127
             W+TLR+LE++TN FS +                 + S VAVK +LN+ GQAE+EF+VEV+
Sbjct:   144 WFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVD 203

Query:   128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
             AIG VRHKNLVRLLGYC EG +R+LVYEY+NNGNLE+WLHG +     LTWE RM ++ G
Sbjct:   204 AIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTG 263

Query:   188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
             T+K L+YLHE +EPKVVHRDIKSSNILID  +N K+SDFGLAKLLG   S++TTRVMGTF
Sbjct:   264 TSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTF 323

Query:   248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
             GYVAPEYA+TG+LNE+SDVYSFG+L++E I+GR PVDY+RP  EVNL+EWLK MV ++  
Sbjct:   324 GYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRL 383

Query:   308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP-SKEDR 363
             E V+DP +  +P +R LKR+LL ALRC+DP+++KRPKM  VV MLE++E P  +E+R
Sbjct:   384 EEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLESEEYPVPREER 440

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 650 (233.9 bits), Expect = 9.7e-64, P = 9.7e-64
 Identities = 132/295 (44%), Positives = 187/295 (63%)

Query:    69 YTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVEA 128
             +T  EL  +TNGFS+                     +VAVK L    GQ EREF+ EVE 
Sbjct:   263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322

Query:   129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
             I RV H++LV L+GYC  GA R+LVYE+V N NLE  LHG+  P   + W  R+ I LG+
Sbjct:   323 ISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPT--MEWSTRLKIALGS 380

Query:   189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
             AKGLSYLHE   PK++HRDIK+SNILID  +  KV+DFGLAK+    +++++TRVMGTFG
Sbjct:   381 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 440

Query:   249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP- 307
             Y+APEYA++G L E+SDV+SFG++++E+I+GR PVD +    + +L++W + ++   +  
Sbjct:   441 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEQ 500

Query:   308 ---EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
                EG+ D K+        + R++  A  CV  +A++RP+M  +V  LE   S S
Sbjct:   501 GDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLS 555

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00019508001 SubName- Full=Chromosome chr7 scaffold_20, whole genome shotgun sequence; (509 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	407
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-44
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-30
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-04

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  173 bits (442), Expect = 7e-52
 Identities = 82/279 (29%), Positives = 127/279 (45%), Gaps = 35/279 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNL 137
            K +GEG +G VY G L+         VAVK L  +   Q   EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           V+LLG C E     +V EY+  G+L  +L  +        L+    ++  L  A+G+ YL
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGMEYL 118

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
                   +HRD+ + N L+ ++   K+SDFGL++ L  +  Y          ++APE  
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDP 313
             G    +SDV+SFG+L+ E+ + G  P  Y     EEV  +E+LK     R P      
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV--LEYLKNG--YRLP------ 223

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             P      L      + L+C   + + RP    +V +L
Sbjct: 224 -QPPNCPPELYD----LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  172 bits (438), Expect = 3e-51
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNL 137
            K +GEG +G VY G L+         VAVK L  +   Q   EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           V+LLG C E    M+V EY+  G+L  +L  +        L+    ++  L  A+G+ YL
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEYL 119

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
                   +HRD+ + N L+ ++   K+SDFGL++ L  +  Y          ++APE  
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDP 313
             G    +SDV+SFG+L+ E+ + G  P  Y      EV  +E+LKK    R P      
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV--LEYLKKG--YRLP------ 224

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             P      L K    + L+C   + + RP    +V +L
Sbjct: 225 -KPPNCPPELYK----LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (426), Expect = 5e-50
 Identities = 68/193 (35%), Positives = 107/193 (55%), Gaps = 11/193 (5%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           +GEGG+G VY     +   KVA+K +   +      E   E+E + ++ H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +  H  LV EY   G+L+  L  + G    L+ +  + I+L   +GL YLH      ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 205 HRDIKSSNILIDK-HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNE 262
           HRD+K  NIL+D  +   K++DFGL+KLL S+ S + T V GT  Y+APE        +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173

Query: 263 RSDVYSFGILIME 275
           +SD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  162 bits (412), Expect = 2e-47
 Identities = 86/288 (29%), Positives = 130/288 (45%), Gaps = 45/288 (15%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK----VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVR 139
           K +GEG +G VY G L+        VAVK L  +   +  ++F  E   + ++ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           LLG C E     LV EY+  G+L  +L            S L+ +  ++  +  AKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-------RVMGTF 247
           L      K VHRD+ + N L+ +    K+SDFGL++ +  +  Y          R M   
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYS-RPPEEVNLIEWLKKMVTNR 305
              APE    G+   +SDV+SFG+L+ E+ + G  P  Y     EEV  +E+L+K     
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--LEYLRKGYRLP 227

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            PE   D              +  + L C   + + RP    +V  LE
Sbjct: 228 KPEYCPD-------------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 1e-46
 Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 32/279 (11%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL 137
           +   + +G G +G VY          VAVK     + + + ++  + E+  + R+ H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VRL+    +  H  LV EY   G+L  +L        PL+ +    I L   +GL YLH 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHS 116

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE---- 253
                ++HRD+K  NIL+D++   K++DFGLAK L   SS +TT V GT  Y+APE    
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172

Query: 254 --YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
                      + DV+S G+++ E+++G+ P         ++ ++ +++++         
Sbjct: 173 GNGYGP-----KVDVWSLGVILYELLTGKPPF---SGENILDQLQLIRRILGPPLEFDEP 224

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
                 +    L+K+ L       DP+  KRP    ++ 
Sbjct: 225 KWSSGSEEAKDLIKKCL-----NKDPS--KRPTAEEILQ 256

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  159 bits (406), Expect = 1e-46
 Identities = 89/279 (31%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 84  DKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            K +GEG +G VY G L        +KVAVK L     + ER EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VRLLG C +G    +V EY+  G+L  +L         LT +  + + L  AKG+ YL  
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES 120

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
                 VHRD+ + N L+ ++   K+SDFGL++ +  +  Y   R  G     ++APE  
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESL 176

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDP 313
             G    +SDV+SFG+L+ E+ + G  P  Y     EEV  +E L+     R P      
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV--LELLEDG--YRLPR----- 225

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             PE      L  ++   L+C   + + RP    +V  L
Sbjct: 226 --PENCPDE-LYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (392), Expect = 2e-44
 Identities = 74/266 (27%), Positives = 125/266 (46%), Gaps = 26/266 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           +   + +GEG +G VY     +    VA+K +   + + +RE    E++ + +++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGLSYLHE 197
           RL     +     LV EY   G+L   L         L+  E R   +      L YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                +VHRD+K  NIL+D+  + K++DFGLA+ L       TT V GT  Y+APE    
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLG 170

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
               +  D++S G+++ E+++G+ P      P +  L+E  KK+   + P    +  +  
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRP 343
           +    L++++L       DP   KR 
Sbjct: 226 EAKD-LIRKLL-----VKDPE--KRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  132 bits (333), Expect = 5e-35
 Identities = 81/306 (26%), Positives = 134/306 (43%), Gaps = 24/306 (7%)

Query: 80  GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRH-K 135
            +   + +GEG +G VY  L  D   VA+K L   L ++ +    F  E++ +  + H  
Sbjct: 1   SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V+L  +  +     LV EYV+ G+LE  L   +G   PL+    + I+      L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117

Query: 196 HEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESS-----YITTRVMGTFGY 249
           H      ++HRDIK  NIL+D+     K+ DFGLAKLL    S      + +  +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 250 VAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           +APE     S    +  SD++S GI + E+++G  P +  +     +      K++    
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP 231

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV-HMLEAQESPSKEDRYR 365
              +  P  P  P         L+  + +  + + R      + H L A     + D   
Sbjct: 232 TPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 366 ASPKNE 371
               ++
Sbjct: 291 LLKPDD 296

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  129 bits (326), Expect = 6e-35
 Identities = 86/274 (31%), Positives = 126/274 (45%), Gaps = 40/274 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           IG+G +G V  G      KVAVK L ++   A+  F  E   +  +RH NLV+LLG   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 147 GAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
           G    +V EY+  G+L  +L   G     + +T   ++   L   +G+ YL    E   V
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNE 262
           HRD+ + N+L+ +    KVSDFGLAK    E+S    +  G     + APE       + 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----EASQ--GQDSGKLPVKWTAPEALREKKFST 178

Query: 263 RSDVYSFGILIMEVIS-GRIPVDYSRPP--EEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
           +SDV+SFGIL+ E+ S GR+P  Y R P  + V  +E   +M     PEG          
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHVEKGYRM---EAPEGCPPE------ 227

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                  +  V   C + +  KRP    +   L 
Sbjct: 228 -------VYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (325), Expect = 9e-35
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 27/265 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           +++G G +G VY  L +D  + +AVK   L  +  +     + E+  +  ++H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 142 GYCAEGAHRML-VY-EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           G   +     L ++ EYV+ G+L   L    G             IL   +GL+YLH   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQIL---EGLAYLHSN- 120

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTG 258
              +VHRDIK +NIL+D     K++DFG AK LG   +   T  + GT  ++APE     
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
                +D++S G  ++E+ +G+ P       E  N +  L K+ ++  P     P++PE 
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPW-----SELGNPMAALYKIGSSGEP-----PEIPEH 228

Query: 319 PTSRLLKRILLVALRCVDPNAQKRP 343
             S   K  L    +C+  + +KRP
Sbjct: 229 -LSEEAKDFL---RKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  126 bits (319), Expect = 6e-34
 Identities = 68/200 (34%), Positives = 120/200 (60%), Gaps = 13/200 (6%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           +G G +G V+ GL ++  +VA+K L ++    +++F+ EV+A+ R+RHK+L+ L   C+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 147 GAHRMLVYEYVNNGNLEQWL---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           G    ++ E +  G+L  +L    G V P + L     +++    A+G++YL    E   
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE---EQNS 125

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRD+ + NIL+ +    KV+DFGLA+L+  E  Y+++     + + APE AS G  + +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Query: 264 SDVYSFGILIMEVIS-GRIP 282
           SDV+SFGIL+ E+ + G++P
Sbjct: 185 SDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 2e-31
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 27/283 (9%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+       ++ +G G +G V+ G     +KVAVK L       E  F  E + + ++RH
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV+L   C+E     +V EY++ G+L  +L    G    L   + M   +  A+G++Y
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMAY 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           L        +HRD+ + NIL+ ++   K++DFGLA+L+  E    T R    F   + AP
Sbjct: 119 LES---RNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAP 173

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           E A+ G    +SDV+SFGIL+ E+++ GR+P       E +  +E   +M          
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------- 223

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            P+ P  P    L  ++   L+C D + ++RP   ++   LE 
Sbjct: 224 -PRPPNCPEE--LYDLM---LQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (299), Expect = 5e-31
 Identities = 70/264 (26%), Positives = 122/264 (46%), Gaps = 23/264 (8%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F   + IG+GG+G VY         +VA+K +     + + +   E++ + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
             G   +     +V E+ + G+L+  L         LT      +     KGL YLH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN- 117

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              ++HRDIK++NIL+      K+ DFGL+  L    +     ++GT  ++APE  +   
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKP 173

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            + ++D++S GI  +E+  G+ P     P +       L K+ TN  P G+ +P+     
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIATN-GPPGLRNPEKWSDE 226

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
               LK       +C+  N +KRP
Sbjct: 227 FKDFLK-------KCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  117 bits (294), Expect = 2e-30
 Identities = 76/264 (28%), Positives = 137/264 (51%), Gaps = 33/264 (12%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGY 143
           IG+G +G+V+  + + + +V A+K + L+   + ERE  + E   + ++    ++R    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT----WEIRMNIILGTAKGLSYLHEGL 199
             +     +V EY  NG+L + L    G   PL     W   + I+LG    L++LH   
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLG----LAHLHSK- 120

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             K++HRDIKS N+ +D + N K+ D G+AKLL   +++  T ++GT  Y++PE      
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            NE+SDV++ G+++ E  +G+ P D +    +  LI  LK +       GV  P + +  
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI--LKII------RGVFPP-VSQMY 225

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
           + +L + I     +C+  + ++RP
Sbjct: 226 SQQLAQLI----DQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (294), Expect = 3e-30
 Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 39/270 (14%)

Query: 85  KVIGEGGYGIVYYGL---LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVR 139
           K IG+G +G VY  L     D     +K + L+N  + ERE  + EV+ + ++ H N+++
Sbjct: 6   KQIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
                 E     +V EY + G+L Q +        P   E  ++  +     L YLH   
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------ 253
             K++HRDIK  NI +  +   K+ DFG++K+L S      T V GT  Y++PE      
Sbjct: 122 -RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKP 179

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
           Y      N +SD++S G ++ E+ + +       P E  NL+E L   +          P
Sbjct: 180 Y------NYKSDIWSLGCVLYELCTLK------HPFEGENLLE-LALKILKGQY-----P 221

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +P +  S  L+ ++      +  + ++RP
Sbjct: 222 PIPSQY-SSELRNLV---SSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 3e-30
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 27/261 (10%)

Query: 86  VIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +IG G +G+VY GL LE    VA+K  +L   + +A +    E++ +  ++H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                    ++ EY  NG+L Q +    GP       + +  +L   +GL+YLHE     
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVL---QGLAYLHE---QG 119

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           V+HRDIK++NIL  K    K++DFG+A  L   S    + V+GT  ++APE       + 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGAST 178

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR 322
            SD++S G  ++E+++G  P  Y   P        L ++V +        P LPE   S 
Sbjct: 179 ASDIWSLGCTVIELLTGNPPY-YDLNPMAA-----LFRIVQDD------HPPLPEG-ISP 225

Query: 323 LLKRILLVALRCVDPNAQKRP 343
            LK  L   ++C   +   RP
Sbjct: 226 ELKDFL---MQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  116 bits (293), Expect = 4e-30
 Identities = 81/286 (28%), Positives = 143/286 (50%), Gaps = 28/286 (9%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQAER-EFKVEVEAI 129
           E+  +  +  KVIG G +G V+ G+L+        VA+K L     + +R +F  E   +
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           G+  H N++RL G   +    M++ EY+ NG L+++L    G  S       + ++ G A
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIA 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTF 247
            G+ YL    +   VHRD+ + NIL++ +   KVSDFGL+++L    E +Y T+      
Sbjct: 118 AGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            + APE  +       SDV+SFGI++ EV+S        RP  +++  E +K +      
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG-----ERPYWDMSNHEVMKAI-----N 224

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +G   P   + P++     +  + L+C   +  +RP+   +V++L+
Sbjct: 225 DGFRLPAPMDCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-29
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 22/206 (10%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLV 138
           +KVIG G +G V  G L+   K    VA+K L      +   +F  E   +G+  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL G   +    M++ EY+ NG+L+++L  + G     T    + ++ G A G+ YL E 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSE- 124

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG------YVAP 252
                VHRD+ + NIL++ +   KVSDFGL++ L    +  TT+     G      + AP
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAP 177

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS 278
           E  +       SDV+SFGI++ EV+S
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (275), Expect = 1e-27
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 36/277 (12%)

Query: 85  KVIGEGGYGIVYYGLL-EDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           KV+G+G  G+VY           A+K + ++   +  ++   E++ +       +V+  G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 143 -YCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-----CSPLTWEIRMNIILGTAKGLSYLH 196
            +  EG    +V EY++ G+L   L   VG       + +  +I         KGL YLH
Sbjct: 67  AFYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQI--------LKGLDYLH 116

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 ++HRDIK SN+LI+     K++DFG++K+L +      T V GT  Y++PE   
Sbjct: 117 TKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
               +  +D++S G+ ++E   G+ P  +  PP + +  E L + + +  P     P LP
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP--FL-PPGQPSFFE-LMQAICDGPP-----PSLP 224

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +  S   +  +     C+  + +KRP       +L+
Sbjct: 225 AEEFSPEFRDFI---SACLQKDPKKRP---SAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  109 bits (276), Expect = 2e-27
 Identities = 82/272 (30%), Positives = 122/272 (44%), Gaps = 39/272 (14%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + + + IGEG  G VY         +VA+K +   R Q +     E+  +   +H N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW-EIRMN------IILGTAKGL 192
                  G    +V EY++ G+L      D+     +T   +RMN      +     +GL
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLT-----DI-----ITQNFVRMNEPQIAYVCREVLQGL 129

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      V+HRDIKS NIL+ K  + K++DFG A  L  E S   + V GT  ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVL 311
           E         + D++S GI+ +E+  G  P  Y R PP        L  + T     G+ 
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP--YLREPPLRA-----LFLITTK----GIP 234

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
             K PEK  S   K  L    +C+  + +KRP
Sbjct: 235 PLKNPEK-WSPEFKDFL---NKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 8e-27
 Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 37/271 (13%)

Query: 85  KVIGEGGYGIVYYGL---LEDNSK--VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           KV+G G +G VY G+     +  K  VA+K L      +A +E   E   +  V H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C       L+ + +  G L  ++     ++G    L W +++      AKG+SYL
Sbjct: 73  RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEY 254
            E    ++VHRD+ + N+L+    + K++DFGLAKLL   E  Y          ++A E 
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
               +   +SDV+S+G+ + E+++ G  P +     E  +L+E           E     
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---------KGE----- 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
           +LP+ P   +   + +V ++C   +A+ RP 
Sbjct: 229 RLPQPPICTI--DVYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  106 bits (267), Expect = 1e-26
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 9/207 (4%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           IG G +G+V+ G   +  KVA+K +      +E +F  E + + ++ H  LV+L G C E
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR 206
            +   LV+E++ +G L  +L    G     + E  + + L   +G++YL       V+HR
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHR 124

Query: 207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDV 266
           D+ + N L+ ++   KVSDFG+ + +  +    +T       + +PE  S    + +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 267 YSFGILIMEVIS-GRIPVDYSRPPEEV 292
           +SFG+L+ EV S G+ P + +R   EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  105 bits (264), Expect = 6e-26
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 47/285 (16%)

Query: 85  KVIGEGGYGIVY---YGLLEDNS--KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           K +GEG +G V    Y  L DN+  +VAVK+L ++   Q   +F+ E+E +  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 139 RLLGYCAEGAHR---MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT------- 188
           +  G   E        L+ EY+ +G+L  +L              R  I L         
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRH-----------RDQINLKRLLLFSSQ 117

Query: 189 -AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG-- 245
             KG+ YL      + +HRD+ + NIL++     K+SDFGLAK+L  +  Y   +  G  
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 246 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT- 303
             F Y APE   T   +  SDV+SFG+ + E+ +       S P E + +I   +  +  
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIV 232

Query: 304 ----NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
                   EG   P+ P  P       +  +   C +   Q RP 
Sbjct: 233 TRLLELLKEGERLPRPPSCPDE-----VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  105 bits (263), Expect = 8e-26
 Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 36/296 (12%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL----EDNSK--VAVKNLLNN-RGQAEREFKVEVE 127
           EV  +  +  + +G G +G VY GL      D  +  VAVK L  +   Q E +F +E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD---VGPCSPLTWEIRMNI 184
            + +  H+N+VRL+G   E   R ++ E +  G+L+ +L  +       S LT +  +  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAK-LLGSESSYI 239
               AKG  YL E      +HRDI + N L+     P    K++DFG+A+ +  +     
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL 298
             R M    ++ PE    G+   ++DV+SFG+L+ E+ S G +P    R  +EV      
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVME---- 232

Query: 299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
              VT     G LDP     P       +  +   C     + RP    ++  ++ 
Sbjct: 233 --FVTG---GGRLDPP-KGCPG-----PVYRIMTDCWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 11/201 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + +G G +G V+ GL  + + VAVK L       + +F  E + + ++RH  L++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  +V E +  G+L ++L G  G    L   I M   +  A G++YL        +
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLEA---QNYI 125

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNE 262
           HRD+ + N+L+ ++   KV+DFGLA+++  E  Y   R    F   + APE A     + 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIK-EDIY-EAREGAKFPIKWTAPEAALYNRFSI 183

Query: 263 RSDVYSFGILIMEVIS-GRIP 282
           +SDV+SFGIL+ E+++ GR+P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  103 bits (259), Expect = 3e-25
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 31/282 (10%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNL 137
             +G G +G V+             + V VK L   + +  + EF+ E++   ++ HKN+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIRMNIILGTAKGL 192
           VRLLG C E     ++ EY + G+L+Q+L       +     PL+ + ++ +    A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            +L      + VHRD+ + N L+      KVS   L+K + +   Y     +    ++AP
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           E       + +SDV+SFG+L+ EV + G +P  Y    EE          V NR   G L
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-YGLSDEE----------VLNRLQAGKL 236

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +  +PE   SRL K    +  RC   N + RP    +V  L 
Sbjct: 237 ELPVPEGCPSRLYK----LMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (257), Expect = 5e-25
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 87  IGEGGYGIVYYGLL------EDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +GEG +G VY G L         + VA+K L  N   + ++EF+ E E +  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPC-------SPLTWEIRMNIILG 187
           LLG C +     +++EY+ +G+L ++L     H DVG         S L     ++I + 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT- 246
            A G+ YL        VHRD+ + N L+ +    K+SDFGL++ + S   Y   RV    
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKS 186

Query: 247 ---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
                ++ PE    G     SD++SFG+++ E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (253), Expect = 1e-24
 Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 22/266 (8%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVR 133
           EV        K +G G +G V+ G    ++KVA+K+L   +G    E F  E   + +++
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQ 59

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H  LVRL     +     ++ EY+ NG+L  +L    G    +   I M   +  A+G++
Sbjct: 60  HPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI--AEGMA 116

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVA 251
           ++        +HRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + A
Sbjct: 117 FIER---KNYIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTA 171

Query: 252 PEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN-PEG 309
           PE  + G    +SDV+SFGIL+ E+++ GRIP      PE +  +E   +M    N PE 
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231

Query: 310 VLD-------PKLPEKPTSRLLKRIL 328
           + +        K  E+PT   L+ +L
Sbjct: 232 LYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (252), Expect = 2e-24
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 33/280 (11%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR 131
           E E   +   +  V+G+G YGIVY    L    ++A+K +     +  +    E+     
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI----ILG 187
           ++H+N+V+ LG  +E     +  E V  G+L   L    GP      E  +      IL 
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIIFYTKQIL- 118

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGT 246
             +GL YLH+    ++VHRDIK  N+L++ +    K+SDFG +K L   +   T    GT
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGT 172

Query: 247 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIP-VDYSRPPEEVNLIEWLKKMVT 303
             Y+APE    G       +D++S G  I+E+ +G+ P ++   P   +  +   K    
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--- 229

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                    P++PE  ++     I    LRC +P+  KR 
Sbjct: 230 --------HPEIPESLSAEAKNFI----LRCFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (262), Expect = 3e-24
 Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 25/282 (8%)

Query: 83  DDKVIGEGGYGIVYYGLLEDNS-KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           ++ VI  G  G  Y G    N  +  VK + +       E       +G+++H N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA----DMGKLQHPNIVKLI 749

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
           G C       L++EY+   NL + L         L+WE R  I +G AK L +LH    P
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            VV  ++    I+ID    P +    L  LL +++    +       YVAPE   T  + 
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDIT 856

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVN--LIEWLKKMVTNRNPEGVLDPKLPEKP 319
           E+SD+Y FG++++E+++G+ P D       V+  ++EW +   ++ + +  +DP +    
Sbjct: 857 EKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913

Query: 320 TS--RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
           +     +  ++ +AL C   +   RP    V+  LE+    S
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.3 bits (248), Expect = 8e-24
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           IG G +G VY  + L+    +AVK   + +N  +  +E   E++ +  ++H NLV+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66

Query: 144 CAEGAHRMLVY---EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             E  HR  VY   EY + G LE+ L    G            + L   +GL+YLH    
Sbjct: 67  -VE-VHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH-- 118

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV---MGTFGYVAPEYAST 257
             +VHRDIK +NI +D +   K+ DFG A  L + ++ +   V    GT  Y+APE  + 
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 258 GMLNER---SDVYSFGILIMEVISGRIP 282
           G        +D++S G +++E+ +G+ P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 49/235 (20%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKV-----EVEAIGRV-R 133
           F   K+IGEG +  V      E N + A+K L  ++ Q  +E KV     E E + R+  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 134 HKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCS-PLTWEIRMNIILGTAKG 191
           H  +++L  Y  +    +  V EY  NG L Q++    G      T      I+L     
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLA---- 114

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM------- 244
           L YLH      ++HRD+K  NIL+DK  + K++DFG AK+L   SS  + +         
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 245 ------------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRIP 282
                       GT  YV+PE     +LNE      SD+++ G +I ++++G+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 38/285 (13%)

Query: 87  IGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVR 139
           +G+G +G+VY GL       E  ++VA+K +  N    ER EF  E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHG------DVGPCSPLTWEIRMNIILGTAKGLS 193
           LLG  + G   ++V E +  G+L+ +L        +     P T +  + +    A G++
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTFGYVA 251
           YL      K VHRD+ + N ++ +    K+ DFG+ + +  E+ Y     + +    ++A
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189

Query: 252 PEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEG 309
           PE    G+   +SDV+SFG+++ E+ +    P  Y     EEV       K V +    G
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQP--YQGLSNEEV------LKFVIDG---G 238

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            LD  LPE    +LL+    +   C   N + RP    +V  L+ 
Sbjct: 239 HLD--LPENCPDKLLE----LMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.8 bits (246), Expect = 1e-23
 Identities = 82/280 (29%), Positives = 133/280 (47%), Gaps = 32/280 (11%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           ++VIG G +G V  G L+   K    VA+K L +   + +R +F  E   +G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            L G   +    M++ E++ NG L+ +L  + G  + +     + ++ G A G+ YL E 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSE- 124

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-TRVMG---TFGYVAPEY 254
                VHRD+ + NIL++ +   KVSDFGL++ L  ++S  T T  +G      + APE 
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
            +       SDV+S+GI++ EV+S G  P       + +N IE               D 
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ--------------DY 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +LP           L+  L C   +   RPK G +V  L+
Sbjct: 229 RLPPPMDCPTALHQLM--LDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 20/220 (9%)

Query: 87  IGEGGYGIVYYGLLEDNS----KVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLL 141
           +G G +G V  G+    S    +VAVK L      A ++EF  E   + ++ H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           G C +G   MLV E    G L ++L    ++ P S L       +    A G++YL    
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREI-PVSDLK-----ELAHQVAMGMAYLES-- 113

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYAST 257
               VHRD+ + N+L+      K+SDFG+++ LG+ S Y      G +   + APE  + 
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
           G  + +SDV+S+G+ + E  S G  P    +  E + ++E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 71/244 (29%), Positives = 117/244 (47%), Gaps = 25/244 (10%)

Query: 85  KVIGEGGYGIVYYG----LLEDNSK--VAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNL 137
           + +GEG +G V+ G    L  +N K  VAVK L       A ++F+ E E +   +H+N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HG--------DVGPCSPLTWEIRMNIILG 187
           V+  G C EG   ++V+EY+ +G+L ++L  HG           P   LT    + I + 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGT 246
            A G+ YL        VHRD+ + N L+      K+ DFG+++ + +   Y +    M  
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
             ++ PE          SDV+SFG+++ E+ + G+ P  Y    EEV  IE + +    +
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEV--IECITQGRLLQ 244

Query: 306 NPEG 309
            P  
Sbjct: 245 RPRT 248

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 97.7 bits (243), Expect = 3e-23
 Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 30/278 (10%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +KVIG G +G V  G L+   K    VA+K L      +  R+F  E   +G+  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            L G   +    M+V EY+ NG+L+ +L    G  + +     + ++ G A G+ YL + 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSD- 124

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYAS 256
                VHRD+ + NIL++ +   KVSDFGL+++L    E++Y T        + APE  +
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKL 315
                  SDV+S+GI++ EV+S      Y  RP  E++  + +K +      EG   P  
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAI-----EEGYRLPAP 231

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            + P +  L +++   L C   +  +RPK   +V +L+
Sbjct: 232 MDCPAA--LHQLM---LDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.2 bits (239), Expect = 8e-23
 Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 22/203 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           ++IGEG +G V  G      KVAVKN+  +   QA   F  E   + ++ HKNLVRLLG 
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67

Query: 144 CA-EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
               G +  +V E ++ GNL  +L         +   ++ +  L  A+G+ YL      K
Sbjct: 68  ILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KK 120

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKL--LGSESSYITTRVMGTFGYVAPEYASTGML 260
           +VHRD+ + NIL+ +    KVSDFGLA++  +G ++S +  +      + APE       
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKF 174

Query: 261 NERSDVYSFGILIMEVIS-GRIP 282
           + +SDV+S+G+L+ EV S GR P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAE---REFKVEVEAIGRVRHKNLV 138
           +++G G +G VY GL L+D    AVK  +L ++    +   ++ + E+  + +++H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           + LG   E  +  +  E V  G+L + L    G        +          GL YLH+ 
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGS---FPEPVIRLYTRQILLGLEYLHDR 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-AST 257
                VHRDIK +NIL+D +   K++DFG+AK +  E S+  +   G+  ++APE  A  
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS-FKGSPYWMAPEVIAQQ 176

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
           G     +D++S G  ++E+ +G+ P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)

Query: 87  IGEGGYGIVYYG----LLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V+      LL +  K  VAVK L      A ++F+ E E +  ++H+++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLH-----------GDVGPCSPLTWEIRMNIILGTA 189
            G C EG   ++V+EY+ +G+L ++L            G+      LT    + I    A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFG 248
            G+ YL   L    VHRD+ + N L+ +    K+ DFG+++ + S   Y +  R M    
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           ++ PE          SD++SFG+++ E+ + G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 41/238 (17%)

Query: 87  IGEGGYGIVYY----GLL--EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVR 139
           IG+G +G V+     GLL  E  + VAVK L        + +F+ E   +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDV------GPCSPLTWEIR 181
           LLG CA G    L++EY+  G+L ++L            H             PL+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-------GS 234
           + I    A G++YL E    K VHRD+ + N L+ ++   K++DFGL++ +        S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           E+  I  R M       PE          SDV+++G+++ E+ S  +   Y    EEV
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           IGEG YG+VY          VA+K +     + G  +   + E++ +  + H N+++LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                    LV+E+++  +L + +         L   +  + +    +GL++ H      
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---G 118

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLN 261
           ++HRD+K  N+LI+     K++DFGLA+  GS     T  V+ T  Y APE        +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 262 ERSDVYSFGILIMEVISGRI 281
              D++S G +  E++S R 
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 25/271 (9%)

Query: 85  KVIGEGGYGI-VYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           +V+G+G +G    Y   ED+S V  K  NL     +  R+   E+  +  ++H N++   
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
            +  +    ++  EY N G L   +    G       E+ +  +      +SY+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKA--- 120

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            ++HRDIK+ NI + K    K+ DFG++K+LGSE S   T V+GT  Y++PE       N
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
            +SD+++ G ++ E+++ +   D + P   V  I     +  N  P            +S
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-----VQGNYTPV-------VSVYSS 227

Query: 322 RLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
            L   I LV    +  + +KRP    V+   
Sbjct: 228 EL---ISLVH-SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.0 bits (233), Expect = 7e-22
 Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 28/270 (10%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           +G+G +G V+ G     ++VA+K L       E  F  E + + ++RH+ LV+L    +E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR 206
                +V EY++ G+L  +L G++G    L   + M   +  A G++Y+        VHR
Sbjct: 73  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126

Query: 207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERS 264
           D++++NIL+ ++   KV+DFGLA+L+  E +  T R    F   + APE A  G    +S
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
           DV+SFGIL+ E+ + GR+P      P  VN      + V ++   G   P  PE P S  
Sbjct: 185 DVWSFGILLTELTTKGRVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-- 231

Query: 324 LKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           L  ++    +C     ++RP   ++   LE
Sbjct: 232 LHDLM---CQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 8e-22
 Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 24/269 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
             +G G  G+V   L     K+ AVK +     +A + +   E++ + +     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                    +  EY++ G+L++ L    G    +   I   I +   KGL+YLHE    K
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLTYLHEKH--K 121

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           ++HRD+K SNIL++     K+ DFG++  L   +S   T V GT  Y+APE       + 
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSV 178

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR 322
           +SD++S G+ ++E+ +GR P      P +  + E L+ +V N  P     P+LP    S 
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEPP-----PRLPSGKFSP 231

Query: 323 LLKRILLVALRCVDPNAQKRPK----MGH 347
             +  +     C+  + ++RP     + H
Sbjct: 232 DFQDFV---NLCLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.4 bits (232), Expect = 8e-22
 Identities = 70/269 (26%), Positives = 131/269 (48%), Gaps = 27/269 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGRVRHKNLVRLL 141
           +V+G G +GIV+    + + K+ +   +      + E    + E + +  + H N++   
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
               E    M+V EY   G L +++       S L  +  ++  +     L ++H  L  
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL-- 121

Query: 202 KVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML 260
            ++HRD+K+ NIL+DKH    K+ DFG++K+L S+S   T  V+GT  Y++PE       
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPY 178

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
           N++SD+++ G ++ E+ S +   + +  P  V     LK M     P    D   P+   
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIMSGTFAPIS--DRYSPD--- 228

Query: 321 SRLLKRILLVALRCVDPNAQKRPKMGHVV 349
              L++++L  L  +DP+  KRP++  ++
Sbjct: 229 ---LRQLILSMLN-LDPS--KRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 33/275 (12%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCA 145
           IG+G +G VY G+L+ N++VAVK   +      +  F  E E + +  H N+V+L+G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VV 204
           +     +V E V  G+L  +L       + LT +  + + L  A G+ Y    LE K  +
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEY----LESKNCI 115

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGML 260
           HRD+ + N L+ ++   K+SDFG+++    E   I T   G       + APE  + G  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 261 NERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
              SDV+S+GIL+ E  S G  P       +    IE   +M           P+L  + 
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA---------PQLCPEE 223

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
             RL+       L+C   + + RP    + + L+ 
Sbjct: 224 IYRLM-------LQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 70/222 (31%), Positives = 114/222 (51%), Gaps = 14/222 (6%)

Query: 87  IGEGGYGIVYYGLLEDNSK---VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
           +G G +G V  G+ +   K   VA+K L N   ++ R E   E E + ++ +  +VR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
            C E    MLV E  + G L ++L    G    +T    + ++   + G+ YL       
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
            VHRD+ + N+L+      K+SDFGL+K LG++ SY   R  G +   + APE  +    
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 261 NERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM 301
           + RSDV+S+GI + E  S G+ P    + PE ++ IE  K++
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 24/264 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F   + +GEG YG VY  +  E    VA+K +     +  +E   E+  + +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK 62

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
             G   +     +V EY   G++   +         LT E    I+  T KGL YLH   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN- 118

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             K +HRDIK+ NIL+++    K++DFG++  L    +   T V+GT  ++APE      
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            N ++D++S GI  +E+  G+ P     P   +  I     M+ N+ P  + DP+     
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP---MRAI----FMIPNKPPPTLSDPEKWSPE 228

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
            +  +K       +C+  + ++RP
Sbjct: 229 FNDFVK-------KCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 22/212 (10%)

Query: 86  VIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAERE---------FKVEVEAIGRVRHK 135
           +IG G +G VY G+   + ++ AVK +      A  +            E+  +  ++H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V+ LG   +  H  +  EYV  G++   L+        L   +R N +    KGL+YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-----VMGTFGYV 250
           H      ++HRDIK +NIL+D     K+SDFG++K L + S    T      + G+  ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE         ++D++S G L++E+++G+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 20/210 (9%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLL---NNRGQAEREFKV---EVEAIGRVRHKNLV 138
           +V+G+G YG VY GL      +AVK +    +N   AE+E++    EV+ +  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           + LG C +     +  E+V  G++   L+   GP     +      IL    G++YLH  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL------GSESSYITTRVMGTFGYVAP 252
               VVHRDIK +N+++  +   K+ DFG A+ L      G+ S+ + + + GT  ++AP
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS-MHGTPYWMAP 177

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E  +      +SD++S G  + E+ +G+ P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 67/273 (24%), Positives = 125/273 (45%), Gaps = 34/273 (12%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAER---EFKVEVEAIGRVRHKNL 137
           + +G G +   Y    ++  + +AVK +    N   + E      + E+  + R+ H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +R+LG   E +H  L  E++  G++   L    G        + +N      +GLSYLHE
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE---AVIINYTEQLLRGLSYLHE 121

Query: 198 GLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPE 253
               +++HRD+K +N+LID      +++DFG A  L ++   +     +++GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                      DV+S G +I+E+ + + P +     +  N +  + K+ +         P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE---KHSNHLALIFKIASATTA-----P 230

Query: 314 KLPE--KPTSRLLKRILLVALRCVDPNAQKRPK 344
            +PE   P  R       V LRC++   + RP 
Sbjct: 231 SIPEHLSPGLR------DVTLRCLELQPEDRPP 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 5e-21
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 64/299 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV----EVEAIGRVRHK 135
           +   + +GEG YG+VY     +    VA+K +  +    E         E+  +  ++H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V+LL          LV+EY +  +L+++L    GP SP    I+ +I+    +GL+Y 
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL--IK-SIMYQLLRGLAYC 114

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           H     +++HRD+K  NILI++    K++DFGLA+  G      T  V+ T  Y APE  
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI- 169

Query: 256 STGMLNERS-----DVYSFGILIMEVISGR--------------------IPVDYSRPPE 290
              +L  +      D++S G +  E+I+G+                     P +    P 
Sbjct: 170 ---LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE-ESWPG 225

Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI------LLVALRCVDPNAQKRP 343
              L ++               PK P K   ++L R+      LL  +   +P   KR 
Sbjct: 226 VTKLPDYKPTF-----------PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA--KRI 271

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.0 bits (227), Expect = 5e-21
 Identities = 72/273 (26%), Positives = 108/273 (39%), Gaps = 61/273 (22%)

Query: 87  IGEGGYGIVY----------YGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
           +G+G +G V           Y +     KV  K  +  R + E     E   + R+ H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAM-----KVLKKKKIIKRKEVEH-TLTERNILSRINHPF 54

Query: 137 LVRLLGYCA--EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK---- 190
           +V+L  + A        LV EY   G L  + H                     A+    
Sbjct: 55  IVKL--HYAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAA 100

Query: 191 ----GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
                L YLH      +++RD+K  NIL+D   + K++DFGLAK L SE S   T   GT
Sbjct: 101 EIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GT 156

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV-NLIEWLKKMVTNR 305
             Y+APE        +  D +S G+L+ E+++G+ P  Y+   +E+   I  LK      
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKI--LKD----- 208

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
                   + PE  +     R L+  L   DP 
Sbjct: 209 ------PLRFPEFLSPEA--RDLISGLLQKDPT 233

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 9/206 (4%)

Query: 80  GFSDDKVIGEGGYGIVY-YGLLEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKN 136
            F   K +G+G YG VY    L DN   A+K + L +  Q ERE  V E+  +  V H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           ++       +G    +V EY   G+L + +         +  +    I +   +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E    K++HRD+KS+NIL+  +   K+ D G++K+L    +      +GT  Y+APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWK 174

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               + +SD++S G L+ E+ +   P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V+ G       VA+K ++     +E +F  E + + ++ H NLV+L G C
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA----KGLSYLHEGLE 200
            +     +V EY+ NG L  +L    G       ++    +L       + + YL     
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN-- 119

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML 260
              +HRD+ + N L+ +    KVSDFGLA+ +  +    +        +  PE       
Sbjct: 120 -GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178

Query: 261 NERSDVYSFGILIMEVIS-GRIPVD 284
           + +SDV+SFG+L+ EV S G++P +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 12/211 (5%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+        K +G G +G V+ G    N+KVAVK L       E  F  E + + ++RH
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV+L    +E     +V EY++ G+L  +L    G    L   + M   +  A G++Y
Sbjct: 61  DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV--AAGMAY 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           +        +HRD++S+NIL+      K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           E A  G    +SDV+SFGIL+ E+++ GR+P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 30/283 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+       +K +G G +G V+      ++KVAVK +       E  F  E   +  ++H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV+L     +     ++ E++  G+L  +L  D G   PL   I  +  +  A+G+++
Sbjct: 61  DKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           + +      +HRD++++NIL+      K++DFGLA+++  E +  T R    F   + AP
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 172

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMV-TNRNPEGV 310
           E  + G    +SDV+SFGIL+ME+++ GRIP      PE +  +E   +M      PE +
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +                 + +RC     ++RP   ++  +L+
Sbjct: 233 YN-----------------IMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 19/264 (7%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE--REFKVEVEAIGRVRHKNLVRLLGYC 144
           +GEG  G V    L++   +     +      +  ++   E+E     +   +V+  G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 145 AEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWE-IRMNIILGTAKGLSYLHEGLEP 201
            + +   +    EY   G+L+  ++  V        E +   I     KGLSYLH     
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---R 124

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGML 260
           K++HRDIK SNIL+ +    K+ DFG++ +L+ S +   T    GT  Y+APE       
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGKPY 180

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
           +  SDV+S G+ ++EV   R P      P  +  IE L  +V   NPE   +P    K  
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMPNPELKDEPGNGIK-W 238

Query: 321 SRLLKRILLVALRCVDPNAQKRPK 344
           S   K  +    +C++ +  +RP 
Sbjct: 239 SEEFKDFI---KQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 11/211 (5%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+        K +G G +G V+ G   +++KVAVK L       +  F  E   +  ++H
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LVRL     +     ++ EY+  G+L  +L  D G    +     ++     A+G++Y
Sbjct: 61  DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAY 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           +        +HRD++++N+L+ +    K++DFGLA+++  E +  T R    F   + AP
Sbjct: 119 IER---KNYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 173

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           E  + G    +SDV+SFGIL+ E+++ G+IP
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 81/258 (31%), Positives = 119/258 (46%), Gaps = 30/258 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG+G +G V  G    N KVAVK + N+     + F  E   + ++RH NLV+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 145 AEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
            E    + +V EY+  G+L  +L       S L  +  +   L   + + YL        
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NF 123

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           VHRD+ + N+L+ +    KVSDFGL K    E+S           + APE       + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 179

Query: 264 SDVYSFGILIMEVIS-GRIPVDYSRPP--EEVNLIEWLKKM-VTNRNPEGV--------- 310
           SDV+SFGIL+ E+ S GR+P  Y R P  + V  +E   KM   +  P  V         
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH 237

Query: 311 LDPKLPEKPTSRLLKRIL 328
           LD     +P+   L+  L
Sbjct: 238 LDAAT--RPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 39/213 (18%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IGEG YG VY     +    VA+K +   R + E+E F +    E++ + ++RH N+VRL
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 141 LGYCAEGAHR--MLVYEYVN---NGNLEQWLHGDVGPCSPLTW-EIR--MNIILGTAKGL 192
                        +V+EY++    G L+        P    T  +I+  M  +L   +GL
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLL---EGL 113

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      ++HRDIK SNILI+     K++DFGLA+     +S   T  + T  Y  P
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 253 EYASTGMLNERS-----DVYSFGILIMEVISGR 280
           E     +L         D++S G ++ E+  G+
Sbjct: 171 EL----LLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 21/204 (10%)

Query: 86  VIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLV 138
           V+GEG YG+V           VA+K    +         A RE KV    + ++RH+N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKV----LRQLRHENIV 63

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            L           LV+EYV    L + L    G   P    +R   I    + ++Y H  
Sbjct: 64  NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDA--VRS-YIWQLLQAIAYCHSH 119

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGYVAPE-YAS 256
               ++HRDIK  NIL+ +    K+ DFG A+ L    +S +T  V  T  Y APE    
Sbjct: 120 ---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVG 175

Query: 257 TGMLNERSDVYSFGILIMEVISGR 280
                +  DV++ G ++ E++ G 
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 51/286 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNL-LNNRGQAEREFKVEVEAIGRVRH-KNLVRLLG- 142
           IG G +G V   L + +  + AVK +      + ++   ++++ + R      +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 143 --------YCAE------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
                    C E            VYE V    + +              EI   I + T
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILGKIAVAT 116

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            K L+YL E L  K++HRD+K SNIL+D++ N K+ DFG++  L    S   TR  G   
Sbjct: 117 VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRP 172

Query: 249 YVAPEYASTGMLNE---RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR 305
           Y+APE       +    RSDV+S GI + EV +G+ P      P+  ++ + L ++V   
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY-----PKWNSVFDQLTQVVKGD 227

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
            P  +L      + +   +  I L    C+  +  KRPK   ++  
Sbjct: 228 PP--ILSNSEEREFSPSFVNFINL----CLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.6 bits (220), Expect = 9e-20
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 28/229 (12%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIV----YYGLLEDN--SKVAVKNLLNNRGQAEREFK--- 123
           E E+  +  +  K +GEG +G V      GL   N  S VAVK L ++    E++     
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLV 63

Query: 124 VEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------------GDV 170
            E+E +  + +HKN++ LLG C +     +V EY  +GNL  +L                
Sbjct: 64  SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK 230
            P   LT +  ++     A+G+ +L      K +HRD+ + N+L+ +    K++DFGLA+
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Query: 231 LLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +     Y  TT       ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 56/176 (31%), Positives = 89/176 (50%), Gaps = 22/176 (12%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVR 139
           IGEG +GIV+     E    VA+K +   R       QA RE K    A+   +H  +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVVK 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHE 197
           LL     G+  +LV EY+ +  L + L  +  P      +++  M ++L   KG++Y+H 
Sbjct: 64  LLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--QVKSYMRMLL---KGVAYMHA 117

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
                ++HRD+K +N+LI      K++DFGLA+L   E   + +  + T  Y APE
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 20/213 (9%)

Query: 87  IGEGGYGIVY----YGLLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V+    Y L  +  K  VAVK L +    A ++F  E E +  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWL--HG-------DVGPCSPLTWEIRMNIILGTAKG 191
            G C EG   ++V+EY+ +G+L ++L  HG       +    + LT    ++I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYV 250
           + YL        VHRD+ + N L+ ++   K+ DFG+++ + S   Y +    M    ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 251 APEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            PE          SDV+S G+++ E+ + G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 83/301 (27%), Positives = 129/301 (42%), Gaps = 59/301 (19%)

Query: 85  KVIGEGGYGIV---YYGLLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G V    Y  L+DN+   VAVK L ++  +  R+F+ E+E +  ++H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWL--HGDVGPCSPL---TWEIRMNIILGTAKGL 192
             G C     R   LV EY+  G+L  +L  H +      L     +I         KG+
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------CKGM 121

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG---TFGY 249
            YL      + VHRD+ + NIL++     K+ DFGL K+L  +  Y   R  G    F Y
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV----------------N 293
            APE  +    +  SDV+SFG+++ E+ +     D S  P                   +
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           LIE LK             P  P  P       I  +   C + +  +RP    +   +E
Sbjct: 235 LIELLK--------NNGRLPAPPGCPA-----EIYAIMKECWNNDPSQRPSFSELALQVE 281

Query: 354 A 354
           A
Sbjct: 282 A 282

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 7/191 (3%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA 145
           +G G YG VY G+ +  S  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
                 ++ E++  GNL  +L  +      +   + + +    +  + YL +      +H
Sbjct: 73  REPPFYIITEFMTYGNLLDYLR-ECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIH 127

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSD 265
           RD+ + N L+ ++   KV+DFGL++L+  ++            + APE  +    + +SD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 266 VYSFGILIMEV 276
           V++FG+L+ E+
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 39/281 (13%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSK---VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVR 139
           K +G+G +G+V  G       K   VAVK L +++      +F  E   +  + H+NL+R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT--WEIRMNIILGTAKGLSYLHE 197
           L G        M+V E    G+L   L  D      ++   +  + I    A G+ YL  
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES 115

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPE 253
               + +HRD+ + NIL+      K+ DFGL + L     +       +V   F + APE
Sbjct: 116 ---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPE 170

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLD 312
              T   +  SDV+ FG+ + E+ +      Y   P   ++  + LKK+  ++  E +  
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQILKKI--DKEGERLER 222

Query: 313 PK-LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
           P+  P+         I  V L+C   N   RP    +   L
Sbjct: 223 PEACPQ--------DIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 21/223 (9%)

Query: 85  KVIGEGGYGIVYYGLL--EDNS---KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           K++G G +G V+ G+   E +S    VA+K + +  G Q  +E    + A+G + H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C  GA   LV +    G+L   +      + P   L W +++      AKG+ YL
Sbjct: 73  RLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEY 254
            E    ++VHR++ + NIL+      +++DFG+A LL   +  Y  +       ++A E 
Sbjct: 126 EE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
              G    +SDV+S+G+ + E++S G  P    RP E  +L+E
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 71/248 (28%), Positives = 123/248 (49%), Gaps = 27/248 (10%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLN-NRGQAEREFKVEV 126
           EL +S   F ++  +GE  +G +Y G L     +    VA+K L + N  Q   EF+ E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIR 181
             +  + H N+V LLG   +     +++EY+N G+L ++L     H DVG  S     ++
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 182 --------MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
                   ++I +  A G+ YL        VH+D+ + NILI +  + K+SD GL++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 234 SESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           S   Y +  + +    ++ PE    G  +  SD++SFG+++ E+ S  +   Y    +EV
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 293 NLIEWLKK 300
             IE ++K
Sbjct: 236 --IEMVRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 33/270 (12%)

Query: 86  VIGEGGYGIVYYGLLEDNS-KVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           VIG G   +VY  +   N+ KVA+K + L     +  E + EV+A+ +  H N+V+    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPK 202
              G    LV  Y++ G+L   +     P   L   I   ++    KGL YLH  G    
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLL---GSESSYITTRVMGTFGYVAPEYASTGM 259
            +HRDIK+ NIL+ +  + K++DFG++  L   G  +  +    +GT  ++APE      
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 260 -LNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
             + ++D++SFGI  +E+ +G  P  YS+ PP +V +      +    +P     P L  
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP--YSKYPPMKVLM------LTLQNDP-----PSLET 229

Query: 318 ----KPTSRLLKRILLVALRCVDPNAQKRP 343
               K  S+  ++  +++L C+  +  KRP
Sbjct: 230 GADYKKYSKSFRK--MISL-CLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.9 bits (212), Expect = 8e-19
 Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 37/272 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           KV+G G +G VY G+     +     VA+K L    G +A  EF  E   +  + H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C     + LV + + +G L  ++H    ++G    L W +++      AKG+ YL
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEY 254
            E    ++VHRD+ + N+L+    + K++DFGLA+LL G E  Y          ++A E 
Sbjct: 126 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                   +SDV+S+G+ I E+++ G  P D     E  +L+E                 
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--------------KGE 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
           +LP+ P   +   + +V ++C   +A  RPK 
Sbjct: 229 RLPQPPICTI--DVYMVMVKCWMIDADSRPKF 258

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.0 bits (211), Expect = 8e-19
 Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 50/260 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLL 141
           + IG+G +G V       D   +  K +   N  + E++  V EV  +  ++H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63

Query: 142 GYCAEGAHRM---------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
            Y      R+         +V EY   G+L Q +         +  E    I+      L
Sbjct: 64  -YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 193 SYLHEGLEPK--VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
              H   +P   V+HRD+K +NI +D + N K+ DFGLAK+LG +SS+  T V GT  Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISG----------------------RIPVDYSRP 288
           +PE  +    +E+SD++S G LI E+ +                       RIP  YS  
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS-- 235

Query: 289 PEEVNLIEWLKKMVTNRNPE 308
             E+N +  +K M+ N +P+
Sbjct: 236 -SELNEV--IKSML-NVDPD 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 84  DKVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKN 136
            K +GEG +G V              + VAVK L  N   +E R+   E   + +V H +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD--VGPC------------------SPL 176
           +++L G C++    +L+ EY   G+L  +L     VGP                     L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           T    ++     ++G+ YL E    K+VHRD+ + N+L+ +    K+SDFGL++ +  E 
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 237 SYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           SY+  ++      ++A E     +   +SDV+SFG+L+ E+++
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 85.3 bits (211), Expect = 9e-19
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 85  KVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRH 134
             +G G +G VY G   D         +VAVK L   +G   Q ++EF  E   +    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKG 191
            N+V+LLG C     + ++ E +  G+L  +L     +      LT +  ++I L  AKG
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 192 LSYLHEGLEPKVVHRDIKSSNILI-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             YL +      +HRD+ + N L+     D     K+ DFGLA+ +   S Y      G 
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-SDYYRKEGEGL 174

Query: 247 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
               ++APE    G    +SDV+SFG+L+ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 39/210 (18%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRG---QAEREFKVEVEAIGRVRHKNLVR 139
           IGEG YG VY    L     VA+K +   L+  G      RE  + ++ +    H N+VR
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIVR 65

Query: 140 LLGYCA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL---TWEIRMNIILGTAKG 191
           LL  C            LV+E+V     +Q L   +  C         I+ +++    +G
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + +LH     ++VHRD+K  NIL+      K++DFGLA++   E +   T V+ T  Y A
Sbjct: 120 VDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYRA 174

Query: 252 PE------YASTGMLNERSDVYSFGILIME 275
           PE      YA+        D++S G +  E
Sbjct: 175 PEVLLQSSYATP------VDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 40/277 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAERE----------FKVEVEAIGRVR 133
           ++IG+G YG VY  L     ++ AVK +      A R            + E+E +  + 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKG 191
           H N+V+ LG+     +  +  EYV  G++   L  +G       L       ++    +G
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--QLVRFFTEQVL----EG 120

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY---ITTRVMGTFG 248
           L+YLH      ++HRD+K+ N+L+D     K+SDFG++K   S+  Y       + G+  
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVF 175

Query: 249 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           ++APE   +     + + D++S G +++E+ +GR      RP  +   I  + K+   R+
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNKRS 229

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 P +P   +  L    L     C   N   RP
Sbjct: 230 A-----PPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           ++++G G +G +  G L+  SK    VA+  L       +R  F  E   +G+  H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL G    G   M+V EY++NG L+ +L    G    L     M ++ G A G+ YL E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSE- 125

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
                VH+ + +  +L++     K+S F   +   SE+ Y T        + APE     
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 259 MLNERSDVYSFGILIMEVIS 278
             +  SDV+SFGI++ EV+S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 8/212 (3%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V+ G      KVA+K + N    +E +F  E + + ++ H  LV+L G C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +     +V E++ NG L  +L    G  S    ++ +++     +G+ YL        +
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFI 122

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD+ + N L+      KVSDFG+ + +  +    ++       +  PE  +    + +S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLI 295
           DV+SFG+L+ EV + G++P +     E V +I
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 34/283 (12%)

Query: 85  KVIGEGGYGIVY----YGLLEDNS--KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKN 136
           K +G G +G V     YGL + ++  KVAVK L      +ERE    E++ +  +  H+N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V LLG C  G   +++ EY   G+L  +L       S LT E  ++     AKG+++L 
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA 158

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVAPE 253
                  +HRD+ + N+L+      K+ DFGLA+ + ++S+Y+     R+     ++APE
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPE 213

Query: 254 YASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                +    SDV+S+GIL+ E+ S G  P  Y   P +    + +K+      PE    
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNP--YPGMPVDSKFYKLIKEGYRMAQPE---- 267

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
                         I  +   C D +  KRP    +V ++  Q
Sbjct: 268 ---------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 84/287 (29%), Positives = 124/287 (43%), Gaps = 36/287 (12%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHK 135
           T  F   +VIGEG YG VY     +    VA+K +++     E E K E   + +   H 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 136 NLVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           N+    G +  +          LV E    G++   + G       L  E    I+  T 
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           +GL+YLHE    KV+HRDIK  NIL+ K+   K+ DFG++  L S      T + GT  +
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYW 179

Query: 250 VAPE-----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           +APE            + RSDV+S GI  +E+  G+ P+    P   +  I         
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-------- 231

Query: 305 RNPEGVLDPKL--PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           RNP     P L  PE  + +    I      C+  N ++RP M  ++
Sbjct: 232 RNPP----PTLKSPENWSKKFNDFI----SECLIKNYEQRPFMEELL 270

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 41/294 (13%)

Query: 87  IGEGGYGIVYY----GLLE-----------DNSKVAVKNLLNNRGQAER-EFKVEVEAIG 130
           +GEG +G V+     GL E               VAVK L  +  +  R +F  E++ + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----------HGDVGPCSPLTWEI 180
           R+++ N++RLLG C       ++ EY+ NG+L Q+L          H +  P   +   +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-I 239
            M + +  A G+ YL        VHRD+ + N L+  H+  K++DFG+++ L S   Y I
Sbjct: 133 YMAVQI--ASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
             R +    ++A E    G     SDV++FG+ + E+ +      YS   +E  +IE   
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-QVIENTG 246

Query: 300 KMVTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
           +   N+  +  L    L   P  +L+       +RC   + + RP    + H L
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVFKLM-------MRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 64/227 (28%), Positives = 116/227 (51%), Gaps = 26/227 (11%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYY----GLLEDNSK----VAVKNLLNNRGQAE-REFKVE 125
           E S +  +  K +GEG +G V      G+ +D  K    VAVK L ++  + +  +   E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 126 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----------DVG--P 172
           +E +  + +HKN++ LLG C +     ++ EY + GNL ++L            D+   P
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              +T++  ++     A+G+ YL      K +HRD+ + N+L+ ++   K++DFGLA+ +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +   Y  TT       ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 30/263 (11%)

Query: 86  VIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRH---KNLVRL 140
           +IG G YG VY G  +     VA+K + L+       + + EV  + ++R     N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
            G   +G    ++ EY   G++   +    GP +     +   II      L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISV---IIREVLVALKYIHKV-- 120

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-M 259
             V+HRDIK++NIL+    N K+ DFG+A LL   SS  +T V GT  ++APE  + G  
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            + ++D++S GI I E+ +G  P         + LI   K             P+L +  
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------PRLEDNG 226

Query: 320 TSRLLKRILLVALRCVDPNAQKR 342
            S+LL+    VA  C+D   ++R
Sbjct: 227 YSKLLRE--FVAA-CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 85  KVIGEGGYG---IVYYGLLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +V+GEG +G   +V +     + K A+K + L     A  + + E   + +++H N+V  
Sbjct: 6   RVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----LTWEIRMNIILGTAKGLSYLH 196
                   H  +V EY + G+L Q +    G   P    L W ++M +      G+ ++H
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E    +V+HRDIKS NI + ++   K+ DFG A+LL S  +Y  T V GT  YV PE   
Sbjct: 118 E---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               N +SD++S G ++ E+ + + P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 12/211 (5%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+       D  +G+G +G V+ G     +KVA+K L       E  F  E + + ++RH
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV L    +E     +V E++  G+L  +L    G    L   + M   +  A G++Y
Sbjct: 61  DKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAY 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           +        +HRD++++NIL+  +   K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 118 IER---MNYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           E A  G    +SDV+SFGIL+ E+++ GR+P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 23/204 (11%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  VY G      + VA+K  +L    G      + E+  +  ++H+N+VRL   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66

Query: 144 CAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                  MLV+EY++  +L++++  HG  G   P T +     +L   KG+++ HE    
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +V+HRD+K  N+LI+K    K++DFGLA+  G   +  +  V+ T  Y AP+     +L 
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV----LLG 174

Query: 262 ERS-----DVYSFGILIMEVISGR 280
            R+     D++S G ++ E+I+GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 36/227 (15%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYC 144
           IG G  G VY  +     ++ A+K +  N      R+   E+E +  V H N+V+     
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  ++ E+++ G+LE     D    + +  +I          G++YLH      +V
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHR---RHIV 190

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE-- 262
           HRDIK SN+LI+   N K++DFG++++L        + V GT  Y++PE  +T  LN   
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LNHGA 248

Query: 263 ----RSDVYSFGILIMEVISGRIP---------------VDYSRPPE 290
                 D++S G+ I+E   GR P               +  S+PPE
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295

Length = 353

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 34/215 (15%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAE--------REFKVEVEAIGRVR 133
            K +GEG Y +VY     E    VA+K + L  R +A+        RE K+  E    ++
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LK 60

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H N++ LL      ++  LV+E++   +LE+ +       +P   +I+ + +L T +GL 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLE 116

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH      ++HRD+K +N+LI      K++DFGLA+  GS +  +T +V+ T  Y APE
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172

Query: 254 ------YASTGMLNERSDVYSFGILIMEVISGRIP 282
                 +   G+     D++S G +  E++  R+P
Sbjct: 173 LLFGARHYGVGV-----DMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 9e-18
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + IG G YG VY    +     VA+K +    G      + E+  +   RH N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   +V EY   G+L+       GP S L  +I   +   T KGL+YLHE      
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--QIAY-VCRETLKGLAYLHE---TGK 122

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA---STGML 260
           +HRDIK +NIL+ +  + K++DFG++  L +  +   + + GT  ++APE A     G  
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181

Query: 261 NERSDVYSFGILIMEVISGRIP 282
           + + D+++ GI  +E+   + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 22/165 (13%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I +   K L YLH  L   V+HRD+K SN+LI+++   K+ DFG++  L    S   T  
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163

Query: 244 MGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
            G   Y+APE  +  +     + +SDV+S GI ++E+ +GR P D  + P      + LK
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK 218

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
           ++V    P     P+LP +  S           +C+  N ++RP 
Sbjct: 219 QVV--EEPS----PQLPAEKFS---PEFQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 23/216 (10%)

Query: 87  IGEGGYGIVY----YGLLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V+    Y L     K  VAVK L +    A ++F+ E E +  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWL--HG-------DVGPCSP---LTWEIRMNIILGT 188
            G C +G   ++V+EY+ +G+L ++L  HG       D  P      L     ++I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTF 247
           A G+ YL        VHRD+ + N L+  +   K+ DFG+++ + S   Y +    M   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 72/281 (25%), Positives = 133/281 (47%), Gaps = 33/281 (11%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL----LNNRGQAEREFKVEVEAIGRV 132
              F  +K IG+G + +VY  + L D   VA+K +    + +    +   K E++ + ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIRMNIILG 187
            H N+++ L    E     +V E  + G+L + +        + P     W+  + +   
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTIWKYFVQL--- 115

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
               L ++H     +++HRDIK +N+ I      K+ D GL +   S+++   + V GT 
Sbjct: 116 -CSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE       N +SD++S G L+ E+ + + P  Y    +++NL    KK+      
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKI------ 220

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
           E    P LP    S  L+   LV+ RC++P+ +KRP + +V
Sbjct: 221 EKCDYPPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 31/180 (17%)

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLG 233
           P+  EI   I +   +GL+YL+     +++HRDIK SNIL++     K+ DFG++ +L+ 
Sbjct: 99  PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156

Query: 234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN 293
           S    I    +GT  Y++PE    G    +SDV+S GI I+E+  G+ P  +S   ++  
Sbjct: 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212

Query: 294 LIEWLKKMVTNRNPEGVLD----------PKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                       +P G+LD          P+LP       L+  +     C+  +  +RP
Sbjct: 213 D-----------DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV---DACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 24/227 (10%)

Query: 87  IGEGGYGIV---YYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           +G G +G V    Y + +    VAVK L N  N    + E   E   + ++ +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL----HGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           G C E    MLV E    G L ++L    H      + L  ++ M        G+ YL E
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
                 VHRD+ + N+L+      K+SDFGL+K LG++ +Y   +  G +   + APE  
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM 301
           +    + +SDV+SFG+L+ E  S G+ P    +  E   +IE  ++M
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM 217

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V YG       VA+K ++     +E EF  E + + ++ H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLH-GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK- 202
            +     +V EY++NG L  +L               + + +L   K +      LE K 
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRF--------QPSQLLEMCKDVCEGMAYLESKQ 120

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGM 259
            +HRD+ + N L+D     KVSDFGL++ +  +  Y ++  +G+     +  PE      
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLLYSK 177

Query: 260 LNERSDVYSFGILIMEVIS-GRIPVD 284
            + +SDV++FG+L+ EV S G++P +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 87  IGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKVEVEAIGR-VRHKNLVRLLG 142
           IGEG  GIV   +  D S   +VAVK + + R Q  RE       I R  +H N+V +  
Sbjct: 27  IGEGSTGIVC--IATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
               G    +V E++  G L      D+   + +  E    + L   K LS+LH      
Sbjct: 84  SYLVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QG 135

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGML 260
           V+HRDIKS +IL+      K+SDFG    +  E   +  R  ++GT  ++APE  S    
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPY 192

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPP 289
               D++S GI+++E++ G  P  ++ PP
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY-FNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 80/290 (27%), Positives = 138/290 (47%), Gaps = 42/290 (14%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLN-NRGQAEREFKV 124
           L+E E     F   KV+G G +G VY GL     +     VA+K L      +A +E   
Sbjct: 4   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGD-VGPCSPLTWEIR 181
           E   +  V + ++ RLLG C     + L+ + +  G L  ++  H D +G    L W ++
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYIT 240
           +      AKG++YL E    ++VHRD+ + N+L+    + K++DFGLAKLLG+ E  Y  
Sbjct: 118 I------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK 299
                   ++A E     +   +SDV+S+G+ + E+++ G  P D     E  +++E   
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--- 225

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
                   E     +LP+ P   +   + ++ ++C   +A  RPK   ++
Sbjct: 226 ------KGE-----RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 31/229 (13%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNN-RGQAEREFKVE 125
           E+ +ST  F ++  +GE  +G VY G L      E    VA+K L +   G    EFK E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPC------- 173
                R++H N+V LLG   +     +++ Y ++ +L ++L     H DVG         
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
           S L     ++I+   A G+ +L       VVH+D+ + N+L+    N K+SD GL + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 234 SESSYITTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           +   Y   ++MG       +++PE    G  +  SD++S+G+++ EV S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 87  IGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           IG G +G V+ G L  DN+ VAVK+         + +F  E   + +  H N+VRL+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-V 203
            +     +V E V  G+   +L  + GP   +   I+M  +   A G+ YL    E K  
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM--VENAAAGMEYL----ESKHC 115

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLN 261
           +HRD+ + N L+ +    K+SDFG+++    +  Y +T  M      + APE  + G  +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 262 ERSDVYSFGILIMEVIS-GRIP 282
             SDV+SFGIL+ E  S G +P
Sbjct: 175 SESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 85  KVIGEGGYGIVYYGLLE-DNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           K IGEG +G +Y    + D+    +K  +L     + +   K EV  + +++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC----SPLTWEIRMNIILGTAKGLSYLHE 197
               E     +V EY + G+L + ++   G        L+W +++++      GL ++H+
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
               K++HRDIKS NI + K+    K+ DFG+A+ L        T  +GT  Y++PE   
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQ 175

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVD 284
               N ++D++S G ++ E+ + + P +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 40/284 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNS----KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +VIG+G +G VY+G L D+       AVK+L  + +  + E +F  E   +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 139 RLLGYC--AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            LLG C  +EG+  ++V  Y+ +G+L  ++          T +  +   L  AKG+ YL 
Sbjct: 60  SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL- 114

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPE 253
                K VHRD+ + N ++D+ +  KV+DFGLA+ +  +  Y      G      ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN---LIEWLKKMVTNRNPEGV 310
              T     +SDV+SFG+L+ E+++   P     P  +V+   +  +L +      PE  
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRLLQPEYC 227

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            DP             +  V L C  P  + RP    +V  +E 
Sbjct: 228 PDP-------------LYEVMLSCWHPKPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 15/206 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV---EVEAIGRVRHKN 136
           F+  + IG+G +G VY  +    N  VA+K +  +  +AE E +    E++ + + R   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           + +  G   +G+   ++ EY   G+       D+     L       I+     GL YLH
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E      +HRDIK++NIL+ +  + K++DFG++  L S  S   T V GT  ++APE   
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               +E++D++S GI  +E+  G  P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 26/212 (12%)

Query: 86  VIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRL 140
           VIGEG +G V    ++ +      A+K +     + + R+F  E+E + ++  H N++ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC--------SPLTWEIRMNIILGT 188
           LG C    +  L  EY  +GNL  +L      +  P         S L+ +  ++     
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           A+G+ YL +    + +HRD+ + NIL+ +++  K++DFGL++    +  Y+  + MG   
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLP 186

Query: 249 --YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 54/182 (29%), Positives = 91/182 (50%), Gaps = 12/182 (6%)

Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK L  +     R +F  EV+ + R+   N+ RLLG C       ++ EY+ NG+L Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 165 WLHGDVGPCS-------PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           +L   V   S        L++   + +    A G+ YL        VHRD+ + N L+ K
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 218 HWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           ++  K++DFG+++ L S   Y +  R      ++A E    G    +SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 277 IS 278
           ++
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 26/214 (12%)

Query: 84  DKVIGEGGYGIVYYGLLE-DNSKV--AVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLV 138
           + VIGEG +G V   +++ D  K+  A+K L     + + R+F  E+E + ++  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHG------------DVGPCSPLTWEIRMNIIL 186
            LLG C    +  +  EY   GNL  +L              + G  S LT +  +    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             A G+ YL E    + +HRD+ + N+L+ ++   K++DFGL++    E  Y+  + MG 
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGR 179

Query: 247 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
               ++A E  +  +   +SDV+SFG+L+ E++S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAE-----REFKVEVEAIGRVRHKNLV 138
           K++G+G +G VY     D  + +AVK +  +    E        + E++ +  ++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   +     +  EY+  G+++  L  +G       LT  +         +G+ YLH
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLH 121

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEY 254
                 +VHRDIK +NIL D   N K+ DFG +K L +  S  T    V GT  +++PE 
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIP 282
            S      ++DV+S G  ++E+++ + P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 32/279 (11%)

Query: 87  IGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQAEREFKV-----EVEAIG-RVR 133
           +G G +G VY    ++N        ++ V N    + + ER+  +     EV  I  ++R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H N+VR      E     +V + +    L +  +         T E   NI +     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH+  E ++VHRD+  +NI++ +     ++DFGLAK    ES    T V+GT  Y  PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYSCPE 183

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                   E++DV++FG ++ ++ + + P  YS      N++    K+V     E V +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQ-PPFYS-----TNMLSLATKIV-----EAVYEP 232

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
            LPE   S   + +  V   C+ P+A+ RP +  V  M+
Sbjct: 233 -LPEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 19/214 (8%)

Query: 85  KVIGEGGYGIVYYGLL--EDNS--KVAVKNL-LNNRGQAE-REFKVEVEAIGRVRHKNLV 138
           K++GEG +G V  G L  +D S  KVAVK + L+    +E  EF  E   +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 139 RLLGYCAEGAHR------MLVYEYVNNGNLEQWLHGDVGPCSP--LTWEIRMNIILGTAK 190
           +L+G C E +        M++  ++ +G+L  +L        P  L  +  +  ++  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FGY 249
           G+ YL        +HRD+ + N ++ +     V+DFGL+K + S   Y   R+      +
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           +A E  +  +   +SDV++FG+ + E+ + G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 61/215 (28%), Positives = 111/215 (51%), Gaps = 22/215 (10%)

Query: 85  KVIGEGGYGIVYYGLL-EDNS--KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           K +GEG +G V  G L +D+S  KVAVK +   +  R + E +F  E   +    H N++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVM 63

Query: 139 RLLGYCAEGAHR------MLVYEYVNNGNLEQWL-HGDVGPCSPLTWEIRMNIILGT--A 189
           RL+G C +          +++  ++ +G+L  +L +  +G C P     +M +   T  A
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-PQYLPTQMLVKFMTDIA 122

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FG 248
            G+ YL        +HRD+ + N +++++ N  V+DFGL+K + +   Y   R+      
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           ++A E  +  +   +SDV+SFG+ + E+ + G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 46/217 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--------EVEAIGRV-RH 134
           K +G+G +G VY     E    VA+K +       +++F          EV+++ ++  H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            N+V+L     E      V+EY+  GNL Q +    G   P +  +  +II    +GL++
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAH 114

Query: 195 LHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES---SYITTRVMGTFGYV 250
           +H+ G      HRD+K  N+L+      K++DFGLA+ + S      Y++TR      Y 
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYR 165

Query: 251 APE-------YASTGMLNERSDVYSFGILIMEVISGR 280
           APE       Y+S        D+++ G ++ E+ + R
Sbjct: 166 APEILLRSTSYSSP------VDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV------EVEAIGRVRHKNLVR 139
           IGEG YG+VY          VA+K +   R + E E  V      E+  +  + H N+VR
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           LL          LV+E+++  +L++++  D  P + L   +  + +    +G++Y H   
Sbjct: 63  LLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------ 253
             +V+HRD+K  N+LID+    K++DFGLA+  G      T  V+ T  Y APE      
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
             ST +     D++S G +  E+++ R
Sbjct: 176 QYSTPV-----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 86  VIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRL 140
           VIGEG +G V    ++ +      A+K +     + + R+F  E+E + ++  H N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHG------------DVGPCSPLTWEIRMNIILGT 188
           LG C    +  L  EY  +GNL  +L                   S L+ +  ++     
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           A+G+ YL +    + +HRD+ + NIL+ +++  K++DFGL++    +  Y+  + MG   
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLP 174

Query: 249 --YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 53/229 (23%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           +   K IG G YG+V   +      KVA+K + N   +   A+R  + E++ +  +RH+N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHEN 60

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGN------------LEQWLHGDVGPCSPLTWEIRMNI 184
           ++ L          +L      + N            L + +        PLT +     
Sbjct: 61  IIGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSP----QPLTDDHIQYF 108

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-------SS 237
           +    +GL YLH      V+HRD+K SNIL++ + + K+ DFGLA+ +  +       + 
Sbjct: 109 LYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRI 281
           Y+ TR      Y APE     +L+        D++S G +  E+++ + 
Sbjct: 166 YVVTRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IGEG YGIVY          VA+K +   R   ER+   +    E+  +  +RH N+V L
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 141 LGYCAEGAHR---MLVYEYVNNGNLEQWLHG--DVGPCSPLTWEIRMNIILGTAKGLSYL 195
                 G H     LV EY      EQ L    D  P  P +      ++L   +GL YL
Sbjct: 72  K-EVVVGKHLDSIFLVMEYC-----EQDLASLLDNMPT-PFSESQVKCLMLQLLRGLQYL 124

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           HE     ++HRD+K SN+L+      K++DFGLA+  G  +  +T +V+ T  Y APE  
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL 180

Query: 256 STGMLNERS--DVYSFGILIMEVISGR 280
             G     +  D+++ G ++ E+++ +
Sbjct: 181 -LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 67/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)

Query: 85  KVIGEGGYG-IVYYGLLEDNSKVAVKNLLNNRGQA-ER-EFKVEVEAIGRVRHKNLVRLL 141
           K IGEG +G  +     ED  +  +K +  ++    ER E + EV  +  ++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----LTWEIRMNIILGTAKGLSYLHE 197
               E  +  +V +Y   G+L + ++   G   P    L W +++ +       L ++H+
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               K++HRDIKS NI + K    K+ DFG+A++L S      T  +GT  Y++PE    
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICEN 175

Query: 258 GMLNERSDVYSFGI-------------------LIMEVISGR---IPVDYSRPPEEVNLI 295
              N +SD+++ G                    L++++I G    +   YS   +  NL+
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYS--YDLRNLV 233

Query: 296 EWLKKMVTNRNP 307
             L K    RNP
Sbjct: 234 SQLFK----RNP 241

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGY 143
           +++G+G +G V+ G L+D + VAVK    +  Q  + +F  E   + +  H N+V+L+G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           C +     +V E V  G+   +L         L  +  +   L  A G++YL        
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNC 114

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +HRD+ + N L+ ++   K+SDFG+++    G  SS    ++     + APE  + G  +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYS 172

Query: 262 ERSDVYSFGILIMEVIS 278
             SDV+S+GIL+ E  S
Sbjct: 173 SESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 63/263 (23%), Positives = 102/263 (38%), Gaps = 40/263 (15%)

Query: 80  GFSDDKVIGEGGYGIV----------YYGLLEDN-----SKVAVKNLLNNRGQAEREFKV 124
            F   +VIG+G +G V           + +   N      K +V+N+LN           
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN----------- 49

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E   +  + H  LV L     +  +  LV + +  G+L   L   V      + E     
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV----KFSEEQVKFW 105

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           I      L YLH      ++HRDIK  NIL+D+  +  ++DF +A  + +  +  T+   
Sbjct: 106 ICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS- 160

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY-SRPPEEVNLIEWLKKMVT 303
           GT GY+APE       +   D +S G+   E + G+ P    SR   +    +   K  T
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET 216

Query: 304 NRNPEGVLDPKLPEKPTSRLLKR 326
                            ++LL+R
Sbjct: 217 ADVLYPATWSTEAIDAINKLLER 239

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 12/200 (6%)

Query: 84  DKVIGEGGYGIVY---YGLLEDNS-KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
            + IGEG +G VY   Y   E+    VAVK   N    + RE F  E   + +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +L+G   E     +V E    G L  +L  +      L     +      +  L+YL   
Sbjct: 71  KLIGVITENP-VWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES- 125

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              + VHRDI + N+L+      K+ DFGL++ L  ES Y  ++      ++APE  +  
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 259 MLNERSDVYSFGILIMEVIS 278
                SDV+ FG+ + E++ 
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 15/206 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDN---SKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKN 136
           F+  + IG+G +G V+ G+  DN     VA+K +     + E E  + E+  + +     
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           + +  G   +G    ++ EY+  G+    L    GP         +  IL   KGL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 118

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                K +HRDIK++N+L+ +  + K++DFG+A  L +++       +GT  ++APE   
Sbjct: 119 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               + ++D++S GI  +E+  G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCA 145
           IGEG  GIV    ++ + K+     ++ R Q  RE    EV  +   +H+N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
            G    +V E++  G L      D+   + +  E    + L   K LS LH      V+H
Sbjct: 88  VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSD 265
           RDIKS +IL+      K+SDFG    +  E     + V GT  ++APE  S        D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198

Query: 266 VYSFGILIMEVISGRIPVDYSRPP 289
           ++S GI+++E++ G  P  ++ PP
Sbjct: 199 IWSLGIMVIEMVDGEPPY-FNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 78/303 (25%), Positives = 140/303 (46%), Gaps = 34/303 (11%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQAER-EFKVEVE 127
           EVS    +  + +G+G +G+VY G   D       ++VAVK +  +    ER EF  E  
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH-----GDVGPCSPL-TWEIR 181
            +      ++VRLLG  ++G   ++V E + +G+L+ +L       +  P  P  T +  
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           + +    A G++YL+     K VHRD+ + N ++   +  K+ DFG+ + +  E+ Y   
Sbjct: 122 IQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRK 177

Query: 242 RVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
              G     ++APE    G+    SD++SFG+++ E+ S       +  P +    E + 
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVL 231

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
           K V +    G LD   P+    R+   + +    C   N + RP    +V++L+    PS
Sbjct: 232 KFVMD---GGYLDQ--PDNCPERVTDLMRM----CWQFNPKMRPTFLEIVNLLKDDLHPS 282

Query: 360 KED 362
             +
Sbjct: 283 FPE 285

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 65/247 (26%), Positives = 118/247 (47%), Gaps = 19/247 (7%)

Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK L  +  + A  +F  E++ + R++  N++RLL  C       ++ EY+ NG+L Q
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 165 WLHGDVGPCSPLTWEIR-------MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           +L       +    ++        + +    A G+ YL        VHRD+ + N L+ K
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165

Query: 218 HWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           ++  K++DFG+++ L S   Y I  R +    +++ E    G     SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 277 ISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD 336
           ++      YS+  +E  +IE   +   ++  +  L PK    P S     +  + L C  
Sbjct: 226 LTLCKEQPYSQLSDE-QVIENTGEFFRDQGRQVYL-PKPALCPDS-----LYKLMLSCWR 278

Query: 337 PNAQKRP 343
            NA++RP
Sbjct: 279 RNAKERP 285

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 26/258 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G VY  + +    +VA+K + N + Q ++E  + E+  +   +H N+V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           D++S GI+ +E++ G  P     P   + LI       TN  PE      L        +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTPE------LQNPEKLSAI 244

Query: 325 KRILLVALRCVDPNAQKR 342
            R  L   RC++ + +KR
Sbjct: 245 FRDFLN--RCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 26/217 (11%)

Query: 85  KVIGEGGYGIVYY----GLLEDN----SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RH 134
           K +GEG +G V      GL ++     +KVAVK L ++  + +  +   E+E +  + +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP---------CSP---LTWEIRM 182
           KN++ LLG C +     ++ EY + GNL ++L     P           P   L+++  +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITT 241
           +     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
                  ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 29/207 (14%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV------RHKNLVR 139
           IGEG YG+VY          VA+K +   R   E E  V   AI  +       H N+V+
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETE-GVPSTAIREISLLKELNHPNIVK 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           LL          LV+E+++  +L++++  D  P S +   +  + +    +GL++ H   
Sbjct: 64  LLDVIHTENKLYLVFEFLHQ-DLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------ 253
             +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+ T  Y APE      
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 176

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
           Y ST +     D++S G +  E+++ R
Sbjct: 177 YYSTAV-----DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 37/218 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           F+D + IG G +G VY+      ++ VA+K +  +  Q+  +++    EV  + ++RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCS--------PLTWEIRMNIILG 187
            +   G C    H   LV EY             +G  S        PL       I  G
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYC------------LGSASDILEVHKKPLQEVEIAAICHG 123

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
             +GL+YLH     + +HRDIK+ NIL+ +    K++DFG A L+   +S++     GT 
Sbjct: 124 ALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTP 175

Query: 248 GYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIP 282
            ++APE       G  + + DV+S GI  +E+   + P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 85  KVIGEGGYG--IVY-YGLLEDNSK--VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           +V+GEG +G   +Y Y    D +   VAVK L    GQ     +K E+  +  + H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 139 RLLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G C+E   +   L+ EYV  G+L  +L     P   L     +       +G++YLH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG---TFGYVAPE 253
                  +HRD+ + N+L+D     K+ DFGLAK +     Y   R  G    F Y A E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180

Query: 254 YASTGMLNERSDVYSFGILIMEVIS 278
                  +  SDV+SFG+ + E+++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)

Query: 85  KVIGEGGYGIVY----YGLLEDN----SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RH 134
           K +GEG +G V     YG+ +        VAVK L +N    +  +   E+E +  + +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC------------SPLTWEIRM 182
           KN++ LLG C +     ++ EY   GNL ++L     P               L+++  +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITT 241
           +     A+G+ YL      + +HRD+ + N+L+ +    K++DFGLA+ +     Y  T+
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
                  ++APE     +   +SDV+SFGIL+ E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IGEG  GIV     +   K VAVK + + R Q  RE    EV  +    H+N+V +    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    +V E++  G L      D+   + +  E    + L   + LSYLH      V+
Sbjct: 89  LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVI 140

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS +IL+      K+SDFG    +  E       ++GT  ++APE  S        
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP------------EGVLD 312
           D++S GI+++E+I G  P  ++ PP     ++ ++++  N  P             G LD
Sbjct: 200 DIWSLGIMVIEMIDGEPPY-FNEPP-----LQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253

Query: 313 PKLPEKPTSRLLKRILLVA--LRCVDPNAQKRPKMGH 347
             L  +P+ R   + LL    L+   P +   P M  
Sbjct: 254 LMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMRQ 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 41/270 (15%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLL-GYC 144
           +G+G +G VY    ++    A   ++    + E E F VE++ +   +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW-EIRMNIILGTAKGLSYLHEGLEPKV 203
            E    +L+ E+ + G L+  +   +     LT  +IR  +     + L++LH     KV
Sbjct: 73  YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRY-VCRQMLEALNFLHSH---KV 124

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE----SSYITTRVMGTFGYVAPEYASTGM 259
           +HRD+K+ NIL+    + K++DFG++    S      ++I     GT  ++APE  +   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACET 179

Query: 260 L-----NERSDVYSFGILIMEVISGRIPVDYSRPPE-EVNLIEWLKKMVTNRNPEGVLDP 313
                 + ++D++S GI ++E+           PP  E+N +  L K +    P  +  P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQM-------EPPHHELNPMRVLLK-ILKSEPPTLDQP 231

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                  +  LK        C+  +   RP
Sbjct: 232 SKWSSSFNDFLK-------SCLVKDPDDRP 254

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 26/227 (11%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYY----GLLEDNSK----VAVKNLLNNRGQAE-REFKVE 125
           E+S    +  K +GEG +G V      G+ +D       VAVK L ++    +  +   E
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 126 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP--------C--- 173
           +E +  + +HKN++ LLG C +     ++ EY + GNL ++L     P        C   
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 174 -SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              LT++  ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +   Y  TT       ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.8 bits (189), Expect = 6e-15
 Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 41/236 (17%)

Query: 105 KVAVKNLLNNRGQAERE---FKVEVEAIGRVRHKNLVRLL--GYCAEGAHRMLVYEYVNN 159
           +VA+K L  +  + E +   F+ E     R+ H N+V LL  G    G     V+EYV  
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPG 63

Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---D 216
             L + L  D G          M  +L     L+  H      +VHRD+K  NI++    
Sbjct: 64  RTLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQTG 116

Query: 217 KHWNPKVSDFGLAKLL-GSESSYI-----TTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
              + KV DFG+  LL G   + +     TT V+GT  Y APE      +   SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 271 ILIMEVISGRI----------------PVDYSRPP--EEVNLIEWLKKMVTNRNPE 308
           ++ +E ++G+                 PVD S PP      L + L+K   N++P 
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRK-ALNKDPR 231

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 19/217 (8%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVE 127
           EV+    +  + +G+G +G+VY G+       E  ++VA+K +       ER EF  E  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-----DVGPC-SPLTWEIR 181
            +      ++VRLLG  ++G   +++ E +  G+L+ +L       +  P  +P + +  
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           + +    A G++YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  E+ Y   
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRK 177

Query: 242 RVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEV 276
              G     +++PE    G+    SDV+SFG+++ E+
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 22/279 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKN 136
           F  +K IG G +  VY    L D   VA+K +        +A ++   E++ + ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +++ L    E     +V E  + G+L Q +         +         +     + ++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                +V+HRDIK +N+ I      K+ D GL +   S+++   + V GT  Y++PE   
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
               N +SD++S G L+ E+ + + P  Y    +++NL    +K+      E    P LP
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLFSLCQKI------EQCDYPPLP 229

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
            +  S  L+   LV++ C+ P+  +RP +G+ VH +  Q
Sbjct: 230 TEHYSEKLRE--LVSM-CIYPDPDQRPDIGY-VHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.0 bits (181), Expect = 9e-15
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 35/274 (12%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G VY  + +    +VA++ + N + Q ++E  + E+  +   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
             G    +V EY+  G+L   +     D G  + +  E          + L +LH     
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALEFLHSN--- 135

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +V+HRDIKS NIL+    + K++DFG    +  E S   + ++GT  ++APE  +     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYG 194

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
            + D++S GI+ +E+I G  P     P   + LI       TN  PE     + PEK  S
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTPE----LQNPEK-LS 243

Query: 322 RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
            + +  L    RC+D + +KR   G    +L+ Q
Sbjct: 244 AIFRDFL---NRCLDMDVEKR---GSAKELLQHQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 20/190 (10%)

Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK L  +  + A  +F  EV+ + R++  N++RLLG C +     ++ EY+ NG+L Q
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 165 WL------------HGDVGPCSPL---TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           +L            +  V P   L   ++   +++ L  A G+ YL        VHRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165

Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ ++   K++DFG+++ L +   Y I  R +    ++A E    G     SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 269 FGILIMEVIS 278
           FG+ + E++ 
Sbjct: 226 FGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 24/227 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G VY  + +    +VA+K + N + Q ++E  + E+  +   ++ N+V  L   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
             G    +V EY+  G+L   +     D G  + +  E          + L +LH     
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALDFLHSN--- 134

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +V+HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +     
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
            + D++S GI+ +E++ G  P     P   + LI       TN  PE
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTPE 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 78/283 (27%), Positives = 121/283 (42%), Gaps = 63/283 (22%)

Query: 87  IGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           I +G YG V+  L +  S       KV  K  +  + Q ++    E + + + +   +V+
Sbjct: 1   ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQ-VLTERDILSQAQSPYVVK 57

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           L  Y  +G   + LV EY+  G+L   L  +VG    L  ++    I      L YLH  
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGS---LDEDVARIYIAEIVLALEYLHSN 112

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI--------TTRVMGTFGYV 250
               ++HRD+K  NILID + + K++DFGL+K +G     I          R++GT  Y+
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 251 APEYASTGMLNE----RSDVYSFGILIMEVISGRIPVDYSRPPEEV------NLIEWLKK 300
           APE     +L +      D +S G ++ E + G IP  +   PEE+        IEW   
Sbjct: 169 APEV----ILGQGHSKTVDWWSLGCILYEFLVG-IPPFHGETPEEIFQNILNGKIEW--- 220

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 PE V          S+LL            P+ +KR 
Sbjct: 221 ------PEDVEVSDEAIDLISKLL-----------VPDPEKRL 246

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 73/277 (26%), Positives = 128/277 (46%), Gaps = 37/277 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           KV+G G +G VY G+   + +     VA+K L  N   +A +E   E   +  V    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C     + LV + +  G L  ++      +G    L W +++      AKG+SYL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-SESSYITTRVMGTFGYVAPEY 254
            E    ++VHRD+ + N+L+    + K++DFGLA+LL   E+ Y          ++A E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                   +SDV+S+G+ + E+++ G  P D     E  +L+E                 
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE--------------KGE 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           +LP+ P       + ++ ++C   +++ RP+   +V 
Sbjct: 229 RLPQPPICT--IDVYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 87  IGEGGYGIV---YYGLLEDNS--KVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V    Y    DN+  +VAVK+L   + G    + K E+E +  + H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 141 LGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            G C E       L+ E++ +G+L+++L  +    + +  + ++   +   KG+ YL   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS- 127

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT---RVMGTFGYVAPEYA 255
              + VHRD+ + N+L++     K+ DFGL K + ++  Y T         F Y APE  
Sbjct: 128 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184

Query: 256 STGMLNERSDVYSFGILIMEVIS 278
                   SDV+SFG+ + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 33/192 (17%)

Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV EY+N G+    L   +G   P  W  +   I     G+  LH+     ++HRDIK  
Sbjct: 74  LVMEYLNGGDCAS-LIKTLGGL-PEDW-AK-QYIAEVVLGVEDLHQR---GIIHRDIKPE 126

Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           N+LID+  + K++DFGL     S +     + +GT  Y+APE       ++ SD +S G 
Sbjct: 127 NLLIDQTGHLKLTDFGL-----SRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181

Query: 272 LIMEVISGRIPVDYSRPPE-----EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           +I E + G  P     P           I W +++    +PE V            L+ R
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV-----------DLINR 230

Query: 327 ILLVALRCVDPN 338
           +L     C+DP 
Sbjct: 231 LL-----CMDPA 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 28/259 (10%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +G+GG+G V    ++   K+ A K L   R    + E+    E + + +V     +  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59

Query: 143 YCAEG-AHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           Y  E      LV   +N G+L+  +   G+ G            II G    L +LH+  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             ++V+RD+K  N+L+D H N ++SD GLA  L      I  R  GT GY+APE     +
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGYMAPEVLQGEV 170

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            +   D ++ G  + E+I+GR P  + +  E+V   E LK+          +  + P+K 
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP--FRQRKEKVEKEE-LKRRTLE------MAVEYPDKF 221

Query: 320 TSRLLKRILLVALRCVDPN 338
           +     + L  AL   DP 
Sbjct: 222 SPEA--KDLCEALLQKDPE 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF---KVEVEAIGRVRHKNL 137
           F+  + IG+G +G VY G+ ++ +K  V   + +  +AE E    + E+  + +     +
Sbjct: 6   FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            R  G   +G    ++ EY+  G+       D+    PL       I+    KGL YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLHS 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               + +HRDIK++N+L+ +  + K++DFG+A  L +++       +GT  ++APE    
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
              + ++D++S GI  +E+  G  P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 68/229 (29%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLN---NRGQAEREFKVEVEAIGRVR-HKNLVRLL 141
           +G+G YGIV+  +     + VA+K + +   N   A+R F+ E+  +  +  H N+V+LL
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73

Query: 142 GYCAEGAHRM-------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI---------- 184
                   +        LV+EY     +E  LH  V         IR NI          
Sbjct: 74  N-----VIKAENDKDIYLVFEY-----METDLHA-V---------IRANILEDVHKRYIM 113

Query: 185 --ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
             +L   K L Y+H G    V+HRD+K SNIL++     K++DFGLA+ L          
Sbjct: 114 YQLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 243 VM----GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 280
           V+     T  Y APE       Y + G+     D++S G ++ E++ G+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 26/258 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G V+  + +    +VA+K + N + Q ++E  + E+  +  +++ N+V  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS N+L+    + K++DFG    +  E S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           D++S GI+ +E++ G  P     P   + LI       TN  PE     + PEK  S + 
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSPIF 245

Query: 325 KRILLVALRCVDPNAQKR 342
           +  L    RC++ + +KR
Sbjct: 246 RDFL---NRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 68/277 (24%), Positives = 129/277 (46%), Gaps = 25/277 (9%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRH 134
           F  +K IG G +  VY    L D   VA+K     +L++   +A  +   E++ + ++ H
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            N+++      E     +V E  + G+L + +         +  +      +     L +
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           +H     +V+HRDIK +N+ I      K+ D GL +   S+++   + V GT  Y++PE 
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
                 N +SD++S G L+ E+ + + P  Y    +++NL    KK+      E    P 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKI------EQCDYPP 227

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           LP    S  L++++ +   C++P+ +KRP + +V  +
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 69/274 (25%), Positives = 129/274 (47%), Gaps = 34/274 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKV---EVEAIGRVRHKNLVRLL 141
           +V+G+G YG V       + K  V   LN R  + RE K    E + + +++H N+V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 142 -GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----LTWEIRMNIILGTAKGLSYLH 196
             +  E     +V  +   G+L   L    G   P    + W +++      A  L YLH
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLH 119

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E     ++HRD+K+ N+ + +    KV D G+A++L ++    +T ++GT  Y++PE  S
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFS 175

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
               N +SDV++ G  + E+ + +    ++   +++N + +       R  EG L P +P
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK----HAFNAKDMNSLVY-------RIIEGKL-PPMP 223

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           +  +  L +  L+  +    P  +KRP +  ++ 
Sbjct: 224 KDYSPELGE--LIATMLSKRP--EKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNN------RGQAEREFKVEVEAIGRVRHKNLVR 139
           IGEG YG+V+     +  + VA+K  + +      +  A RE ++    + +++H NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRM----LKQLKHPNLVN 64

Query: 140 LLGYCAEGAHRMLVYEYVNN---GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           L+          LV+EY ++     LE+   G       +   +   II  T + +++ H
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--- 253
           +      +HRD+K  NILI K    K+ DFG A++L       T  V  T  Y APE   
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLV 173

Query: 254 ----YASTGMLNERSDVYSFGILIMEVISG 279
               Y          DV++ G +  E+++G
Sbjct: 174 GDTQYGPP------VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 31/214 (14%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           K IG G YGIV      E N KVA+K   N  +NR  A+R  + E++ +  + H+N++ +
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 141 LGYCAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
                   HR       +VYE ++       LH  +     L+ +     +    +GL Y
Sbjct: 70  KD-IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           +H      V+HRD+K SN+L++ + + K+ DFGLA+    +  ++T  V+ T  Y APE 
Sbjct: 124 IHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL 179

Query: 255 ASTGMLNERS-----DVYSFGILIMEVISGRIPV 283
               +LN        DV+S G +  E++ GR P+
Sbjct: 180 ----LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 78  TNGFSDDKVIGEGGYGIV--YYGLLEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRV 132
           TN + D + +G G +G+V      L     VA+K ++        A+R ++ E++ +  +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66

Query: 133 RHKNLVRLLG-YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           RH+N++ L   + +       V E +   +L + L     P      +  +  IL   +G
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQIL---RG 120

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYV 250
           L Y+H      VVHRD+K SNILI+++ + K+ DFGLA++   + + Y++TR      Y 
Sbjct: 121 LKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172

Query: 251 APEYASTGM-LNERSDVYSFGILIMEVISGR 280
           APE   T    +   D++S G +  E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 60/251 (23%), Positives = 110/251 (43%), Gaps = 23/251 (9%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN------NRGQAEREFKVEVEA 128
           E+  + F     +G G  G+V+    + +  +  + L++       R Q  RE +V  E 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
                   +V   G         +  E+++ G+L+Q L         +  +I   + +  
Sbjct: 61  ----NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 112

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G     +    +GT  
Sbjct: 113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRS 167

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           Y++PE       + +SD++S G+ ++E+  GR P+    PP +   +E +       +P 
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMFGCPVEGDPA 223

Query: 309 GVLDPKLPEKP 319
                  P  P
Sbjct: 224 ESETSPRPRPP 234

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 42/291 (14%)

Query: 86  VIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAE-REFKV-EVEAIGRVRHKNLVRLLG 142
           ++GEG YG+V     ++  + VA+K  L +      ++  + E+  + ++RH+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 143 YCAEGAHRMLVYEYVNN---GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
                    LV+E+V++    +LE++ +G       L        +    +G+ + H   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSH- 119

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE----SSYITTRVMGTFGYVAPEYA 255
              ++HRDIK  NIL+ +    K+ DFG A+ L +     + Y+ TR      Y APE  
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELL 172

Query: 256 STGMLNERS-DVYSFGILIMEVISGR--IPVD------YSRPPEEVNLIEWLKKMVTNRN 306
                  R+ D+++ G L+ E+++G    P D      Y       NLI   +++   +N
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKN 231

Query: 307 P--EGVLDPKLPE-KPTSRLLKRILLVAL----RCVDPNAQKRPKMGHVVH 350
           P   G+  P++ E +P  +   ++  + L    +C+  +   RP    ++H
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           F+D + IG G +G VY+   +  N  VA+K +  +  Q+  +++    EV+ + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYL 195
            +   G         LV EY   G+    L     P      E+ +  I  G  +GL+YL
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAITHGALQGLAYL 141

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY- 254
           H      ++HRDIK+ NIL+ +    K++DFG A +    +S++     GT  ++APE  
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193

Query: 255 --ASTGMLNERSDVYSFGILIMEVISGRIPV 283
                G  + + DV+S GI  +E+   + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           FSD + IG G +G VY+   + ++  VA+K +  +  Q+  +++    EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            ++  G         LV EY   G+    L     P   +  EI   +  G  +GL+YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV--EIAA-VTHGALQGLAYLH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-- 254
                 ++HRD+K+ NIL+ +    K+ DFG A ++   + ++     GT  ++APE   
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184

Query: 255 -ASTGMLNERSDVYSFGILIMEVISGRIPV 283
               G  + + DV+S GI  +E+   + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 13/218 (5%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF---KVEVEAIGRVRHKNL 137
           F+  + IG+G +G V+ G+     KV    +++   +AE E    + E+  + +     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYV 64

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            +  G   +     ++ EY+  G+    L        PL       I+    KGL YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               K +HRDIK++N+L+ +H   K++DFG+A  L +++       +GT  ++APE    
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
              + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 41/275 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLG- 142
           +++G G YG VY G      ++A   +++  G  E E K E+  + +   H+N+    G 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 143 YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +  +    M     LV E+   G++   +    G  + L  E    I     +GLS+LH+
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ 129

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFG----LAKLLGSESSYITTRVMGTFGYVAPE 253
               KV+HRDIK  N+L+ ++   K+ DFG    L + +G  +++I     GT  ++APE
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 181

Query: 254 YAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
             +         + +SD++S GI  +E+  G  P+    P   + LI         RNP 
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPA 233

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P+L  K  S+  +  +     C+  N  +RP
Sbjct: 234 ----PRLKSKKWSKKFQSFI---ESCLVKNHSQRP 261

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 12/198 (6%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IGEG  GIV     + + + VAVK +++ R Q  RE    EV  +   +H+N+V +    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    ++ E++  G L      D+   + L  E    +     + L YLH      V+
Sbjct: 88  LVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGVI 139

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS +IL+      K+SDFG    + S+       ++GT  ++APE  S        
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 265 DVYSFGILIMEVISGRIP 282
           D++S GI+++E++ G  P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K++G+G +G VY     D  + +A K +  +    E   +V     E++ +  ++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 139 RLLGYCAEGAHRMLV--YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   + A + L    EY+  G+++  L         +T +    I+    +G+SYLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTFGYVAPEY 254
             +   +VHRDIK +NIL D   N K+ DFG +K L +   S      V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIP 282
            S      ++DV+S G  ++E+++ + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 41/275 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGY 143
           +V+G G YG VY G      ++A   +++     E E K+E+  + +   H+N+    G 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 144 CAEGA------HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             + +         LV E+   G++   +    G      W     I     +GL++LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLHA 139

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFG----LAKLLGSESSYITTRVMGTFGYVAPE 253
               KV+HRDIK  N+L+ ++   K+ DFG    L + +G  +++I     GT  ++APE
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 191

Query: 254 YAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
             +         + RSD++S GI  +E+  G  P+    P   + LI         RNP 
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPP 243

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               PKL  K  S   K+ +     C+  N   RP
Sbjct: 244 ----PKLKSKKWS---KKFIDFIEGCLVKNYLSRP 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K +G G +G V     + + K  A+K L  ++ +  +  +V     E   +  +RH  LV
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---NIILGTAKGLSYL 195
            L G   + ++  LV EYV  G L   L        P     R     ++L     L YL
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQVVLA----LEYL 117

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGYVAP 252
           H      +V+RD+K  N+L+D     K++DFG AK        +  R     GT  Y+AP
Sbjct: 118 HSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAP 167

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E   +    +  D ++ GILI E+++G  P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 30/171 (17%)

Query: 185 ILG-----TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLGSESSY 238
           ILG       K L YL E  +  V+HRD+K SNIL+D   N K+ DFG++ +L+ S++  
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171

Query: 239 ITTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
             TR  G   Y+APE       N     R+DV+S GI ++E+ +G+ P    +   EV  
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-- 227

Query: 295 IEWLKKMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRPK 344
              L K +    P     P LP  +  S      +     C+  + +KRPK
Sbjct: 228 ---LTK-ILQEEP-----PSLPPNEGFSPDFCSFV---DLCLTKDHRKRPK 266

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 19/203 (9%)

Query: 87  IGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +G GG+G V   L++  S       K   K  +   GQ +     E E +    H  +V+
Sbjct: 1   LGVGGFGRVE--LVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVK 57

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L     +  +  ++ EY   G L   L  D G      +  R   I        YLH   
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD--EYTARF-YIACVVLAFEYLHN-- 111

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +++RD+K  N+L+D +   K+ DFG AK L S     T    GT  YVAPE      
Sbjct: 112 -RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKG 168

Query: 260 LNERSDVYSFGILIMEVISGRIP 282
            +   D +S GIL+ E+++GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 32/217 (14%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNS--KVAVK---NLLNNRGQAEREFKVEVEAIGRVRHK 135
           +   + IG G YG+V   + +  S  KVA+K   +  +    A+R  + E++ +   +H 
Sbjct: 7   YKPIENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHD 64

Query: 136 NLVRLLG-YCAEGAHRMLVYEYVN--NGNLEQWLHGDVGPCSPLTWE-IR--MNIILGTA 189
           N++ +       GA    VY  ++    +L   +H D     PLT E IR  +  +L   
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL--- 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES---SYITTRVMGT 246
           +GL Y+H      V+HRD+K SN+L+++    ++ DFG+A+ L S      Y  T  + T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 247 FGYVAPEYASTGMLNERS---DVYSFGILIMEVISGR 280
             Y APE   +  L E +   D++S G +  E++ GR
Sbjct: 175 RWYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 19/222 (8%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKNLVR 139
           D+ IG G +G+V+      D  +VA+K + N   N    +R F+ E++ +   +H N++ 
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLS 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE-IRMNI--ILGTAKGLSYLH 196
            L              YV    ++  LH  +    PL+ + +++ +  IL   +GL YLH
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLH 120

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-SESSYITTRVMGTFGYVAPEYA 255
                 ++HRDIK  N+L++ +   K+ DFGLA++    ES ++T  V+  + Y APE  
Sbjct: 121 SA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEIL 176

Query: 256 STGMLNERS--DVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
             G  +  S  D++S G +  E++  RI      P ++++LI
Sbjct: 177 -MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 34/281 (12%)

Query: 85  KVIGEGGYGIVY-YGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLG 142
           + IG+G YG VY     +D S  AVK +L+     + E + E   +  +  H N+V+  G
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 143 --YCAE---GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             Y A+   G    LV E  N G++ + + G +     L   +   I+ G   GL +LH 
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               +++HRD+K +NIL+      K+ DFG++  L S      T V GT  ++APE  + 
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202

Query: 258 GM-----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                   + R DV+S GI  +E+  G  P+    P + +  I         RNP   L 
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--------RNPPPTL- 253

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
              PEK        I     +C+  + + RP    V H+LE
Sbjct: 254 -LHPEKWCRSFNHFI----SQCLIKDFEARPS---VTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 56/284 (19%), Positives = 121/284 (42%), Gaps = 49/284 (17%)

Query: 86  VIGEGGYGIVYYGLLEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +I E     +Y G+  +N +V ++                + E++ + R+   N++++ G
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 143 Y----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +      +     L+ EY   G L + L  +      L+++ ++++ +   KGL  L++ 
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK- 140

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYAST 257
                 ++++ S + L+ +++  K+   GL K+L S     +   V          Y S 
Sbjct: 141 -YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----------YFSY 189

Query: 258 GMLN-------ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL-IEWLKKMVTNRNPEG 309
            MLN        + D+YS G+++ E+ +G+IP +        NL  + +  ++ N+N   
Sbjct: 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE--------NLTTKEIYDLIINKNNSL 241

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            L    P       +K I+     C   ++ KRP +  +++ L 
Sbjct: 242 KLPLDCP-----LEIKCIV---EACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 33/261 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K++G+G +G VY     D  + +AVK +  +    E   +V     E++ +  + H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 139 RLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   +   R L    E++  G+++  L         +T +    I+    +G+SYLH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTFGYVAPEY 254
             +   +VHRDIK +NIL D   N K+ DFG +K L +   S      V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDP 313
            S      ++D++S G  ++E+++        +PP  E   +  + K+ T        +P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLT-------EKPPWAEFEAMAAIFKIATQPT-----NP 228

Query: 314 KLP---EKPTSRLLKRILLVA 331
            LP          LKRI + A
Sbjct: 229 VLPPHVSDHCRDFLKRIFVEA 249

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 59/229 (25%), Positives = 115/229 (50%), Gaps = 30/229 (13%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYGLL--EDNSK---VAVKNLLNNRGQAEREFKV-EVE 127
           + +S +  +   ++ EG +G ++YG+L  E   K   V VK + ++  + +    + E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 128 AIGRVRHKNLVRLLGYCAE-GAHRMLVYEYVNNGNLEQWL----HGDVGPCSPLTWEIRM 182
            +  + H+N++ +L  C E G    ++Y Y+N GNL+ +L     G+      L+ +  +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--------LLGS 234
           ++ +  A G+SYLH+     V+H+DI + N +ID+    K++D  L++         LG 
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG- 176

Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           ++     + M      A E       +  SDV+SFG+L+ E+++ G+ P
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 39/99 (39%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I +   KGL+YL   L  K++HRD+K SN+L++     K+ DFG++  L +    I    
Sbjct: 100 IAVAVVKGLTYLW-SL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTY 153

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +GT  Y+APE  S       SDV+S GI  ME+  GR P
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGY 143
           IGEG YG V+     E +  VA+K + L++  +      + E+  +  ++HKN+VRL   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY +  +L+++     G   P   +  M  +L   KGL++ H      V
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRD+K  N+LI+K+   K++DFGLA+  G      +  V+ T  Y  P+      L   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179

Query: 264 S-DVYSFGILIMEVISGRIPV 283
           S D++S G +  E+ +   P+
Sbjct: 180 SIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 37/214 (17%)

Query: 85  KVIGEGGYGIV---YYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           K IG G  GIV   Y  +   N  VA+K L     N   A+R ++ E+  +  V HKN++
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNII 78

Query: 139 RLLGY------CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKG 191
            LL          E     LV E ++  NL Q +  D      L  E RM+ +L     G
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHE-RMSYLLYQMLCG 130

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFG 248
           + +LH      ++HRD+K SNI++      K+ DFGLA+  G+    + Y+ TR      
Sbjct: 131 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 182

Query: 249 YVAPEYASTGM-LNERSDVYSFGILIMEVISGRI 281
           Y APE    GM   E  D++S G ++ E+I G +
Sbjct: 183 YRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTV 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 30/208 (14%)

Query: 87  IGEGGYGIVYYGLLED---NSKVAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKNLV 138
           IGEG YG+VY     D   N  +A+K +   R + E E        E+  +  ++H N+V
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL           LV+EY++   L+   H D  P       +    +    +G++Y H  
Sbjct: 65  RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
              +V+HRD+K  N+LID+  N  K++DFGLA+  G      T  V+ T  Y APE    
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI--- 174

Query: 258 GMLNERS-----DVYSFGILIMEVISGR 280
            +L  R      D++S G +  E+++ +
Sbjct: 175 -LLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 49/225 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVK-------NLLNNRGQAEREFKVEVEAIGRV 132
           + +   IGEG YG+V          KVA+K            R    RE K+    + R 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR--TLREIKI----LRRF 60

Query: 133 RHKNLVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
           +H+N++ +L               +V E      +E  L+  +     L+ +     +  
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY-KLIKTQHLSNDHIQYFLYQ 114

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-------SYIT 240
             +GL Y+H      V+HRD+K SN+L++ + + K+ DFGLA++   E         Y+ 
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 241 TRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           TR      Y APE     MLN +      D++S G ++ E++S R
Sbjct: 172 TR-----WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 49/287 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV--EVEAIGRVR---HKNLVRL 140
           IG G YG VY      +   VA+K++     +         EV  + R+    H N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 141 LGYCA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           +  CA           LV+E+V+  +L  +L     P  P   E   +++    +GL +L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           H      +VHRD+K  NIL+      K++DFGLA++   + +   T V+ T  Y APE  
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVL 179

Query: 256 STGMLNERSDVYSFGILIMEVIS--------------GRIPVDYSRPPEEVNLIEWLKKM 301
                    D++S G +  E+                G+I      PPE+    +W + +
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED----DWPRDV 235

Query: 302 VTNRNPEGVLDPKLPEKPTSRLLKRI------LLVALRCVDPNAQKR 342
                P G   P+ P +P   ++  I      LL+ +   +P   KR
Sbjct: 236 TL---PRGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNP--HKR 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           K IG G +G V  G  E NS     +V VK L  +   Q + +F  E +    ++H NL+
Sbjct: 1   KEIGNGWFGKVILG--EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH----GDVGPCSPLTWEIRMNIILGTAKGLSY 194
           + LG C E    +LV E+   G+L+ +L      ++    P T + RM   +  A GL +
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLH 115

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPE 253
           LH+      +H D+   N L+      K+ D+GL+     E  Y+T  ++     ++APE
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Query: 254 YASTGMLN-------ERSDVYSFGILIMEV 276
                  N       + S+V+S G+ I E+
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K++G G +G VY     D  + +AVK +  +    E   +V     E++ +  +RH  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 139 RLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   +   + L    EY+  G+++  L         LT  +         +G+SYLH
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTFGYVAPEY 254
             +   +VHRDIK +NIL D   N K+ DFG +K + +   S      V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIP 282
            S      ++DV+S    ++E+++ + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 55/245 (22%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLG--- 142
           +G+G +G VY    ++   +A   +++ + + E E + VE++ +    H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 143 ----------YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKG 191
                     +CA GA   ++ E      LE+          PLT E ++ ++   T + 
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLE------LER----------PLT-EPQIRVVCKQTLEA 115

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA----KLLGSESSYITTRVMGTF 247
           L+YLHE    K++HRD+K+ NIL     + K++DFG++    + +    S+I     GT 
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTP 167

Query: 248 GYVAPEYASTGMLNER-----SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV 302
            ++APE        +R     +DV+S GI ++E+           P  E+N +  L K+ 
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM------AQIEPPHHELNPMRVLLKIA 221

Query: 303 TNRNP 307
            +  P
Sbjct: 222 KSEPP 226

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 78/293 (26%), Positives = 116/293 (39%), Gaps = 58/293 (19%)

Query: 87  IGEGGYGIVYYG--LLEDNSKVAVKNLLNNRGQAE---------REFKVEVEAIGRVRHK 135
           IGEG YG V+    L      VA+K +   R Q           RE  V +  +    H 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAV-LRHLETFEHP 64

Query: 136 NLVRLLGYCA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++    +
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLLR 121

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL +LH     +VVHRD+K  NIL+      K++DFGLA++   +     T V+ T  Y 
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176

Query: 251 APEYASTGMLNERSDVYSFGILIMEVIS--------------GRIPVDYSRPPEEVNLIE 296
           APE           D++S G +  E+                G+I      P EE    +
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE----D 232

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI------LLVALRCVDPNAQKRP 343
           W + +     P      K   +P  + +  I      LL  L+C+  N  KR 
Sbjct: 233 WPRDVAL---PRQAFHSK-SAQPIEKFVTDIDELGKDLL--LKCLTFNPAKRI 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 40/213 (18%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKNLVRL 140
           IGEG YG+VY G   +    VA+K +   R ++E E        E+  +  ++H N+V L
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                + +   L++E+++  +L+++L             +     +      SYL++ L+
Sbjct: 65  QDVLMQESRLYLIFEFLSM-DLKKYLD-----------SLPKGQYMDAELVKSYLYQILQ 112

Query: 201 P-------KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
                   +V+HRD+K  N+LID     K++DFGLA+  G      T  V+ T  Y APE
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPE 171

Query: 254 YA------STGMLNERSDVYSFGILIMEVISGR 280
                   ST +     D++S G +  E+ + +
Sbjct: 172 VLLGSPRYSTPV-----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +G G YG V      +   +VAVK L     +   A+R ++ E+  +  ++H+N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                       E  N+  L   L G    ++  C  LT +    +I    +GL Y+H  
Sbjct: 84  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYAST 257
               ++HRD+K SN+ +++    K+ DFGLA+    E + Y+ TR      Y APE    
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 191

Query: 258 GM-LNERSDVYSFGILIMEVISGR 280
            M  N+  D++S G ++ E+++GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 54/162 (33%), Positives = 74/162 (45%), Gaps = 21/162 (12%)

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           E     RH  LV L        H   V EY   G+L   +H DV    P        ++L
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVVL 112

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL-LGSESSYITTRVMG 245
           G    L YLHE    K+V+RD+K  N+L+D     K++DFGL K  +G      T+   G
Sbjct: 113 G----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCG 163

Query: 246 TFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           T  ++APE     +L E S     D +  G+LI E++ G  P
Sbjct: 164 TPEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 67/269 (24%), Positives = 123/269 (45%), Gaps = 39/269 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLG-YC 144
           +G+G +G VY    ++   +A   ++  + + E E + VE+E +    H  +V+LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 145 AEGAHRMLVYEYVNNGNLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
            +G   +++ E+   G ++   L  D G   P   +I++ I     + L YLH     K+
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLA----KLLGSESSYITTRVMGTFGYVAPEYASTGM 259
           +HRD+K+ N+L+    + K++DFG++    K L    S+I     GT  ++APE      
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186

Query: 260 LNE-----RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
           + +     ++D++S GI ++E+           P  E+N +  L K +    P  +  P 
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM------AQIEPPHHELNPMRVLLK-IAKSEPPTLSQPS 239

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                    LK  L       D + + RP
Sbjct: 240 KWSMEFRDFLKTAL-------DKHPETRP 261

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA 145
           +G G YG VY    L      AVK +    G      + E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
                 +  EY   G+L+   H   GP S L       +   T +GL+YLH   +   +H
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY---VCRETLQGLAYLHSKGK---MH 129

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYAS---TGML 260
           RDIK +NIL+  + + K++DFG+A  +   ++ I  R   +GT  ++APE A+    G  
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKI---TATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 261 NERSDVYSFGILIMEV 276
           N+  D+++ GI  +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGY 143
           + IG+G YG V+  L + N   A   +L+     + E + E   +  +  H N+V+  G 
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 144 -----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                   G    LV E  N G++   + G +     +   I   I+     GL +LH  
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST- 257
              K +HRD+K +NIL+      K+ DFG++  L S      T V GT  ++APE  +  
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 199

Query: 258 ----GMLNERSDVYSFGILIMEVISGRIPV 283
                  + R DV+S GI  +E+  G  P+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 20/213 (9%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLG-Y 143
           +G+G YG VY  L        A+K +     +++  +  +E++ + +     +V   G +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             EGA  M + EY++ G+L++ L+        +  ++   I     KGL +L E  E  +
Sbjct: 69  FIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRD+K +N+L++ +   K+ DFG++  L   +S   T + G   Y+APE   +G  N+ 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQN 181

Query: 264 ------SDVYSFGILIMEVISGRIPVDYSRPPE 290
                 SDV+S G+ I+E+  GR P     PPE
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPY----PPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 18/172 (10%)

Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+++ G+L+Q L         +  EI   + +   +GL+YL E  + +++HRD+K SNIL
Sbjct: 83  EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136

Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
           ++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 275 EVISGRIPVDYSRPPEEVNLIEWL--KKMVTNRNPEG---VLDPKLPEKPTS 321
           E+  GR P+    PP +   +E +  + +V     E       P+ P +P S
Sbjct: 194 ELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 40/268 (14%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           F     IG G +G VY+      N  VAVK +  +  Q   +++    EV+ + +++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            +   G   +     LV EY   G+    L     P   +  EI   I  G  +GL+YLH
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEV--EIAA-ITHGALQGLAYLH 138

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-- 254
                 ++HRDIK+ NIL+ +    K++DFG A      +S++     GT  ++APE   
Sbjct: 139 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190

Query: 255 -ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP------ 307
               G  + + DV+S GI  +E ++ R P     P   +N +  L  +  N +P      
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIE-LAERKP-----PLFNMNAMSALYHIAQNDSPTLQSNE 244

Query: 308 -----EGVLD---PKLP-EKPTSRLLKR 326
                 G +D    K+P E+P S  L R
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 41/219 (18%)

Query: 86  VIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVR 139
            IGEG YG VY    +D    VA+K +   R   E+E F +    E++ + ++ H+N+V 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 140 L----------LGYCAEGAHRMLVYEYVNN---GNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           L          L +  +     LV+EY+++   G LE  L          + +   + + 
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-------VHFSEDHIKSFMK 123

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
              +GL+Y H+      +HRDIK SNIL++     K++DFGLA+L  SE S   T  + T
Sbjct: 124 QLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 247 FGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
             Y  PE     +L E       DV+S G ++ E+ + +
Sbjct: 181 LWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 60/223 (26%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKN-LLNNRGQ-----AEREFKVEVEAIGRVRHKNLVR 139
           IG+G +G V+    +   + VA+K  L+ N  +     A RE K+    +  ++H+N+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKI----LQLLKHENVVN 75

Query: 140 LLGYC---AEGAHR-----MLVYEY--------VNNGNLEQWLHGDVGPCSPLTWEIR-- 181
           L+  C   A   +R      LV+E+        ++N N++  L            EI+  
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS-----------EIKKV 124

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL----GSESS 237
           M ++L    GL Y+H     K++HRD+K++NILI K    K++DFGLA+       S+ +
Sbjct: 125 MKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
             T RV+ T  Y  PE     +L ER      D++  G ++ E
Sbjct: 179 RYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLG 142
           +G+GG+G V    +++  K+ A K L   R +    E+   +E E + +V    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMN-IILGTAK---GLSYLH 196
                 H  LV   +N G+L+  ++  G+ G        + M  +I  +A+   G+ +LH
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILHLH 112

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +V+RD+K  N+L+D   N ++SD GLA  L    +   T+  GT GY+APE   
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILK 167

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               +   D ++ G  I E+++GR P
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKN 136
           KV+G+G +G V    L+        KV  K+++      E    E +V   A    +H  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA---GKHPF 57

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           L +L            V EYVN G+L   +        P        I+LG    L +LH
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLH 113

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFGYVAPEY 254
           E     +++RD+K  N+L+D   + K++DFG+ K  +LG  +   T+   GT  Y+APE 
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEI 167

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            S        D ++ G+L+ E+++G+ P +
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 31/280 (11%)

Query: 84  DKVIGEGGYGIVYYG-LLEDNSKVAVKNL--------LNNRGQAEREFKVEVEAIGRVR- 133
            +V+G G  G V     + D    AVK +          NR QAE    +  +    V+ 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 134 HKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           H++  +      E    + LV +Y N G+L Q +                 + +     +
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVA 251
            ++H      ++HRDIKS+NIL+  +   K+ DFG +K+  +  S    R   GT  YVA
Sbjct: 157 HHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           PE       ++++D++S G+L+ E+++ +      RP +  N+ E     V ++   G  
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLK------RPFDGENMEE-----VMHKTLAGRY 262

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           DP LP   +  +  + ++ AL   DP  ++RP    +++M
Sbjct: 263 DP-LPPSISPEM--QEIVTALLSSDP--KRRPSSSKLLNM 297

Length = 496

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 33/216 (15%)

Query: 81  FSDDKVIGEGGYGIV---YYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRH 134
           + + K IG G  GIV   Y  +LE N  VA+K L     N+  A+R ++ E+  +  V H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82

Query: 135 KNLVRLLGY-----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL 186
           KN++ LL         E    + +   + + NL          C  +  E+   RM+ +L
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL----------CQVIQMELDHERMSYLL 132

Query: 187 -GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
                G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G  +S++ T  + 
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV 187

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           T  Y APE        E  D++S G ++ E+I G +
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 35/217 (16%)

Query: 81  FSDDKVIGEGGYGIV---YYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRH 134
           + + K IG G  GIV   Y  +L+ N  VA+K L     N+  A+R ++ E+  +  V H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 135 KNLVRLLGY------CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNII 185
           KN++ LL          E     LV E +           D   C  +  E+   RM+ +
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELM-----------DANLCQVIQMELDHERMSYL 124

Query: 186 L-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           L     G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G  +S++ T  +
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 179

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
            T  Y APE        E  D++S G ++ E++  +I
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 17/134 (12%)

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLGS-ESSYITTRVMGTF 247
           +GL+YL E  + K++HRD+K SNIL++     K+ DFG++ +L+ S  +S++ TR     
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR----- 162

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE         +SD++S G+ ++E+  GR P+    PP +   +E     +  R  
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAKELE----AMFGRPV 214

Query: 308 EGVLDPKLPEKPTS 321
                 +     + 
Sbjct: 215 SEGEAKESHRPVSG 228

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           K IG G  GIV      D      VAVK L     N+  A+R ++ E+  +  V HKN++
Sbjct: 27  KPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNII 83

Query: 139 RLLGY------CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKG 191
            LL          E     LV E ++  NL Q +H ++          RM+ +L     G
Sbjct: 84  SLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD-------HERMSYLLYQMLCG 135

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + +LH      ++HRD+K SNI++      K+ DFGLA+   + ++++ T  + T  Y A
Sbjct: 136 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRA 190

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRI 281
           PE        E  D++S G ++ E++ G +
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 76/264 (28%), Positives = 118/264 (44%), Gaps = 28/264 (10%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNR---GQAEREFKVEVEAIGRVRHKN 136
           F   +V+G+GG+G V    +    K+ A K L   R    + E     E + + +V  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLS 193
           +V L  Y  E    + LV   +N G+L+  ++  G+ G            I  G    L 
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LE 116

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
            LH+    ++V+RD+K  NIL+D H + ++SD GLA  +  E   I  RV GT GY+APE
Sbjct: 117 DLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYMAPE 171

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                      D ++ G L+ E+I+G+ P    +   +   +E L K V     E     
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF--- 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDP 337
                P +R L ++LL    C DP
Sbjct: 229 ----SPDARSLCKMLL----CKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 85  KVIGEGGYGIV----------YYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           KVIG+G +G V          +Y +     K  +K    N   AER   ++      ++H
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK-----NLKH 55

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGL 192
             LV L  Y  + A ++  V +YVN G L  + H     C     E R        A  +
Sbjct: 56  PFLVGL-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERC---FLEPRARFYAAEVASAI 109

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      +++RD+K  NIL+D   +  ++DFGL K  G E    T+   GT  Y+AP
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAP 165

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR 287
           E       +   D +  G ++ E++ G +P  YSR
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG-LPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 65/234 (27%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLVR 139
           +GEG +G VY    ++    VA+K +L +  +      A RE K+    + +++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI----LKKLKHPNVVP 71

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----------------LTWEIRMN 183
           L+          +  E  +     +   G V   +P                LT      
Sbjct: 72  LID---------MAVERPDK---SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL----------- 232
            +L   +G++YLHE     ++HRDIK++NILID     K++DFGLA+             
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 233 -GSESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            G    Y  T ++ T  Y  PE     +L ER      D++  G +  E+ + R
Sbjct: 177 GGGTRKY--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)

Query: 85  KVIGEGGYGIVYY----GLLEDNS----KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
           +V+G G YG V+     G  +       KV  K  +  + +     + E + +  VR   
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGLSY 194
            +  L Y  +   ++ L+ +YVN G L   L+           E  + + +      L +
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDH 120

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LH+     +++RDIK  NIL+D   +  ++DFGL+K   +E         GT  Y+APE 
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 255 ASTGML--NERSDVYSFGILIMEVISGRIP 282
              G    ++  D +S G+L  E+++G  P
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 85  KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFK---VEVEAIGRV-RHKNLVR 139
           K++G+G +G V+   L+  N   A+K L  +    + + +   VE   +     H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLE---QWLHG-DVGPCSPLTWEIRMNIILGTAKGLSYL 195
           L        +   V EY+N G+L    Q  H  D+   +    EI          GL +L
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--------GLQFL 112

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFGYVAPE 253
           H      +V+RD+K  NIL+D   + K++DFG+ K  +LG      T    GT  Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPE 166

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIP 282
                  N   D +SFG+L+ E++ G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 31/254 (12%)

Query: 85  KVIGEGGYGIV----------YYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           K++G+G +G V          YY +     K+  K ++  + +       E   +   RH
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAM-----KILKKEVIIAKDEVAHTL-TESRVLKNTRH 54

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
             L  L  Y  +   R+  V EYVN G L   L  +       T      I+      L 
Sbjct: 55  PFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SALD 109

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH G   K+V+RD+K  N+++DK  + K++DFGL K   ++++ + T   GT  Y+APE
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPE 165

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE---EVNLIEWLKKMVT-NRNPEG 309
                      D +  G+++ E++ GR+P  Y++  E   E+ L+E +K   T + + + 
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEDIKFPRTLSADAKS 224

Query: 310 VLDPKLPEKPTSRL 323
           +L   L + P  RL
Sbjct: 225 LLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 21/207 (10%)

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           E   +   RH  L  L  Y  +   R+  V EY N G L   L  +              
Sbjct: 45  ESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITT 241
           I+      L YLH      VV+RD+K  N+++DK  + K++DFGL K      S      
Sbjct: 104 IVSA----LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 153

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE---EVNLIEWL 298
              GT  Y+APE           D +  G+++ E++ GR+P  Y++  E   E+ L+E +
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEI 212

Query: 299 KKMVTNRNPEG--VLDPKLPEKPTSRL 323
            +     +PE   +L   L + P  RL
Sbjct: 213 -RFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 75/248 (30%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQ-----AEREFKVEVEAIGRV 132
           KVIG G +G V+  L+ D         KV  K+ +  R Q     AER+   +  A    
Sbjct: 7   KVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--ADSPW 62

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAK- 190
               +V+L     +  H  LV EY+  G+L             +   IR ++    TA+ 
Sbjct: 63  ----IVKLYYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARF 105

Query: 191 -------GLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK------------ 230
                   L  +H+ G     +HRDIK  NILID   + K++DFGL K            
Sbjct: 106 YIAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 231 -----------LLGSESSYITTRVM-----GTFGYVAPEYASTGMLNERSDVYSFGILIM 274
                      +L     +   RV      GT  Y+APE           D +S G+++ 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 275 EVISGRIP 282
           E++ G  P
Sbjct: 222 EMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 40/234 (17%)

Query: 85  KVIGEGGYGIV---YYGLLEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVR-HKNL 137
           K +G+G YGIV         +   VA+K   N+ + +  A+R  + E++ +   R HKN+
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNI 64

Query: 138 VRL--LGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             L  +     G    L +YE +   +L Q +        PLT     + I     GL Y
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKY 120

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL----GSESSYITTRVMGTFGYV 250
           +H      V+HRD+K  N+L++     K+ DFGLA+      G  + ++T  V  T  Y 
Sbjct: 121 IHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYR 176

Query: 251 APEYASTGMLNERS-----DVYSFGILIMEVISGRIPV----DYSRPPEEVNLI 295
           APE     ML+ +S     DV+S G ++ E++ GR PV    DY    +++N I
Sbjct: 177 APEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYV---DQLNQI 222

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 31/212 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSK-------VAVKNLLNNRGQAEREFKVEVEAIG---RVRHKN 136
           +G+G +  +Y G+L   S          V  +L   G   R+     E      ++ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L G C    + M V EYV  G L+ +LH +      L W  ++++    A  L YL 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHRE-KNNVSLHW--KLDVAKQLASALHYLE 118

Query: 197 EGLEPKVVHRDIKSSNILIDKH-----WNP--KVSDFGLAKLLGSESSYITTRVMGTFGY 249
           +    K+VH ++   NIL+ ++     + P  K+SD G+   + S       R+     +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-EERVERI----PW 170

Query: 250 VAPEYASTGMLNERS--DVYSFGILIMEVISG 279
           +APE    G  +     D +SFG  ++E+ S 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)

Query: 85  KVIGEGGYGIVY-------------YGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR 131
           KV+G+G +G V+             Y +     KV  K  L  R +     K+E + +  
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAM-----KVLKKATLKVRDRVRT--KMERDILAE 54

Query: 132 VRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E     +   A 
Sbjct: 55  VNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELAL 109

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGY 249
            L +LH  L   +++RD+K  NIL+D+  + K++DFGL+K  +  E         GT  Y
Sbjct: 110 ALDHLH-SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEY 164

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +APE  +     + +D +SFG+L+ E+++G +P       E + +I
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 55/160 (34%), Positives = 79/160 (49%), Gaps = 15/160 (9%)

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           E   +  V H  ++RL  +  E   R L  + EYV  G L  +L  + G  S  T     
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYA 107

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
           + I+     L YLH   E  +V+RD+K  NIL+DK  + K++DFG AK L       T  
Sbjct: 108 SEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT 157

Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           + GT  Y+APE   +   N+  D ++ GILI E++ G  P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           +E   +  V H +++R+      GA   +V  + ++ +L  +L     P   L  +  + 
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRP---LPIDQALI 161

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I     +GL YLH     +++HRD+K+ NI I+      + D G A+      +++   +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPPEE--VNLIEWLK 299
            GT    APE  +    N ++D++S GI++ E+++    I  D    PEE   +    L 
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 300 KMVTNR--NPEGVLDPKLPEKPTSRL 323
           K+++    +PE     + P  P SRL
Sbjct: 277 KIISTLKVHPE-----EFPRDPGSRL 297

Length = 357

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 14/154 (9%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE- 308
           APE    G+  + S D +S G ++ +++ G  P    +  ++      + +M      E 
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAVEL 218

Query: 309 -GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
                P+L       LL+R +   L C+   AQ+
Sbjct: 219 PDSFSPEL-RSLLEGLLQRDVNRRLGCLGRGAQE 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 22/250 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA-----IGRVRHKNLVR 139
           KVIG+G +G V     + + K     +L  +   +++ +  + A     +  V+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGLSYLHE 197
           L  Y  + A ++  V +YVN G L  + H       P   E R        A  L YLH 
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHS 114

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                +++RD+K  NIL+D   +  ++DFGL K  G E S  T+   GT  Y+APE    
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIEWLKKMVTNRNPE--GVLDP 313
              +   D +  G ++ E++ G +P  YSR   E+  N++    ++  N +     +L+ 
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG-LPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEG 229

Query: 314 KLPEKPTSRL 323
            L +  T RL
Sbjct: 230 LLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 87  IGEGGYGIVYYGL--LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  V+ G   L +N  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY+++ +L+Q+L       S    +I M  +L   +GLSY H+    K+
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKI 124

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP-------EYAS 256
           +HRD+K  N+LI++    K++DFGLA+     +   +  V+ T  Y  P       EY++
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
                   D++  G ++ E+ +GR     S   EE++LI
Sbjct: 184 P------IDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 13/213 (6%)

Query: 87  IGEGGYGIVYYGL--LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  V+ G   L +N  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY++  +L+Q++       S    +I +  IL   +GL+Y H     KV
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHR---RKV 125

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNE 262
           +HRD+K  N+LI++    K++DFGLA+     +   +  V+ T  Y  P+    +   + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           + D++  G +  E+ SGR     S   +E++LI
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 13/226 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV----AVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +VIG G Y  V    L+ N ++     VK  L +  +     + E     +      +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 141 LGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  C +   R+ LV EYVN G+L   +         L  E            L++LHE  
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHE-- 114

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE      
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR 305
                D ++ G+L+ E+++GR P D      ++N  ++L +++  +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 12/204 (5%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +VIG+G YG+V   +      KVA+K   ++  +   A R  + E++ +  +RH ++V +
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEI 64

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                  + R     YV    +E  LH  +     LT E     +    + L Y+H    
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA-- 122

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFGYVAPEYAST- 257
             V HRD+K  NIL +     K+ DFGLA+     + ++   T  + T  Y APE   + 
Sbjct: 123 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181

Query: 258 -GMLNERSDVYSFGILIMEVISGR 280
                   D++S G +  EV++G+
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 28/248 (11%)

Query: 85  KVIGEGGYGIVYYG---LLEDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRL 140
             IG G +G V  G        ++V VK L  +    E+  F  EV+    + H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW-EIRMNIILGTAKGLSYLHEGL 199
           LG C E    +LV E+   G+L+ +L  + G  + +   ++   +    A GL +LH+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FGYVAPEYAS-- 256
               +H D+   N  +    + K+ D+GLA     E  YIT         ++APE     
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 257 -----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
                     ++S+++S G+ + E+ +        +P  +++  + LK++V  +      
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQ------ 226

Query: 312 DPKLPEKP 319
           D KLP KP
Sbjct: 227 DIKLP-KP 233

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 28/220 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL-----LNNRGQ----AEREFKVEVEAIGRVRH 134
           KVIG+G +G V     + + K  AVK L     LN + Q    AER   ++      V+H
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK-----NVKH 55

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI-ILGTAKGL 192
             LV L  Y  +   ++  V ++VN G L  + H       P   E R        A  L
Sbjct: 56  PFLVGL-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYAAEIASAL 109

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      +V+RD+K  NIL+D   +  ++DFGL K  G   S  TT   GT  Y+AP
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAP 165

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           E       +   D +  G ++ E++ G +P  Y R   E+
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG-LPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 28/208 (13%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           K +G G YG V   +      KVA+K L     +   A+R ++ E+  +  ++H+N++ L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL 79

Query: 141 LGY--CAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           L     A          LV  Y+   +L++ +        PL+ +    ++     GL Y
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKY 132

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPE 253
           +H      ++HRD+K  N+ +++    K+ DFGLA+   +E + Y+ TR      Y APE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184

Query: 254 YASTGM-LNERSDVYSFGILIMEVISGR 280
                M  N+  D++S G ++ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA--IGRVRHKNLVRLLGYC 144
           +GEG Y  VY G  + N K+    ++  + +    F    EA  +  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  LV+EYV+  +L Q++    G   P   ++ +  +L   +GLSY+H+     ++
Sbjct: 73  HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNER 263
           HRD+K  N+LI      K++DFGLA+     S   +  V+ T  Y  P+    +   +  
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184

Query: 264 SDVYSFGILIMEVISG 279
            D++  G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 78/278 (28%), Positives = 122/278 (43%), Gaps = 52/278 (18%)

Query: 79  NGFSDDKVIGEGGYGIVYYGLL---EDNSKVAVKNL----LNNRGQAEREFKVEVEAIGR 131
             F   K+I  G YG VY  L+   E   + A+K +    L  R Q ++ F VE + +  
Sbjct: 1   EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTF 57

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
             +  +V +        H  +V EYV  G+    L  ++G    L  ++       T   
Sbjct: 58  AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGA---LPVDMARMYFAETVLA 113

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL-LGSESS------------- 237
           L YLH      +VHRD+K  N+LI    + K++DFGL+K+ L S ++             
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV----- 292
           ++  +V GT  Y+APE        +  D ++ GI++ E + G +P  +   PEE+     
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDTPEELFGQVI 229

Query: 293 -NLIEWLKKMVTNRNPEGVLDPKLPEKP---TSRLLKR 326
            + IEW         PEG  D  LP       SRLL++
Sbjct: 230 SDDIEW---------PEG--DEALPADAQDLISRLLRQ 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 28/253 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRL 140
           +V+G+G +G V    L+++ ++ AVK L  +    + + +    E   +   R+   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 141 LGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGLSYLHEG 198
           L  C +   R+  V E+VN G+L    H  +        E R           L +LH+ 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL--MFH--IQKSRRFD-EARARFYAAEITSALMFLHD- 114

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               +++RD+K  N+L+D   + K++DFG+ K  G  +   T+   GT  Y+APE     
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPE--------EVNLIEWLKKMVTNRNPEGV 310
           +     D ++ G+L+ E++ G  P +     +        EV    WL +     +   +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ-----DAVDI 226

Query: 311 LDPKLPEKPTSRL 323
           L   + + PT RL
Sbjct: 227 LKAFMTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 13/205 (6%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV----AVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +VIG G Y  V    L+   ++     VK  L N  +     + E     +  +   +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 141 LGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  C +   R+  V EYVN G+L   +         L  E         +  L+YLHE  
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE-- 114

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE      
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 260 LNERSDVYSFGILIMEVISGRIPVD 284
                D ++ G+L+ E+++GR P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 66/266 (24%), Positives = 118/266 (44%), Gaps = 45/266 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA 145
           IG G YG VY    +      A+K +    G+     + E+  +   +H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
                 +  E+   G+L+   H   GP S         +   T +GL YLH   +   +H
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAY---VSRETLQGLYYLHSKGK---MH 129

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYAST---GML 260
           RDIK +NIL+  + + K++DFG++  +   ++ I  R   +GT  ++APE A+    G  
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 261 NERSDVYSFGILIMEVISGRIPV--------------DYSRPPEEVNLIEW------LKK 300
           N+  D+++ GI  +E+   + P+                 +PP+  + ++W        K
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246

Query: 301 MVTNRNPEGVLDPKLPEKPTS-RLLK 325
           M   +NP+        ++PT+ +LL+
Sbjct: 247 MALTKNPK--------KRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH     ++V+RD+K  NIL+D + + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYM 168

Query: 251 APEYASTGMLNER----SDVYSFGILIMEVISGRIP 282
           APE       NER     D +  G LI E+I G+ P
Sbjct: 169 APEVVK----NERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 39/218 (17%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKN 136
           + D K +G G YG V   L     +KVA+K L     +   A+R ++ E+  +  ++H+N
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQW---------LHGDVGPC---SPLTWEIRMNI 184
           ++ LL              +  + +L+++         +  D+G       L+ +    +
Sbjct: 76  VIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRV 243
           +    KGL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   SE + Y+ TR 
Sbjct: 124 VYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR- 179

Query: 244 MGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR 280
                Y APE     M   +  D++S G ++ E+++G+
Sbjct: 180 ----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 24/224 (10%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEV 126
           +R+L++    +   KVIG G +G V     + + KV    LL+     +R     F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-DVGPCSPLTWE--IRMN 183
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAKFYTAE 150

Query: 184 IILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
           ++L     L  +H  GL    +HRD+K  N+L+DKH + K++DFG    +          
Sbjct: 151 VVLA----LDAIHSMGL----IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 243 VMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIP 282
            +GT  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +G G YG V          KVAVK L     +   A R ++ E+  +  ++H+N++ LL 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                       E     NL      ++  C  L+ E    +I    +GL Y+H      
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---G 138

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-L 260
           ++HRD+K SN+ +++    ++ DFGLA+    E + Y+ TR      Y APE     M  
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHY 193

Query: 261 NERSDVYSFGILIMEVISGRI 281
           N+  D++S G ++ E++ G+ 
Sbjct: 194 NQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 49/232 (21%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE------------------REFKV 124
              +GEG YG V           VA+K +       +                  RE K+
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
             E    ++H+N++ L+    EG    LV + +   +L++ +   +     LT      I
Sbjct: 74  MNE----IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCI 124

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--------SES 236
           +L    GL+ LH+      +HRD+  +NI I+     K++DFGLA+  G        S+ 
Sbjct: 125 LLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 237 SY------ITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 280
                   +T++V+ T  Y APE    +    +   D++S G +  E+++G+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 37/291 (12%)

Query: 81  FSDDKVIGEGGYGIVYYGLL--EDNS--KVAVKNL---LNNRGQAEREFKVEVEAIGRVR 133
           F+  +++G+G +G V    L  ED S  KVAVK L   + +    E EF  E   +    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 134 HKNLVRLLGYCAEGAHR------MLVYEYVNNGNLEQWLHGDVGPCSPLTW--EIRMNII 185
           H N+++L+G       +      M++  ++ +G+L  +L        P T   +  +  +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
           +  A G+ YL        +HRD+ + N +++++    V+DFGL+K + S   Y       
Sbjct: 120 IDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 246 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT 303
               ++A E  +  +    SDV++FG+ + E+++ G+ P  Y+   E   +  +L K   
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YA-GVENSEIYNYLIKGNR 233

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            + P     P   E         +  +  +C  P  + RP   H+   LE 
Sbjct: 234 LKQP-----PDCLED--------VYELMCQCWSPEPKCRPSFQHLRDQLEL 271

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 79  NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE-REFKV-EVEAIGRVRHK 135
           N F    V+GEG YG+V      E    VA+K   ++    E +E  + E++ +  ++ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V L           LV+EYV    LE     +  P      ++R + I    K + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKAIHWC 116

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPE 253
           H+     +VHRDIK  N+LI  +   K+ DFG A+ L  GS ++Y  T  + T  Y +PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRSPE 171

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
                   +  D++S G ++ E+  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 7/93 (7%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIP 282
           APE    G   + S D +S G ++ +++ G  P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 38/268 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNS----------KVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           KV+G G YG V+  L+   +          KV  K  L  + +     + E   +  VR 
Sbjct: 6   KVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ 63

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---NIILGTAK 190
              +  L Y  +   ++ L+ +YV+ G +   L+           E+R     IIL    
Sbjct: 64  SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA--- 117

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L +LH+     +V+RDIK  NIL+D   +  ++DFGL+K   SE    T    GT  Y+
Sbjct: 118 -LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 251 APEYA-STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
           APE     G   +  D +S GILI E+++G  P  ++   E     E  ++++       
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEGERNTQSEVSRRILK------ 225

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDP 337
             DP  P         + LL  L   DP
Sbjct: 226 -CDPPFP--SFIGPEAQDLLHKLLRKDP 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 8/94 (8%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFG 248
           GL +LH+     +++RD+K  N+L+DK  + K++DFG+ K  + G       +   GT  
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPD 161

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           Y+APE       NE  D +SFG+L+ E++ G+ P
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.0 bits (142), Expect = 3e-09
 Identities = 78/301 (25%), Positives = 137/301 (45%), Gaps = 54/301 (17%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGR 131
           E   N +   K IG G +G V+    +   +      ++ RG  ERE     +EV  +  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 132 VRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           ++HKN+VR +      A++ L  + E+ + G+L +    ++  C  +  +I  + I+   
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR----NIQKCYKMFGKIEEHAIVDIT 124

Query: 190 K----GLSYLHEGLE----PKVVHRDIKSSNILID---KHWN--------------PKVS 224
           +     L+Y H   +     +V+HRD+K  NI +    +H                 K+ 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+K +G ES  +    +GT  Y +PE     T   +++SD+++ G +I E+ SG+ P
Sbjct: 185 DFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
             + +      LI  LK+            P LP K  S+ L  IL+  L  ++ +A++R
Sbjct: 243 --FHKANNFSQLISELKR-----------GPDLPIKGKSKELN-ILIKNL--LNLSAKER 286

Query: 343 P 343
           P
Sbjct: 287 P 287

Length = 1021

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 21/226 (9%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRLLG 142
           +G+GG+G V    +    K+ A K L   R +  + ++   VE   + +V  + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK---GLSYLHEGL 199
                    LV   +N G+L   ++ +V   +P   E R      TA+   GL +LH+  
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR- 116

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             ++++RD+K  N+L+D   N ++SD GLA  L    S  T    GT G++APE      
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR 305
            +   D ++ G+ + E+I+ R P  +    E+V       K +  R
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP--FRARGEKVE-----NKELKQR 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 31/227 (13%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNL-------LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +G+GGYG V+    +D  + VA+K +       LN      R    E + +   + + LV
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV----RHVLTERDILTTTKSEWLV 64

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +LL    +  +  L  EYV  G+    L+  G +       +   M       + +  LH
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM------FEAVDALH 118

Query: 197 E-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           E G     +HRD+K  N LID   + K++DFGL+K            V+G+  Y+APE  
Sbjct: 119 ELG----YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVL 170

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE-VNLIEWLKKM 301
                +   D +S G ++ E + G  P   S P E   NL  W K+ 
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-KET 216

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 19/150 (12%)

Query: 141 LGYCAEGAHRM-LVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           L  C +   R+  V EYVN G+L   +   G       + +   +++      GL +LH 
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-GTFGYVAPEY 254
                +++RD+K  N+++D   + K++DFG+ K    E     +TTR   GT  Y+APE 
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            +     +  D +++G+L+ E+++G+ P D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 15/214 (7%)

Query: 87  IGEGGYGIVYYGL--LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  VY G   L DN  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY++  +L+Q+L  D G    +   +++  +    +GL+Y H     KV
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLD-DCGNSINMH-NVKL-FLFQLLRGLNYCHR---RKV 125

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--YASTGMLN 261
           +HRD+K  N+LI++    K++DFGLA+     +   +  V+ T  Y  P+    ST   +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-S 183

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            + D++  G +  E+ +GR     S   E+++ I
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 69/288 (23%)

Query: 21  SPTGY-NKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTN 79
           +  G   K  ++  K +      N + G   D+   +  +++                  
Sbjct: 20  ANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDIN-------------RSPNK 66

Query: 80  GFSDDKVIGEGGYGIVYYGLLEDNS-KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
            +    +IG G +G+VY  +  D S KVA+K +L +     RE  +    +  + H N++
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINII 122

Query: 139 RL---------------------LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
            L                     + +  +  H+ + +   NN  L  +L          +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL------VKLYS 176

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAK-LLGSE 235
           +++         + L+Y+H      + HRD+K  N+LID + +  K+ DFG AK LL  +
Sbjct: 177 YQL--------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225

Query: 236 S--SYITTRVMGTFGYVAPEYASTGMLNERS--DVYSFGILIMEVISG 279
              SYI +R      Y APE    G  N  +  D++S G +I E+I G
Sbjct: 226 RSVSYICSRF-----YRAPELM-LGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST------ 257
           VHRDIK  N+LID+  + K++DFG A  L +     +   +GT  Y+APE  +T      
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
           G      D +S G++  E+I GR P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 10/99 (10%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-G 245
           A GL +LH      +++RD+K  N+++D   + K++DFG+ K    E+ +   TTR   G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCG 163

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           T  Y+APE  +     +  D ++FG+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 18/97 (18%)

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFG 248
           +GL Y+H      ++HRD+K SNI +++    K+ DFGLA+    E + Y+ TR      
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180

Query: 249 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           Y APE     MLN        D++S G ++ E+++G+
Sbjct: 181 YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 85/277 (30%)

Query: 85  KVIGEGGYGIVY----YGLLEDNS--KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKN 136
           K +G G +G V     +GL ++++  +VAVK L  +    ERE    E++ +  + +HKN
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKN 103

Query: 137 LVRLLG-------------YCAEG---------AHRMLVY------------EYVNNGNL 162
           +V LLG             YC  G         A   L +            +Y N    
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163

Query: 163 EQWLHGDVG-------------PCS-------------------PLTWEIRMNIILGTAK 190
           ++++  D G             P S                   PL  +  +      A+
Sbjct: 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQ 223

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---- 246
           G+ +L        +HRD+ + N+L+      K+ DFGLA+ + ++S+Y+   V G     
Sbjct: 224 GMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLP 277

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
             ++APE     +   +SDV+S+GIL+ E+ S G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH       V+RD+K  NIL+D + + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRV-GTVGYM 168

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE  +        D +  G LI E+I G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA--IGRVRHKNLVRLLG 142
           + +GEG Y  VY G+   N ++    +++ + +    F    EA  +  ++H N+V L  
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                     V+EY++  +L Q++    G   P    + M  +L   +GL+Y+H      
Sbjct: 71  IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYIHG---QH 123

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           ++HRD+K  N+LI      K++DFGLA+     S   ++ V+ T  Y  P+    G  + 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDY 181

Query: 263 RS--DVYSFGILIMEVISGR 280
            S  D++  G + +E++ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH      +++RD+K  N+L+D   + KV+DFG AK +       T  + GT  Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIP 282
              +    +  D ++ G+L+ E I+G  P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNS--------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
           KV+G+GGYG V+       +        KV  K  +    +     K E   +  V+H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNL------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           +V L+     G    L+ EY++ G L      E     D   C  L+ EI +        
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-CFYLS-EISL-------- 111

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L +LH+     +++RD+K  NIL+D   + K++DFGL K    E + +T    GT  Y+
Sbjct: 112 ALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYM 167

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE        +  D +S G L+ ++++G  P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 24/183 (13%)

Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
           SPLT E  +      A+G+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ + 
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225

Query: 234 SESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP 289
            +  Y+   + R+     ++APE     +   +SDV+SFG+L+ E+ S G  P    +  
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           EE    + LK     R PE            +  + RI+   L C   + ++RP    +V
Sbjct: 284 EE--FCQRLKDGTRMRAPEN----------ATPEIYRIM---LACWQGDPKERPTFSALV 328

Query: 350 HML 352
            +L
Sbjct: 329 EIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 30/174 (17%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-- 246
           AKG+S+L        +HRD+ + NIL+      K+ DFGLA+ + ++S+Y+   V G   
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277

Query: 247 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT 303
               ++APE     +    SDV+S+GIL+ E+ S G  P  Y   P +    + +K    
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMPVDSKFYKMIK---- 331

Query: 304 NRNPEG--VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
               EG  +L P+        ++K        C D +  KRP    +V ++E Q
Sbjct: 332 ----EGYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLIEQQ 374

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 28/226 (12%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---FKVEVE 127
           + +L +    F   KVIG G +G V     + + +V    LL+     +R    F  E  
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 128 AIGRVRHKN---LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-DVGPCSPLTWEI--R 181
            I  + H N   +V+L     +  +  +V EY+  G+L   +   D+    P  W     
Sbjct: 95  DI--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI----PEKWARFYT 148

Query: 182 MNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
             ++L     L  +H  G     +HRD+K  N+L+DK  + K++DFG    + +      
Sbjct: 149 AEVVLA----LDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200

Query: 241 TRVMGTFGYVAPEY----ASTGMLNERSDVYSFGILIMEVISGRIP 282
              +GT  Y++PE        G      D +S G+ + E++ G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 57/238 (23%), Positives = 110/238 (46%), Gaps = 36/238 (15%)

Query: 81  FSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + D + +G G  G+V+  +  D + +VAVK ++    Q+ +    E++ I R+ H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 140 LLGYCAEGAHRM--------------LVYEYVNNG---NLEQWLHGDVGPCSPLTWEIRM 182
           +          +              +V EY+       LEQ      GP S     + M
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ------GPLSEEHARLFM 120

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESS---Y 238
             +L   +GL Y+H      V+HRD+K +N+ I+ +    K+ DFGLA+++    S   Y
Sbjct: 121 YQLL---RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 239 ITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           ++  ++  + Y +P    S     +  D+++ G +  E+++G+     +   E++ LI
Sbjct: 175 LSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE           D +  G+++ E++ GR+P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 70/250 (28%), Positives = 112/250 (44%), Gaps = 22/250 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG----QAEREFKVEVEAIGR-VRHKNLVR 139
           KVIG+G +G V     +   K     +L  +     + E+    E   + + V+H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           L  +  + A ++  V +Y+N G L   L  +     P        I    A  L YLH  
Sbjct: 61  L-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS- 114

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               +V+RD+K  NIL+D   +  ++DFGL K    E +  T+   GT  Y+APE     
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIE---WLKKMVTNRNPEGVLDP 313
             +   D +  G ++ E++ G +P  YSR   E+  N++     LK  +TN +   +L+ 
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG-LPPFYSRNTAEMYDNILNKPLQLKPNITN-SARHLLEG 229

Query: 314 KLPEKPTSRL 323
            L +  T RL
Sbjct: 230 LLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 25/153 (16%)

Query: 141 LGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVG----PCSPL-TWEIRMNIILGTAKGLSY 194
           L  C +   R+  V EYVN G+L   +   VG    P +     EI + +    +KG   
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-GTFGYVA 251
                   +++RD+K  N+++D   + K++DFG+ K    E+ +  +TT+   GT  Y+A
Sbjct: 122 --------IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIA 169

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           PE  +     +  D ++FG+L+ E+++G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 24/169 (14%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF- 247
           A G+ +L        VHRD+ + N+LI +    K+ DFGLA+ +  +S+YI+     TF 
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303

Query: 248 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN 304
              ++APE     +    SDV+SFGIL+ E+ + G  P  Y   P        +K+    
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP--YPELPMNEQFYNAIKRGYRM 361

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
             P    D              I  +  +C +   + RP    +VH++ 
Sbjct: 362 AKPAHASD-------------EIYEIMQKCWEEKFEIRPDFSQLVHLVG 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 42/272 (15%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLL--EDNSKVAVKNL----LNNRGQAEREFK 123
             R+ ++    F+  + +G G +G V       ED   VA+K      +  + Q +  F 
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------GDVGPCSPLT 177
            E + +  + H   V L G   + ++  LV E+V  G    +L        DVG      
Sbjct: 81  -ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG----CF 135

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
           +  ++ +I    + L+         +V+RD+K  N+L+DK    K++DFG AK++ +   
Sbjct: 136 YAAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW 297
             T  + GT  Y+APE        + +D ++ GI I E++ G  P  Y+  P        
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEP-------- 233

Query: 298 LKKMVTNRNPEGVLD-PKLPEKPTSRLLKRIL 328
              ++  +  EG++  PK  +     L+K++L
Sbjct: 234 --LLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263

Length = 340

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 87  IGEGGYGIVYYGLLEDNSKVA---VKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
           IG G +G V    +  ++ VA   VK L  N    E+ EF  + +    ++H N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 143 YCAEGAHRMLVYEYVNNGNL------EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            C E    +LV+EY   G+L      EQW   +    S L    RM   +  A G++++H
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT--RVMGTFGYVAPEY 254
              +   +H D+   N  +      KV D+G+      E  YI T         ++APE 
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172

Query: 255 AST---GML----NERSDVYSFGILIMEV 276
                 G++     + S+V++ G+ + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  L      ++V+RD+K  NIL+D   + ++SD GLA  +  E   +  RV GT GY+
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYM 168

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE  +        D +  G LI E+I G+ P
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 22/223 (9%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEV 126
           +R+L +    +   KVIG G +G V     +   KV    LL+     +R     F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-DVGPCSPLTWE--IRMN 183
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFYTAE 150

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           ++L     L  +H       +HRD+K  N+L+DK  + K++DFG    +  E        
Sbjct: 151 VVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203

Query: 244 MGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIP 282
           +GT  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNS----------KVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           KV+G G YG V+  L+   S          KV  K  +  + +     + E + +  +R 
Sbjct: 6   KVLGTGAYGKVF--LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGL 192
              +  L Y  +   ++ L+ +Y+N G L   L            E  + I  G     L
Sbjct: 64  SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLAL 118

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            +LH+     +++RDIK  NIL+D + +  ++DFGL+K    +         GT  Y+AP
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 253 EYASTGML--NERSDVYSFGILIMEVISGRIP 282
           +    G    ++  D +S G+L+ E+++G  P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 7/135 (5%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T   GT  Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLKKMVTNRNPE 308
           PE           D +  G+++ E++ GR+P    D+ R  E + + E       +   +
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223

Query: 309 GVLDPKLPEKPTSRL 323
            +L   L + P  RL
Sbjct: 224 SLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 51/198 (25%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE-------------AIGR-V 132
           IG G YG VY        K   KN  + +  A ++FK + E             A+ R +
Sbjct: 8   IGRGTYGRVY--------KAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL 59

Query: 133 RHKNLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLH----GDVGPCSP-----LTWEIR 181
           +H+N+V L+    E A +   L+++Y  + +L Q +            P     L W+I 
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI- 117

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGS--E 235
           +N       G+ YLH      V+HRD+K +NIL+     +    K+ D GLA+L  +  +
Sbjct: 118 LN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 236 SSYITTRVMGTFGYVAPE 253
                  V+ T  Y APE
Sbjct: 168 PLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 16/144 (11%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L++LHE     +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+A
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDY--SRPPEEVNLIEWLKKMVTNR---- 305
           PE           D ++ G+L+ E+++GR P D        + N  ++L +++  +    
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI 224

Query: 306 ------NPEGVLDPKLPEKPTSRL 323
                     VL   L + P  RL
Sbjct: 225 PRSLSVKASSVLKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
            PLT E  ++     A+G+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ + 
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 234 SESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +  Y+     R+     ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L  LH+     V++RD+K  NIL+D   +  + DFGL KL   +     T   GT  Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN--RNPEG 309
           PE        +  D ++ G+L+ E+++G +P  Y    E VN  E  +K++    R P+G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFYD---ENVN--EMYRKILQEPLRFPDG 215

Query: 310 V-------LDPKLPEKPTSRL 323
                   L   L   PT RL
Sbjct: 216 FDRDAKDLLIGLLSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 36/211 (17%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           I EG YG+VY     +    VA+K L   +   E+E F +    E+  + +++H N+V +
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIVTV 69

Query: 141 ----LGYCAEGAHRMLVYEYVNNGNLEQWLHG--DVGPCSPLTWEIRMNIILGTAKGLSY 194
               +G  +      +V EYV     E  L    +      L  E++  ++L    G+++
Sbjct: 70  KEVVVG--SNLDKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVK-CLMLQLLSGVAH 121

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LH+     ++HRD+K+SN+L++     K+ DFGLA+  GS     T  V+ T  Y APE 
Sbjct: 122 LHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPEL 177

Query: 255 ASTGMLNERS-----DVYSFGILIMEVISGR 280
               +L  +      D++S G +  E+++ +
Sbjct: 178 ----LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 24/160 (15%)

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ HK+LV   G C  G   ++V EYV  G+L+ +L  +      ++W+      L  AK
Sbjct: 55  QLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAK 107

Query: 191 GLSYLHEGLEPK-VVHRDIKSSNILI-----DKHWNP---KVSDFGLA-KLLGSESSYIT 240
            L++    LE K + H ++ + N+L+      K  NP   K+SD G++  +L  E   + 
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE--ILL 165

Query: 241 TRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
            R+     +V PE       L+  +D +SFG  + E+ SG
Sbjct: 166 ERI----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 53/256 (20%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLL------------NNRGQAEREFKVEVEAIGRVRH 134
           +G+G +G VY  L++D   VA + L             N   QA      E + + ++ H
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLSKLDH 61

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNL----EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
             +V+      E     ++ EY    +L    E+  H           E  + ++LG   
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG--- 118

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            + Y+H+    +++HRD+K+ NI +  +   K+ DFG+++LL       TT   GT  Y+
Sbjct: 119 -VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYM 172

Query: 251 APEYASTGMLNERSDVYSFGILIME-------------------VISGRIPVDYSRPPEE 291
           +PE       + +SD++S G ++ E                   ++ G  P        +
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232

Query: 292 VNLIEWLKKMVTNRNP 307
           +N I  ++ M+ N++P
Sbjct: 233 LNSI--MQSML-NKDP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 29/157 (18%)

Query: 86  VIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE------AIGRV------R 133
            +GEG Y  VY G          ++ L  +  A +E ++E E      AI         +
Sbjct: 12  KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H N+V L           LV+EY++  +L+Q++    G  S     + +  +L   +GL+
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK 230
           Y H+    +V+HRD+K  N+LI +    K++DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 8/107 (7%)

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            LT E  +      AKG+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ +  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 235 ESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           +  Y+     R+     ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFG 248
           GL +LH      +++RD+K  N+++D+  + K++DFG+ K  + G   +   +   GT  
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPD 161

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           Y+APE           D +SFG+L+ E++ G+ P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L +LH      V++RD+K  NIL+D   + K++DFG+ K  G  +   TT   GT  Y+A
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIA 164

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           PE           D ++ G+L+ E+++G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF- 247
           A+G+ +L        VHRD+ + N+L+ +    K+ DFGLA+ +  +S+Y++     TF 
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301

Query: 248 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
              ++APE     +    SDV+S+GIL+ E+ S G  P
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 21/210 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEVEAIGRVRHKNLVRL 140
           KVIG G +G V    L++  KV    +LN     +R     F+ E + +    ++ +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHG--DVGPCSPLTWEI-RMNIILGTAKGLSYLHE 197
                +  +  LV +Y   G+L   L    D  P     + +  M I + +   L Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                 VHRDIK  NIL+D + + +++DFG    L  + +  ++  +GT  Y++PE    
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 258 -----GMLNERSDVYSFGILIMEVISGRIP 282
                G      D +S G+ + E++ G  P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 5e-07
 Identities = 59/235 (25%), Positives = 91/235 (38%), Gaps = 47/235 (20%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++G+G  G V+   L+        KV  K  +  R + +R    E E +  + H  L  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATLDHPFLPT 65

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---NIILGTAKGLSYLH 196
           L        +  LV +Y   G L + L    G C       R     ++L     L YLH
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAAEVLLA----LEYLH 120

Query: 197 -EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--------------------- 234
             G    +V+RD+K  NIL+ +  +  +SDF L+K                         
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 235 -------ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
                  E S+ +   +GT  Y+APE  S        D ++ GIL+ E++ G  P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 16/184 (8%)

Query: 101 EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL-GYCAEGAHRMLVYEYVNN 159
           E   KV VK          +    E++ +  + H+ ++ L+  Y  +    M++ +Y  +
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                 L   V    PL  E  + I     + L+YLH      ++HRD+K+ NI +D+  
Sbjct: 172 ------LFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPE 222

Query: 220 NPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           N  + DFG A KL     +       GT    +PE  +      ++D++S G+++ E+  
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282

Query: 279 GRIP 282
             + 
Sbjct: 283 KNVT 286

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 43/224 (19%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIG---------------- 130
           +G G    +Y G+L            ++    E+E KV ++ +                 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDE-----DDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57

Query: 131 --RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
             +V HK++V L G C      ++V E+V  G L+ ++H        LT   +  +    
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNIL-----IDKHWNP--KVSDFGLAKLLGSESSYITT 241
           A  LSYL    +  +VH ++ + NIL     ID    P  K+SD G+   + S    +  
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE- 170

Query: 242 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRIPV 283
                  ++APE    +  L+  +D +SFG  + E+  +G IP+
Sbjct: 171 ----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 20/172 (11%)

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           + +V H +L  + G C  G+  ++V E+V +G L+  L  + G   P+ W+I +   L +
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKITVAQQLAS 128

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDK-----HWNP--KVSDFGLAKLLGSESSYITT 241
           A  LSYL    +  +VH ++ + NIL+ +       +P  K+SD G++    S    +  
Sbjct: 129 A--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182

Query: 242 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRIPVDYSRPPEE 291
                  ++APE       L+  +D +SFG  ++E+   G +P+    P E+
Sbjct: 183 ----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 68/290 (23%), Positives = 116/290 (40%), Gaps = 61/290 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-KVAVKN---------LLNNRGQAEREFKVEVEAIGRVRH 134
           ++IG+GG G VY       S +VA+K          LL  R    RE K+  + I    H
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR--FLREAKIAADLI----H 61

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR--------MNIIL 186
             +V +   C++G        Y+    L+  L   V     L+ E+         ++I  
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-------------- 232
                + Y+H      V+HRD+K  NIL+       + D+G A                 
Sbjct: 121 KICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 233 -GSESSYITT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP 289
                S +T   +++GT  Y+APE       +E +D+Y+ G+++ ++++   P  Y R  
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRR-- 233

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPK--LPEKPTSRLLKRILLVALRCVDP 337
                 +  +K+      + +L P    P +     L +I + AL  VDP
Sbjct: 234 ------KKGRKIS---YRDVILSPIEVAPYREIPPFLSQIAMKAL-AVDP 273

Length = 932

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 39/117 (33%), Positives = 55/117 (47%), Gaps = 29/117 (24%)

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
           NI+ G  +GL+YLH+      +HR+IK+S+ILI        S  GL  L G    Y   R
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILI--------SGDGLVSLSGLSHLYSLVR 153

Query: 243 --VMGTFGYVAPEYASTGML---------------NERSDVYSFGILIMEVISGRIP 282
                   Y  P++ ST +L               N +SD+YS GI   E+ +GR+P
Sbjct: 154 NGQKAKVVYDFPQF-STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.3 bits (116), Expect = 3e-06
 Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 12/114 (10%)

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITT 241
            II    + L+ LH+     ++H DIK  N+L D+      + D+GL K++G+ S Y   
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--- 166

Query: 242 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
              GT  Y +PE    G   + S D ++ G+L  E+++G+ P       EE++L
Sbjct: 167 --DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDL 216

Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVR-HKNLVRLLG- 142
           IGEG +  V      +     A+K +  +    E+   + E++A+ R+  H N++RL+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 143 -YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
            +  +     LV+E ++  NL + + G   P      +  M  +L   K L ++H     
Sbjct: 67  LFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHRN--- 119

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPE-YAST 257
            + HRDIK  NILI      K++DFG  + + S+   + YI+TR      Y APE   + 
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECLLTD 173

Query: 258 GMLNERSDVYSFGILIMEVIS 278
           G    + D+++ G +  E++S
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 38/183 (20%), Positives = 80/183 (43%), Gaps = 19/183 (10%)

Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL--------LGYCAEGAHRMLVYE 155
            +  +   +    +A  + + E+ A+GR+ H+N++++          Y     +   +Y 
Sbjct: 192 CERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYS 251

Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++ +     W         PL  + R  I+      + Y+H+    K++HRDIK  NI +
Sbjct: 252 FMYDEAF-DWKD------RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300

Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           +      + DFG A     E        +GT    +PE  +     E +D++S G+++++
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360

Query: 276 VIS 278
           ++S
Sbjct: 361 MLS 363

Length = 501

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 41/211 (19%)

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGML 260
           K++HRD+KS+NI +      K+ DFG +K      S  + +   GT  Y+APE       
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---------EGVL 311
           ++++D++S G+++ E+++   P    + P +  +++  + +    +P         + +L
Sbjct: 249 SKKADMWSLGVILYELLTLHRPF---KGPSQREIMQ--QVLYGKYDPFPCPVSSGMKALL 303

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA----QESPSKEDRYRAS 367
           DP L + P  R   + LL               + +V ++ +      E+ S  DR    
Sbjct: 304 DPLLSKNPALRPTTQQLL-----------HTEFLKYVANLFQDIVRHSETISPHDREE-- 350

Query: 368 PKNELIEKQVTESGDN----STNETGVHTNE 394
                I +Q+ ESG+     S+   GV T++
Sbjct: 351 -----ILRQLQESGERAPPPSSIRYGVVTSD 376

Length = 478

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 13/96 (13%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L +LH+     +V+RD+K  NIL+D   +  + DFGL+K   +++   T    GT  Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLA 164

Query: 252 PEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           PE     +L+E+      D +S G+L+ E+  G  P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 66/287 (22%), Positives = 110/287 (38%), Gaps = 55/287 (19%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEVEAIGRVRHKN 136
           F   KVIG G +G V     +D   V    +L      E+E     + E + +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V++     +  +  L+ E++  G++   L         LT E     I  T   +  +H
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH 118

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL---------------------------- 228
           +      +HRDIK  N+L+D   + K+SDFGL                            
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 229 ------AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
                 A+        +    +GT  Y+APE       N+  D +S G+++ E++ G  P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              S  P+E       KK++  +  E ++ P  PE P S   K ++L
Sbjct: 236 F-CSETPQET-----YKKVMNWK--ETLIFP--PEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 5/84 (5%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-----ASTG 258
           VHRDIK  N+L+DK+ + +++DFG    L ++ +  +   +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 259 MLNERSDVYSFGILIMEVISGRIP 282
                 D +S G+ + E++ G  P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 37/215 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKN-LVR 139
           IGEG YG VY    ++  K VA+K     R + + E        E+  +  +     +VR
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 140 LLGYCAEGAHR-------MLVYEYVNNGNLEQWLHGDV-GPCSPLTWEIRMNIILGTAKG 191
           LL    E            LV+EY+++ +L++++  +  GP  PL  +   + +    KG
Sbjct: 66  LL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           +++ H   +  V+HRD+K  N+L+DK     K++D GL +         T  ++ T  Y 
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178

Query: 251 APE------YASTGMLNERSDVYSFGILIMEVISG 279
           APE      + ST +     D++S G +  E+   
Sbjct: 179 APEVLLGSTHYSTPV-----DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 59/275 (21%), Positives = 100/275 (36%), Gaps = 76/275 (27%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHK 135
           F   K IG G +G V      D + + A+K L    +  R QA    K E + +    ++
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-HVKAERDILAEADNE 61

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI---------IL 186
            +V+L     +  +   V +Y+  G++   L             IR+ I         I 
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEEDLARFYIA 108

Query: 187 GTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA---------------- 229
                +  +H+ G     +HRDIK  NILID+  + K++DFGL                 
Sbjct: 109 ELTCAIESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 230 ----------KLLGSESSYITTRV----------------MGTFGYVAPEYASTGMLNER 263
                     +            +                +GT  Y+APE        + 
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224

Query: 264 SDVYSFGILIMEVISGRIPVDYSRPPE-EVNLIEW 297
            D +S G+++ E++ G+ P     P E ++ +I W
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 25/162 (15%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKV-AVK-----NLLN----NRGQAEREFKVEVEAIG 130
           F   K I  G +G VY G  ++NSK+ AVK     +++N    ++ QAER+      A+ 
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERD------ALA 59

Query: 131 RVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
             +   +V L  Y  + A+ + LV EY+  G+++  LH           E+ +  I   A
Sbjct: 60  LSKSPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVA 114

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L YLH      ++HRD+K  N+LI    + K++DFGL+K+
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----G 258
           VHRDIK  N+L+D + + +++DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 259 MLNERSDVYSFGILIMEVISGRIP 282
                 D +S G+ + E++ G  P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 61/290 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEVEAIGRVRHKN 136
           F   KVIG G +G V     +D   +    +L      E+E     + E + +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V++     +  +  L+ E++  G++   L         L+ E     I  T   +  +H
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH 118

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG----------------SESSY-- 238
           +      +HRDIK  N+L+D   + K+SDFGL   L                 S+ S+  
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 239 ----------------ITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRI 281
                           +    +GT  Y+APE +  TG  N+  D +S G+++ E++ G  
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYP 234

Query: 282 PVDYSRPPEEV--NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
           P   S  P+E    ++ W + +V             PE P S   K ++L
Sbjct: 235 PF-CSETPQETYRKVMNWKETLVFP-----------PEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 57/253 (22%), Positives = 105/253 (41%), Gaps = 30/253 (11%)

Query: 66  GHWYTL--RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GH+Y +   +++VST  F    ++GEG +G V         +     ++ N  +  R+ K
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173

Query: 124 VEVEAIGRVRHKN------LVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSP 175
           +E++ + +VR  +      L+++  Y       M +        L  W+  HG      P
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG------P 227

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-----------KHWNPKVS 224
            +      II  T   L Y H   E  ++H D+K  NIL++           +   P   
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285

Query: 225 DFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
              +  L G  +  +  T ++ T  Y +PE          +D++S G +I E+ +G++  
Sbjct: 286 RVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345

Query: 284 DYSRPPEEVNLIE 296
           D     E ++L+E
Sbjct: 346 DTHDNLEHLHLME 358

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           + + YLHE    +++HRDIK+ NI I+   +  + DFG A      ++       GT   
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            APE  +        D++S GI++ E+ +  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 6/86 (6%)

Query: 192 LSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGY 249
           + Y+H EG    ++HRDIK+ N+L++   +  + DFG A    GS S+     + GT   
Sbjct: 273 IDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 250 VAPEYASTGMLNERSDVYSFGILIME 275
            APE  +        D++S G++I E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 38/172 (22%), Positives = 54/172 (31%), Gaps = 34/172 (19%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           + L     L  LH         R  KS NIL+   W+  +   G       E S      
Sbjct: 22  VCLQCLGALRELH---------RQAKSGNILLT--WDGLLKLDGSVAFKTPEQSRPDPYF 70

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           M      APE        E++D+YS GI + E +   +P  Y+   E   ++E L   + 
Sbjct: 71  M------APEVIQGQSYTEKADIYSLGITLYEALDYELP--YNEERELSAILEILLNGMP 122

Query: 304 NR------NPEGVLDPK---------LPEKPTSRLLKRILLVALRCVDPNAQ 340
                   N EGV   +             P  R      L   R +     
Sbjct: 123 ADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETL 174

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 30/218 (13%)

Query: 84  DKVIGEG--GYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV---EVEAIGRVRHKNL 137
             +IG+      IV+    +  +  VAVK + N    ++ + K+   E+    +++H N+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           +  +      +   +V   +  G+ E  L  H   G    L       I+      L Y+
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG----LPELAIAFILKDVLNALDYI 117

Query: 196 H-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG------ 248
           H +G     +HR +K+S+IL+    + KV   GL   +         RV+  F       
Sbjct: 118 HSKGF----IHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 249 --YVAPEYASTGML--NERSDVYSFGILIMEVISGRIP 282
             +++PE     +   NE+SD+YS GI   E+ +G +P
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 16/26 (61%), Positives = 21/26 (80%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLA 229
           +HRDIK  NILID+  + K+SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 35/126 (27%), Positives = 53/126 (42%), Gaps = 40/126 (31%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGL----------------AKLLGSESSYITTRVM--- 244
           +HRDIK  N+L+D   + K+SDFGL                +  L S      ++ M   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 245 ------------------GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVDY 285
                             GT  Y+APE +  TG  N+  D +S G+++ E++ G  P   
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF-C 240

Query: 286 SRPPEE 291
           S  P+E
Sbjct: 241 SDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 15/109 (13%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I+ G  K L Y+H       VHR +K+S+ILI    + KV   GL   L   +     RV
Sbjct: 106 ILQGVLKALDYIHH---MGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHGQRLRV 160

Query: 244 MGTFG--------YVAPEYASTGM--LNERSDVYSFGILIMEVISGRIP 282
           +  F         +++PE     +   + +SD+YS GI   E+ +G +P
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 8/100 (8%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVY----YGLLEDNSK--VAVKNLLNNRGQAERE-FKVEVE 127
           E   N  S  K +G G +G V     YGL + ++   VAVK L  +    ERE    E++
Sbjct: 31  EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90

Query: 128 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL 166
            +  +  H N+V LLG C  G   +++ EY   G+L  +L
Sbjct: 91  VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	407
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
COG4248	637	Uncharacterized protein with protein kinase and he	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.09
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.01
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
PRK09902	216	hypothetical protein; Provisional	98.76
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.72
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.68
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.65
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.59
PF01636	239	APH: Phosphotransferase enzyme family This family	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.4
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.33
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.11
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.06
PRK10593	297	hypothetical protein; Provisional	98.0
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.99
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.9
PRK05231	319	homoserine kinase; Provisional	97.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.8
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.74
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.72
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.71
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.68
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.5
KOG2270	520	consensus Serine/threonine protein kinase involved	97.49
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.39
PLN02236	344	choline kinase	97.3
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.21
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.92
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.89
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.83
PLN02756	418	S-methyl-5-thioribose kinase	96.82
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.74
COG2334	331	Putative homoserine kinase type II (protein kinase	96.73
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.67
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.67
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.53
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.36
PRK06148	1013	hypothetical protein; Provisional	96.3
PRK11768	325	serine/threonine protein kinase; Provisional	96.19
PRK12396	409	5-methylribose kinase; Reviewed	95.94
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.82
PTZ00384	383	choline kinase; Provisional	95.69
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.27

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=401.48  Aligned_cols=290  Identities=52%  Similarity=0.911  Sum_probs=254.8

Q ss_pred             CCccccHHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeee
Q 015395           65 WGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (407)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  144 (407)
                      ....|++.++..++++|.....||+|+||.||+|...++..||||++.........+|..|+.+|.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45778999999999999999999999999999999998899999987665443155699999999999999999999999


Q ss_pred             ecCC-eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEE
Q 015395          145 AEGA-HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (407)
Q Consensus       145 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  223 (407)
                      .+.+ ..+||+|||++|+|.++|+.....  +++|..+++|+.++|+||+|||..+.+.|+|||||++|||||.++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9988 599999999999999999987532  8999999999999999999999988778999999999999999999999


Q ss_pred             eecccceecCCCCceeeeee-eccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          224 SDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       224 ~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      +|||+|+........ .... .||.+|+|||.+..+..+.++||||||++|.||+||+.|.+...+.......+|....+
T Consensus       219 sDFGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999665441111 1222 79999999999999999999999999999999999999998766666667889998888


Q ss_pred             hcCCCCCcCCCCCC-CCccH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          303 TNRNPEGVLDPKLP-EKPTS-RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       303 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ......+++|+.+. ..+.. .....+..+..+|++.+|..||+|.+|++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            88889999999987 44443 577779999999999999999999999999965543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-52  Score=378.40  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=217.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC-eeEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRMLV  153 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv  153 (407)
                      ..++++.++.||+|.-|+||++.++ ++..+|+|++... .....+++.+|++++++.+|||||++++.|..++ ..+|+
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            3446778889999999999999976 5777999999544 4556678999999999999999999999999998 49999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||++|+|.+++...    +.+++...-+++.++++||.|||+ +   +||||||||+||||+..|.|||||||.+..+
T Consensus       157 mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             hhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999999765    579999999999999999999996 6   9999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...   ...+++||..|||||.+.+..|+.++||||||++++|+.+|++||.... .......+.+..+....       
T Consensus       230 vnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~p-------  298 (364)
T KOG0581|consen  230 VNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEP-------  298 (364)
T ss_pred             hhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCC-------
Confidence            543   4567889999999999999999999999999999999999999997641 11233444444444322       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                        .|..+...++.++..+|..||++||.+||++.++++.-.
T Consensus       299 --pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf  337 (364)
T KOG0581|consen  299 --PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF  337 (364)
T ss_pred             --CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence              222222257788999999999999999999999997443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-53  Score=371.08  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=215.4

Q ss_pred             CCCCccceecccCceEEEEEE-ECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeee-eecC-CeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGY-CAEG-AHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~~~-~~~~lv  153 (407)
                      .+|++.++||+|+||.||++. ..++..+|.|.+...  .......+..|+.+|+.|+|||||+++++ +.+. ..++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458899999999999999999 557889999988754  33445578889999999999999999983 4444 448999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCC-ceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-KVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||.+|+|.+.|+..+.....+++..+|+++.|++.||.++|+..+. -|+||||||.||+|+.+|.+||+||||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999987665557899999999999999999999994332 3899999999999999999999999999998


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...... ..+.+|||.||+||.+....|+.+|||||+||++|||+.-+.||.+.      +..++-.++...        
T Consensus       179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg--------  243 (375)
T KOG0591|consen  179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG--------  243 (375)
T ss_pred             cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC--------
Confidence            766543 44578999999999999999999999999999999999999999865      334433443332        


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                       .++..+...++..+..||..|+..||+.||+.-.++..+.
T Consensus       244 -d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  244 -DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence             2233344678889999999999999999998655554443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-51  Score=392.54  Aligned_cols=248  Identities=25%  Similarity=0.431  Sum_probs=215.7

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .+|...++||+|||+.||.++. ..|..||+|++...   +......+.+|+++.+.|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999997 78999999998653   3445567888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |+|..++|..+++.+    .++++.+++.+++||+.||.|||++   +|+|||||..|++++++.+|||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999999865    6899999999999999999999999   999999999999999999999999999999875


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .... ..+.+|||.|.|||++....++..+||||+|||||.||.|++||+...-.+.      ..++.....       .
T Consensus       171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~~Y-------~  236 (592)
T KOG0575|consen  171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLNEY-------S  236 (592)
T ss_pred             cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhcCc-------c
Confidence            5443 4457899999999999999999999999999999999999999985443333      333332221       1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      +    +..++.+..+||..+|++||.+|||+++|+..
T Consensus       237 ~----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  237 M----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             c----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1    12455678999999999999999999999974

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-51  Score=387.04  Aligned_cols=263  Identities=32%  Similarity=0.545  Sum_probs=216.8

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCC-ee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-HR  150 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~  150 (407)
                      +.+...++.+.+.||.|+||+||+|.++....||+|++.....  ...+.|.+|+.+|.+++|||||+++|++.+.. .+
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            3444555667777999999999999998555599999865432  22568999999999999999999999999887 79


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc-eeccCCCCccEEEeCCC-CcEEeeccc
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHW-NPKVSDFGL  228 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~DfGl  228 (407)
                      +|||||+++|+|.++++..  ....+++..++.++.||++||.|||++   + ||||||||+||||+.++ ++||+|||+
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            9999999999999999873  226899999999999999999999999   7 99999999999999997 999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ++...... ...+...||+.|||||++.  ...|+.++||||||++||||+||+.||....+      .+....+.....
T Consensus       191 sr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~  263 (362)
T KOG0192|consen  191 SREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL  263 (362)
T ss_pred             ceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC
Confidence            98876432 2233367999999999999  56999999999999999999999999986654      122222222221


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           .+.++.    .++..+..||.+||+.||..||++.+|+..|+.+..
T Consensus       264 -----Rp~~p~----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 -----RPPIPK----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -----CCCCCc----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                 122222    255678999999999999999999999999997654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-51  Score=374.40  Aligned_cols=248  Identities=24%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|.+.+.||.|+||+||+|+++ ++..||||.+...  .....+-+..|+++|+.++|||||.+++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57888899999999999999965 5788999999766  55666778889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC------CCcEEeecccc
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH------WNPKVSDFGLA  229 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~DfGla  229 (407)
                      ||+||+|.+||+.+    +.+++..+..++.||+.||++||++   +||||||||+||||+..      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999987    5799999999999999999999999   99999999999999764      45899999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +.+....  ...+.+|++-|||||++....|+.|+|+||+|+|||++++|+.||+..+..+....+      ....... 
T Consensus       163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~------~k~~~~~-  233 (429)
T KOG0595|consen  163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI------KKGNEIV-  233 (429)
T ss_pred             hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------hcccccc-
Confidence            9987443  345678999999999999999999999999999999999999999876655443322      2221111 


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV  349 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl  349 (407)
                             .......+..+.+|+...+..++.+|-++.+..
T Consensus       234 -------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  234 -------PVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             -------CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence                   111223333455677777777877777665544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-51  Score=375.68  Aligned_cols=256  Identities=23%  Similarity=0.376  Sum_probs=212.5

Q ss_pred             cCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChh-------hHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ-------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      .+.|.+.+.||+|+||.|-+|. .++++.||||++......       ....+.+|+++|++|+|||||+++++|...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            4568889999999999999999 557999999998654211       23346789999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC---CCcEEeec
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDF  226 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Df  226 (407)
                      .||||||++||+|.+.+-.+    +.+.+.....++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999876    5688888899999999999999999   99999999999999766   77999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      |+|++.+..  ..+.+.|||+.|.|||++.+..   +..++|+|||||+||-+|+|.+||........      +.+.+.
T Consensus       324 GlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQIL  395 (475)
T ss_pred             chhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHh
Confidence            999998733  3466789999999999997654   33478999999999999999999986554321      111111


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ...      ..+.......++++..+||.+||..||++|||+.|+|+.-+.
T Consensus       396 ~G~------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~  440 (475)
T KOG0615|consen  396 KGR------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF  440 (475)
T ss_pred             cCc------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence            111      122233467889999999999999999999999999986654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=384.54  Aligned_cols=265  Identities=27%  Similarity=0.467  Sum_probs=224.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .+.+++....+..++.||+|.||.||.|.++...+||+|.+... ......|.+|+.+|++|+|+|||++++++.....+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            34456666677888999999999999999998889999988776 34556788999999999999999999999998899


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +||||||+.|+|.+||....+  ..+...+.+.++.|||+|++||.++   ++|||||..+||||+++..+||+|||||+
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            999999999999999987332  5788899999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....+.........-...|+|||.+....++.+||||||||+||||+| |+.||..++..+....++      ..     
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le------~G-----  420 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE------RG-----  420 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh------cc-----
Confidence            655444333333334568999999999999999999999999999999 999998877665544442      11     


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           ..-..+..++.++.++|..||+.+|++||||+.+...|+.+..
T Consensus       421 -----yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  421 -----YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                 1112234577789999999999999999999999999987644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-50  Score=362.71  Aligned_cols=243  Identities=25%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|+++++||+|+||+||.++.+ +++.+|+|++.+..   ....+....|..+|.+++||+||+++..|++...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4578999999999999999999955 57789999886653   2344567789999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |+||+.||.|...|.+.    +.+++..+..++.+|+.||.|||++   +||||||||+|||+|.+|+++|+||||++..
T Consensus       103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999876    6899999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... ...+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+..      .+..++.....      
T Consensus       176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~------  242 (357)
T KOG0598|consen  176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKL------  242 (357)
T ss_pred             ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcC------
Confidence            43322 244579999999999999999999999999999999999999999865533      23333333220      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCC
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRP  343 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  343 (407)
                          ..++.-++.+.++++.++|..||++|.
T Consensus       243 ----~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ----PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                011222445688999999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-49  Score=370.05  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=212.6

Q ss_pred             HHhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  149 (407)
                      .-..++|..++.||.|+|++|++|+. .+++.+|||++.+.   .......+..|-.+|.+| .||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            44567899999999999999999994 46888999988543   223334566788899999 79999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +|+|+||+++|+|.++|++.    +.+++..+..++.+|+.||+|||++   |||||||||+|||||.++++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999887    7899999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCce----------e--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH
Q 015395          230 KLLGSESSY----------I--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW  297 (407)
Q Consensus       230 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  297 (407)
                      ..+.+....          .  ...++||..|.+||++.+...++++|||+||||||+|+.|.+||.+....-..+.+  
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--  299 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--  299 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--
Confidence            987532211          1  14589999999999999999999999999999999999999999876543332222  


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          +..       +-.++    ..+++.+.+||.+.|..||.+|+|..+|-+.
T Consensus       300 ----~~l-------~y~fp----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  300 ----QAL-------DYEFP----EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ----HHh-------cccCC----CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                211       12222    2233568899999999999999999988763

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-48  Score=361.82  Aligned_cols=267  Identities=26%  Similarity=0.324  Sum_probs=218.7

Q ss_pred             cCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l  152 (407)
                      .+.|+.++.||+|.||.||+|+ ..+|+.||+|++....  ........+||.+|++|+||||+++.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3468999999999999999999 4578899999997654  45556677899999999999999999998776  78999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |+|||+. +|.-++....   -.|++.++..++.||+.||+|+|++   +|+|||||.+|||||++|.+||+|||||+++
T Consensus       196 VFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999966 8988887643   4799999999999999999999999   9999999999999999999999999999998


Q ss_pred             CCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC---
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---  308 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---  308 (407)
                      ........+..+-|.+|+|||++.+. .|+.+.|+||.||||.||++|++.|.+.+..+....+-.+..-.......   
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            87776667777889999999998775 59999999999999999999999999888766665554443322222111   


Q ss_pred             ----CcCCCCCCCC-----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 ----GVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ----~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          ..+.+..+..     ....++....+|+..+|..||++|.|+.+++..
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence                0111111100     112244567899999999999999999999873

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-47  Score=338.95  Aligned_cols=264  Identities=22%  Similarity=0.332  Sum_probs=210.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +.|+.+..+|+|+||.||+|+++ +|+.||||++....  ....+-..+|+++|+.++|+|+|.++.+|..+..+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35888899999999999999966 58889999997653  3445567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ||+. ++.+-|....   ..++...+.+++.|++.|+.|+|++   ++|||||||+||||+.+|.+||||||.|+.+...
T Consensus        82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9976 5555554442   4588899999999999999999999   9999999999999999999999999999998753


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH--------Hhh-cC
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK--------MVT-NR  305 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--------~~~-~~  305 (407)
                      . ...+..+.|.+|+|||++.+ .+|+..+||||+||++.||++|.+-|.+.+..+....+.....        +.. +.
T Consensus       155 g-d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  155 G-DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             c-chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3 23555678999999999877 7899999999999999999999999998876655444322111        111 11


Q ss_pred             CCCCcCCCCCCC-----CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          306 NPEGVLDPKLPE-----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       306 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ....+.-|....     .....++.-+.+++..||+.||++|++.++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111221121111     112234556889999999999999999998885

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-47  Score=362.09  Aligned_cols=261  Identities=24%  Similarity=0.307  Sum_probs=213.9

Q ss_pred             ccHHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeee
Q 015395           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (407)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~  144 (407)
                      ..++..++..++|+++++||+|+||.||+|+.+ +|..+|+|++.+..   ......+..|-.+|...++|+||+++..|
T Consensus       131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            344445578889999999999999999999955 68889999987653   33345677799999999999999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                      ++..++||||||++||++..+|.+.    +.|++..+..++.+++.|++.||+.   |+|||||||+|+|||..|++||+
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence            9999999999999999999999876    6899999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCC-----------------------CCc-----e------------------eeeeeeccccccCccccCCC
Q 015395          225 DFGLAKLLGS-----------------------ESS-----Y------------------ITTRVMGTFGYVAPEYASTG  258 (407)
Q Consensus       225 DfGla~~~~~-----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~  258 (407)
                      ||||+.-+..                       ...     .                  .....+|||-|||||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            9999853210                       000     0                  00124799999999999999


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcC
Q 015395          259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN  338 (407)
Q Consensus       259 ~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  338 (407)
                      .|+..+|+||||||+||||.|.+||...++.+....+..-+..+.           +  .....+..+..+||.+||. |
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----------f--P~~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----------F--PEEVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----------C--CCcCcccHHHHHHHHHHhc-C
Confidence            999999999999999999999999998888766544422221111           1  1122334678999999999 9


Q ss_pred             CCCCCC---HHHHHH
Q 015395          339 AQKRPK---MGHVVH  350 (407)
Q Consensus       339 p~~RPt---~~evl~  350 (407)
                      |+.|..   ++||-+
T Consensus       430 ~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  430 PENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHhcCcccHHHHhc
Confidence            999985   556655

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=361.09  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=210.5

Q ss_pred             hcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC----Ch-hhHHHHHHHHHHHhcCC-CCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN----RG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  149 (407)
                      ..+.|.+.+.||+|+||+|++|.. .++..||+|++...    .. .....+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999984 46899999966443    11 23446668999999998 9999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEeeccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGL  228 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGl  228 (407)
                      +++|||||.||+|.+++...    +.+.+..+..+|+|++.|++|||++   +|+||||||+|||++.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999884    6899999999999999999999999   99999999999999999 9999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGM-LN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      +.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+.....      ....++.... 
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~~-  239 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKGE-  239 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcCC-
Confidence            99874 2223456678999999999999877 75 7899999999999999999999863322      2222222221 


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                            ..+|....   +.++..|+.+||..||..|+++.+|+..-+..
T Consensus       240 ------~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  240 ------FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             ------ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence                  11111111   56789999999999999999999999644443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=351.11  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=207.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC--eeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e  155 (407)
                      .++...+.||+|+||.||++... +|...|||.+..........+.+|+.+|++++|||||+++|......  .++|.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45778899999999999999965 48889999886654444667889999999999999999999754443  6999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecccceecCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~  234 (407)
                      |+.+|+|.+++.+..   +.+++..+..+++||++||.|||++   +|+||||||+||||+. ++.+||+|||++.....
T Consensus        97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999998763   2699999999999999999999999   9999999999999999 79999999999987763


Q ss_pred             --CCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          235 --ESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       235 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                        ..........||+.|||||++..+ ....++|||||||++.||+||+.||...     ....+++.........    
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~----  241 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL----  241 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC----
Confidence              112223346799999999999853 3445999999999999999999999753     1122222333222211    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                       |.+    +..++.+..+++.+|+..||+.|||+.++|...-.
T Consensus       242 -P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  242 -PEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             -CCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence             122    23366779999999999999999999999986544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=361.78  Aligned_cols=249  Identities=26%  Similarity=0.393  Sum_probs=217.1

Q ss_pred             CCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ..|.....||+|+.|.||.+. ..++..||||.+........+-+.+|+.+|+..+|+|||++++.|...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            458888999999999999999 4467889999998887777888899999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      +||+|.+.+...     .+++.++..++++++.||+|||.+   +|+|||||.+|||++.+|.+||+|||.+..+.....
T Consensus       353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999999764     599999999999999999999999   999999999999999999999999999988866554


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       ...+.+||+.|||||++....|+++.||||||++++||+.|.+||-...+-.      .+..+..++        ....
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng--------~P~l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG--------TPKL  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcC--------CCCc
Confidence             4556789999999999999999999999999999999999999997544322      222222222        1222


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .....++..+.+++.+||+.|+++|+++.|+|+
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            334567778999999999999999999999997

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=354.91  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=211.7

Q ss_pred             cCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHH-HHHHHHHHHhcCC-CCccceeeeeeecCC-eeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVR-HKNLVRLLGYCAEGA-HRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~-~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~~lv  153 (407)
                      .++|.+++.||.|+||.||+|. ..++..||||+++..-...++ .-.+|+..|++|+ ||||+++.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4679999999999999999999 557888999998766444332 3456999999998 999999999998887 99999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||||+. +|+++++.+.   ..+++..+..|+.||++||+|+|.+   |++|||+||+|||+.....+||+|||||+-..
T Consensus        89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999954 9999998874   6899999999999999999999999   99999999999999988899999999999775


Q ss_pred             CCCceeeeeeeccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC----
Q 015395          234 SESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE----  308 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----  308 (407)
                      ....  .+..+.|.+|+|||++ +...|+.+.|||++|||++|+.+-++-|.+.+..+....+..+..-.......    
T Consensus       162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            4433  4556789999999987 45679999999999999999999999998876554433332221111100000    


Q ss_pred             --CcCC---CCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          309 --GVLD---PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       309 --~~~~---~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                        ..+.   +......    ....+.+..+||.+||.+||++|||+.++++.--
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf  293 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF  293 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence              0111   1111111    1225677899999999999999999999998543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=329.85  Aligned_cols=239  Identities=26%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ...++|+.++.||.|+||.|.+++.+ ++..+|+|++....-   ...+...+|.++|+.+.||+++++++.+.+.+.++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            34567999999999999999999955 577899998866532   33445677999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||++||.|..++++.    +.+++..+..++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|||.|+.
T Consensus       121 mvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999999999876    6899999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ....    ..+.||||.|+|||++..+.|+.++|+|||||++|||+.|.+||...++      +....++.....     
T Consensus       194 v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v-----  258 (355)
T KOG0616|consen  194 VSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKV-----  258 (355)
T ss_pred             ecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcc-----
Confidence            7544    4567899999999999999999999999999999999999999987665      233333333221     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCC
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKR  342 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  342 (407)
                        .+    +.-+...+.+|+...|+.|-.+|
T Consensus       259 --~f----P~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KF----PSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cC----CcccCHHHHHHHHHHHhhhhHhh
Confidence              11    22334468899999999999999

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=339.46  Aligned_cols=263  Identities=24%  Similarity=0.369  Sum_probs=212.8

Q ss_pred             HhcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ...+.|++.++||.|..+.||+|+ ...+..||||++... .......+.+|+..|+.++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            345789999999999999999999 446789999998544 333457889999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |.||.+|++.+++.....  ..+++..+..|.+++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999976532  3499999999999999999999999   99999999999999999999999999876554


Q ss_pred             CCCceee---eeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          234 SESSYIT---TRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       234 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......   ...+||++|||||++..  ..|+.|+||||||++..||.+|+.||....+...     ++.++ .+ .++
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tL-qn-~pp  250 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTL-QN-DPP  250 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHh-cC-CCC
Confidence            3332221   45689999999999543  4599999999999999999999999986554221     11111 11 111


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ...-..++.+....+.+.+.++|..||++||.+|||++++++
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111112223334456778999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.9e-46  Score=322.16  Aligned_cols=273  Identities=23%  Similarity=0.301  Sum_probs=216.4

Q ss_pred             CCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .+|...+.||+|.||.||+|+ ..+|+.||||++.....  .......+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999999 45789999999976532  234566789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |++ .+|+..|+...   ..++..++..|+.++++||+|||.+   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        82 fm~-tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            995 59999998764   5789999999999999999999999   9999999999999999999999999999998876


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc---C
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV---L  311 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  311 (407)
                      ....... +-|.+|+|||++.+ ..|+..+||||.|||+.||+.|.+-|.+.+.-+....+-....-......+++   .
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            5543333 67999999998866 56999999999999999999999888877665544433222111111111111   0


Q ss_pred             C----CCCCCC----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          312 D----PKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       312 ~----~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      |    ..+|..    .....+....+|+..+|..||.+|+++.++++.-.....+.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            0    001111    12234456789999999999999999999998766554443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-45  Score=354.10  Aligned_cols=266  Identities=27%  Similarity=0.423  Sum_probs=208.1

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEE------CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  145 (407)
                      |+++.++|++.+.||+|+||.||+|.+      .++..||+|++..... .....+..|+.++..+ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            345677899999999999999999974      2345799998865432 3345688899999999 8999999999886


Q ss_pred             cC-CeeEEEEEeccCCChHHhhhCCCCC----------------------------------------------------
Q 015395          146 EG-AHRMLVYEYVNNGNLEQWLHGDVGP----------------------------------------------------  172 (407)
Q Consensus       146 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  172 (407)
                      .. ..++++|||+++|+|.+++......                                                    
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999998653210                                                    


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce-eeeeeec
Q 015395          173 ------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMG  245 (407)
Q Consensus       173 ------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~g  245 (407)
                            ..++++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ......+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  13578889999999999999999999   9999999999999999999999999999865432221 1122345


Q ss_pred             cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHH
Q 015395          246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL  324 (407)
Q Consensus       246 t~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (407)
                      +..|+|||++.+..++.++|||||||++|||++ |..||......+.      +.........     ...    ...++
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-----~~~----~~~~~  303 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR-----MRA----PENAT  303 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC-----CCC----CCCCC
Confidence            678999999999999999999999999999997 9999976543221      1111111111     011    12234


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          325 KRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       325 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            568999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.6e-46  Score=350.63  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=211.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+..  ....+.+.+|++++++++||||+.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57889999999999999999954 67789999885543  3345678899999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ||.| +|..+|...    +.+++..+..++.+++.||.|||+.   +|+|||+||.|||++.+|++|+||||+|+.+...
T Consensus        82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9966 999999877    6899999999999999999999999   9999999999999999999999999999988764


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      . ...+...||+.|||||+..+.+|+..+|+||||||+||+.+|++||...      ...+.++.+..+.          
T Consensus       154 t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~----------  216 (808)
T KOG0597|consen  154 T-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP----------  216 (808)
T ss_pred             c-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC----------
Confidence            3 3455678999999999999999999999999999999999999999632      2333344433321          


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                       ..++...+..+..++...|.+||..|.+-.+++.
T Consensus       217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence             1123366677899999999999999999988875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-46  Score=372.91  Aligned_cols=270  Identities=29%  Similarity=0.497  Sum_probs=227.8

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      ++...++...+.+..+.||+|.||+||+|+..      +...||||.++..... ...+|++|+++|+.++|||||+++|
T Consensus       477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            44556677888899999999999999999843      2345999999887666 7789999999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCC------C----CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVG------P----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      +|.+++.+++|+|||..|+|.++|.....      .    ..+++..+.+.|+.|||.|+.||-++   .+|||||..+|
T Consensus       557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRN  633 (774)
T KOG1026|consen  557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRN  633 (774)
T ss_pred             EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhh
Confidence            99999999999999999999999964321      1    23489999999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCceeee-eeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~  290 (407)
                      +||.++..|||+||||++..-..+..... ...-..+||+||.|..+.|+.+||||||||+|||+++ |+.||.+.+..+
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence            99999999999999999866444433322 3345779999999999999999999999999999998 999999887765


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      ....+.       .+        .+ ...+..++.++.+||.+||+.+|.+||+|.+|-..|+.....
T Consensus       714 VIe~i~-------~g--------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 VIECIR-------AG--------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHH-------cC--------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            544332       11        11 233556778899999999999999999999999999986543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=349.72  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=214.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..|...+.||+|+||.||+|.+. .++.||+|++... ......++++|+.+|..++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45788899999999999999954 6778999998655 344557889999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      |.||++.+.+...    ..+.+..+.-++++++.||.|||.+   +.+|||||+.|||+..+|.+||+|||++-.+....
T Consensus        93 ~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999999765    4558888899999999999999999   99999999999999999999999999998876665


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      ... .+++||+.|||||++....|+.++||||||++.+||.+|.+|+....+......+                ....|
T Consensus       166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~P  228 (467)
T KOG0201|consen  166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAP  228 (467)
T ss_pred             hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCC
Confidence            543 6678999999999999889999999999999999999999999877764333222                12222


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ......+++.+.++|..||++||+.||++.++++
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2223367778999999999999999999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=352.62  Aligned_cols=270  Identities=27%  Similarity=0.441  Sum_probs=220.2

Q ss_pred             ccHHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 015395           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (407)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  146 (407)
                      .+..+|++..+.+.+...||+|.||+||+|.|-  ..||||++...  ..+..+.|++|+.+|++-+|.||+-+.|++..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            345788899999999999999999999999985  36999988655  34556789999999999999999999999998


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      +.. .||+.+|+|.+|+.+|+-..   .++.....+.|++||++|+.|||.+   +|||||||..||++.++++|||+||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence            877 99999999999999998764   5789999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCC-ceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          227 GLAKLLGSES-SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       227 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      ||+.....-. ........|...|||||+++   ..+|++.+||||||||+|||++|.+||.. ...+..  + |   ++
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI--i-f---mV  605 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI--I-F---MV  605 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe--E-E---Ee
Confidence            9997543211 11112234778999999985   35799999999999999999999999983 222211  0 0   01


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      ..+    .+. .........+++++.+|+..||..++++||.+.+|+..|+.+....
T Consensus       606 GrG----~l~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  606 GRG----YLM-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ccc----ccC-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            111    111 1123345677889999999999999999999999999998887753

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=367.66  Aligned_cols=263  Identities=24%  Similarity=0.350  Sum_probs=218.6

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCC-CEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeee-ec----
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDN-SKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYC-AE----  146 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~-~~----  146 (407)
                      +.+...++++.+.|.+|||+.||+|+...+ .+||+|++........+.+.+|+++|+.|+ |+|||.+++.. ..    
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            456677899999999999999999997765 999999998888888999999999999996 99999999942 21    


Q ss_pred             --CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          147 --GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                        ...++|.||||+||.|-+++..+..  ..|++.++++|+.|+|+|+.+||.. ++.|||||||-+||||+.+|+.|||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence              2367899999999999999987654  3499999999999999999999987 6679999999999999999999999


Q ss_pred             ecccceecCCCC-ceee-------eeeeccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh
Q 015395          225 DFGLAKLLGSES-SYIT-------TRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN  293 (407)
Q Consensus       225 DfGla~~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~  293 (407)
                      |||.+....... ....       -...-|+.|+|||++   .+.+.++|+|||+|||+||-|+....||+.....    
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence            999987543221 1000       012358999999977   6788999999999999999999999999854321    


Q ss_pred             HHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                                     .+++..+.-.+...++..|.+||..||++||++||++-+++..+..+...
T Consensus       265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                           23334444444567888999999999999999999999999988776543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=356.33  Aligned_cols=246  Identities=26%  Similarity=0.361  Sum_probs=209.0

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCC
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA  148 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  148 (407)
                      ..+..++|.++++||+|+||+|+++..+ +++.+|||.+++..   ....+....|.+++... +||.+++++.+|+.+.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3566789999999999999999999965 57789999997763   34555677788888877 4999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ++|+||||+.||++..+++.     ..+++..+..|+..++.||+|||++   +|||||||.+|||||.+|.+||+|||+
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             eEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence            99999999999997777665     4699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ++-.-.... ...+++||+.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+..+.+      ...    
T Consensus       515 cKe~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d----  583 (694)
T KOG0694|consen  515 CKEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VND----  583 (694)
T ss_pred             ccccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcC----
Confidence            986543322 467789999999999999999999999999999999999999999877654433222      221    


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                         ++    .++..++.+...++.++|.+||++|..+
T Consensus       584 ---~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ---EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence               11    2344567788999999999999999965

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-45  Score=354.31  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=212.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +-|++++.||.|+.|.|-+|.+. +|+.+|||++....   ......+.+|+-+|+.+.||||+.++++++++.++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888999999999999999954 79999999986652   233456888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|.|++++...    +++++.++.+++.||+.|+.|+|..   +|+||||||+|+||+..+++||+|||+|.+.-+
T Consensus        92 Eyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            999999999999877    7899999999999999999999999   999999999999999999999999999987544


Q ss_pred             CCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      +.  ...+.||+++|.|||++.+.+| +.++||||+|||||.||||++||++.      ++-..+.+......       
T Consensus       165 gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G~f-------  229 (786)
T KOG0588|consen  165 GK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRGVF-------  229 (786)
T ss_pred             Cc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCcc-------
Confidence            32  3455689999999999999987 57899999999999999999999843      33333444333221       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..    +..++.+..+|+.+||..||+.|.|+++|++...
T Consensus       230 ~M----Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  230 EM----PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             cC----CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            11    2345567899999999999999999999998543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-45  Score=336.84  Aligned_cols=249  Identities=21%  Similarity=0.398  Sum_probs=213.2

Q ss_pred             CCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhH---HHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .+|++.+.||+|.||+|-+|. ...|+.||||.+.+....+.   -.+.+|+++|..|+||||++++.+|++.+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            579999999999999999998 47899999999977654444   45778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||..+|.|++|+...    +.+++.++..+|+||..|+.|+|.+   +++|||||.+|||+|.++++||+||||+.++..
T Consensus       133 EYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999876    6899999999999999999999999   999999999999999999999999999988754


Q ss_pred             CCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..  ...+++|++-|.+||++.+.+| ++.+|-||||++||.|+.|..||++.+-.      .+++++...    ....+
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQIs~G----aYrEP  273 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQISRG----AYREP  273 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHHhhcc----cccCC
Confidence            43  3466899999999999999987 57899999999999999999999876432      223333222    22333


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .-|+        ...-||..||..||++|.|+.+|....+-
T Consensus       274 ~~PS--------dA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  274 ETPS--------DASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             CCCc--------hHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence            3332        25568899999999999999999987764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-45  Score=347.38  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=214.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe-eEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-RMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  154 (407)
                      ++|..++.+|+|+||.+++++++ ++..+++|++....  ....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57999999999999999999955 67789999886543  3334467789999999999999999999998887 99999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      +||+||+|.+.|...++  ..+++..++.|+.|++.|+.|||++   +|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999987653  5699999999999999999999998   999999999999999999999999999999877


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ... ...+.+||+.||+||++.+.+|+.++|||||||++|||++-+.+|...+...      .+.++....         
T Consensus       159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~---------  222 (426)
T KOG0589|consen  159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGL---------  222 (426)
T ss_pred             chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhcc---------
Confidence            653 3455789999999999999999999999999999999999999998655432      233332221         


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       ....+..++.++..+|..||..+|..||++.+++..
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             111234566679999999999999999999999975

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-44  Score=335.65  Aligned_cols=247  Identities=20%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChhh---HHHHHHHHHHHhcCCCCccceeeeeeec----CCeeEEEEEec
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQA---EREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLVYEYV  157 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~  157 (407)
                      ..||+|++|.||+|.+ +++.||||.+.......   ...+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 48899999886543322   4667789999999999999999999876    45789999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++...    ..+++...+.++.|++.||.|||+..  +++||||||+|||++.++.+||+|||++....... 
T Consensus       105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999765    46899999999999999999999731  78899999999999999999999999988654322 


Q ss_pred             eeeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                         ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+      .......... .    ..+
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~-~----~~~  243 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNN-S----LKL  243 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCC-C----CCC
Confidence               22357899999999976  679999999999999999999999998554322      1112211111 0    111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      +    ..++..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus       244 ~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        244 P----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             C----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            1    1345579999999999999999999999999987653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.5e-44  Score=337.30  Aligned_cols=264  Identities=24%  Similarity=0.404  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCceEEEEEEECC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccce
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED-----------------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVR  139 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~  139 (407)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|.+.... ......+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4679999999999999999998532                 2369999886643 334557889999999999999999


Q ss_pred             eeeeeecCCeeEEEEEeccCCChHHhhhCCCC---------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCcee
Q 015395          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVG---------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV  204 (407)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv  204 (407)
                      +++++.+.+..++||||+.+++|.+++.....               ....+++..++.++.||+.||.|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999999865321               113478889999999999999999999   999


Q ss_pred             ccCCCCccEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCC
Q 015395          205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRI  281 (407)
Q Consensus       205 H~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt--g~~  281 (407)
                      ||||||+|||++.++.+||+|||+++......... .....++..|+|||++....++.++|||||||++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999998664433221 222345788999999988899999999999999999987  567


Q ss_pred             CCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       282 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ||......+.   .............. .. ...    ...++..+.++|.+||+.||.+|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~---~~~~~~~~~~~~~~-~~-~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQV---IENAGEFFRDQGRQ-VY-LFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHH---HHHHHHHhhhcccc-cc-ccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7765443222   22222221111100 00 000    1123456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.4e-44  Score=332.00  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=206.3

Q ss_pred             hcCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|.+.... ......+..|+.+++.++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3467899999999999999999753    35579999887653 233457888999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999997642   4689999999999999999999999   999999999999999999999999998765


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||......+.      +.... ....   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~------~~~~~-~~~~---  226 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV------IKAVE-DGFR---  226 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHH-CCCC---
Confidence            43222111112235678999999999999999999999999999875 9999976543221      11111 1100   


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                        ...    ...++..+.+++.+||+.+|++||++.+|++.|..+
T Consensus       227 --~~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 --LPA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              111    223455689999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.3e-44  Score=334.40  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46999999999999999999976 57789999886542  2334567789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |++++.+..+....    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99887776554332    4689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH---------HHHhhcCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL---------KKMVTNRN  306 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~  306 (407)
                      .........|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+..+         ........
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            332333456899999999999888999999999999999999999999865443322211111         00000000


Q ss_pred             CCCcCCCCCC------CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          307 PEGVLDPKLP------EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       307 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ......+...      ......++..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      0011224567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=338.24  Aligned_cols=247  Identities=25%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999965 68889999885432   223456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999999765    5689999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.      ........       ..
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~-------~~  216 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAGK-------LE  216 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-------cC
Confidence            2    1234689999999999999999999999999999999999999976543221      12222111       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~L~  353 (407)
                      ++    ..+...+.+||.+||+.||.+||+     ++++++...
T Consensus       217 ~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  256 (291)
T cd05612         217 FP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW  256 (291)
T ss_pred             CC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence            11    122446889999999999999995     778776543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-44  Score=329.88  Aligned_cols=258  Identities=24%  Similarity=0.431  Sum_probs=210.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +..++|++.+.||+|+||.||+|...++..||+|.+.... .....+..|+.+++.++|+||+++++++......+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            4457899999999999999999998888889999876543 335678889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999975422  4688899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .........++..|+|||.+....++.++|||||||++|+|++ |..||........      .........      ..
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~~~~~------~~  224 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV------MSALQRGYR------MP  224 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH------HHHHHcCCC------CC
Confidence            3222222345678999999988889999999999999999998 9999975433221      111111110      01


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .    ...++..+.+++.+||..+|++||+++++++.|+++
T Consensus       225 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 R----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             C----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1    112445689999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-43  Score=332.80  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .|+..+.||+|+||.||+|.. .++..||+|.+....   ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999995 478899999885432   2233456789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++|+|.+++.....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999988864321  3689999999999999999999999   9999999999999999999999999999875433


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..  .....||..|+|||++.+..++.++|||||||++|+|++|+.||..........   .+........         
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~---------  221 (285)
T cd05631         156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQ---------  221 (285)
T ss_pred             Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhccc---------
Confidence            22  233468999999999999999999999999999999999999998654322111   1111111100         


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  351 (407)
                       ......++..+.+|+.+||+.||.+||+     ++++++.
T Consensus       222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             0112234557899999999999999997     6777763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-44  Score=343.05  Aligned_cols=246  Identities=22%  Similarity=0.323  Sum_probs=203.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....   ......+..|+.++++++||||+++++++.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            467999999999999999999965 57889999886432   23345678899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+.+++|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            9999999999999765    5689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...    ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .........       .
T Consensus       170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~-------~  232 (329)
T PTZ00263        170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKILAGR-------L  232 (329)
T ss_pred             CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC-------c
Confidence            332    23468999999999999999999999999999999999999997543321      112222111       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~  351 (407)
                      .++.    .++..+.+||.+||+.||.+||+     +.+++..
T Consensus       233 ~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 KFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1111    13456889999999999999996     5777654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=348.54  Aligned_cols=251  Identities=27%  Similarity=0.496  Sum_probs=209.2

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .|++..+....++-||.|+.|.||+|+.. ++.||||++..-+       ..+|+.|++|+||||+.+.|+|.....+||
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            35566666777888999999999999987 7889999874432       237888999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |||||..|-|...|+..    .++.......|..+||.|+.|||.+   .|||||||.-||||..+..|||+|||.++..
T Consensus       190 iMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             eeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999999876    5788899999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....  ...++||..|||||++.+.+.+.|+|||||||+|||||||..||..-....    +     ++.-+.  ..+.
T Consensus       263 ~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I-----IwGVGs--NsL~  329 (904)
T KOG4721|consen  263 SDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I-----IWGVGS--NSLH  329 (904)
T ss_pred             hhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e-----EEeccC--Cccc
Confidence            65422  234689999999999999999999999999999999999999996432211    0     011110  1111


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      -.+    +..+++-+.-||..||+-.|..||+|.+|+..|+..
T Consensus       330 Lpv----PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  330 LPV----PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccC----cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            222    345666788899999999999999999999999864

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=312.14  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=215.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----C
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----A  148 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~  148 (407)
                      .+..++|++.+.||+|||+.||++. ..+++.+|+|++.....+..+..++|++..++++||||++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            4566789999999999999999999 567888999999888888888889999999999999999999987543     3


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..||+++|...|+|.+.+.........+++.+++.|+.++++||++||+. .+.++||||||+|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            48999999999999999987665556899999999999999999999998 22499999999999999999999999999


Q ss_pred             ceecCCCCcee--------eeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH
Q 015395          229 AKLLGSESSYI--------TTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW  297 (407)
Q Consensus       229 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  297 (407)
                      ++...-.-...        ......|..|+|||++..   ...+.++|||||||+||+|+.|..||+..-..        
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------  247 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------  247 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence            87543111100        012346899999999854   45788999999999999999999999632110        


Q ss_pred             HHHHhhcCCC-CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          298 LKKMVTNRNP-EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       298 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                            .... -.+............+++.+.++|..||+.||.+||++.+++..++.+.
T Consensus       248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                  0100 1122222222223347888999999999999999999999999988763

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-44  Score=342.87  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=207.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++....   ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999966 57899999886442   233456778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+   ...   .   ..+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~---~---~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---KYW---K---ETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---Hhc---c---ccccCC
Confidence                223456899999999999999999999999999999999999999865543322211   110   0   001111


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ........++..+.+++.+||..+|.+||++.++++..
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            11111123556789999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-43  Score=326.72  Aligned_cols=252  Identities=23%  Similarity=0.428  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .++|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            35688899999999999999998878889999875432 33457788999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            9999999997543   3589999999999999999999999   999999999999999999999999999886543322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+.      +........   .   ..+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~~---~---~~~  223 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGFR---L---YRP  223 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCC---C---CCC
Confidence            22222235668999999988889999999999999999999 8999975543222      122211111   0   011


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      .    ..+..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 K----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1    1234689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.9e-44  Score=341.15  Aligned_cols=242  Identities=22%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68889999886432   233346678999999999999999999999999999999999999


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceee
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  240 (407)
                      +|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  152 (323)
T cd05571          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence            999999765    5789999999999999999999999   999999999999999999999999999875422211 22


Q ss_pred             eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCcc
Q 015395          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (407)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (407)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .........       ..++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~-------~~~p----  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE-------IRFP----  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC-------CCCC----
Confidence            34569999999999999999999999999999999999999997543211      111111111       1111    


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          321 SRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      ..++..+.++|.+||+.||++||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            23455689999999999999999     78888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-43  Score=338.75  Aligned_cols=266  Identities=21%  Similarity=0.327  Sum_probs=208.7

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ..++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++|+.++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3578999999999999999999965 57789999886542 344567889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            999999999999765    46899999999999999999999851  599999999999999999999999999876533


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC---CCC---
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---NPE---  308 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~---  308 (407)
                      ..   .....||..|+|||++.+..++.++|||||||++|+|++|+.||......+..   ..+.......   ...   
T Consensus       157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccccC
Confidence            21   23346899999999999999999999999999999999999999754332111   1110000000   000   


Q ss_pred             ----------------------------CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          309 ----------------------------GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       309 ----------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                                                  .+.....+......++.++.+||.+||+.||++|||+.++++....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                                        0000001111122355679999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-44  Score=327.11  Aligned_cols=256  Identities=24%  Similarity=0.289  Sum_probs=212.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .+..++|++++.||+|.-|+||+|+.++ +..+|+|++.+..   .....+.+.|.+||..++||.++.+|..|+.....
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            3556679999999999999999999764 5789999986653   23344667799999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |++||||+||+|..++++..+  ..+++..+..++.+++-||+|||..   |||+|||||+||||.++|++.|+||.|+.
T Consensus       153 cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999999987654  5799999999999999999999999   99999999999999999999999999874


Q ss_pred             ecCC---------------------------------C-C---------------------ceeeeeeeccccccCcccc
Q 015395          231 LLGS---------------------------------E-S---------------------SYITTRVMGTFGYVAPEYA  255 (407)
Q Consensus       231 ~~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~  255 (407)
                      ....                                 . .                     ......++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                 0 0                     0112246899999999999


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHcc
Q 015395          256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCV  335 (407)
Q Consensus       256 ~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  335 (407)
                      .+...+.++|+|+|||+|||||.|..||.+.+..+....+      +..       +..++..+  ..+..+.+||.+.|
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI------v~~-------~l~Fp~~~--~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI------VGQ-------PLKFPEEP--EVSSAAKDLIRKLL  372 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH------hcC-------CCcCCCCC--cchhHHHHHHHHHh
Confidence            9999999999999999999999999999988776554332      221       22333333  55667999999999


Q ss_pred             CcCCCCCCC----HHHHHH
Q 015395          336 DPNAQKRPK----MGHVVH  350 (407)
Q Consensus       336 ~~dp~~RPt----~~evl~  350 (407)
                      .+||.+|..    +.||-+
T Consensus       373 vKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ccChhhhhccccchHHhhc
Confidence            999999997    667665

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-43  Score=338.30  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=197.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            346778899999999999999965 68899999986543 3344678899999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+..        ...+..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999986532        356778889999999999999999   9999999999999999999999999999876433


Q ss_pred             CceeeeeeeccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .. ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+..   ..+....... .   
T Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~-~---  293 (353)
T PLN00034        222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA---SLMCAICMSQ-P---  293 (353)
T ss_pred             cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHHhccC-C---
Confidence            22 1233468999999998743     23456899999999999999999999743322111   1111111110 0   


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                        .    .....++..+.+||.+||+.||++||++.++++.-.
T Consensus       294 --~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        294 --P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             --C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence              0    111234557899999999999999999999988543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-44  Score=309.57  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=213.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      +.++|++++.||+|.||.||+|+.+ ++-.||+|++.+..   ......+.+|+++-..|+||||++++++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4578999999999999999999954 56679999986653   3455678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ++||..+|+|...|....+  ..+++...+.++.|+|.||.|+|..   +|+||||||+|+|++..+.+||+|||-+...
T Consensus       100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            9999999999999985433  5799999999999999999999999   9999999999999999999999999988764


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .   .....+.+||.-|++||+..+..++..+|+|++|++.||++.|.+||......+.      .+++...       +
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~k~-------~  238 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIRKV-------D  238 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHHHc-------c
Confidence            3   2235667899999999999999999999999999999999999999975543222      2222211       1


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      -.+    +..++....++|.+|+..+|.+|.+..+++..-..
T Consensus       239 ~~~----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  239 LKF----PSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             ccC----CcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence            122    23455678999999999999999999999886553

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-43  Score=325.17  Aligned_cols=259  Identities=26%  Similarity=0.433  Sum_probs=209.9

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++..++|++.+.||+|++|.||+|...++..||+|.+.... .....+..|+.++++++||||+++++++...+..+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            34567899999999999999999998777889999886543 33556888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999997643  24689999999999999999999999   999999999999999999999999999987753


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...........+..|+|||.+.+..++.++||||||+++|+|++ |+.||........      ...+.....      .
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~------~  223 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV------LQQVDQGYR------M  223 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHcCCC------C
Confidence            32211111223457999999998899999999999999999999 9999975442211      111111110      0


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .    .....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       224 ~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 P----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             C----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            0    1122345689999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=332.11  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--------------hhhHHHHHHHHHHHhcCCCCcccee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--------------GQAEREFKVEVEAIGRVRHKNLVRL  140 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~E~~~l~~l~hpniv~~  140 (407)
                      ...++|++.+.||+|.||+|-+|+.. +++.||||++.+..              ....+.+.+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45678999999999999999999954 68889999885431              1122467889999999999999999


Q ss_pred             eeeeecC--CeeEEEEEeccCCChHHhhhCCCCCCCC-CCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC
Q 015395          141 LGYCAEG--AHRMLVYEYVNNGNLEQWLHGDVGPCSP-LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (407)
Q Consensus       141 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  217 (407)
                      +.+..+.  +.+|||+|||..|.+...=..     .+ +++.++++|+++++.||+|||.+   +||||||||+|+||+.
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            9998764  688999999998876433211     34 89999999999999999999999   9999999999999999


Q ss_pred             CCCcEEeecccceecCCCC----ceeeeeeeccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 015395          218 HWNPKVSDFGLAKLLGSES----SYITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (407)
Q Consensus       218 ~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwslG~il~elltg~~Pf~~~~~~  289 (407)
                      +|++||+|||.+.......    .......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+..  
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--  323 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--  323 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence            9999999999998663221    11223357999999999886632    4567899999999999999999996433  


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                          .++...+++...         +......++.+.+.+||.++|++||+.|.+..+|....+...
T Consensus       324 ----~~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  324 ----ELELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ----HHHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                344445554432         111122245667999999999999999999999988776543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-43  Score=343.50  Aligned_cols=264  Identities=27%  Similarity=0.414  Sum_probs=207.5

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEE------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  145 (407)
                      +.+..++|++.+.||+|+||.||+|.+      .++..||+|++.... ......+.+|+.+|+.+ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            455567899999999999999999973      235579999886443 23445678899999999 8999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCC------------------------------------------------------
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVG------------------------------------------------------  171 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  171 (407)
                      .....++|||||++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999999864321                                                      


Q ss_pred             -----------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          172 -----------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       172 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                                       ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             012578899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          235 ESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       235 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .....    ......     
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~-----  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYR-----  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCcc-----
Confidence            33221 112234567999999999999999999999999999998 899997543221  11111    111110     


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ...+    ...+.++.+++.+||+.||++||++.+|++.|+..
T Consensus       336 ~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSP----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0111    11235689999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-43  Score=352.80  Aligned_cols=252  Identities=19%  Similarity=0.287  Sum_probs=206.7

Q ss_pred             CCCccceecccCceEEEEEEEC-C-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-D-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+|+.++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999854 3 5678898776555555567788999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++........++++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998865433335789999999999999999999999   999999999999999999999999999987654322


Q ss_pred             -eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 -YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      +.+.........      .. 
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~------~~-  291 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYD------PF-  291 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC------CC-
Confidence             1233456999999999999999999999999999999999999999754322      222222221110      11 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         ...++..+.++|.+||..||++||++.+++.
T Consensus       292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               1223456899999999999999999999875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-43  Score=326.58  Aligned_cols=257  Identities=28%  Similarity=0.508  Sum_probs=212.3

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +..+|.+.+.||.|+||.||+|...++..+|+|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578999999999999999999888889999998776665566788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999976432  4689999999999999999999999   99999999999999999999999999997664332


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      .. .....++..|+|||.+....++.++||||||+++|+|++ |+.||......+..      ........      ...
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~------~~~~~~~~------~~~  225 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY------DQITAGYR------MPC  225 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH------HHHHhCCc------CCC
Confidence            21 122345678999999988899999999999999999998 89999755432211      11111100      011


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                          ...++..+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 ----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                123345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-43  Score=340.40  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             hcCCCCccceecccCceEEEEEEECC--CCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|.+.+.||+|+||.||+|.+..  +..||+|.+....   ......+..|+.+++.++||||+++++++.+....+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            45679999999999999999998543  3579999885432   233456778999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+.+|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999999765    4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ....    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++...      ........ .    
T Consensus       181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~-~----  245 (340)
T PTZ00426        181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILEGI-I----  245 (340)
T ss_pred             cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhcCC-C----
Confidence            6432    2335689999999999988899999999999999999999999975543211      12222111 0    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                        .++    ..++..+.++|.+||+.||.+|+     +++++++.
T Consensus       246 --~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 --YFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              111    12334578999999999999995     78888764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=323.83  Aligned_cols=272  Identities=23%  Similarity=0.347  Sum_probs=208.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEec--cCChhhHHHHHHHHHHHhcCCCCccceeeeeeec-----CCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLL--NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  149 (407)
                      ...|...+.||+|+||.|+.+... ++..||||++.  .......++..+|+.+|+.++|+||+.+++++..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345677899999999999999954 78999999997  4455566677789999999999999999998754     356


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +|+|+|+| +.+|.+.|+..    ..++...+..++.|+++||.|+|+.   +|+||||||+|+|++.+..+||+|||+|
T Consensus       101 vYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            89999999 66999999876    4599999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCC-ceeeeeeeccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH-------
Q 015395          230 KLLGSES-SYITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK-------  300 (407)
Q Consensus       230 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------  300 (407)
                      +...... ....+..+.|.+|.|||++. ...|+.+.||||+|||+.|||+|++-|.+.+..+....+..+..       
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9886431 12235567899999999875 45799999999999999999999999988764433322211100       


Q ss_pred             -HhhcCCCCCcCC--CCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHhccC
Q 015395          301 -MVTNRNPEGVLD--PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM--LEAQES  357 (407)
Q Consensus       301 -~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~  357 (407)
                       .+........+.  +..+..+    .........+|+.+||..||.+|+|++++|..  |.....
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence             000000000000  1111111    11233457899999999999999999999974  444433

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=345.22  Aligned_cols=268  Identities=29%  Similarity=0.432  Sum_probs=218.7

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEECC--C--CE-EEEEEecc---CChhhHHHHHHHHHHHhcCCCCccceee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED--N--SK-VAVKNLLN---NRGQAEREFKVEVEAIGRVRHKNLVRLL  141 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vaiK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~  141 (407)
                      ....|++..++..+.+.||+|+||.||+|....  +  .. ||+|....   .......++..|+++|+.++|||||+++
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            345577788888899999999999999999542  2  23 89998874   3456677899999999999999999999


Q ss_pred             eeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                      |+......++||||+|.||+|.++|....   ..++..+.+.++.+.+.||+|||++   +++||||..+|+|++.++.+
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence            99999999999999999999999998764   3699999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCceeee-eeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      ||+|||+++......  ... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....+..      .
T Consensus       302 KISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------~  373 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------A  373 (474)
T ss_pred             EeCccccccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------H
Confidence            999999987643111  111 1124578999999999999999999999999999999 88899876654222      2


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCCc
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  360 (407)
                      ++......         ...+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       374 kI~~~~~r---------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  374 KIVKNGYR---------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHhcCcc---------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            22122211         11122445678889999999999999999999999998866543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-43  Score=330.60  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999965 67889999886443 2234466789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+.+ +|.+++....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            9964 9999886542   3578999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC---------
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---------  305 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------  305 (407)
                      ... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+   .......         
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  232 (288)
T cd07871         157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI---FRLLGTPTEETWPGIT  232 (288)
T ss_pred             Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHHhhccc
Confidence            221 223467999999998865 56899999999999999999999999866544332221   1111100         


Q ss_pred             ---CCCCcCCCCCCCC----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          306 ---NPEGVLDPKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       306 ---~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .......+.....    .......++.+|+.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               0000000110000    01123456889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.8e-43  Score=327.11  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=208.0

Q ss_pred             cCCCCccceecccCceEEEEEEECCC------CEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDN------SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~------~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .++|++.+.||+|+||.||+|.....      ..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            35789999999999999999985432      468999886543 33445788899999999999999999999998999


Q ss_pred             EEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          151 MLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      +++|||+++++|.+++.....            ....+++..++.++.|++.||.|||+.   +++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            999999999999999975421            114588899999999999999999999   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHH
Q 015395          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  296 (407)
                      +.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.   . 
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~-  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---I-  236 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-
Confidence            99999999999865433221 1223356788999999988899999999999999999998 9999976544221   1 


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                        .. +......         .....++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus       237 --~~-i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 --EM-IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HH-HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              11 1111111         1123455679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=335.06  Aligned_cols=240  Identities=21%  Similarity=0.262  Sum_probs=194.6

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||+|+||.||+|... ++..||+|.+...   .......+..|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 5778999988543   223345677899999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  242 (407)
                      .+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++........ ....
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  152 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT  152 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence            9999764    5689999999999999999999999   999999999999999999999999999876432222 2234


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||......      +.........       ..+    +..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~-------~~~----~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP-------LRF----PDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC-------CCC----CCc
Confidence            56899999999999999999999999999999999999999754322      2222222211       111    123


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ++..+.+++.+||+.||.+||++..+.+.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence            44568999999999999999865443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-43  Score=316.60  Aligned_cols=270  Identities=23%  Similarity=0.279  Sum_probs=212.6

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv  153 (407)
                      ++|+.+..|++|+||.||+|++ +++..||+|+++.....  ..-.-.+|+.+|.+++|||||.+-.+...  -+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4688999999999999999995 47888999998665322  12234679999999999999999888753  4679999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||||+. +|..++.+..   .++...++..++.|+++||+|||.+   .|+|||||++|+|+++.|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999965 9999998875   5899999999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... .+..+-|.+|+|||++.+. .|+.+.|+||+|||+.||+++++-|.+.+..+..+.+-.+.........+.+-.
T Consensus       229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            76443 4455679999999998775 599999999999999999999999998876655554433332222221111111


Q ss_pred             ------CCCCCCccH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          313 ------PKLPEKPTS---------RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       313 ------~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                            -.++..+..         .+.+.-.+|+..+|..||.+|.|+.+.|+.=....
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence                  111111111         14466788999999999999999999998555443

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.4e-43  Score=324.02  Aligned_cols=258  Identities=23%  Similarity=0.390  Sum_probs=208.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +...+|.+.+.||+|+||.||+|.+. .+..||+|.+.... .....+.+|+.+++.++||||+++++++......+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            34556888999999999999999965 57789999876443 33456888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          82 EFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999965421  4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.      ........      ..
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~------~~  224 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKGY------RM  224 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCC------CC
Confidence            33222222234568999999998999999999999999999998 9999975432211      11111110      01


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ..    ...++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       225 ~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ER----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11    122446799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.4e-43  Score=326.71  Aligned_cols=257  Identities=25%  Similarity=0.466  Sum_probs=207.9

Q ss_pred             cCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+...... ....+.+|+++|+.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4568889999999999999998532      467999988665443 456888999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCC----------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC
Q 015395          151 MLVYEYVNNGNLEQWLHGDV----------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN  220 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  220 (407)
                      +++|||+++++|.+++....          .....+++..++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999997542          1224578999999999999999999999   9999999999999999999


Q ss_pred             cEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (407)
                      +||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+..      
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~------  234 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI------  234 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------
Confidence            999999999765332221 1223345788999999999999999999999999999998 99999755433211      


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .... .....     .    ....++..+.+++.+||+.||++||++.++++.|+
T Consensus       235 ~~~~-~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECIT-QGRLL-----Q----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHH-cCCcC-----C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1111 11110     1    11234456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-43  Score=335.78  Aligned_cols=242  Identities=24%  Similarity=0.300  Sum_probs=197.1

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      +.||+|+||.||++... ++..||+|.+....   ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999954 68899999886532   233445677999999999999999999999999999999999999


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceee
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  240 (407)
                      +|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  152 (323)
T cd05595          81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence            999988765    4689999999999999999999999   999999999999999999999999999875322211 12


Q ss_pred             eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCcc
Q 015395          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (407)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (407)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....      ........       ..++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~~-------~~~p----  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEE-------IRFP----  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCC-------CCCC----
Confidence            335689999999999999999999999999999999999999975433211      11111111       1111    


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          321 SRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      ..++..+.++|.+||+.||.+||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            12445688999999999999998     78888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-43  Score=342.43  Aligned_cols=265  Identities=25%  Similarity=0.433  Sum_probs=207.9

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      .+....++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+..|+.+++.+ +|+||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            34455678999999999999999998842      23479999886543 33345678899999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC-----------------------------------------------------
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG-----------------------------------------------------  171 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  171 (407)
                      ......++||||+.+|+|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999999854210                                                     


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          172 -------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       172 -------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                                   ...++++..++.++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         113578899999999999999999999   9999999999999999999999999999865433221


Q ss_pred             e-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          239 I-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       239 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . .....++..|||||++.+..++.++|||||||++|+|++ |+.||........      +........     ....+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~-----~~~~~  337 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY-----QMSRP  337 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc-----CccCC
Confidence            1 112234567999999988899999999999999999997 9999975433211      111111110     01111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .    ..+.++.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       338 ~----~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 D----FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1    1245689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-43  Score=340.58  Aligned_cols=263  Identities=18%  Similarity=0.234  Sum_probs=201.1

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ..++|++.+.||+|+||.||+|... +++.||+|...      ...+.+|+.+|++++||||+++++++......++|||
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            4467999999999999999999964 67889999643      2345679999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ++ +++|..++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       164 ~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        164 RY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             cC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            99 46898888654    4689999999999999999999999   9999999999999999999999999999764333


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh----hhHHHHHHHHhhcCC-----
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE----VNLIEWLKKMVTNRN-----  306 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~~~~~~-----  306 (407)
                      .........||+.|+|||++.+..++.++|||||||++|||++|..||........    ...+..+........     
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            22223345799999999999999999999999999999999999988754322110    000111100000000     


Q ss_pred             --------------CCCcCCCC-CCC-CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          307 --------------PEGVLDPK-LPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       307 --------------~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                                    ......+. .+. ......+..+.+||.+||+.||.+|||+.++++.-.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence                          00000000 000 011234667899999999999999999999997443

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-43  Score=342.52  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=202.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ......+..|+.+|+.++||||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999965 68889999986432   233456778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999999765    4699999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCce-------------------------------------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 015395          235 ESSY-------------------------------------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  277 (407)
Q Consensus       235 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ell  277 (407)
                      ....                                     .....+||+.|+|||++....++.++|||||||++|+|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011246899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 015395          278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MGHVVHM  351 (407)
Q Consensus       278 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~  351 (407)
                      +|..||......+.      ..........     ..++.  ...++..+.++|.+|+. +|.+|++   +.+++..
T Consensus       234 ~G~~Pf~~~~~~~~------~~~i~~~~~~-----~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQET------YRKIINWKET-----LQFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHHH------HHHHHcCCCc-----cCCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999976543221      1222111100     01111  11234568889999996 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-43  Score=335.71  Aligned_cols=242  Identities=24%  Similarity=0.318  Sum_probs=197.8

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      +.||+|+||.||++... ++..||+|++....   ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68899999886532   233456778999999999999999999999999999999999999


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceee
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  240 (407)
                      +|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  152 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM  152 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence            999998765    4689999999999999999999999   999999999999999999999999999875432211 22


Q ss_pred             eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCcc
Q 015395          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (407)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (407)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.      .......       ...++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~~-------~~~~p----  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME-------DIKFP----  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhccC-------CccCC----
Confidence            345689999999999999999999999999999999999999975433211      1111111       01111    


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          321 SRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      ..++..+.+++.+||+.||.+|+     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            12445688999999999999997     88888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.1e-43  Score=335.41  Aligned_cols=252  Identities=25%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             CCCccceecccCceEEEEEEEC----CCCEEEEEEeccC----ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNN----RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      +|++.+.||+|+||.||++...    ++..||+|++...    .......+..|+.+++.+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999853    5788999988543    122334577899999999 599999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999765    4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..............||..|+|||++.+. .++.++|||||||++|+|++|..||...........  ....... .    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--~~~~~~~-~----  226 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE--VSRRILK-C----  226 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH--HHHHHhc-C----
Confidence            6544333333345799999999999765 478899999999999999999999975433222111  1111111 1    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                        ++.++    ..++..+.+++.+||+.||++||     +++++++.
T Consensus       227 --~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 --DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              11221    12345688999999999999999     66677654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.6e-43  Score=321.86  Aligned_cols=253  Identities=25%  Similarity=0.444  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .++|.+.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            35688899999999999999998777779999876443 33456888999999999999999999999888999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      .+++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999999997642   3689999999999999999999999   999999999999999999999999999886644332


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.      .........      ...+
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~~~~~------~~~~  223 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------VEKVSQGLR------LYRP  223 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHhcCCC------CCCC
Confidence            22222235678999999988889999999999999999998 9999975443211      111111110      0111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .    ..+..+.+++.+||+.+|.+||++.+++..|+
T Consensus       224 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 H----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1    12457899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-42  Score=332.52  Aligned_cols=263  Identities=21%  Similarity=0.345  Sum_probs=204.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ..++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999966 5778899987654 3334467889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+++|.+++...    ..+++..+..++.|++.||.|||+..  +|+|+||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999999764    46899999999999999999999741  699999999999999999999999999876532


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC-----
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG-----  309 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  309 (407)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..........   .+.. ........     
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~  229 (333)
T cd06650         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL---MFGC-PVEGDPAESETSP  229 (333)
T ss_pred             h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH---HhcC-cccCCccccccCc
Confidence            2   1223468999999999998889999999999999999999999997543211110   0000 00000000     


Q ss_pred             ----------------------------cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          310 ----------------------------VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       310 ----------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                                                  +.....+......++.++.+|+.+||+.||++|||+.+++..-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                                        0000000011112345688999999999999999999998743

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-42  Score=320.83  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=206.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +..++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+||+++++++.. ...+++||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            34567999999999999999999988888899998865433 34568889999999999999999998754 56789999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+.+++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            999999999997532  14589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .........++..|+|||.+....++.++||||||+++|+|++ |..||......+      ....+.....      ..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~------~~  223 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYR------MP  223 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC------CC
Confidence            3222222235668999999988889999999999999999999 899997543322      1122211100      11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .    ....+..+.+++.+||..+|++|||+.++.+.|++
T Consensus       224 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 C----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             C----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1    12344569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=341.05  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=206.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999965 68899999886432   234456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999765    5789999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC----------------------------ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 015395          235 ES----------------------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS  286 (407)
Q Consensus       235 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~  286 (407)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                            11123346899999999999999999999999999999999999999865


Q ss_pred             CCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHHH
Q 015395          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHML  352 (407)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L  352 (407)
                      ...+.      ...+.....  ..   .++..  ..++..+.++|.+||. ||.+||+ +.++++..
T Consensus       234 ~~~~~------~~~i~~~~~--~~---~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         234 TLQET------YNKIINWKE--SL---RFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CHHHH------HHHHhccCC--cc---cCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            53221      111211000  00   11111  1145678999999997 9999999 99999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-42  Score=321.23  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=206.7

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..++|++.+.||+|+||.||+|.+.++..||+|.+.... .....+..|+.+++.++||||+++++++.+ ...++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            456799999999999999999998777789999886533 234567889999999999999999998754 557999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999975421  3578999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.      .........      .  
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~------~--  222 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYR------M--  222 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHHhcCCC------C--
Confidence            222223346678999999988889999999999999999999 8889875543221      111111100      0  


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                        .....++..+.+++.+||+.+|++||++.++++.|+..
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              11224556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.9e-43  Score=337.78  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|+.++..++||||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999865 57889999886432   223346778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999999765    5799999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 015395          235 ESS----------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  280 (407)
Q Consensus       235 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~  280 (407)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012347999999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccC--cCCCCCCCHHHHHHH
Q 015395          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD--PNAQKRPKMGHVVHM  351 (407)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPt~~evl~~  351 (407)
                      .||......+.      ..........  +   .++..  ..++..+.++|.+++.  .++..||++++|++.
T Consensus       234 ~Pf~~~~~~~~------~~~i~~~~~~--~---~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQET------YKKVMNWKET--L---IFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHHHH------HHHHHcCcCc--c---cCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99976543322      1222211100  0   11111  1133456677776443  334457899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-42  Score=320.76  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=208.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++..++|++.+.||+|+||.||+|...++..||+|.+..... ....+..|+.++++++|+||+++++++. .+..+++|
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            345678999999999999999999988889999998865443 3456788999999999999999999874 45689999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999865432  4689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........++..|+|||.+....++.++||||||+++|+|++ |+.||......+..      ..+.....      .
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~------~  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI------QNLERGYR------M  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH------HHHHcCCC------C
Confidence            32222222345678999999988889999999999999999999 99999765433221      11111100      0


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ..    ....+.++.+++.+||+.+|++||++++++..|++
T Consensus       223 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PR----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11    12234569999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.9e-43  Score=340.67  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .|++++.||+|+||.||+|... ++..||||++....   ......+..|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5889999999999999999854 57889999886532   2334567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999999765    4689999999999999999999999   9999999999999999999999999997543110


Q ss_pred             Cc----------------------------------------------eeeeeeeccccccCccccCCCCCCcchhHHHH
Q 015395          236 SS----------------------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSF  269 (407)
Q Consensus       236 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwsl  269 (407)
                      ..                                              ......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123469999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHH--ccCcCCCCCCCHHH
Q 015395          270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALR--CVDPNAQKRPKMGH  347 (407)
Q Consensus       270 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPt~~e  347 (407)
                      ||++|||++|..||......+..      .........     ...+  ....++.++.++|.+  |+..++..||++.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~-----~~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWENT-----LHIP--PQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHH------HHHHccccc-----cCCC--CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            99999999999999765432221      111111100     0111  111234567788877  55667777999999


Q ss_pred             HHHH
Q 015395          348 VVHM  351 (407)
Q Consensus       348 vl~~  351 (407)
                      ++..
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=361.64  Aligned_cols=262  Identities=28%  Similarity=0.469  Sum_probs=215.4

Q ss_pred             hcCCCCccceecccCceEEEEEEECC--CC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED--NS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ..........||+|.||.||.|...+  +.    .||||.+... +.+...+|.+|..+|+.++|||||+++|++.+...
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            35567788999999999999999553  33    4899998665 45666789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGP---CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      .+|++|||++|+|..||...+..   ...++..+.+.++.|||+|+.||+++   ++|||||..+|+||+....|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999875321   24689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeee-eccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          227 GLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |+|+.+...+....... .-...|||||.+.++.++.++|||||||+|||++| |..||...+..+....      ....
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~~g  920 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VLEG  920 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HHhC
Confidence            99995443333222222 23468999999999999999999999999999999 9999986665443221      1222


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .          .-.++..+++.+.+||..||+.+|++||+|..|++.+..+..
T Consensus       921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1          112244566779999999999999999999999998887644

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.4e-42  Score=319.08  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=210.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... ++..||||.+...   .......+..|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999954 6889999987532   2334456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.........+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998864333335689999999999999999999999   999999999999999999999999999887654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......    ...........         .
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~---------~  224 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQC---------D  224 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhcC---------C
Confidence            3221 12345788999999998888999999999999999999999998643221    11222221111         1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .+.......+..+.++|.+||+.+|++||++.+|++.|+.+
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11122334556799999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-42  Score=320.30  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEECC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+.... ......+..|+.+++.++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4679999999999999999998642    3468999876543 3344578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +|||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999997643   4689999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+   .   ..........   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~~---  227 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---V---IKAVEDGYRL---  227 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---H---HHHHHcCCCC---
Confidence            522221 1122234678999999998899999999999999999998 999996543221   1   1111111100   


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         ..    ...++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       228 ---~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ---PP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               01    123345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-42  Score=339.31  Aligned_cols=266  Identities=25%  Similarity=0.406  Sum_probs=210.7

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~  144 (407)
                      .+++..++|++.++||+|+||.||+|.+..      ...||||++..... .....+.+|+.+|+++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            456677899999999999999999998531      24699998865433 33457888999999996 99999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC-----------------------------------------------------
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG-----------------------------------------------------  171 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  171 (407)
                      .+....+||||||++|+|.++|.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999999864311                                                     


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          172 ---------------------------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       172 ---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                                                             ....+++..++.++.|++.||.|||+.   +|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                   012478888999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~  290 (407)
                      ||++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99999999999999999876433221 1222346788999999998899999999999999999997 999997543221


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .      +.........     ..    ....++..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       348 ~------~~~~~~~~~~-----~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 T------FYNKIKSGYR-----MA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H------HHHHHhcCCC-----CC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1      1111111110     01    11234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.2e-43  Score=335.69  Aligned_cols=253  Identities=22%  Similarity=0.292  Sum_probs=205.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+....   ......+..|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999955 68889999886542   234456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999997652   4689999999999999999999999   999999999999999999999999999987755


Q ss_pred             CCceeeeeeeccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ..........||+.|+|||++.      ...++.++|||||||++|+|++|..||........      +..+...... 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~-  227 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF-  227 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc-
Confidence            4443334456899999999986      45678999999999999999999999975543221      2222211110 


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        +  .++.  ...++..+.+|+..||. +|.+||++.+++..
T Consensus       228 --~--~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 --L--KFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             --c--CCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence              0  1111  11244568899999998 99999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.4e-43  Score=340.52  Aligned_cols=257  Identities=19%  Similarity=0.275  Sum_probs=206.2

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .+..++|++.+.||+|+||.||+|... ++..||+|.+...   .......+..|+.+++.++||||+++++++.+....
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            445678999999999999999999965 5788999988542   223334567899999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999998653     578889999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ..............||+.|+|||++.+.    .++.++|||||||++|||++|..||.......      ..........
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~  264 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKN  264 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCC
Confidence            7654333223345799999999998653    47899999999999999999999997654321      1222222111


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHML  352 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L  352 (407)
                      .     ..++.  ...++..+.++|.+||+.+|.+  |+++.+++...
T Consensus       265 ~-----~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         265 S-----LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             c-----CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence            0     01111  1234567889999999999988  99999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-42  Score=325.23  Aligned_cols=262  Identities=25%  Similarity=0.432  Sum_probs=211.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..+|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+.++++++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            356888899999999999999742      24458899887666666677889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC
Q 015395          152 LVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  219 (407)
                      +||||+++++|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999975421            123589999999999999999999999   999999999999999999


Q ss_pred             CcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHH
Q 015395          220 NPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW  297 (407)
Q Consensus       220 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  297 (407)
                      .++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.      
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------  234 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------  234 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence            9999999999765433221 1223346788999999999999999999999999999999 9999875443221      


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      +... ......     ..    ...++..+.+++.+||+.+|++||++.+|++.|+.+.+.
T Consensus       235 ~~~~-~~~~~~-----~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECI-TQGRVL-----ER----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHH-hCCCCC-----CC----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1111 111111     01    112345689999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-42  Score=331.03  Aligned_cols=244  Identities=26%  Similarity=0.363  Sum_probs=194.8

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHH---hcCCCCccceeeeeeecCCeeEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAI---GRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      |++.+.||+|+||.||+|... +++.||||.+....   ......+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999965 68889999886432   22234555666554   567899999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|..++..     ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988864     3689999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+.      ........       .
T Consensus       153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~~-------~  218 (324)
T cd05589         153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVNDE-------V  218 (324)
T ss_pred             CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-------C
Confidence            2221 22345689999999999999999999999999999999999999975543221      12221111       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVH  350 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~  350 (407)
                      .++    ..++..+.++|.+||+.||.+||     ++.++++
T Consensus       219 ~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            111    12345688999999999999999     4566655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-42  Score=325.18  Aligned_cols=261  Identities=25%  Similarity=0.446  Sum_probs=210.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+..........+..|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467999999999999999999842      23458999887666566677889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCC---------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          152 LVYEYVNNGNLEQWLHGDV---------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      ++|||+++++|.+++....         .....+++..++.++.|++.||+|||++   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999996432         1123589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       223 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      |+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+      ....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIEC  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence            9999999865433221 1122335778999999998899999999999999999998 999997544322      1122


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .......      ..+    ..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       235 i~~~~~~------~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVL------QRP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcC------CCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2111100      111    1233468999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=319.89  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=203.2

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4588899999999999999998777789999875433 234467789999999999999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999997543   3689999999999999999999999   9999999999999999999999999999866433221


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.      ........      ....+ 
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~------~~~~~-  223 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAGY------RLYRP-  223 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHHHHcCC------cCCCC-
Confidence            1111223457999999998899999999999999999999 8999975443221      11111110      01111 


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                         ..++..+.+++.+||..+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 ---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               12455799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=331.18  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=218.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh---hHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l  152 (407)
                      ...|++.+.||+|.||.||+|... +|+.+|+|.+......   ....+.+|+.+|+++. ||||+.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            356888999999999999999966 4899999998665433   4468889999999998 9999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC----CCcEEeeccc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVSDFGL  228 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGl  228 (407)
                      |||+|.||.|.+.|...     .+++.++..++.|++.++.|||+.   ||+||||||+|+|+...    +.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999765     299999999999999999999999   99999999999999533    5799999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+......      .....    
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~----  253 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG----  253 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC----
Confidence            998876  334566789999999999999999999999999999999999999998776543332      11111    


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         +..+...+...++....++|..|+..||.+|+|+.++++..+
T Consensus       254 ---~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  254 ---DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             ---CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence               124555667778888999999999999999999999999654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-44  Score=324.82  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=203.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----CeeEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRMLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv  153 (407)
                      .|...+++|.|+||.||.|... ++..||||++..+....    ..|+.+|+.++|||||++..+|...     -...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4777889999999999999955 56889999997765433    3488999999999999999887532     244689


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~~~  232 (407)
                      ||||+. +|.++++........++...+.-+..||++||.|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999965 99999985433346788899999999999999999998   99999999999999976 89999999999998


Q ss_pred             CCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC----
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP----  307 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----  307 (407)
                      ......  .+...|..|+|||++.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+....+-.+........+    
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            766553  33456899999998876 56999999999999999999999999987765554443332221111111    


Q ss_pred             ---CCcCCCCCCCC-----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          308 ---EGVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       308 ---~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .+...+.+...     .....+.+..+|+.++|..+|.+|.++.+++.
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               11111222111     22345567899999999999999999999986

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=331.40  Aligned_cols=242  Identities=25%  Similarity=0.366  Sum_probs=196.4

Q ss_pred             ceecccCceEEEEEEE----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           85 KVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +.||+|+||.||++..    ..++.||+|.+....    ......+..|+.+|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    257789999886432    22334567899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.+++|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999765    4688899999999999999999999   99999999999999999999999999987543222


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .+.......       ..++
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~-------~~~~  220 (323)
T cd05584         155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGK-------LNLP  220 (323)
T ss_pred             C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-------CCCC
Confidence            2 2233568999999999998889999999999999999999999997544321      122222211       0111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                          ..++..+.++|.+||+.||++||     ++.+++..
T Consensus       221 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         221 ----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                12345688999999999999999     78887763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-43  Score=336.03  Aligned_cols=263  Identities=23%  Similarity=0.347  Sum_probs=197.4

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----CeeE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM  151 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~  151 (407)
                      +|++.+.||+|+||.||+|... ++..||||++...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4888999999999999999955 6889999988643  223345678899999999999999999987533     3579


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+ +++|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            999999 46899988754    4689999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCc--eeeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH---------
Q 015395          232 LGSESS--YITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL---------  298 (407)
Q Consensus       232 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~---------  298 (407)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...........+...         
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432221  11233568999999999865  67899999999999999999999999765432211111000         


Q ss_pred             HHHhhc---CCCCCcCCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          299 KKMVTN---RNPEGVLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       299 ~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ......   ..... +....+..   .....+..+.+++.+||+.||++|||++++++.
T Consensus       233 ~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000   00000 00000000   011234567899999999999999999999974

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=347.73  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=207.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC---
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA---  148 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---  148 (407)
                      ....++|.+.+.||+|+||.||+|.. .+++.||||.+...  .......+..|+.++..++|+||+++++.+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999985 46889999988554  2344456788999999999999999988764322   


Q ss_pred             -----eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEE
Q 015395          149 -----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (407)
Q Consensus       149 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  223 (407)
                           .+++||||+++|+|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 36899999999999999976544446799999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          224 SDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       224 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      +|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..+....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~  258 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL  258 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh
Confidence            99999987643322 1223457999999999999999999999999999999999999999754322      1222222


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ....     + .+    +..++..+.+++.+||+.||.+||++.+++..
T Consensus       259 ~~~~-----~-~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGRY-----D-PL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCCC-----C-CC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            2111     1 11    12344578999999999999999999999863

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-42  Score=330.87  Aligned_cols=241  Identities=23%  Similarity=0.317  Sum_probs=195.2

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCC-CccceeeeeeecCCeeEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~  154 (407)
                      +|++.+.||+|+||.||+|... +++.||+|++...   .......+..|..++..++| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999965 5678999988643   22334566779999999976 56888999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.      ........       ..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~~~~-------~~  219 (324)
T cd05587         154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQSIMEHN-------VS  219 (324)
T ss_pred             CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC-------CC
Confidence            221 23345689999999999999999999999999999999999999975543221      11121111       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                      ++    ..++..+.+++.+||..||.+|++.
T Consensus       220 ~~----~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YP----KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            11    1234568899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-42  Score=324.82  Aligned_cols=260  Identities=25%  Similarity=0.343  Sum_probs=195.8

Q ss_pred             CCCCccceecccCceEEEEEEEC--CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC---CCCccceeeeeee-----c
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRV---RHKNLVRLLGYCA-----E  146 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~-----~  146 (407)
                      ++|++.+.||+|+||.||+|...  ++..||+|.+....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999863  46779999886432  22223445566666655   6999999999875     3


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ...+++||||+. ++|.+++.....  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999995 699999865422  3589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+   ........
T Consensus       155 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i---~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPG  229 (290)
T ss_pred             cceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHHhCCCC
Confidence            9998764432  223446899999999998889999999999999999999999999866543322211   11110000


Q ss_pred             C----------CCcCCCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          307 P----------EGVLDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       307 ~----------~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .          ...+... +...    ...++..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCC-CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0          0000000 0000    1124456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.2e-42  Score=324.85  Aligned_cols=264  Identities=22%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999965 678899998864432 233456779999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+. ++|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            995 68888876542   4688999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC---CC--
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EG--  309 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~--  309 (407)
                      .. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .....+.........   ..  
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence            22 1233468999999998865 458899999999999999999999998654321  111111111110000   00  


Q ss_pred             ---cCCC-CC----CCCc-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 ---VLDP-KL----PEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 ---~~~~-~~----~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         ...+ .+    +...     ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence               0000 00    0000     00123467899999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-42  Score=338.47  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=197.0

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .|++++.||+|+||.||+|... ++..||+|++....   ......+..|+.+++.++||||+++++.+.+++.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999964 57789999886432   2334567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ||++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999999764    4689999999999999999999999   9999999999999999999999999997532100


Q ss_pred             C----------------------------------------------ceeeeeeeccccccCccccCCCCCCcchhHHHH
Q 015395          236 S----------------------------------------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSF  269 (407)
Q Consensus       236 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwsl  269 (407)
                      .                                              .......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000122468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC---HH
Q 015395          270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MG  346 (407)
Q Consensus       270 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~  346 (407)
                      ||++|||++|+.||...++.+..      ........       .+.......++.++.++|.+|+ .+|.+|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQ------MKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHH------HHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            99999999999999865442221      11111110       0001111233455777887765 59999997   77


Q ss_pred             HHHH
Q 015395          347 HVVH  350 (407)
Q Consensus       347 evl~  350 (407)
                      +++.
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            7765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.4e-43  Score=338.00  Aligned_cols=260  Identities=20%  Similarity=0.286  Sum_probs=205.8

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      .+....++|++.+.||+|+||.||++... +++.+|+|.+...   .......+..|+.+++.++||||+++++++.+..
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34455678999999999999999999965 5778999988542   2233445778999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999653     588899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      +...............||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.......      ........
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~  262 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH  262 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence            987654433333455799999999998654    37889999999999999999999997554322      12222221


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLE  353 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L~  353 (407)
                      ...     ..++.  ...++..+.+++..||..++.+  |+++.++++.-.
T Consensus       263 ~~~-----~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         263 KNS-----LNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             Ccc-----cCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            110     01111  1234556888999999855543  889999988643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=318.02  Aligned_cols=258  Identities=28%  Similarity=0.493  Sum_probs=210.1

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++..++|.+.+.||+|+||.||+|...++..+|+|.+.... .....+..|+.++++++|+||+++++++......+++|
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            35667899999999999999999998878889999886543 33457888999999999999999999999888999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.....  ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999976432  4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.......      .+........      .
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~------~  223 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVERGYR------M  223 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC------C
Confidence            22211122234568999999998889999999999999999998 999997544321      1122211110      0


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ..    ....+..+.+++.+||..+|++||+++++.+.|+.
T Consensus       224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PR----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11    11224568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.4e-42  Score=317.37  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=205.3

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..++|.+.+.||+|+||.||+|....+..+|+|.+.... .....+..|+.+++.++|+|++++++++.. +..+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            345689999999999999999998777789999875443 334567889999999999999999998754 567899999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.+++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999975421  3588999999999999999999999   99999999999999999999999999998764433


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.      .........      ...
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~------~~~  224 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV------LEQVERGYR------MPC  224 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCC------CCC
Confidence            222222345678999999988889999999999999999999 9999975443221      111111110      011


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ....+..+.+++.+||.+||++||++++|++.|++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 ----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                12345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=332.45  Aligned_cols=267  Identities=27%  Similarity=0.418  Sum_probs=219.6

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhH-HHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +.+.+...+.+.||+|-||.|.+|....+.+||+|+++....... ++|..|+++|.+++||||+.++++|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            456778899999999999999999998889999999988765544 7999999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      +|||++|+|.+++..+..+  .+......+++.||+.|++||.+.   ++|||||.+.|+|++.++++||+|||.++.+-
T Consensus       614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999876432  245556678999999999999999   99999999999999999999999999999665


Q ss_pred             CCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          234 SESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       234 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ...... ....+-..+|||+|.+..+.++.+||+|+||+++||+++  ...||...+.......   ...+.......-+
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven---~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN---AGEFFRDQGRQVV  765 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh---hhhhcCCCCccee
Confidence            544433 334556789999999999999999999999999999866  7889876554333222   2222222221111


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                            ...+.-++..+.++|.+||..+-++||+++++-..|+..
T Consensus       766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  112334666789999999999999999999999988764

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.3e-43  Score=340.98  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=199.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++++.||+|+||.||+|... +++.||+|.+....   ......+..|+.+|++++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999954 57889999885432   223456778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999753210


Q ss_pred             CC------------------------------------------ceeeeeeeccccccCccccCCCCCCcchhHHHHHHH
Q 015395          235 ES------------------------------------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL  272 (407)
Q Consensus       235 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~i  272 (407)
                      ..                                          .......+||+.|||||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000113469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC---CHHHHH
Q 015395          273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP---KMGHVV  349 (407)
Q Consensus       273 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~evl  349 (407)
                      +|+|++|+.||......+...      .......       .+.......++..+.++|.+|+ .+|.+|+   ++.+++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~------~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQL------KVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHH------HHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999999998655432211      1111100       0001111223456778888876 5999999   888888


Q ss_pred             HH
Q 015395          350 HM  351 (407)
Q Consensus       350 ~~  351 (407)
                      +.
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-42  Score=329.01  Aligned_cols=241  Identities=25%  Similarity=0.375  Sum_probs=191.9

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhc-CCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... ++..||+|.+....   ......+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57789999886432   2223344556666665 4899999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            9999998764    4689999999999999999999999   99999999999999999999999999997653322 22


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      ....+... .      +.++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~-~------~~~~---  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILND-R------PHFP---  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC-C------CCCC---
Confidence            334568999999999999999999999999999999999999997544321      11121111 0      1111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMG-HVVH  350 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~  350 (407)
                       ..++..+.+++.+||+.||.+||++. ++++
T Consensus       217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             12345688999999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=338.91  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=199.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+++.||+|+||.||++... +++.||||++....   ......+..|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46899999999999999999854 68889999885432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999764    5689999999999999999999999   999999999999999999999999999863321


Q ss_pred             CCce----------------------------------------------eeeeeeccccccCccccCCCCCCcchhHHH
Q 015395          235 ESSY----------------------------------------------ITTRVMGTFGYVAPEYASTGMLNERSDVYS  268 (407)
Q Consensus       235 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiws  268 (407)
                      ....                                              .....+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                              001246899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCC---CCH
Q 015395          269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR---PKM  345 (407)
Q Consensus       269 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~  345 (407)
                      |||++|||++|..||......+.      ...+......     ..++.  ...++..+.++|.+||. +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~-----~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHET------YRKIINWRET-----LYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHH------HHHHHccCCc-----cCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            99999999999999976543221      1122111100     01111  11234568899999997 66665   589


Q ss_pred             HHHHHHH
Q 015395          346 GHVVHML  352 (407)
Q Consensus       346 ~evl~~L  352 (407)
                      .+++...
T Consensus       300 ~~~l~hp  306 (377)
T cd05629         300 HEIKSHP  306 (377)
T ss_pred             HHHhcCC
Confidence            8888753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.2e-43  Score=333.83  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=196.4

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      +.||+|+||.||++... ++..||+|.+....   ......+..|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999954 68889999886532   233445677999999999999999999999999999999999999


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      +|..++...    ..+++..++.++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  152 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T  152 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence            999988765    468999999999999999999997 7   999999999999999999999999999875432221 1


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........      ....... .      ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~~-~------~~~p---  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME-E------IRFP---  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhcC-C------CCCC---
Confidence            2335689999999999999999999999999999999999999975433211      1111111 0      1111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                       ..++..+.+++.+||+.||++|+     ++.++++.
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 -RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             12345688999999999999997     88888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.2e-42  Score=321.31  Aligned_cols=259  Identities=22%  Similarity=0.427  Sum_probs=204.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      +..++|++.+.||+|+||.||+|.+.      .+..||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999998753      24569999875432 233456788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCC------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGP------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      ..++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998653211      13467888999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCceee-eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      |+|||++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.      ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~------~~~  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV------LRF  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHH
Confidence            999999876543322111 12245778999999998899999999999999999999 7889875543221      111


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .. .....     ..+    ..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ~~-~~~~~-----~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VM-EGGLL-----DKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HH-cCCcC-----CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11 11110     111    123456899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-42  Score=313.71  Aligned_cols=269  Identities=22%  Similarity=0.297  Sum_probs=207.9

Q ss_pred             CCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCc-cceeeeeeecCC------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKN-LVRLLGYCAEGA------  148 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------  148 (407)
                      ..|..++.||+|+||+||+|+ ..+|..||+|++......  ......+|+.+|++++|+| |+.+++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            347777889999999999999 457889999999665432  3345677999999999999 999999998766      


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++||||+ ..+|..++.........++...+..+++||+.||+|||++   +|+||||||.||||++.|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            789999999 5599999977542213467788999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      |+...-.... .+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+....+....+-.+.........
T Consensus       167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            9976533332 3456789999999999886 6999999999999999999999999887764433333222222211111


Q ss_pred             CCcC-----CCCCCCCc-cHHHH-------HHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          308 EGVL-----DPKLPEKP-TSRLL-------KRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       308 ~~~~-----~~~~~~~~-~~~~~-------~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      +.+.     +..++... ...+.       ....+++.+||+.+|.+|.|++.++..-
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~  303 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP  303 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence            1111     11111111 11111       2678999999999999999999999863

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.3e-42  Score=320.51  Aligned_cols=248  Identities=22%  Similarity=0.265  Sum_probs=196.8

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||+|+||+||++... +++.||+|.+.....   .....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 678899998864322   2234567799999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  242 (407)
                      .+++.........+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            988854333335799999999999999999999999   9999999999999999999999999999766443221 233


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ..........         .  ......
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~---------~--~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILND---------S--VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhccc---------C--CCCccc
Confidence            46899999999999999999999999999999999999999754332111  1111111110         0  011223


Q ss_pred             HHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      ++..+.+++.+||+.||++||     +++++++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            456789999999999999999     56667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-42  Score=330.96  Aligned_cols=264  Identities=27%  Similarity=0.436  Sum_probs=206.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCccceeeeeeec
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  146 (407)
                      .++.++|++.+.||+|+||.||+|...      +++.||+|++..... .....+..|+.++.++ +|+||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            455678999999999999999999632      246799998865432 2334677899999999 79999999998764


Q ss_pred             -CCeeEEEEEeccCCChHHhhhCCCCC-----------------------------------------------------
Q 015395          147 -GAHRMLVYEYVNNGNLEQWLHGDVGP-----------------------------------------------------  172 (407)
Q Consensus       147 -~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  172 (407)
                       ...++++|||+++++|.+++......                                                     
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             45788999999999999998643210                                                     


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee-eeeeeccc
Q 015395          173 ----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTF  247 (407)
Q Consensus       173 ----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~  247 (407)
                          ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.++|+|||++..+....... .....++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                13689999999999999999999999   99999999999999999999999999998764332211 22234567


Q ss_pred             cccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHH
Q 015395          248 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR  326 (407)
Q Consensus       248 ~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (407)
                      .|+|||++.+..++.++|||||||++|+|++ |..||......+.      +..........     ..    ....+.+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~-----~~----~~~~~~~  304 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM-----RA----PEYATPE  304 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC-----CC----CccCCHH
Confidence            8999999999999999999999999999998 9999975433221      11111111110     01    1123456


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          327 ILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       327 l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      +.+++.+||+.+|++||++.++++.|+.+.
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.1e-42  Score=326.21  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=204.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.+.... ......+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            467999999999999999999853 333    38999886543 34456788899999999999999999998764 578


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +++||+.+|+|.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            9999999999999997643   4588999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceee-eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.       .........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--  229 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER--  229 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCC--
Confidence            654332211 22234678999999999999999999999999999998 9999975432211       111111110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         ...+    ..+...+.+++.+||..+|++||++.+++..|..+..
T Consensus       230 ---~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         230 ---LPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ---CCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence               0111    1233468899999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-42  Score=329.47  Aligned_cols=236  Identities=22%  Similarity=0.324  Sum_probs=191.7

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57889999886432   23344566788888776 699999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~  152 (320)
T cd05590          81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T  152 (320)
T ss_pred             chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence            9999998765    4689999999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      .........       ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~-------~~~~---  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDE-------VVYP---  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCC-------CCCC---
Confidence            234568999999999999999999999999999999999999997554322      122222111       0111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                       ..++..+.+++.+||+.||.+||++
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 -TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCC
Confidence             1234568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=310.40  Aligned_cols=253  Identities=20%  Similarity=0.290  Sum_probs=209.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +.|++-++||+|.|+.|+++.+. +|+.+|+|++...  .....+++.+|+++-+.|+||||+++.+.+.+....|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            56888899999999999999854 6888999977432  23356788899999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe---CCCCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~  232 (407)
                      +|.|++|..-|-.+    .-+++..+-.+++||+++|.|+|.+   +|||||+||.|+|+-   ..--+||+|||+|..+
T Consensus        91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999997666544    3588999999999999999999999   999999999999994   3345899999999988


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..  .......+|||.|||||++...+|+..+|||+.|+|||-||.|.+||.+.+....      ..++...       +
T Consensus       164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g-------~  228 (355)
T KOG0033|consen  164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAG-------A  228 (355)
T ss_pred             CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhcc-------c
Confidence            72  3334556899999999999999999999999999999999999999986443221      2222222       1


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..++..+...+.++..+|+.+||..||.+|.|+.|.|..-+
T Consensus       229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence            23444456667778999999999999999999999987443

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-42  Score=335.43  Aligned_cols=262  Identities=20%  Similarity=0.283  Sum_probs=207.0

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  146 (407)
                      +.++.+..++|++.+.||+|+||.||+|... +++.+|+|.+...   .......+..|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445667789999999999999999999965 5778999987542   22234457789999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ....++||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999653     588899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |++...............||+.|+|||++...    .++.++|||||||++|+|++|..||...+..      .....+.
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~  260 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM  260 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence            99987654433333455799999999998654    3789999999999999999999999754432      1222222


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLE  353 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L~  353 (407)
                      ......     .++  ....++..+.++|..||..++.+  |+++.++++...
T Consensus       261 ~~~~~~-----~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         261 NHKNSL-----TFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             cCCCcc-----cCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            211110     111  11235567889999999844433  778999887653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.4e-42  Score=333.45  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC-----eeE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  151 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~  151 (407)
                      +|++.+.||+|+||.||++.. .++..||||++...  .......+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999996 46889999988543  2234456788999999999999999999988766     789


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+. ++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999995 5888888654    5689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH-------------
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW-------------  297 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-------------  297 (407)
                      .............++..|+|||++.+. .++.++|||||||++|||++|+.||....+.+....+..             
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            654433333344678999999998774 478999999999999999999999987654332222111             


Q ss_pred             ---HHHHhhcC-CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          298 ---LKKMVTNR-NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       298 ---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                         ........ ..........  ......+.++.+||.+||+.||.+|||+.+++..-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence               00000000 0000000000  00112245688999999999999999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.3e-42  Score=315.51  Aligned_cols=257  Identities=25%  Similarity=0.459  Sum_probs=207.7

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++..++|.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            34567899999999999999999997777889999876543 334577889999999999999999999887 7789999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999976432  4578899999999999999999999   999999999999999999999999999986643


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........++..|+|||++....++.++|+|||||++|+|++ |+.||........   ...+   . .....     
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~---~-~~~~~-----  222 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL---E-RGYRM-----  222 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH---h-CCCCC-----
Confidence            32222222345678999999988889999999999999999999 9999975443221   1111   1 11100     


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .    .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 P----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             C----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0    112344568999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.1e-42  Score=319.95  Aligned_cols=258  Identities=27%  Similarity=0.435  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCceEEEEEEE-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|..     ..+..|++|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            35788999999999999999984     245679999886433 334467888999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCC-------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          152 LVYEYVNNGNLEQWLHGDVG-------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      ++|||+++++|.+++.....             ....+++..++.++.|++.||.|||++   +++||||||+|||++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence            99999999999999853321             113578899999999999999999999   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHH
Q 015395          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  296 (407)
                      +.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.   .+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            99999999999865433221 1222345678999999988889999999999999999998 9999975443211   11


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ........     ..    ...++..+.+++.+||+.||.+||++.+|++.|..
T Consensus       238 ----~~~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 ----MVRKRQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHcCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                11111110     11    12234568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-41  Score=315.64  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=210.8

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|.. .++..+|||.+....   ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999995 478899999875432   233457788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999874333335689999999999999999999999   999999999999999999999999999877644


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......    ...........         .
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~---------~  224 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQC---------D  224 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcC---------C
Confidence            3321 22345889999999998888999999999999999999999999643221    11111111111         1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .+......++..+.+++.+||+.||++|||+.+|++.++.+
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11112234566799999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-42  Score=320.60  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=202.6

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +|++.+.||+|+||.||++... ++..||+|.+....   ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999954 68889999886432   2223456779999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999998886432  14689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..  .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........   +.+........         
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~---------  221 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ---------  221 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc---------
Confidence            22  22346899999999999889999999999999999999999999865432211   11111111110         


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                       ......++..+.++|.+||+.||.+||     ++.+++..
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             111223556689999999999999999     77787664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-41  Score=313.21  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=197.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      +.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999964 68889999875443 34456788999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceee-e
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-T  241 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~  241 (407)
                      .+++....   ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99997542   4589999999999999999999999   999999999999999999999999999876543211111 1


Q ss_pred             eeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCcc
Q 015395          242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (407)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (407)
                      ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.........       .......     ....    .
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~~~-----~~~~----~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQGV-----RLPC----P  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCC-----CCCC----c
Confidence            1122456999999998889999999999999999998 89998654332111       1111110     0111    1


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          321 SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            233557899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-42  Score=329.26  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ++||+|+||.||+|... +++.||+|++....   ......+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999965 57789999886532   23334566788888866 799999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~  152 (321)
T cd05591          81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T  152 (321)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence            9999998765    4689999999999999999999999   999999999999999999999999999876432222 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      ..........       ..+   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~~-------~~p---  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDDV-------LYP---  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC-------CCC---
Confidence            234568999999999999999999999999999999999999997554322      1222222110       111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCC-------CHHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRP-------KMGHVVHM  351 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RP-------t~~evl~~  351 (407)
                       ..++..+.+++.+||+.||++||       ++.++++.
T Consensus       217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             12345688999999999999999       77777754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-42  Score=320.42  Aligned_cols=249  Identities=33%  Similarity=0.574  Sum_probs=195.0

Q ss_pred             ccceecccCceEEEEEEEC-----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           83 DDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ......+..|++.+++++||||+++++++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999966     24569999996543 33467889999999999999999999999988889999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++|+|.++|....  ...+++..++.++.||+.||.|||+.   +++|+||+++||+++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999998761  25789999999999999999999999   99999999999999999999999999998773332


Q ss_pred             ce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          237 SY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       237 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .. ......+...|+|||.+....++.++||||||+++|||++ |+.||......      +..........      . 
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~~~~~~------~-  224 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKLKQGQR------L-  224 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHHHTTEE------T-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccc------c-
Confidence            22 2223456788999999988889999999999999999999 78998654322      22222211111      0 


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                         .....++..+.++|.+||..||++||++.++++.|
T Consensus       225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               01223455688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=313.55  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=203.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-----hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-----QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ++|.+.+.||+|++|.||+|... ++..||+|.+.....     .....+.+|+.++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46899999999999999999854 688999998764321     123467889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +|||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999999765    4689999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          233 GSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       233 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ........  ....++..|+|||.+.+..++.++|||||||++|+|++|+.||........      ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~---  225 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPTN---  225 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccCCC---
Confidence            43322111  234578899999999998899999999999999999999999975432211      1111111111   


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ..+    ...+...+.+++.+||..+|.+|||+.++++.
T Consensus       226 --~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              111    12344568899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-42  Score=328.53  Aligned_cols=241  Identities=22%  Similarity=0.318  Sum_probs=195.0

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +|.+.+.||+|+||.||+|... ++..||+|.+....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999965 56789999886532   22233456677888777 5899999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999998765    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      .........       ..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~-------~~  219 (323)
T cd05616         154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN-------VA  219 (323)
T ss_pred             CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            221 2234568999999999999999999999999999999999999997554321      122222111       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                      ++    ..++.++.+++.+||+.||.+|++.
T Consensus       220 ~p----~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 YP----KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CC----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            11    2245578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.5e-43  Score=331.89  Aligned_cols=238  Identities=24%  Similarity=0.333  Sum_probs=194.0

Q ss_pred             ceecccCceEEEEEEE----CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           85 KVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      +.||+|+||.||++..    .++..||+|++.....  .....+..|+.+|++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3578899998865321  223456679999999999999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999999764    4689999999999999999999999   999999999999999999999999999876543322 


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      .+.......       ..++  
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~~-------~~~p--  218 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKAK-------LGMP--  218 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcCC-------CCCC--
Confidence            2234568999999999998889999999999999999999999997543321      122222111       0111  


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRPKMGH  347 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPt~~e  347 (407)
                        ..++..+.+++.+||+.||++||++.+
T Consensus       219 --~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 --QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              123456889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-42  Score=328.06  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ++||+|+||.||+|... ++..||+|++....   ......+..|..++..+ +||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 57889999986532   23344577899999888 699999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++...    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence            9999988654    5799999999999999999999999   999999999999999999999999999874322111 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch--hhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE--EVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      .....||..|+|||++.+..++.++|||||||++|+|++|+.||......+  ......++.+.......      .++ 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p-  225 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC-
Confidence            234578999999999999999999999999999999999999997433221  11122222222222111      111 


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCC------HHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPK------MGHVVH  350 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~  350 (407)
                         ..++..+.+++.+||+.||.+|++      +.++++
T Consensus       226 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         226 ---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence               123456889999999999999997      566664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-41  Score=311.47  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChH
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE  163 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (407)
                      ++||+|+||.||+|...++..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998888899999876553 333456888999999999999999999999999999999999999999


Q ss_pred             HhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeee
Q 015395          164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV  243 (407)
Q Consensus       164 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  243 (407)
                      +++....   ..+++..++.++.|++.+|.|||+.   +++|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            9986543   4578999999999999999999999   999999999999999999999999999876543222111222


Q ss_pred             eccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       244 ~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      .++..|+|||++....++.++||||||+++|+|++ |..||.........      ..... ...     ...    ...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~------~~~~~-~~~-----~~~----~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR------EQVEK-GYR-----MSC----PQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHHc-CCC-----CCC----CCC
Confidence            34567999999988889999999999999999998 99999755432211      11111 100     011    112


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ++..+.+++.+||..+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            3457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=346.08  Aligned_cols=265  Identities=29%  Similarity=0.473  Sum_probs=226.1

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECC-C---CEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLED-N---SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      .++..+...+.++||.|.||.||+|+++. +   ..||||.++..- ....++|+.|+.+|.+++||||+++.|+.....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            34566678899999999999999999653 3   359999998764 445668999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ...||.|||++|+|..+|+.+.   +.+++.+...+.+.|+.|+.||-++   ++|||||...||||+.+..+|++||||
T Consensus       704 PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence            9999999999999999998765   5699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeec--cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          229 AKLLGSESSYITTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ++++.++.....++.-|  ..+|.|||.+....++.+|||||+|++|||.++ |..||..++.++..+.++         
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---------  848 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---------  848 (996)
T ss_pred             eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH---------
Confidence            99886555333333223  468999999999999999999999999999887 999998877665544432         


Q ss_pred             CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCCc
Q 015395          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (407)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  360 (407)
                             ..+...++.+++..|.+||+.||++|-.+||+|.+|+..|+++.+...
T Consensus       849 -------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  849 -------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             -------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence                   122333456677789999999999999999999999999998866543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.9e-43  Score=304.34  Aligned_cols=253  Identities=21%  Similarity=0.331  Sum_probs=212.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcC-CCCccceeeeeeecC
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--------GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG  147 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  147 (407)
                      .+.|...+.||.|..+.|.+|..+ +++.+|+|++....        ....++-..|+.+|+++ .||||+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356888899999999999998854 68889999884321        12233556799999998 699999999999999


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ..+++|+|.|+.|.|.++|...    -.+++....+|++|+.+|++|||..   +||||||||+|||++++.++||+|||
T Consensus        96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999876    5799999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      .++.+.+...  ....+||++|+|||.+.+      ..|+..+|+|++|+|||.||.|.+||....       .-.+.++
T Consensus       169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~  239 (411)
T KOG0599|consen  169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM  239 (411)
T ss_pred             eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence            9998876543  455789999999999854      347788999999999999999999996321       1223334


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      +..+.      ..+.+....+++....+||.+||+.||.+|.|++|+|..-
T Consensus       240 ImeGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  240 IMEGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             HHhcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            43332      2345556788899999999999999999999999999743

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-41  Score=332.34  Aligned_cols=262  Identities=19%  Similarity=0.265  Sum_probs=197.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||....      ..+.+|+++|++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447999999999999999999965 477899995422      2345799999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      + .++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+||||+.++.+||+|||+++......
T Consensus       242 ~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 Y-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9 468988886542   4699999999999999999999999   99999999999999999999999999998764332


Q ss_pred             ce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-Cchh----hhHHHHHHHHhhc-CCCCC
Q 015395          237 SY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR-PPEE----VNLIEWLKKMVTN-RNPEG  309 (407)
Q Consensus       237 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~-~~~~----~~~~~~~~~~~~~-~~~~~  309 (407)
                      .. ......||..|+|||++.+..++.++|||||||+||||++|..|+.... ....    ......+...... .....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            21 1223569999999999999999999999999999999999876653221 1111    1111111111000 00000


Q ss_pred             ----------------cCCCCCCCCccH---HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          310 ----------------VLDPKLPEKPTS---RLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       310 ----------------~~~~~~~~~~~~---~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                                      ...+........   .....+.+||.+||+.||.+|||+.|+|+.-
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp  456 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP  456 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence                            000000000011   2234688999999999999999999999753

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.3e-42  Score=316.95  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=204.6

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|.. .++..||+|++..........+.+|+.+++.++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45799999999999999999996 46788999988765555556778899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999998754    4689999999999999999999999   99999999999999999999999999998664322


Q ss_pred             ceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      . ......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||....+.+...      .+...    ....+
T Consensus       161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~----~~~~~  229 (267)
T cd06646         161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKS----NFQPP  229 (267)
T ss_pred             c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecC----CCCCC
Confidence            1 122345888999999874   3457889999999999999999999986443221110      00000    01111


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ...  ....++..+.++|.+||..+|++||+++++++.|
T Consensus       230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            111  1223456789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.8e-42  Score=322.04  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=210.0

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      .+++..++|++.+.||+|+||.||++....      ...+|+|.+.... ......+..|+.+++++ +|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            355667889999999999999999998542      3568999886542 33345678899999999 799999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      ...+..+++|||+++++|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            99999999999999999999996432            2235689999999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~  290 (407)
                      |++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999998765433211 122234678999999988899999999999999999998 999997543322


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .      .........      ...    ....+..+.+|+.+||..||++|||+.++++.|+++
T Consensus       243 ~------~~~~~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 L------FKLLKEGYR------MEK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H------HHHHHcCCc------CCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1      111111110      011    112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4e-42  Score=326.96  Aligned_cols=240  Identities=23%  Similarity=0.345  Sum_probs=192.4

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... ++..||+|.+....   ......+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 57889999886532   22334556677777754 899999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence            9999998764    4689999999999999999999999   999999999999999999999999999875322221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+   .   .......       .+.++.  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~~~~~-------~~~~~~--  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FESIRVD-------TPHYPR--  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhC-------CCCCCC--
Confidence            334568999999999999999999999999999999999999997544321   1   1111111       011111  


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMG-HVV  349 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~-evl  349 (407)
                        .++.++.+++.+||+.||++||++. +++
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 --WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              2345688999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-42  Score=340.97  Aligned_cols=262  Identities=21%  Similarity=0.279  Sum_probs=195.6

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec--------C
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------G  147 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~  147 (407)
                      ...+|.+.+.||+|+||.||+|... ++..||||++.....    ...+|+.+|+.++||||+++++++..        .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4567999999999999999999964 578899998854432    23469999999999999999887642        1


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeec
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDF  226 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df  226 (407)
                      ..+++||||++ ++|.+++.........+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            24679999996 478777754322335799999999999999999999999   999999999999998664 6999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      |+++.+.....  .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+.   ......
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~---~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII---QVLGTP  290 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHhCCC
Confidence            99986643322  2234689999999988664 68999999999999999999999998765443222111   110000


Q ss_pred             C-------CCCcCCCCCCCC--------ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 N-------PEGVLDPKLPEK--------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 ~-------~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .       .....+..++..        .+...+.++.+||.+||..||.+|||+.+++..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0       000000011110        011234578999999999999999999999964

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-41  Score=317.17  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+. ++.    ++++|.+.... .....++..|+..+++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            357889999999999999999864 343    47788775433 2334567778889999999999999998754 4578


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +++||+++|+|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        85 ~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            8999999999999997543   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.........       +........ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~-  230 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGERL-  230 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCcC-
Confidence            6433221 1223346778999999988899999999999999999998 99999765432211       111111110 


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                          ..+.    .+...+.+++.+||..||++|||+.++++.|..+..
T Consensus       231 ----~~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ----AQPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ----CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                0111    123457889999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.3e-42  Score=325.12  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=192.9

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhc-CCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... ++..||+|.+....   ......+..|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57789999886532   2233445567777775 4899999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence            9999999754    4689999999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||......+.      ........       +.++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~~-------~~~~---  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL------FQSIRMDN-------PCYP---  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-------CCCC---
Confidence            2345689999999999999999999999999999999999999975443221      11111110       1111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMG-HVVH  350 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~  350 (407)
                       ..+...+.+++.+||+.||.+||++. ++++
T Consensus       217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 -RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             12345688999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-41  Score=325.84  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=193.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ....+|++.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            44567999999999999999999965 4678999964332      2235899999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |++ .++|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             Ecc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            999 468888886542   4689999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh----hHHHHHHHHhhc-C-CCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV----NLIEWLKKMVTN-R-NPE  308 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~-~-~~~  308 (407)
                      ..  ......||..|+|||++.+..++.++|||||||++|||+++..|+....+....    .....+...... . ...
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            21  123346899999999999999999999999999999999865544222211100    001111111110 0 000


Q ss_pred             CcC------------------CCCCCC---CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 GVL------------------DPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~~~------------------~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .+.                  ......   .....++..+.+||.+||+.||.+|||+.++++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000                  000000   0001223456679999999999999999999874

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.5e-41  Score=310.20  Aligned_cols=261  Identities=23%  Similarity=0.399  Sum_probs=211.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|.+...   .......+.+|++++++++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999966 7889999987532   2233557888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.........+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999865433335689999999999999999999999   999999999999999999999999999886644


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....    ............         .
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~---------~  224 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEKC---------D  224 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhcC---------C
Confidence            3221 2234588899999999888899999999999999999999999964331    111111211111         1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .+..+...++..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111112245567899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=319.25  Aligned_cols=260  Identities=26%  Similarity=0.455  Sum_probs=207.7

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecC
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  147 (407)
                      ++..++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+..|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            3456789999999999999999998542      3579999876543 23445678899999999999999999999999


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCC------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVG------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                      ...++||||+++++|.+++.....      ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            999999999999999999965321      113478899999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      ||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||...+..+..      .
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~  232 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL------K  232 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH------H
Confidence            99999998765433221 1223346788999999988889999999999999999998 99999755432221      1


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ... ....     ...+.    .++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       233 ~~~-~~~~-----~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVI-DGGH-----LDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHh-cCCC-----CCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111 1111     11111    12557899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6e-42  Score=320.35  Aligned_cols=257  Identities=24%  Similarity=0.369  Sum_probs=204.3

Q ss_pred             CCCCccceecccCceEEEEEEECC------CCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .+|++.+.||+|+||.||+|...+      +..||+|++..... .....+..|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457888999999999999998532      46799998865433 33456888999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC
Q 015395          152 LVYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  219 (407)
                      +++||+.+++|.+++....            .....+++..++.++.|++.||.|||++   +|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence            9999999999999985321            1123588899999999999999999999   999999999999999999


Q ss_pred             CcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHH
Q 015395          220 NPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW  297 (407)
Q Consensus       220 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  297 (407)
                      .+||+|||+++........ ......+++.|+|||.+....++.++|||||||++|||++ |..||......+      .
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~  235 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------V  235 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence            9999999998865433221 1223345778999999988889999999999999999998 888987543321      1


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ....... ..     ..    ....++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       236 ~~~i~~~-~~-----~~----~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNR-QV-----LP----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcC-Cc-----CC----CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            2221111 11     01    122345668999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.5e-42  Score=325.78  Aligned_cols=242  Identities=24%  Similarity=0.345  Sum_probs=195.5

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... ++..||+|.+....   ......+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57789999886532   23334566788888877 699999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  152 (318)
T cd05570          81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T  152 (318)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence            9999998765    4799999999999999999999999   999999999999999999999999999875322221 1


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ........ .      ..++   
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~-~------~~~~---  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILED-E------VRYP---  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcC-C------CCCC---
Confidence            233468999999999999999999999999999999999999997543211      11122111 1      1111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHM  351 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~  351 (407)
                       ..++..+.++|.+||+.||.+||++     .+++..
T Consensus       217 -~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 -RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             1234568999999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-41  Score=318.38  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=206.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..+|...+.||+|+||.||++...      ++..+|+|.+..........+..|+++++.++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457888999999999999999732      34578999887666666678899999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCC-----------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC
Q 015395          152 LVYEYVNNGNLEQWLHGDVG-----------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN  220 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  220 (407)
                      ++|||+++++|.+++.....           ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            99999999999999975421           113588999999999999999999999   9999999999999999999


Q ss_pred             cEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (407)
                      +||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.      +
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~  234 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I  234 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H
Confidence            9999999997654332211 122235678999999998999999999999999999998 9999964433221      1


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ........      ...    ...++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       235 ~~~~~~~~------~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQGRE------LER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHcCcc------CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11111110      011    1123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-41  Score=317.84  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=205.1

Q ss_pred             CCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+..|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999853      12468888776543 2334578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          153 VYEYVNNGNLEQWLHGDVG--------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      +|||+.+++|.+++.....                    ....+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999864311                    123588999999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~  290 (407)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....+.+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999997654332211 122345678999999988889999999999999999998 999997554332


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .   .+.+.    ...     ....    ...++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       238 ~---~~~~~----~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 L---FNLLK----TGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H---HHHHh----CCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1   11111    110     0111    12344578999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=311.84  Aligned_cols=251  Identities=29%  Similarity=0.449  Sum_probs=206.5

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..++|++.+.||.|+||.||+|... ++.||+|.+..... ....+..|+.+++.++|+||+++++++.+....++||||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            3567999999999999999999875 78899998876644 456788899999999999999999999988999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            999999999976521  3689999999999999999999999   99999999999999999999999999998763221


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      .    ....+..|+|||.+....++.++||||||+++|+|++ |..||......+.       .........     ...
T Consensus       157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-----~~~  220 (256)
T cd05039         157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHVEKGYR-----MEA  220 (256)
T ss_pred             c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC-----CCC
Confidence            1    2234667999999988889999999999999999997 9999965432211       111111100     111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ...++..+.+++.+||..+|++||++.++++.|+.
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                12234678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-41  Score=314.40  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=207.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEECC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      +..++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            345678899999999999999998543    2468999876554 4455678899999999999999999998875 457


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence            89999999999999997642   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..............++..|+|||.+....++.++|||||||++|+|++ |..||......+.      +.........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~--  227 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERL--  227 (270)
T ss_pred             ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcC--
Confidence            765443222222234568999999988889999999999999999996 9999976543221      1111111110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                          ..    ...++..+.++|.+||..+|++|||+.+++..|+.+..
T Consensus       228 ----~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 ----PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                11    12334578999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-41  Score=317.12  Aligned_cols=258  Identities=28%  Similarity=0.454  Sum_probs=203.6

Q ss_pred             hcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ..++|.+.+.||+|+||.||+|.+..      +..||+|.+.... ......+..|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34679999999999999999999653      4578999876443 3345568889999999999999999999998889


Q ss_pred             eEEEEEeccCCChHHhhhCCCC---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC---CcEE
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKV  223 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl  223 (407)
                      .+++|||+++++|.+++.....   ....+++..++.++.||+.||+|||++   +++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999975431   113589999999999999999999999   999999999999998764   5899


Q ss_pred             eecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHH
Q 015395          224 SDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       224 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+..      . .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~------~-~  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM------E-F  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H-H
Confidence            9999998763322111 111223568999999988899999999999999999997 99999765433211      1 1


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ......     ...    ...++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 ~~~~~~-----~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGGR-----LDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCCc-----CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111110     011    1223456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.3e-42  Score=327.73  Aligned_cols=237  Identities=25%  Similarity=0.317  Sum_probs=189.4

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHH-HHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999965 68889999886432   122233444444 56789999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-T  152 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-c
Confidence            9999998765    4789999999999999999999999   999999999999999999999999999875422221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      +......... .      .++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-~------~~~---  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKP-L------RLK---  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC-C------CCC---
Confidence            23456899999999999999999999999999999999999999754322      1222222111 0      111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMG  346 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~  346 (407)
                       ..++..+.+++.+||+.||.+||++.
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 -PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             12345688999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-41  Score=325.39  Aligned_cols=243  Identities=24%  Similarity=0.357  Sum_probs=192.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... +++.||+|++...   .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 5778999988653   223344567788888776 799999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~  152 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence            9999988654    4699999999999999999999999   999999999999999999999999999875422221 1


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch--hhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE--EVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||.......  ......++.........      .++ 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p-  225 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCC-
Confidence            234568999999999999999999999999999999999999996422211  11122222222222111      111 


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                         ..++..+.+++.+||+.||++||++
T Consensus       226 ---~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         226 ---RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ---CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence               1234568899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.8e-41  Score=316.67  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=209.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEECC-----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeec-CC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GA  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  148 (407)
                      +..++|.+.+.||+|+||.||+|.+..     +..|++|.+.... ......+..|+.++++++||||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456789999999999999999999765     6778999876543 3445667889999999999999999998765 57


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCC----CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGP----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                      ..++++||+.+++|.+++......    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998654321    14689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHh
Q 015395          225 DFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       225 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |||+++.+....... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||....+.+   ...+   ..
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~---~~  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY---LK  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH---HH
Confidence            999998654332211 122345678999999988889999999999999999999 999997543322   1111   11


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ....      ...    ...++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus       234 ~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 DGYR------LAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             cCCC------CCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1110      001    11234568999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=318.91  Aligned_cols=264  Identities=25%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             cCCCCccceecccCceEEEEEEECC---------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED---------------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLL  141 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~  141 (407)
                      .++|++.+.||+|+||.||+|....               ...||+|.+.... ......+.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999987532               1248999886543 33445788899999999999999999


Q ss_pred             eeeecCCeeEEEEEeccCCChHHhhhCCCC--------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccE
Q 015395          142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVG--------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI  213 (407)
Q Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Ni  213 (407)
                      +++......++||||+.+++|.+++.....        ....+++..++.++.|++.||+|||+.   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999864321        112478899999999999999999999   999999999999


Q ss_pred             EEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCch
Q 015395          214 LIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPPE  290 (407)
Q Consensus       214 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt--g~~Pf~~~~~~~  290 (407)
                      ++++++.+||+|||++.......... .....++..|+|||.+....++.++|||||||++|+|++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999997654332211 122345678999999988889999999999999999998  677887544322


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ....   ..............      ......+..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 ~~~~---~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIEN---TGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHH---HHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            2111   11111111000000      001123456999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-41  Score=318.50  Aligned_cols=267  Identities=24%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             CCccceecccCceEEEEEEE-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRML  152 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l  152 (407)
                      |.+.+.||+|+||+||++..     .++..||+|.+.... ......+.+|+.+|+.++||||+++++++..  ....++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988652     356789999886543 2345677889999999999999999998765  346899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +|||+.+++|.+++...     .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++...
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999999753     589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          233 GSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       233 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .......  .....++..|+|||.+....++.++|||||||++|+|++|..||........ ..................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence            5432211  1122356679999999888899999999999999999999999864322100 000000000000000000


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .+..........++..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000000112234567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.2e-42  Score=319.61  Aligned_cols=262  Identities=24%  Similarity=0.373  Sum_probs=203.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-----CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~  151 (407)
                      .+|++.+.||+|+||.||+|...     ++..||+|.+..........+..|+.+++.++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57889999999999999999742     477899999877666666788899999999999999999998643  35689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999999999997542   4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh---------hhHHHHHHH
Q 015395          232 LGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE---------VNLIEWLKK  300 (407)
Q Consensus       232 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~---------~~~~~~~~~  300 (407)
                      .........  ....++..|+|||.+.+..++.++|||||||++|||++|..|+........         ......+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            644332111  112234569999999888899999999999999999998777543211000         000001111


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .....         ........++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11110         00011123445799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-41  Score=321.19  Aligned_cols=266  Identities=26%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~  143 (407)
                      +.+..++|.+.+.||+|+||.||+|...        ++..||+|.+.... ......+..|+.+++.+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3456778999999999999999999742        23468999876442 34456788899999999 79999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCc
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~  211 (407)
                      +......+++|||+.+++|.+++.....            ....+++..++.++.||+.||.|||++   +++||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            9999999999999999999999976421            123578889999999999999999999   9999999999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~  289 (407)
                      ||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999998765433221 122335678999999988889999999999999999998 88888654322


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      +      ...........      ..    ...++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus       247 ~------~~~~~~~~~~~------~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E------LFKLLKEGHRM------DK----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H------HHHHHHcCCcC------CC----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1      12222111100      01    123456789999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-41  Score=331.88  Aligned_cols=265  Identities=25%  Similarity=0.425  Sum_probs=209.7

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~  144 (407)
                      ++++..++|.+.+.||+|+||.||+|.+.      .+..||+|++.... ......+..|+.+|.++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            35677778999999999999999999854      23579999987543 233446888999999997 99999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC-----------------------------------------------------
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG-----------------------------------------------------  171 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  171 (407)
                      ......++||||+.+|+|.++++....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            998999999999999999999965321                                                     


Q ss_pred             -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCC
Q 015395          172 -----------------------------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (407)
Q Consensus       172 -----------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  210 (407)
                                                               ....+++..++.++.|++.||.|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                     113467888899999999999999999   999999999


Q ss_pred             ccEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~  288 (407)
                      +|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            9999999999999999999865332221 1122346788999999988889999999999999999998 8999865432


Q ss_pred             chhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .+.      ..........     ...    +..++.++.+++.+||..+|.+||++.+|+..|+.+
T Consensus       348 ~~~------~~~~~~~~~~-----~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 NEQ------FYNAIKRGYR-----MAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             hHH------HHHHHHcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            221      1111111110     111    112345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-41  Score=317.96  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=203.7

Q ss_pred             CCCCccceecccCceEEEEEEECC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLED-NS--KVAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.+... .......+..|+.+++++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999998653 32  4788877643 334456788899999999 799999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          154 YEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                      |||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999965321            113588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      ||+|||++.......  .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+.      ...
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YEK  230 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHH
Confidence            999999986432111  1111123457999999988899999999999999999997 9999975543221      111


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      .....      ....    ...++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus       231 ~~~~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         231 LPQGY------RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HhcCC------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11110      0111    112445689999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.4e-41  Score=317.36  Aligned_cols=264  Identities=25%  Similarity=0.419  Sum_probs=206.9

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecC
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  147 (407)
                      ++..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+..|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            455678999999999999999999743      24479999875443 23334677899999999999999999999999


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCC------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVG------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                      ...++||||+.+|+|.+++.....      ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999965321      123467788899999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      +|+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+      ...
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~  232 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLK  232 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence            999999988654322211 122235678999999988899999999999999999998 788997543322      111


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ........      ..+    ...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       233 ~~~~~~~~------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         233 FVMDGGYL------DQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHHcCCCC------CCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            11111110      111    1224579999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.4e-41  Score=311.87  Aligned_cols=256  Identities=24%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             CCccceecccCceEEEEEEECCCC---EEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------Ce
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------AH  149 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~  149 (407)
                      |.+.+.||+|+||.||+|......   .+|+|.+...  .......+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            356788999999999999965432   5899987543  234456788899999999999999999976432      35


Q ss_pred             eEEEEEeccCCChHHhhhCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      .+++|||+.+|+|.+++....  .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999874322  1124589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceee-eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          228 LAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       228 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ++........... ....+++.|+|||.+....++.++|||||||++|+|++ |..||......+   .   ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I---YDYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHHcCC
Confidence            9987654332111 12235678999999999999999999999999999999 899997543221   1   11111111


Q ss_pred             CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ..      ..    ...++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus       232 ~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL------KQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC------CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10      11    112345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-41  Score=313.24  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=205.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-C---CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-D---NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|... +   ...+|+|.+.... ......+..|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357889999999999999999853 2   3368999886543 3345578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999997643   4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeee--eeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          233 GSESSYITTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       233 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..........  ..++..|+|||.+.+..++.++|+|||||++|++++ |..||......+.   .   ........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~---~~~~~~~~---  227 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I---KAIEEGYR---  227 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H---HHHhCCCc---
Confidence            5433222211  223568999999998889999999999999999886 9999975543221   1   11111100   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         ...    ...++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ---LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               011    122345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.2e-42  Score=327.47  Aligned_cols=241  Identities=24%  Similarity=0.297  Sum_probs=190.6

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHH-HHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... ++..||+|.+....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 56789999886432   12223333443 456788999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~  152 (325)
T cd05602          81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T  152 (325)
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence            9999999765    4688899999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      ..........       .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~-------~~----  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKPL-------QL----  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhCCc-------CC----
Confidence            334569999999999999999999999999999999999999997544322      1222221110       01    


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ...++..+.+++.+||+.||.+||++.+.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            1123456889999999999999998875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5e-41  Score=308.99  Aligned_cols=250  Identities=25%  Similarity=0.446  Sum_probs=205.4

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|.+.+.||+|++|.||+|... ++..|++|.+...  .......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999965 6788999987543  334456788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999976422  4689999999999999999999999   99999999999999999999999999988765433


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||......      .......... .     +.. 
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~~-  221 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRGV-F-----PPV-  221 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-C-----CCC-
Confidence            22 22345889999999999999999999999999999999999999754421      1112221111 0     111 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         ...++..+.+++.+||+.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               12345679999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-41  Score=323.75  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=194.8

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57789999886542   23344577899998888 699999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  152 (327)
T cd05617          81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T  152 (327)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence            9999988654    4699999999999999999999999   999999999999999999999999999875322221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||............+.+.........      .++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p---  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIP---  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCC---
Confidence            23457999999999999999999999999999999999999999754433322223333333222111      111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                       ..++..+.+++.+||+.||.+|+++
T Consensus       224 -~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 -RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCC
Confidence             1234568899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4e-41  Score=310.42  Aligned_cols=246  Identities=28%  Similarity=0.448  Sum_probs=196.7

Q ss_pred             eecccCceEEEEEEEC---CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           86 VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      .||+|+||.||+|.+.   ++..+|+|++....  ......+..|+.+++.++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999743   56789999875443  334567888999999999999999999875 45678999999999


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceee
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  240 (407)
                      +|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999754    4689999999999999999999999   999999999999999999999999999987654433211


Q ss_pred             --eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          241 --TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       241 --~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                        ....++..|+|||.+....++.++|||||||++|||++ |..||......+   .   ..... ....     ...+ 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~i~-~~~~-----~~~~-  220 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V---TQMIE-SGER-----MECP-  220 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHH-CCCC-----CCCC-
Confidence              11234578999999988889999999999999999998 999997543321   1   11111 1110     1111 


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         ..++..+.++|.+||+.||++||++.+|.+.|++.
T Consensus       221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               12445689999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.5e-41  Score=312.54  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=205.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC---EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS---KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|...+.||+|+||.||+|... ++.   .+|+|.+.... ......+..|+++++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999864 332   68999886542 3345578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999997542   4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeee--eeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          233 GSESSYITTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       233 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..........  ...+..|+|||++....++.++|||||||++|+|++ |+.||......+      ....+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~~~~--  229 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGFRL--  229 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcCCCC--
Confidence            4332211111  123457999999988889999999999999999997 999997544321      11211111000  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         +     ....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       230 ---~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 ---P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               1     1123445689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-41  Score=321.66  Aligned_cols=264  Identities=27%  Similarity=0.431  Sum_probs=207.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      ++..++|.+.+.||+|+||.||++...        ....+|+|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            444578999999999999999999753        12469999886542 33445677899999999 799999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      ......++||||+.+++|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999976421            123588999999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~  290 (407)
                      |+++.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            999999999999999987654322111 111224568999999988889999999999999999998 889986433211


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                            ..... .....     ...    ...++..+.+++.+||..+|++||++.++++.|+.+..
T Consensus       251 ------~~~~~-~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         251 ------LFKLL-KEGHR-----MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ------HHHHH-HcCCC-----CCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                  11111 11110     011    12334578899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.8e-41  Score=317.29  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=206.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..+|++.+.||+|+||.||+|... ++..||+|.+..........+..|+.+++.++|+||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357999999999999999999854 6788999988766555566788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++..     ..+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999999864     3588999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...      .........        ..
T Consensus       171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~--------~~  235 (296)
T cd06654         171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT--------PE  235 (296)
T ss_pred             cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCC--------CC
Confidence            21 2234588999999999888899999999999999999999999975443211      111111110        00


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ......+...+.+++.+||..+|++||++.+++..
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            11123355668899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=323.92  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=199.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||++... +++.||+|++...   .......+..|+.++..++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999965 5788999988542   2223345778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            9999999999996532   4689999999999999999999999   999999999999999999999999999876654


Q ss_pred             CCceeeeeeeccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..........||+.|+|||++..     ..++.++|||||||++|+|++|+.||......+      ............ 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~-  227 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHF-  227 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcc-
Confidence            33322333468999999999863     457889999999999999999999997543322      122222211100 


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCC--CCCCCHHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNA--QKRPKMGHVVHML  352 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp--~~RPt~~evl~~L  352 (407)
                          .++.. ...++..+.++|.+||..++  ..|+++.+++..-
T Consensus       228 ----~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         228 ----QFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             ----cCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence                11111 11245567888888775533  3478999888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-41  Score=320.50  Aligned_cols=261  Identities=25%  Similarity=0.392  Sum_probs=204.2

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS--KVAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|++.+.||+|+||.||+|.+. ++.  .+|+|.+... .......+.+|+.++.++ +||||+++++++...+..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            3468999999999999999999964 343  3577766543 234456788899999999 8999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC
Q 015395          152 LVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  219 (407)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            99999999999999965421            123588999999999999999999999   999999999999999999


Q ss_pred             CcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHH
Q 015395          220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       220 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (407)
                      .+||+|||++........  .....++..|+|||.+.+..++.++|||||||++|+|+| |..||......+.      .
T Consensus       162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~  233 (303)
T cd05088         162 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------Y  233 (303)
T ss_pred             cEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------H
Confidence            999999999864321111  111224567999999988889999999999999999998 9999975443221      1


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      ........      ...    ....+..+.+++.+||+.+|++||++.+++..|+.+...
T Consensus       234 ~~~~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         234 EKLPQGYR------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHHhcCCc------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11111100      011    112345688999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.5e-41  Score=313.74  Aligned_cols=247  Identities=23%  Similarity=0.279  Sum_probs=195.6

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||+|+||.||++... +++.||+|.+....   ......+..|+.++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999854 68899999885432   12233455699999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  242 (407)
                      .+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~  153 (277)
T cd05607          81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ  153 (277)
T ss_pred             HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence            98886532  13588999999999999999999999   999999999999999999999999999987654322  233


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|+.||.......  .............         .. .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~---------~~-~~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE---------VK-FEHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc---------cc-ccccc
Confidence            468999999999998889999999999999999999999997543211  1111112211110         00 01123


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ++.++.+++.+||+.||++||++.++++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            455789999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.3e-41  Score=316.86  Aligned_cols=265  Identities=25%  Similarity=0.415  Sum_probs=204.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-----------------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccce
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-----------------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVR  139 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~  139 (407)
                      .++|++.+.||+|+||.||++...                 +...+|+|.+.... ......+..|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            467999999999999999998633                 23358999886543 344567889999999999999999


Q ss_pred             eeeeeecCCeeEEEEEeccCCChHHhhhCCCCC-------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      +++++......+++|||+.+++|.+++......       ...+++..++.++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999999764321       13477889999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCc
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPP  289 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt--g~~Pf~~~~~~  289 (407)
                      ||++.++.++|+|||++.......... .....++..|++||......++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999998654332211 122234678999999888889999999999999999998  77888654433


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      +....   .............. +.     ...++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       241 ~~~~~---~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVIEN---TGEFFRDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHH---HHHHHhhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            22211   11111111000000 11     11234568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.5e-41  Score=313.25  Aligned_cols=257  Identities=25%  Similarity=0.410  Sum_probs=204.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+. ++.    .||+|.+... .......+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            467899999999999999999853 343    4899988654 334456788899999999999999999998754 578


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ++|||+++|+|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            9999999999999997642   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...    ........ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~-  230 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD----LLEKGERL-  230 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCcC-
Confidence            65332211 111234678999999988899999999999999999998 999997543221   111    11111110 


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                          ..    ...++..+.+++.+||+.||+.||++.+++..|..+..
T Consensus       231 ----~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 ----PQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                01    12244568899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-41  Score=323.69  Aligned_cols=241  Identities=22%  Similarity=0.321  Sum_probs=194.4

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +|+..+.||+|+||.||+|... +++.||+|++....   ......+..|..+++.+. |++|+++++++...+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999965 67889999886432   233345667888888885 578889999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999998765    4699999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......      .........       ..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~-------~~  219 (323)
T cd05615         154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN-------VS  219 (323)
T ss_pred             CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            221 1233468999999999999999999999999999999999999997554321      122222111       01


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                      ++    ..++..+.+++.+||+.+|.+|++.
T Consensus       220 ~p----~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YP----KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CC----ccCCHHHHHHHHHHcccCHhhCCCC
Confidence            11    1234568899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.6e-41  Score=336.24  Aligned_cols=267  Identities=23%  Similarity=0.302  Sum_probs=195.2

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC------CCccceeeeeeec
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR------HKNLVRLLGYCAE  146 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~  146 (407)
                      +....++|++.+.||+|+||+||+|... .+..||||++.... .....+..|+.+++.++      |.+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4455688999999999999999999965 57789999885432 22334455666666654      4568888888865


Q ss_pred             C-CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCC-----
Q 015395          147 G-AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHW-----  219 (407)
Q Consensus       147 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~-----  219 (407)
                      . ..+|+|||++ +++|.+++...    ..+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++     
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence            4 5789999988 77999988765    579999999999999999999997 6   999999999999998765     


Q ss_pred             -----------CcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015395          220 -----------NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (407)
Q Consensus       220 -----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~  288 (407)
                                 .+||+|||++......    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                       4999999987643221    2345789999999999999999999999999999999999999987654


Q ss_pred             chhhhHHHHHHH-----------------Hhhc-CCCCCcCCCC-----CCCCcc--HHHHHHHHHHHHHccCcCCCCCC
Q 015395          289 PEEVNLIEWLKK-----------------MVTN-RNPEGVLDPK-----LPEKPT--SRLLKRILLVALRCVDPNAQKRP  343 (407)
Q Consensus       289 ~~~~~~~~~~~~-----------------~~~~-~~~~~~~~~~-----~~~~~~--~~~~~~l~~li~~cl~~dp~~RP  343 (407)
                      .+....+.....                 .... .......++.     ......  ......+.+||.+||+.||.+||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            333322211100                 0000 0000000000     000000  00124577999999999999999


Q ss_pred             CHHHHHHHHH
Q 015395          344 KMGHVVHMLE  353 (407)
Q Consensus       344 t~~evl~~L~  353 (407)
                      |++++++.-.
T Consensus       431 ta~e~L~Hp~  440 (467)
T PTZ00284        431 NARQMTTHPY  440 (467)
T ss_pred             CHHHHhcCcc
Confidence            9999997433

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-41  Score=321.27  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=202.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999965 57789999886443 22334567799999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++ +|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            965 8888886542   3588999999999999999999999   99999999999999999999999999997654332


Q ss_pred             ceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH-----HhhcC-CCCC
Q 015395          237 SYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK-----MVTNR-NPEG  309 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~-~~~~  309 (407)
                      .. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....     .+... ....
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            21 223457899999998865 4689999999999999999999999986654433222211100     00000 0000


Q ss_pred             cCCCCCCC-------CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          310 VLDPKLPE-------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       310 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..+...+.       .....++.++.+||.+||+.||.+|||+.++++.-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  288 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY  288 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence            00000000       011224567889999999999999999999987443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.7e-42  Score=331.77  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=198.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++...   .......+..|+.++..++||||+++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999965 5788999988643   2233456778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999999765    5689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 015395          235 ESS----------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  280 (407)
Q Consensus       235 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~  280 (407)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0011346999999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC---HHHHHH
Q 015395          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MGHVVH  350 (407)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~  350 (407)
                      .||...++.+..      ........ . +   .++.  ...++.++.++|.+|+ .||.+|++   +.++++
T Consensus       234 ~Pf~~~~~~~~~------~~i~~~~~-~-~---~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQETY------RKVMNWKE-T-L---VFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHHHHH------HHHHcCCC-c-e---ecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999865543221      11111100 0 0   1111  1113456788888876 49999985   556554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.5e-41  Score=318.47  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=208.2

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  145 (407)
                      +.+..++|.+.+.||+|+||.||++...      .+..||+|.+.... ......+..|+.+++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3455678999999999999999999742      24469999876543 33345788899999999 7999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      ..+..+++|||+.+++|.+++.....  ..+++..++.++.|++.||.|||++   +|+|+||||+|||++.++.++|+|
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            99999999999999999999975432  2389999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          226 FGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       226 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      ||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.      +.....
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~  258 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIK  258 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHH
Confidence            9999866443221 1122345678999999998899999999999999999998 9999975443221      111111


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ....     ...    ....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       259 ~~~~-----~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGYR-----MAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCc-----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1110     001    112345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.6e-41  Score=311.78  Aligned_cols=252  Identities=23%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.++||+|+||.||+|.. .++..||+|.+... .......+..|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3688889999999999999985 46788999988654 334456788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|..+        ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            999998654        2478888999999999999999999   99999999999999999999999999997654321


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh-hHHHHHHHHhhcCCCCCcCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV-NLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                         .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......... ....... .......     +.+
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~  220 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDEDP-----PVL  220 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccCC-----CCC
Confidence               22346899999999999989999999999999999999999999653322111 1111111 1111111     111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         .....+..+.++|.+||+.+|++||+++++++...
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         221 ---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             ---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence               11223456889999999999999999999987544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.7e-41  Score=309.41  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=203.5

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      +|++.+.||+|+||.||++... ++..+|+|.+... .......+..|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999965 6888999988543 3344567778999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||++   +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999998865322  4578999999999999999999999   999999999999999999999999999987644322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......      ........ ...     .+  
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~-----~~--  220 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVCQG-SYK-----PL--  220 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHhcC-CCC-----CC--
Confidence             1223468899999999988889999999999999999999999997543211      11111111 110     11  


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ...++..+.++|.+||+.||++||++.+++..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              12244568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-41  Score=310.68  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=201.4

Q ss_pred             CCccceecccCceEEEEEEECC----CCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe-----
Q 015395           81 FSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  149 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  149 (407)
                      |.+.+.||+|+||.||+|....    +..||+|.+....  ......+..|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998542    3579999886542  2334578889999999999999999998765443     


Q ss_pred             -eEEEEEeccCCChHHhhhCCCC--CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          150 -RMLVYEYVNNGNLEQWLHGDVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       150 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                       .+++|||+++++|..++.....  ....+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7999999999999999854321  224689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          227 GLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       227 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||......+      ........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcC
Confidence            9998764332211 111234678999999988899999999999999999999 899997544322      12222111


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ..      ...    +..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus       232 ~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NR------LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC------CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11      111    123445789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.3e-41  Score=309.74  Aligned_cols=253  Identities=26%  Similarity=0.496  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ..+|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+++++.++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            34688899999999999999998778889999876443 23456788999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      .+++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            9999999987543   4688999999999999999999999   999999999999999999999999999876543322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+      ..........   ...+.  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~---~~~~~--  224 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFR---LYKPR--  224 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCCCC---CCCCC--
Confidence            11122234568999999988889999999999999999998 999997443221      1122111110   01111  


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                           ..+..+.+++.+||+.+|++||++.++++.|.
T Consensus       225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 12356899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-41  Score=312.47  Aligned_cols=255  Identities=29%  Similarity=0.454  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEECC-C---CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLED-N---SKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ++|++.+.||+|+||.||+|.... +   ..||+|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            458889999999999999999643 3   35999988654 334456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++....   ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999997543   4689999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcee--eeeee--ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          234 SESSYI--TTRVM--GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       234 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ......  .....  .+..|+|||.+....++.++|||||||++|||++ |..||......+   ....   ......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~---i~~~~~--  229 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINA---IEQDYR--  229 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHH---HHcCCc--
Confidence            332211  11111  2457999999998999999999999999999886 999997544322   1111   111110  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                          ...    ...++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus       230 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ----LPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                011    123345688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5e-42  Score=332.76  Aligned_cols=262  Identities=22%  Similarity=0.289  Sum_probs=204.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-C-----CccceeeeeeecCCeeEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-H-----KNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~~~~l  152 (407)
                      +|.+.++||+|+||.|.+|.+. +++.||||++++...- .+....|+.+|..|+ |     -|||+++++|...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            6899999999999999999954 6889999988776543 344556999999996 4     399999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC--CCcEEeecccce
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH--WNPKVSDFGLAK  230 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~DfGla~  230 (407)
                      |+|.+ ..+|.++|+.+.  ...++...+..++.||+.||.+||..   +|||+||||+||||.+.  ..|||+|||+++
T Consensus       266 VfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999 669999998764  35699999999999999999999999   99999999999999654  469999999999


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh--------
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV--------  302 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------  302 (407)
                      .....-.    ..+.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+....+..+..+.        
T Consensus       340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            8654422    4567889999999999999999999999999999999998898876555443332211100        


Q ss_pred             -------hc-C-CC-----CC-----------------cCCCCCC-CCc------cHHHHHHHHHHHHHccCcCCCCCCC
Q 015395          303 -------TN-R-NP-----EG-----------------VLDPKLP-EKP------TSRLLKRILLVALRCVDPNAQKRPK  344 (407)
Q Consensus       303 -------~~-~-~~-----~~-----------------~~~~~~~-~~~------~~~~~~~l~~li~~cl~~dp~~RPt  344 (407)
                             .. . .+     ..                 ..+...| ...      ...--..+.+++.+||++||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                   00 0 00     00                 0000111 000      0112245789999999999999999


Q ss_pred             HHHHHHHH
Q 015395          345 MGHVVHML  352 (407)
Q Consensus       345 ~~evl~~L  352 (407)
                      ..++++.-
T Consensus       496 p~qal~Hp  503 (586)
T KOG0667|consen  496 PAQALNHP  503 (586)
T ss_pred             HHHHhcCc
Confidence            99999743

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-41  Score=308.85  Aligned_cols=247  Identities=28%  Similarity=0.472  Sum_probs=196.0

Q ss_pred             eecccCceEEEEEEEC---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCC
Q 015395           86 VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      .||+|+||.||+|.+.   .+..||+|.+.... ......+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999754   34568999886553 3344568899999999999999999998754 57899999999999


Q ss_pred             hHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeee
Q 015395          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT  241 (407)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  241 (407)
                      |.+++....   ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++............
T Consensus        81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            999997542   4689999999999999999999999   9999999999999999999999999999865443322111


Q ss_pred             e--eeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          242 R--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       242 ~--~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                      .  ..++..|+|||.+....++.++|||||||++|+|++ |..||......+.      .........      ...+  
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~------~~~~--  220 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------MSFIEQGKR------LDCP--  220 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHHCCCC------CCCC--
Confidence            1  123568999999988889999999999999999996 9999975543221      111111110      1111  


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                        ..++.++.++|.+||..+|++||++.+|.+.|+..
T Consensus       221 --~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 --AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              12345688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-41  Score=321.23  Aligned_cols=268  Identities=26%  Similarity=0.422  Sum_probs=210.6

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECC--------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLG  142 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~  142 (407)
                      ++++...+|.+.+.||+|+||.||+|....        ...||+|.+.... ......+..|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            456666789999999999999999997421        2358999776442 33456788899999999 7999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCC
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  210 (407)
                      ++......+++|||+++++|.+++.....            ....+++..++.++.|++.||.|||++   +++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence            99999999999999999999999975321            223588899999999999999999999   999999999


Q ss_pred             ccEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~  288 (407)
                      +|||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999998764432211 111234567999999999999999999999999999998 8899875432


Q ss_pred             chhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      .+      ......... .     ...    ...++..+.+++.+||+.+|++||++.+++..|+.+....
T Consensus       243 ~~------~~~~~~~~~-~-----~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 EE------LFKLLKEGH-R-----MDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HH------HHHHHHcCC-C-----CCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            22      111111111 1     011    1123456889999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.5e-42  Score=326.37  Aligned_cols=239  Identities=26%  Similarity=0.321  Sum_probs=190.0

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHH-HHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|... ++..||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999954 68899999885432   222334444544 56779999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  152 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T  152 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence            9999988754    5789999999999999999999999   999999999999999999999999999875422221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      ..........   .+.+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~~---~~~~------  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKPL---VLRP------  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCCc---cCCC------
Confidence            234568999999999999999999999999999999999999997544322      1222221110   0111      


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHV  348 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~ev  348 (407)
                        ..+..+.+++.+||+.+|.+||++.+.
T Consensus       218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         218 --GASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             --CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence              133457889999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-41  Score=309.66  Aligned_cols=249  Identities=29%  Similarity=0.417  Sum_probs=201.0

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee-cCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~  156 (407)
                      ..+|.+.+.||+|+||.||++... +..+|+|.+....  ....+..|+.++++++|+|++++++++. .....+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            457899999999999999999765 7789999875442  3456788999999999999999999754 55678999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.....  ..+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            999999999976432  3588999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                          ....++..|+|||++....++.++|||||||++|+|++ |+.||......+      ....... ...     ...
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~-~~~-----~~~  220 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEK-GYK-----MDA  220 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhc-CCC-----CCC
Confidence                12234568999999988889999999999999999998 999986443211      1111111 111     111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ...++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                12345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.3e-41  Score=317.16  Aligned_cols=263  Identities=22%  Similarity=0.348  Sum_probs=204.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||+|+||.||++... ++..+|+|.+... .......+..|++++++++||||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999965 5677888887654 233445688899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+ .   +++|+||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999765    568999999999999999999997 5   8999999999999999999999999998755322


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC-------
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE-------  308 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  308 (407)
                      .   .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........   +..........       
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM---FGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh---hcCccccccccCCccccc
Confidence            1   2334688999999999888899999999999999999999999965432211111   10000000000       


Q ss_pred             -----------------CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          309 -----------------GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       309 -----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                                       .......+..+...++..+.+++.+||..+|++||++.+++.....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                             0000000111111245678999999999999999999999986553

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-41  Score=329.17  Aligned_cols=268  Identities=18%  Similarity=0.245  Sum_probs=204.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ...+|.+.+.||+|+||.||+|...   .+..||+|.+...     ....+|+.+|+.++||||+++++++......+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3457999999999999999999753   3567999987543     2345699999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||++. ++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.++|+|||++....
T Consensus       165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            99995 6898888543    5799999999999999999999999   99999999999999999999999999997665


Q ss_pred             CCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC----
Q 015395          234 SESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE----  308 (407)
Q Consensus       234 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----  308 (407)
                      ..... ......||+.|+|||++....++.++|||||||++|||++|+.||.+............+.+........    
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            43221 2234569999999999999999999999999999999999999997655432222111111111100000    


Q ss_pred             -------------CcCCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          309 -------------GVLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       309 -------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                                   ....+.....   ....+...+.++|.+||..||++|||+.+++..-.....
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                         0000000000   001234568889999999999999999999987655433

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-41  Score=307.87  Aligned_cols=247  Identities=27%  Similarity=0.457  Sum_probs=197.9

Q ss_pred             ceecccCceEEEEEEECC----CCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|.+..    +..+|+|.+..... .....+..|+.+++.++|+||+++++++.. ...+++|||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997432    25799998865543 345678889999999999999999998764 568999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999765    3689999999999999999999999   99999999999999999999999999998765443322


Q ss_pred             eee--eeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          240 TTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       240 ~~~--~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      ...  ..++..|+|||.+.+..++.++|||||||++|+|++ |..||......+   ....+.   .... .        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~---~~~~-~--------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE---SGER-L--------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH---cCCc-C--------
Confidence            111  123467999999998899999999999999999998 999997554322   111111   1110 0        


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                       .....++..+.++|.+||..+|++||++.++++.|+..
T Consensus       218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             11122345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-41  Score=312.22  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888999999999999999854 5788999988766555556678899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...    +.+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            9999999998765    5789999999999999999999999   99999999999999999999999999987664322


Q ss_pred             ceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      . ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+....      .........    .+
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~----~~  229 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQ----PP  229 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCC----CC
Confidence            1 123346899999999874   456889999999999999999999998654332211      111111100    01


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ...  ....++..+.++|.+||..+|++||+++++++
T Consensus       230 ~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            110  11123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.4e-41  Score=323.88  Aligned_cols=264  Identities=24%  Similarity=0.304  Sum_probs=198.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999964 5888999988543  233445677899999999999999999988643      3


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||+++ +|.+.+..      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            57999999964 67776643      478899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH-------------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI-------------  295 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~-------------  295 (407)
                      +.......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+.....             
T Consensus       170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            97643322  123346899999999999999999999999999999999999999865432211000             


Q ss_pred             ---HHHHHHhhcC-CCCCc-CCCC-----CC--CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          296 ---EWLKKMVTNR-NPEGV-LDPK-----LP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       296 ---~~~~~~~~~~-~~~~~-~~~~-----~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         ..+....... ..... +...     .+  ..........+.+||.+||..||++|||+.+++..-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence               0011111100 00000 0000     00  0001123456889999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-41  Score=322.94  Aligned_cols=255  Identities=20%  Similarity=0.263  Sum_probs=200.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+.+.||+|+||.||++... +++.||+|.+....   ......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999965 57789999885421   223345777999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999997632   4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+      ...........  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~--  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEER--  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCc--
Confidence            44333334569999999999865     467889999999999999999999997544322      12222221110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHM  351 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~  351 (407)
                         ..++. ....++..+.+++.+||..++.+  |++++++++.
T Consensus       227 ---~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 ---FQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---ccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               01111 11234567889999999866544  4578887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.7e-41  Score=346.88  Aligned_cols=261  Identities=20%  Similarity=0.348  Sum_probs=205.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999965 58899999986532   233457888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCC-------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          155 EYVNNGNLEQWLHGDVG-------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ||++|++|.+++.....       ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211       113456778899999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCc-----------------eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          228 LAKLLGSESS-----------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       228 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                      ++........                 ......+||+.|||||++.+..++.++|||||||++|||+||..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                 01122468999999999999999999999999999999999999997533211


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHhcc
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQE  356 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~  356 (407)
                      ...     ....        ..+ ....+...++..+.+++.+||+.||++|| +++++++.|+...
T Consensus       239 i~~-----~~~i--------~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 ISY-----RDVI--------LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhh-----hhhc--------cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            100     0000        000 00011224456688999999999999997 6677777777653

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=351.06  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=200.8

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~  149 (407)
                      ....++|.+++.||+|+||.||+|... ++..||+|.+...  .......+..|+.+|+.++||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445678999999999999999999965 4667889987543  23344578889999999999999999998854  457


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCC----CceeccCCCCccEEEeC--------
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE----PKVVHRDIKSSNILIDK--------  217 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~Dlkp~Nill~~--------  217 (407)
                      +||||||+++++|.++|.........+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999997543333579999999999999999999998510    15999999999999964        


Q ss_pred             ---------CCCcEEeecccceecCCCCceeeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 015395          218 ---------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYS  286 (407)
Q Consensus       218 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~  286 (407)
                               .+.+||+|||++........  .....||+.|+|||++.+  ..++.++||||||||||+|++|..||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     23489999999987643321  234568999999999854  45889999999999999999999999754


Q ss_pred             CCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ....     ..+..+...        +.++   ....+..+.+||..||..+|.+||++.+++.
T Consensus       247 ~~~~-----qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFS-----QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHH-----HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3221     112211111        1111   1123456899999999999999999999985

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.1e-41  Score=311.30  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=205.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .++|++.+.||+|+||.||+|...      +...+++|.+...... ....+..|++++++++|+||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            357899999999999999999854      2356899987654433 456788899999999999999999999998999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCC-----CCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPC-----SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      ++||||+++++|.+++.......     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999997653211     2689999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      .+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~~~  234 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQAG  234 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHHcC
Confidence            99987543332222233456778999999988889999999999999999999 888986433221      12221111


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      . ..    ..    ....++..+.+++.+||+.+|.+||++.+++..|.
T Consensus       235 ~-~~----~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 K-LE----LP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             C-cC----CC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1 00    00    11124457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=326.90  Aligned_cols=266  Identities=25%  Similarity=0.404  Sum_probs=221.3

Q ss_pred             cccHHHHHHhcCCCCccceecccCceEEEEEEECC---CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceee
Q 015395           68 WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED---NS--KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLL  141 (407)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~  141 (407)
                      .++.+.+++........++||.|.||.||.|.+.+   |.  .||||..+.+ .....+.|..|+.+|+.++||||++++
T Consensus       378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI  457 (974)
T KOG4257|consen  378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI  457 (974)
T ss_pred             CCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence            34455667777778888999999999999998542   33  4899988774 455567899999999999999999999


Q ss_pred             eeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                      |+|.+ ...|||||.++-|.|..||..+.   ..++......++.||+.||.|||+.   +.|||||...||||....-|
T Consensus       458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  458 GVCVE-QPMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             eeeec-cceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCccee
Confidence            99977 57899999999999999998765   5789999999999999999999999   99999999999999999899


Q ss_pred             EEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      ||+||||++.+........+...-...|||||.+.-..++.+||||-||+++||++. |..||.+-...+....+     
T Consensus       531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-----  605 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-----  605 (974)
T ss_pred             eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-----
Confidence            999999999998776665554445678999999999999999999999999999987 99999876543322111     


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                                 ...-....+..++..|..|+.+||..+|.+||++.++...|..+.
T Consensus       606 -----------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  606 -----------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             -----------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                       111111223456667999999999999999999999998887653

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.5e-41  Score=313.99  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .|+..+.||+|+||.||++... +++.||+|.+....   ......+..|+.+++.++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3778889999999999999965 67889999885432   2223456779999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+.+++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999999864321  3589999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..  .....|+..|+|||++.+..++.++|||||||++|+|++|+.||..............+.....         .. 
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~-  223 (285)
T cd05630         156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------EE-  223 (285)
T ss_pred             cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------hh-
Confidence            22  1234689999999999999999999999999999999999999975433211111111110000         01 


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHML  352 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~L  352 (407)
                         ....++..+.+|+.+||+.||++|||     +.++++.-
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         224 ---YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             ---cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence               11223456889999999999999999     78888643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.8e-41  Score=314.74  Aligned_cols=264  Identities=26%  Similarity=0.431  Sum_probs=206.1

Q ss_pred             cCCCCccceecccCceEEEEEEECC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccce
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED-----------------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVR  139 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~  139 (407)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+.... ......+..|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4679999999999999999988542                 2358999886553 344567888999999999999999


Q ss_pred             eeeeeecCCeeEEEEEeccCCChHHhhhCCCC-------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVG-------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      +++++......+++|||+.+++|.+++.....       ....+++..++.++.|++.||+|||+.   +|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999998999999999999999999976531       112689999999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCc
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPP  289 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt--g~~Pf~~~~~~  289 (407)
                      |+++.++.++|+|||++......... ......++..|+|||.+....++.++|||||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99999999999999998765433221 1223346778999999988889999999999999999998  77888654332


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      +.   .................      .....++.++.+++.+||+.||.+|||+.+|++.|+
T Consensus       241 ~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QV---IENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH---HHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            21   11111111111000000      011223457999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.8e-41  Score=313.12  Aligned_cols=261  Identities=23%  Similarity=0.387  Sum_probs=210.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|+++++.++||||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            467899999999999999999965 57889999876543 3445678889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |+++++|.+++...    +.+++..+..++.+++.||.|||+ +   +++|+||||+||++++++.++|+|||++.....
T Consensus        84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            99999999998764    468999999999999999999997 5   899999999999999999999999999865422


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch-----hhhHHHHHHHHhhcCCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE-----EVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..   .....|+..|+|||++.+..++.++|||||||++|+|++|..||......+     .....+.+.......    
T Consensus       157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence            21   123468999999999988889999999999999999999999998554321     111222333332211    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           .+......++..+.+++.+||+.||++|||+.++++.+..++.
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                 1111122355678999999999999999999999987655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6e-41  Score=322.48  Aligned_cols=265  Identities=27%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             HHhcCCCCccceecccCceEEEEEEE------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeeeec
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  146 (407)
                      .+..++|++.+.||+|+||.||+|.+      .+++.||||.+.... ......+..|+.++.++ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            44567899999999999999999973      246789999986543 23345678899999999 68999999998764


Q ss_pred             -CCeeEEEEEeccCCChHHhhhCCCCC-----------------------------------------------------
Q 015395          147 -GAHRMLVYEYVNNGNLEQWLHGDVGP-----------------------------------------------------  172 (407)
Q Consensus       147 -~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  172 (407)
                       ....+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             45678999999999999998653210                                                     


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce-eee
Q 015395          173 ----------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITT  241 (407)
Q Consensus       173 ----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~  241 (407)
                                ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......... ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      12467888899999999999999999   9999999999999999999999999998765332211 112


Q ss_pred             eeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCcc
Q 015395          242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (407)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (407)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ..    ........     ...+.   
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~-----~~~~~---  305 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTR-----MRAPD---  305 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCC-----CCCCC---
Confidence            2235678999999988899999999999999999997 9999975433211  11    11111110     01111   


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          321 SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                       ..+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       306 -~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         306 -YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             123458899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.6e-41  Score=314.21  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=205.7

Q ss_pred             hcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ..++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+..|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3567999999999999999999853      45679999886543 3445678889999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCC------------------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDV------------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~  211 (407)
                      .+++|||+++++|.+++....                  .....+++..++.++.|++.||.|||+.   +++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            999999999999999996431                  1123578899999999999999999999   9999999999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~  289 (407)
                      ||+++.++.++|+|||++.......... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987654332211 112234667999999988899999999999999999998 88898654332


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      +      ...... .....     ..    ...++..+.+++.+||+.+|++|||+.++++.|++
T Consensus       240 ~------~~~~~~-~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 E------VIYYVR-DGNVL-----SC----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H------HHHHHh-cCCCC-----CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            2      122211 11110     00    11234568999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.8e-41  Score=318.19  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~  143 (407)
                      +.+..++|.+.+.||+|+||.||+|...        ....+|+|.+.... ......+..|+.+++.+ +||||++++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            3445578999999999999999999742        23468999876543 33445678899999999 69999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCc
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~  211 (407)
                      +......+++|||+.+++|.+++.....            ....+++..+..++.|++.||.|||++   +++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  163 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR  163 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence            9988999999999999999999965321            124589999999999999999999999   9999999999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~  289 (407)
                      |||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998664322211 111224467999999988889999999999999999999 89999654332


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      +..      .... .....     ..    ...++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       244 ~~~------~~~~-~~~~~-----~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 ELF------KLLR-EGHRM-----DK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHH------HHHH-cCCCC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            211      1111 11110     11    12234468899999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-41  Score=311.38  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=201.6

Q ss_pred             CCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHH--HHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           81 FSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAER--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      |++.+.||+|+||+||++.... +..||+|.+.........  ....|+.++++++||||+++++++.+....+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6778999999999999999764 567999998776544333  3345999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      .+++|.+++...    ..+++..++.++.|+++||.+||+.   +++|+||||+||+++.++.++|+|||.+...... .
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N  152 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred             cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence            999999999833    5789999999999999999999999   9999999999999999999999999999865222 2


Q ss_pred             eeeeeeeccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH-HhhcCCCCCcCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK-MVTNRNPEGVLDPKL  315 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  315 (407)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||................. ......         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------
Confidence            2334456899999999998 88899999999999999999999999986522222222211111 000000         


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        .........+.+++.+||+.||++||++.++++.
T Consensus       224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0000112679999999999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.9e-41  Score=314.60  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .+|.+.+.||+|+||.||+|.. .++..||+|.+..........+..|+.+++.++|+||+++++++......++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5799999999999999999995 468899999987665555667888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999999865     3588999999999999999999999   999999999999999999999999999876543322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      . .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+......      ....        .....
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~--------~~~~~  235 (297)
T cd06656         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN--------GTPEL  235 (297)
T ss_pred             C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccC--------CCCCC
Confidence            1 2234578899999999988899999999999999999999999975443211100      0000        00011


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .....++..+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1123445668899999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.8e-41  Score=321.75  Aligned_cols=255  Identities=21%  Similarity=0.277  Sum_probs=199.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+.+.||+|+||.||++... ++..+|+|.+...   .......+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46899999999999999999965 4677999988542   1222345778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++|+|.+++....   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999997632   4689999999999999999999999   999999999999999999999999999876544


Q ss_pred             CCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|+.||......+      ...........  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~--  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKER--  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcc--
Confidence            3333333456999999999885     3468899999999999999999999997544322      22222221110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHM  351 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~  351 (407)
                         ..++. ....++..+.+|+.+|+..++.+  |+++.++++.
T Consensus       227 ---~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 ---FQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---ccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               01111 11234567888999988654444  6889988875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-40  Score=311.90  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ......+..|+.+++.++|+||+.+++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677889999999999999964 67889999885442   22234567799999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999988865321  3699999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .  .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........   +........      ..  
T Consensus       157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~------~~--  223 (285)
T cd05632         157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE------EV--  223 (285)
T ss_pred             c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc------cc--
Confidence            2  2234689999999999988999999999999999999999999975443221111   111111110      01  


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                        ....++..+.+|+.+||+.||++||+     +.+++.
T Consensus       224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 --YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              11233456889999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=305.95  Aligned_cols=250  Identities=30%  Similarity=0.501  Sum_probs=203.6

Q ss_pred             ceecccCceEEEEEEECC----CCEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|....    +..|++|.+....... ...+..|+..++.++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    7789999887654433 56788899999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCC-----CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          160 GNLEQWLHGDVGP-----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       160 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ++|.+++......     ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999775211     25799999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          235 ESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ... .......++..|+|||.+....++.++|||||||++|+|++ |..||......+   .   .........      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~------  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---V---LEYLRKGYR------  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHHcCCC------
Confidence            432 11223457889999999988889999999999999999999 699997653322   1   111111110      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...    ...++..+.+++.+||+.+|++||++.+++..|+
T Consensus       226 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 LPK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            011    1223557899999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=304.49  Aligned_cols=247  Identities=27%  Similarity=0.435  Sum_probs=200.1

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChH
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE  163 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (407)
                      ++||+|+||.||++...+++.||+|.+...... ....+..|+++++.++|+||+++++++.+....++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999776899999988655433 4567888999999999999999999999999999999999999999


Q ss_pred             HhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceee-ee
Q 015395          164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-TR  242 (407)
Q Consensus       164 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~  242 (407)
                      +++....   ..+++..++.++.+++.||.|||++   +++||||||+||+++.++.+||+|||++........... ..
T Consensus        81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9996542   3688999999999999999999999   999999999999999999999999999876543222111 11


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS  321 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (407)
                      ..++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........       ......     ..    ...
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-------~~~~~~-----~~----~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-------IESGYR-----MP----APQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-------HhcCCC-----CC----CCc
Confidence            223567999999988899999999999999999999 8899865543221111       111100     01    112


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          322 RLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       322 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..+..+.+++.+||..+|++||++.++++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            34557999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.7e-41  Score=313.18  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=194.5

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC---CCCccceeeeeeec-----CC
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRV---RHKNLVRLLGYCAE-----GA  148 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~~  148 (407)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  ......+..|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999965 57889999886432  12223445566666655   79999999998754     34


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..+++|||+. ++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            5799999996 589888865421  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC--
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--  306 (407)
                      +........  .....||..|+|||++.+..++.++|||||||++|+|++|++||...........+   ........  
T Consensus       155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI---FDLIGLPPED  229 (288)
T ss_pred             cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH---HHHhCCCChh
Confidence            987643321  22346799999999998889999999999999999999999999755433222111   11110000  


Q ss_pred             -C-------CCcCCCCCC---CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          307 -P-------EGVLDPKLP---EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       307 -~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                       .       .....+..+   ......+...+.+++.+||+.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0       000000000   0011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=328.29  Aligned_cols=245  Identities=31%  Similarity=0.485  Sum_probs=207.1

Q ss_pred             ceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChH
Q 015395           85 KVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE  163 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (407)
                      -+||+|.||+||.|++.+ ...+|||.+.........-+..|+.+.+.|+|.|||+++|.+.+++.+-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            369999999999999664 4568999998887777888889999999999999999999999999999999999999999


Q ss_pred             HhhhCCCCCCCCC--CHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCCcEEeecccceecCCCCceee
Q 015395          164 QWLHGDVGPCSPL--TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYIT  240 (407)
Q Consensus       164 ~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~  240 (407)
                      +++...=   +++  ++..+-.+..||++||.|||++   .|||||||-+||||+ -.|.+||+|||.++.+..-.. ..
T Consensus       661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~T  733 (1226)
T KOG4279|consen  661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CT  733 (1226)
T ss_pred             HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cc
Confidence            9997653   566  8889999999999999999999   999999999999995 578999999999988754433 35


Q ss_pred             eeeeccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          241 TRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                      .++.||.-|||||++..++  |+.++|||||||++.||.||++||-....+...     +.+.   +    +  .+....
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----MFkV---G----m--yKvHP~  799 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----MFKV---G----M--YKVHPP  799 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----hhhh---c----c--eecCCC
Confidence            5677999999999997654  899999999999999999999999765543221     1111   1    1  112223


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .+..++.+...+|.+|+.++|.+||++.+++.
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            35678889999999999999999999999986

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-41  Score=321.99  Aligned_cols=237  Identities=24%  Similarity=0.302  Sum_probs=188.0

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHH-HHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ++||+|+||.||+|... ++..||+|.+....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57889999885432   12233444454 467889999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++...    ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T  152 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence            9999888654    4688999999999999999999999   999999999999999999999999999875322221 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      ..........       ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~-------~~~~---  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKP-------LQLP---  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCC-------CCCC---
Confidence            23456899999999999989999999999999999999999999754321      1122222111       0111   


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMG  346 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~  346 (407)
                       ......+.+++.+||+.||.+||++.
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 -GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             12234688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=306.12  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=207.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||.|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++.+...++++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999964 5778999998766555667888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.+++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            99999999987542   4689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ceeeeeeeccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      . ......++..|+|||.+...   .++.++|+|||||++|+|++|..||......+....      ......     .+
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~~~~~-----~~  223 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------ISKSNF-----PP  223 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhccC-----CC
Confidence            1 12234678899999999776   789999999999999999999999975543222111      111100     00


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .. .......+..+.+++.+||..+|..|||+.+|+.
T Consensus       224 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PK-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cc-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00 1123345667999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-40  Score=311.96  Aligned_cols=253  Identities=22%  Similarity=0.314  Sum_probs=203.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .+.|++.+.||.|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            456999999999999999999965 4788999998776666677788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|..++....   ..+++..++.++.|++.+|.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          91 CPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            99999988876432   4689999999999999999999999   99999999999999999999999999987643321


Q ss_pred             ceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          237 SYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      . ......++..|+|||++.     ...++.++|||||||++|+|++|..||.......      ..........     
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~-----  232 (292)
T cd06644         165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEP-----  232 (292)
T ss_pred             c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcCCC-----
Confidence            1 122345788999999884     3457889999999999999999999997543211      1111111110     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       +..  .....++..+.++|.+||+.+|++||++.++++.
T Consensus       233 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 -PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             000  1122344568899999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-40  Score=307.74  Aligned_cols=239  Identities=24%  Similarity=0.394  Sum_probs=189.9

Q ss_pred             ceecccCceEEEEEEECC-------------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           85 KVIGEGGYGIVYYGLLED-------------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +.||+|+||.||+|...+             ...|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998432             2258888876655555567888999999999999999999999988999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC-------cEEe
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-------PKVS  224 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~  224 (407)
                      ++|||+++++|..++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999999887543   4689999999999999999999999   9999999999999987664       8999


Q ss_pred             ecccceecCCCCceeeeeeeccccccCccccC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI-SGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       225 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |||++......     ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+..       ...
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~  222 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY  222 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH
Confidence            99998755322     2235788999999886 466899999999999999998 588888654322111       111


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ... .      ...    ......+.+||.+||+.||.+||++.+|++.|
T Consensus       223 ~~~-~------~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EGQ-C------MLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hcC-c------cCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            110 0      000    11234688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-40  Score=313.79  Aligned_cols=250  Identities=22%  Similarity=0.378  Sum_probs=206.2

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .+|++.+.||.|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++......++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4699999999999999999985 468899999887665555667888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|..++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999999865     3589999999999999999999999   999999999999999999999999999876544322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      . .....++..|+|||.+.+..++.++|||||||++|+|++|..||.........      ........ .       ..
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~~-~-------~~  235 (296)
T cd06655         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT-P-------EL  235 (296)
T ss_pred             c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCC-c-------cc
Confidence            1 22345788999999999888999999999999999999999999765432211      11111110 0       00


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .....++..+.++|.+||..||.+||++.+++..
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            1122344568899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.5e-41  Score=315.93  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=202.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|.+.+.||.|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357999999999999999999865 57889999886442 2334456789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+. ++|.+++....   ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            996 58998886542   4688999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC---CCCC--
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---NPEG--  309 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~--  309 (407)
                      ... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....   +.......   ....  
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCChhhchhhh
Confidence            221 122356889999998865 4578899999999999999999999986554322211   11111100   0000  


Q ss_pred             ----cCCCCCCC-------CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          310 ----VLDPKLPE-------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       310 ----~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                          ......+.       .....++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence                00000000       011234556889999999999999999999987443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-40  Score=307.41  Aligned_cols=250  Identities=26%  Similarity=0.444  Sum_probs=201.9

Q ss_pred             CCCccceecccCceEEEEEEECCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +|.+.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999998788899999875432      12234578899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    .++++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999764    4689999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCC-----ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          234 SES-----SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       234 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ...     ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.........      ......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~-  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRGL-  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccCC-
Confidence            211     11122345889999999999888999999999999999999999999754322111      111111000 


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .+.++    ..++..+.++|.+||+.+|++||++.+++.
T Consensus       227 ---~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ---MPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               11111    224556899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-40  Score=310.87  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++......++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677889999999999999966 4667889988666555666788899999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++....   .++++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            99999886532   4689999999999999999999999   999999999999999999999999999876533221 1


Q ss_pred             eeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          240 TTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .....++..|+|||++.     +..++.++|||||||++|+|++|..||......+      .+.........      .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~------~  227 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPP------T  227 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCCC------C
Confidence            22345889999999873     4457889999999999999999999997543221      11111111110      0


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .  .....++..+.++|.+||+.||.+||++.++++...
T Consensus       228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            0  011234557899999999999999999999986554

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-40  Score=307.11  Aligned_cols=248  Identities=26%  Similarity=0.463  Sum_probs=200.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh---------hHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      +|.+.+.||+|+||.||+|... ++..+|+|.+......         ....+..|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 5788999988544221         22467789999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .+++|||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999765    4689999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCce-----eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          230 KLLGSESSY-----ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       230 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      .........     ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.......      .+......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~  227 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIGEN  227 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHhcc
Confidence            876422111     1122357889999999988889999999999999999999999997543211      11111110


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                            ..+.++    ..++..+.++|.+||+.||.+||++.++++
T Consensus       228 ------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ------ASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------CCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  111111    234557899999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-41  Score=311.67  Aligned_cols=253  Identities=22%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||.|+||.||++... ++..+|+|.+..........+..|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356899999999999999999964 5788999998766666667788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            99999999987542   4689999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          237 SYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      . ......+++.|+|||.+.     ...++.++|+|||||++|+|++|+.||.......      .+........     
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-----  225 (280)
T cd06611         158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSEP-----  225 (280)
T ss_pred             c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCCC-----
Confidence            2 123346899999999874     3457789999999999999999999997543322      1111111110     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       +.+  .....++..+.+++.+||+.+|.+||++.++++.
T Consensus       226 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 -PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             000  1122345568899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-40  Score=321.81  Aligned_cols=264  Identities=24%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------  147 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------  147 (407)
                      ..++|.+.+.||+|+||.||+|... .++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3578999999999999999999854 5788999988653  233345677899999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ...++||||+++ +|.+++..      .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            357999999964 77777753      478899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH------------
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI------------  295 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~------------  295 (407)
                      +++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+.....            
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998654322  223346899999999999999999999999999999999999999765432211100            


Q ss_pred             ----HHHHHHhhcC-CCCCcC------CCCCC--CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          296 ----EWLKKMVTNR-NPEGVL------DPKLP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       296 ----~~~~~~~~~~-~~~~~~------~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                          ..+....... ......      +...+  ..........+.+||.+||+.||++|||+.++++.-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence                0001110000 000000      00000  001112345688999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-40  Score=304.01  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=206.1

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|+..+.||.|+||.||.+... ++..+++|.+...  .......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4888999999999999999844 5788999987543  234455778899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999997643  24689999999999999999999999   99999999999999999999999999998764433


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......+      ......... ..    +   
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~-~~----~---  220 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQGN-YT----P---  220 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-CC----C---
Confidence            2 2233468999999999988889999999999999999999999997544322      122222111 10    0   


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                        ....++..+.+++.+||..+|++||++.++++.+
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              1133456789999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=317.29  Aligned_cols=260  Identities=24%  Similarity=0.318  Sum_probs=214.8

Q ss_pred             ccccHHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeee
Q 015395           67 HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      +|-.++...+..+.|+.-++||+||||.||-|+.+ +|+-+|.|.+.+.   ....+....+|-.+|.+++.+.||.+-.
T Consensus       173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            44445555678889999999999999999999955 6778999987443   2344456678999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      .|+.++.+|+||..|+||+|.-.|.+...  +.+++..++.++.+|+.||++||+.   +||+|||||+|||+|++|+++
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence            99999999999999999999988876643  5799999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |+|+|||.-+.....  ....+||.+|||||++.++.|+.+.|+|||||+||||+.|+.||........   .+.+.+++
T Consensus       328 ISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~  402 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRT  402 (591)
T ss_pred             eeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHH
Confidence            999999998765543  2334799999999999999999999999999999999999999974432211   12233332


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHH
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG  346 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~  346 (407)
                      ..          .+..++..++++..+++...|.+||.+|....
T Consensus       403 ~~----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  403 LE----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hc----------chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            21          12344567788899999999999999997543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-40  Score=304.90  Aligned_cols=250  Identities=26%  Similarity=0.424  Sum_probs=205.5

Q ss_pred             cCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||.|+||.||+|.... +..+++|.+.....  ...+.+|++++++++||||+++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3679999999999999999999764 78899998865432  66888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.+++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99999999986532   4689999999999999999999999   99999999999999999999999999988765433


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........       ......     ..  
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~-----~~--  218 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKPP-----PT--  218 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCCC-----CC--
Confidence            2 12234578899999999888999999999999999999999999975433221100       000000     00  


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ......+...+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1112234567899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=307.94  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=196.4

Q ss_pred             ceecccCceEEEEEEECC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLED-NS--KVAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ++||+|+||.||+|...+ +.  .+++|.+... .......+..|+.++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999653 33  4688877643 234456788899999999 799999999999999999999999999


Q ss_pred             CChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          160 GNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       160 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999975321            123578999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ++........  ......+..|+|||++....++.++|||||||++|+|++ |..||......+      ..........
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~  229 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGYR  229 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhCCCC
Confidence            9863221111  111223567999999988889999999999999999997 999996543221      1222211110


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .      ..    ....+..+.+++.+||..||.+|||+.+++..|..+.
T Consensus       230 ~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         230 L------EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C------CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0      11    1123456889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-40  Score=309.76  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=198.9

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecC------C
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~------~  148 (407)
                      +.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.+++++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            3567889999999999999999955 57789999876543 3345677899999998 699999999998642      4


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .++++|||+.+++|.+++.....  ..+++..+..++.|++.||+|||++   +|+|+||||+||++++++.++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence            68999999999999999876421  4689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      +........ ......|+..|+|||++.     +..++.++|||||||++|+|++|..||..........      ....
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~~  230 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR  230 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhc
Confidence            986543222 223356899999999985     3458889999999999999999999996443221111      1111


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      . ...        ......++..+.+|+.+||..+|.+|||+.++++
T Consensus       231 ~-~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 N-PAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C-CCC--------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1 000        0111234456899999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-40  Score=305.13  Aligned_cols=248  Identities=27%  Similarity=0.401  Sum_probs=200.7

Q ss_pred             ceecccCceEEEEEEECC--CC--EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLED--NS--KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~--~~--~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|++|.||+|.+.+  +.  .||+|.+..... .....+..|+.++++++||||+++++++.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998643  22  589998877655 566788899999999999999999999888 889999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999976532  4689999999999999999999999   99999999999999999999999999998765432211


Q ss_pred             --eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          240 --TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       240 --~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                        .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+.      +.........     ... 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~-----~~~-  222 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKEGER-----LER-  222 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCc-----CCC-
Confidence              112346788999999998899999999999999999999 9999975443221      1111111110     001 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         ....+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               1123457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-40  Score=312.12  Aligned_cols=262  Identities=26%  Similarity=0.384  Sum_probs=202.8

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeee----
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCA----  145 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~----  145 (407)
                      +.+....++|++.+.||+|+||.||+|... ++..+|+|.+.... .....+..|+.+++.+ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            344556789999999999999999999864 57789999775432 2345677899999999 6999999999873    


Q ss_pred             -cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          146 -EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                       .....++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEc
Confidence             34578999999999999998864332335689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCceeeeeeeccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       225 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      |||++........ ......|+..|+|||++..     ..++.++|||||||++|+|++|..||.........      .
T Consensus       167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~------~  239 (286)
T cd06638         167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL------F  239 (286)
T ss_pred             cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH------h
Confidence            9999887643221 1223468999999998753     44788999999999999999999999754332111      1


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ..... .......       ...+...+.++|.+||+.||++|||+.++++.+
T Consensus       240 ~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            11000 0000101       112345688999999999999999999998754

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=308.79  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=210.4

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      |.+++.||+|+||.||+|.++ +|+.+|||.+...  .+..++..|+.++.+++.|++|++||.+.....+|||||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            677889999999999999965 6888999987554  5567888899999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |++.+.+.-+.   .++++.++..+++..++||+|||..   .-+|||||..|||++-+|.+||+|||.|-.+..... .
T Consensus       113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K  185 (502)
T KOG0574|consen  113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K  185 (502)
T ss_pred             CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence            99999998665   6899999999999999999999999   899999999999999999999999999987654332 3


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      ..++.||+.|||||++..-.|+.++||||||++..||..|++||..-.+......+            +  ..+...-..
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------P--T~PPPTF~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------P--TKPPPTFKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------c--CCCCCCCCC
Confidence            45578999999999999999999999999999999999999999765543221111            0  111222223


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +...+.++.+++..||-++|++|-|+-.+++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            5667888999999999999999999988776

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.1e-40  Score=304.21  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=193.8

Q ss_pred             ceecccCceEEEEEEECC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeee-cCCeeEEEEEecc
Q 015395           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEYVN  158 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~  158 (407)
                      +.||+|+||.||+|...+    ...||+|.+... .......+..|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998532    346899987543 3344567788999999999999999999765 4556899999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++....   ...++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999997543   3467888899999999999999999   9999999999999999999999999999765432211


Q ss_pred             e---eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          239 I---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       239 ~---~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .   .....++..|+|||.+....++.++|||||||++|||++| .+||......      ...........      ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~~~~~~~------~~  222 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVYLLQGRR------LL  222 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhcCCC------CC
Confidence            1   1123456789999999888899999999999999999995 6666543321      11222211110      01


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .    ...++..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       223 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 Q----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            1    1123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-40  Score=309.29  Aligned_cols=239  Identities=24%  Similarity=0.417  Sum_probs=189.2

Q ss_pred             eecccCceEEEEEEECC-------------------------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcccee
Q 015395           86 VIGEGGYGIVYYGLLED-------------------------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL  140 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  140 (407)
                      .||+|+||.||+|....                         ...|++|.+..........+..|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         12488888866555555678889999999999999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-
Q 015395          141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-  219 (407)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-  219 (407)
                      ++++.+....++||||+++++|..++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            999999999999999999999999986532   4688999999999999999999999   999999999999997654 


Q ss_pred             ------CcEEeecccceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCchh
Q 015395          220 ------NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVI-SGRIPVDYSRPPEE  291 (407)
Q Consensus       220 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~ell-tg~~Pf~~~~~~~~  291 (407)
                            .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.+.
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                  3799999987644222     12346788999998865 56899999999999999995 69999976544322


Q ss_pred             hhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..   ....   .        ...+..    ....+.++|.+||+.+|++||++.+|++.|.
T Consensus       231 ~~---~~~~---~--------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ER---FYEK---K--------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH---HHHh---c--------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11   1111   0        011111    1235889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-40  Score=321.55  Aligned_cols=263  Identities=24%  Similarity=0.301  Sum_probs=198.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|.+.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999954 5788999988653  233345677899999999999999999987533      3


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||++ ++|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            5799999995 478777753      478899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH-----------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW-----------  297 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-----------  297 (407)
                      ++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+-.           
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98654322  12334689999999999999999999999999999999999999976543322111100           


Q ss_pred             -----HHHHhhcCC-CCC-----cCCC-CCC--CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          298 -----LKKMVTNRN-PEG-----VLDP-KLP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       298 -----~~~~~~~~~-~~~-----~~~~-~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                           +........ ...     .... ..+  ..........+.+||.+||+.||.+|||+.++++.-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence                 000000000 000     0000 000  001111235688999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-40  Score=309.12  Aligned_cols=262  Identities=23%  Similarity=0.397  Sum_probs=203.0

Q ss_pred             CCCCccceecccCceEEEEEEE-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--Cee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  150 (407)
                      ..|++.+.||+|+||.||+|..     .++..||+|.+.... ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478899999999999999973     346789999886543 34456788999999999999999999998765  568


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            99999999999999996542   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------hhhhHHHHHHH
Q 015395          231 LLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--------EEVNLIEWLKK  300 (407)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~  300 (407)
                      ........  ......++..|+|||.+.+..++.++|||||||++|+|++++.|+......        ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76543321  112344677899999998888999999999999999999987765321100        00000111111


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .......       .  .....++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       238 ~~~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKR-------L--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCcc-------C--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111110       0  01123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.2e-40  Score=302.56  Aligned_cols=250  Identities=21%  Similarity=0.355  Sum_probs=201.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec-CCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e  155 (407)
                      +|++.+.||+|++|.||++... +++.||+|.+....  ......+..|+.++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999955 57789999885432  2344567889999999999999999988764 446799999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++.....  ..+++..++.++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999975322  4689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      .. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||......      .......... .     +. 
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~~-~-----~~-  221 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEGK-L-----PP-  221 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcC-C-----CC-
Confidence            22 223345889999999999999999999999999999999999999744321      1111121111 0     01 


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         .....+..+.+++.+||+.||++||++.+++..
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               122355679999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-40  Score=314.20  Aligned_cols=198  Identities=23%  Similarity=0.357  Sum_probs=160.8

Q ss_pred             cceecccCceEEEEEEEC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEEEEEecc
Q 015395           84 DKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYVN  158 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~  158 (407)
                      .+.||+|+||.||+|...   ++..||+|.+....  ....+.+|+.+|++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999854   45789999885442  23456779999999999999999998854  456899999995


Q ss_pred             CCChHHhhhCCCC-----CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE----eCCCCcEEeecccc
Q 015395          159 NGNLEQWLHGDVG-----PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (407)
Q Consensus       159 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGla  229 (407)
                       ++|.+++.....     ....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             588888753211     123589999999999999999999999   99999999999999    45678999999999


Q ss_pred             eecCCCCce--eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 015395          230 KLLGSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSR  287 (407)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~  287 (407)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876543221  1234568999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=306.66  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=205.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||.|+||.||+|... ++..||+|.+.... ......+..|+.+++.++|+||+++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999965 57889999886543 33445678899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...     .+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999999753     689999999999999999999999   99999999999999999999999999998775442


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+...      ....... ..     +.++
T Consensus       153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~~~-~~-----~~~~  219 (274)
T cd06609         153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIPKN-NP-----PSLE  219 (274)
T ss_pred             c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhhhc-CC-----CCCc
Confidence            2 12334578899999999988899999999999999999999999975442211      1111111 11     1111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      .   ..++..+.+++.+||..+|++|||++++++.-
T Consensus       220 ~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         220 G---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             c---cccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence            1   11455689999999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.7e-40  Score=305.33  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=192.7

Q ss_pred             ceecccCceEEEEEEECC---CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           85 KVIGEGGYGIVYYGLLED---NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998543   3568999876543 233457888999999999999999999999988999999999999


Q ss_pred             ChHHhhhCCCC-CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          161 NLEQWLHGDVG-PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       161 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      +|.+++..... .....++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999975322 123467778889999999999999999   99999999999999999999999999987544332211


Q ss_pred             e-eeeeccccccCccccCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          240 T-TRVMGTFGYVAPEYASTG-------MLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       240 ~-~~~~gt~~y~aPE~~~~~-------~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      . ....++..|+|||++.+.       .++.++|||||||++|||++ |..||......+....      .... .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~-~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------TVRE-QQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH------Hhhc-ccCCC
Confidence            1 223567889999988542       35789999999999999996 9999975543322111      1111 11111


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .++...    ...+..+.+++.+|| .+|++|||+++|+..|+
T Consensus       231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111    123345788999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.9e-40  Score=302.44  Aligned_cols=251  Identities=29%  Similarity=0.506  Sum_probs=202.6

Q ss_pred             CCccceecccCceEEEEEEECC-----CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +++.+.||.|+||.||++....     +..||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999653     377999988665433 5667888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999976421  1289999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........++..|+|||.+....++.++|||||||++|+|++ |..||.......      ..........      .
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~~~~------~  223 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEYLKKGYR------L  223 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCC------C
Confidence            43222212236789999999988889999999999999999998 888886533211      1122211111      0


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ..    ....+..+.+++.+||..||++|||+.++++.|
T Consensus       224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11    112456789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-41  Score=313.31  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=210.5

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      =|.+.+.||+|.|..|-+|++ -+|.+||||++.+.+-.  ....+.+|++.|+.++|||||++|.+......+|+|+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            377788999999999999984 47999999999665433  334677799999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~~~  235 (407)
                      -++|+|++||-++.   ..+.+..+.++|.||+.|+.|+|+.   .+|||||||+||++. .-|-|||+|||.+..+.+.
T Consensus        99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999997654   5699999999999999999999999   999999999998874 5689999999998776655


Q ss_pred             CceeeeeeeccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ..  ..+.+|+..|-|||++.+..|+ +++||||||||||.|++|+.||+.....+.+..+               +|=+
T Consensus       173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDCK  235 (864)
T KOG4717|consen  173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDCK  235 (864)
T ss_pred             ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hccc
Confidence            43  4556899999999999998886 5789999999999999999999877665554332               1211


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      +  ..+...++++.+||..||..||.+|.+.++|...-
T Consensus       236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~  271 (864)
T KOG4717|consen  236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS  271 (864)
T ss_pred             c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence            1  23567888999999999999999999999998643

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-41  Score=316.26  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=203.8

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEecc--CChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  150 (407)
                      +.+....|++++.||+||.+.||++...+.+.+|+|++..  ...+....+..|+.+|.+|+ |.+|+++++|-..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            3456677999999999999999999988888899987743  35566678999999999995 99999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |+||||- .-+|..+|....   ..++.-.+..+..|++.++.++|.+   ||||.||||+|+|+-.+ .+||+|||+|.
T Consensus       436 YmvmE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIAN  507 (677)
T ss_pred             EEEeecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhc
Confidence            9999976 569999998764   2344337788999999999999999   99999999999999865 89999999999


Q ss_pred             ecCCCCcee-eeeeeccccccCccccCCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH
Q 015395          231 LLGSESSYI-TTRVMGTFGYVAPEYASTGM-----------LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       231 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  298 (407)
                      .+..+.... ....+||+.||+||.+....           .+.+|||||||||||+|+.|++||.     ...+.+..+
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aKl  582 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAKL  582 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHHH
Confidence            887665443 34578999999999885432           5578999999999999999999996     222333333


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ..+....  .++   .++..+..   .++.++|..||..||.+||++.++|+
T Consensus       583 ~aI~~P~--~~I---efp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPN--HEI---EFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCC--ccc---cccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            3322211  111   22222111   12889999999999999999999997

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=323.83  Aligned_cols=244  Identities=28%  Similarity=0.417  Sum_probs=205.7

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      -|..++.||.|+||.||.|++ .+...||||++.....+   ...++..|++.|+.++|||++.+-|+|......|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            377778899999999999994 46788999999765433   34578889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      || -|+-.|++.-..   .++.+.++..|+.+.+.||+|||+.   +.||||||..|||+++.|.|||+|||.|....+.
T Consensus       107 YC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            99 568888875443   5799999999999999999999999   9999999999999999999999999999887654


Q ss_pred             CceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          236 SSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .     +++|||.|||||++.   .+.|+-++||||||++-.||...++|+-.+      +.+..+..+..+..      
T Consensus       180 n-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNes------  242 (948)
T KOG0577|consen  180 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES------  242 (948)
T ss_pred             h-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcCC------
Confidence            3     468999999999884   467999999999999999999999997533      33444444443322      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         |.....+.+..+..++..||++-|.+|||.++++.
T Consensus       243 ---PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 ---PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ---CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence               22235567788999999999999999999987775

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-40  Score=311.58  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|.+......   ....+..|+++++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999965 4889999988654322   4456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+++|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999987542  24689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCce----------------------------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 015395          235 ESSY----------------------------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS  286 (407)
Q Consensus       235 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~  286 (407)
                      ....                            ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            011235788999999999888999999999999999999999999755


Q ss_pred             CCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC----HHHHHHH
Q 015395          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK----MGHVVHM  351 (407)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~~  351 (407)
                      +....      +.......       ..++.  ....+..+.+++.+||+.||++||+    +++++..
T Consensus       236 ~~~~~------~~~~~~~~-------~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         236 NRDET------FSNILKKE-------VTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             chHHH------HHHHhcCC-------ccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            43221      11111111       01111  1125667999999999999999999    6666663

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-40  Score=308.54  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|++.+.||+|++|.||+|... ++..||+|++....  ......+..|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999965 68889999885432  22345677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +. ++|.+++..... ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            96 689888865321 24689999999999999999999999   99999999999999999999999999997654332


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc-----------
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN-----------  304 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----------  304 (407)
                      . ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||..........  ..+......           
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchhh
Confidence            2 12223568899999988654 57899999999999999999999997554322111  000000000           


Q ss_pred             ----CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          305 ----RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       305 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                          ......... ........++.++.++|.+||+.||++|||+.+|+.
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                000000000 000011224567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.1e-40  Score=304.38  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=201.8

Q ss_pred             CCCccceecccCceEEEEEEECC--CCEEEEEEeccC----------ChhhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLED--NSKVAVKNLLNN----------RGQAEREFKVEVEAIGR-VRHKNLVRLLGYCAE  146 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~  146 (407)
                      +|++.+.||+|+||.||+|....  +..+|+|.+...          .......+..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999664  677999987532          12233456678888865 799999999999999


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999885432223568999999999999999999996 5   899999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ||++.......  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......      ........ 
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~~~-  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIVEA-  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHhhc-
Confidence            99998765443  2234468899999999998889999999999999999999999996433211      11111111 


Q ss_pred             CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...    +    .....++..+.++|.+||+.||++||++.++..+++
T Consensus       229 ~~~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYE----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCC----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            100    0    011123456899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-40  Score=306.32  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=205.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..+|++.+.||+|+||.||+|.+. ++.    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            457889999999999999999854 232    58999776553 3345678889999999999999999999887 7889


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ++|||+.+|+|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            9999999999999997643   4589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCceee-eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ......... ....++..|+|||.+....++.++|+|||||++|||++ |+.||......+..      ... .....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~-~~~~~--  229 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP------DLL-EKGER--  229 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHH-hCCCC--
Confidence            654332211 11223568999999988889999999999999999998 99999765432211      111 11110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         ...+    ..+...+.+++.+||..+|..||++.++++.|..+.+
T Consensus       230 ---~~~~----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ---LPQP----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---CCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               0111    1123458899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.8e-40  Score=308.32  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=202.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++....  ......+..|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999966 57889999885432  2234567789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|..++...    ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99998888877543    4689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH--------HhhcC-
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK--------MVTNR-  305 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--------~~~~~-  305 (407)
                      .. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+.....        ..... 
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            32 1223357889999999866 5588999999999999999999999986554332221110000        00000 


Q ss_pred             CCCCcCCCCCCCC-----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          306 NPEGVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       306 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .......+.....     .....+..+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000000     01223567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.2e-40  Score=303.48  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=203.4

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ++.+.+.+.....||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3455666777789999999999999954 577899998877666667788899999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCC--CHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecccc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPL--TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLA  229 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla  229 (407)
                      +|||+++++|.+++....   ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999997542   234  7888899999999999999999   9999999999999976 678999999998


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ........ ......|+..|+|||.+....  ++.++|+||||+++|+|++|..||..........    .......   
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~~~---  228 (268)
T cd06624         157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGMFK---  228 (268)
T ss_pred             eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhhhc---
Confidence            76543222 122235788999999986543  7889999999999999999999996433211110    0000000   


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         ..+.+    +..+...+.+++.+||+.+|.+|||+.+++..
T Consensus       229 ---~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 ---IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               00111    22345668999999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.4e-40  Score=306.29  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999965 6888999988654 233345788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      +++++|..++.... ....+++..+..++.|++.||.|||+ .   +|+|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999987531 12468999999999999999999996 5   8999999999999999999999999998765322


Q ss_pred             CceeeeeeeccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      .   .....++..|+|||.+.+.      .++.++|+|||||++|+|++|+.||.........   ..+....... .  
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~-~--  227 (286)
T cd06622         157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVDGD-P--  227 (286)
T ss_pred             c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHHHHhhcC-C--
Confidence            1   2233578899999988544      3578999999999999999999999754322211   1111111110 0  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                         +.+    ...++..+.++|.+||+.+|++||++.+++..-
T Consensus       228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         228 ---PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             ---CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence               111    223566789999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.9e-40  Score=307.96  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=202.4

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeec-
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE-  146 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-  146 (407)
                      ++.++..+.+.|++.+.||.|+||.||+|... ++..+|+|.+.... .....+..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34455556678999999999999999999964 57889999875543 3345677899999998 69999999999853 


Q ss_pred             -----CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          147 -----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                           ....+++|||+.+++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence                 4678999999999999999875432  4588888999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH
Q 015395          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~  296 (407)
                      +|+|||++........ ......|+..|+|||.+.     ...++.++|+|||||++|+|++|..||....+.....   
T Consensus       161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---  236 (282)
T cd06636         161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---  236 (282)
T ss_pred             EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence            9999999876532211 122346889999999875     3457889999999999999999999997543321111   


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .....         ..+......++..+.++|.+||..||.+||++.++++
T Consensus       237 ---~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 ---LIPRN---------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---hHhhC---------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               11100         1111112235567999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=320.76  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=196.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|++.....  .....+.+|+.+|+.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            468999999999999999999954 678899998865422  2334567899999999999999999987533      4


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..+++|+++ +++|.+++..     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence            568999988 7899988864     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +......    .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....   +.........
T Consensus       165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~  237 (343)
T cd07878         165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR---IMEVVGTPSP  237 (343)
T ss_pred             ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHhCCCCH
Confidence            9876432    223468999999999876 5689999999999999999999999976443221111   1110000000


Q ss_pred             -----------CCcCC--CCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          308 -----------EGVLD--PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       308 -----------~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                                 ...+.  +..+...    .......+.+|+.+||+.||.+|||+.+++..-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp  299 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP  299 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                       00000  0000000    011223478999999999999999999999753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9e-40  Score=312.29  Aligned_cols=262  Identities=18%  Similarity=0.230  Sum_probs=195.4

Q ss_pred             ccceeccc--CceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           83 DDKVIGEG--GYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        83 ~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++++||+|  +|++||++... ++..||+|++....  ......+..|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999854 68889999886542  334456778999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++.....  ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999965321  3589999999999999999999999   999999999999999999999999986543321111


Q ss_pred             e------eeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc-----
Q 015395          238 Y------ITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN-----  304 (407)
Q Consensus       238 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----  304 (407)
                      .      ......++..|+|||++.+  ..++.++|||||||++|+|++|..||........  ...........     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCcccccccc
Confidence            0      0112246778999999876  4589999999999999999999999975432111  11100000000     


Q ss_pred             ---------CCCCCcCC-----------------CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          305 ---------RNPEGVLD-----------------PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       305 ---------~~~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                               .......+                 ..........+...+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                     00000000                 000011122345678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-39  Score=303.42  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=206.1

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .|+..+.||.|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            5778889999999999999965 57889999876443 344567888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++..     .++++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999864     3588999999999999999999999   999999999999999999999999999977644322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.....      .. .         ...+.
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~-~---------~~~~~  219 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LI-P---------KNNPP  219 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------hh-h---------cCCCC
Confidence             1223457889999999988889999999999999999999999997554322111      00 0         01111


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .....++..+.+++.+||+.+|++||++.+++.....
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            2234566779999999999999999999999876443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.6e-40  Score=300.67  Aligned_cols=247  Identities=26%  Similarity=0.406  Sum_probs=202.2

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +|+..+.||+|+||.||+|... ++..|++|.+....     .+....+..|+.+++.++|+||+++++++.+...++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999966 78899999875533     23456788899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999764    4688999999999999999999999   99999999999999999999999999988764


Q ss_pred             CCCceeeeeeeccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...  ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||.......      ...........     
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-----  220 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL-----  220 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----
Confidence            433  123345889999999987766 8999999999999999999999997543211      11111111111     


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +.+    ...+...+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            111    1223456889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-41  Score=320.70  Aligned_cols=240  Identities=23%  Similarity=0.276  Sum_probs=187.4

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcC---CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ||+|+||.||+|... ++..||+|++.....   .....+..|..++..+   +||||+++++++......++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 588999998854321   1222344466666654   699999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~  152 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T  152 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence            9999998764    5789999999999999999999999   999999999999999999999999999875432221 1


Q ss_pred             eeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          240 TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                      .....||..|+|||++.+. .++.++|||||||++|+|++|..||......+      .........       ..++. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~-------~~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGK-------VRFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCC-------CCCCC-
Confidence            2345689999999998764 48999999999999999999999997543221      122222111       01111 


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCC----CHHHHHH
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRP----KMGHVVH  350 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RP----t~~evl~  350 (407)
                        ..++..+.+++.+||+.||.+||    ++.++++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              12345688999999999999998    4556654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-40  Score=303.19  Aligned_cols=248  Identities=30%  Similarity=0.451  Sum_probs=199.7

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .++|.+.+.||+|+||.||++.. .+..||+|.+....  ....+..|+.+++.++||||+++++++... ..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            35689999999999999999875 47789999875442  345678899999999999999999998764 479999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      .+++|.+++.....  ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            99999999976421  3588999999999999999999999   99999999999999999999999999987643221 


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                         .....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......+.      .... .....     ..  
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~-~~~~~-----~~--  217 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------KECV-EKGYR-----ME--  217 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHH-hCCCC-----CC--
Confidence               11234567999999988889999999999999999998 9999975543221      1111 11110     01  


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                        ....++..+.+++.+||+.+|+.||++.+++..|+.
T Consensus       218 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 --PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              112345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-40  Score=306.88  Aligned_cols=240  Identities=21%  Similarity=0.406  Sum_probs=190.0

Q ss_pred             ceecccCceEEEEEEECC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           85 KVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +.||+|+||.||+|....        ..++|+|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998542        224788877655555556788899999999999999999999998899999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC--------cEEeeccc
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--------PKVSDFGL  228 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~DfGl  228 (407)
                      +.+|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999997653   3689999999999999999999999   9999999999999987765        59999998


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      +......     ....++..|+|||++.+ ..++.++|||||||++|+|++| ..||..........   .    .... 
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---~----~~~~-  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---F----YEDR-  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---H----HHcc-
Confidence            8655332     22357889999999976 4578999999999999999998 46665433221111   1    0110 


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                            ..++.    ....++.+++.+||+.||++|||++++++.|+
T Consensus       222 ------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  11111    12245889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-39  Score=300.77  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=203.5

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVY  154 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~  154 (407)
                      +|++.+.||.|+||.||++... ++..+|+|.+...  .......+..|+.+++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999854 6788999988643  23344567889999999999999999997753  45689999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-----hcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH-----EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      ||+++++|.+++........++++..++.++.|++.||.|||     +.   +++|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999764333467999999999999999999999     77   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ......... .....++..|+|||.+....++.++|+||||+++|+|++|+.||......+   .   . ........  
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~---~-~~~~~~~~--  227 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---L---A-SKIKEGKF--  227 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---H---H-HHHhcCCC--
Confidence            877544321 223468999999999988889999999999999999999999997554211   1   1 11111111  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         +.+    ...++..+.+++.+||+.+|++||++.+|++.
T Consensus       228 ---~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ---RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               111    22345678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.7e-40  Score=305.42  Aligned_cols=262  Identities=24%  Similarity=0.408  Sum_probs=206.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-----CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeec--CCee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  150 (407)
                      .+|.+.+.||+|+||.||+|...     ++..+|+|.+...... ....+..|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999853     3578999988765443 46678899999999999999999999877  5678


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +++|||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999997653   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--------hHHHHHHH
Q 015395          231 LLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--------NLIEWLKK  300 (407)
Q Consensus       231 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~--------~~~~~~~~  300 (407)
                      ..........  ....++..|+|||.+....++.++|||||||++|+|++|..||.........        .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            7753322111  1123456799999998889999999999999999999999998643221100        01111111


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .......       .  .....++.++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~-------~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGER-------L--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCc-------C--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111110       0  01122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=325.07  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=206.3

Q ss_pred             CCCccceecccCceEEEEEEECCCCE-EEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      -|.++..||.|+||+||+|..++... .|.|++........+++..|+++|..++||+||++++.|+..+.+||+.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            46778889999999999999765443 56787777777778899999999999999999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      ||-+...+-.-.   ..+.+.++..+++|++.||.|||++   +|||||||..|||++-+|.++|+|||.+....... .
T Consensus       113 GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-Q  185 (1187)
T ss_pred             CchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-h
Confidence            999988875542   5799999999999999999999999   99999999999999999999999999875433221 1


Q ss_pred             eeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          239 ITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....+.||++|||||+..     +.+|+.++||||||++|.||..+.+|-...++.      .-+.++.... ++.+   
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSe-PPTL---  255 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE-PPTL---  255 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcC-CCcc---
Confidence            245578999999999874     468999999999999999999999997644432      2222222211 1111   


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                          ..+...+..+.+++.+||.+||..||++.++++.-
T Consensus       256 ----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  256 ----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             ----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence                22456677799999999999999999999998743

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.4e-40  Score=304.64  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=197.3

Q ss_pred             eecccCceEEEEEEECC-------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           86 VIGEGGYGIVYYGLLED-------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .||+|+||.||+|...+       +..+|+|.+.... ......+.+|+.+++.++||||+++++++......+++|||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999998542       2468999775543 234557888999999999999999999999989999999999


Q ss_pred             cCCChHHhhhCCCC---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-----CcEEeecccc
Q 015395          158 NNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-----NPKVSDFGLA  229 (407)
Q Consensus       158 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~DfGla  229 (407)
                      ++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999975322   123578999999999999999999999   999999999999999887     8999999998


Q ss_pred             eecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          230 KLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       230 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ......... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+      .......... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~-  231 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQHVTAGGR-  231 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHHHHhcCCc-
Confidence            765432211 1122345678999999999999999999999999999998 999997443221      1111111110 


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                               ......++..+.++|.+||..+|.+||++.++++.|++
T Consensus       232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         232 ---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     01122345678999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=319.88  Aligned_cols=264  Identities=23%  Similarity=0.389  Sum_probs=219.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      .+.|++...+..+-.+||-|.||.||.|.|+. .-.||||.++.+. ...++|+.|+.+|+.++|||+|+++|+|.....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            46788888888999999999999999999774 5569999886654 556788899999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +|||+|||..|+|.+||..-.  ...++....+.++.||+.|++||..+   ++|||||...|+||.++..||++||||+
T Consensus       338 FYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence            999999999999999997532  24577788899999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +++..+.........-...|.|||-+....++.++|||+|||+||||.| |-.||.+-+......++       ..    
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-------Ek----  481 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-------EK----  481 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-------hc----
Confidence            9986654332222223567999999999999999999999999999998 88998765432222222       11    


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                           .+.-..+..|+..+.+||+.||+++|.+||++.|+-+.++.+-
T Consensus       482 -----gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  482 -----GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -----cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                 1212224456678999999999999999999999999888753

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-39  Score=302.67  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=190.6

Q ss_pred             eecccCceEEEEEEECC---CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCC
Q 015395           86 VIGEGGYGIVYYGLLED---NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      .||+|+||.||+|....   ...+|+|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997432   3468888765443 3344567889999999999999999999999999999999999999


Q ss_pred             hHHhhhCCCCC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee-
Q 015395          162 LEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-  239 (407)
Q Consensus       162 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-  239 (407)
                      |.+++...... ....++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999765321 13356788899999999999999999   99999999999999999999999999987543322111 


Q ss_pred             eeeeeccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          240 TTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+      .+........ ....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccCC
Confidence            122345678999998742       456889999999999999999 788886543322      1122221111 1111


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .+..    ...++..+.+++..|| .||++|||+++|++.|.
T Consensus       232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111    2234456778888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.3e-40  Score=307.17  Aligned_cols=261  Identities=27%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecC--
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG--  147 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--  147 (407)
                      .++..+.++|.+.+.||+|+||.||++... ++..+|+|.+.... .....+..|+.+++++ +||||+++++++...  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            334445678999999999999999999964 67889999875432 2345667799999998 799999999998643  


Q ss_pred             ---CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          148 ---AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       148 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                         ...++||||+++++|.++++........+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEe
Confidence               368999999999999998864332335689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCceeeeeeeccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       225 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      |||++......... .....|+..|+|||.+...     .++.++|||||||++|+|++|+.||........      +.
T Consensus       171 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~  243 (291)
T cd06639         171 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LF  243 (291)
T ss_pred             ecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HH
Confidence            99998765432221 2234578899999987543     368899999999999999999999975433211      11


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..... ....+.       ........+.++|.+||+.+|++||++.++++.
T Consensus       244 ~~~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KIPRN-PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHhcC-CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11111 111111       112234568999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.3e-40  Score=306.32  Aligned_cols=248  Identities=24%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......+..|+.++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999854 57789999876443 344457888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999999864     3689999999999999999999999   999999999999999999999999999976643322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+....      .. .....     .+.   
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~~-----~~~---  220 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IPKNS-----PPT---  220 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hhcCC-----CCC---
Confidence             122235788999999999888999999999999999999999998644332111      10 11100     111   


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                       ....++..+.+++.+||+.+|++||++.+++..-
T Consensus       221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         221 -LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence             1223455689999999999999999999999853

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-39  Score=300.99  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=196.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  150 (407)
                      .+|...+.||+|+||.||+|... ++..||+|.+....     ......+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999864 58889999875432     1233467889999999999999999998865  3678


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +++|||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            8999999999999999764    4689999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCc--eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......  .......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......      .+........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~--  226 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT--  226 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC--
Confidence            6543211  11122457889999999998889999999999999999999999997443211      1111111111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .+.+    ...+...+.+++ +||..+|++||++++|+.
T Consensus       227 ---~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ---NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               1111    223445567777 788899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-40  Score=330.01  Aligned_cols=272  Identities=17%  Similarity=0.252  Sum_probs=191.9

Q ss_pred             cCCCCccceecccCceEEEEEEECC--CCEEEEEE--------------e---ccCChhhHHHHHHHHHHHhcCCCCccc
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED--NSKVAVKN--------------L---LNNRGQAEREFKVEVEAIGRVRHKNLV  138 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~--------------~---~~~~~~~~~~~~~E~~~l~~l~hpniv  138 (407)
                      .++|++++.||+|+||.||+|..+.  +..+++|.              +   ..........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987532  21122220              1   011223345678899999999999999


Q ss_pred             eeeeeeecCCeeEEEEEeccCCChHHhhhCCCCC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC
Q 015395          139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (407)
Q Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  217 (407)
                      ++++++...+..+++++++ +++|..++...... ........+..++.||+.||.|||++   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            9999999999999999999 45787777543211 12344667788999999999999999   9999999999999999


Q ss_pred             CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCchhhhHHH
Q 015395          218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPPEEVNLIE  296 (407)
Q Consensus       218 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~P-f~~~~~~~~~~~~~  296 (407)
                      ++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ |.............
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999999987754433333445799999999999999999999999999999999998754 43332222222222


Q ss_pred             HHHHHhhc-CCCCC-------c-----CCC---CCCC-CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          297 WLKKMVTN-RNPEG-------V-----LDP---KLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       297 ~~~~~~~~-~~~~~-------~-----~~~---~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .+...... .....       .     +..   .++. .....++..+.+++.+||+.||.+|||+.|++..-.
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            11111000 00000       0     000   0000 000112345678899999999999999999997433

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-39  Score=301.60  Aligned_cols=252  Identities=24%  Similarity=0.454  Sum_probs=202.3

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      +|+..+.||+|+||.||++.. .++..||+|.+....      ......+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 568889999886432      1234578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeeccccee
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKL  231 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~  231 (407)
                      ||||+++++|.+++...    .++++..++.++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999999764    4689999999999999999999999   999999999999998775 599999999877


Q ss_pred             cCCCCce---eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          232 LGSESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       232 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......   ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........   ........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~---  227 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASAT---  227 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccC---
Confidence            6533211   11234578899999999888899999999999999999999999964433221111   11111110   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                            ........+...+.+++.+||..+|++||++.+++.
T Consensus       228 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 ------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                  011122345567899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.5e-40  Score=303.24  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=190.7

Q ss_pred             eecccCceEEEEEEECCCC---EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCC
Q 015395           86 VIGEGGYGIVYYGLLEDNS---KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      .||+|+||.||++...++.   .+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999854333   45667665433 3445678889999999999999999999999999999999999999


Q ss_pred             hHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc-eee
Q 015395          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-YIT  240 (407)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~  240 (407)
                      |.+++.........+++..++.++.||+.||+|||+.   +++||||||+|||++.++.++|+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976533334567788889999999999999999   999999999999999999999999999864322111 112


Q ss_pred             eeeeccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          241 TRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       241 ~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......+      .+....... .....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKDQ-QVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhhc-ccccCC
Confidence            23457889999998743       245789999999999999997 577886443322      122222111 112222


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      +....    .+...+.+++..|| .+|++||++++|++.|.
T Consensus       232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22222    23456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.6e-40  Score=309.33  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=203.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+.+.||+|+||.||++... .++.||+|.+.....   .....+..|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999965 567899998865432   23346778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999864211


Q ss_pred             CCc--------------eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH
Q 015395          235 ESS--------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       235 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      ...              .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+      ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQ  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence            100              01112357888999999988889999999999999999999999997543321      1222


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ......       ..+.. ...++..+.++|.+||+.||++||++.++++.|+..
T Consensus       228 ~~~~~~-------~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISDDI-------EWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhccc-------CCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            211110       00111 113455689999999999999999987777766653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-39  Score=298.64  Aligned_cols=253  Identities=24%  Similarity=0.425  Sum_probs=209.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||+|++|.||+|... ++..|++|++..... .....+..|+..+.+++|+||+++++++......+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46889999999999999999966 588999998866543 4456788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      +++++|.+++...    ..+++..++.++.|+++||+|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999765    578999999999999999999999 8   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ... .....++..|+|||.+....++.++|+||||+++|+|++|..||........   .+..........      +..
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~------~~~  223 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAICDGPP------PSL  223 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHhcCCC------CCC
Confidence            332 2234578999999999998999999999999999999999999976543111   222222221111      111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         ....++..+.+++.+||..+|++||++.++++.
T Consensus       224 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 ---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               111155679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.9e-40  Score=309.14  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=201.8

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      |.....||+|+||.||++... ++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999854 5788999988666555666788899999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++..     ..+++..++.++.||+.||.|||++   +|+||||||+||++++++.++|+|||++........ .
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~  174 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K  174 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence            999998854     3588999999999999999999999   999999999999999999999999999876543222 1


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|..||.........   ..+..    ..     ...+..  
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~----~~-----~~~~~~--  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRD----NL-----PPRVKD--  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----cC-----CCcccc--
Confidence            23346899999999998888999999999999999999999999754432211   11111    10     111111  


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ....+..+.+++.+||..||.+|||++++++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11234568899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.3e-40  Score=301.79  Aligned_cols=238  Identities=26%  Similarity=0.456  Sum_probs=190.4

Q ss_pred             ceecccCceEEEEEEECCCC-----------EEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           85 KVIGEGGYGIVYYGLLEDNS-----------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999965433           4778876544333 6778889999999999999999999887 778999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-------CcEEeec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-------NPKVSDF  226 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Df  226 (407)
                      |||+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999997653   2689999999999999999999999   999999999999999887       7999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      |++......     ....++..|+|||++...  .++.++|||||||++|+|++ |..||...+..+...   +..    
T Consensus       153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~----  220 (259)
T cd05037         153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ----  220 (259)
T ss_pred             Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh----
Confidence            998865431     123467789999999776  78999999999999999999 588886554222111   111    


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...       ..+...    ...+.+++.+||..+|.+|||+.++++.|.
T Consensus       221 ~~~-------~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH-------RLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC-------CCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000       000000    156889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-39  Score=300.11  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--Cee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  150 (407)
                      .+|++.+.||+|+||.||+|... ++..||+|.+....     ......+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999964 57889999875321     22345778899999999999999999988663  567


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +++|||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999998754    4588899999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ........  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......      ..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~--  226 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPT--  226 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHHHHhcCCC--
Confidence            65432111  1223458889999999988889999999999999999999999997432211      1111111110  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         .+.    .+......+.+++.+||. +|.+||+++++++.
T Consensus       227 ---~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 ---NPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---CCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               111    123455668889999995 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.9e-40  Score=307.69  Aligned_cols=264  Identities=23%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+..|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999975 578899998754322  234567789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|..+....    ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99998888877543    3589999999999999999999999   9999999999999999999999999998876443


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH--------HHhhcC-
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK--------KMVTNR-  305 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~-  305 (407)
                      .. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+....+....        ...... 
T Consensus       154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            32 2233457889999998865 447889999999999999999999997544322111111000        000000 


Q ss_pred             CCCCcCCCCCCCC-----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          306 NPEGVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       306 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .......+.....     ....++..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000000000     01234567999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.9e-40  Score=309.34  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=201.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... .....+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            467889999999999999999854 343    478887765432 3334678899999999999999999998754 467


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +++||+++|+|.+++....   ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            9999999999999987642   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+   ...    .......  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~--  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD----LLEKGER--  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHCCCC--
Confidence            64332211 122335678999999998899999999999999999997 999996543221   111    1111110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         ...+    ..++..+.+++.+||..+|++||++.++++.|..+..
T Consensus       230 ---~~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         230 ---LPQP----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ---CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               0011    1123468899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.3e-40  Score=306.84  Aligned_cols=244  Identities=25%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+....   ......+..|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999965 57889999885432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999999765    5789999999999999999999999   999999999999999999999999999887644


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .    .....+++.|+|||.+.+...+.++||||||+++|+|++|..||......      ..........       ..
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-------~~  216 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGK-------VR  216 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC-------cc
Confidence            3    22345889999999998888999999999999999999999999754421      1111111111       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVH  350 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~  350 (407)
                      ++.    .++..+.+++.+||..||.+|+     ++++++.
T Consensus       217 ~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 FPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            111    1245688999999999999999     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=306.81  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=203.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|.+...  .......+..|+++++.++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999965 5778999987543  23334678889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |++++.+..++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99887776665443    4589999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc----------
Q 015395          236 SSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN----------  304 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----------  304 (407)
                      .........++..|+|||++... .++.++||||||+++|+|++|+.||......+....   .......          
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL---IQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHHhhhcc
Confidence            43223345678899999999888 789999999999999999999999975543322111   1111100          


Q ss_pred             --CCCC--CcCCCCCC----CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          305 --RNPE--GVLDPKLP----EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       305 --~~~~--~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                        ....  ...+...+    ......++..+.++|.+||..+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              0000  00000000    0011123677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-39  Score=305.31  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=203.1

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|++.+.||.|+||.||+|... ++..||+|++....  ......+..|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4888999999999999999964 68889999886543  33446788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      + +++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999986543   4699999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC--------
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP--------  307 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------  307 (407)
                      ........++..|+|||.+.+. .++.++|||||||++|+|++|.+||......+..   ..+.........        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccC
Confidence            2222334688999999988654 4689999999999999999998888654432211   111111100000        


Q ss_pred             ----CCcCCCCCCC----CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 ----EGVLDPKLPE----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ----~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          ..+..+....    .........+.+++.+||+.+|++||++++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0000000000    0011234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-39  Score=302.24  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~  154 (407)
                      ++|+..+.||.|++|.||+|... ++..+|+|.+..... .....+.+|++++++++||||+++++++.+  ...+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999965 577899998865432 345678889999999999999999998854  34789999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988764333335689999999999999999999999   999999999999999999999999999875533


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...   ....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+......... ...+ ...
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~-~~~  231 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMP-NPEL-KDE  231 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCC-chhh-ccC
Confidence            221   2235788999999999889999999999999999999999999765321 111122222222111 1111 111


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .  ......+..+.+++.+||+.+|++|||+.+++..-.
T Consensus       232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence            1  001234567899999999999999999999998443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=302.33  Aligned_cols=255  Identities=32%  Similarity=0.439  Sum_probs=201.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCC------
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA------  148 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~------  148 (407)
                      ..++|++.+.||+|+||.||+|... ++..+++|.+..... ....+..|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3578999999999999999999965 577899998765543 345788899999999 6999999999986544      


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            48999999999999999865432235789999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      +........ ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||.......      .+.....
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~  232 (275)
T cd06608         160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPR  232 (275)
T ss_pred             ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhc
Confidence            876543322 1233458899999998753     346789999999999999999999997433211      1111111


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .. .     +..  .....++..+.++|.+||..||++|||+.++++
T Consensus       233 ~~-~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NP-P-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cC-C-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 0     011  112335667999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.5e-39  Score=297.74  Aligned_cols=248  Identities=24%  Similarity=0.430  Sum_probs=201.6

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|+..+.||+|+||.||++... ++..+|+|.+....  ......+..|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788999999999999999864 67789999886542  33456788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~  235 (407)
                      +++++|.+++.....  ..+++..++.++.|++.+|+|||++   +++|+||||+||++++++ .+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999976421  4589999999999999999999999   999999999999998654 5799999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........      ........ .     ...
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~-~-----~~~  221 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSGT-F-----API  221 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhcC-C-----CCC
Confidence            22  2234578899999999988899999999999999999999999975543221      11111111 0     011


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                          ...++..+.+++.+||+.+|++|||+.++++
T Consensus       222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1124456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-39  Score=305.71  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=205.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++|.+.+.||+|+||.||++... ++..||+|.+..........+..|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57999999999999999999854 67889999886555455567888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++...     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999753     578999999999999999999999   999999999999999999999999999876544332


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      . .....+++.|+|||.+....++.++|+|||||++|+|++|..||...........      ....        .....
T Consensus       171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~--------~~~~~  235 (293)
T cd06647         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN--------GTPEL  235 (293)
T ss_pred             c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcC--------CCCCC
Confidence            1 2234588899999999888899999999999999999999999975443221110      0000        01111


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      .....++..+.++|.+||..+|++||++.+++..-
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            12233556789999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3e-39  Score=298.53  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=203.4

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|.+.+.||+|+||.||+|... ++..|++|.+.....  .....+..|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999854 678899998866544  3567888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999999764    4588999999999999999999999   99999999999999999999999999998765433


Q ss_pred             ceeee---eeeccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          237 SYITT---RVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       237 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .....   ...++..|+|||.+.+..   ++.++||||||+++|+|++|..||.......     .........      
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~------  222 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGAG------  222 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhcC------
Confidence            32211   245788999999997766   8899999999999999999999997543211     111111111      


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ..+.++.  ...+...+.+++.+||+.+|.+||++.+++.
T Consensus       223 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0111221  1223556889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=298.54  Aligned_cols=243  Identities=25%  Similarity=0.284  Sum_probs=201.8

Q ss_pred             HhcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +..++|..+++||+|.||+|.+|+ ..+++.+|||++++...-   ....-..|-++|...+||.+..+-..|+.++.+|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            456789999999999999999999 557888999988765332   2334456899999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+.||.|.-.|.+.    ..+++.....+...|+.||.|||++   +||+||||.+|+|+|.+|++||+||||++-
T Consensus       245 FVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence            999999999998888765    5799999999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      -... .....+++||+.|+|||++.+..|+.++|+|.+|+++|||++|++||...+......++       ...      
T Consensus       318 ~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-------l~e------  383 (516)
T KOG0690|consen  318 EIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-------LME------  383 (516)
T ss_pred             cccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-------Hhh------
Confidence            4332 23456789999999999999999999999999999999999999999755433222221       111      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCC
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP  343 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  343 (407)
                      +-++    +..++.+...|+...|.+||.+|.
T Consensus       384 d~kF----Pr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 DLKF----PRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hccC----CccCCHHHHHHHHHHhhcChHhhc
Confidence            1122    223445678899999999999997

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-39  Score=298.89  Aligned_cols=250  Identities=22%  Similarity=0.388  Sum_probs=203.5

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|++.+.||+|+||.||++... +++.||+|.+...  .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999854 6788999988543  233445788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.+++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999999875421  3578999999999999999999999   99999999999999999999999999998764432


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .. .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||......      +.+........      +.. 
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~------~~~-  221 (256)
T cd08218         156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGSY------PPV-  221 (256)
T ss_pred             hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCCC------CCC-
Confidence            21 22345788999999998888999999999999999999999999743322      11222222111      111 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         ...++..+.++|.+||+.+|++||++.+|++.
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               12345568999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.9e-40  Score=308.13  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      |.....||+|+||.||++... ++..||+|.+..........+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            445567999999999999864 6889999988655545556788899999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|..++..     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ .
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~  173 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K  173 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence            999998754     3589999999999999999999999   999999999999999999999999999875543322 1


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||......+.      +...... ...     .  ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~-~~~-----~--~~~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRLRDS-PPP-----K--LKN  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhcc-CCC-----C--ccc
Confidence            2334689999999999888899999999999999999999999975443221      1111111 000     0  001


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...+...+.+++.+||+.+|.+||++.++++.-.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~  273 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDHPF  273 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence            1123456889999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.6e-40  Score=306.20  Aligned_cols=262  Identities=22%  Similarity=0.332  Sum_probs=197.6

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|++.+.||+|+||.||+|... ++..||+|.+....  ......+..|+.++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999965 68889999885432  22234567799999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +. ++|.+++....   ..+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            96 58888876532   4689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC---------
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN---------  306 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  306 (407)
                      .. .....++..|+|||++.+. .++.++|||||||++|+|++|..||......+.  ....+........         
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhh
Confidence            21 1223578899999988664 478999999999999999999988643332211  1111111110000         


Q ss_pred             -CCCcCCCCCCC-----CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 -PEGVLDPKLPE-----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 -~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       .....-+..+.     .....++..+.+++.+||+.||.+|||+++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence             00000000000     0112345678899999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-39  Score=300.01  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=206.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|+..+.||.|+||.||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36888899999999999999965 57889999886653 34456788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      +.+++|.+++....   ..+++..++.++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999997643   468999999999999999999999 8   9999999999999999999999999998765332


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..   ....++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....+.+........      +.+
T Consensus       155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------~~~  224 (265)
T cd06605         155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP------PRL  224 (265)
T ss_pred             Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC------CCC
Confidence            21   11568889999999999899999999999999999999999996543211 112222222222111      111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         ....++..+.++|.+||..||++|||+.+++..
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               112256679999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-39  Score=299.04  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=206.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||.|+||.||+|... ++..+++|.+.... ......+..|+.+++.++|+||+++++.+......+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999954 57789999886443 33456788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++..... ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999975421 24689999999999999999999999   99999999999999999999999999987665433


Q ss_pred             ce---eeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          237 SY---ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       237 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..   ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||........      +.+..... .     
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~-~-----  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQND-P-----  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCC-C-----
Confidence            22   12334688999999998776 789999999999999999999999975443221      11111111 0     


Q ss_pred             CCCCCC-ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          313 PKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       313 ~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +.+... ....++..+.+++.+||+.||++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111111 12345677899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-39  Score=301.19  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=200.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh----------hhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG----------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      +|.+.+.||.|+||.||+|... ++..+|+|.+.....          ...+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999854 678899998753211          11235778999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999999765    5789999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCce-eeeeeeccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          229 AKLLGSESSY-ITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       229 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      +......... ......|+..|+|||.+....  ++.++|+||||+++|+|++|..||......      ..+.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc
Confidence            8765432211 122345788999999987654  789999999999999999999999643221      1111111111


Q ss_pred             CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                           ....++......++..+.+++.+||..+|+.||++.+|++.
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 -----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 11112222223456779999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-39  Score=303.08  Aligned_cols=254  Identities=25%  Similarity=0.421  Sum_probs=196.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHH-HhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||++... ++..||+|.+.... ......+..|+.. ++.++||||+++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999965 68899999886542 2233445556554 566789999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |++ ++|.+++.........+++..++.++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            995 6888887654333357999999999999999999999742  7999999999999999999999999998865432


Q ss_pred             CceeeeeeeccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          236 SSYITTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ..  .....++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||......     .+.+....... .    
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~----  225 (283)
T cd06617         158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEP-S----  225 (283)
T ss_pred             cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcC-C----
Confidence            11  122457889999998864    45688999999999999999999999643211     11111111110 0    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       +.+   +...++..+.++|.+||..+|++||++.+++..
T Consensus       226 -~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 -PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111   122355679999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-39  Score=307.71  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=159.8

Q ss_pred             cceecccCceEEEEEEEC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee--cCCeeEEEEEecc
Q 015395           84 DKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYVN  158 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~  158 (407)
                      ...||+|+||.||+|...   ++..||+|.+....  ....+.+|+.+++.++||||+++++++.  .....+++|||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999965   34679999875442  2345678999999999999999999885  3567899999995


Q ss_pred             CCChHHhhhCCC-----CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE----eCCCCcEEeecccc
Q 015395          159 NGNLEQWLHGDV-----GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (407)
Q Consensus       159 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGla  229 (407)
                       ++|.+++....     .....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             58887774321     1123588999999999999999999999   99999999999999    45678999999999


Q ss_pred             eecCCCCce--eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 015395          230 KLLGSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYS  286 (407)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~  286 (407)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221  1233468999999999876 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.3e-39  Score=304.07  Aligned_cols=261  Identities=24%  Similarity=0.303  Sum_probs=201.6

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +|.+.+.||+|+||.||+|... +++.||+|.+......     ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999965 6889999998654322     344567799999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+ +++|.+++....   ..+++..++.++.||++||.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999997642   3699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC-------
Q 015395          234 SESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR-------  305 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-------  305 (407)
                      ..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||......+....+   .......       
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI---FEALGTPTEENWPG  229 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH---HHHcCCCchhhhhh
Confidence            43221 222346788999998854 46789999999999999999998888765443221111   1110000       


Q ss_pred             --CCCCcCCCCC-CC----CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 --NPEGVLDPKL-PE----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 --~~~~~~~~~~-~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        .......... +.    ......+..+.++|.+||+.+|++|||+.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              0000000000 00    0112345678999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=318.28  Aligned_cols=244  Identities=25%  Similarity=0.430  Sum_probs=198.5

Q ss_pred             CccceecccCceEEEEEEEC-CCCEEE---EEEecc--CChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe--eEEE
Q 015395           82 SDDKVIGEGGYGIVYYGLLE-DNSKVA---VKNLLN--NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLV  153 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~-~~~~va---iK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lv  153 (407)
                      +...+||+|+|-+||+|.+. +|-.||   +| +..  .......+|..|+.+|+.|+||||+++++++.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk-~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVK-IRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHh-HHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            34578999999999999965 455565   23 211  233445788899999999999999999999987654  8899


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~  232 (407)
                      +|.+..|+|..|+.+.    ..++...+..|++||++||.|||++ .+.|||||||.+||+|+. .|.|||+|+|||..+
T Consensus       122 TEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            9999999999999887    5788999999999999999999998 568999999999999975 589999999999987


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....   ...+.|||.|||||+.. ..|+..+||||||++++||+|+.+||..-.     +..+-.++......+..+-.
T Consensus       197 r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  197 RKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             hccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhc
Confidence            5432   33478999999999886 889999999999999999999999997433     34444555555544433322


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      -+.         .+++++|.+||.. .++|||+.|+|.
T Consensus       268 V~d---------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 VKD---------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             cCC---------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            111         2489999999999 999999999997

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.4e-39  Score=298.59  Aligned_cols=256  Identities=23%  Similarity=0.408  Sum_probs=198.6

Q ss_pred             CCccceecccCceEEEEEEEC----CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC------
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  148 (407)
                      |.+.+.||+|+||.||+|...    .+..||||.+...  .......+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    3578999988654  2334556788999999999999999999875432      


Q ss_pred             eeEEEEEeccCCChHHhhhCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ..++++||+.+++|.+++....  .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875322  1123578999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          227 GLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       227 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |+++........ ......++..|++||.+....++.++|||||||++|+|++ |..||......+.      .......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI------YNYLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH------HHHHHcC
Confidence            999866433211 1122235678999999988889999999999999999999 8899875433211      1111111


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ...      ..    ....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~~------~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRL------KQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcC------CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110      00    112345799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=299.48  Aligned_cols=248  Identities=26%  Similarity=0.429  Sum_probs=200.2

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCC---CCccceeeeeeecCCeeEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .|+..+.||+|+||.||+|.+ .++..||+|.+... .......+..|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477888999999999999996 46888999987654 2334456778999998886   999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999998653     689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.........      ... ...     ..+
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~~~-~~~-----~~~  220 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------MLI-PKS-----KPP  220 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------hcc-ccC-----CCC
Confidence            4322 233468899999998865 45789999999999999999999999754322111      000 000     011


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .++   ...++..+.+++.+||+.||++||++.+++..
T Consensus       221 ~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         221 RLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            111   11245678999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=320.01  Aligned_cols=250  Identities=24%  Similarity=0.381  Sum_probs=208.8

Q ss_pred             CCCCccceecccCceEEEEEEEC--CCC--EEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE--DNS--KVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ++..+.++||+|.||.|++|.|.  +|+  .||||.+...... ...+|.+|+.+|.+|+|||++++||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34667789999999999999976  343  4899999776544 66789999999999999999999999988 778999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||+++.|+|.+.|+.  .....|.......|+.|||.|+.||.++   ++|||||...|+||-....|||+||||.+-++
T Consensus       189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999987  2346788999999999999999999999   99999999999999988899999999999887


Q ss_pred             CCCceeee--eeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          234 SESSYITT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       234 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ..+.....  ...-.+.|+|||.+....++.+||||+|||+||||+| |..||.+......+..++      ..      
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------~~------  331 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------AG------  331 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------cc------
Confidence            65543321  1224568999999999999999999999999999999 899998776544333332      11      


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                          -....+..+++.|++++.+||..+|.+||||..|.+
T Consensus       332 ----erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  332 ----ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ----ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                011123457788999999999999999999999974

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=289.14  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=199.2

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  152 (407)
                      ...++.+.+..||.|+.|.||+++.+ +|...|||.+.... .+...++...+.++... ++|+||+.+|+|..+...+|
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            44566778889999999999999966 57889999997653 44455666677766655 48999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      .||.| ..-+..++....   +++++..+-++...++.||.||..++  +|+|||+||+|||+|+.|++||||||++-++
T Consensus       169 cMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  169 CMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence            99988 435555555433   57999999999999999999998876  9999999999999999999999999998766


Q ss_pred             CCCCceeeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      -+..  ..+...|-+.|||||.+.-   ..|+.++||||||++++||.||..||.+.....     +.+.+..... +  
T Consensus       243 vdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~e-P--  312 (391)
T KOG0983|consen  243 VDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEE-P--  312 (391)
T ss_pred             eccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcC-C--
Confidence            4322  2344568899999999854   358999999999999999999999998654321     2222222211 1  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         +.++.  ...++..+.+++..||.+|+.+||...++++.
T Consensus       313 ---P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 ---PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               11111  22266779999999999999999999999873

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=303.09  Aligned_cols=263  Identities=24%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367999999999999999999965 678899998865432 223456679999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+.+ +|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9974 9999887543   3688999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC------
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE------  308 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------  308 (407)
                      ... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........  ....+..........      
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhh
Confidence            211 122346889999998865 4588999999999999999999999975542111  111111111000000      


Q ss_pred             ---CcCC---CCCCCCc----cHHH--HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          309 ---GVLD---PKLPEKP----TSRL--LKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       309 ---~~~~---~~~~~~~----~~~~--~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         ....   .......    ....  ...+.+++.+||+.+|++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               0000   0000000    0011  256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-39  Score=298.51  Aligned_cols=247  Identities=23%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +|++.+.||.|+||.||+|... ++..||+|.+....   ......+..|+.++++++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999965 58889999886542   2345678889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+.+++|.+++...    .++++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999765    4789999999999999999999999   9999999999999999999999999998876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..  .....|+..|+|||.+....++.++|+||||+++|+|++|..||...........    .......  .    ...
T Consensus       154 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~--~----~~~  221 (258)
T cd05578         154 TL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQETA--D----VLY  221 (258)
T ss_pred             cc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhccc--c----ccC
Confidence            21  2334578899999999888899999999999999999999999986654311111    1111110  0    111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCH--HHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKM--GHVV  349 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~--~evl  349 (407)
                          +...+..+.++|.+||+.||.+||++  .+++
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 ----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                12234678999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-38  Score=297.24  Aligned_cols=247  Identities=25%  Similarity=0.420  Sum_probs=201.4

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      -|++.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3778889999999999999864 67889999875433 233456888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++++|.+++..     ..+++..+..++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999999864     3689999999999999999999999   999999999999999999999999999876644322


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......      ...... ....     +.+  
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~-----~~~--  221 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLIP-KNNP-----PTL--  221 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHHh-cCCC-----CCC--
Confidence             1223457889999999988889999999999999999999999997543211      111111 1111     111  


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ...++..+.+++.+||+.+|.+||++.+++..
T Consensus       222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              12344568899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.7e-39  Score=300.83  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=197.6

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|+..+.||.|+||.||+|... ++..||||.+....  ......+..|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999865 68889999885432  22335678899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +. ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            95 689988865422  4689999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ceeeeeeeccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC----------
Q 015395          237 SYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR----------  305 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----------  305 (407)
                      .. .....++..|+|||.+.+.. ++.++|||||||++|+|+||+.||......+.  ............          
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHH
Confidence            21 12234688999999886644 68899999999999999999999975443221  111111100000          


Q ss_pred             -----CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          306 -----NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       306 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                           .........+ ......+...+.++|.+||+.||.+|||+++++.
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         232 PDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                 0000000000 0001123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8e-39  Score=299.81  Aligned_cols=248  Identities=27%  Similarity=0.380  Sum_probs=201.8

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      .|...+.||+|++|.||++.. .++..+++|.+..........+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455667999999999999985 4678899998866555555667889999999999999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++..     ..+++..++.++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999999876     3589999999999999999999999   999999999999999999999999998875543222 


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+.+.      +...... ...     ...  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~-~~~-----~~~--  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDN-LPP-----KLK--  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhc-CCC-----CCc--
Confidence            12234588999999999888899999999999999999999999975433211      1221111 111     110  


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ....++..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11123456899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-38  Score=301.98  Aligned_cols=249  Identities=27%  Similarity=0.390  Sum_probs=200.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ..|...+.||+|+||.||+|... +++.||+|.+....   ......+..|+.+++.++||||+++++++.+....++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56889999999999999999965 68889999885432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+. |+|.+++....   ..+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 57777775432   4689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ..     ...++..|+|||++.   ...++.++||||||+++|+|++|..||........      ........      
T Consensus       168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~------  230 (307)
T cd06607         168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND------  230 (307)
T ss_pred             CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCC------
Confidence            32     235788999999874   45688999999999999999999999975432211      11111111      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                         .+......++..+.+++.+||..+|++||++.+++.....
T Consensus       231 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  270 (307)
T cd06607         231 ---SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV  270 (307)
T ss_pred             ---CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence               1111223456679999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-38  Score=290.47  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=206.3

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      +|...+.||+|++|.||++... ++..+++|++..........+.+|+.+++.++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999975 678899999877655566788899999999999999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++....   ..+++..++.++.|++.||.+||+.   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999987653   4689999999999999999999998   999999999999999999999999999987655432 


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                       .....++..|+|||.+....++.++|+||||+++|+|++|..||...+......      .... ....     ..+. 
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-~~~~-----~~~~-  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIAT-NGPP-----GLRN-  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHh-cCCC-----CcCc-
Confidence             233468899999999988889999999999999999999999997543221111      1111 1111     1111 


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       ...++..+.+++.+||+.||++|||+.++++.
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             11134568999999999999999999999763

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-38  Score=292.38  Aligned_cols=252  Identities=24%  Similarity=0.410  Sum_probs=207.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|.+.+.||.|+||.||++... ++..+++|++.....  .....+..|+++++.++|||++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999965 688899998865533  4556788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.........+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999976532235799999999999999999999999   99999999999999999999999999998765543


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......|++.|+|||.+....++.++|+||||+++|+|++|..||......      .......... .     ..++
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~~~  224 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQ-Y-----PPIP  224 (258)
T ss_pred             c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCC-C-----CCCC
Confidence            2 233346889999999998888999999999999999999999999754422      1122222111 1     1111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          ..++..+.+++.+||..+|++|||+.++++.
T Consensus       225 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         225 ----SQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                1344568999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=333.33  Aligned_cols=261  Identities=22%  Similarity=0.291  Sum_probs=217.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  146 (407)
                      +.++++..++|.++++||+|+||.|.+++.+ +++.||+|++.+.   ......-|..|-.+|.--+.+.|++++..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4567788899999999999999999999955 5777899988663   33445568889999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ..++|+|||||+||+|..++.+.    ..+++..+..|+..|+.||.-||+.   |+|||||||+|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999999876    5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccC----C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAS----T-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |.+..+..+........+|||-|.+||++.    + +.|+..+|+||+||++||||.|..||...+      +.+...++
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KI  293 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKI  293 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHH
Confidence            999998877777777789999999999984    2 568999999999999999999999997433      34444444


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MGHVVHML  352 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~L  352 (407)
                      +.....-     .+|  ....++.+..+||.+.+. +|+.|..   ++++-...
T Consensus       294 m~hk~~l-----~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  294 MNHKESL-----SFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             hchhhhc-----CCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            4432221     222  123366778888877655 5778887   88877644

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-39  Score=304.16  Aligned_cols=268  Identities=19%  Similarity=0.278  Sum_probs=198.4

Q ss_pred             CCCccceecccCceEEEEEEEC---CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  151 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~  151 (407)
                      +|.+.+.||+|+||.||+|...   ++..||+|.+....   ......+..|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999965   47889999887633   33345667899999999999999999999887  8899


Q ss_pred             EEEEeccCCChHHhhhCCCCCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC----CCCcEEeec
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK----HWNPKVSDF  226 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df  226 (407)
                      +||||+++ +|.+++....... ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 7777765433222 3789999999999999999999999   9999999999999999    899999999


Q ss_pred             ccceecCCCCc--eeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh------hhHHHH
Q 015395          227 GLAKLLGSESS--YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE------VNLIEW  297 (407)
Q Consensus       227 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~  297 (407)
                      |++........  .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........      ......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987644322  11223457889999998866 4588999999999999999999999976543220      000000


Q ss_pred             HHHHhhcC------------CCC----CcCCCCCCCCcc-H------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          298 LKKMVTNR------------NPE----GVLDPKLPEKPT-S------RLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       298 ~~~~~~~~------------~~~----~~~~~~~~~~~~-~------~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      +.......            ...    .......+.... .      .....+.+++.+||+.||++|||+.+++..
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            10000000            000    000011110000 0      233468899999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-38  Score=297.97  Aligned_cols=263  Identities=20%  Similarity=0.246  Sum_probs=196.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467999999999999999999854 688999998865432 223456779999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+. ++|.+++....   ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            995 68877775432   3578888999999999999999999   9999999999999999999999999998764332


Q ss_pred             CceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh-----------
Q 015395          236 SSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-----------  303 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-----------  303 (407)
                      ... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........  ..........           
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhh
Confidence            211 1223578899999998654 578899999999999999999999975543211  1111100000           


Q ss_pred             -cC-CCCCcCCCCCCCCc-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          304 -NR-NPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       304 -~~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                       .. ..........+...     .......+.+++.+||..||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             00 00000000000000     0011346789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.4e-39  Score=303.91  Aligned_cols=266  Identities=25%  Similarity=0.301  Sum_probs=201.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|.+.....  .....+..|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999965 588999998864322  2223456799999999999999999998654  56899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+. ++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999996 58888886542   4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC---CC-
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---NP-  307 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~-  307 (407)
                      ...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.   ......   .. 
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (309)
T cd07845         159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWP  234 (309)
T ss_pred             CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhch
Confidence            543221 122345788999998865 558899999999999999999999998665443322221   111000   00 


Q ss_pred             --------CCcCCCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          308 --------EGVLDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       308 --------~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                              .....+.-+...    ....+..+.++|.+||+.||++|||+.+++..-..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence                    000000000000    01135668899999999999999999999975544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.7e-39  Score=308.71  Aligned_cols=264  Identities=25%  Similarity=0.298  Sum_probs=200.0

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------  147 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------  147 (407)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999954 6889999987543  233345667799999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ...++||||+. ++|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999995 588888753      288899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH------------
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI------------  295 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~------------  295 (407)
                      ++........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+            
T Consensus       164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9987654322  22345788999999999999999999999999999999999999755432211110            


Q ss_pred             HH----HHHHhhcCCC------CCcC----CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          296 EW----LKKMVTNRNP------EGVL----DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       296 ~~----~~~~~~~~~~------~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ..    ..........      ....    .+..........+..+.++|.+||+.||++|||+.+++..-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence            00    0000000000      0000    00000111223456788999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=298.25  Aligned_cols=254  Identities=26%  Similarity=0.361  Sum_probs=206.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .+.|+..+.||+|++|.||+|... ++..+++|.+..... ....+..|+.+++.++|+||+++++++......++++||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            456888999999999999999966 688899998866544 456778899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999998752   3799999999999999999999998   99999999999999999999999999887654332


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+...      ........ ..     .  
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~-----~--  235 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITTKG-IP-----P--  235 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-CC-----C--
Confidence            2 12233578899999999888899999999999999999999999975433211      11111111 10     0  


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ......++..+.++|.+||+.+|..||++.+++....
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence            1112224567899999999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8e-39  Score=300.92  Aligned_cols=264  Identities=22%  Similarity=0.283  Sum_probs=196.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCC-CCccceeeeeeecCCe-----
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAH-----  149 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~-----  149 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|.+.....  .....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999965 688899998754422  23356777999999995 6999999999876555     


Q ss_pred             eEEEEEeccCCChHHhhhCCCCC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFG  227 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfG  227 (407)
                      .+++|||+++ +|.+++...... ...+++..++.++.||+.||.|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 898888654322 24689999999999999999999999   9999999999999998 8899999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+  +. ......
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~--~~-~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI--FK-LLGTPT  232 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HH-HhCCCC
Confidence            98765432211 122346888999998765 45789999999999999999999999765443221111  11 100000


Q ss_pred             C---CCcC-----------CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          307 P---EGVL-----------DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       307 ~---~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .   ....           .+.........++..+.++|.+||..||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   0000           000000011235567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-38  Score=293.15  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=205.1

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|++.+.||+|+||.||++... ++..+|+|.+....  ......+..|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999854 67889999886432  33345677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++.........+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999876433335789999999999999999999999   99999999999999999999999999998765441


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                         .....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+..       .......        .+
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~--------~~  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGK--------YP  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCC--------CC
Confidence               22345788999999999988999999999999999999999999765432111       1111111        11


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       .....+...+.+++.+||..+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             1122456679999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-38  Score=293.73  Aligned_cols=250  Identities=22%  Similarity=0.414  Sum_probs=201.0

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|.+.+.||+|+||.||+|... ++..+|+|.+....  ......+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999965 57889999885432  23345677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC-cEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~DfGla~~~~~~  235 (407)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++. +||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999975432  3579999999999999999999999   9999999999999988864 699999998876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      .. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      .......... .    .+. 
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~----~~~-  222 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQGY-F----API-  222 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhccc-C----CCC-
Confidence            22 122345888999999998888999999999999999999999999744321      1122211111 1    111 


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          ...++..+.+++.+||..+|++|||+.++++.
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                11234568999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.9e-39  Score=301.31  Aligned_cols=265  Identities=25%  Similarity=0.328  Sum_probs=200.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----  148 (407)
                      ...++|++.+.||+|+||.||+|... ++..||+|.+....  ......+..|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            44578999999999999999999965 57889999886432  233346677999999999999999999886544    


Q ss_pred             ------eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          149 ------HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       149 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                            .+++++||+++ +|.+++....   ..+++..++.++.|++.||+|||+.   +|+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999975 7777776542   4689999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+..   ..+...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~---~~~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL---ELISRL  233 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHH
Confidence            99999998765433222222346788999998865 45789999999999999999999999754432222   222222


Q ss_pred             hhcCCCC---CcC--------CCCC-----CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          302 VTNRNPE---GVL--------DPKL-----PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       302 ~~~~~~~---~~~--------~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .......   .+.        +...     .......++..+.+++.+||+.||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111100   000        0000     00001124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.4e-39  Score=300.67  Aligned_cols=261  Identities=23%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv  153 (407)
                      ++|++.+.||.|+||.||+|... ++..+|+|.+.....  .....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46889999999999999999975 578899998864432  2233566799999999999999999998777  889999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+. ++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99996 59999887643   3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc--------
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN--------  304 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--------  304 (407)
                      ..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+   ......        
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI---FKLLGTPTEKIWPG  233 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCchHHHHH
Confidence            43221 2233578899999988654 4689999999999999999999999765543222111   111000        


Q ss_pred             ---------CCCCCcCCCCCCCCccHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          305 ---------RNPEGVLDPKLPEKPTSR-LLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       305 ---------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                               ..........+....... ....+.++|.+||+.+|++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                     000000000000000111 3566889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=297.69  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=198.3

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      |++.+.||.|++|.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999864 68899999886543  223356778999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      + ++|.+++.....  ..+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            4 699999876421  3689999999999999999999999   999999999999999999999999999976543222


Q ss_pred             eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC--------CCC
Q 015395          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--------NPE  308 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~  308 (407)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|..||.........  ...+.......        ...
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhch
Confidence            1 1223468899999987654 5789999999999999999999999765432211  11111000000        000


Q ss_pred             C----cCC--CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 G----VLD--PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .    +..  ..........++..+.++|.+||+.+|.+|||+.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0    000  000001122344678899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=298.65  Aligned_cols=258  Identities=17%  Similarity=0.232  Sum_probs=187.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCC----CEEEEEEeccCChhhH-----------HHHHHHHHHHhcCCCCcccee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDN----SKVAVKNLLNNRGQAE-----------REFKVEVEAIGRVRHKNLVRL  140 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~  140 (407)
                      +..++|.+.+.||+|+||.||+|...++    ..+|+|..........           .....+...+..++|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3456899999999999999999996543    4566664332221111           111223445667789999999


Q ss_pred             eeeeecCC----eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe
Q 015395          141 LGYCAEGA----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID  216 (407)
Q Consensus       141 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~  216 (407)
                      ++++....    ..+++++++ ..++.+.+...    ...++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            98765432    347788887 34676666543    3467888999999999999999999   999999999999999


Q ss_pred             CCCCcEEeecccceecCCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          217 KHWNPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       217 ~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                      .++.++|+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999876432211      1122468999999999999999999999999999999999999998663322


Q ss_pred             hhh---HHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          291 EVN---LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       291 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...   ..+++..+...         ...   ....++.+.+++..||..+|++||++.++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 NLIHAAKCDFIKRLHEG---------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhHHHHHHHhhhh---------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111   11112221111         000   1122466899999999999999999999998763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=297.89  Aligned_cols=261  Identities=25%  Similarity=0.320  Sum_probs=200.3

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeEEEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYE  155 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e  155 (407)
                      |.+.+.||.|+||.||+|... ++..+|+|.+....  ......+..|+.+++.++|+|++++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999966 47889999987653  33445677899999999999999999999887  89999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |++ ++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            996 48988886542   4689999999999999999999999   9999999999999999999999999999877554


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC---CCc-
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EGV-  310 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~-  310 (407)
                      .........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........   +.........   ... 
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVS  230 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhccccc
Confidence            3222233456888999997764 4578999999999999999999999976554322211   1111110000   000 


Q ss_pred             -------CCC--CCC----CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          311 -------LDP--KLP----EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       311 -------~~~--~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                             ...  ..+    ......++..+.+++.+||..+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   000  000    00001125678999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=286.77  Aligned_cols=256  Identities=21%  Similarity=0.275  Sum_probs=206.0

Q ss_pred             cCCCCcc-ceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeec----CCee
Q 015395           78 TNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE----GAHR  150 (407)
Q Consensus        78 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~~  150 (407)
                      +++|.+. ++||-|-.|.|..|.++ ++.++|+|++....     ..++|+++.-.. .|||||.+++++++    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4567663 78999999999999854 78899999775442     334466654444 69999999999864    3567


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeecc
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFG  227 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfG  227 (407)
                      .+|||+|+||.|.+.|..+..  ..+++.++..|+.||+.|+.|||+.   +|.||||||+|+|...   +-.+||+|||
T Consensus       135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            899999999999999987643  5799999999999999999999999   9999999999999964   4568999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .|+.......  ..+.+-|+.|.|||++....|+...|+||+||++|-||+|.+||.......   +.--++..+.... 
T Consensus       210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq-  283 (400)
T KOG0604|consen  210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ-  283 (400)
T ss_pred             cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC-
Confidence            9987544322  344567999999999999999999999999999999999999997544321   1111222222222 


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                           ..+|.......++...++|+.+|..+|.+|.|+.+++..-+.
T Consensus       284 -----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  284 -----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             -----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence                 367778888999999999999999999999999999886553

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-38  Score=299.21  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=200.0

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .|...+.||+|+||.||++... ++..+|+|.+....   ......+..|+.+++.++|||++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4778889999999999999954 67889999886432   2334567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+. |+|.+++....   .++++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            996 57887775432   4689999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          236 SSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                           ....|+..|+|||.+.   ...++.++|||||||++|+|++|..||........      .........      
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~------  241 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES------  241 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhccC------
Confidence                 2235788999999873   45688999999999999999999999865432111      111111111      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                         +......++..+.+++.+||+.+|.+||++.+++..+....
T Consensus       242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence               11112234556899999999999999999999998766543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-38  Score=295.61  Aligned_cols=258  Identities=22%  Similarity=0.288  Sum_probs=195.0

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCccceeeeeeecC--CeeEEEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLVYE  155 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e  155 (407)
                      |++.+.||+|+||.||+|... ++..||+|.+.... .........|+.+++++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999954 67889999886542 222233446888888885 99999999999877  88999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+. ++|.+++....   ..+++..++.++.|++.||.|||+.   +++||||||+||+++. +.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 58888886542   4689999999999999999999999   9999999999999999 99999999999876433


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC--------C
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--------N  306 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~  306 (407)
                      ...  ....++..|+|||.+.. ..++.++|||||||++|+|++|..||...+..+....   ........        .
T Consensus       153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK---IHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH---HHHHcCCCCHHHHHhhc
Confidence            221  22357889999997644 5578899999999999999999999976554332111   11110000        0


Q ss_pred             CCCcCCCCCCCC-------ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPEK-------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .....+...+..       ....++..+.++|.+||+.+|++||++.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000001111110       012356789999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-38  Score=295.25  Aligned_cols=243  Identities=22%  Similarity=0.297  Sum_probs=188.3

Q ss_pred             eecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHH---HHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           86 VIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVE---AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      +||+|+||.||++... ++..+|+|.+.....   .....+..|..   ++...+||||+.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999965 578899998854321   11222333443   3344579999999999999899999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            99999998755    4699999999999999999999999   99999999999999999999999999987554322  


Q ss_pred             eeeeeeccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       .....|+..|+|||.+. +..++.++|||||||++|+|++|..||.........    .+......      ....+  
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~~~--  218 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNVEL--  218 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCcCC--
Confidence             12235899999999886 456899999999999999999999999755432211    11111111      01111  


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L  352 (407)
                        +..++..+.++|.+||+.||.+||     ++.++++..
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence              223456789999999999999999     588887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-39  Score=308.21  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----Cee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|.+... .......+..|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            367999999999999999999854 6889999988543 233445677899999999999999999886543     357


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++++||+. ++|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            99999995 588888754     3689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCce--eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ........  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........   ...+.........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence            75432221  1123467899999998754 5689999999999999999999999975432211   1111111110000


Q ss_pred             C-----------CcCC--CCCCCC----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 E-----------GVLD--PKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ~-----------~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .           ..+.  +..+..    .....+..+.++|.+||+.+|++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0           0000  000000    011234568999999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=291.03  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=198.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC--Cee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  150 (407)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+...     .......+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46899999999999999999954 5888999987432     123345788899999999999999999998654  568


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +++|||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            8999999999999998754    4588999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCc--eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......  .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......      .+.+......  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--  226 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQPT--  226 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCCC--
Confidence            6532111  11123458889999999988889999999999999999999999997443221      1111111110  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .+.    .+..+.+.+.+++.+||. +|..||++.+++.
T Consensus       227 ---~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 ---KPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               111    123455679999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-38  Score=292.32  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=196.9

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||.|+||.||+|... ++..+|+|.+....   ......+..|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 47889999886543   23445788899999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  242 (407)
                      .+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9999765    4589999999999999999999999   99999999999999999999999999998765432  1223


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      ..++..|++||.+....++.++|+||||+++|+|++|..||......    .............     ....+    ..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~-----~~~~~----~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG-----KLEFP----NY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC-----CCCCC----cc
Confidence            46788999999998888999999999999999999999999765421    1122222221110     01111    12


Q ss_pred             HHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                      .+..+.++|.+||..+|++||+     ++++++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2557999999999999999999     777766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=288.42  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=204.0

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +|++.+.||+|++|.||++... ++..|++|.+.....  .....+..|++++++++|||++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 577899998866543  4556788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999999765    5789999999999999999999999   99999999999999999999999999998775543


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .. .....++..|+|||...+..++.++||||||+++|+|++|..||.......      ..........      +.+ 
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~------~~~-  219 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIVQDDH------PPL-  219 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhccCC------CCC-
Confidence            32 223457889999999988888999999999999999999999997443211      1111111110      111 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         ....+..+.+++.+||..+|++||++.+++.
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               1123456889999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.9e-38  Score=287.00  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY  154 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~  154 (407)
                      +|...+.||+|++|.||+|... ++..|++|.+.....  .....+..|+.++++++||||+++++.+...  ...+++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999976 688899998865542  4556788899999999999999999999888  8899999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999999765    3799999999999999999999998   999999999999999999999999999987765


Q ss_pred             CCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... ......++..|+|||.+.....+.++||||||+++|+|++|..||.....     ....+.......        
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--------  220 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSG--------  220 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccC--------
Confidence            4321 12234578899999999888899999999999999999999999975541     111111111100        


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       .........+..+.+++.+||+.||++||++.+++..
T Consensus       221 -~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         221 -EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence             0011122335679999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-38  Score=298.03  Aligned_cols=257  Identities=27%  Similarity=0.401  Sum_probs=196.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|...+.||+|+||.||++... ++..+|+|.+.... ......+..|+.++.++. |+||+++++++......+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35667788999999999999965 57889999886543 344557788999999996 9999999999998889999999


Q ss_pred             eccCCChHHhhhCC-CCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          156 YVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       156 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |+. ++|.++.... ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            985 4655443210 001156899999999999999999999632  899999999999999999999999999876543


Q ss_pred             CCceeeeeeeccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ...  .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....     ...+.+.......      
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------  227 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------  227 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------
Confidence            221  1223578899999998766   68999999999999999999999997433     1112222221111      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .+.+.......++..+.+|+.+||+.+|++|||+++|+..
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112222223456679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-38  Score=294.80  Aligned_cols=244  Identities=24%  Similarity=0.302  Sum_probs=192.9

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||+|+||.||+|... +++.||+|.+....   ......+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 67889999885432   22344566799999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  242 (407)
                      .+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........  ...
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~  153 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG  153 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence            999976532  3689999999999999999999999   999999999999999999999999999876543221  223


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|+.||...........   +.......      ...    ....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~------~~~----~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRTLEM------AVE----YPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhccccc------ccc----CCcc
Confidence            4578899999999888899999999999999999999999975543211111   11111100      011    1122


Q ss_pred             HHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRP-----KMGHVVH  350 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~  350 (407)
                      ++..+.++|.+||+.||.+||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            355689999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.9e-38  Score=340.27  Aligned_cols=262  Identities=27%  Similarity=0.535  Sum_probs=205.7

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ..|...++||+|+||.||+|.. .++..||+|++.......    ..|+..+++++||||+++++++.+....++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4577888999999999999996 478899999886443222    23688899999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.++++       .++|..+..++.|+++||+|||..+..+|+||||||+||+++.++..++. ||........  
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            9999999995       37899999999999999999995545599999999999999998888775 6655433211  


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                         ....+|..|||||++.+..++.++|||||||++|||+||+.||...... .....+|.+...........+++....
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccC
Confidence               1235789999999999999999999999999999999999999643321 223444444333222223333443322


Q ss_pred             --CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          318 --KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       318 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                        ........++.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence              12334556788999999999999999999999999987553

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8e-39  Score=307.03  Aligned_cols=260  Identities=21%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----Cee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (407)
                      ++|.+.+.||+|+||.||+|... ++..||||.+...  .......+..|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            57999999999999999999954 6788999987643  223344567799999999999999999987643     357


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +++|||+. ++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            99999995 6899988754    5699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC---
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN---  306 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  306 (407)
                      ....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+...   .+........   
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~  232 (337)
T cd07858         157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEED  232 (337)
T ss_pred             ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChHH
Confidence            7644321 1233457889999998765 468999999999999999999999997654322111   1111110000   


Q ss_pred             ---------------CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 ---------------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                     .....+..+. .....++..+.++|.+||+.+|++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                           0000000000 0112345678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=291.45  Aligned_cols=244  Identities=24%  Similarity=0.293  Sum_probs=190.4

Q ss_pred             ceecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHH-hcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAI-GRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||.|+||.||+|... +++.||+|.+.....   .....+..|..++ ...+|+||+++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999964 578899998865432   1222334454443 455899999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999999764    4689999999999999999999999   999999999999999999999999999876433     


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||........      ........ .      ..+...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~------~~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRR-I------NWPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcc-c------CCCCcc
Confidence            1223578899999999888889999999999999999999999975443221      11111111 0      011111


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...++..+.+++.+||+.+|++||++..+.+.|.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            1234567999999999999999998766655444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-38  Score=305.44  Aligned_cols=265  Identities=22%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec----CCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~  151 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++....  ......+..|+.+|+.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67999999999999999999954 68899999886542  2334566779999999999999999998753    35689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+. ++|.+++...    ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999995 6899998754    4699999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCce---eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC-
Q 015395          232 LGSESSY---ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (407)
Q Consensus       232 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (407)
                      .......   ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+.   ....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~---~~~g~~~~  233 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL---SVLGSPSE  233 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH---HHhCCChh
Confidence            5433221   1123468899999998865 458899999999999999999999997654432211111   1000000 


Q ss_pred             ----------CCCc---CC--CCCC-CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          307 ----------PEGV---LD--PKLP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       307 ----------~~~~---~~--~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                                ....   ..  ...+ .......+..+.++|.+||+.+|++||++.+++.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence                      0000   00  0000 00012245679999999999999999999999985543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.8e-38  Score=295.48  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=200.3

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      +|++.+.||.|++|.||+|... ++..||+|.+..... .....+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4888999999999999999975 578899998865432 23456677999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      .+ +|.+++..... ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            75 89888865421 24689999999999999999999999   999999999999999999999999999976543222


Q ss_pred             eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC---------CC
Q 015395          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---------NP  307 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~  307 (407)
                      . .....++..|++||.+.+. .++.++|||||||++|+|++|..||...+..+....+   .......         ..
T Consensus       156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI---FRIMGTPTESTWPGISQL  231 (284)
T ss_pred             c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhCCCChhhHHHHhcC
Confidence            1 1233578899999988654 5788999999999999999999999866543322211   1100000         00


Q ss_pred             CCcCCCCCCCC-------ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          308 EGVLDPKLPEK-------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       308 ~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .. .....+..       .....+..+.+++.+||+.||.+||++.++++
T Consensus       232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PE-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ch-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00 00111110       01123566889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-38  Score=296.81  Aligned_cols=246  Identities=26%  Similarity=0.379  Sum_probs=199.5

Q ss_pred             ccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCC
Q 015395           83 DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      ....||+|+||.||++... ++..||+|++..........+.+|+.+++.++|+||+++++++...+..+++|||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3467999999999999864 688899998866555556678889999999999999999999999999999999999999


Q ss_pred             hHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeee
Q 015395          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT  241 (407)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  241 (407)
                      |.+++..     ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus       104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~  174 (292)
T cd06657         104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK  174 (292)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence            9998754     3589999999999999999999999   999999999999999999999999999876543321 122


Q ss_pred             eeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccH
Q 015395          242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS  321 (407)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (407)
                      ...|+..|+|||.+.+..++.++|+||||+++|+|++|..||......+..   ..+....    .     ..+..  ..
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~~~----~-----~~~~~--~~  240 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDNL----P-----PKLKN--LH  240 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhhC----C-----cccCC--cc
Confidence            345889999999998888999999999999999999999999754332211   1111110    0     11100  11


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          322 RLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       322 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .++..+.+++.+||+.+|.+||++.+++..
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            234468899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-38  Score=292.33  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=197.5

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||.|+||.||++... ++..+++|.+.....   .....+..|++++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 488999998865433   3455778899999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc-----
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-----  237 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~-----  237 (407)
                      .+++...    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9999765    4689999999999999999999999   999999999999999999999999999876543311     


Q ss_pred             --eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          238 --YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       238 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                        .......++..|+|||.+.....+.++|+||||+++|+|++|..||......+      ......... .      ..
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~-~------~~  220 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILNGK-I------EW  220 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC-c------CC
Confidence              01223457889999999988889999999999999999999999997554321      112221111 0      11


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      +.  ....+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus       221 ~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11  1113567899999999999999999966666555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.6e-38  Score=296.19  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=203.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  153 (407)
                      ++|.+.+.||+|+||.||+|... ++..||+|++...   .......+..|+.++++++ ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46899999999999999999965 6888999988553   2233456778999999998 99999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999765    4799999999999999999999999   99999999999999999999999999988765


Q ss_pred             CCCc-------------------eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhH
Q 015395          234 SESS-------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL  294 (407)
Q Consensus       234 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~  294 (407)
                      ....                   .......++..|+|||.+....++.++|+||||+++|+|++|..||.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----  229 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----  229 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence            4321                   11223457889999999988889999999999999999999999997554211    


Q ss_pred             HHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH----HHHHH
Q 015395          295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM----GHVVH  350 (407)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~  350 (407)
                        .+.......       ..+    ...++..+.+++.+||+.+|.+||++    +++++
T Consensus       230 --~~~~~~~~~-------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 --TFQKILKLE-------YSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHHHHHhcC-------CCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              112221110       111    12235568999999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=294.66  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=201.6

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      |.+.+.||.|++|.||+|... ++..+++|.+.....  .....+..|+.++++++|+||+++++++..+...+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999964 688899998865432  24457778999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++ +|.+++....   ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||.+........
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            65 8888886642   4789999999999999999999999   999999999999999999999999999987755431


Q ss_pred             eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC---CCcCC-
Q 015395          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EGVLD-  312 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  312 (407)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....   ..........   ....+ 
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhh
Confidence             12224578899999998776 789999999999999999999999976543222111   1111000000   00000 


Q ss_pred             --------CC----CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 --------PK----LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 --------~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                              +.    ........++.++.++|.+||++||.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    00    0001123456789999999999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.4e-38  Score=297.18  Aligned_cols=267  Identities=23%  Similarity=0.298  Sum_probs=196.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  148 (407)
                      .++|++.+.||+|+||.||+|... ++..||||.+....  ......+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999965 58889999885432  222334567999999999999999999876543      


Q ss_pred             --eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          149 --HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       149 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                        ..++||||+. ++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              4599999995 58888876542   3689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCce---eeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          227 GLAKLLGSESSY---ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       227 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |++.........   ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+..+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999866433221   11223578899999988664 47889999999999999999999997655433332222211100


Q ss_pred             hcCCCCCc-----CC-CCCCCCccH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          303 TNRNPEGV-----LD-PKLPEKPTS---------RLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       303 ~~~~~~~~-----~~-~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ........     .+ ...+.....         .....+.++|.+||..||.+|||++++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000000     00 000000000         012456789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=304.16  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC-----eeE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  151 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~  151 (407)
                      +|.+.+.||.|+||.||+|... ++..||+|.+....  ......+..|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4888999999999999999965 48899999886543  344567888999999999999999999987765     789


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ++|||+. ++|.+++...    ..+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999996 5899988765    4799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc--eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC-
Q 015395          232 LGSESS--YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP-  307 (407)
Q Consensus       232 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  307 (407)
                      ......  .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+....   +......... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChh
Confidence            755431  112334578899999999887 789999999999999999999999976653322111   1110000000 


Q ss_pred             ----------CCcCC---CCCC---CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 ----------EGVLD---PKLP---EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ----------~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                .....   ....   .......+..+.++|.+||+.+|++||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                      00000   0000   00011245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.5e-38  Score=293.38  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=197.1

Q ss_pred             CCCccceecccCceEEEEEEEC----CCCEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      +|++.+.||+|+||.||+|...    ++..||+|.+....    ......+..|+.+++.+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999853    57889999886432    22345677899999999 599999999999998999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999764    4688999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ..............|+..|+|||.+...  .++.++||||||+++|+|++|..||.........  ...........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~---  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE---  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhccC---
Confidence            7644332222345688999999998653  4678999999999999999999999643322111  11111111111   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~  350 (407)
                          +..    ...+...+.+++.+||+.||++||     ++.+++.
T Consensus       229 ----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                111    112345688999999999999997     5566654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6e-38  Score=294.14  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             CCCccceecccCceEEEEEEEC----CCCEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      +|.+.+.||+|++|.||++...    ++..||+|.+....    ......+..|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999998843    46789999886432    22334677899999999 599999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+.+++|.+++...    ..+++..+..++.|++++|.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999998754    4689999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ..............|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||........  ............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~---  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK---  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC---
Confidence            75443332233345889999999987655  78899999999999999999999964332211  111112221111   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                          +..    ...+...+.+++.+||+.||++|||+.++.+.|+..
T Consensus       229 ----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 ----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                111    112345688999999999999999999888877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.3e-38  Score=295.35  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|++|.||+|... +++.||+|.+.....  .....+..|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999965 678899998754322  233567789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecccceecCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~  234 (407)
                      |++ ++|.+++.....  ..+++..++.++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            995 588888754421  3467888899999999999999999   9999999999999985 45789999999976543


Q ss_pred             CCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC--
Q 015395          235 ESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL--  311 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  311 (407)
                      .... .....+++.|+|||.+.+ ..++.++|||||||++|+|+||..||......+.....   ........ ....  
T Consensus       156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~-~~~~~~  230 (294)
T PLN00009        156 PVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPN-EETWPG  230 (294)
T ss_pred             Cccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCC-hhhccc
Confidence            2211 122356889999998866 45789999999999999999999999765433221111   11000000 0000  


Q ss_pred             ----------CCCCCCC----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 ----------DPKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ----------~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                .+.....    .....+..+.+++.+||+.+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000000    011234568899999999999999999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=294.04  Aligned_cols=270  Identities=27%  Similarity=0.437  Sum_probs=204.0

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCccceeeeeeecCC----eeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEGA----HRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~----~~~  151 (407)
                      .....+.++||+|.||.||+|... ++.||||++..   +....+..|-++.+.  +.|+||+++++.-....    .++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345677889999999999999987 58999998844   344556667766665  57999999999865444    889


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc------CCCceeccCCCCccEEEeCCCCcEEee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG------LEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      ||++|.+.|+|.+||..+     .++|....+++..+++||+|||+.      +++.|+|||||..||||.++++..|+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999876     699999999999999999999965      367899999999999999999999999


Q ss_pred             cccceecCCCCce-eeeeeeccccccCccccCCCC-CC-----cchhHHHHHHHHHHHHhCCCCCCC-CCCchhh-----
Q 015395          226 FGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGM-LN-----ERSDVYSFGILIMEVISGRIPVDY-SRPPEEV-----  292 (407)
Q Consensus       226 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDiwslG~il~elltg~~Pf~~-~~~~~~~-----  292 (407)
                      ||+|..+...... .....+||.+|||||++.+.. +.     .+.||||+|.+||||+++..-+.. ..+.-..     
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999988654332 123368999999999996642 22     357999999999999987544431 1110000     


Q ss_pred             ----hHHHHHHHHhhcCCCCCcCCCCCCCCc-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCCc
Q 015395          293 ----NLIEWLKKMVTNRNPEGVLDPKLPEKP-TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (407)
Q Consensus       293 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  360 (407)
                          --++.++..+....    ..|.+++.. ......-+.+.+..||+.||+.|.|+.=+.+++..+....+
T Consensus       440 vG~hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             hcCCCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence                01222333322221    223333321 12345668899999999999999999999999998876543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=306.08  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=209.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .+.|.+.+.||+|.|+.|.++.+. ++..||||.+.+...  .....+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456999999999999999999954 688999998866532  33345778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+|.+++|+..+    +.+.+..+..++.|+.+|++|||++   .|+|||||.+||||+.+.++||+|||++.++..
T Consensus       135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999877    5788899999999999999999999   999999999999999999999999999998874


Q ss_pred             CCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .  ....+.+|++.|.|||++.+..| ++.+|+||+|++||.|+.|.+||++....+.....               +..
T Consensus       208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~g  270 (596)
T KOG0586|consen  208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LRG  270 (596)
T ss_pred             c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------eee
Confidence            3  33566789999999999998875 57899999999999999999999976654322111               011


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .+.-  +.-.+.++.++|.++|..+|.+|++++++.+.-+
T Consensus       271 k~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  271 KYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             eecc--cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            1110  1112335788999999999999999999887443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=283.29  Aligned_cols=254  Identities=21%  Similarity=0.324  Sum_probs=209.2

Q ss_pred             cceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEeccCCC
Q 015395           84 DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      .+.||+|+++.|-.|. ..++..+|||++.+...-...++.+|++++...+ |+||++++++|++...+|+|||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3679999999999888 6789999999998877777788889999999995 9999999999999999999999999999


Q ss_pred             hHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC---CcEEeecccceecCCCCc-
Q 015395          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKVSDFGLAKLLGSESS-  237 (407)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~~~~~~~-  237 (407)
                      |...|+.+    ..+++.++.++..+|+.||.|||.+   ||.||||||+|||.....   -+|||||.|..-...... 
T Consensus       163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            99999887    5799999999999999999999999   999999999999997654   479999998764432221 


Q ss_pred             -----eeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------hhhhHHHHHH
Q 015395          238 -----YITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--------EEVNLIEWLK  299 (407)
Q Consensus       238 -----~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~  299 (407)
                           ....+.+|+..|||||+..     ...|+.+.|.||||+|||-||.|.+||.+.=..        .-..-.+.+-
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                 1223457899999999762     345899999999999999999999999764321        1111122222


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .-+..+.      ..+|......++.+..+||...|..|+.+|.++..++.
T Consensus       316 esIQEGk------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  316 ESIQEGK------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHhccC------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            2222221      35677888999999999999999999999999988887

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.6e-37  Score=296.91  Aligned_cols=261  Identities=21%  Similarity=0.288  Sum_probs=193.5

Q ss_pred             ceeccc--CceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEG--GYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ..||+|  +||+||++.+. +++.||+|.+....  ....+.+..|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999964 68999999886432  23346788899999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999876432  3589999999999999999999999   99999999999999999999999998654322111100


Q ss_pred             ------eeeeeccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh---------
Q 015395          240 ------TTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV---------  302 (407)
Q Consensus       240 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  302 (407)
                            .....++..|+|||++.+.  .++.++|||||||++|+|++|..||........  ....+....         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccccc
Confidence                  0111245679999998764  478999999999999999999999975432211  110000000         


Q ss_pred             -----------------------hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          303 -----------------------TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       303 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                                             ............+.......+...+.+|+.+||+.||++|||+.++++.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                                   00000001111111122334667899999999999999999999998743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-37  Score=294.12  Aligned_cols=264  Identities=17%  Similarity=0.202  Sum_probs=194.7

Q ss_pred             CccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      .+.+.+|.|+++.|+++.. ++..||+|++...  .......+..|+.+++.++|+||+++++++.+....+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3444455555555555544 5889999998654  344556788999999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce-
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-  238 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-  238 (407)
                      ++|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+......... 
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          84 GSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999975422  3588999999999999999999999   9999999999999999999999999988755322110 


Q ss_pred             -----eeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc-------
Q 015395          239 -----ITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN-------  304 (407)
Q Consensus       239 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-------  304 (407)
                           ......++..|+|||++..  ..++.++|+|||||++|+|++|..||.......  ...+........       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence                 1122346778999999866  358899999999999999999999997543221  111111100000       


Q ss_pred             ----CCCCC----cCC----CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          305 ----RNPEG----VLD----PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       305 ----~~~~~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                          .....    ..+    ..........+...+.+++.+||..||++|||++++++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence                00000    000    01111223345667899999999999999999999998443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.6e-38  Score=300.24  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=198.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCccceeeeeeec--CCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE--GAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|... ++..+|+|++...  .......+..|+.+++.+ +||||+++++++..  ....+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457899999999999999999965 5788999988542  223334566799999999 99999999998764  34689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+. ++|.+++...     .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999996 5999988653     578899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCce----eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH--------
Q 015395          232 LGSESSY----ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL--------  298 (407)
Q Consensus       232 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--------  298 (407)
                      .......    ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+........        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6443221    2223468899999998754 56789999999999999999999999765433221111000        


Q ss_pred             ----HHHhhcCCCCCcCCCC--CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          299 ----KKMVTNRNPEGVLDPK--LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       299 ----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          ...........+....  ........++..+.++|.+||+.||++|||+.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                0000000000000000  0001111245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-37  Score=286.74  Aligned_cols=243  Identities=22%  Similarity=0.286  Sum_probs=189.9

Q ss_pred             cCCCCcccee--cccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVI--GEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.+  |.|+||.||++... ++..+|+|.+........     |+.....+ +||||+++++++...+..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            4567777776  99999999999954 677889998754321111     22222222 699999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~  232 (407)
                      |||+++++|.+++...    ..+++..++.++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            9999999999999765    3799999999999999999999999   999999999999999998 9999999998866


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....     ...++..|+|||++.+..++.++|||||||++|+|++|..||...... ......+.... ..        
T Consensus       161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~--------  225 (267)
T PHA03390        161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK--------  225 (267)
T ss_pred             CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc--------
Confidence            4332     235789999999999989999999999999999999999999744332 11111111111 10        


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~  350 (407)
                       ..  .....++..+.++|.+||+.+|.+||+ ++++++
T Consensus       226 -~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 -KL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -cC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             00  111245567899999999999999995 688874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-38  Score=324.96  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=188.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeec----------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----------  146 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------  146 (407)
                      ++|+.+++||+||||.||+++.+ ||+.||||++.... ......+.+|+.+|++|+|||||+++..+.+          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            57889999999999999999966 89999999986553 3444567789999999999999998632200          


Q ss_pred             --------------------------------------------------------------------C-----------
Q 015395          147 --------------------------------------------------------------------G-----------  147 (407)
Q Consensus       147 --------------------------------------------------------------------~-----------  147 (407)
                                                                                          +           
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                0           


Q ss_pred             ------------------------------CeeEEEEEeccCCChHHhhhCCCCCCCCC-CHHHHHHHHHHHHHHHHhhh
Q 015395          148 ------------------------------AHRMLVYEYVNNGNLEQWLHGDVGPCSPL-TWEIRMNIILGTAKGLSYLH  196 (407)
Q Consensus       148 ------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~qi~~~L~~LH  196 (407)
                                                    ..+||-||||+..+|.+++..+.    .. .....|+++++|+.||.|+|
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHH
Confidence                                          12478899999988888887652    11 47888999999999999999


Q ss_pred             hcCCCceeccCCCCccEEEeCCCCcEEeecccceecC-----------------CCCceeeeeeeccccccCccccCCCC
Q 015395          197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-----------------SESSYITTRVMGTFGYVAPEYASTGM  259 (407)
Q Consensus       197 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~  259 (407)
                      ++   |||||||||.||+++.++.|||+|||+|....                 .......+..+||.-|+|||++.+..
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99   99999999999999999999999999998721                 01111234568999999999997655


Q ss_pred             ---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccC
Q 015395          260 ---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD  336 (407)
Q Consensus       260 ---~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  336 (407)
                         |+.|+|+||||+||+||+.   ||...     ...+..+..+. ....+..  +.+   .....+ .-..+|..+++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~LR-~g~iP~~--~~f---~~~~~~-~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTNLR-KGSIPEP--ADF---FDPEHP-EEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHhcc-cCCCCCC--ccc---ccccch-HHHHHHHHHhc
Confidence               9999999999999999986   56521     12222222222 2211111  011   222222 24679999999


Q ss_pred             cCCCCCCCHHHHHH
Q 015395          337 PNAQKRPKMGHVVH  350 (407)
Q Consensus       337 ~dp~~RPt~~evl~  350 (407)
                      .||.+|||+.++|.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-37  Score=289.21  Aligned_cols=242  Identities=23%  Similarity=0.332  Sum_probs=188.0

Q ss_pred             eecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHH---HHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           86 VIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVE---VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E---~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|   +..++...||||+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999854 578999998865321   111222333   334555689999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......  
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999988654    5699999999999999999999999   99999999999999999999999999987553322  


Q ss_pred             eeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........    ......      ....++.
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~~~  220 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVELPD  220 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCCCC
Confidence             2234689999999998754 689999999999999999999999976533222111    111111      0111211


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                          .++..+.+++.+||..+|.+||     ++.++++.
T Consensus       221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                2345789999999999999999     88888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=289.84  Aligned_cols=260  Identities=24%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCccceeeeeeecCCe-----
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCAEGAH-----  149 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~-----  149 (407)
                      |++.+.||+|+||.||+|... ++..||+|.+.....  .....+..|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999976 488999998864322  2234455677766655   69999999999987766     


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .+++|||+. ++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999996 589988865422  3589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC---
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN---  306 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  306 (407)
                      ........  .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+....+  +........   
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  230 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI--FDVIGLPSEEEW  230 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH--HHHcCCCChHhc
Confidence            87644322  12234788999999999889999999999999999999999999865543322111  111000000   


Q ss_pred             C------CCcCCCCC---CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          307 P------EGVLDPKL---PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       307 ~------~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .      ........   ...........+.++|.+||+.||++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0      00000000   01112244567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.3e-37  Score=292.04  Aligned_cols=244  Identities=27%  Similarity=0.401  Sum_probs=195.0

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      |...+.||+|+||.||+|... ++..|++|.+....   ......+..|+.+++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999964 57889999886432   23334677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +. ++|.+++....   .++++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++...... 
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-  174 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-  174 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence            95 58888776543   4689999999999999999999999   9999999999999999999999999988643222 


Q ss_pred             ceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                          ....|+..|+|||++.   ...++.++|||||||++|+|++|..||........      +........       
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~-------  237 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNDS-------  237 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCC-------
Confidence                2346888999999984   45688899999999999999999999975433221      112211111       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        +......++..+.+++.+||+.+|.+||++.+++..
T Consensus       238 --~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 --PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              111122334568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-37  Score=293.28  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +.|...+.||+|+||.||+|... ++..+|+|.+...   .......+..|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777889999999999999965 5778999987542   2233456778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+. ++|.+++....   ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 68888775432   4689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .     ....++..|+|||.+.   ...++.++|||||||++|+|++|..||......+      .........      
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~------  230 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------  230 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcC------
Confidence            2     2235788999999874   3567889999999999999999999986433211      111111111      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         .+......++..+.++|.+||+.+|++||++.+++......
T Consensus       231 ---~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             ---CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence               11111224556789999999999999999999999865544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-37  Score=293.13  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=198.0

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (407)
                      .+..++|.+.+.||+|+||.||+|.+.. +..||||.+.... ......+..|+.++.+. .||||+++++++.+....+
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            3456789999999999999999999764 8889999886543 23344556677766666 4999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++|||+. ++|.+++....   ..+++..+..++.|++.||+|||+ .   +|+||||+|+||++++++.+||+|||++.
T Consensus        91 ~v~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEeeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence            9999984 57777765432   468999999999999999999997 5   89999999999999999999999999987


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      .......  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     .+.+........
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~  236 (296)
T cd06618         164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP  236 (296)
T ss_pred             hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC
Confidence            6543222  12234778999999987553    788999999999999999999999643211     111222222111


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                            +..+.  ...++.++.+++.+||..||.+||++.+++....
T Consensus       237 ------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         237 ------PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             ------CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence                  01111  1124557899999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.6e-37  Score=297.79  Aligned_cols=264  Identities=21%  Similarity=0.271  Sum_probs=198.5

Q ss_pred             CCCC-ccceecccCceEEEEEEEC-CCCEEEEEEeccCChhh--------------HHHHHHHHHHHhcCCCCccceeee
Q 015395           79 NGFS-DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA--------------EREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        79 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      ++|. +.+.||.|+||.||+|... ++..||+|++.......              ...+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4578999999999999955 68899999885442221              124678999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      ++......+++|||+. ++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999996 6999998654    4689999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCC-------------ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015395          223 VSDFGLAKLLGSES-------------SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (407)
Q Consensus       223 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~  288 (407)
                      |+|||++.......             ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997664111             0111223467889999988764 478999999999999999999999976554


Q ss_pred             chhhhHHHHHHHHhhcCCCC---Cc--------CCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          289 PEEVNLIEWLKKMVTNRNPE---GV--------LDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~---~~--------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .+...   .+..........   ..        .....+..   .....+..+.+++.+||+.+|++||++++++....
T Consensus       240 ~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        240 IDQLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            32221   111111110000   00        00000000   01123466889999999999999999999997544

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.7e-38  Score=296.26  Aligned_cols=266  Identities=24%  Similarity=0.296  Sum_probs=195.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecC-------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------  147 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-------  147 (407)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+.....  .....+.+|+++++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 578899998854322  2233566799999999999999999987543       


Q ss_pred             -CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          148 -AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                       ..+++||||+. ++|...+....   ..+++..+..++.|+++||+|||++   +|+|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence             34699999995 47777776432   4699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCce----------eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH
Q 015395          227 GLAKLLGSESSY----------ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       227 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~  295 (407)
                      |++.........          ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211          1123457888999998765 45889999999999999999999999765543322211


Q ss_pred             HHHHHHhhcC------CCCC----cCCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          296 EWLKKMVTNR------NPEG----VLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       296 ~~~~~~~~~~------~~~~----~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ..........      ....    ......+..   ........+.+++.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1100000000      0000    000000000   01123356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.9e-38  Score=300.71  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecC----------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG----------  147 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----------  147 (407)
                      ++|.+.+.||.|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67999999999999999999964 5788999998766656667788899999999999999999776543          


Q ss_pred             ----CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCCcE
Q 015395          148 ----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPK  222 (407)
Q Consensus       148 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~k  222 (407)
                          ...++||||+. ++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++ .++.+|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence                35789999996 589888864     3589999999999999999999999   999999999999997 456789


Q ss_pred             EeecccceecCCCCcee--eeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYI--TTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      |+|||++..........  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+.....  +.
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~--~~  233 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI--LE  233 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH
Confidence            99999998664322111  122357889999997654 56888999999999999999999999765432221111  00


Q ss_pred             HHhhc----------CCCCCcC-CCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          300 KMVTN----------RNPEGVL-DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       300 ~~~~~----------~~~~~~~-~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .....          ....... ....+...    ...+..++.+++.+||+.||.+|||+.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000          0000000 00000000    11244678899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=292.15  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=207.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCC-C-C----ccceeeeeeecCC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-H-K----NLVRLLGYCAEGA  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~~~~~~~~~~  148 (407)
                      .-.++|.+++.+|+|.||.|..|.+.. +..||||+++.-. ...+....|+++|.++. + |    -++++.++|...+
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            336889999999999999999998653 5789999775543 33345566999999993 2 2    4688889999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-----------
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-----------  217 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----------  217 (407)
                      +.|||+|.+ |.++.+++..+.  ..+++...+..++.|++++++|||+.   +++|.||||+|||+.+           
T Consensus       165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            999999998 779999997653  46899999999999999999999999   9999999999999941           


Q ss_pred             ---------CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015395          218 ---------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (407)
Q Consensus       218 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~  288 (407)
                               +..+||+|||.|++.....    ...+.|..|+|||++.+-.|+.++||||+||||+|+.||..-|.....
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                     2348999999999876554    446679999999999999999999999999999999999999998887


Q ss_pred             chhhhHHHHHHHHhhcCCCCC----------cCC---------------CCCCC----CccHHHHHHHHHHHHHccCcCC
Q 015395          289 PEEVNLIEWLKKMVTNRNPEG----------VLD---------------PKLPE----KPTSRLLKRILLVALRCVDPNA  339 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~----------~~~---------------~~~~~----~~~~~~~~~l~~li~~cl~~dp  339 (407)
                      .|.+..++.+.+.........          -+|               +..+.    ......-..|.+|+.+||..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            666655444332111110000          001               00000    0112233568999999999999


Q ss_pred             CCCCCHHHHHHHH
Q 015395          340 QKRPKMGHVVHML  352 (407)
Q Consensus       340 ~~RPt~~evl~~L  352 (407)
                      .+|+|+.|+++.-
T Consensus       395 ~~RiTl~EAL~Hp  407 (415)
T KOG0671|consen  395 ARRITLREALSHP  407 (415)
T ss_pred             cccccHHHHhcCH
Confidence            9999999998743

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=288.05  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHh--cCCCCccceeeeeeecC----CeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIG--RVRHKNLVRLLGYCAEG----AHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~~~~~~~~~----~~~~  151 (407)
                      ..+..+.+.||+|.||.||+|.++ |..||||++....   ++...+|.++..  .|+|+||+.+++.-...    ..+|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            457889999999999999999998 8899999885543   233344555554  46999999999875322    3679


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-----CCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG-----LEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ||++|.+.|+|+|||...     .++....++++..+|.||+|||..     .++.|.|||||..||||..++...|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999874     699999999999999999999964     4788999999999999999999999999


Q ss_pred             ccceecCCCCce---eeeeeeccccccCccccCCCC------CCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 015395          227 GLAKLLGSESSY---ITTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISG----------RIPVDYSR  287 (407)
Q Consensus       227 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwslG~il~elltg----------~~Pf~~~~  287 (407)
                      |||.........   .....+||.+|||||++....      .-..+||||||.++||+..+          .+||.+..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            999876544322   123468999999999985432      22468999999999999762          57887654


Q ss_pred             CchhhhHHHHHHHHhhcCCCCCcCCCCCC-CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      +.+..  .+.+++.+-.....    |..+ ..........+.++|..||..||..|.|+-.|-+.|.++..
T Consensus       441 p~DPs--~eeMrkVVCv~~~R----P~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPS--FEEMRKVVCVQKLR----PNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCC--HHHHhcceeecccC----CCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            43321  22334433333222    2222 22345677889999999999999999999999999987754

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.9e-37  Score=286.14  Aligned_cols=251  Identities=19%  Similarity=0.318  Sum_probs=196.5

Q ss_pred             CCCccceecccCceEEEEEEECC-CCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +|.+.+.||+|+||.||++.... +..+++|.+...     .......+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998653 344555554321     222334566789999999999999999999998999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865333335799999999999999999999999   9999999999999976 569999999987764


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...........      .+
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~------~~  223 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVEGP------TP  223 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHcCC------CC
Confidence            3322 12234578899999999888899999999999999999999999964322      11122221111      01


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..    ...++..+.++|.+||..+|++||++.++++.
T Consensus       224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            11    23455678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=333.14  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=203.7

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++.-...||.|.||.||.|.. .+|.-.|+|.+....  ......+.+|+.+|..++|||+|+++|+-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            466778899999999999994 467788999775433  33344677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      |++|+|.+.+...    ...++.....+..|++.|++|||++   |||||||||+||+++.+|.+|++|||.|..+....
T Consensus      1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999765    3567777788999999999999999   99999999999999999999999999998876553


Q ss_pred             cee---eeeeeccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          237 SYI---TTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       237 ~~~---~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ...   ....+||+.|||||++.+..   ...++||||||||+.||+||+.||...+.     ..+-+.+....+.    
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V~~gh~---- 1459 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHVAAGHK---- 1459 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHHhccCC----
Confidence            222   23457999999999997643   56789999999999999999999974443     2333344333322    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        |.+    +..++.+-.+++.+||+.||.+|+++.++++.
T Consensus      1460 --Pq~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --PQI----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --CCC----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence              222    22377788999999999999999999887764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=286.22  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=197.5

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEec
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      |.+.+.||+|+||.||+|... +++.|+||.+..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999975 477899998765432 22234456899999999 999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                       +++|.+++....  ...+++..++.++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             789999887643  13689999999999999999999999   999999999999999999999999999987644322


Q ss_pred             eeeeeeeccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH----------HHHHhhcCC
Q 015395          238 YITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW----------LKKMVTNRN  306 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~~  306 (407)
                        .....++..|+|||++. ...++.++|+||||+++|+|++|+.||......+.......          .........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              22345788999999874 45578999999999999999999999976654332211110          000000000


Q ss_pred             CCCcCCCCCCC---CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ....+......   .........+.+++.+||+.+|++|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000   0001113568999999999999999999998753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=309.29  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=213.9

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeee---
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCA---  145 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~---  145 (407)
                      +..+....+.|++.+.||.|.+|.||++. .++++.+|+|+..... ...+++..|.++|+.+ .|||++.+++++.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            33444556789999999999999999999 4568888999775544 3345667789999888 5999999999985   


Q ss_pred             --cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEE
Q 015395          146 --EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (407)
Q Consensus       146 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  223 (407)
                        .++.+|||||||.+|+..+++++-.  ...+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.|||
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence              3578999999999999999998766  36799999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCceeeeeeeccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH
Q 015395          224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       224 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  298 (407)
                      +|||++..+...... ..+..||+.|||||++.+.     .|+..+|+||||++..||--|.+|+.++.+...+..+   
T Consensus       165 vDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---  240 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---  240 (953)
T ss_pred             eeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence            999999887655443 3446799999999999654     3778999999999999999999999877664322111   


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .        ..|......+...++++.++|..||.+|.++||++.++++
T Consensus       241 ---p--------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 ---P--------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---C--------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               1        1233333446778899999999999999999999998886

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-37  Score=296.10  Aligned_cols=265  Identities=22%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecC-
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-  147 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-  147 (407)
                      ..+....++|.+.+.||+|+||.||+|.. .++..||+|++....  ......+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34445668899999999999999999985 468889999886532  22345677899999999999999999987532 


Q ss_pred             -----CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          148 -----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       148 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                           ...+++++++ +++|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence                 3468888887 7899988864     3589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+   ...
T Consensus       161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~  233 (345)
T cd07877         161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRL  233 (345)
T ss_pred             Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHH
Confidence            9999998765322    223457889999998866 56889999999999999999999999754432211111   000


Q ss_pred             hhcCCCCCcCC--------------CCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          302 VTNRNPEGVLD--------------PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       302 ~~~~~~~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .... ...+..              +..+...    ....+..+.++|.+||+.||.+||++.+++..-.
T Consensus       234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         234 VGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             hCCC-CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            0000 000000              0000000    0112456889999999999999999999987543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.4e-37  Score=294.60  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=197.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec-CCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  152 (407)
                      ..++|.+.+.||.|+||.||+|... ++..||+|++...  .......+..|+.+++.++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            5678999999999999999999855 6889999987543  22334567789999999999999999998865 567899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +|||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++...
T Consensus        88 v~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          88 VTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             Eeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            99999 6689988864     3578888899999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH--------HHHhh
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL--------KKMVT  303 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~  303 (407)
                      ....    ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...        .....
T Consensus       159 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         159 DPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            3321    22356889999998765 56899999999999999999999999765432211111100        00000


Q ss_pred             cCCCCCcC-----CCCCCC-CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          304 NRNPEGVL-----DPKLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       304 ~~~~~~~~-----~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ......+.     ....+. .....++..+.++|.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000     000000 0011234678999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-37  Score=295.30  Aligned_cols=264  Identities=22%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|++....  ......+..|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999954 68899999886432  22334577899999999999999999988644      3


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++|+||+. .+|..++.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            5699999995 47777653      3588999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH--------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK--------  299 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------  299 (407)
                      +......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+....        
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            8765332    123357889999999866 468899999999999999999999997654322111110000        


Q ss_pred             HHhhcCCCCCcC--CCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHhc
Q 015395          300 KMVTNRNPEGVL--DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM--LEAQ  355 (407)
Q Consensus       300 ~~~~~~~~~~~~--~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~  355 (407)
                      ............  .+..+...    .......+.++|.+||+.||.+||++.+++..  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            000000000000  00000000    01234568899999999999999999999853  4443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.9e-37  Score=292.21  Aligned_cols=262  Identities=23%  Similarity=0.289  Sum_probs=192.5

Q ss_pred             CCCccceecccCceEEEEEEEC-C--CCEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCccceeeeeeec----CCe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-D--NSKVAVKNLLNN--RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE----GAH  149 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~  149 (407)
                      +|.+.+.||+|+||.||++... .  +..||+|.+...  .......+..|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999965 3  678999987643  222345677899999999 59999999987532    245


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++++||+. ++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788999985 6899988654    5689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCce---eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH---------
Q 015395          230 KLLGSESSY---ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE---------  296 (407)
Q Consensus       230 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~---------  296 (407)
                      .........   ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.         
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            866432211   1123468999999998765 568999999999999999999999997644221111000         


Q ss_pred             HHHHHhhc------CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          297 WLKKMVTN------RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       297 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .+......      ..........+. .........+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000      000000000000 001112456889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=304.08  Aligned_cols=266  Identities=26%  Similarity=0.410  Sum_probs=200.8

Q ss_pred             CCccceecccCceEEEEEE-ECCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC------eeEE
Q 015395           81 FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRML  152 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~l  152 (407)
                      +...+.||+|+||.||+++ ..+|+.||||.+.... ....+....|+++|++++|+|||+++++-+...      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            5566789999999999999 5579999999886643 233445667999999999999999999865433      5689


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC--CCC--cEEeeccc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWN--PKVSDFGL  228 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~--~kl~DfGl  228 (407)
                      |||||.||+|...+....+ +..+++.+.+.+..+++.||.|||++   +|+||||||.||++-.  +|+  -||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999987543 35699999999999999999999999   9999999999999943  333  69999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      |+-++.+.  ...+.+||..|++||++.. ..|+..+|.|||||++|+..||..||.....+.....+  +....... +
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~--~~~~~tkk-p  245 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI--MWHIITKK-P  245 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh--hhhhhccC-C
Confidence            99887665  5677899999999999984 88999999999999999999999999765543221111  11111111 1


Q ss_pred             CCc-------------CCCCC--CCCccHHHHHHHHHHHHHccCcCCCCCC--CHHHHHHHHHhc
Q 015395          308 EGV-------------LDPKL--PEKPTSRLLKRILLVALRCVDPNAQKRP--KMGHVVHMLEAQ  355 (407)
Q Consensus       308 ~~~-------------~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RP--t~~evl~~L~~~  355 (407)
                      ..+             ....+  +..........+-..+..+|..+|.+|.  .+.+....+..+
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            000             00111  2222334445566667778888999998  655555544443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=286.58  Aligned_cols=259  Identities=25%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      |+..+.||+|++|.||+|... +++.+|+|.+....  ......+..|+.+++.++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999965 58899999886653  333456778999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      . ++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 59999997642   3689999999999999999999999   999999999999999999999999999987644322


Q ss_pred             eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC----------
Q 015395          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN----------  306 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------  306 (407)
                      . .....++..|+|||.+... .++.++|||||||++|+|++|..||......+....+   ........          
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI---FQILGTPTEESWPGVTKL  229 (282)
T ss_pred             c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HHHhCCCcHHHHHhhccc
Confidence            1 2223457789999998766 7899999999999999999999999765432221111   11100000          


Q ss_pred             --CCCcCCC---CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          307 --PEGVLDP---KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       307 --~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                        .......   ..........+..+.+++.+||..||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000000   0000111123567999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=288.39  Aligned_cols=246  Identities=24%  Similarity=0.314  Sum_probs=201.6

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  149 (407)
                      ++...+|..+.+||+|+||+|.++..+ +...+|||++++..   ..+.+--..|-++|+... -|.+++++.+|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            445568999999999999999999855 45669999886652   222233345777787664 6799999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +|+||||+.||+|--.|+..    +.+.+..+..++.+|+-||-|||++   ||++||||.+|||++.+|++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999998888765    6788999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +---.. .....+++||+.|+|||++...+|+.++|+||+|++|||||.|++||++.+..+..+.+      . ..+   
T Consensus       498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------~-ehn---  566 (683)
T KOG0696|consen  498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------M-EHN---  566 (683)
T ss_pred             cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------H-Hcc---
Confidence            743222 22356689999999999999999999999999999999999999999977654433222      1 111   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                             ..++..++++..+++...|.++|.+|...
T Consensus       567 -------vsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  567 -------VSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence                   23455677788899999999999999744

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=313.32  Aligned_cols=265  Identities=30%  Similarity=0.500  Sum_probs=214.0

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC----C----CCEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCccceeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE----D----NSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLG  142 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~  142 (407)
                      .+++..++..+.+.||+|.||.|++|...    .    ...||||.+..... .....+..|+.+|+.+ .|+||+.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            56777777888889999999999999832    1    34589998876543 4556788999999999 5999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCC---C-------CC--CCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCC
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDV---G-------PC--SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  210 (407)
                      ++...+..++|+||+..|+|..++...+   .       ..  ..++..+.+.++.|||.|++||++.   +++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998765   0       01  1389999999999999999999999   999999999


Q ss_pred             ccEEEeCCCCcEEeecccceecCCCCceeeeeeec--cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSR  287 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~  287 (407)
                      +|||+..+..+||+|||+|+..............|  ...|||||.+....|+.+|||||||++||||+| |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999765544443332223  345999999999999999999999999999999 899997633


Q ss_pred             CchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ..+..  .++++    .+.         ....+..+..++.++|..||+.+|++||++.++.+.++..
T Consensus       527 ~~~~l--~~~l~----~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEEL--LEFLK----EGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHHH--HHHHh----cCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            22221  22222    111         1112334567799999999999999999999999999984

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=278.99  Aligned_cols=236  Identities=27%  Similarity=0.340  Sum_probs=192.8

Q ss_pred             ecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        87 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ||.|+||.||++... ++..+|+|.+.....   .....+..|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 588899998865432   2445778899999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  242 (407)
                      .+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence            9999765    4689999999999999999999998   999999999999999999999999999987644321 1233


Q ss_pred             eeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      ..++..|++||.+.+...+.++|+||||+++|+|++|..||......      ..........       ..++    ..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~-------~~~~----~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKILKDP-------LRFP----EF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhcCC-------CCCC----CC
Confidence            45788999999998888999999999999999999999999644321      1112221110       1111    11


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRPKMGH  347 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPt~~e  347 (407)
                      .+..+.+++.+||..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2456889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-37  Score=294.81  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe-----
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  149 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|++...  .......+..|+.+++.++||||+++++++.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            567999999999999999999965 5788999987543  22233556779999999999999999988765544     


Q ss_pred             -eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          150 -RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       150 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                       .++|+||+ +++|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence             89999999 6799999875     3689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC-
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (407)
                      +......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+   ........ 
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i---~~~~~~~~~  237 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI---MNLVGTPDE  237 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHhcCCCCH
Confidence            9865432    223357889999998865 46789999999999999999999999765432221111   11000000 


Q ss_pred             -----------------CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 -----------------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                       ........+.. .....+..+.++|.+||+.+|.+|||+.+|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                             00000000000 001235678999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-36  Score=314.62  Aligned_cols=146  Identities=29%  Similarity=0.414  Sum_probs=131.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++....   ......+..|+.+++.++||||+++++++.....+|||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            467999999999999999999966 68889999886432   23345678899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |||+.+++|.+++...    ..+++..++.++.||+.||.|||..   +|+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999764    4688999999999999999999999   99999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-36  Score=292.83  Aligned_cols=260  Identities=22%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC-----
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----  148 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  148 (407)
                      ..++|.+.+.||+|+||.||++... ++..||||.+....  ......+..|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3567999999999999999999854 68899999885432  223446778999999999999999999886543     


Q ss_pred             -eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          149 -HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       149 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                       .+++||||+ +++|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             458999999 7799988864     3689999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH---------HH
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---------EW  297 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~---------~~  297 (407)
                      ++.......    ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+         .+
T Consensus       164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            987654321    22357889999998866 45889999999999999999999999755432111100         00


Q ss_pred             HHHHhhc------CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          298 LKKMVTN------RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       298 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .......      ..........+ ......+...+.++|.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000      00000000000 0001123446889999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-37  Score=274.63  Aligned_cols=276  Identities=18%  Similarity=0.266  Sum_probs=201.6

Q ss_pred             cCCCCccceecccCceEEEEEEE-CC----CCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeec-CCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-ED----NSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  149 (407)
                      ...|+.++.||+|.||.||+|.. ++    ...+|||++...+.  .......+|+.+++.++||||+.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            45799999999999999999963 22    22589998865422  222344569999999999999999999877 788


Q ss_pred             eEEEEEeccCCChHHhhhCCCCC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC----CCcEEe
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVS  224 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~  224 (407)
                      +++++||++. +|.+.|+-.... ...++...+..|+.||+.|+.|||++   -|+||||||+||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence            9999999966 899998654332 24688899999999999999999999   99999999999999877    899999


Q ss_pred             ecccceecCCCCcee--eeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCch------hhhHH
Q 015395          225 DFGLAKLLGSESSYI--TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPE------EVNLI  295 (407)
Q Consensus       225 DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~------~~~~~  295 (407)
                      |||+++.+...-...  ...++-|.+|+|||++.+. .|+.+.|||+.|||+.||||-.+-|.+....-      ..+-.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999887654432  3456789999999998775 58999999999999999999988886543211      11112


Q ss_pred             HHHHHHhhcCCC---CCcCC-C-------CCCCCccHH------------HHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          296 EWLKKMVTNRNP---EGVLD-P-------KLPEKPTSR------------LLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       296 ~~~~~~~~~~~~---~~~~~-~-------~~~~~~~~~------------~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ..+.........   +.+.. |       .+...+...            -+..-.+|+.++|..||-+|.|++++++..
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            222222211110   00000 0       000000000            011256899999999999999999999866


Q ss_pred             HhccC
Q 015395          353 EAQES  357 (407)
Q Consensus       353 ~~~~~  357 (407)
                      -....
T Consensus       339 yF~~d  343 (438)
T KOG0666|consen  339 YFTED  343 (438)
T ss_pred             ccccC
Confidence            55544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=252.25  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=205.6

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .|...+.||+|.||+||+|+.. +++.||+|.+....  ........+|+.+|+.++|.|||+++++......+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3556678999999999999954 57789999886543  22334567799999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      | ..+|..|...-.   +.+..+.+..++.|+++||.|+|++   ++.||||||.|+||+.+|.+||+|||+++-++-.-
T Consensus        83 c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             h-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9 568888876543   5688999999999999999999999   99999999999999999999999999999876554


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc---C
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV---L  311 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  311 (407)
                      .. ....+-|.+|.+|.++.+. .|+.+.|+||.|||+.|+.. |++-|.+.+..+....+-++.........+.+   -
T Consensus       156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            33 3344679999999998764 58999999999999999987 77778776655555555444444443333222   1


Q ss_pred             CCCC----CCC-ccHH----HHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          312 DPKL----PEK-PTSR----LLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       312 ~~~~----~~~-~~~~----~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      |...    +.. ...+    +...=++|+++.|.-+|..|.++++.++.-
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            1111    111 1112    223346888899999999999999887643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-37  Score=294.51  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=195.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ....-|..++.||-|+||.|.++...+ ...+|+|.+.+..   ......+..|..||..-+.+.||++|..|.+++.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            455568899999999999999999554 5568999886543   223345677999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||+|++||++-.+|.+.    +.+.+..++.++.++..|+++.|..   |+|||||||+|||||.+|++||+||||+.-
T Consensus       706 FVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             EEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccc
Confidence            999999999999999876    6799999999999999999999999   999999999999999999999999999853


Q ss_pred             cC---------CCCc--------------------------------eeeeeeeccccccCccccCCCCCCcchhHHHHH
Q 015395          232 LG---------SESS--------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFG  270 (407)
Q Consensus       232 ~~---------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG  270 (407)
                      +.         ..+.                                ......+||+.|+|||++....|+..+|+||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            30         0000                                001234799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC
Q 015395          271 ILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP  343 (407)
Q Consensus       271 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  343 (407)
                      ||||||+.|+.||-..++-+....+.         +....++    ..+...++++..+||.+++ -+++.|.
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~---------nw~~~l~----~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVI---------NWRNFLH----IPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeee---------ehhhccc----cccccccCHHHHHHHHHHh-cChhhhh
Confidence            99999999999998887765543321         1111222    2234455566666666432 2455665

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=292.61  Aligned_cols=254  Identities=23%  Similarity=0.281  Sum_probs=212.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCC-EEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNS-KVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +...+++.+..||-||||.|=++..+... .+|+|.+++.   .....+.+..|-++|...+.|+||++|..|.+...+|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            44567888889999999999999866433 3788877554   3344456677999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +.||-|-||.|+..+..+    +.+....+..++..+++|++|||++   +||+|||||+|++++.+|-+||.|||.|+.
T Consensus       497 mLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999887    7899999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      +.....  .-+++||+.|.|||++.++..+.++|.||||+++||||+|.+||.+.++....+.+-.--.++         
T Consensus       570 i~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------  638 (732)
T KOG0614|consen  570 IGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------  638 (732)
T ss_pred             hccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence            876543  567899999999999999999999999999999999999999999888766555542211111         


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~L~  353 (407)
                            ..+..+.+...+||.+.+..+|.+|..     +.+|-+.-+
T Consensus       639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence                  112345566888999999999999986     456655444

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=275.61  Aligned_cols=258  Identities=27%  Similarity=0.389  Sum_probs=196.2

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhc-CCCCccceeeeeeecCCeeEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ...++.+.+..||.|+||+|++-.++ .|+..|||.+..... ....++..|.+...+ -++||||+++|.+...+..||
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            33455667788999999999998865 688899999976654 445567777775544 479999999999999999999


Q ss_pred             EEEeccCCChHHhh---hCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          153 VYEYVNNGNLEQWL---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       153 v~e~~~~g~L~~~l---~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .||+| ..+|..+.   +.-  ....+++...-.|....+.||.||....  .|||||+||+|||++..|.+||||||++
T Consensus       141 CMELM-d~SlDklYk~vy~v--q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYSV--QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHHH--HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccch
Confidence            99999 44664433   211  1146888888889999999999998764  8999999999999999999999999998


Q ss_pred             eecCCCCceeeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      -.+-..  ...+.-.|-..|||||.+..  ..|+.+||+||||++|||+.||+.|+.....     ..+-+........+
T Consensus       216 GqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp  288 (361)
T KOG1006|consen  216 GQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPP  288 (361)
T ss_pred             HhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCC
Confidence            655321  11222357889999999854  3589999999999999999999999975443     22333333333221


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      . +    .......+++..+..+|-.||-+|-+.||.+.++++
T Consensus       289 ~-l----~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  289 I-L----LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             e-e----cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1 1    112223456777999999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-38  Score=270.40  Aligned_cols=274  Identities=22%  Similarity=0.327  Sum_probs=209.3

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec--------C
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------G  147 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~  147 (407)
                      +.|+-..+||+|.||.||+|+. +++++||+|++...  ....-....+|+.+|..+.|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4577788899999999999994 46778999876442  22223345679999999999999999988742        3


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ..+|+||++|+. +|.-++....   ..++...+.+++.++..||.|+|.+   .|+|||+|++|+||+.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            458999999965 8888887654   5789999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCce---eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          228 LAKLLGSESSY---ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       228 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      +++.+......   ..+..+-|.+|++||.+.+ ..|+++.|||..|||+.||+||.+-|.+.+.......+..+....+
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99766433221   1234456999999998876 5699999999999999999999999998877666666655544444


Q ss_pred             cCCCCCcCC---------CCCCCCccHH---HH------HHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          304 NRNPEGVLD---------PKLPEKPTSR---LL------KRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       304 ~~~~~~~~~---------~~~~~~~~~~---~~------~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      ....+.+-.         ++++......   ..      .+..+|+..+|..||.+|+++.+++..-.....+.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            332222211         1122211111   11      25678999999999999999999998665554443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=299.15  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=209.2

Q ss_pred             CCccceecccCceEEEEEEEC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .+..++||+|+||+||+|.+- ++.    +||||++... ..+...++..|+.+|.+++|||++++++++.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            566789999999999999953 333    5899988655 4456678999999999999999999999997765 88999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      +|++.|+|.+|++.++   ..+..+..+.|..||++||.|||.+   +++||||..+||||..-..+||.|||+++.+..
T Consensus       777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            9999999999998765   6788899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCceeeee-eeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          235 ESSYITTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       235 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ........ ..-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+..+.++.       .       
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------g-------  916 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------G-------  916 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------c-------
Confidence            65543322 223568999999999999999999999999999998 9999987765544433321       1       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                       . ....+..++.++..++.+||..|++.||+|+++...+...
T Consensus       917 -e-RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  917 -E-RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             -c-cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence             1 1122334556689999999999999999999998877654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.3e-36  Score=271.81  Aligned_cols=220  Identities=20%  Similarity=0.202  Sum_probs=176.3

Q ss_pred             cCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChHHhhhC
Q 015395           90 GGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG  168 (407)
Q Consensus        90 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  168 (407)
                      |.+|.||++... +++.||+|.+....     .+..|...+....||||+++++++.+....+++|||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999954 67889999886543     223344555556799999999999999999999999999999999876


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeecccc
Q 015395          169 DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG  248 (407)
Q Consensus       169 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~  248 (407)
                      .    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||.+.......    ....++..
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  147 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM  147 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence            4    4589999999999999999999999   99999999999999999999999999876554321    22345678


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHH
Q 015395          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (407)
Q Consensus       249 y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (407)
                      |+|||.+....++.++|+|||||++|+|++|..||......     .       .     ......++    ..++..+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-------~-----~~~~~~~~----~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-------N-----THTTLNIP----EWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-------c-----cccccCCc----ccCCHHHH
Confidence            99999998888999999999999999999999887532110     0       0     00000111    22445688


Q ss_pred             HHHHHccCcCCCCCCCHH
Q 015395          329 LVALRCVDPNAQKRPKMG  346 (407)
Q Consensus       329 ~li~~cl~~dp~~RPt~~  346 (407)
                      +++.+||+.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=290.52  Aligned_cols=244  Identities=26%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             cceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCC
Q 015395           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      .++||.|.||+||-|.++ +|+.||||++.+-  ....+..+.+|+.+|..++||.||.+.-.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            588999999999999854 7999999988543  2344567889999999999999999999999999999999999665


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeecccceecCCCCc
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~~~~~~~~  237 (407)
                      -|+-.|....   +.+++..-..++.||+.||.|||.+   +|+|+||||+|||+..   -..+||||||.|+++++...
T Consensus       649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            4555554443   6799999899999999999999999   9999999999999954   35799999999999876543


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                        ...++||+.|+|||+++++.|+..-|+||.|+|+|--|+|..||.....     +-    ..+.+   ..+   .+|.
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----In----dQIQN---AaF---MyPp  785 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IN----DQIQN---AAF---MYPP  785 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hh----HHhhc---ccc---ccCC
Confidence              4567899999999999999999999999999999999999999964322     11    11111   111   3455


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      .+..+++....+||...|+..-.+|-+....+.
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            667888888999999999999999999887665

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=291.37  Aligned_cols=243  Identities=23%  Similarity=0.284  Sum_probs=196.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ...|.+...+|.|+|+.|-.|... +++..++|++.....+    ..+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            457888888999999999999854 6778999988665222    23466555544 79999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE-eCCCCcEEeecccceecCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~DfGla~~~~~  234 (407)
                      .+.|+-|.+.+....    .+. .++..|+++|+.|+.|||++   |||||||||+|||+ +..++++|+|||-++....
T Consensus       397 ~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999888886642    233 77888999999999999999   99999999999999 6899999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .    ..+.+-|..|.|||++....|++++||||||++||+||+|+.||......     ++....+ ..        +.
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i-~~--------~~  530 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRI-QM--------PK  530 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhh-cC--------Cc
Confidence            4    22234588999999999999999999999999999999999999755433     1111111 11        11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ....++...++|+.+||+.||.+||++.++...-..
T Consensus       531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                125567789999999999999999999999875554

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=278.06  Aligned_cols=256  Identities=24%  Similarity=0.435  Sum_probs=197.1

Q ss_pred             CCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChh-------hHHHHHHHHHHHhcCCCCccceeeeeee-cCCe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ-------AEREFKVEVEAIGRVRHKNLVRLLGYCA-EGAH  149 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~  149 (407)
                      ++|-++.+||+|||+.||+|. ....+.||+|+-......       ......+|.++.+.|+||-||+++++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            358889999999999999999 445778999976433221       1223556999999999999999999985 6678


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeec
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDF  226 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df  226 (407)
                      +|-|+|||+|.+|.-||+.+    ..+++.++..|+.||+.||.||... ++.|||-||||.|||+.+   .|.+||+||
T Consensus       543 FCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            99999999999999999877    5799999999999999999999986 778999999999999954   478999999


Q ss_pred             ccceecCCCCce------eeeeeeccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH
Q 015395          227 GLAKLLGSESSY------ITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       227 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~  296 (407)
                      ||++.+..+...      ......||.+|++||.+.-+    ..+.++||||+|||+|.-+.|+.||.......+.  ++
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hh
Confidence            999988654432      23345799999999987433    4788999999999999999999999754332211  11


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                       ...++..   .+   ..+|..+  -.+.+..++|.+||+..-++|....++..
T Consensus       696 -eNTIlkA---tE---VqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 -ENTILKA---TE---VQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -hhchhcc---ee---ccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence             0111111   11   1222222  23446789999999999999977666543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=263.13  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=201.9

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCC
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA  148 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  148 (407)
                      +.+..++|.++.+||+|+|.+|.++++. +.+.+|+|++++.   ..++....+.|-.+.... +||.+|.++.+|....
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            3467789999999999999999999954 6778999988553   334445566677777666 6999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++|.||++||+|--.+...    .++++..+..+...|+.||.|||+.   ||++||||.+|||++..|++||+|+|.
T Consensus       325 rlffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             eEEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence            999999999999997666554    5799999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-hhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~  307 (407)
                      ++---... ....+++||+.|.|||++++..|+.++|+|+||++++||+.|+.||+.-... .+.+..+++.+.+....+
T Consensus       398 cke~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  398 CKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hhcCCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            87533222 2356689999999999999999999999999999999999999999753321 233444555555444322


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK  344 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt  344 (407)
                      .      .|    ..++.....++..-|++||.+|..
T Consensus       477 r------ip----rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 R------IP----RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             c------cc----ceeehhhHHHHHHhhcCCcHHhcC
Confidence            1      11    122223455677788999999863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-34  Score=293.62  Aligned_cols=262  Identities=20%  Similarity=0.254  Sum_probs=172.1

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-C----CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeee------ee
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-D----NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY------CA  145 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~  145 (407)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......  +....+  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            6778999999999999999999965 4    678999987543211  111111  1222223333333222      23


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCC----------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCC
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGP----------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK  209 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk  209 (407)
                      .....++||||+.+++|.+++......                ........+..++.||+.||.|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            556789999999999999998654210                00112344668999999999999999   99999999


Q ss_pred             CccEEEeC-CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCC----------------------CCCcchhH
Q 015395          210 SSNILIDK-HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG----------------------MLNERSDV  266 (407)
Q Consensus       210 p~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDi  266 (407)
                      |+|||++. ++.+||+|||+++.+............+|+.|||||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57999999999987654443344556789999999965322                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC----CCcCCCCCCCC------ccHHHHHHHHHHHHHccC
Q 015395          267 YSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP----EGVLDPKLPEK------PTSRLLKRILLVALRCVD  336 (407)
Q Consensus       267 wslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~------~~~~~~~~l~~li~~cl~  336 (407)
                      |||||+||||+++..|+...       ...+...+......    .....+.....      ..........+||.+||+
T Consensus       363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999987765421       11111111100000    00000000000      000011235589999999


Q ss_pred             cCCCCCCCHHHHHHHH
Q 015395          337 PNAQKRPKMGHVVHML  352 (407)
Q Consensus       337 ~dp~~RPt~~evl~~L  352 (407)
                      .||.+|||+.++++.-
T Consensus       436 ~dP~kR~ta~e~L~Hp  451 (566)
T PLN03225        436 FKGRQRISAKAALAHP  451 (566)
T ss_pred             CCcccCCCHHHHhCCc
Confidence            9999999999999853

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4e-34  Score=259.72  Aligned_cols=238  Identities=24%  Similarity=0.389  Sum_probs=193.7

Q ss_pred             CceEEEEEEEC-CCCEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChHHhhhC
Q 015395           91 GYGIVYYGLLE-DNSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG  168 (407)
Q Consensus        91 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  168 (407)
                      +||.||+|... ++..+|+|.+....... ...+..|++.+++++|+||+++++++......+++|||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48899999987654444 67888999999999999999999999998999999999999999999976


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeecccc
Q 015395          169 DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG  248 (407)
Q Consensus       169 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~  248 (407)
                      .    ..+++..++.++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            4    2389999999999999999999999   99999999999999999999999999998775442  2233457889


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHH
Q 015395          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (407)
Q Consensus       249 y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (407)
                      |++||.+....++.++||||||+++|+|++|..||......+  ...+    ........       .......++..+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~----~~~~~~~~-------~~~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK----KIGKPKPP-------FPPPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH----HHhccCCC-------CccccccCCHHHH
Confidence            999999988889999999999999999999999997532211  1111    11111100       0000011445789


Q ss_pred             HHHHHccCcCCCCCCCHHHHHH
Q 015395          329 LVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       329 ~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +++.+||..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.8e-34  Score=281.64  Aligned_cols=270  Identities=21%  Similarity=0.281  Sum_probs=183.9

Q ss_pred             HhcCCCCccceecccCceEEEEEEE-----------------CCCCEEEEEEeccCChhhHHH--------------HHH
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLL-----------------EDNSKVAVKNLLNNRGQAERE--------------FKV  124 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~  124 (407)
                      ...++|++.++||+|+||.||+|..                 ..++.||||++.........+              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3567899999999999999999963                 234679999986543322222              234


Q ss_pred             HHHHHhcCCCCcc-----ceeeeeeec--------CCeeEEEEEeccCCChHHhhhCCCCC-------------------
Q 015395          125 EVEAIGRVRHKNL-----VRLLGYCAE--------GAHRMLVYEYVNNGNLEQWLHGDVGP-------------------  172 (407)
Q Consensus       125 E~~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------  172 (407)
                      |+.++.+++|.++     ++++++|..        .+..++||||+.+++|.++++.....                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6677777766544     667777643        35689999999999999998753211                   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccC
Q 015395          173 -CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA  251 (407)
Q Consensus       173 -~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a  251 (407)
                       ...+++..+..++.|++.+|.|||+.   +|+||||||+|||++.++.+||+|||++...............+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence             12346778899999999999999999   99999999999999999999999999997654332222222235789999


Q ss_pred             ccccCCCC--------------------CC--cchhHHHHHHHHHHHHhCCC-CCCCCCCchhh-hHHHHHHHHhhcCCC
Q 015395          252 PEYASTGM--------------------LN--ERSDVYSFGILIMEVISGRI-PVDYSRPPEEV-NLIEWLKKMVTNRNP  307 (407)
Q Consensus       252 PE~~~~~~--------------------~~--~~sDiwslG~il~elltg~~-Pf~~~~~~~~~-~~~~~~~~~~~~~~~  307 (407)
                      ||.+....                    ++  .+.||||+||++|+|++|.. ||......... .........+.... 
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-
Confidence            99875432                    11  24699999999999999875 76532211110 00000000000000 


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCC---CCCCCHHHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNA---QKRPKMGHVVHMLE  353 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~~L~  353 (407)
                      ...  ..+  ...........+|+.+||..+|   .+|+|+.++++.-.
T Consensus       458 ~~~--~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        458 GQK--YDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             ccC--CCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            000  011  1122345668899999999766   68999999987543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=243.30  Aligned_cols=210  Identities=25%  Similarity=0.381  Sum_probs=169.4

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      +++..+++..+..||+|++|.|-+-++ .+|...|+|.+... ..+....+..|+.+..+. .+|++|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344556667778899999999988884 46888999998655 344455677788876655 699999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +|.||.| ..+|..+...-....+.+++..+-+|+..+..||.|||++.  .++|||+||+||||+.+|++|+||||.+-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 55887665443333368999999999999999999999975  89999999999999999999999999987


Q ss_pred             ecCCCCceeeeeeeccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwslG~il~elltg~~Pf~~~~~  288 (407)
                      .+.+.-.  .+-..|-..|||||.+..    ..|+.+|||||||+++.||.+++.||+....
T Consensus       198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            6643211  111347788999998853    3689999999999999999999999975443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=259.87  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=204.3

Q ss_pred             CCCccceecccCceEEEEEEE-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----CeeE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM  151 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~  151 (407)
                      +.+..+.||-|+||.||.+.+ ++|+.||+|++..-  +-...+.+-+|+.+|.-++|.|++..+++..-.     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            456678999999999999984 57999999988543  223445667799999999999999998876543     2467


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +++|.| ..+|...|-..    ..++...+.-+..||++||.|||+.   +|.||||||.|+|++.+..+||||||+++.
T Consensus       134 V~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            889988 44888877655    6788888899999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh-------
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-------  303 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------  303 (407)
                      ...+....++..+-|-.|+|||++.+. .|+.+.||||.|||+.|||..+.-|....+.+..+.+..+.....       
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            887777667777789999999999775 589999999999999999999999988877666554432211000       


Q ss_pred             -cCCCCCcC-----CCCCCCC----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          304 -NRNPEGVL-----DPKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       304 -~~~~~~~~-----~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                       .+...-++     .+.++..    .......+-..+...++.+||++|.+..+.+..+.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence             00000011     1111111    11122334567788899999999999988887654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.8e-34  Score=244.25  Aligned_cols=284  Identities=21%  Similarity=0.329  Sum_probs=212.5

Q ss_pred             cccccccccCCCCccccHHHHHH---hcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHH
Q 015395           54 AAVVPEVSHLGWGHWYTLRELEV---STNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAI  129 (407)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l  129 (407)
                      +.+..++......++++++...+   ..++|++++.+|+|.++.||.|. ..++.+++||+++.-   ....+.+|+.+|
T Consensus        10 ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL   86 (338)
T KOG0668|consen   10 ARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKIL   86 (338)
T ss_pred             hhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHH
Confidence            33444555556667777777655   45679999999999999999998 456889999988554   345677899999


Q ss_pred             hcCC-CCccceeeeeeecC--CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceecc
Q 015395          130 GRVR-HKNLVRLLGYCAEG--AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (407)
Q Consensus       130 ~~l~-hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~  206 (407)
                      ..|. ||||++++++..++  ....+|+||+++.+...+.       +.++..++..++.+++.||.|+|++   ||+||
T Consensus        87 ~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHR  156 (338)
T KOG0668|consen   87 QNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHR  156 (338)
T ss_pred             HhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---Ccccc
Confidence            9996 99999999998765  4678999999988877765       5688899999999999999999999   99999


Q ss_pred             CCCCccEEEeCC-CCcEEeecccceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015395          207 DIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVD  284 (407)
Q Consensus       207 Dlkp~Nill~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~  284 (407)
                      |+||.|++||.. ..++|+|+|||.+.++......  .+.+..|--||++.+ ..|+.+-|+|||||+|..|+..+-||-
T Consensus       157 DVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  157 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             cCCcceeeechhhceeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence            999999999864 5799999999999987755332  245778999998866 458999999999999999999998885


Q ss_pred             CCC-CchhhhHHH----------HHHHHhhc--CCCCCcCCC--------CCCCCccHHHHHHHHHHHHHccCcCCCCCC
Q 015395          285 YSR-PPEEVNLIE----------WLKKMVTN--RNPEGVLDP--------KLPEKPTSRLLKRILLVALRCVDPNAQKRP  343 (407)
Q Consensus       285 ~~~-~~~~~~~~~----------~~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  343 (407)
                      ... ..+..-.+.          ++.+....  .....++..        ..+.....-...+..+++.+.|..|-.+|+
T Consensus       235 hG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl  314 (338)
T KOG0668|consen  235 HGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL  314 (338)
T ss_pred             CCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc
Confidence            443 333222221          12111111  000111110        111111112236788999999999999999


Q ss_pred             CHHHHHHHH
Q 015395          344 KMGHVVHML  352 (407)
Q Consensus       344 t~~evl~~L  352 (407)
                      |+.|++..-
T Consensus       315 TakEam~Hp  323 (338)
T KOG0668|consen  315 TAKEAMAHP  323 (338)
T ss_pred             chHHHhcCc
Confidence            999998643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-34  Score=272.15  Aligned_cols=276  Identities=21%  Similarity=0.243  Sum_probs=214.3

Q ss_pred             CccccHHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC------CCccc
Q 015395           66 GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR------HKNLV  138 (407)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv  138 (407)
                      ..||.+.-.++-.++|.+....|+|-|++|.+|.+. -+..||||++.+........ +.|+++|++|+      .-|++
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtG-l~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTG-LKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhh-hHHHHHHHHhhccCchhhhHHH
Confidence            356777777888899999999999999999999954 46789999998775554444 35999999995      34899


Q ss_pred             eeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      +++..|...+++|||+|.+ ..+|.+.|..... ...|....+..|+.|+..||..|-..   +|+|.||||+||||++.
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence            9999999999999999998 5699999976532 24578888999999999999999998   99999999999999876


Q ss_pred             -CCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH
Q 015395          219 -WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW  297 (407)
Q Consensus       219 -~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  297 (407)
                       ..+||||||.|........   +...-+..|.|||++.+.+|+...|+||+||+||||.||+.-|.+.+....+.+.-.
T Consensus       573 k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             cceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence             4589999999988765432   223345679999999999999999999999999999999999998776443332221


Q ss_pred             HH-----HHhhcCCCC-C--------------------------cCCC------------CCCCCccHHHHHHHHHHHHH
Q 015395          298 LK-----KMVTNRNPE-G--------------------------VLDP------------KLPEKPTSRLLKRILLVALR  333 (407)
Q Consensus       298 ~~-----~~~~~~~~~-~--------------------------~~~~------------~~~~~~~~~~~~~l~~li~~  333 (407)
                      ++     +++....+. .                          .+.|            .++ .........+.+|+..
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~-deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLP-DEQPKIVQQLRDLLDK  728 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCC-chhHHHHHHHHHHHHH
Confidence            11     111111100 0                          0011            111 1233456778999999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 015395          334 CVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       334 cl~~dp~~RPt~~evl~~  351 (407)
                      ||..||++|.|..++|..
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999998864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=260.29  Aligned_cols=267  Identities=19%  Similarity=0.265  Sum_probs=195.0

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----C---Cccceeeeeee--
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----H---KNLVRLLGYCA--  145 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~~--  145 (407)
                      ..++|.+.++||.|.|++||+|.+. ..+.||+|+++... ...+....||.+|+.++     |   .+||++++.|.  
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            4578999999999999999999954 56779999775433 33445667999999873     2   48999999986  


Q ss_pred             --cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-----
Q 015395          146 --EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-----  218 (407)
Q Consensus       146 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----  218 (407)
                        .+.++|+|+|++ |.+|..+|....  ..-++...+..|++||+.||.|||..+  +|||.||||+|||+..+     
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~  229 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA  229 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence              457899999999 779999997653  256899999999999999999999986  99999999999999400     


Q ss_pred             --------------------------------------------------------------------------------
Q 015395          219 --------------------------------------------------------------------------------  218 (407)
Q Consensus       219 --------------------------------------------------------------------------------  218 (407)
                                                                                                      
T Consensus       230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~  309 (590)
T KOG1290|consen  230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI  309 (590)
T ss_pred             hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 015395          219 --------------------------------------------------------------------------------  218 (407)
Q Consensus       219 --------------------------------------------------------------------------------  218 (407)
                                                                                                      
T Consensus       310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~  389 (590)
T KOG1290|consen  310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC  389 (590)
T ss_pred             CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence                                                                                            


Q ss_pred             -CCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh------
Q 015395          219 -WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE------  291 (407)
Q Consensus       219 -~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~------  291 (407)
                       -++||+|||-|+.....    .+.-..|..|+|||++.+..|++.+||||++|++|||.||.+-|+..+....      
T Consensus       390 di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             ceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence             01355555555554322    1222457889999999999999999999999999999999999976554322      


Q ss_pred             -hhHHHHHHHHhh----c-CCCCCcCCC--------CCCC-----------CccHHHHHHHHHHHHHccCcCCCCCCCHH
Q 015395          292 -VNLIEWLKKMVT----N-RNPEGVLDP--------KLPE-----------KPTSRLLKRILLVALRCVDPNAQKRPKMG  346 (407)
Q Consensus       292 -~~~~~~~~~~~~----~-~~~~~~~~~--------~~~~-----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~  346 (407)
                       ..+++++-.+..    . .....+++.        .+..           ....+-..++.+++.-||+.+|++|||+.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence             112222222111    1 111111110        1111           11334456788999999999999999999


Q ss_pred             HHHHHHH
Q 015395          347 HVVHMLE  353 (407)
Q Consensus       347 evl~~L~  353 (407)
                      +.++.-.
T Consensus       546 ~cl~hPw  552 (590)
T KOG1290|consen  546 QCLKHPW  552 (590)
T ss_pred             HHhcCcc
Confidence            9987543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-34  Score=258.43  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=215.5

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      .+.++.+...+++...++-+|.||.||.|.+.+      .+.|.+|.++....+ ....+..|.-.|..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            355677788889999999999999999997653      334677877665443 3456778889999999999999999


Q ss_pred             eee-cCCeeEEEEEeccCCChHHhhhC----CCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC
Q 015395          143 YCA-EGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (407)
Q Consensus       143 ~~~-~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  217 (407)
                      ++. +....++++.++.-|+|..++..    .......++..+...++.|++.|++|||++   +|||.||...|++|++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            875 45677899999999999999971    112235678889999999999999999999   9999999999999999


Q ss_pred             CCCcEEeecccceecCCCCceee-eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHH
Q 015395          218 HWNPKVSDFGLAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       218 ~~~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~  295 (407)
                      .-.+||+|=.+++.+-+.+.... ........||+||.+.+..|+.++|+||||++||||+| |+.|+..-++.|....+
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            99999999999987755443322 22334568999999999999999999999999999999 99999876665433222


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         +             .......+.++++++..+|.-||...|++||+++++..-|...
T Consensus       512 ---k-------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 ---K-------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ---h-------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence               1             1222233556788999999999999999999999999988754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=277.31  Aligned_cols=246  Identities=27%  Similarity=0.380  Sum_probs=187.1

Q ss_pred             CCccceecccCceE-EEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEecc
Q 015395           81 FSDDKVIGEGGYGI-VYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        81 ~~~~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      |.-.+++|.|+.|+ ||+|... ++.||||++....   .....+|+..|+.- .|||||++++.-.+.+..||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            55567899998876 5788876 7899999875432   33456799999988 5999999999999999999999999 


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---C--CCcEEeecccceecC
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---H--WNPKVSDFGLAKLLG  233 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~DfGla~~~~  233 (407)
                      ..+|.+++...............+.+..|++.||++||+.   +||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            4599999977411111122255678899999999999998   9999999999999975   3  468999999999887


Q ss_pred             CCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          234 SESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       234 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ......  .....||.+|+|||++....-+.++|||||||++|+.++| ..||...-..+. +       +......-. 
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-N-------Il~~~~~L~-  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-N-------ILTGNYTLV-  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-h-------hhcCcccee-
Confidence            654432  2345699999999999988888899999999999999995 999974322111 1       111110000 


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         .+  .+..+.  +..+||.+|++++|..||++.+|+.
T Consensus       734 ---~L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 ---HL--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---ee--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               00  011112  5789999999999999999999985

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-33  Score=270.21  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=208.3

Q ss_pred             hcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ..++|+.+..+|.|.+|.||+++ ..++...|+|.++-.......-+++|+-+++..+||||+.+++.+...+..||.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            34689999999999999999999 45788899999988888888888999999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ||.+|+|.+..+..    +++++.++...++..++||+|||++   +-+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus        93 ycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999988765    7899999999999999999999999   9999999999999999999999999998766443


Q ss_pred             CceeeeeeeccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          236 SSYITTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      -. ....+.||+.|||||+.   ..+.|...+|||++|+...|+---+.|.-...+....      . ++....+   ..
T Consensus       166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l------~-LmTkS~~---qp  234 (829)
T KOG0576|consen  166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL------F-LMTKSGF---QP  234 (829)
T ss_pred             hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH------H-HhhccCC---CC
Confidence            22 34567899999999976   4567999999999999999997777775433322111      1 1111111   11


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +.+.  ........+.+++..||-++|.+||+++.++.
T Consensus       235 p~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Cccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2221  22344556889999999999999999986654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=261.39  Aligned_cols=197  Identities=24%  Similarity=0.395  Sum_probs=169.2

Q ss_pred             cCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHH--------HHHHHHHHHhcCC---CCccceeeeeee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAER--------EFKVEVEAIGRVR---HKNLVRLLGYCA  145 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~--------~~~~E~~~l~~l~---hpniv~~~~~~~  145 (407)
                      ..+|...+.+|.|+||.|++|.++. ...|+||.+.+.+.-...        .+-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3468999999999999999999764 556899987655322111        2345999999997   999999999999


Q ss_pred             cCCeeEEEEEec-cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          146 EGAHRMLVYEYV-NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       146 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                      +++++||+||-. ++-+|.++|...    +.+++.++..|++|++.|+++||++   +|||||||-+||.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            999999999976 456999999876    6799999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 015395          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVD  284 (407)
Q Consensus       225 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~  284 (407)
                      |||.+.......   ...++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus       713 dfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999987764432   344679999999999999876 566899999999999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.2e-30  Score=231.01  Aligned_cols=210  Identities=32%  Similarity=0.585  Sum_probs=182.5

Q ss_pred             ecccCceEEEEEEECC-CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChHH
Q 015395           87 IGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ  164 (407)
Q Consensus        87 lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  164 (407)
                      ||+|++|.||++...+ +..+++|++...... ....+.+|+..++.++|++|+++++++......+++|||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 888999988665432 34678889999999999999999999999899999999999899999


Q ss_pred             hhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecccceecCCCCceeeeee
Q 015395          165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGSESSYITTRV  243 (407)
Q Consensus       165 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~  243 (407)
                      ++....   ..+++..++.++.+++++|.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987542   3589999999999999999999999   9999999999999999 89999999999987654431 12223


Q ss_pred             eccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHH
Q 015395          244 MGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (407)
Q Consensus       244 ~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (407)
                      .+...|++||.+... ..+.++|+|+||+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            478899999999877 788999999999999998                                              


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          323 LLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ..+.+++..|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              248889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=245.16  Aligned_cols=262  Identities=24%  Similarity=0.270  Sum_probs=196.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      ..+|.-++.+|.|.- .|..+.+. .++.||+|++...  .....++..+|..++..+.|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356888889999988 66666533 6889999987443  233445666799999999999999999998533      4


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..|+|||+| ..+|.+.+..      .+.-..+..++.|++.|++|||+.   +|+||||||+||++..++.+||.|||+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            679999999 5699999874      367788889999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhH--------------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL--------------  294 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~--------------  294 (407)
                      |+..+..  ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+...-+....              
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            9876544  456677889999999999998899999999999999999999999876442211111              


Q ss_pred             --HHHHHHHhhc------CCCCC-cCCCCCCCC--ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          295 --IEWLKKMVTN------RNPEG-VLDPKLPEK--PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       295 --~~~~~~~~~~------~~~~~-~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                        ....+.....      ....+ +-|..++..  ....-+....+++.+||..||++|.+++++|..-
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence              0011111110      00000 111111111  0111233478899999999999999999999754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.1e-30  Score=233.01  Aligned_cols=199  Identities=31%  Similarity=0.474  Sum_probs=173.3

Q ss_pred             CCccceecccCceEEEEEEECC-CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEecc
Q 015395           81 FSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      |.+.+.||.|++|.||++...+ +..+++|.+...... ....+..|+..+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677889999999999999764 788999998766544 56788889999999999999999999998899999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +++|.+++....   ..+++..++.++.+++.+|.+||+.   +++|+||+|.||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999997652   1188999999999999999999999   9999999999999999999999999999877554311


Q ss_pred             eeeeeeccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVDY  285 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~elltg~~Pf~~  285 (407)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334578899999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=227.99  Aligned_cols=252  Identities=21%  Similarity=0.391  Sum_probs=186.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeee-eecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGY-CAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~-~~~~~~~~lv~e  155 (407)
                      +.|.+.+.||+|.||.+-+|.++ +...+++|-+... ....++|.+|...--.| .|.||+..++. |+..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            56999999999999999999977 4566888966544 34456788887765555 48999998876 566778899999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe--CCCCcEEeecccceecC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~~~~  233 (407)
                      |++.|+|.+-+...     .+.+.....++.|+++|+.|+|++   ++||||||.+||||-  +..++||||||+.+..+
T Consensus       103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999887553     477888899999999999999999   999999999999993  33579999999987654


Q ss_pred             CCCceeeeeeeccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .....    ..-+..|.+||+....     ...+.+|+|.||+++|..|||++||.... ..+....+|++-..+..   
T Consensus       175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~---  246 (378)
T KOG1345|consen  175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN---  246 (378)
T ss_pred             ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC---
Confidence            33221    2235679999976332     25678999999999999999999998432 23334444443322211   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                          +.+|.. ...++..+..+..+-|..++++|-...++.+..
T Consensus       247 ----~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 ----PALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ----ccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence                122211 123445577788899999999995444444433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.6e-30  Score=238.94  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=195.8

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCC
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGA  148 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  148 (407)
                      +....+.|..+.+||+|.|+.||++...    .++.||+|.+....  ....+..|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3345567999999999999999999843    46789999886553  3345778999999994 999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEeecc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFG  227 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfG  227 (407)
                      ...+||||++.....+++.       .++..++..+++.++.||.++|.+   |||||||||+|+|.+.. +.-.|+|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            9999999999999988884       477899999999999999999999   99999999999999754 678999999


Q ss_pred             cceecC-----------------C-----------------CCc---------eeeeeeeccccccCccccCCC-CCCcc
Q 015395          228 LAKLLG-----------------S-----------------ESS---------YITTRVMGTFGYVAPEYASTG-MLNER  263 (407)
Q Consensus       228 la~~~~-----------------~-----------------~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~  263 (407)
                      ||....                 .                 ...         .......||++|.|||++... .-+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997210                 0                 000         001124699999999988654 46889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCc-hhhhHHH------HHHHHhhc---------CCCCCc---------CC-----C
Q 015395          264 SDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIE------WLKKMVTN---------RNPEGV---------LD-----P  313 (407)
Q Consensus       264 sDiwslG~il~elltg~~Pf~~~~~~-~~~~~~~------~~~~~~~~---------~~~~~~---------~~-----~  313 (407)
                      +||||.|+|+..+++++.||-..... .....+.      .+.+....         .+...+         ++     +
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999999543321 1110000      01111100         000000         00     0


Q ss_pred             --C--C-CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 --K--L-PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 --~--~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        .  . .......++..+.+|+.+||+.||.+|.|++++|+.
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              0  0 001112234468899999999999999999999873

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.1e-29  Score=267.03  Aligned_cols=196  Identities=18%  Similarity=0.238  Sum_probs=140.7

Q ss_pred             cCCC-Cccceeeeee-------ecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc
Q 015395          131 RVRH-KNLVRLLGYC-------AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK  202 (407)
Q Consensus       131 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  202 (407)
                      .++| +||.+++++|       .....++++|||+ +++|.++|....   ..+++..++.++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4445 6888888877       2334678889988 669999997532   4699999999999999999999999   9


Q ss_pred             eeccCCCCccEEEeC-------------------CCCcEEeecccceecCCCCc---------------eeeeeeecccc
Q 015395          203 VVHRDIKSSNILIDK-------------------HWNPKVSDFGLAKLLGSESS---------------YITTRVMGTFG  248 (407)
Q Consensus       203 ivH~Dlkp~Nill~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~  248 (407)
                      |+||||||+||||+.                   ++.+|++|||+++.......               ......+||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   44566666666653211000               00112358899


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHH
Q 015395          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (407)
Q Consensus       249 y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (407)
                      |||||++.+..++.++|||||||+||||++|..|+....     ...   ......     .+.+..    .. ......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~---~~~~~~-----~~~~~~----~~-~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM---SSLRHR-----VLPPQI----LL-NWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH---HHHHHh-----hcChhh----hh-cCHHHH
Confidence            999999999999999999999999999999988865211     111   111110     011111    01 122356


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHH
Q 015395          329 LVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       329 ~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .++.+||+++|.+||++.++++.
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            78889999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=5.9e-28  Score=209.62  Aligned_cols=167  Identities=22%  Similarity=0.241  Sum_probs=128.5

Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++....   ..+++..++.++.|++.||.|||+.   +      ||+|||++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            68999997642   4699999999999999999999998   6      999999999999999  99998765432   


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.||.......  .....+........      +. ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~-~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------PR-DRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------cc-cccc
Confidence               258999999999999999999999999999999999999996443211  11111111111100      00 0011


Q ss_pred             cHHHHH--HHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          320 TSRLLK--RILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       320 ~~~~~~--~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ...+..  .+.++|.+||..+|.+||++.++++.+...
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            233343  699999999999999999999999988765

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-26  Score=218.50  Aligned_cols=260  Identities=18%  Similarity=0.238  Sum_probs=195.7

Q ss_pred             CCCccceecccCceEEEEEEECCC--CEEEEEEeccCChhhHHHHHHHHHHHhcCC----CCccceeeeee-ecCCeeEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDN--SKVAVKNLLNNRGQAEREFKVEVEAIGRVR----HKNLVRLLGYC-AEGAHRML  152 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~----hpniv~~~~~~-~~~~~~~l  152 (407)
                      +|.+.+.||+|+||.||+|.....  ..+|+|............+..|+.++..+.    .+++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996653  468888776543333236677888888886    36899999988 47778899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-----CCcEEeecc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-----WNPKVSDFG  227 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~DfG  227 (407)
                      ||+.+ |.+|.++.....  ...++...++.++.|++.+|++||+.   |++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 889999885543  36799999999999999999999999   99999999999999765     468999999


Q ss_pred             cce--ecCCCCce------e-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH
Q 015395          228 LAK--LLGSESSY------I-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       228 la~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  298 (407)
                      +++  ........      . .....||..|+++.++.+...+.+.|+||++.++.+++.|..||..........   .+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~---~~  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS---KF  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---HH
Confidence            998  32111110      1 123459999999999999999999999999999999999999997655432221   12


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ...........         .....+..+..+...+-..+...+|....+...|+....
T Consensus       250 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  250 EKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            22211111110         111122345555555666899999999999998876543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=208.73  Aligned_cols=258  Identities=19%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             CCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .|++++.||+|+||.++.|. .-++..||||.  .........+..|.+..+.|. .++|.+++.+..++.+-.+|||++
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf--EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF--EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEe--ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            59999999999999999998 44789999993  333344556777888888884 799999998888888889999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-----CCcEEeecccceec
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-----WNPKVSDFGLAKLL  232 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~DfGla~~~  232 (407)
                       |.+|+|+..-=.   ..++...++.++.|++.-++|+|++   .+|+|||||+|+||...     ..+.++|||+|+.+
T Consensus       107 -GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  107 -GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             -CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence             889988774211   3699999999999999999999999   99999999999999644     35899999999987


Q ss_pred             CCCCcee------eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          233 GSESSYI------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       233 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      .+.....      .....||.+||+-....+..-+.+-|+-|||-++++.|.|.+||.+.........-+.+-.-..   
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr---  256 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR---  256 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc---
Confidence            6554332      2345799999999999999999999999999999999999999987654433222222211111   


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                            ......-...++.++..-+.-.-..+-.+-|..+.+...+..+
T Consensus       257 ------~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  257 ------STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             ------cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                  0111111333455566555555566777778887666555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.3e-26  Score=217.92  Aligned_cols=174  Identities=19%  Similarity=0.224  Sum_probs=133.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC--CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCccce-eeeeeecC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVR-LLGYCAEG  147 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~  147 (407)
                      ...++|.+.+.||+|+||+||+|.+.  ++..||||++...     .......+.+|+++|++++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34578999999999999999999864  4677899986533     2233556889999999999999985 4432    


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCC-CCccEEEeCCCCcEEeec
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI-KSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Df  226 (407)
                      +..++||||++|++|... ..       ..   ...++.|++++|.|||++   +|+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            457999999999999632 11       11   146788999999999999   9999999 999999999999999999


Q ss_pred             ccceecCCCCceee-------eeeeccccccCccccCCCC------CCcchhHH
Q 015395          227 GLAKLLGSESSYIT-------TRVMGTFGYVAPEYASTGM------LNERSDVY  267 (407)
Q Consensus       227 Gla~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~sDiw  267 (407)
                      |+++.+........       ....+++.|+|||.+....      .+..+|-|
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99997754432111       2456788899999885433      23445666

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=203.45  Aligned_cols=252  Identities=21%  Similarity=0.329  Sum_probs=193.0

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEecc--CChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++.+..+|.+...|..|+|++..+ .+++|++..  ......++|..|.-.|+.+.||||+.+++.|..+.++.++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3455667789999999999999844 455665533  3445567889999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      |+.|+|+..++...+  -.....++.+++.++++|++|||+.. +-|.---|....++||++.+++|+- +-+++     
T Consensus       269 mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----  339 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----  339 (448)
T ss_pred             ccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----
Confidence            999999999987632  34677889999999999999999972 2333446888999999998888752 11111     


Q ss_pred             ceeeeeeeccccccCccccCCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLN---ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ++......-.+.||+||.++..+-+   .++|+|||++++|||.|...||....+.+..-.+.+               .
T Consensus       340 sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------e  404 (448)
T KOG0195|consen  340 SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------E  404 (448)
T ss_pred             eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------------c
Confidence            1112222347889999999876643   578999999999999999999987776554333211               1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .+....+..++..+.+||.-|++.||.+||.+..|+.+|+..
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            122222345566789999999999999999999999999875

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.9e-26  Score=196.76  Aligned_cols=264  Identities=17%  Similarity=0.218  Sum_probs=204.2

Q ss_pred             HhcCCCCccceecccCceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  153 (407)
                      +..+.|.+++.||.|+||.+|.|. ..+|..||||.-....  ....+..|..+.+.|+ ...|..+..+..+...-.+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            345789999999999999999999 5679999999664432  2235566888888886 46888888888888999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC---CCcEEeecccce
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~  230 (407)
                      |+.+ |.+|+++..-=.   ..++...++-++-|++.-++|+|.+   +.+||||||+|+|..-+   ..+.|+|||||+
T Consensus        90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            9999 889998875321   3588899999999999999999999   99999999999999533   468999999998


Q ss_pred             ecCCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          231 LLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       231 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      .+.+....      ......||.+|.+-..+.+...+.+.|+-|+|.+|.++..|..||.+.......+..+.+......
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            76433221      123457999999998888888889999999999999999999999988777666665555443322


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ..+         ..-...++.++.-.+.-|-..--++-|....+.+....+..
T Consensus       243 ~~i---------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  243 TPI---------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             CCH---------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            111         11123345566777778888888888888777766655443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=6.2e-24  Score=200.48  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=198.5

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCChh---hHHHHHHHHHHHhcCCCC-ccceeeeeeecCCeeEEEEEe
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~  156 (407)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999976  77899988655332   467788899999999988 799999999777778999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~  235 (407)
                      +.++++.+++...... ..+.......++.|++.++.|+|..   +++|||+||+||+++..+ .++++|||++......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777654211 2689999999999999999999999   999999999999999988 6999999999866544


Q ss_pred             Cce-----eeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-hhhhHHHHHHHHhhcCC
Q 015395          236 SSY-----ITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       236 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~  306 (407)
                      ...     ......||..|+|||.+..   ..++...|+|++|++++++++|..||...... ........+......  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            322     2345679999999999987   57889999999999999999999997655431 011111111111100  


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         .................+.+++..|+..+|..|.+.......
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence               000000000002233568889999999999999988876653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.3e-26  Score=232.79  Aligned_cols=256  Identities=22%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             CccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHH----HHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           82 SDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAER----EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ....++|.|++|.|+.+... .....+.|.....  .....+    .+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988777643 2333444433210  111111    2555777788899999999888887776666669


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |||++ +|..++...    ..+...++..++.|++.||+|||+.   ||.|||+|++|++++.+|.+||+|||.+.....
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999999765    4688899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCc---eeeeeeeccccccCccccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          235 ESS---YITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       235 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ...   ......+|+..|+|||++.+..|++. .||||.|++++.|++|+.||......+...     ...   ......
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~---~~~~~~  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTN---NYSDQR  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhh---cccccc
Confidence            433   34556789999999999999999875 699999999999999999998665443321     000   000001


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ....-+......++.+.+.+|.++|+.||.+|.|+++|++.=+
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            1111122234556778899999999999999999999987544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=4e-24  Score=189.94  Aligned_cols=173  Identities=14%  Similarity=0.159  Sum_probs=134.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHH---------HHHHHHHHhcCCCCccceeeeeee
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---------FKVEVEAIGRVRHKNLVRLLGYCA  145 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~E~~~l~~l~hpniv~~~~~~~  145 (407)
                      .+..++|+..++||.|+||.||++.. ++..+|+|.+..........         +.+|+..+.++.|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34578999999999999999999766 57789999986554333322         578999999999999999988865


Q ss_pred             cC--------CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC
Q 015395          146 EG--------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (407)
Q Consensus       146 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  217 (407)
                      ..        +..+++|||++|.+|.++..        ++.    ....+++.+|..||+.   |++|||++|+||+++.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            32        35789999999999988742        222    2456899999999999   9999999999999999


Q ss_pred             CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 015395          218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  277 (407)
Q Consensus       218 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ell  277 (407)
                      +| ++|+|||...........             ...+....++.++|+|+||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88 999999987654221110             01334455678999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2e-24  Score=219.48  Aligned_cols=246  Identities=23%  Similarity=0.219  Sum_probs=180.4

Q ss_pred             CCCccceecccCceEEEEEEECCCCEEEEEEeccCCh-hhHHHHHH---HHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-QAEREFKV---EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~---E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +|...+.||.+.|=+|.+|.+.+|. |+||++.+... -..+.+.+   |++ ...+++||++++.-+.......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6788899999999999999988776 89998866542 22333333   444 556689999999888777778899999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee--cC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL--LG  233 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~--~~  233 (407)
                      |... +|+|.|..+    +-+...+...|+.|++.||.-+|..   ||+|||||.+||||+.-+-+.|+||..-+.  +.
T Consensus       102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9954 999999876    4578888889999999999999999   999999999999999999999999986542  22


Q ss_pred             CCCce----eeeeeeccccccCccccCCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHH
Q 015395          234 SESSY----ITTRVMGTFGYVAPEYASTG----------M-LNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW  297 (407)
Q Consensus       234 ~~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  297 (407)
                      .++..    ...+.....+|.|||.+...          . .+++-||||+||++.||++ |++||...         ++
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL  244 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QL  244 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HH
Confidence            22211    11222335589999987431          2 6778899999999999988 78888521         11


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      +..........+.+-....+       ..++.|+..|++.||++|.++++.|+.
T Consensus       245 ~aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  245 LAYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11111101100000011111       138899999999999999999999984

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=3.3e-23  Score=181.59  Aligned_cols=139  Identities=16%  Similarity=0.144  Sum_probs=108.2

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChh--h------------------------HHHHHHHHHHHhcCCCCcc
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--A------------------------EREFKVEVEAIGRVRHKNL  137 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpni  137 (407)
                      ...||+|+||.||+|...+|+.||||++......  .                        ......|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998654211  0                        1122358999999988776


Q ss_pred             ceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhh-hhcCCCceeccCCCCccEEEe
Q 015395          138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL-HEGLEPKVVHRDIKSSNILID  216 (407)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp~Nill~  216 (407)
                      .....+..  ...+|||||++++++...+...    ..+++..+..++.|++.+|.+| |+.   +|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            43332222  2238999999887776553322    4688999999999999999999 688   999999999999998


Q ss_pred             CCCCcEEeecccceec
Q 015395          217 KHWNPKVSDFGLAKLL  232 (407)
Q Consensus       217 ~~~~~kl~DfGla~~~  232 (407)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.3e-24  Score=207.26  Aligned_cols=225  Identities=24%  Similarity=0.275  Sum_probs=180.5

Q ss_pred             eecccCceEEEEEEE----CCCCEEEEEEeccCChh--hHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEecc
Q 015395           86 VIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      ++|+|.||.|+++..    ..+..+|+|.++.....  .......|..++..++ ||.++++...++.....++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998873    23566888877544211  1114445788888887 9999999999999999999999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      +|.|...+...    ..+.+.....+...++-+++++|+.   +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus        81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            99999888766    4677888888889999999999999   9999999999999999999999999999865433221


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (407)
                           +||..|||||++.  ....++|.||||++++||+||..||..          +.+..+....           ..
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~-----------~~  205 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAE-----------LE  205 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhc-----------cC
Confidence                 8999999999998  678899999999999999999999974          1122222211           12


Q ss_pred             ccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          319 PTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                      .+........+++..++..+|..|.-.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            245666778899999999999999755

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=5.7e-22  Score=174.24  Aligned_cols=141  Identities=20%  Similarity=0.167  Sum_probs=110.6

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChh--------------------------hHHHHHHHHHHHhcCCCCcc
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--------------------------AEREFKVEVEAIGRVRHKNL  137 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpni  137 (407)
                      .+.||+|+||.||+|...+|+.||||++......                          ....+..|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999778999999988654211                          01224568899999999987


Q ss_pred             ceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEe
Q 015395          138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILID  216 (407)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~  216 (407)
                      .....+...  ..++||||++|+++.......    ..++...+..++.|++.+|.+||+ .   ||+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            544333332  248999999887554432222    357888999999999999999999 8   999999999999999


Q ss_pred             CCCCcEEeecccceecCC
Q 015395          217 KHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       217 ~~~~~kl~DfGla~~~~~  234 (407)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.4e-22  Score=173.24  Aligned_cols=184  Identities=18%  Similarity=0.154  Sum_probs=138.4

Q ss_pred             CccceecccCceEEEEEEECCCCEEEEEEeccCChh----hHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEe
Q 015395           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ----AEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      -+...|++|+||+||.+.. .+.+++.+.+....-.    ....+.+|+++|++|+ +++|++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999997765 5778887766544321    1225788999999995 5889999886    346999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCC-CCccEEEeCCCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI-KSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      +.|.+|.+.+..          . ...++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999998754321          1 135788999999999999   9999999 799999999999999999999865543


Q ss_pred             Cce----e--------eeeeeccccccCccccCCC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 015395          236 SSY----I--------TTRVMGTFGYVAPEYASTG-MLN-ERSDVYSFGILIMEVISGRIPVD  284 (407)
Q Consensus       236 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDiwslG~il~elltg~~Pf~  284 (407)
                      ...    .        ......++.|++|+...-. ..+ ...++++.|+.+|.++|+..++-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            321    0        0112346777888754322 223 56799999999999999998864

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=3.8e-22  Score=206.33  Aligned_cols=199  Identities=20%  Similarity=0.201  Sum_probs=162.1

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCccceeeeeeecCCe
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAH  149 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~  149 (407)
                      +.++....|.+.+.||+|+||.||+|...+++.||+|+-.........-   -.+++.+|+   -+.|+.+..++.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            4556777899999999999999999998889999999766554332211   122333443   3456666666666778


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-------CCCcE
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-------HWNPK  222 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~~k  222 (407)
                      .++|+||.+.|+|.+++...    ..++|..++.++.|+++.+++||..   +|||+||||+|+||..       ...++
T Consensus       769 S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            89999999999999999855    6799999999999999999999999   9999999999999942       34589


Q ss_pred             EeecccceecCCC-CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 015395          223 VSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI  281 (407)
Q Consensus       223 l~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~  281 (407)
                      |+|||.+..+... ........++|-.+-++|+..+.+|+..+|.|.|+.+++-||.|++
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999998765432 2234566788999999999999999999999999999999999864

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=7.5e-22  Score=180.59  Aligned_cols=234  Identities=21%  Similarity=0.336  Sum_probs=147.7

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCC----------Cccceeeeee-
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRH----------KNLVRLLGYC-  144 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h----------pniv~~~~~~-  144 (407)
                      .+...+.||.|+++.||.+.+. +++.+|+|++.....   ...+.+.+|.-....+.+          -.++--++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3566789999999999999976 588999998855432   233455555544444321          1222222221 


Q ss_pred             --------ecC---C-----eeEEEEEeccCCChHHhhh---CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceec
Q 015395          145 --------AEG---A-----HRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH  205 (407)
Q Consensus       145 --------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH  205 (407)
                              ...   .     +.+++|+-+ .++|.+++.   ........+....++.+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                    111   1     336788877 558887753   2211112244555677889999999999999   9999


Q ss_pred             cCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCC--------CCCCcchhHHHHHHHHHHHH
Q 015395          206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVI  277 (407)
Q Consensus       206 ~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwslG~il~ell  277 (407)
                      +||||+|++++.+|.+.|+||+.....+....   . ...+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999998766543211   1 234567999997633        24788999999999999999


Q ss_pred             hCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCC
Q 015395          278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR  342 (407)
Q Consensus       278 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  342 (407)
                      +|..||....+......                   .+.. .. +.++.+..||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543221110                   1111 22 788899999999999999987

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=9.9e-22  Score=190.76  Aligned_cols=217  Identities=28%  Similarity=0.507  Sum_probs=166.8

Q ss_pred             HhcCCCCccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCce-eccC
Q 015395          129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV-VHRD  207 (407)
Q Consensus       129 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-vH~D  207 (407)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+....   ..+++.....++++|+.||.|||..   .| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            467889999999999999999999999999999999998743   5789999999999999999999987   44 9999


Q ss_pred             CCCccEEEeCCCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCC-------CCcchhHHHHHHHHHHHHhC
Q 015395          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISG  279 (407)
Q Consensus       208 lkp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDiwslG~il~elltg  279 (407)
                      ++..|++++....+||+|||+......... .......-..-|.|||.+....       .+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999999887643111 1111122345799999987642       45678999999999999999


Q ss_pred             CCCCCCCCCchhh-hHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          280 RIPVDYSRPPEEV-NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       280 ~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      +.||......+.. ..+..+++     .....+.|......  +....+..++.+||..+|..||+++.|-..++.....
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9999865443332 22222222     11112222222111  4445789999999999999999999999988877554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-21  Score=180.16  Aligned_cols=197  Identities=21%  Similarity=0.267  Sum_probs=139.7

Q ss_pred             CCCccceeeeeeec---------------------------CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHH
Q 015395          133 RHKNLVRLLGYCAE---------------------------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII  185 (407)
Q Consensus       133 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~  185 (407)
                      +|||||.++++|.+                           +..+|+||..++ .+|..|+..+     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence            59999999887632                           235689999884 5999999875     46667778899


Q ss_pred             HHHHHHHHhhhhcCCCceeccCCCCccEEEe--CC--CCcEEeecccceecCCCCce-----eeeeeeccccccCccccC
Q 015395          186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KH--WNPKVSDFGLAKLLGSESSY-----ITTRVMGTFGYVAPEYAS  256 (407)
Q Consensus       186 ~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~--~~~kl~DfGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~  256 (407)
                      .|+++|+.|||.+   ||.|||+|.+||||.  ++  ..+.|+|||.+--.....-.     .....-|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   999999999999993  33  35789999987543321111     111234777899999886


Q ss_pred             CCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHH
Q 015395          257 TGM------LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLV  330 (407)
Q Consensus       257 ~~~------~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  330 (407)
                      ..+      ...++|.|+.|.+.||+++...||..... .......+          .+-.-+.+++    .++..+.+|
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Y----------qe~qLPalp~----~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTY----------QESQLPALPS----RVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhh----------hhhhCCCCcc----cCChHHHHH
Confidence            543      23589999999999999999999975321 11111110          1111122222    334458889


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHH
Q 015395          331 ALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       331 i~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      +...|+.||++|++..=....|.
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999998765554443

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.2e-20  Score=167.03  Aligned_cols=137  Identities=18%  Similarity=0.238  Sum_probs=106.7

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-----CCCccceeeeeeecCC---e-eE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-----RHKNLVRLLGYCAEGA---H-RM  151 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~-~~  151 (407)
                      +.-.++||+|+||.||. ...+.. .+||++........+.+.+|+.+++.+     .||||++++++++.+.   . +.
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34457899999999995 323344 479988765555567789999999999     5799999999998763   4 34


Q ss_pred             EEEEe--ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHH-HhhhhcCCCceeccCCCCccEEEeCC----CCcEEe
Q 015395          152 LVYEY--VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL-SYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVS  224 (407)
Q Consensus       152 lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~  224 (407)
                      +||||  +.+++|.+++...     .+++.  ..++.+++.++ +|||++   +|+||||||+|||++..    +.++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  5579999999653     35554  35677888777 999999   99999999999999743    479999


Q ss_pred             ecccc
Q 015395          225 DFGLA  229 (407)
Q Consensus       225 DfGla  229 (407)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95433

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=5.2e-20  Score=166.86  Aligned_cols=142  Identities=18%  Similarity=0.138  Sum_probs=111.6

Q ss_pred             CCCccceecccCceEEEEEE--ECCCCEEEEEEeccCChh------------------------hHHHHHHHHHHHhcCC
Q 015395           80 GFSDDKVIGEGGYGIVYYGL--LEDNSKVAVKNLLNNRGQ------------------------AEREFKVEVEAIGRVR  133 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  133 (407)
                      .|.+.+.||+|+||.||+|.  ..+|..||+|++......                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  567999999988643210                        1123567999999997


Q ss_pred             CC--ccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc-eeccCCCC
Q 015395          134 HK--NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKS  210 (407)
Q Consensus       134 hp--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp  210 (407)
                      +.  .+++++++    ...++||||+++.+|..+....    ..+....+..++.|++.+|.+||+.   + |+||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            53  33444442    2358999999998887765332    3456667789999999999999999   9 99999999


Q ss_pred             ccEEEeCCCCcEEeecccceecC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=5.3e-21  Score=194.63  Aligned_cols=209  Identities=25%  Similarity=0.364  Sum_probs=148.0

Q ss_pred             cCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|..++.|..|++|.||.++++. .+.+|+| +.+...     +.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence            4679999999999999999999764 5668885 322211     1000  22222334333                  


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC-
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~-  235 (407)
                         |+-...+...    ++++...        +.+++|||+.   +|+|||+||+|.+|+.-|++|++|||+.+..... 
T Consensus       136 ---gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ---GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ---chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence               3444444433    3455433        6789999999   9999999999999999999999999998643110 


Q ss_pred             -------------CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          236 -------------SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       236 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                                   .......++||+.|.|||++....|+..+|+|++|+|+||.+-|+.||.+.++++....      .+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~------vi  271 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------VI  271 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh------hh
Confidence                         11122446899999999999999999999999999999999999999998887654322      22


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK  344 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt  344 (407)
                      ....       ..+.. ...++.+..++|.+.|+.+|..|.-
T Consensus       272 sd~i-------~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  272 SDDI-------EWPEE-DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhc-------ccccc-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            2110       11111 1223446889999999999999973

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=2.9e-21  Score=184.34  Aligned_cols=174  Identities=21%  Similarity=0.367  Sum_probs=131.9

Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ..+||.|++|...+|.+||.++... ...++.....++.|++.|++|   +   +.+|+|+||.||+...+..+||.|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence            3578999999999999999754322 456788889999999999999   6   99999999999999999999999999


Q ss_pred             cceecCCCC-----ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHH
Q 015395          228 LAKLLGSES-----SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       228 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      +........     ....+..+||..||+||.+.+..|+.++||||||++|+||++ -..+|+         .+..+.. 
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~d-  471 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLTD-  471 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhhh-
Confidence            998776554     223455689999999999999999999999999999999998 333332         1111111 


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH  347 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e  347 (407)
                              +.+..+|.....+.+. -..|++.++.+.|.+||++.+
T Consensus       472 --------~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  472 --------IRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             --------hhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence                    1122222222222332 346889999999999994443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=5.7e-19  Score=157.82  Aligned_cols=134  Identities=20%  Similarity=0.338  Sum_probs=111.9

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCCh---h-----hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG---Q-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +.||+|++|.||+|.+ .+..+++|.......   .     ....+..|+.++..+.|++|.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 577899997653321   1     123567799999999999987777676677788999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ++|++|.+++...       .. .+..++.+++.+|.+||+.   +++|+|++|+|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998643       12 7789999999999999999   999999999999999 78999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.1e-18  Score=154.62  Aligned_cols=131  Identities=21%  Similarity=0.364  Sum_probs=105.4

Q ss_pred             eecccCceEEEEEEECCCCEEEEEEeccCC---hh-----hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           86 VIGEGGYGIVYYGLLEDNSKVAVKNLLNNR---GQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .||+|+||.||+|.+ ++..+++|......   ..     ....+.+|+.++..++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 46789999864321   11     1245678999999998887655444455566679999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +|++|.+++....    .       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999875431    0       7899999999999999   999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2e-18  Score=152.84  Aligned_cols=139  Identities=19%  Similarity=0.134  Sum_probs=109.1

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChh----------------------hHHHHHHHHHHHhcCCCC
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ----------------------AEREFKVEVEAIGRVRHK  135 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp  135 (407)
                      ...|.+.+.||+|+||.||++...+++.||||++......                      ....+..|+.++..+.++
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3348889999999999999999888999999986543210                      112356688888888777


Q ss_pred             c--cceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccE
Q 015395          136 N--LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI  213 (407)
Q Consensus       136 n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Ni  213 (407)
                      +  ++..++    ....+++|||++|++|......          .....++.+++.++.++|+.   +|+|+||||+||
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni  156 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI  156 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence            4  444443    2345899999999998765421          23467889999999999999   999999999999


Q ss_pred             EEeCCCCcEEeecccceecC
Q 015395          214 LIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       214 ll~~~~~~kl~DfGla~~~~  233 (407)
                      +++.++.++|+|||++....
T Consensus       157 ll~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEcCCCcEEEEECCccccCC
Confidence            99999999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=3.9e-18  Score=173.16  Aligned_cols=137  Identities=20%  Similarity=0.308  Sum_probs=110.6

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccC--C------hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--R------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ..|...+.||+|+||.||++.+.... +++|+....  .      ......+.+|+++++.++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34567899999999999999876443 444432211  1      11234678899999999999998877777777778


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++++|.+++.            ....++.+++.+|.+||+.   +++||||||+|||+ .++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999999874            3467899999999999999   99999999999999 57799999999987


Q ss_pred             ec
Q 015395          231 LL  232 (407)
Q Consensus       231 ~~  232 (407)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=4.9e-19  Score=179.60  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             CCCCccceecccCceEEEEEEECC--CCEEEEEEeccCC--hhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  153 (407)
                      ..|.+.+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+....+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457788889999999999887543  3345666554432  223334445777777776 99999999999999999999


Q ss_pred             EEeccCCChHHhh-hCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCceeccCCCCccEEEeCCC-CcEEeecccce
Q 015395          154 YEYVNNGNLEQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~  230 (407)
                      ++|..++++.+.+ ....   ...+...+-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ .++++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999999988 4432   24666677889999999999999 77   999999999999999999 99999999998


Q ss_pred             ecCC--CCceeeeeeec-cccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          231 LLGS--ESSYITTRVMG-TFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       231 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ....  .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......... ...|....     
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-----  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-----  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-----
Confidence            7765  33334445678 9999999999874 4567889999999999999999999865543311 11111100     


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                            ..+.............+++.+++..+|..|.+.+++-..
T Consensus       248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                  011122234455567788899999999999999887653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=6.7e-17  Score=141.58  Aligned_cols=136  Identities=22%  Similarity=0.234  Sum_probs=96.7

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhH--HH----------------------HHHHHHHHhcCCCC--cc
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE--RE----------------------FKVEVEAIGRVRHK--NL  137 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~--~~----------------------~~~E~~~l~~l~hp--ni  137 (407)
                      .+.||+|+||.||+|...+++.||||++........  ..                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999987899999998765321111  11                      12355555555333  23


Q ss_pred             ceeeeeeecCCeeEEEEEeccCCChHHh-hhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEE
Q 015395          138 VRLLGYCAEGAHRMLVYEYVNNGNLEQW-LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILI  215 (407)
Q Consensus       138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill  215 (407)
                      .+.+++    ...+++|||++++.+... +...     ... ..+..++.+++.++.++|. .   +|+|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            444432    245899999998554321 1111     011 5678899999999999999 8   99999999999999


Q ss_pred             eCCCCcEEeecccceecC
Q 015395          216 DKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       216 ~~~~~~kl~DfGla~~~~  233 (407)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999987553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.3e-16  Score=134.02  Aligned_cols=135  Identities=19%  Similarity=0.173  Sum_probs=112.7

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC--CccceeeeeeecCCeeEEEEEeccCC
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      +.+.||.|.++.||++...+ ..+++|.......  ...+..|+.+++.+++  .++++++.+....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45779999999999999764 7899998755433  4567889999999976  58999998888878899999999887


Q ss_pred             ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       161 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      .+..+           +......++.+++.+|++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543           4456677899999999999986434799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=4.5e-16  Score=141.39  Aligned_cols=135  Identities=19%  Similarity=0.267  Sum_probs=103.2

Q ss_pred             ceec-ccCceEEEEEEECCCCEEEEEEeccCC-------------hhhHHHHHHHHHHHhcCCCCcc--ceeeeeeecC-
Q 015395           85 KVIG-EGGYGIVYYGLLEDNSKVAVKNLLNNR-------------GQAEREFKVEVEAIGRVRHKNL--VRLLGYCAEG-  147 (407)
Q Consensus        85 ~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~-  147 (407)
                      ..|| .||.|+||.+... +..++||.+....             ......+.+|+.++..+.|++|  +..+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4577 7888899988775 6788998774321             1223457789999999998775  6677664332 


Q ss_pred             C---eeEEEEEeccC-CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEE
Q 015395          148 A---HRMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (407)
Q Consensus       148 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  223 (407)
                      .   ..++|||+++| .+|.+++...     .++..    .+.+++.+|.+||+.   ||+|+||||+|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2   23599999997 6899888642     35543    356899999999999   9999999999999999889999


Q ss_pred             eecccceec
Q 015395          224 SDFGLAKLL  232 (407)
Q Consensus       224 ~DfGla~~~  232 (407)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999987653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=1.3e-15  Score=148.41  Aligned_cols=248  Identities=22%  Similarity=0.240  Sum_probs=183.8

Q ss_pred             CCCCccceecc--cCceEEEEEEE---CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCee
Q 015395           79 NGFSDDKVIGE--GGYGIVYYGLL---EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        79 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  150 (407)
                      ..|.+.+.+|.  |.+|.||.+..   .++..+|+|+-....  ......-.+|+...+.++ |+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35777888999  99999999885   357788998743322  222223334666666774 99999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHH----HHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEee
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK----GLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSD  225 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~D  225 (407)
                      ++-+|+| +.+|..+.+...   ..++...++..+.+...    ||.++|+.   +++|-|+||+||+...+ ...+++|
T Consensus       194 fiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence            9999999 578888887652   45788888899999888    99999999   99999999999999988 8899999


Q ss_pred             cccceecCCCCceee----eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          226 FGLAKLLGSESSYIT----TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       226 fGla~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      ||+...++.......    ....|...|++||+. ...++..+|+|+||.++.+..++..+....-.      ..|    
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W----  335 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSW----  335 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCc----
Confidence            999988876542211    222577889999987 55678999999999999998887655432200      000    


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                            ..+....++.++......++..++..+++.+|..|++.+.+..
T Consensus       336 ------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 ------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                  0011111233333344455667899999999999998877654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=2.5e-14  Score=140.97  Aligned_cols=142  Identities=20%  Similarity=0.216  Sum_probs=97.5

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhH----------------------------------------HHHH
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE----------------------------------------REFK  123 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~  123 (407)
                      .+.||.|++|.||+|...+|+.||||+.........                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            467999999999999999999999998865421110                                        0133


Q ss_pred             HHHHHHhcC----CCCccceeeeee-ecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHH-HHHhhhh
Q 015395          124 VEVEAIGRV----RHKNLVRLLGYC-AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK-GLSYLHE  197 (407)
Q Consensus       124 ~E~~~l~~l----~hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~  197 (407)
                      .|+..+.++    ++.+-+.+-.++ ......++||||++|++|.++.....   ....   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence            344444444    222222222222 22345699999999999988764321   1122   2345555555 4677888


Q ss_pred             cCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       198 ~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      .   |++|+|++|.||+++.++.++|+|||++..+..
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   999999999999999999999999999877643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=2.1e-14  Score=129.83  Aligned_cols=201  Identities=20%  Similarity=0.313  Sum_probs=140.2

Q ss_pred             HhcCCCCccceeeeeeecC-----CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCce
Q 015395          129 IGRVRHKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV  203 (407)
Q Consensus       129 l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  203 (407)
                      |-.+-|.|||+++.++.+.     ....++.|||..|+|.++|++.......+......+|+.||+.||.|||+. .+.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            4445699999999998654     457899999999999999987665556788888899999999999999996 6789


Q ss_pred             eccCCCCccEEEeCCCCcEEeecccceecCC----CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC
Q 015395          204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGS----ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG  279 (407)
Q Consensus       204 vH~Dlkp~Nill~~~~~~kl~DfGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg  279 (407)
                      +|+++..+-|++..+|-+|+.-- .......    ..........+-++|.+||.=.....+.++|||+||.+..+|..+
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999988887421 1111110    000011112356789999977677788899999999999999887


Q ss_pred             CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       280 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ...-......  ....+-+...+..      +...           .-..++..|++..|..||++++++.
T Consensus       279 Eiq~tnseS~--~~~ee~ia~~i~~------len~-----------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESK--VEVEENIANVIIG------LENG-----------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCcce--eehhhhhhhheee------ccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence            6542221111  0000001111000      0000           1245778999999999999998775

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=5e-14  Score=140.56  Aligned_cols=145  Identities=16%  Similarity=0.136  Sum_probs=92.6

Q ss_pred             CCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChh----------------------------------hHHHH-
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQ----------------------------------AEREF-  122 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~----------------------------------~~~~~-  122 (407)
                      ..|.. +.||+|++|.||+|...+ |+.||||+..+....                                  ..+.+ 
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 789999999999999877 999999998654211                                  01112 


Q ss_pred             -----HHHHHHHhcCC----CCccceeeeeee-cCCeeEEEEEeccCCChHHhh--hCCCCCCCCCCHHHHHHHHHHHHH
Q 015395          123 -----KVEVEAIGRVR----HKNLVRLLGYCA-EGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAK  190 (407)
Q Consensus       123 -----~~E~~~l~~l~----hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~~  190 (407)
                           ..|+..+.+++    +.+.+.+-.++. -....+|||||++|+.+.++-  .........+....+..++.|+. 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence                 22332222221    222222222221 134567999999999998742  22111111244444444555554 


Q ss_pred             HHHhhhhcCCCceeccCCCCccEEEeCCC----CcEEeecccceecCC
Q 015395          191 GLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDFGLAKLLGS  234 (407)
Q Consensus       191 ~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla~~~~~  234 (407)
                            ..   |++|+|+||.||+++.++    .++++|||++..++.
T Consensus       278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  34   999999999999999888    999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=4.2e-13  Score=115.43  Aligned_cols=130  Identities=18%  Similarity=0.110  Sum_probs=94.6

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEEEeccCCCh
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      ++.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+.++ ++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            456899999999999875 77899997654432 22345678888888865444 44554433  345899999999887


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--CCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--EPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      .+.-         .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5430         0   11345678999999999982  12359999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=2.8e-12  Score=126.60  Aligned_cols=166  Identities=21%  Similarity=0.242  Sum_probs=125.7

Q ss_pred             ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHH
Q 015395          100 LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE  179 (407)
Q Consensus       100 ~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~  179 (407)
                      ..++.+|.|...............+-+..|+.++||||+++++.++..+..|||+|.+.  .|..++..       +...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence            44677888877765555444456667888999999999999999999999999999983  67777754       3466


Q ss_pred             HHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCC
Q 015395          180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM  259 (407)
Q Consensus       180 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  259 (407)
                      .+..-+.||+.||.|||+.+  +++|++|.-+.|+|+..|..||++|-++........ .......--.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            67778899999999998653  999999999999999999999999988765432221 011111122466676553322


Q ss_pred             CCcchhHHHHHHHHHHHHhC
Q 015395          260 LNERSDVYSFGILIMEVISG  279 (407)
Q Consensus       260 ~~~~sDiwslG~il~elltg  279 (407)
                        -..|.|.|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              456999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=9.1e-12  Score=108.57  Aligned_cols=137  Identities=15%  Similarity=0.137  Sum_probs=98.4

Q ss_pred             cceecccCceEEEEEEECC-------CCEEEEEEeccCC----------------------hhhHHH----HHHHHHHHh
Q 015395           84 DKVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNR----------------------GQAERE----FKVEVEAIG  130 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~----------------------~~~~~~----~~~E~~~l~  130 (407)
                      ...||.|--+.||.|...+       +..+|||+.+...                      ......    ...|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543       4789999663210                      011122    337999999


Q ss_pred             cCCC--CccceeeeeeecCCeeEEEEEeccCCChHH-hhhCCCCCCCCCCHHHHHHHHHHHHHHHHhh-hhcCCCceecc
Q 015395          131 RVRH--KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYL-HEGLEPKVVHR  206 (407)
Q Consensus       131 ~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~  206 (407)
                      ++..  -++++.+++    ..-+|||||+.+..+.. .+..     ..++......+..+++.+|..| |..   +|+|+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            8853  466677764    45689999997654422 2221     2345556677889999999998 888   99999


Q ss_pred             CCCCccEEEeCCCCcEEeecccceecC
Q 015395          207 DIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       207 Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||++.|||+++ +.+.|+|||.+....
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999974 689999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.36  E-value=1.3e-13  Score=141.35  Aligned_cols=252  Identities=22%  Similarity=0.225  Sum_probs=175.3

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      .+...+.+.+.+.+-.|.++.++.+.-. .+...++|......   ....+....+-.++-..++|.++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            3456778889999999999999988743 34444554332211   1111112222222222345666655555556678


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .+++++|+.+++|...++..    +..+..-...++..+..++++||..   .+.|+|++|.|+++..++..+++|||+.
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             cchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence            89999999999999999876    4566666677778888999999998   7999999999999999999999999843


Q ss_pred             eecCCC------------------------------CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC
Q 015395          230 KLLGSE------------------------------SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG  279 (407)
Q Consensus       230 ~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg  279 (407)
                      ...+..                              .........||+.|.+||...+......+|+|++|++++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            322100                              00112235689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHH
Q 015395          280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG  346 (407)
Q Consensus       280 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~  346 (407)
                      .+||...++......+      ...       +...+. -.........+++.+.+..+|.+|..+.
T Consensus      1032 ~pp~na~tpq~~f~ni------~~~-------~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENI------LNR-------DIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhhhhhcc------ccC-------CCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence            9999876665433111      111       111111 1223444578888999999999998765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=9.1e-13  Score=128.70  Aligned_cols=248  Identities=19%  Similarity=0.195  Sum_probs=176.0

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC--CCCEEEEEEeccCChhhHHH--HHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNNRGQAERE--FKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~~~~~--~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      ....+|..+..||.|.|+.|+.+..+  ++..+++|.+.+.......+  -..|+-+...+ .|.+++.++..+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567999999999999999988854  57789999776653332222  22355555555 488999988888888888


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEeecccc
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLA  229 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla  229 (407)
                      ++--|||+++++...+...    ..+.+...+.+..|++.++.++|+.   .++|+|+||+||++.++ +..++.|||.+
T Consensus       342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            8999999999887776332    4577888899999999999999999   99999999999999886 78899999998


Q ss_pred             eecCCCCceeeeeeecccccc--CccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYV--APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ..+...    .......-+++  ++.......+..+.|++|||.-+.+.+++..--. ...       .|          
T Consensus       415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~-------~~----------  472 (524)
T KOG0601|consen  415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV-------QS----------  472 (524)
T ss_pred             ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCc-ccc-------cc----------
Confidence            642211    11112233444  5666677789999999999999999998753211 100       00          


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ..+.....+....  ....+..+...++.+++..||.+.++....+.
T Consensus       473 ~~i~~~~~p~~~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  473 LTIRSGDTPNLPG--LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eeeecccccCCCc--hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            0011111111111  11456777778889999999998887665443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.9e-11  Score=102.13  Aligned_cols=131  Identities=21%  Similarity=0.351  Sum_probs=98.2

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccC---Chh-----hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNN---RGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ..+++|+-+.+|.+.+. |.++++|.=..+   .+.     ......+|+++++++.--.|.--+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 445666643222   111     123456799999888654444333345566778899999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ++|-.|.+++...           ...++..+-..+.-||..   +|+|+||.++||++..++ +.++||||+.+
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888653           245677788888999999   999999999999998874 99999999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=2.3e-11  Score=109.16  Aligned_cols=142  Identities=20%  Similarity=0.249  Sum_probs=108.8

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCC--CccceeeeeeecC---CeeEEEEEecc
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRH--KNLVRLLGYCAEG---AHRMLVYEYVN  158 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~---~~~~lv~e~~~  158 (407)
                      +.|+.|..+.||++...+|..+++|....... .....+..|+.+++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987668899997654332 134567889999999865  3467777776654   36689999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC---------------------------------------
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL---------------------------------------  199 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  199 (407)
                      |.++.+.+..     ..++......++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776532     24677777788888888888888421                                       


Q ss_pred             --------------CCceeccCCCCccEEEeC--CCCcEEeeccccee
Q 015395          200 --------------EPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKL  231 (407)
Q Consensus       200 --------------~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~  231 (407)
                                    ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.29  E-value=2.1e-10  Score=107.76  Aligned_cols=265  Identities=14%  Similarity=0.145  Sum_probs=167.0

Q ss_pred             CccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeee------ecC-CeeEEE
Q 015395           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYC------AEG-AHRMLV  153 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~------~~~-~~~~lv  153 (407)
                      .....||+|+-+.+|-.-  +-...+.|+.............   ..|... .||-+-.-+.+=      -+. ...-++
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            355679999999999432  2223456766555444333322   223333 466433212211      122 236788


Q ss_pred             EEeccCCC-hHHhhh--CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          154 YEYVNNGN-LEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~-L~~~l~--~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |..+.+.. +..++.  .++..+....|...++.++.++.+.+.||..   |.+-+|+.++|+||++++.|.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            88886652 223321  2345567789999999999999999999999   99999999999999999999999855433


Q ss_pred             ecCCCCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCc-----hhhhHHHHHH
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISG-RIPVDYSRPP-----EEVNLIEWLK  299 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~-----~~~~~~~~~~  299 (407)
                      ....+.  ...-.+|...|.+||.-.     +..-+..+|.|.||++++++|.| +.||.+-...     .....+....
T Consensus       166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            322221  222346899999999764     33446678999999999999986 9999763211     0000111000


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcC--CCCCCCHHHHHHHHHhccC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN--AQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--p~~RPt~~evl~~L~~~~~  357 (407)
                       .........-+.+.....+..-++..+..|..+|+...  +.-|||++..+..|..+..
T Consensus       244 -f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         244 -FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             -eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence             00000111112233334455566778889999998764  5689999988887776543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=5e-11  Score=100.22  Aligned_cols=143  Identities=17%  Similarity=0.265  Sum_probs=104.1

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccC--------ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--------RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ...+|-+|+-+.|+++.+. |+...||.-...        ..-...+..+|+++|.++.--.|.--.=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999886 777777743222        1123346778999999886444433333455666678999


Q ss_pred             EeccC-CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC---cEEeecccce
Q 015395          155 EYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAK  230 (407)
Q Consensus       155 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGla~  230 (407)
                      ||++| .++.+++.....  ..........++..|-+.+.-||.+   +|+|+||..+||++..++.   +.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99976 478888865432  1222233367889999999999999   9999999999999966543   5899999976


Q ss_pred             e
Q 015395          231 L  231 (407)
Q Consensus       231 ~  231 (407)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=9.1e-10  Score=95.66  Aligned_cols=126  Identities=25%  Similarity=0.288  Sum_probs=82.7

Q ss_pred             EEEEEEECCCCEEEEEEeccCC--------------------------hhhHHHHHHHHHHHhcCCCC--ccceeeeeee
Q 015395           94 IVYYGLLEDNSKVAVKNLLNNR--------------------------GQAEREFKVEVEAIGRVRHK--NLVRLLGYCA  145 (407)
Q Consensus        94 ~V~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~  145 (407)
                      .||.|...++..+|||......                          ........+|++.|.++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999763211                          01123466799999999755  567776553 


Q ss_pred             cCCeeEEEEEecc--CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHh-hhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          146 EGAHRMLVYEYVN--NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY-LHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       146 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                         .-+|||||++  |..+..+....      ++......++.+++..+.. +|..   ||+|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  55554443321      2233445677777775555 5787   99999999999999988 999


Q ss_pred             EeecccceecC
Q 015395          223 VSDFGLAKLLG  233 (407)
Q Consensus       223 l~DfGla~~~~  233 (407)
                      |+|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.09  E-value=4.2e-09  Score=101.45  Aligned_cols=171  Identities=18%  Similarity=0.246  Sum_probs=128.2

Q ss_pred             CceEEEEEE-ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee----cCCeeEEEEEeccC-CChHH
Q 015395           91 GYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA----EGAHRMLVYEYVNN-GNLEQ  164 (407)
Q Consensus        91 ~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~lv~e~~~~-g~L~~  164 (407)
                      --.+.|++. ..+|..|++|++.............-++.++++.|+|||++.++|.    ....+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345678888 4579999999995544444433444677889999999999998876    34568999999976 46666


Q ss_pred             hhhCCC-----------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          165 WLHGDV-----------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       165 ~l~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      +-....           ......++..+|.++.|+..||.++|+.   |+.-+-|.+.+||++.+.+++|+..|...++.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            542211           1124578899999999999999999999   99999999999999999999998888776654


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP  282 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~P  282 (407)
                      .+..               |.+..   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4320               11111   2356899999999999998643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.05  E-value=1.4e-09  Score=97.42  Aligned_cols=135  Identities=23%  Similarity=0.197  Sum_probs=97.6

Q ss_pred             CCCccceecccCceEEEEEEECCCCEEEEEEeccCC----------------------hhhHHHHHHHHHHHhcCCCC--
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR----------------------GQAEREFKVEVEAIGRVRHK--  135 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp--  135 (407)
                      =..+...||-|--+.||.|...+|.++|||.-....                      .......++|.++|.+|.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356778999999999999999999999999542211                      11223466799999998654  


Q ss_pred             ccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE
Q 015395          136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI  215 (407)
Q Consensus       136 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill  215 (407)
                      .|++.+++    +.-.+||||++|-.|...-         +.....-.++..|+.-+..+-..   ||||+|+.+-||++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV  235 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV  235 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence            67777664    4568999999886664432         12223334444445555544455   99999999999999


Q ss_pred             eCCCCcEEeecccce
Q 015395          216 DKHWNPKVSDFGLAK  230 (407)
Q Consensus       216 ~~~~~~kl~DfGla~  230 (407)
                      +++|.+.++||--+.
T Consensus       236 ~~dg~~~vIDwPQ~v  250 (304)
T COG0478         236 TEDGDIVVIDWPQAV  250 (304)
T ss_pred             ecCCCEEEEeCcccc
Confidence            999999999997554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.01  E-value=7.1e-09  Score=95.41  Aligned_cols=140  Identities=16%  Similarity=0.089  Sum_probs=97.1

Q ss_pred             eecccCceEEEEEEECCCCEEEEEEeccCChh-----------hHHHHHHHHHHHhcCCCCcc--ceeeeeeec-----C
Q 015395           86 VIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-----------AEREFKVEVEAIGRVRHKNL--VRLLGYCAE-----G  147 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpni--v~~~~~~~~-----~  147 (407)
                      .+-.-....|+++.. +|+.+.||......-.           ....+.+|...+.++..-+|  +..+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333333344666655 4678999966332210           11136678888877743333  444555432     2


Q ss_pred             CeeEEEEEeccCC-ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-------CC
Q 015395          148 AHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-------HW  219 (407)
Q Consensus       148 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~  219 (407)
                      ...+||||++++. +|.+++.....  .+.+......++.+++..+.-||..   ||+|+|+++.|||++.       ++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            3568999999876 89998854211  3456677788999999999999999   9999999999999975       46


Q ss_pred             CcEEeeccccee
Q 015395          220 NPKVSDFGLAKL  231 (407)
Q Consensus       220 ~~kl~DfGla~~  231 (407)
                      .+.|+||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=2.4e-08  Score=88.71  Aligned_cols=106  Identities=21%  Similarity=0.241  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHhcCCCC--ccceeeeeeecC----CeeEEEEEeccCC-ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHH
Q 015395          120 REFKVEVEAIGRVRHK--NLVRLLGYCAEG----AHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL  192 (407)
Q Consensus       120 ~~~~~E~~~l~~l~hp--niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L  192 (407)
                      ....+|...+..+..-  .+++.+++.+..    ...+||+|++++. +|.+++....    ..+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            3456677777766433  345666665542    2458999999874 8999987642    256667788999999999


Q ss_pred             HhhhhcCCCceeccCCCCccEEEeCCC---CcEEeecccceec
Q 015395          193 SYLHEGLEPKVVHRDIKSSNILIDKHW---NPKVSDFGLAKLL  232 (407)
Q Consensus       193 ~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~~  232 (407)
                      .-||..   ||+|+|+++.|||++.++   .+.++||+.++..
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=2e-07  Score=81.73  Aligned_cols=139  Identities=16%  Similarity=0.126  Sum_probs=101.4

Q ss_pred             ecccCceEEEEEEECCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCC--ccceeeeeeec----CCeeEEEE
Q 015395           87 IGEGGYGIVYYGLLEDNSKVAVKNLLNNR------GQAEREFKVEVEAIGRVRHK--NLVRLLGYCAE----GAHRMLVY  154 (407)
Q Consensus        87 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~----~~~~~lv~  154 (407)
                      -|+||.+-|+..... |..+.+|.....-      +-....|.+|+..|..+..-  .+++.+.....    ....+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467999999987765 4478899764211      22456788899988888532  25555522211    12458999


Q ss_pred             EeccC-CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC--cEEeeccccee
Q 015395          155 EYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--PKVSDFGLAKL  231 (407)
Q Consensus       155 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla~~  231 (407)
                      |-+.+ .+|.+++.....  .+.+......++.+++..+.-||+.   |+.|+|+.+.||+++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 488888865321  3567777889999999999999999   9999999999999986677  99999976543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.72  E-value=6.2e-08  Score=96.55  Aligned_cols=142  Identities=18%  Similarity=0.205  Sum_probs=88.8

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChhhH----------------------------------------HHHHH
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE----------------------------------------REFKV  124 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~~  124 (407)
                      ..|+.++-|.||+|...+|+.||||+.++.-....                                        -++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999998765422111                                        01222


Q ss_pred             HHHHHhcCC-----CCccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 015395          125 EVEAIGRVR-----HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL  199 (407)
Q Consensus       125 E~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  199 (407)
                      |+.-+.+++     .++|.=--=+++-.+...++|||++|-.+.+......   ..++...+.....++.  +.-+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence            333333331     2222111112223455689999999999988743221   1234333322222221  1111123 


Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                        |++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              999999999999999999999999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.68  E-value=3e-09  Score=105.85  Aligned_cols=150  Identities=20%  Similarity=0.292  Sum_probs=102.4

Q ss_pred             HHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee--------eeeeeccccccCccccCC
Q 015395          186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI--------TTRVMGTFGYVAPEYAST  257 (407)
Q Consensus       186 ~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~  257 (407)
                      .+++.||.|+|..  .++||++|.|++|.++.++..||+.|+.+..........        ..-..-...|.|||.+..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3445999999986  489999999999999999999999999876543311110        011123457999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccC
Q 015395          258 GMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD  336 (407)
Q Consensus       258 ~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  336 (407)
                      ...+.++|+|||||.+|.+..| +.-+............     .        ..+..-...+...++.++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----~--------~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----R--------NLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----h--------cccccccccccccCcHHHHHHHHHHhc
Confidence            8889999999999999999854 4444322211111000     0        000111112234566778888899999


Q ss_pred             cCCCCCCCHHHHHH
Q 015395          337 PNAQKRPKMGHVVH  350 (407)
Q Consensus       337 ~dp~~RPt~~evl~  350 (407)
                      .++..||++..+..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999997776654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.65  E-value=5.6e-07  Score=79.18  Aligned_cols=138  Identities=15%  Similarity=0.181  Sum_probs=93.0

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHH---------HHHHHHhcC---CCCccceeeee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK---------VEVEAIGRV---RHKNLVRLLGY  143 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~E~~~l~~l---~hpniv~~~~~  143 (407)
                      +..++|...+++-......|.+-... +..+++|..........+.+.         +++..+.++   ..-....++-+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            45678999999998888888777665 788999987665433333322         233333333   22233332222


Q ss_pred             ee-----cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          144 CA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       144 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      ..     -....+++|||++|-.|.+...        +++    .+...+..++.-||..   |+.|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            22     2234578999999988866532        222    2445667789999999   99999999999999966


Q ss_pred             CCcEEeecccce
Q 015395          219 WNPKVSDFGLAK  230 (407)
Q Consensus       219 ~~~kl~DfGla~  230 (407)
                       .++++||+..+
T Consensus       172 -~i~iID~~~k~  182 (229)
T PF06176_consen  172 -GIRIIDTQGKR  182 (229)
T ss_pred             -cEEEEECcccc
Confidence             49999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=4.3e-07  Score=81.79  Aligned_cols=139  Identities=19%  Similarity=0.179  Sum_probs=84.3

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc--cceeeeeeecCCeeEEEEEeccCCC-
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYVNNGN-  161 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~g~-  161 (407)
                      ..||+|..+.||+.   .+..+++|......  ....+.+|.++++.+..-.  +.+.+++....+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999974   25567888765432  3345678999998885333  4677888777778899999998863 


Q ss_pred             hHHh---------------------hhCCCCCCCCCCHHHHHHHHHHH----------HH-HHHhhhhc-CCCceeccCC
Q 015395          162 LEQW---------------------LHGDVGPCSPLTWEIRMNIILGT----------AK-GLSYLHEG-LEPKVVHRDI  208 (407)
Q Consensus       162 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~qi----------~~-~L~~LH~~-~~~~ivH~Dl  208 (407)
                      +...                     ||.-......+.... ..+..++          .. ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            2111                     121100001111000 0010000          00 11122211 1235789999


Q ss_pred             CCccEEEeCCCCcEEeecccce
Q 015395          209 KSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       209 kp~Nill~~~~~~kl~DfGla~  230 (407)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999887 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.59  E-value=8.2e-07  Score=79.03  Aligned_cols=150  Identities=21%  Similarity=0.228  Sum_probs=95.1

Q ss_pred             HHHHHHhcCCCCcc---ceecccCceEEEEEEECCCCEEEEEEeccCChhhH------------------------HHHH
Q 015395           71 LRELEVSTNGFSDD---KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE------------------------REFK  123 (407)
Q Consensus        71 ~~~~~~~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~------------------------~~~~  123 (407)
                      +..+.--.++..+.   ..|+.|--+.||+|...++..+|+|+.........                        ....
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            33443334444443   35667888899999988899999998754321111                        1123


Q ss_pred             HHHHHHhcCC--CCccceeeeeeecCCeeEEEEEeccCCCh-HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cC
Q 015395          124 VEVEAIGRVR--HKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GL  199 (407)
Q Consensus       124 ~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~  199 (407)
                      .|+.-|+++.  +=.+++-+.+.    .-.|||||+....+ .-.|..     .++...+...+..++++.+.-|-. . 
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            4555555552  23334444433    23799999954311 111111     123333677778888888888876 5 


Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                        ++||+||+.-|||+. ++.+.|+|||-|....
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence              999999999999999 7799999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.56  E-value=1.7e-06  Score=77.94  Aligned_cols=144  Identities=22%  Similarity=0.252  Sum_probs=83.7

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ccceeeeeee---cCCeeEEEEEecc
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGYCA---EGAHRMLVYEYVN  158 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~---~~~~~~lv~e~~~  158 (407)
                      ++.|+.|..+.||++...+ +.+++|.....  .....+..|..+++.+...  .+.+++.+..   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999886 69999976444  4556777788888877432  3566666432   3345789999999


Q ss_pred             CCChHH----------------hh---hCCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHhhhh
Q 015395          159 NGNLEQ----------------WL---HGDVGPCSPLTWEIR---------MNI------------ILGTAK-GLSYLHE  197 (407)
Q Consensus       159 ~g~L~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~qi~~-~L~~LH~  197 (407)
                      |..+..                .+   +........+.....         ...            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111011111111110         000            011112 2333332


Q ss_pred             c----CCCceeccCCCCccEEEe-CCCCcEEeecccce
Q 015395          198 G----LEPKVVHRDIKSSNILID-KHWNPKVSDFGLAK  230 (407)
Q Consensus       198 ~----~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~  230 (407)
                      .    ....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1    234799999999999999 55666799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=9.6e-07  Score=87.88  Aligned_cols=141  Identities=18%  Similarity=0.190  Sum_probs=88.5

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhh-------------------------------HH------HHHHHH
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQA-------------------------------ER------EFKVEV  126 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~------~~~~E~  126 (407)
                      .+.||.-+.|.||+|+.++|..||||+-++.-...                               .+      +|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46799999999999999999999999765542111                               00      122233


Q ss_pred             HHHhcC----CCCc------cceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 015395          127 EAIGRV----RHKN------LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH  196 (407)
Q Consensus       127 ~~l~~l----~hpn------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH  196 (407)
                      +-..+.    .|-+      |++++-.  -.....++||||+|..+.+.-.-..   ..++...+..-+.++..-+-+-|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHHHHHHHhc
Confidence            322222    2333      3333322  2345789999999987765432211   23555554444433322222222


Q ss_pred             hcCCCceeccCCCCccEEEeC----CCCcEEeecccceecCC
Q 015395          197 EGLEPKVVHRDIKSSNILIDK----HWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       197 ~~~~~~ivH~Dlkp~Nill~~----~~~~kl~DfGla~~~~~  234 (407)
                           |.+|+|-.|.||+++.    ++.+.+.|||+...+..
T Consensus       321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence                 8999999999999983    67899999999876643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=2.2e-06  Score=72.30  Aligned_cols=131  Identities=16%  Similarity=0.243  Sum_probs=89.4

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccc-eeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ....+.|++|.+|.||+|.+. +..+|+|+-..+  .....+..|+++|..+.-.++. +++.+-    ..++.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence            445678999999999999998 558899965443  4456788899999988776664 444433    23556999988


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCC-CccEEEeCCCCcEEeecccceec
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK-SSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk-p~Nill~~~~~~kl~DfGla~~~  232 (407)
                      -.|..+-...       ...    -...+++.---|-..   ||-|+.|. |...+|..++.+.|+||..|+..
T Consensus        97 ~~L~~~~~~~-------~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIGG-------DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhcc-------cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8887665321       112    223344443344445   99999987 44444444559999999988743

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.39  E-value=3.2e-08  Score=97.71  Aligned_cols=185  Identities=17%  Similarity=0.114  Sum_probs=131.6

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc-cceeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +....-+++|+++++++.+....+....+.+...     ....-++++|.+++||| .+..++-+......+++++++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3444558889999999887433333334444322     33445889999999999 66777777777889999999977


Q ss_pred             C-ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce
Q 015395          160 G-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       160 g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  238 (407)
                      + +........   .-.+...+...+.+.-+++|++||+.   .=+|+|    ||+..+ +..+..||+....+....  
T Consensus       319 ~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  319 GRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             CccccccCChh---hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence            6 222211110   01244445556677778899999986   558888    777766 579999999988776554  


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV  283 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf  283 (407)
                      ......+|+.|+|||+.....+..+.|.|++|.-..+|--|-+|-
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            234456899999999999999999999999998766666666654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.39  E-value=1.4e-05  Score=69.66  Aligned_cols=105  Identities=22%  Similarity=0.244  Sum_probs=81.9

Q ss_pred             HHHHHHHhcCCC-CccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCC
Q 015395          123 KVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP  201 (407)
Q Consensus       123 ~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  201 (407)
                      ..|.-+|+.+++ +++++++|+|-.    +++.||...+++...- .........+|..+.+++.++++.+.+|+.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            347888888875 699999999843    7799999876654220 0000113478999999999999999999986544


Q ss_pred             ceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       202 ~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      .+.-.|++++|+-+++++++|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=4.8e-06  Score=76.01  Aligned_cols=140  Identities=17%  Similarity=0.125  Sum_probs=82.6

Q ss_pred             ecccCc-eEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEeccCCChHH
Q 015395           87 IGEGGY-GIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ  164 (407)
Q Consensus        87 lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  164 (407)
                      |..|.. ..||+.... +..+++|......   ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            344444 888988754 4678888764432   334566888887773 3446677777776667899999999887764


Q ss_pred             hh-------------------hCCCCCCCCCCHH--HHHHHHHH--------------------HHHHHHhhhh----cC
Q 015395          165 WL-------------------HGDVGPCSPLTWE--IRMNIILG--------------------TAKGLSYLHE----GL  199 (407)
Q Consensus       165 ~l-------------------~~~~~~~~~l~~~--~~~~i~~q--------------------i~~~L~~LH~----~~  199 (407)
                      ..                   +.......++...  ........                    +...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   1111000111100  00000000                    1111112211    11


Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      .+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3468999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.34  E-value=6.1e-06  Score=88.33  Aligned_cols=79  Identities=10%  Similarity=0.255  Sum_probs=57.3

Q ss_pred             cceecccCceEEEEEEECCC---CEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCcc--ceeeeeeecC---CeeEEE
Q 015395           84 DKVIGEGGYGIVYYGLLEDN---SKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNL--VRLLGYCAEG---AHRMLV  153 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~---~~~~lv  153 (407)
                      ++.|+.|.++.+|+....++   ..+++|+..... ......+.+|+++|+.+. |.+|  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999886653   367778654332 123456788999999985 6665  7778877654   467899


Q ss_pred             EEeccCCCh
Q 015395          154 YEYVNNGNL  162 (407)
Q Consensus       154 ~e~~~~g~L  162 (407)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.33  E-value=1.1e-05  Score=70.66  Aligned_cols=129  Identities=21%  Similarity=0.317  Sum_probs=90.4

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCC----------------hhhHHHHHHHHHHHhcCC------CCcccee
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR----------------GQAEREFKVEVEAIGRVR------HKNLVRL  140 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~~  140 (407)
                      -...||+|+.=.||  .+.+....+||+.....                .....+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            34579999999999  56667778899886655                122344445555544443      7899999


Q ss_pred             eeeeecCCeeEEEEEeccC------CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEE
Q 015395          141 LGYCAEGAHRMLVYEYVNN------GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (407)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil  214 (407)
                      +|+.+.+.-..+|+|.+.+      -+|.+++...     .++. .....+   -+-..||-+.   +|+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L---~~f~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQAL---DEFKRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHH---HHHHHHHHHc---CCeecCCCcccEE
Confidence            9999998888999998743      2678888543     3554 333333   3445677777   8999999999999


Q ss_pred             EeCCC----CcEEee
Q 015395          215 IDKHW----NPKVSD  225 (407)
Q Consensus       215 l~~~~----~~kl~D  225 (407)
                      +....    .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            95432    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.6e-05  Score=72.09  Aligned_cols=73  Identities=14%  Similarity=0.190  Sum_probs=45.0

Q ss_pred             ceecccCce-EEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC---ccceeeeeeecC---CeeEEEEEec
Q 015395           85 KVIGEGGYG-IVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK---NLVRLLGYCAEG---AHRMLVYEYV  157 (407)
Q Consensus        85 ~~lg~G~~g-~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~---~~~~lv~e~~  157 (407)
                      +.|+.|+.. .||+.    +..+++|.....  .....+..|..+|+.+...   -+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457767666 48865    235777854332  2344677899888877521   344444443322   2458899999


Q ss_pred             cCCChH
Q 015395          158 NNGNLE  163 (407)
Q Consensus       158 ~~g~L~  163 (407)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.11  E-value=3.6e-05  Score=69.75  Aligned_cols=74  Identities=15%  Similarity=0.065  Sum_probs=47.8

Q ss_pred             cceecccCceEEEEEEECC--CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC-ccceeeeeeecCCeeEEEEEeccCC
Q 015395           84 DKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVYEYVNNG  160 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~~~~g  160 (407)
                      ++.|..|-...+|++...+  +..|++|+...... .......|+.+++.+... -.+++++.+.    -.++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567888889999988664  67889996643321 112334688888877433 3445554432    24899999987


Q ss_pred             Ch
Q 015395          161 NL  162 (407)
Q Consensus       161 ~L  162 (407)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            66

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.06  E-value=2.9e-05  Score=71.44  Aligned_cols=139  Identities=12%  Similarity=0.057  Sum_probs=78.1

Q ss_pred             ecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEEEeccCCChHHh
Q 015395           87 IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNNGNLEQW  165 (407)
Q Consensus        87 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L~~~  165 (407)
                      +..|-.+.+|+... ++.++++|...............|..+++.+..-.+ .+++....    -++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55678889998874 466788886543322211234668888888754333 44444432    3689999988765421


Q ss_pred             -----------------hhCCCCCCCCCCHHH-HHHHHHHH---------HHHHHhhhhc-----CCCceeccCCCCccE
Q 015395          166 -----------------LHGDVGPCSPLTWEI-RMNIILGT---------AKGLSYLHEG-----LEPKVVHRDIKSSNI  213 (407)
Q Consensus       166 -----------------l~~~~~~~~~l~~~~-~~~i~~qi---------~~~L~~LH~~-----~~~~ivH~Dlkp~Ni  213 (407)
                                       ||.......+++... +..+..++         ...+..+-..     .+..++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             122211111222221 11221111         1111111111     123589999999999


Q ss_pred             EEeCCCCcEEeeccccee
Q 015395          214 LIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       214 ll~~~~~~kl~DfGla~~  231 (407)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 89999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.00  E-value=8.7e-05  Score=69.79  Aligned_cols=79  Identities=10%  Similarity=0.041  Sum_probs=56.2

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC---Cccceeeeeeec---CCeeEEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH---KNLVRLLGYCAE---GAHRMLVY  154 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~---~~~~~lv~  154 (407)
                      ....+.||.|..+.||.....++ ++++|....  ......+..|+..|+.+.-   -.++++++++..   .+..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            44456799999999998876555 466776432  1123467778888888742   367888887654   36689999


Q ss_pred             EeccCCCh
Q 015395          155 EYVNNGNL  162 (407)
Q Consensus       155 e~~~~g~L  162 (407)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.99  E-value=8.1e-05  Score=64.90  Aligned_cols=125  Identities=26%  Similarity=0.361  Sum_probs=88.8

Q ss_pred             CCCCccceecccCc-eEEEEEEECCCCEEEEEEeccC---C--------h----------hhHHHHHHHHHHHhcCC---
Q 015395           79 NGFSDDKVIGEGGY-GIVYYGLLEDNSKVAVKNLLNN---R--------G----------QAEREFKVEVEAIGRVR---  133 (407)
Q Consensus        79 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~---~--------~----------~~~~~~~~E~~~l~~l~---  133 (407)
                      .+++.++.||.|.- |.||++... |..+|+|.+...   .        .          .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            57889999999999 999999987 679999983210   0        0          11124677888877774   


Q ss_pred             CCcc--ceeeeeeecC------------------CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 015395          134 HKNL--VRLLGYCAEG------------------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS  193 (407)
Q Consensus       134 hpni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~  193 (407)
                      +.++  ++++||..-.                  ....||.||++...             .+..    .-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence            5566  8999986311                  12367888875532             1222    23456667788


Q ss_pred             hhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       194 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .+|..   ||+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89988   9999999999986     3589999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.90  E-value=3.7e-05  Score=81.45  Aligned_cols=196  Identities=20%  Similarity=0.253  Sum_probs=133.7

Q ss_pred             HHHHHHHHhcCCCCccceeeeeeecCCee----EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh
Q 015395          122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE  197 (407)
Q Consensus       122 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  197 (407)
                      ...|+..+..+.|+|++.++.+..+....    .+..++|..-++.+.+..-    ...+....+.+..++..||.|+|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHHH
Confidence            44577788889999999999887654332    3456778777888877665    578889999999999999999999


Q ss_pred             cCCCceeccCCCCc---cEEEeCCCCcEEe--ecccceecCCCCceeeeeeeccccccCccccCCCCCCcc--hhHHHHH
Q 015395          198 GLEPKVVHRDIKSS---NILIDKHWNPKVS--DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER--SDVYSFG  270 (407)
Q Consensus       198 ~~~~~ivH~Dlkp~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDiwslG  270 (407)
                      .   ...|.-|..+   +.-++..+.+.++  ||+....+.......  ....+..|.++|......+..+  .|+|++|
T Consensus       305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence            8   5544444433   3444555666666  888777655433221  1233556788887766655544  7999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          271 ILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       271 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ..+..+..|..+-......                  ..+++....        ..+.++..+|+..++++|+++.+++.
T Consensus       380 ll~~~~~~~~~i~~~~~~~------------------~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVP------------------VSLLDVLST--------SELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCcccccccch------------------hhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhh
Confidence            9999998876553211100                  011111111        14677888999999999999999987


Q ss_pred             HH
Q 015395          351 ML  352 (407)
Q Consensus       351 ~L  352 (407)
                      ..
T Consensus       434 ~~  435 (1351)
T KOG1035|consen  434 HP  435 (1351)
T ss_pred             ch
Confidence            44

>PRK05231 homoserine kinase; Provisional

Probab=97.84  E-value=0.00037  Score=66.27  Aligned_cols=143  Identities=13%  Similarity=0.131  Sum_probs=76.1

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ccceeeee------eecCCeeEEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGY------CAEGAHRMLVYE  155 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~------~~~~~~~~lv~e  155 (407)
                      .+.|+.|....+|+....++ .+++|+....   ....+..|+.+++.|...  .+++++..      ....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45577788889998886654 6888976521   122333345555444211  13333321      223456789999


Q ss_pred             eccCCChHH-----h---------hhCCCCCC-------CCC-CHHHHHH------------HHHH-HHHHHHhhhh---
Q 015395          156 YVNNGNLEQ-----W---------LHGDVGPC-------SPL-TWEIRMN------------IILG-TAKGLSYLHE---  197 (407)
Q Consensus       156 ~~~~g~L~~-----~---------l~~~~~~~-------~~l-~~~~~~~------------i~~q-i~~~L~~LH~---  197 (407)
                      |++|..+..     +         +|......       ..+ .+...+.            ...+ +...++.+..   
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            998874421     1         11111000       011 1111111            1111 1112222221   


Q ss_pred             -cCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       198 -~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                       ..+.+++|+|+.+.||+++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             135589999999999999976556899999775

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.80  E-value=2.3e-05  Score=72.37  Aligned_cols=143  Identities=17%  Similarity=0.109  Sum_probs=94.8

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh------------------h----hHHHHHHHHHH
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG------------------Q----AEREFKVEVEA  128 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~----~~~~~~~E~~~  128 (407)
                      +..+.....=+.++..||-|.-+.||.+...+|.+.++|.-.....                  .    ..-....|...
T Consensus        84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            3344333334778899999999999999999999999984321110                  0    11134456666


Q ss_pred             HhcCCC--CccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceecc
Q 015395          129 IGRVRH--KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (407)
Q Consensus       129 l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~  206 (407)
                      |+.|.-  --|++.+++    +..++|||++.|..|.+.-+-.       .   .-.+...+..-+--|-.+   |+||+
T Consensus       164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d---~~~ly~~lm~~Iv~la~~---GlIHg  226 (465)
T KOG2268|consen  164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------D---PPTLYDDLMGLIVRLANH---GLIHG  226 (465)
T ss_pred             HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-------C---hHHHHHHHHHHHHHHHHc---Cceec
Confidence            776632  124444443    4568999999988886654221       1   122333333444555566   99999


Q ss_pred             CCCCccEEEeCCCCcEEeecccce
Q 015395          207 DIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       207 Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |+.--||+|++++.++++||--..
T Consensus       227 DFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  227 DFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             ccchheeEEecCCCEEEeechHhh
Confidence            999999999999999999997443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.75  E-value=0.00051  Score=66.80  Aligned_cols=76  Identities=18%  Similarity=0.246  Sum_probs=53.6

Q ss_pred             cceecccCceEEEEEEECCC-CEEEEEEeccC-----C--hhhHHHHHHHHHHHhcCC---CCccceeeeeeecCCeeEE
Q 015395           84 DKVIGEGGYGIVYYGLLEDN-SKVAVKNLLNN-----R--GQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~l  152 (407)
                      .+.||.|.+..||++...+| +.++||.-...     .  .....+...|.+.|+.+.   -.++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998776 48999974321     1  223455666888888763   2467777776  3455789


Q ss_pred             EEEeccCCC
Q 015395          153 VYEYVNNGN  161 (407)
Q Consensus       153 v~e~~~~g~  161 (407)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.74  E-value=0.00048  Score=64.66  Aligned_cols=144  Identities=17%  Similarity=0.198  Sum_probs=82.9

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ccceeeee------eecCCeeEEEE
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGY------CAEGAHRMLVY  154 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~------~~~~~~~~lv~  154 (407)
                      -.+.|..|....+|+.... +..+++|....   .....+..|+.++..+...  .+++++..      ....+..++++
T Consensus        18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             heecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            3566778888899988765 45788897654   2234455677777766422  24444432      12345668999


Q ss_pred             EeccCCChHH----h----------hhCCC----CC---CCCCCHHHHH----------HHHHHHHHHHHhhhh----cC
Q 015395          155 EYVNNGNLEQ----W----------LHGDV----GP---CSPLTWEIRM----------NIILGTAKGLSYLHE----GL  199 (407)
Q Consensus       155 e~~~~g~L~~----~----------l~~~~----~~---~~~l~~~~~~----------~i~~qi~~~L~~LH~----~~  199 (407)
                      +|++|..+..    .          +|...    ..   .....|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998876532    0          11100    00   0011111110          011112233444432    22


Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3479999999999999988767899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.72  E-value=0.00021  Score=67.39  Aligned_cols=141  Identities=24%  Similarity=0.276  Sum_probs=81.7

Q ss_pred             ceecccCceEEEEEEECC-------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc-cceeeeeeecCCeeEEEEEe
Q 015395           85 KVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~  156 (407)
                      +.|..|-...+|+....+       +..+++|+..... ........|..++..+.... ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667778999888654       4788999765433 22234556777777774322 3455555532    358999


Q ss_pred             ccCCChHHh-----------------hhCCCCCC-----CCCC--HHHHHH--------------------------HHH
Q 015395          157 VNNGNLEQW-----------------LHGDVGPC-----SPLT--WEIRMN--------------------------IIL  186 (407)
Q Consensus       157 ~~~g~L~~~-----------------l~~~~~~~-----~~l~--~~~~~~--------------------------i~~  186 (407)
                      ++|..+...                 +|......     ...+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988766431                 12111110     0111  111111                          111


Q ss_pred             HHHHHHHhhhh------cCCCceeccCCCCccEEEeCC----CCcEEeecccce
Q 015395          187 GTAKGLSYLHE------GLEPKVVHRDIKSSNILIDKH----WNPKVSDFGLAK  230 (407)
Q Consensus       187 qi~~~L~~LH~------~~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~  230 (407)
                      .+...+..|-.      ..+..++|+|+.+.|||++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22222334432      134578999999999999985    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.71  E-value=1.3e-05  Score=86.71  Aligned_cols=161  Identities=14%  Similarity=0.024  Sum_probs=119.6

Q ss_pred             HHHHHHHHhcCCCCccceeeeeee--cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 015395          122 FKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL  199 (407)
Q Consensus       122 ~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  199 (407)
                      ...|...++...|+++.....-..  +....+..++|+.+|.+.+.|.+.......+...-+.....+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            334555566678988877655443  334568999999999999999876655555555544444444355666655542


Q ss_pred             --CCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 015395          200 --EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  277 (407)
Q Consensus       200 --~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ell  277 (407)
                        ..-.+|+++|+-|.+|..+.++|+.++|+.+...+.. ...+...+++.|++|++...-.++.++|+|..|+-+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence              2237899999999999999999999999998543332 2344556888999999998888999999999999999998


Q ss_pred             hCCCCC
Q 015395          278 SGRIPV  283 (407)
Q Consensus       278 tg~~Pf  283 (407)
                      .|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            888776

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.68  E-value=0.00073  Score=63.89  Aligned_cols=145  Identities=18%  Similarity=0.204  Sum_probs=81.0

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ccceeeee------eecCCeeEEEE
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGY------CAEGAHRMLVY  154 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~------~~~~~~~~lv~  154 (407)
                      .++.++.|....+|+....++ .+++|+......  ...+..|+.++..|...  .+++++..      ....+..+++|
T Consensus        26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            356677787789998876544 678887644321  23344566666665321  24444432      12245678999


Q ss_pred             EeccCCChHH--------------hhhCCCCCC----CC----CCHHHHH------------HHHHHHHHHHHhhhh---
Q 015395          155 EYVNNGNLEQ--------------WLHGDVGPC----SP----LTWEIRM------------NIILGTAKGLSYLHE---  197 (407)
Q Consensus       155 e~~~~g~L~~--------------~l~~~~~~~----~~----l~~~~~~------------~i~~qi~~~L~~LH~---  197 (407)
                      +|++|..+..              .+|......    ..    -.|....            .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9998854421              012110000    00    0111100            001112334444432   


Q ss_pred             -cCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       198 -~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                       ..+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             234589999999999999988767899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.50  E-value=0.0016  Score=61.26  Aligned_cols=143  Identities=22%  Similarity=0.203  Sum_probs=85.6

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEec-cCChhhHHHHHHHHHHHhcCCC--CccceeeeeeecCC--eeEEEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGA--HRMLVYE  155 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~--~~~lv~e  155 (407)
                      ..+++.+..|.-..+|..... ++++++..-. ...........+|+.+++.+.-  --+...+++|.+..  ..++||+
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             CceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            344445544444444444333 7778887221 1233444566678888887742  23455566776655  6799999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHH-HHHHHHHHhhhhc------------------------------------
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNII-LGTAKGLSYLHEG------------------------------------  198 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~-~qi~~~L~~LH~~------------------------------------  198 (407)
                      |++|..+.+.+...     ...    ..++ ..+++.|.-||+-                                    
T Consensus       106 ~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173         106 WVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             EecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence            99885443333211     011    1111 2444444444422                                    


Q ss_pred             -------------------CCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          199 -------------------LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       199 -------------------~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                                         .+..++|+|+.+.||++++++.+=++||+++.+-+
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                               13469999999999999999889999999987644

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.49  E-value=0.001  Score=62.73  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=93.4

Q ss_pred             CccceecccCceEEEEEEECCCCEEEEEEeccC--------------------------ChhhHHHHHHHHHHHhcCCCC
Q 015395           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--------------------------RGQAEREFKVEVEAIGRVRHK  135 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~~~~~E~~~l~~l~hp  135 (407)
                      .+...|..|--+.||.|...+|..+|||+.+-.                          .....-....|++-|.+|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            345678889999999999888999999965211                          111222345677777777544


Q ss_pred             ccceeeeeeecCCeeEEEEEeccCCChH-HhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEE
Q 015395          136 NLVRLLGYCAEGAHRMLVYEYVNNGNLE-QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (407)
Q Consensus       136 niv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil  214 (407)
                      .|.----+..  ..-.|||+|+...... -.|..     -.++...+..+-.+++.-+.-|.+.+  ++||.||.--|+|
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L  297 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL  297 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence            4321111111  2347899999432211 11111     35777778888888888888887665  9999999999999


Q ss_pred             EeCCCCcEEeecccce
Q 015395          215 IDKHWNPKVSDFGLAK  230 (407)
Q Consensus       215 l~~~~~~kl~DfGla~  230 (407)
                      +.++ .+.|+|.+-+.
T Consensus       298 yhdG-~lyiIDVSQSV  312 (520)
T KOG2270|consen  298 YHDG-KLYIIDVSQSV  312 (520)
T ss_pred             EECC-EEEEEEccccc
Confidence            9755 89999987654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.39  E-value=0.0019  Score=60.00  Aligned_cols=31  Identities=32%  Similarity=0.479  Sum_probs=25.6

Q ss_pred             CceeccCCCCccEEEeCCCC-cEEeeccccee
Q 015395          201 PKVVHRDIKSSNILIDKHWN-PKVSDFGLAKL  231 (407)
Q Consensus       201 ~~ivH~Dlkp~Nill~~~~~-~kl~DfGla~~  231 (407)
                      ..++|+|+.+.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.30  E-value=0.0024  Score=61.44  Aligned_cols=143  Identities=20%  Similarity=0.200  Sum_probs=81.8

Q ss_pred             cceecccCceEEEEEEECC-----CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEEEec
Q 015395           84 DKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++.|..|-...+|++...+     +..|++|+........ -....|..+++.+..-++ .++++.+...    .|.+|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            4456568889999987532     3578899765543222 223568888887754434 4556665332    579999


Q ss_pred             cCCChHHh-----------------hhCCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHhh----hh
Q 015395          158 NNGNLEQW-----------------LHGDVGPCS--PLTWEIRMNIILGT-----------------AKGLSYL----HE  197 (407)
Q Consensus       158 ~~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~~L~~L----H~  197 (407)
                      ++.+|...                 +|....+..  ...+..+..+..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87666421                 122111111  12233333333222                 1111112    11


Q ss_pred             -cCCCceeccCCCCccEEEeC-CCCcEEeeccccee
Q 015395          198 -GLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKL  231 (407)
Q Consensus       198 -~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~  231 (407)
                       .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             12336899999999999986 46799999987653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.21  E-value=0.0043  Score=57.85  Aligned_cols=76  Identities=14%  Similarity=0.196  Sum_probs=46.5

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCccceeeeeeecCCeeEEEEEec
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .+..+.++.|....+|+.. .+++.+.||.-.   ......|..|+.-|+.|.   --.+++++++....+..+|+|||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445678989999999877 567889999765   223345666777777763   446788888887777779999999


Q ss_pred             cCC
Q 015395          158 NNG  160 (407)
Q Consensus       158 ~~g  160 (407)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.92  E-value=0.00077  Score=66.10  Aligned_cols=48  Identities=19%  Similarity=0.275  Sum_probs=38.0

Q ss_pred             HHHHHHHHHhcCCCCccceeeeeeecC-CeeEEEEEeccCCChHHhhhCC
Q 015395          121 EFKVEVEAIGRVRHKNLVRLLGYCAEG-AHRMLVYEYVNNGNLEQWLHGD  169 (407)
Q Consensus       121 ~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~  169 (407)
                      .+.--...++.+.|+|...++++.... ....+|||++ +.+|++++..+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            444567788999999999999887543 4578899998 67999998765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.89  E-value=0.011  Score=56.63  Aligned_cols=72  Identities=17%  Similarity=0.204  Sum_probs=47.4

Q ss_pred             eecccCceEEEEEEECCC-CEEEEEEecc-------CChhhHHHHHHHHHHHhcCC--CC-ccceeeeeeecCCeeEEEE
Q 015395           86 VIGEGGYGIVYYGLLEDN-SKVAVKNLLN-------NRGQAEREFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        86 ~lg~G~~g~V~~~~~~~~-~~vaiK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-niv~~~~~~~~~~~~~lv~  154 (407)
                      .||-|....||++...++ +.|+||.-..       .-.....+...|...|+...  .| .+++++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999997654 5799985421       11233345556788887663  34 4555544  3555667999


Q ss_pred             EeccC
Q 015395          155 EYVNN  159 (407)
Q Consensus       155 e~~~~  159 (407)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.83  E-value=0.019  Score=54.25  Aligned_cols=32  Identities=22%  Similarity=0.291  Sum_probs=28.4

Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +.+++|+|+.+.|||++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44799999999999999999999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.82  E-value=0.02  Score=55.75  Aligned_cols=73  Identities=14%  Similarity=0.217  Sum_probs=49.2

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCCh-------hhHHHHHHHHHHHhcCC---CCccceeeeeeecCCeeEEE
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-------QAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv  153 (407)
                      .+.||.|....||+.... ++.++||.-.....       ....+...|+..|+.+.   -.++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567899999999998864 55688996542111       12233334677776653   247888888776  446889


Q ss_pred             EEeccC
Q 015395          154 YEYVNN  159 (407)
Q Consensus       154 ~e~~~~  159 (407)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.74  E-value=0.041  Score=51.89  Aligned_cols=29  Identities=28%  Similarity=0.347  Sum_probs=25.4

Q ss_pred             CceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       201 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999988 578999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.73  E-value=0.02  Score=54.46  Aligned_cols=142  Identities=20%  Similarity=0.269  Sum_probs=80.1

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc---ce---eee----eeecCCeeEEEE
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL---VR---LLG----YCAEGAHRMLVY  154 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni---v~---~~~----~~~~~~~~~lv~  154 (407)
                      ..|.+ .-..+|+....+++. ++|+....  ....++..|...|..|.-.+|   ++   .=|    ........+-++
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            33554 667889888876666 88866554  444555667777776632111   22   111    111223678899


Q ss_pred             EeccCCChHH-hh--------------h----CC----CCCCCCCCHHH-------------HHHHHHHHHHHHHhhhhc
Q 015395          155 EYVNNGNLEQ-WL--------------H----GD----VGPCSPLTWEI-------------RMNIILGTAKGLSYLHEG  198 (407)
Q Consensus       155 e~~~~g~L~~-~l--------------~----~~----~~~~~~l~~~~-------------~~~i~~qi~~~L~~LH~~  198 (407)
                      +|++|..+.. ..              +    ..    ........|..             ......++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999887762 11              1    00    01111222320             011223333344444332


Q ss_pred             ----CCCc---eeccCCCCccEEEeCCCC-cEEeecccce
Q 015395          199 ----LEPK---VVHRDIKSSNILIDKHWN-PKVSDFGLAK  230 (407)
Q Consensus       199 ----~~~~---ivH~Dlkp~Nill~~~~~-~kl~DfGla~  230 (407)
                          .+..   +||+|+.|.||+++.+.. +-++||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                2334   999999999999998875 8999999664

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.67  E-value=0.013  Score=55.97  Aligned_cols=142  Identities=19%  Similarity=0.258  Sum_probs=78.8

Q ss_pred             ceecccCceEEEEEEECC----CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.|..|-...+|++...+    +..|++|+....... .-...+|..+++.+..-++ +++++++. ++   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            445558888899887543    237889976544322 2223457888887754444 45565553 22   58899877


Q ss_pred             CChHH-----------------hhhCCCCCCC--CCCHHHHHHHHHHHH----------------------HHHHhhhh-
Q 015395          160 GNLEQ-----------------WLHGDVGPCS--PLTWEIRMNIILGTA----------------------KGLSYLHE-  197 (407)
Q Consensus       160 g~L~~-----------------~l~~~~~~~~--~l~~~~~~~i~~qi~----------------------~~L~~LH~-  197 (407)
                      .+|..                 .+|....+..  +-.+..+..+..++.                      .-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65521                 1122111111  112333333332221                      11111111 


Q ss_pred             ----cCCCceeccCCCCccEEEeC-CCCcEEeeccccee
Q 015395          198 ----GLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKL  231 (407)
Q Consensus       198 ----~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~  231 (407)
                          ..+.-.+|+|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11224799999999999975 46899999987753

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.67  E-value=0.0092  Score=52.63  Aligned_cols=116  Identities=17%  Similarity=0.153  Sum_probs=71.3

Q ss_pred             cCceEEEEEEECCCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCChHHhhhC
Q 015395           90 GGYGIVYYGLLEDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG  168 (407)
Q Consensus        90 G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  168 (407)
                      ++.++.-.+..+- ....+|++..-.-. ...-+..+.+++++++  .|+++..-  +.-.+.++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3444444443332 23455555433322 3345567888888775  36666632  44567899999954211      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          169 DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       169 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                             +.   .-.+... +.+|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus       142 -------~~---~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 -------NF---SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             -------ch---hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence                   11   1111111 4667888854 34899999999999999999999999663

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.53  E-value=0.012  Score=52.31  Aligned_cols=30  Identities=37%  Similarity=0.511  Sum_probs=21.3

Q ss_pred             ceeccCCCCccEEE-eCCCCcEEeeccccee
Q 015395          202 KVVHRDIKSSNILI-DKHWNPKVSDFGLAKL  231 (407)
Q Consensus       202 ~ivH~Dlkp~Nill-~~~~~~kl~DfGla~~  231 (407)
                      -++|+|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57999999999999 8889999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.36  E-value=0.013  Score=55.42  Aligned_cols=75  Identities=21%  Similarity=0.204  Sum_probs=58.8

Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      .-..|++|++- |++|.-.        ....+.++..++.+.+..+.-+....  ..-|||+.-.||||+ .|+|.|+||
T Consensus       298 ~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             ceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence            34557788875 5555432        23567888999999988888887654  789999999999999 899999999


Q ss_pred             ccceecC
Q 015395          227 GLAKLLG  233 (407)
Q Consensus       227 Gla~~~~  233 (407)
                      -+++...
T Consensus       366 klsRl~~  372 (488)
T COG5072         366 KLSRLSY  372 (488)
T ss_pred             eeeeccc
Confidence            9998543

>PRK06148 hypothetical protein; Provisional

Probab=96.30  E-value=0.064  Score=58.96  Aligned_cols=144  Identities=16%  Similarity=0.215  Sum_probs=77.8

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-------CCCccceeee-----eeec-CC--e
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-------RHKNLVRLLG-----YCAE-GA--H  149 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~-----~~~~-~~--~  149 (407)
                      +.|+ |..-.+|+....++..+++|+.......  ..+..|...|..|       .-|.+++..+     .... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4565 4568889888777888999987654322  2333344445433       2333333221     1111 22  4


Q ss_pred             eEEEEEeccCCChHHhh-----------------hC----C--CCCCCCCCHHH-----------------HHHHHHHHH
Q 015395          150 RMLVYEYVNNGNLEQWL-----------------HG----D--VGPCSPLTWEI-----------------RMNIILGTA  189 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l-----------------~~----~--~~~~~~l~~~~-----------------~~~i~~qi~  189 (407)
                      .+-+++|++|..|.+..                 +.    .  ......+.|..                 ...++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            67789999997776511                 00    0  00001122211                 112222222


Q ss_pred             HHHHh----hhhcCCCceeccCCCCccEEEeCCC--CcE-Eeeccccee
Q 015395          190 KGLSY----LHEGLEPKVVHRDIKSSNILIDKHW--NPK-VSDFGLAKL  231 (407)
Q Consensus       190 ~~L~~----LH~~~~~~ivH~Dlkp~Nill~~~~--~~k-l~DfGla~~  231 (407)
                      ....-    .-...+.++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22211    1122355899999999999998775  555 999997653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.19  E-value=0.099  Score=49.82  Aligned_cols=72  Identities=17%  Similarity=0.073  Sum_probs=42.9

Q ss_pred             cCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ccceee---e--eeecCCeeEEEEEeccCCCh
Q 015395           90 GGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLL---G--YCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        90 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~---~--~~~~~~~~~lv~e~~~~g~L  162 (407)
                      +.-..||+....++..+++|...... .....+..|...+..|...  .++...   |  +...++..+.++++++|..+
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            56678999888778889999664322 2344555677666655311  122211   1  12234567889999987643

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.94  E-value=0.037  Score=53.67  Aligned_cols=74  Identities=18%  Similarity=0.211  Sum_probs=49.8

Q ss_pred             cceecccCceEEEEEEECC-CCEEEEEEecc------CChhhHHHHHHHHHHHhcCC--CC-ccceeeeeeecCCeeEEE
Q 015395           84 DKVIGEGGYGIVYYGLLED-NSKVAVKNLLN------NRGQAEREFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-niv~~~~~~~~~~~~~lv  153 (407)
                      .+.||-|.-..||++...+ ++.|+||.-..      .-.....+...|.+.|+...  .| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999998743 56789985421      12334456666888888763  34 45566543  45567889


Q ss_pred             EEeccC
Q 015395          154 YEYVNN  159 (407)
Q Consensus       154 ~e~~~~  159 (407)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.82  E-value=0.062  Score=49.07  Aligned_cols=80  Identities=18%  Similarity=0.101  Sum_probs=54.5

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec-cCCC
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV-NNGN  161 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~-~~g~  161 (407)
                      ....+..|..+.|+.++..+|..+++|+......... +.. ....|+..+-...|++++.-  ...-.+++|.+ ++.+
T Consensus         6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E~~-g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~   81 (253)
T PF04655_consen    6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-EAR-GEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRS   81 (253)
T ss_pred             cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-hhh-HHhHhheeCCCCceeeeccc--cccchhhhhhccCCCc
Confidence            3345677999999999999999999997754432221 111 12447777777889998864  33457888998 4456


Q ss_pred             hHHhh
Q 015395          162 LEQWL  166 (407)
Q Consensus       162 L~~~l  166 (407)
                      |.+..
T Consensus        82 L~~~~   86 (253)
T PF04655_consen   82 LASLP   86 (253)
T ss_pred             hhhcc
Confidence            76554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00384 choline kinase; Provisional

Probab=95.69  E-value=0.098  Score=50.96  Aligned_cols=76  Identities=16%  Similarity=0.276  Sum_probs=45.6

Q ss_pred             ccceecccCceEEEEEEECCC--CE-----EEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEE
Q 015395           83 DDKVIGEGGYGIVYYGLLEDN--SK-----VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~  154 (407)
                      .++.|..|-...+|++...++  ..     |.++. ........-.-..|+.+++.+...++ .++++.+..    +++.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            344565688999999975433  22     33332 22221212233458888888865545 556666543    6999


Q ss_pred             EeccCCChH
Q 015395          155 EYVNNGNLE  163 (407)
Q Consensus       155 e~~~~g~L~  163 (407)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999887764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.27  E-value=0.32  Score=43.43  Aligned_cols=77  Identities=17%  Similarity=0.224  Sum_probs=50.5

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC---CCCccceeeeeeecCCeeEEEEEeccC
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      ..+.+.-|..-..|...+. ..++.+|.-.   ......|..|+.-|+.|   +--.+.+++.+-.+.++.|+||||++-
T Consensus        20 er~~v~gG~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          20 EREEVSGGDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             cccccCCccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            3445555655566655433 5567888432   23334555666655555   445688889998999999999999987


Q ss_pred             CChH
Q 015395          160 GNLE  163 (407)
Q Consensus       160 g~L~  163 (407)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	407
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-56
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-55
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-47
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-33
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-25
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-06
3soa_A	444	Full-Length Human Camkii Length = 444		7e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 117/317 (36%), Positives = 185/317 (58%), Gaps = 10/317 (3%)
Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQ 117
           PEV HLG    ++LREL+V+++ FS+                  D + VAVK L   R Q
Sbjct: 18  PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQ 76
Query: 118 A-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L        PL
Sbjct: 77  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W  R  I LG+A+GL+YLH+  +PK++HRD+K++NIL+D+ +   V DFGLAKL+  + 
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--EEVNL 294
            ++   V GT G++APEY STG  +E++DV+ +G++++E+I+G+   D +R    ++V L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           ++W+K ++  +  E ++D  L        +++++ VAL C   +  +RPKM  VV MLE 
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316
Query: 355 Q------ESPSKEDRYR 365
                  E   KE+ +R
Sbjct: 317 DGLAERWEEWQKEEMFR 333

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  211 bits (538), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 115/317 (36%), Positives = 182/317 (57%), Gaps = 10/317 (3%)
Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQ 117
           PEV HLG    ++LREL+V+++ F +                  D   VAVK L   R Q
Sbjct: 10  PEV-HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ 68
Query: 118 A-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L        PL
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W  R  I LG+A+GL+YLH+  +PK++HRD+K++NIL+D+ +   V DFGLAKL+  + 
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--EEVNL 294
            ++   V G  G++APEY STG  +E++DV+ +G++++E+I+G+   D +R    ++V L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           ++W+K ++  +  E ++D  L        +++++ VAL C   +  +RPKM  VV MLE 
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
Query: 355 Q------ESPSKEDRYR 365
                  E   KE+ +R
Sbjct: 309 DGLAERWEEWQKEEMFR 325

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 164/285 (57%), Gaps = 6/285 (2%)
Query: 71  LRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
           L +LE +TN F                    D +KVA+K       Q   EF+ E+E + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
             RH +LV L+G+C E    +L+Y+Y+ NGNL++ L+G   P   ++WE R+ I +G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE--SSYITTRVMGTFG 248
           GL YLH      ++HRD+KS NIL+D+++ PK++DFG++K  G+E   +++   V GT G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLG 206
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           Y+ PEY   G L E+SDVYSFG+++ EV+  R  +  S P E VNL EW  +   N   E
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            ++DP L +K     L++    A++C+  +++ RP MG V+  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 164/285 (57%), Gaps = 6/285 (2%)
Query: 71  LRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
           L +LE +TN F                    D +KVA+K       Q   EF+ E+E + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
             RH +LV L+G+C E    +L+Y+Y+ NGNL++ L+G   P   ++WE R+ I +G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE--SSYITTRVMGTFG 248
           GL YLH      ++HRD+KS NIL+D+++ PK++DFG++K  G+E   +++   V GT G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLG 206
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           Y+ PEY   G L E+SDVYSFG+++ EV+  R  +  S P E VNL EW  +   N   E
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            ++DP L +K     L++    A++C+  +++ RP MG V+  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 150/259 (57%), Gaps = 16/259 (6%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W +R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 113 PNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 168
Query: 218 HWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
            +  K+SDFGLA+   SE    + + +R++GT  Y+APE A  G +  +SD+YSFG++++
Sbjct: 169 AFTAKISDFGLAR--ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLL 225
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRC 334
           E+I+G   VD  R P+ + L    +     +  E  +D K+ +  ++  ++ +  VA +C
Sbjct: 226 EIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQC 283
Query: 335 VDPNAQKRPKMGHVVHMLE 353
           +     KRP +  V  +L+
Sbjct: 284 LHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 149/259 (57%), Gaps = 16/259 (6%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W +R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 113 PNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 168
Query: 218 HWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
            +  K+SDFGLA+   SE    + +  R++GT  Y+APE A  G +  +SD+YSFG++++
Sbjct: 169 AFTAKISDFGLAR--ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLL 225
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRC 334
           E+I+G   VD  R P+ + L    +     +  E  +D K+ +  ++  ++ +  VA +C
Sbjct: 226 EIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQC 283
Query: 335 VDPNAQKRPKMGHVVHMLE 353
           +     KRP +  V  +L+
Sbjct: 284 LHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 148/259 (57%), Gaps = 16/259 (6%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+
Sbjct: 47  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 106
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W +R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 107 PNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 162
Query: 218 HWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
            +  K+SDFGLA+   SE      +  R++GT  Y+APE A  G +  +SD+YSFG++++
Sbjct: 163 AFTAKISDFGLAR--ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLL 219
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRC 334
           E+I+G   VD  R P+ + L    +     +  E  +D K+ +  ++  ++ +  VA +C
Sbjct: 220 EIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQC 277
Query: 335 VDPNAQKRPKMGHVVHMLE 353
           +     KRP +  V  +L+
Sbjct: 278 LHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 142/257 (55%), Gaps = 12/257 (4%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++   + +H+NLV LLG+ ++G    LVY Y 
Sbjct: 44  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYX 103
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W  R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 104 PNGSLLDRLSCLDGT-PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 159
Query: 218 HWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
            +  K+SDFGLA+     +  +  +R++GT  Y APE A  G +  +SD+YSFG++++E+
Sbjct: 160 AFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEI 218
Query: 277 ISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD 336
           I+G   VD  R P+ + L    +     +  E  +D K  +  ++  ++    VA +C+ 
Sbjct: 219 ITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKXNDADSTS-VEAXYSVASQCLH 276
Query: 337 PNAQKRPKMGHVVHMLE 353
               KRP +  V  +L+
Sbjct: 277 EKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/182 (38%), Positives = 107/182 (58%), Gaps = 7/182 (3%)
Query: 104 SKVAVKNLLNNRGQAER--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           S VAVK L+     AER  EF  EV  + R+RH N+V  +G   +  +  +V EY++ G+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + LH   G    L    R+++    AKG++YLH    P +VHRD+KS N+L+DK +  
Sbjct: 121 LYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTV 178
Query: 222 KVSDFGLAKLLGSESSYITTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           KV DFGL++L    S ++ ++   GT  ++APE       NE+SDVYSFG+++ E+ + +
Sbjct: 179 KVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 281 IP 282
            P
Sbjct: 237 QP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 69/182 (37%), Positives = 109/182 (59%), Gaps = 7/182 (3%)
Query: 104 SKVAVKNLLNNRGQAER--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           S VAVK L+     AER  EF  EV  + R+RH N+V  +G   +  +  +V EY++ G+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + LH   G    L    R+++    AKG++YLH    P +VHR++KS N+L+DK +  
Sbjct: 121 LYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTV 178
Query: 222 KVSDFGLAKLLGSESSYITTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           KV DFGL++L    S++++++   GT  ++APE       NE+SDVYSFG+++ E+ + +
Sbjct: 179 KVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 281 IP 282
            P
Sbjct: 237 QP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 103 NSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
           N KVA+K +      + +  + F+ EV    ++ H+N+V ++    E     LV EY+  
Sbjct: 36  NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 160 GNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
             L +++  HG      PL+ +  +N       G+ + H+    ++VHRDIK  NILID 
Sbjct: 96  PTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDS 146
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
           +   K+ DFG+AK L   S   T  V+GT  Y +PE A     +E +D+YS GI++ E++
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 278 SGRIPVD 284
            G  P +
Sbjct: 207 VGEPPFN 213

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 120/240 (50%), Gaps = 17/240 (7%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 30  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 89  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVI 142
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202
Query: 281 IPVDYSRPPEEVNLIE----WLKKMVTNRNPEGVLDPKLPEKP-----TSRLLKRILLVA 331
           IP +     E V  I       K  + + +   +++    E+P      SRLL+++  +A
Sbjct: 203 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIA 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 28  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 87  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 140
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
Query: 281 IPVD 284
           IP +
Sbjct: 201 IPYE 204

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 30  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 89  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 142
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202
Query: 281 IPVD 284
           IP +
Sbjct: 203 IPYE 206

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 33  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 92  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 145
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 146 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205
Query: 281 IPVD 284
           IP +
Sbjct: 206 IPYE 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 50  NKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 108
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 109 LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 162
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 163 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222
Query: 281 IPVD 284
           IP +
Sbjct: 223 IPYE 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV E++ +G 
Sbjct: 31  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 90  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 143
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 144 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203
Query: 281 IPVD 284
           IP +
Sbjct: 204 IPYE 207

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 39/266 (14%)
Query: 102 DNSKVAVKNLL--NNRGQAE-----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           D S VA+K+L+  ++ G+ E     +EF+ EV  +  + H N+V+L G       RM V 
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VM 100
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+V  G+L    H  +    P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI 
Sbjct: 101 EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIF 156
Query: 215 I-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVY 267
           +     +     KV+DFGL++    +S +  + ++G F ++APE   A      E++D Y
Sbjct: 157 LQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 268 SFGILIMEVISGRIPVD-YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           SF +++  +++G  P D YS          + K    N   E  L P +PE    RL   
Sbjct: 213 SFAMILYTILTGEGPFDEYS----------YGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 327 ILLVALRCVDPNAQKRPKMGHVVHML 352
           I L    C   + +KRP   ++V  L
Sbjct: 263 IEL----CWSGDPKKRPHFSYIVKEL 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 126/251 (50%), Gaps = 24/251 (9%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     + +R +F  E   +G+  H N++RL G  ++    M++ EY+ NG L++
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  S L     + ++ G A G+ YL        VHRD+ + NIL++ +   KVS
Sbjct: 136 FLREKDGEFSVLQL---VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T+       + APE  S       SDV+SFGI++ EV++    
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  E +K +      +G   P   + P++     I  + ++C      +R
Sbjct: 248 ---ERPYWELSNHEVMKAI-----NDGFRLPTPMDCPSA-----IYQLMMQCWQQERARR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFADIVSILD 305

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 39/266 (14%)
Query: 102 DNSKVAVKNLL--NNRGQAE-----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           D S VA+K+L+  ++ G+ E     +EF+ EV  +  + H N+V+L G       RM V 
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VM 100
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+V  G+L    H  +    P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI 
Sbjct: 101 EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIF 156
Query: 215 I-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVY 267
           +     +     KV+DFG ++    +S +  + ++G F ++APE   A      E++D Y
Sbjct: 157 LQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 268 SFGILIMEVISGRIPVD-YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           SF +++  +++G  P D YS          + K    N   E  L P +PE    RL   
Sbjct: 213 SFAMILYTILTGEGPFDEYS----------YGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 327 ILLVALRCVDPNAQKRPKMGHVVHML 352
           I L    C   + +KRP   ++V  L
Sbjct: 263 IEL----CWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 39/266 (14%)
Query: 102 DNSKVAVKNLL--NNRGQAE-----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           D S VA+K+L+  ++ G+ E     +EF+ EV  +  + H N+V+L G       RM V 
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VM 100
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+V  G+L    H  +    P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI 
Sbjct: 101 EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIF 156
Query: 215 I-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVY 267
           +     +     KV+DF L++    +S +  + ++G F ++APE   A      E++D Y
Sbjct: 157 LQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 268 SFGILIMEVISGRIPVD-YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           SF +++  +++G  P D YS          + K    N   E  L P +PE    RL   
Sbjct: 213 SFAMILYTILTGEGPFDEYS----------YGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 327 ILLVALRCVDPNAQKRPKMGHVVHML 352
           I L    C   + +KRP   ++V  L
Sbjct: 263 IEL----CWSGDPKKRPHFSYIVKEL 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 35/263 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           + +K L+    + +R F  EV+ +  + H N+++ +G   +      + EY+  G L   
Sbjct: 38  MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD 225
           +       S   W  R++     A G++YLH      ++HRD+ S N L+ ++ N  V+D
Sbjct: 98  IKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151
Query: 226 FGLAKLLGSESSY-------------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           FGLA+L+  E +                  V+G   ++APE  +    +E+ DV+SFGI+
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVA 331
           + E+I GR+  D    P  ++            N  G LD   P   P S        + 
Sbjct: 212 LCEII-GRVNADPDYLPRTMDF---------GLNVRGFLDRYCPPNCPPS-----FFPIT 256
Query: 332 LRCVDPNAQKRPKMGHVVHMLEA 354
           +RC D + +KRP    + H LE 
Sbjct: 257 VRCCDLDPEKRPSFVKLEHWLET 279

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY+N G+L
Sbjct: 39  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M+  +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 152 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 210 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 253
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 254 EERPTFEYLQAFLE 267

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 268 FTATEGQYQPQP 279

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY+N G+L
Sbjct: 39  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M+  +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 152 VADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 210 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 253
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 254 EERPTFEYLQAFLE 267

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 45  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 102
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 103 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 157
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 158 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 215
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 216 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 275
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 276 FTATEGQYQPQP 287

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 96/176 (54%), Gaps = 9/176 (5%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     + +R +F  E   +G+  H N++RL G    G   M+V EY+ NG+L+ 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  + +     + ++ G   G+ YL    +   VHRD+ + N+L+D +   KVS
Sbjct: 140 FLRTHDGQFTIMQL---VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL+++L    +++Y TT       + APE  +    +  SDV+SFG+++ EV++
Sbjct: 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 47  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 104
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 105 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 160 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 217
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 218 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 277
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 278 FTATEGQYQPQP 289

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 43  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 101 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 155
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 156 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 214 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 274 FTATEGQYQPQP 285

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 46  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 103
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 104 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 158
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 159 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 217 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 276
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 277 FTATEGQFQPQP 288

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           S VA+K L     + +R EF  E   +G+  H N++RL G        M++ E++ NG L
Sbjct: 45  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           + +L  + G  + +     + ++ G A G+ YL E      VHRD+ + NIL++ +   K
Sbjct: 105 DSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCK 158
Query: 223 VSDFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           VSDFGL++ L   SS  T T  +G      + APE  +       SD +S+GI++ EV+S
Sbjct: 159 VSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218
Query: 279 -GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
            G  P       + +N IE   ++           P  P+ PTS  L +++   L C   
Sbjct: 219 FGERPYWDMSNQDVINAIEQDYRL-----------PPPPDCPTS--LHQLM---LDCWQK 262
Query: 338 NAQKRPKMGHVVHMLE 353
           +   RP+   VV  L+
Sbjct: 263 DRNARPRFPQVVSALD 278

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 17/190 (8%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L      A ++F+ E E +  ++H+++VR  G C EG   ++V+EY+ +G+
Sbjct: 41  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 100
Query: 162 LEQWL--HG----------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG          DV P  PL     + +    A G+ YL  GL    VHRD+ 
Sbjct: 101 LNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLA 156
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ +    K+ DFG+++ + S   Y +  R M    ++ PE          SDV+S
Sbjct: 157 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 216
Query: 269 FGILIMEVIS 278
           FG+++ E+ +
Sbjct: 217 FGVVLWEIFT 226

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 268 FTATEGQYQPQP 279

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 17/190 (8%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L      A ++F+ E E +  ++H+++VR  G C EG   ++V+EY+ +G+
Sbjct: 47  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 106
Query: 162 LEQWL--HG----------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG          DV P  PL     + +    A G+ YL  GL    VHRD+ 
Sbjct: 107 LNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLA 162
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ +    K+ DFG+++ + S   Y +  R M    ++ PE          SDV+S
Sbjct: 163 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 222
Query: 269 FGILIMEVIS 278
           FG+++ E+ +
Sbjct: 223 FGVVLWEIFT 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           S VA+K L     + +R EF  E   +G+  H N++RL G        M++ E++ NG L
Sbjct: 43  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           + +L  + G  + +     + ++ G A G+ YL E      VHRD+ + NIL++ +   K
Sbjct: 103 DSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCK 156
Query: 223 VSDFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           VSDFGL++ L   SS  T T  +G      + APE  +       SD +S+GI++ EV+S
Sbjct: 157 VSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216
Query: 279 -GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
            G  P       + +N IE   ++           P  P+ PTS  L +++   L C   
Sbjct: 217 FGERPYWDMSNQDVINAIEQDYRL-----------PPPPDCPTS--LHQLM---LDCWQK 260
Query: 338 NAQKRPKMGHVVHMLE 353
           +   RP+   VV  L+
Sbjct: 261 DRNARPRFPQVVSALD 276

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 17/190 (8%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L      A ++F+ E E +  ++H+++VR  G C EG   ++V+EY+ +G+
Sbjct: 70  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 162 LEQWL--HG----------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG          DV P  PL     + +    A G+ YL  GL    VHRD+ 
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLA 185
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ +    K+ DFG+++ + S   Y +  R M    ++ PE          SDV+S
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 269 FGILIMEVIS 278
           FG+++ E+ +
Sbjct: 246 FGVVLWEIFT 255

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 43  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 101 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 155
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 156 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 214 RIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 38  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 95
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 96  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 150
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 151 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 208
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 209 RIPYPGMTNPEVIQNLERGYRMVRPDN 235

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 39  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 97  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 152 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 210 RIPYPGMTNPEVIQNLERGYRMVRPDN 236

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 42  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 100 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 155 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 213 RIPYPGMTNPEVIQNLERGYRMVRPDN 239

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E    +++ EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 32  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 89
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 90  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 144
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 145 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 202
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 203 RIPYPGMTNPEVIQNLERGYRMVRPDN 229

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 33  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 90
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 91  LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 145
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 146 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 203
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 204 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 247
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 248 EERPTFEYLQAFLE 261

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E    +++ EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 31  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 88
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 89  LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 143
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 144 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 201
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 202 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 245
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 246 EERPTFEYLQAFLE 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 28/250 (11%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K +     ++ER+ F VE+  + RV H N+V+L G C       LV EY   G+L  
Sbjct: 35  VAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYN 89
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNP-K 222
            LHG   P    T    M+  L  ++G++YLH  ++PK ++HRD+K  N+L+       K
Sbjct: 90  VLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHS-MQPKALIHRDLKPPNLLLVAGGTVLK 147
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           + DFG A  + +      T   G+  ++APE       +E+ DV+S+GI++ EVI+ R P
Sbjct: 148 ICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 203
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
            D    P     I W     T R P   L   LP KP   L+        RC   +  +R
Sbjct: 204 FDEIGGP--AFRIMWAVHNGT-RPP---LIKNLP-KPIESLMT-------RCWSKDPSQR 249
Query: 343 PKMGHVVHML 352
           P M  +V ++
Sbjct: 250 PSMEEIVKIM 259

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   + +R +F  E   +G+  H N++ L G   +    M++ E++ NG+L+ 
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G A G+ YL +      VHRD+ + NIL++ +   KVS
Sbjct: 124 FLRQNDGQFTVIQL---VGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVS 177
Query: 225 DFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           DFGL++ L  ++S  T T  +G      + APE          SDV+S+GI++ EV+S G
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P       + +N IE               D +LP  P       +  + L C   + 
Sbjct: 238 ERPYWDMTNQDVINAIEQ--------------DYRLP--PPMDCPSALHQLMLDCWQKDR 281
Query: 340 QKRPKMGHVVHMLE 353
             RPK G +V+ L+
Sbjct: 282 NHRPKFGQIVNTLD 295

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 291 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 403
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 404 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 462 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 505
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 506 EERPTFEYLQAFLE 519

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 208 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 265
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 320
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 321 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 379 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 422
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 423 EERPTFEYLQAFLE 436

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 28/250 (11%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K +     ++ER+ F VE+  + RV H N+V+L G C       LV EY   G+L  
Sbjct: 34  VAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYN 88
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNP-K 222
            LHG   P    T    M+  L  ++G++YLH  ++PK ++HRD+K  N+L+       K
Sbjct: 89  VLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           + DFG A  + +      T   G+  ++APE       +E+ DV+S+GI++ EVI+ R P
Sbjct: 147 ICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
            D    P     I W     T R P   L   LP KP   L+        RC   +  +R
Sbjct: 203 FDEIGGP--AFRIMWAVHNGT-RPP---LIKNLP-KPIESLMT-------RCWSKDPSQR 248
Query: 343 PKMGHVVHML 352
           P M  +V ++
Sbjct: 249 PSMEEIVKIM 258

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 119/251 (47%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++ L G   +    M+V EY+ NG+L+ 
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G + G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 113 FLKKNDGQFTVIQL---VGMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVS 166
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + APE  +       SDV+S+GI++ EV+S    
Sbjct: 167 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS---- 222
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
             Y   P      E   + V     EG   P   + P +     +  + L C       R
Sbjct: 223 --YGERP----YWEMTNQDVIKAVEEGYRLPSPMDCPAA-----LYQLMLDCWQKERNSR 271
Query: 343 PKMGHVVHMLE 353
           PK   +V+ML+
Sbjct: 272 PKFDEIVNMLD 282

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 208 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 265
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 320
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 321 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 379 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 422
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 423 EERPTFEYLQAFLE 436

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 9/176 (5%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     + +R +F  E   +G+  H N++RL G    G   M+V EY+ NG+L+ 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  + +     + ++ G   G+ YL    +   VHRD+ + N+L+D +   KVS
Sbjct: 140 FLRTHDGQFTIMQL---VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 225 DFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL+++L  +     T   G     + APE  +    +  SDV+SFG+++ EV++
Sbjct: 194 DFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 209 TTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 266
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 267 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHRDLRAANILVGENLVCK 321
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGL +L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 322 VADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 379
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 380 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 423
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 424 EERPTFEYLQAFLE 437

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD+ ++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLAAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 32  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-XIVTEYMSKGSL 89
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 90  LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 144
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 145 VADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 202
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 203 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 246
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 247 EERPTFEYLQAFLE 260

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 35  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 92
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 93  LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 147
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 148 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 205
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 206 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 249
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 250 EERPTFEYLQAFLE 263

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 208 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSL 265
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHRDLRAANILVGENLVCK 320
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 321 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 379 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 422
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 423 EERPTFEYLQAFLE 436

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 94/176 (53%), Gaps = 20/176 (11%)
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           Q     + E +    ++H N++ L G C +  +  LV E+   G L + L G   P    
Sbjct: 48  QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--- 104
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--------KVSDFGL 228
             +I +N  +  A+G++YLH+     ++HRD+KSSNILI +            K++DFGL
Sbjct: 105 --DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162
Query: 229 AKLLGSESSYITTRV--MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A+       + TT++   G + ++APE     M ++ SDV+S+G+L+ E+++G +P
Sbjct: 163 AR-----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGLA++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 33  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 90
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HR+++++NIL+    + K
Sbjct: 91  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRNLRAANILVSDTLSCK 145
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 146 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 203
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 204 RIPYPGMTNPEVIQNLERGYRMVRPDN 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 127/256 (49%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 95
Query: 164 QWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH      S   +E++  ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 96  HHLH-----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 147
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE      +   + +SDVY+FGI++ E++
Sbjct: 148 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 207
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +IE + +        G L P L  K  S   KR+  +   C+  
Sbjct: 208 TGQLP--YSNINNRDQIIEMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKK 256
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 257 KRDERPSFPRILAEIE 272

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +  R+F  E   +G+  H N++ L G   +    M++ EY+ NG+L+ 
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G   G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 120 FLRKNDGRFTVIQL---VGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVS 173
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFG++++L    E++Y T        + APE  +       SDV+S+GI++ EV+S G  
Sbjct: 174 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 233
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P       + +  IE           EG   P   + P +  L +++   L C       
Sbjct: 234 PYWDMSNQDVIKAIE-----------EGYRLPPPMDCPIA--LHQLM---LDCWQKERSD 277
Query: 342 RPKMGHVVHMLE 353
           RPK G +V+ML+
Sbjct: 278 RPKFGQIVNMLD 289

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     +A+  E   E + + ++ +  +VRL+G C   A  MLV E    G L +
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK 98
Query: 165 WLHG--DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +L G  +  P S +       ++   + G+ YL E      VHRD+ + N+L+      K
Sbjct: 99  FLVGKREEIPVSNVA-----ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAK 150
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           +SDFGL+K LG++ SY T R  G +   + APE  +    + RSDV+S+G+ + E +S G
Sbjct: 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 280 RIPVDYSRPPEEVNLIEWLKKM 301
           + P    + PE +  IE  K+M
Sbjct: 211 QKPYKKMKGPEVMAFIEQGKRM 232

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +  R+F  E   +G+  H N++ L G   +    M++ EY+ NG+L+ 
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G   G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 105 FLRKNDGRFTVIQL---VGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVS 158
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFG++++L    E++Y T        + APE  +       SDV+S+GI++ EV+S G  
Sbjct: 159 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 218
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P       + +  IE           EG   P   + P +  L +++   L C       
Sbjct: 219 PYWDMSNQDVIKAIE-----------EGYRLPPPMDCPIA--LHQLM---LDCWQKERSD 262
Query: 342 RPKMGHVVHMLE 353
           RPK G +V+ML+
Sbjct: 263 RPKFGQIVNMLD 274

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +  R+F  E   +G+  H N++ L G   +    M++ EY+ NG+L+ 
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G   G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 99  FLRKNDGRFTVIQL---VGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVS 152
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFG++++L    E++Y T        + APE  +       SDV+S+GI++ EV+S G  
Sbjct: 153 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 212
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P       + +  IE           EG   P   + P +  L +++   L C       
Sbjct: 213 PYWDMSNQDVIKAIE-----------EGYRLPPPMDCPIA--LHQLM---LDCWQKERSD 256
Query: 342 RPKMGHVVHMLE 353
           RPK G +V+ML+
Sbjct: 257 RPKFGQIVNMLD 268

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 134 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 187
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 188 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 245
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 246 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 292
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 293 PKFEQIVSILD 303

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 107 FLRKHDAQFTVIQ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 160
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 218
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 219 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 265
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 266 PKFEQIVSILD 276

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK +       E  F  E   +  ++H  LV+L     +     ++ E++  G+L
Sbjct: 212 HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL 269
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L  D G   PL   I  +  +  A+G++++ +      +HRD++++NIL+      K
Sbjct: 270 LDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVSASLVCK 324
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+++  E +  T R    F   + APE  + G    +SDV+SFGIL+ME+++ G
Sbjct: 325 IADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           RIP      PE +  +E   +M    N         PE+        +  + +RC     
Sbjct: 383 RIPYPGMSNPEVIRALERGYRMPRPEN--------CPEE--------LYNIMMRCWKNRP 426
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++  +L+
Sbjct: 427 EERPTFEYIQSVLD 440

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 123
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 124 FLRKHDAQFTVIQ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 177
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 178 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---- 233
Query: 283 VDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y  RP  E++  + +K +      EG   P   + P +     +  + L C   +   
Sbjct: 234 --YGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNN 281
Query: 342 RPKMGHVVHMLE 353
           RPK   +V +L+
Sbjct: 282 RPKFEQIVSILD 293

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 121/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL ++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 98  LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV 283
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 152 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P +   L+E   +M     PEG      PEK        +  +   C   N   RP
Sbjct: 212 PGIDPSQVYELLEKDYRM---ERPEGC-----PEK--------VYELMRACWQWNPSDRP 255
Query: 344 KMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGD 382
               +    E          ++ S  ++ +EK++ + G+
Sbjct: 256 SFAEIHQAFETM--------FQESSISDEVEKELGKRGE 286

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 125/258 (48%), Gaps = 30/258 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK +       E  F  E   +  ++H  LV+L     +     ++ E++  G+L
Sbjct: 39  HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L  D G   PL   I  +  +  A+G++++ +      +HRD++++NIL+      K
Sbjct: 97  LDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVSASLVCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+++  E +  T R    F   + APE  + G    +SDV+SFGIL+ME+++ G
Sbjct: 152 IADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
           RIP      PE +  +E   +M    N PE + +                 + +RC    
Sbjct: 210 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYN-----------------IMMRCWKNR 252
Query: 339 AQKRPKMGHVVHMLEAQE 356
            ++RP   ++  +L+  E
Sbjct: 253 PEERPTFEYIQSVLDDFE 270

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 28/254 (11%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   + +R +F  E   +G+  H N++ L G   +    M++ E++ NG+L+ 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G A G+ YL +      VHR + + NIL++ +   KVS
Sbjct: 98  FLRQNDGQFTVIQL---VGMLRGIAAGMKYLADM---NYVHRALAARNILVNSNLVCKVS 151
Query: 225 DFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           DFGL++ L  ++S  T T  +G      + APE          SDV+S+GI++ EV+S G
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 211
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P       + +N IE               D +LP  P       +  + L C   + 
Sbjct: 212 ERPYWDMTNQDVINAIE--------------QDYRLP--PPMDCPSALHQLMLDCWQKDR 255
Query: 340 QKRPKMGHVVHMLE 353
             RPK G +V+ L+
Sbjct: 256 NHRPKFGQIVNTLD 269

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY +      +V ++    +L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLY 107
Query: 164 QWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH      S   +E++  ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 108 HHLH-----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 159
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE      +   + +SDVY+FGI++ E++
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +IE + +        G L P L  K  S   KR+  +   C+  
Sbjct: 220 TGQLP--YSNINNRDQIIEMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKK 268
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 269 KRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 107
Query: 164 QWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH      S   +E++  ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 108 HHLH-----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 159
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE      +   + +SDVY+FGI++ E++
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +IE + +        G L P L  K  S   KR+  +   C+  
Sbjct: 220 TGQLP--YSNINNRDQIIEMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKK 268
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 269 KRDERPSFPRILAEIE 284

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     +A+  E   E + + ++ +  +VRL+G C   A  MLV E    G L +
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK 424
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L   VG    +       ++   + G+ YL E      VHR++ + N+L+      K+S
Sbjct: 425 FL---VGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKIS 478
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL+K LG++ SY T R  G +   + APE  +    + RSDV+S+G+ + E +S G+ 
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 282 PVDYSRPPEEVNLIEWLKKM 301
           P    + PE +  IE  K+M
Sbjct: 539 PYKKMKGPEVMAFIEQGKRM 558

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 98  LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV 283
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 152 DFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P +   L+E   +M     PEG      PEK        +  +   C   N   RP
Sbjct: 212 PGIDPSQVYELLEKDYRM---ERPEGC-----PEK--------VYELMRACWQWNPSDRP 255
Query: 344 KMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGD 382
               +    E          ++ S  ++ +EK++ + G+
Sbjct: 256 SFAEIHQAFETM--------FQESSISDEVEKELGKRGE 286

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV-- 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 101 --YKELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 9/176 (5%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N+V L G    G   M+V E++ NG L+ 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDA 133
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  + +     + ++ G A G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 134 FLRKHDGQFTVIQL---VGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVS 187
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL++++    E+ Y TT       + APE          SDV+S+GI++ EV+S
Sbjct: 188 DFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 117/256 (45%), Gaps = 27/256 (10%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 98  LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV 283
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 152 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P +   L+E   +M     PEG      PEK        +  +   C   N   RP
Sbjct: 212 PGIDPSQVYELLEKDYRM---ERPEGC-----PEK--------VYELMRACWQWNPSDRP 255
Query: 344 KMGHVVHMLEA--QES 357
               +    E   QES
Sbjct: 256 SFAEIHQAFETMFQES 271

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 56  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 112
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 113 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 167
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 168 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 225 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 97/183 (53%), Gaps = 12/183 (6%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N+KVA+K L       E  F  E + + +++H  LV+L    +E     +V EY+N G+L
Sbjct: 33  NTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSL 90
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    L   + M      A G++Y+        +HRD++S+NIL+      K
Sbjct: 91  LDFLKDGEGRALKLPNLVDMAA--QVAAGMAYIERM---NYIHRDLRSANILVGNGLICK 145
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+++ G
Sbjct: 146 IADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 203
Query: 280 RIP 282
           R+P
Sbjct: 204 RVP 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 65  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 121
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 122 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 176
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 177 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 234 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESG 381
            RP    +    E          ++ S  ++ +EK++ + G
Sbjct: 260 DRPSFAEIHQAFETM--------FQESSISDEVEKELGKQG 292

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 99  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 101 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 42  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 100
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 101 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 155 DFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 215 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 255
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 256 DRPSFAEIHQAFETMFQES 274

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 42  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 100
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 101 LR----ECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 155 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 215 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 255
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 256 DRPSFAEIHQAFETMFQES 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESG 381
            RP    +    E          ++ S  ++ +EK++ + G
Sbjct: 255 DRPSFAEIHQAFETM--------FQESSISDEVEKELGKRG 287

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 102 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 156 DFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 216 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 256
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 257 DRPSFAEIHQAFETMFQES 275

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESG 381
            RP    +    E          ++ S  ++ +EK++ + G
Sbjct: 255 DRPSFAEIHQAFETM--------FQESSISDEVEKELGKRG 287

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESG 381
            RP    +    E          ++ S  ++ +EK++ + G
Sbjct: 260 DRPSFAEIHQAFETM--------FQESSISDEVEKELGKRG 292

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 14/192 (7%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L +    A ++F  E E +  ++H+++V+  G C EG   ++V+EY+ +G+
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 162 LEQWL--HG-------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
           L ++L  HG       +  P + LT    ++I    A G+ YL        VHRD+ + N
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRN 158
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
            L+ ++   K+ DFG+++ + S   Y +    M    ++ PE          SDV+S G+
Sbjct: 159 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218
Query: 272 LIMEVIS-GRIP 282
           ++ E+ + G+ P
Sbjct: 219 VLWEIFTYGKQP 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 99  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 260 DRPSFAEIHQAFETMFQES 278

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V E + NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---- 245
Query: 283 VDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y  RP  E++  + +K +      EG   P   + P +     +  + L C   +   
Sbjct: 246 --YGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNN 293
Query: 342 RPKMGHVVHMLE 353
           RPK   +V +L+
Sbjct: 294 RPKFEQIVSILD 305

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 38  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 95  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 149
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 150 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 207 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 36  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 92
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 93  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 147
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 148 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 205 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 255 DRPSFAEIHQAFETMFQES 273

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 102 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 156 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 216 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 256
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 257 DRPSFAEIHQAFETMFQES 275

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 255 DRPSFAEIHQAFETMFQES 273

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 45  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 104 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 218 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 258
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 259 DRPSFAEIHQAFETMFQES 277

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 102 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 156 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 216 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 256
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 257 DRPSFAEIHQAFETMFQES 275

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 43  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 100 --YRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 155 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 212 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 54  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 112
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 113 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 166
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 167 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 227 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 267
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 268 DRPSFAEIHQAFETMFQES 286

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 31/254 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEA 354
            RP    +    E 
Sbjct: 260 DRPSFAEIHQAFET 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 255 DRPSFAEIHQAFETMFQES 273

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V E + NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 31/254 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEA 354
            RP    +    E 
Sbjct: 260 DRPSFAEIHQAFET 273

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 102 DNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVRHKNLVRLL----GYCAEGAHRM 151
           D+  VAVK L   R    R+      F+ E +    + H  +V +          G    
Sbjct: 36  DHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NILI      KV DFG+A+ +    + +  T  V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 40  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 97  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 152 DFGWS--CHAPSSRRTT-LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V E + NG+L+ 
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 107 FLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 160
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---- 216
Query: 283 VDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y  RP  E++  + +K +      EG   P   + P +     +  + L C   +   
Sbjct: 217 --YGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNN 264
Query: 342 RPKMGHVVHMLE 353
           RPK   +V +L+
Sbjct: 265 RPKFEQIVSILD 276

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLE 353
            RP    +    E
Sbjct: 255 DRPSFAEIHQAFE 267

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 102 DNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVRHKNLVRLL----GYCAEGAHRM 151
           D+  VAVK L   R    R+      F+ E +    + H  +V +          G    
Sbjct: 36  DHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 102 DNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVRHKNLVRLL----GYCAEGAHRM 151
           D+  VAVK L   R    R+      F+ E +    + H  +V +          G    
Sbjct: 36  DHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 101 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 41  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 152
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           +FG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 153 NFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 210 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 43  KVLFKTQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+  +   K++
Sbjct: 99  -VYRELQKLSRFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G  P +
Sbjct: 155 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
                E    I  ++    +   EG  D        SRLLK
Sbjct: 212 AHTYQETYRRISRVEFTFPDFVTEGARD------LISRLLK 246

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 40  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 97  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 152 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 248 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HR++ + N L+ ++   KV+
Sbjct: 307 LR----ECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVA 360
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 361 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 421 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 461
Query: 341 KRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESG 381
            RP    +    E          ++ S  ++ +EK++ + G
Sbjct: 462 DRPSFAEIHQAFETM--------FQESSISDEVEKELGKRG 494

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 93/182 (51%), Gaps = 12/182 (6%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK ++     +E EF  E + + ++ H  LV+  G C++     +V EY++NG L  +
Sbjct: 35  VAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 166 L--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
           L  HG     S L     + +     +G+++L      + +HRD+ + N L+D+    KV
Sbjct: 94  LRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV 145
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           SDFG+ + +  +    +        + APE       + +SDV++FGIL+ EV S G++P
Sbjct: 146 SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
Query: 283 VD 284
            D
Sbjct: 206 YD 207

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK +       E  F  E   +  ++H  LV+L     +     ++ E++  G+L
Sbjct: 206 HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL 263
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L  D G   PL   I  +  +  A+G++++ +      +HRD++++NIL+      K
Sbjct: 264 LDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVSASLVCK 318
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA            RV   F   + APE  + G    +SDV+SFGIL+ME+++ G
Sbjct: 319 IADFGLA------------RVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 366
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLDPKL-------PEKPTSRLLKRILLVA 331
           RIP      PE +  +E   +M    N PE + +  +        E+PT   ++ +L   
Sbjct: 367 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426
Query: 332 LRCVDPNAQKRP 343
               +   Q++P
Sbjct: 427 YTATESQXQQQP 438

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 99  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           +FG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 NFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 40  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS   T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 152 DFGWS--VHAPSSRRDT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 100 -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE       +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWS--VHAPSSRRTT-LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
            +   E    I  ++    +   EG  D        SRLLK
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARD------LISRLLK 247

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGE--- 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 100 -VYKELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWSVHAPSSRR---XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 287 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 345
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HR++ + N L+ ++   KV+
Sbjct: 346 LR----ECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVA 399
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 400 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 460 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 500
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 501 DRPSFAEIHQAFETMFQES 519

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 110 IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 162
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 223 GCVLYEVLTGEPPFTGDSP 241

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           V H  ++R+ G   +     ++ +Y+  G L   L       +P+       + L     
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA---- 118
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L YLH      +++RD+K  NIL+DK+ + K++DFG AK +      +T  + GT  Y+A
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIA 171
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           PE  ST   N+  D +SFGILI E+++G  P 
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 19/217 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       +V EY+  GNL  +
Sbjct: 60  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDY 118
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 119 LR----ECNRE--EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVA 172
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 173 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
             +D S+      + + L+K      PEG   PK+ E
Sbjct: 233 PGIDLSQ------VYDLLEKGYRMEQPEGC-PPKVYE 262

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 33  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 92
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 93  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 145
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 252

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 50  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 107
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 108 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 161
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 222 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 266
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
           +C  P A+ RP    +V  + A  S    + Y
Sbjct: 267 KCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           + H+N+V+  G+  EG  + L  EY + G L   +  D+G   P        ++ G    
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-SESSYITTRVMGTFGYV 250
             YLH G+   + HRDIK  N+L+D+  N K+SDFGLA +   +    +  ++ GT  YV
Sbjct: 119 --YLH-GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 251 APEYASTGMLN-ERSDVYSFGILIMEVISGRIPVD--------YSRPPEEVNLIEWLKKM 301
           APE       + E  DV+S GI++  +++G +P D        YS   E+   +   KK+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKI 233
Query: 302 VTNRNPEGVLDPKLPEKPTSRL 323
             +  P  +L   L E P++R+
Sbjct: 234 --DSAPLALLHKILVENPSARI 253

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 122/256 (47%), Gaps = 30/256 (11%)
Query: 106 VAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGN 161
            AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+
Sbjct: 61  CAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGD 118
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++D+ +  
Sbjct: 119 LRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 222 KVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L+ E+++
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
              P     P  +VN  +    ++  R    +L P+    P          V L+C  P 
Sbjct: 233 RGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPK 277
Query: 339 AQKRPKMGHVVHMLEA 354
           A+ RP    +V  + A
Sbjct: 278 AEMRPSFSELVSRISA 293

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 41  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 97  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 152
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 153 DFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 210 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 110
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 111 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 164
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 165 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 224
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 225 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 269
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 270 KCWHPKAEMRPSFSELVSRISA 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 111
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 112 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 165
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 166 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 225
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 226 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 270
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
           +C  P A+ RP    +V  + A  S    + Y
Sbjct: 271 KCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 302

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGN 161
            +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+
Sbjct: 35  GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 92
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    
Sbjct: 93  LVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVA 147
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR
Sbjct: 148 KVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203
Query: 281 IPVDYSRPP 289
           +P  Y R P
Sbjct: 204 VP--YPRIP 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 65  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 120
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 121 -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 176
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS     + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 177 DFGWS--VHAPSSR-RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 234 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 112
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 113 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 166
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 167 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 227 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 271
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
           +C  P A+ RP    +V  + A  S    + Y
Sbjct: 272 KCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 303

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGT--- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     KV+HRDIK  N+L+      K++
Sbjct: 95  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 41/284 (14%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VAVK L      +ERE    E++ + ++  H+N+V LLG C       L++EY   G+L
Sbjct: 77  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 163 EQWLHGDVGPCSP-------------------LTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +L       S                    LT+E  +      AKG+ +L        
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSC 193
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNE 262
           VHRD+ + N+L+      K+ DFGLA+ + S+S+Y+          ++APE    G+   
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 263 RSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
           +SDV+S+GIL+ E+ S G  P  Y   P + N  + ++       P              
Sbjct: 254 KSDVWSYGILLWEIFSLGVNP--YPGIPVDANFYKLIQNGFKMDQP-------------F 298
Query: 322 RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYR 365
              + I ++   C   +++KRP   ++   L  Q + ++E  Y+
Sbjct: 299 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQ 342

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  -VYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 52  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 109
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 163
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 164 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 224 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 268
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 269 KCWHPKAEMRPSFSELVSRISA 290

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           ++A+K +     +  +    E+     ++HKN+V+ LG  +E     +  E V  G+L  
Sbjct: 49  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108
Query: 165 WLHGDVGPC--SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP- 221
            L    GP   +  T       IL   +GL YLH+    ++VHRDIK  N+LI+ +    
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVL 162
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISG 279
           K+SDFG +K L   +   T    GT  Y+APE    G     + +D++S G  I+E+ +G
Sbjct: 163 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
Query: 280 RIPV-DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
           + P  +   P   +  +   K           + P++PE  ++     I    L+C +P+
Sbjct: 222 KPPFYELGEPQAAMFKVGMFK-----------VHPEIPESMSAEAKAFI----LKCFEPD 266
Query: 339 AQKR 342
             KR
Sbjct: 267 PDKR 270

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 47  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 104
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 105 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 158
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 159 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 218
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 219 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 263
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 264 KCWHPKAEMRPSFSELVSRISA 285

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 122/256 (47%), Gaps = 30/256 (11%)
Query: 106 VAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGN 161
            AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+
Sbjct: 79  CAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGD 136
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++D+ +  
Sbjct: 137 LRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTV 190
Query: 222 KVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L+ E+++
Sbjct: 191 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
              P     P  +VN  +    ++  R    +L P+    P          V L+C  P 
Sbjct: 251 RGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPK 295
Query: 339 AQKRPKMGHVVHMLEA 354
           A+ RP    +V  + A
Sbjct: 296 AEMRPSFSELVSRISA 311

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 95  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 26/243 (10%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           ++A+K +     +  +    E+     ++HKN+V+ LG  +E     +  E V  G+L  
Sbjct: 35  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 94
Query: 165 WLHGDVGPC--SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP- 221
            L    GP   +  T       IL   +GL YLH+    ++VHRDIK  N+LI+ +    
Sbjct: 95  LLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVL 148
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISG 279
           K+SDFG +K L   +   T    GT  Y+APE    G     + +D++S G  I+E+ +G
Sbjct: 149 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           + P      P+       + K          + P++PE  ++     I    L+C +P+ 
Sbjct: 208 KPPFYELGEPQAAMFKVGMFK----------VHPEIPESMSAEAKAFI----LKCFEPDP 253
Query: 340 QKR 342
            KR
Sbjct: 254 DKR 256

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 98/184 (53%), Gaps = 11/184 (5%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +++KVAVK L      + + F  E   +  ++H  LVRL           ++ EY+  G+
Sbjct: 36  NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGS 94
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L  D G    L   I  +  +  A+G++Y+        +HRD++++N+L+ +    
Sbjct: 95  LLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE---RKNYIHRDLRAANVLVSESLMC 149
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS- 278
           K++DFGLA+++  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ 
Sbjct: 150 KIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTY 207
Query: 279 GRIP 282
           G+IP
Sbjct: 208 GKIP 211

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 74  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 131
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 132 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 185
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 186 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 245
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 246 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 290
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 291 KCWHPKAEMRPSFSELVSRISA 312

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 95  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 43  KVLFKTQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+  +   K++
Sbjct: 99  -VYRELQKLSRFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS   T + GT  Y+ PE     M +E+ D++S G+L  E + G  P +
Sbjct: 155 DFGWS--VHAPSSRRDT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
                E    I  ++    +   EG  D        SRLLK
Sbjct: 212 AHTYQETYRRISRVEFTFPDFVTEGARD------LISRLLK 246

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 121/246 (49%), Gaps = 32/246 (13%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L    G +A  EF  E   +  + H +LVRLLG C     + LV + + +G L +
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 105
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++H    ++G    L W +++      AKG+ YL E    ++VHRD+ + N+L+    + 
Sbjct: 106 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHV 156
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLA+LL G E  Y          ++A E         +SDV+S+G+ I E+++ G
Sbjct: 157 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D     E  +L+E           +G    +LP+ P   +   + +V ++C   +A
Sbjct: 217 GKPYDGIPTREIPDLLE-----------KG---ERLPQPPICTI--DVYMVMVKCWMIDA 260
Query: 340 QKRPKM 345
             RPK 
Sbjct: 261 DSRPKF 266

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 119/246 (48%), Gaps = 32/246 (13%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L    G +A  EF  E   +  + H +LVRLLG C     + LV + + +G L +
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 128
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++H    ++G    L W +++      AKG+ YL E    ++VHRD+ + N+L+    + 
Sbjct: 129 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHV 179
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLA+LL G E  Y          ++A E         +SDV+S+G+ I E+++ G
Sbjct: 180 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 239
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D     E  +L+E                 +LP+ P   +   + +V ++C   +A
Sbjct: 240 GKPYDGIPTREIPDLLE--------------KGERLPQPPICTI--DVYMVMVKCWMIDA 283
Query: 340 QKRPKM 345
             RPK 
Sbjct: 284 DSRPKF 289

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWSVHAPSSRR---DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/188 (34%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNL 162
           +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+L
Sbjct: 30  NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    K
Sbjct: 88  VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAK 142
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           VSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR+
Sbjct: 143 VSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 282 PVDYSRPP 289
           P  Y R P
Sbjct: 199 P--YPRIP 204

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/188 (34%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNL 162
           +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+L
Sbjct: 217 NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    K
Sbjct: 275 VDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAK 329
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           VSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR+
Sbjct: 330 VSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385
Query: 282 PVDYSRPP 289
           P  Y R P
Sbjct: 386 P--YPRIP 391

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 102 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 155
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +  +   +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 214 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 259
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 260 -EIYMIMTECWNNNVNQRPSF 279

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGN 161
            +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+
Sbjct: 44  GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    
Sbjct: 102 LVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVA 156
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR
Sbjct: 157 KVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212
Query: 281 IPVDYSRPP 289
           +P  Y R P
Sbjct: 213 VP--YPRIP 219

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 293 VLMWEIFT 300

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTAR 173
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 234 VLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 175
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 236 VLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 178
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 239 VLMWEIFT 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 105 DYLQAHAERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 158
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 216
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 217 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 262
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 263 -EIYMIMTECWNNNVNQRPSF 282

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 63  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 120
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 121 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 174
Query: 223 VSDFGLAK-LLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +L  E   +  +        ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 175 VADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 234
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 235 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 279
Query: 340 QKRPKMGHVVHMLEAQESPSKEDRY 364
           + RP    +V  + A  S    + Y
Sbjct: 280 EMRPSFSELVSRISAIFSTFIGEHY 304

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 31/266 (11%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L +    A ++F+ E E +  ++H+++V+  G C +G   ++V+EY+ +G+
Sbjct: 44  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 162 LEQWL--HG-------DVGPCSP---LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG       D  P      L     ++I    A G+ YL        VHRD+ 
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLA 160
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+  +   K+ DFG+++ + S   Y +    M    ++ PE          SDV+S
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL 328
           FG+++ E+ +      Y + P       W  ++      E +   ++ E+P     K + 
Sbjct: 221 FGVILWEIFT------YGKQP-------WF-QLSNTEVIECITQGRVLERPRV-CPKEVY 265
Query: 329 LVALRCVDPNAQKRPKMGHVVHMLEA 354
            V L C     Q+R  +  +  +L A
Sbjct: 266 DVMLGCWQREPQQRLNIKEIYKILHA 291

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   +++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + + +    TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 30/256 (11%)
Query: 106 VAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGN 161
            AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+
Sbjct: 60  CAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGD 117
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++D+ +  
Sbjct: 118 LRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTV 171
Query: 222 KVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           KV+DFGLA+ +  +   S +  T       ++A E   T     +SDV+SFG+L+ E+++
Sbjct: 172 KVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
              P     P  +VN  +    ++  R    +L P+    P          V L+C  P 
Sbjct: 232 RGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPK 276
Query: 339 AQKRPKMGHVVHMLEA 354
           A+ RP    +V  + A
Sbjct: 277 AEMRPSFSELVSRISA 292

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + + +    TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HR++ + NIL++     K+
Sbjct: 103 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRNLATRNILVENENRVKI 156
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +  Y   +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 214
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 215 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 260
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 261 -EIYMIMTECWNNNVNQRPSF 280

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 119
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 120 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 171
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 172 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 232 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 280
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 281 KRDERPLFPQILASIE 296

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 96
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 97  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 148
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 149 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 209 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 257
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 258 KRDERPLFPQILASIE 273

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 118
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 119 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 170
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 171 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 231 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 279
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 280 KRDERPLFPQILASIE 295

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 96
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 97  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 148
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 149 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 209 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 257
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 258 KRDERPLFPQILASIE 273

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 93
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 94  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 145
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 146 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 206 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 254
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 255 KRDERPLFPQILASIE 270

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY +      +V ++    +L 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLY 91
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 92  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 143
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 204 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 252
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 253 KRDERPLFPQILASIE 268

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 99/184 (53%), Gaps = 11/184 (5%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +++KVAVK L      + + F  E   +  ++H  LVRL     +     ++ E++  G+
Sbjct: 35  NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGS 93
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L  D G    L   I  +  +  A+G++Y+        +HRD++++N+L+ +    
Sbjct: 94  LLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE---RKNYIHRDLRAANVLVSESLMC 148
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS- 278
           K++DFGLA+++  E +  T R    F   + APE  + G    +S+V+SFGIL+ E+++ 
Sbjct: 149 KIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTY 206
Query: 279 GRIP 282
           G+IP
Sbjct: 207 GKIP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 91
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 92  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 143
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 204 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 252
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 253 KRDERPLFPQILASIE 268

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 162 LEQWLHGDVGP----C--------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L     P    C          L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 162
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 223 FGVLLWEIFT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 60  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 117
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 118 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 171
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 172 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 231
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 232 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 276
Query: 340 QKRPKMGHVVHMLEAQESPSKEDRY 364
           + RP    +V  + A  S    + Y
Sbjct: 277 EMRPSFSELVSRISAIFSTFIGEHY 301

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM---LVYEYVNNGNL 162
           VAVK L ++    +R+F+ E++ +  +    +V+  G  + G  R    LV EY+ +G L
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCL 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K
Sbjct: 101 RDFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           ++DFGLAKLL  +  Y   R  G     + APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 155 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRN 306
              D S  P      E+L+ M + R+
Sbjct: 214 --CDKSCSPSA----EFLRMMGSERD 233

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 63  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 120
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 121 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 174
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 175 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 234
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 235 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 279
Query: 340 QKRPKMGHVVHMLEAQESPSKEDRY 364
           + RP    +V  + A  S    + Y
Sbjct: 280 EMRPSFSELVSRISAIFSTFIGEHY 304

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K  +   G  +R  + EV+   +++H +++ L  Y  +  +  LV E  +NG + +
Sbjct: 42  KMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNR 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L   V P S       M+ I+    G+ YLH      ++HRD+  SN+L+ ++ N K++
Sbjct: 101 YLKNRVKPFSENEARHFMHQII---TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA 154
Query: 225 DFGLAKLLG--SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGLA  L    E  Y    + GT  Y++PE A+       SDV+S G +   ++ GR P
Sbjct: 155 DFGLATQLKMPHEKHYT---LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 283 VD 284
            D
Sbjct: 212 FD 213

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 67  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 124
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 125 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 178
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 179 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 238
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 239 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 283
Query: 340 QKRPKMGHVVHMLEAQESPSKEDRY 364
           + RP    +V  + A  S    + Y
Sbjct: 284 EMRPSFSELVSRISAIFSTFIGEHY 308

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 27/198 (13%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L  N   +E R+   E   + +V H ++++L G C++    +L+ EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 163 EQWLHGD--VGPC------------------SPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
             +L     VGP                     LT    ++     ++G+ YL E    K
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
           +VHRD+ + NIL+ +    K+SDFGL++ +  E SY+  R  G     ++A E     + 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIY 229
Query: 261 NERSDVYSFGILIMEVIS 278
             +SDV+SFG+L+ E+++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 32/272 (11%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 112
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++
Sbjct: 113 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCML 166
Query: 216 DKHWNPKVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L
Sbjct: 167 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 227 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 271
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
           +C  P A+ RP    +V  + A  S    + Y
Sbjct: 272 KCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 303

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 62  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 119
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 120 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 173
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 174 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 233
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 234 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 278
Query: 340 QKRPKMGHVVHMLEAQESPSKEDRY 364
           + RP    +V  + A  S    + Y
Sbjct: 279 EMRPSFSELVSRISAIFSTFIGEHY 303

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 106 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 159
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 217
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 218 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 263
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 264 -EIYMIMTECWNNNVNQRPSF 283

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/108 (44%), Positives = 63/108 (58%), Gaps = 8/108 (7%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           EI   I L T K L++L E L  K++HRDIK SNIL+D+  N K+ DFG++  L    S 
Sbjct: 125 EILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSI 180
Query: 239 ITTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRIP 282
             TR  G   Y+APE     AS    + RSDV+S GI + E+ +GR P
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 107 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 160
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 218
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 219 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 264
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 265 -EIYMIMTECWNNNVNQRPSF 284

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 101 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 154
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 212
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 213 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 258
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 259 -EIYMIMTECWNNNVNQRPSF 278

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 126/266 (47%), Gaps = 30/266 (11%)
Query: 106 VAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGN 161
            AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+
Sbjct: 120 CAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGD 177
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  
Sbjct: 178 LRNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 231
Query: 222 KVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           KV+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
              P     P  +VN  +    ++  R    +L P+    P          V L+C  P 
Sbjct: 292 RGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPK 336
Query: 339 AQKRPKMGHVVHMLEAQESPSKEDRY 364
           A+ RP    +V  + A  S    + Y
Sbjct: 337 AEMRPSFSELVSRISAIFSTFIGEHY 362

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 100 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 153
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 211
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 212 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 257
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 258 -EIYMIMTECWNNNVNQRPSF 277

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHGDVGP----C--------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L     P    C          L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 105 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 158
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 216
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 217 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 262
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 263 -EIYMIMTECWNNNVNQRPSF 282

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++  Y + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 108 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 161
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 219
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 220 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 265
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 266 -EIYMIMTECWNNNVNQRPSF 285

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 32/282 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM---LVYEYVNNGNL 162
           VAVK L ++    +R+F+ E++ +  +    +V+  G  + G  R    LV EY+ +G L
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCL 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K
Sbjct: 102 RDFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVK 155
Query: 223 VSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           ++DFGLAKLL  +  Y   R  G     + APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 156 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY- 214
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL--------DPKLPEKPTSRLLKRILLVAL 332
              D S  P      E+L+ M   R+   +           +LP  P        L+   
Sbjct: 215 --CDKSCSPSA----EFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKL- 267
Query: 333 RCVDPNAQKRPK---MGHVVHMLEAQESPSKEDRYRASPKNE 371
            C  P+ Q RP    +G  + ML +     +   + A P+ +
Sbjct: 268 -CWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGK 308

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 170
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 231 FGVLLWEIFT 240

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 109 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 162
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-- 219
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 220 -YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 266
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 267 -EIYMIMTECWNNNVNQRPSF 286

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 109
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 166
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 167 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 227 FGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 169
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 170 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 230 FGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 133 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 186
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 244
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 245 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 290
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 291 -EIYMIMTECWNNNVNQRPSF 310

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM---LVYEYVNNGNL 162
           VAVK L ++    +R+F+ E++ +  +    +V+  G  + G  R    LV EY+ +G L
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCL 113
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K
Sbjct: 114 RDFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVK 167
Query: 223 VSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           ++DFGLAKLL  +  Y   R  G     + APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY- 226
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRN 306
              D S  P      E+L+ M   R+
Sbjct: 227 --CDKSCSPSA----EFLRMMGCERD 246

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 102 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 155
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 214 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 259
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 260 -EIYMIMTECWNNNVNQRPSF 279

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 102 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 155
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 214 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 259
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 260 -EIYMIMTECWNNNVNQRPSF 279

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 120 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 173
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-- 230
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 231 -YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 277
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 278 -EIYMIMTECWNNNVNQRPSF 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 120 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 173
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-- 230
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 231 -YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 277
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 278 -EIYMIMTECWNNNVNQRPSF 297

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ E++  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
           ++L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 105 EYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 158
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 216
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 217 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 262
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 263 -EIYMIMTECWNNNVNQRPSF 282

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++  Y + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 119
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 120 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 171
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 172 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 232 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 280
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 281 KRDERPLFPQILASIE 296

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 111
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 112 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 163
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 164 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 223
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 224 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 272
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 273 KRDERPLFPQILASIE 288

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHGDVGPCSPLTWEIRMN------------IILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L     P    ++    N                 A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +   +    TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 218
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 279 FGVLLWEIFT 288

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 104 SKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L        + +F+ E   +    + N+V+LLG CA G    L++EY+  G+L
Sbjct: 78  TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 163 EQWL------------HGDV---------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
            ++L            H D+         GP  PL+   ++ I    A G++YL E    
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGP-PPLSCAEQLCIARQVAAGMAYLSER--- 193
Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-------ITTRVMGTFGYVAPEY 254
           K VHRD+ + N L+ ++   K++DFGL++ + S   Y       I  R      ++ PE 
Sbjct: 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPES 247
Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
                    SDV+++G+++ E+ S  +   Y    EEV
Sbjct: 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 91
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 92  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 143
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 144 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 204 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 252
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 253 KRDERPLFPQILASIE 268

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 17/187 (9%)
Query: 106 VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   G    EF+ E     R++H N+V LLG   +     +++ Y ++G+L +
Sbjct: 59  VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 118
Query: 165 WL-----HGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +L     H DVG         S L     ++++   A G+ YL       VVH+D+ + N
Sbjct: 119 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+    N K+SD GL + + +   Y +    +    ++APE    G  +  SD++S+G+
Sbjct: 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235
Query: 272 LIMEVIS 278
           ++ EV S
Sbjct: 236 VLWEVFS 242

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLS 193
           +N V+ +    + +   +  EY  NG L   +H + +       W +   I+    + LS
Sbjct: 75  RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EALS 130
Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK---------LLGSE----SSYIT 240
           Y+H      ++HRD+K  NI ID+  N K+ DFGLAK          L S+    SS   
Sbjct: 131 YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 241 TRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  +GT  YVA E    TG  NE+ D+YS GI+  E+I       +S   E VN+++ L+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVNILKKLR 242
Query: 300 KMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRP 343
             V+   P    D K+  EK   RLL          +D +  KRP
Sbjct: 243 S-VSIEFPPDFDDNKMKVEKKIIRLL----------IDHDPNKRP 276

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 17/187 (9%)
Query: 106 VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   G    EF+ E     R++H N+V LLG   +     +++ Y ++G+L +
Sbjct: 42  VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
Query: 165 WL-----HGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +L     H DVG         S L     ++++   A G+ YL       VVH+D+ + N
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 158
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+    N K+SD GL + + +   Y +    +    ++APE    G  +  SD++S+G+
Sbjct: 159 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218
Query: 272 LIMEVIS 278
           ++ EV S
Sbjct: 219 VLWEVFS 225

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 195
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 196 ARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 255
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 256 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 300
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 74  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 133
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 134 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 190
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 191 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 250
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 251 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 295
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 296 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 327

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 188
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 189 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 248
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 249 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 293
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 294 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 325

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHG------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
             +L        D     PL     ++     A+G+++L        +HRD+ + N+L+ 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 194
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GIL+ E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 276 VIS 278
           + S
Sbjct: 255 IFS 257

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 119/240 (49%), Gaps = 26/240 (10%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           + F+ EV  + + RH N++  +GY  +  +  +V ++    +L + LH  V       ++
Sbjct: 77  QAFRNEVAVLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLH--VQETKFQMFQ 133
Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-SY 238
           + ++I   TA+G+ YLH      ++HRD+KS+NI + +    K+ DFGLA +    S S 
Sbjct: 134 L-IDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189
Query: 239 ITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
              +  G+  ++APE          + +SDVYS+GI++ E+++G +P  +    +++   
Sbjct: 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF- 248
Query: 296 EWLKKMVTNRNPEGVLDPKLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                MV      G   P L +  K   + +KR  LVA  CV    ++RP    ++  +E
Sbjct: 249 -----MVG----RGYASPDLSKLYKNCPKAMKR--LVA-DCVKKVKEERPLFPQILSSIE 296

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 163 EQWLHG------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
             +L        D     PL     ++     A+G+++L        +HRD+ + N+L+ 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 186
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GIL+ E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 276 VIS 278
           + S
Sbjct: 247 IFS 249

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 6/167 (3%)
Query: 117 QAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPC 173
           +AE++  V EV  +  ++H N+VR      +  +  L  V EY   G+L   +       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEP--KVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L  E  + ++      L   H   +    V+HRD+K +N+ +D   N K+ DFGLA++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           L  ++S+  T V GT  Y++PE  +    NE+SD++S G L+ E+ +
Sbjct: 166 LNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 172
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 233 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 277
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 195
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 196 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 255
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 256 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 300
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 30/212 (14%)
Query: 103 NSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH----RMLVYEYV 157
           N  VAVK   + ++   + E+  EV ++  ++H+N+++ +G    G        L+  + 
Sbjct: 47  NEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-------GLEPKVVHRDIKS 210
             G+L  +L  +V     ++W    +I    A+GL+YLHE       G +P + HRDIKS
Sbjct: 105 EKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 211 SNILIDKHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS----- 264
            N+L+  +    ++DFGLA K    +S+  T   +GT  Y+APE     +  +R      
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 265 DVYSFGILIMEVIS----GRIPVD-YSRPPEE 291
           D+Y+ G+++ E+ S       PVD Y  P EE
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 105 KVAVKNLLNNRGQAER-----EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
           KVAVK L  NR +        + K E++ +   RH ++++L    +      +V EYV+ 
Sbjct: 38  KVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 160 GNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           G L  ++  HG V        E R  +       + Y H  +   VVHRD+K  N+L+D 
Sbjct: 96  GELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDA 146
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEV 276
           H N K++DFGL+ ++ S+  ++ T   G+  Y APE  S  +      D++S G+++  +
Sbjct: 147 HMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 277 ISGRIPVDYSRPP 289
           + G +P D    P
Sbjct: 205 LCGTLPFDDEHVP 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 127/266 (47%), Gaps = 33/266 (12%)
Query: 106 VAVKNLL--NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN---G 160
           VA+K  L  ++    ++    E++ + ++RH+NLV LL  C +     LV+E+V++    
Sbjct: 53  VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD 112
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +LE + +G       L +++    +     G+ + H      ++HRDIK  NIL+ +   
Sbjct: 113 DLELFPNG-------LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGV 162
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISG 279
            K+ DFG A+ L +        V  T  Y APE     +   ++ DV++ G L+ E+  G
Sbjct: 163 VKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
Query: 280 R--IPVDYSRPPEEVNLIEWLKKMV------TNRNP--EGVLDPKLPEK-PTSR----LL 324
               P D S   +  +++  L  ++       N+NP   GV  P++ E+ P  R    L 
Sbjct: 222 EPLFPGD-SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 325 KRILLVALRCVDPNAQKRPKMGHVVH 350
           + ++ +A +C+  +  KRP    ++H
Sbjct: 281 EVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 27/198 (13%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L  N   +E R+   E   + +V H ++++L G C++    +L+ EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 163 EQWLHGD--VGPC------------------SPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
             +L     VGP                     LT    ++     ++G+ YL E    K
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
           +VHRD+ + NIL+ +    K+SDFGL++ +  E S +  R  G     ++A E     + 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIY 229
Query: 261 NERSDVYSFGILIMEVIS 278
             +SDV+SFG+L+ E+++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKV------EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN 158
           KVAVK L  NR Q  R   V      E++ +   RH ++++L    +  +   +V EYV+
Sbjct: 43  KVAVKIL--NR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH 218
            G L  ++  +      L  +    +      G+ Y H  +   VVHRD+K  N+L+D H
Sbjct: 100 GGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAH 152
Query: 219 WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVI 277
            N K++DFGL+ ++ S+  ++     G+  Y APE  S  +      D++S G+++  ++
Sbjct: 153 MNAKIADFGLSNMM-SDGEFLRXSC-GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210
Query: 278 SGRIPVDYSRPP 289
            G +P D    P
Sbjct: 211 CGTLPFDDDHVP 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLG--YCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++    +R+F+ E++ +  +    +V+  G  Y        LV EY+ +G L 
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K+
Sbjct: 99  DFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 152
Query: 224 SDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           +DFGLAKLL  +      R  G     + APE  S  + + +SDV+SFG+++ E+ +   
Sbjct: 153 ADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY-- 210
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRN 306
             D S  P      E+L+ M   R+
Sbjct: 211 -CDKSCSPSA----EFLRMMGCERD 230

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLD 106
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 107 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 157
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 158 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 217
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 218 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 261
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 262 DSRPKFRELI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 117 QAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPC 173
           +AE++  V EV  +  ++H N+VR      +  +  L  V EY   G+L   +       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEP--KVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L  E  + ++      L   H   +    V+HRD+K +N+ +D   N K+ DFGLA++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           L  ++S+    V GT  Y++PE  +    NE+SD++S G L+ E+ +
Sbjct: 166 LNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 22/174 (12%)
Query: 120 REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC- 173
           R+F  E+E + ++  H N++ LLG C    +  L  EY  +GNL  +L      +  P  
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 119
Query: 174 -------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                  S L+ +  ++     A+G+ YL +    + +HRD+ + NIL+ +++  K++DF
Sbjct: 120 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 176
Query: 227 GLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           GL++    +  Y+  + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 177 GLSR---GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 106
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 107 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 157
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 158 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 217
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 218 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 261
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 262 DSRPKFRELI 271

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 22/174 (12%)
Query: 120 REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC- 173
           R+F  E+E + ++  H N++ LLG C    +  L  EY  +GNL  +L      +  P  
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 174 -------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                  S L+ +  ++     A+G+ YL +    + +HRD+ + NIL+ +++  K++DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 186
Query: 227 GLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           GL++    +  Y+  + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 187 GLSR---GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           V +K + +  G Q+ +     + AIG + H ++VRLLG C  G+   LV +Y+  G+L  
Sbjct: 63  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 121
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
            +    G +GP   L W +++      AKG+ YL E     +VHR++ + N+L+      
Sbjct: 122 HVRQHRGALGPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQV 172
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           +V+DFG+A LL   +   + +       ++A E    G    +SDV+S+G+ + E+++ G
Sbjct: 173 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 232
Query: 280 RIPVDYSRPPEEVNLIE 296
             P    R  E  +L+E
Sbjct: 233 AEPYAGLRLAEVPDLLE 249

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 99
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 100 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 211 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 254
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 255 DSRPKFRELI 264

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 53  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 111
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 112 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 162
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 163 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 222
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 223 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 266
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 267 DSRPKFRELI 276

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 130
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 131 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 181
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 182 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 241
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 242 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 285
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 286 DSRPKFRELI 295

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 109
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 110 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 160
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 161 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 220
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 221 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 264
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 265 DSRPKFRELI 274

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLS 193
           +N V+ +    + +   +  EY  N  L   +H + +       W +   I+    + LS
Sbjct: 75  RNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EALS 130
Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK---------LLGSE----SSYIT 240
           Y+H      ++HRD+K  NI ID+  N K+ DFGLAK          L S+    SS   
Sbjct: 131 YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 241 TRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  +GT  YVA E    TG  NE+ D+YS GI+  E+I       +S   E VN+++ L+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVNILKKLR 242
Query: 300 KMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRP 343
             V+   P    D K+  EK   RLL          +D +  KRP
Sbjct: 243 S-VSIEFPPDFDDNKMKVEKKIIRLL----------IDHDPNKRP 276

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 105 KVAVKNLLNNRGQAER-----EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
           KVAVK L  NR +        + K E++ +   RH ++++L    +      +V EYV+ 
Sbjct: 38  KVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 160 GNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           G L  ++  HG V        E R  +       + Y H  +   VVHRD+K  N+L+D 
Sbjct: 96  GELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDA 146
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEV 276
           H N K++DFGL+ ++ S+  ++     G+  Y APE  S  +      D++S G+++  +
Sbjct: 147 HMNAKIADFGLSNMM-SDGEFLRDSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 277 ISGRIPVDYSRPP 289
           + G +P D    P
Sbjct: 205 LCGTLPFDDEHVP 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           V +K + +  G Q+ +     + AIG + H ++VRLLG C  G+   LV +Y+  G+L  
Sbjct: 45  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 103
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
            +    G +GP   L W +++      AKG+ YL E     +VHR++ + N+L+      
Sbjct: 104 HVRQHRGALGPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQV 154
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           +V+DFG+A LL   +   + +       ++A E    G    +SDV+S+G+ + E+++ G
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 280 RIPVDYSRPPEEVNLIE 296
             P    R  E  +L+E
Sbjct: 215 AEPYAGLRLAEVPDLLE 231

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 27/198 (13%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L  N   +E R+   E   + +V H ++++L G C++    +L+ EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 163 EQWLHGD--VGPC------------------SPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
             +L     VGP                     LT    ++     ++G+ YL E     
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---S 170
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
           +VHRD+ + NIL+ +    K+SDFGL++ +  E S +  R  G     ++A E     + 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIY 229
Query: 261 NERSDVYSFGILIMEVIS 278
             +SDV+SFG+L+ E+++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHG-----DVGPC-----SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             +L       +  P      S L+    ++     A+G+++L        +HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+      K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GI
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 272 LIMEVIS 278
           L+ E+ S
Sbjct: 255 LLWEIFS 261

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP--------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
             +L        P        LT E  +      AKG+ +L      K +HRD+ + NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
           + +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SFG+L+
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 274 MEVIS 278
            E+ S
Sbjct: 237 WEIFS 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP--------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
             +L        P        LT E  +      AKG+ +L      K +HRD+ + NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
           + +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SFG+L+
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 274 MEVIS 278
            E+ S
Sbjct: 237 WEIFS 241

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 47  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 106 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S  +T V GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC+D + +
Sbjct: 214 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLDMDVE 259
Query: 341 KR 342
           KR
Sbjct: 260 KR 261

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 163 EQWLH----GDVGPC---------------SPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +L       +GP                 PL     ++     A+G+++L        
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNC 179
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNE 262
           +HRD+ + N+L+      K+ DFGLA+ + ++S+YI          ++APE     +   
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 263 RSDVYSFGILIMEVIS 278
           +SDV+S+GIL+ E+ S
Sbjct: 240 QSDVWSYGILLWEIFS 255

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K+ L   G  E + + E+E    +RH N++R+  Y  +     L+ E+   G L +
Sbjct: 45  KVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK 103
Query: 165 WL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
            L  HG        T+      +   A  L Y HE    KV+HRDIK  N+L+      K
Sbjct: 104 ELQKHGRFDEQRSATF------MEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154
Query: 223 VSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           ++DFG +      +  +  R M GT  Y+ PE       +E+ D++  G+L  E + G  
Sbjct: 155 IADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
Query: 282 PVD 284
           P D
Sbjct: 211 PFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K+ L   G  E + + E+E    +RH N++R+  Y  +     L+ E+   G L +
Sbjct: 46  KVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK 104
Query: 165 WL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
            L  HG        T+   +      A  L Y HE    KV+HRDIK  N+L+      K
Sbjct: 105 ELQKHGRFDEQRSATFMEEL------ADALHYCHER---KVIHRDIKPENLLMGYKGELK 155
Query: 223 VSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           ++DFG +      +  +  R M GT  Y+ PE       +E+ D++  G+L  E + G  
Sbjct: 156 IADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 211
Query: 282 PVD 284
           P D
Sbjct: 212 PFD 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 125/267 (46%), Gaps = 32/267 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E++Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 165 HDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP--KLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 224 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 267
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPS 359
            C   N + RP    +V++L+    PS
Sbjct: 268 -CWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 21/165 (12%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 84  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 137
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++  L  E   +    +GT  Y++PE       + +SD++S G+
Sbjct: 138 NILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGL 194
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
            ++E+  GR    Y RPP  + + E L  +V N  P     PKLP
Sbjct: 195 SLVEMAVGR----YPRPP--MAIFELLDYIV-NEPP-----PKLP 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R Q  RE +V  E         +V   G         +  E+++ G+L+Q L        
Sbjct: 48  RNQIIRELQVLHEC----NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AG 99
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            +  +I   + +   KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G 
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQ 154
Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV------DYSRP 288
               +    +GT  Y++PE       + +SD++S G+ ++E+  GR P+      + SRP
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRP 214
Query: 289 PEEV-NLIEWLKKMVTNRNPEGVL 311
           P  +  L++++      + P GV 
Sbjct: 215 PMAIFELLDYIVNEPPPKLPSGVF 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 178
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 239 GVLLWEIFS 247

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 237 GVLLWEIFS 245

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H+N+VRL           LV+E+++N +L++++       +P   E+ +  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 185 ILG--TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                  +GL++ HE    K++HRD+K  N+LI+K    K+ DFGLA+  G   +  ++ 
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 243 VMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           V+ T  Y AP+          S D++S G ++ E+I+G+     +   E++ LI
Sbjct: 169 VV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 31/238 (13%)
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGD-VGPC 173
           +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  ++  H D +G  
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 151
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
             L W +++      AKG++YL +    ++VHRD+ + N+L+    + K++DFGLAKLLG
Sbjct: 152 YLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 202
Query: 234 S-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE 291
           + E  Y          ++A E     +   +SDV+S+G+ + E+++ G  P D   P  E
Sbjct: 203 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 261
Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           ++ I  L+K             +LP+ P   +   + ++ ++C   +A  RPK   ++
Sbjct: 262 ISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 117 QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCS 174
           +++R+   E+E + R  +H N++ L     +G H  LV E +  G L ++ L        
Sbjct: 62  KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR------Q 115
Query: 175 PLTWEIRMNIILGT-AKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP---KVSDFGLA 229
               E   + +L T  K + YLH      VVHRD+K SNIL +D+  NP   ++ DFG A
Sbjct: 116 KFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY--SR 287
           K L +E+  + T    T  +VAPE       +E  D++S GIL+  +++G  P     S 
Sbjct: 173 KQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 288 PPEEV 292
            PEE+
Sbjct: 232 TPEEI 236

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 117 QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCS 174
           +++R+   E+E + R  +H N++ L     +G H  LV E +  G L ++ L        
Sbjct: 62  KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR------Q 115
Query: 175 PLTWEIRMNIILGT-AKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP---KVSDFGLA 229
               E   + +L T  K + YLH      VVHRD+K SNIL +D+  NP   ++ DFG A
Sbjct: 116 KFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY--SR 287
           K L +E+  + T    T  +VAPE       +E  D++S GIL+  +++G  P     S 
Sbjct: 173 KQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 288 PPEEV 292
            PEE+
Sbjct: 232 TPEEI 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 274 GVLLWEIFS 282

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 57  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 115
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 116 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 166
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 167 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 226
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 227 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 270
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 271 DSRPKFRELI 280

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 44  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 102
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      A+G++YL +    ++VHRD+ + N+L+    + 
Sbjct: 103 YVREHKDNIGSQYLLNWCVQI------AEGMNYLEDR---RLVHRDLAARNVLVKTPQHV 153
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 154 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 213
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 214 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 257
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 258 DSRPKFRELI 267

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL 328
           G+L+ E+ S G  P    +  EE      LK+    R P    D   PE         + 
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRMRAP----DYTTPE---------MY 272
Query: 329 LVALRCVDPNAQKRPKMGHVV-HMLEAQESPSKEDR 363
              L C      +RP    +V H+    ++ +++DR
Sbjct: 273 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 32/267 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 165 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 224 EITS------LAEQPYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTD--LMRM----- 267
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPS 359
            C   N + RP    +V++L+    PS
Sbjct: 268 -CWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 32/267 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 47  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 106
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 107 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 163
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 164 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 222
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 223 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 266
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPS 359
            C   N + RP    +V++L+    PS
Sbjct: 267 -CWQFNPKMRPTFLEIVNLLKDDLHPS 292

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 12/186 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK + + R Q  RE    EV  +    H N+V +      G    +V E++  G L 
Sbjct: 72  QVAVKKM-DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT 130
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                D+   + +  E    + L   + LSYLH      V+HRDIKS +IL+      K+
Sbjct: 131 -----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKL 182
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           SDFG    +  E       ++GT  ++APE  S        D++S GI+++E+I G  P 
Sbjct: 183 SDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241
Query: 284 DYSRPP 289
            ++ PP
Sbjct: 242 -FNEPP 246

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 42/276 (15%)
Query: 103 NSKVAVKNL-LNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYE 155
           N  VAVK   L ++   Q+ERE    + +   ++H+NL++ +     G++      L+  
Sbjct: 38  NDFVAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFIAAEKRGSNLEVELWLITA 93
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE--------GLEPKVVHRD 207
           + + G+L  +L G++     +TW    ++    ++GLSYLHE        G +P + HRD
Sbjct: 94  FHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRD 148
Query: 208 IKSSNILIDKHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS-- 264
            KS N+L+       ++DFGLA +    +    T   +GT  Y+APE     +  +R   
Sbjct: 149 FKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAF 208
Query: 265 ---DVYSFGILIMEVIS----GRIPVDYSRPPEEVNL-----IEWLKKMVTNRNPEGVLD 312
              D+Y+ G+++ E++S       PVD    P E  +     +E L+++V ++     + 
Sbjct: 209 LRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIK 268
Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
               + P    L ++ +    C D +A+ R   G V
Sbjct: 269 DHWLKHPG---LAQLCVTIEECWDHDAEARLSAGCV 301

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHGDVGPCSPLTWEIRMN------------IILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L     P    ++    N                 A+G+++L        +HRD+ +
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            N+L+      K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 270 GILIMEVIS 278
           GIL+ E+ S
Sbjct: 255 GILLWEIFS 263

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 31  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 90  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 142
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 143 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200
Query: 282 PVD 284
           P +
Sbjct: 201 PYE 203

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 35  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 94  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 146
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 147 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 204
Query: 282 PVD 284
           P +
Sbjct: 205 PYE 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 116/244 (47%), Gaps = 19/244 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV + +L++ + +A+     E++ + ++ H N+++      E     +V E  + G+L +
Sbjct: 64  KVQIFDLMDAKARAD--CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +         +         +     L ++H     +V+HRDIK +N+ I      K+ 
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG 178
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           D GL +   S+++   + V GT  Y++PE       N +SD++S G L+ E+ + + P  
Sbjct: 179 DLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF- 236
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
           Y    +++NL    KK+      E    P LP    S  L++++ +   C++P+ +KRP 
Sbjct: 237 YG---DKMNLYSLCKKI------EQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPD 284
Query: 345 MGHV 348
           + +V
Sbjct: 285 VTYV 288

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 102 DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           DN+ VAVK+         + +F  E   + +  H N+VRL+G C +     +V E V  G
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +   +L  +    + L  +  + ++   A G+ YL        +HRD+ + N L+ +   
Sbjct: 198 DFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNV 251
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEV 276
            K+SDFG+++    E+  +     G       + APE  + G  +  SDV+SFGIL+ E 
Sbjct: 252 LKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
Query: 277 IS 278
            S
Sbjct: 309 FS 310

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
            P  + LG+G W      E+     +  K                    VA+K ++    
Sbjct: 8   APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
               +   +L   K +    E LE K  +HRD+ + N L++     KVSDFGL++ +  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 236 SSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD 284
               T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++P +
Sbjct: 174 EE--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 91/174 (52%), Gaps = 22/174 (12%)
Query: 120 REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC- 173
           R+F  E+E + ++  H N++ LLG C    +  L  EY  +GNL  +L      +  P  
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 126
Query: 174 -------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                  S L+ +  ++     A+G+ YL +    + +HR++ + NIL+ +++  K++DF
Sbjct: 127 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADF 183
Query: 227 GLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           GL++    +  Y+  + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 184 GLSR---GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 48  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 102 DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 153
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 154 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 211
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 212 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 250

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 47  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 101 DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 153 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 211 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 249

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 38  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 91
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 92  DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 143
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 144 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 201
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 202 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 240

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 15/185 (8%)
Query: 102 DNS--KVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEY 156
           DN+  +VAVK+L   + G    + K E+E +  + H+N+V+  G C E  G    L+ E+
Sbjct: 47  DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +G+L+++L  +    + +  + ++   +   KG+ YL      + VHRD+ + N+L++
Sbjct: 107 LPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 160
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT---RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
                K+ DFGL K + ++    T    R    F Y APE          SDV+SFG+ +
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTL 219
Query: 274 MEVIS 278
            E+++
Sbjct: 220 HELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 15/185 (8%)
Query: 102 DNS--KVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEY 156
           DN+  +VAVK+L   + G    + K E+E +  + H+N+V+  G C E  G    L+ E+
Sbjct: 35  DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 94
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +G+L+++L  +    + +  + ++   +   KG+ YL      + VHRD+ + N+L++
Sbjct: 95  LPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVE 148
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT---RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
                K+ DFGL K + ++    T    R    F Y APE          SDV+SFG+ +
Sbjct: 149 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTL 207
Query: 274 MEVIS 278
            E+++
Sbjct: 208 HELLT 212

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 29/193 (15%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----------- 150
           D     +K +  N  +AERE    V+A+ ++ H N+V   G C +G              
Sbjct: 35  DGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSR 89
Query: 151 ------MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  +  E+ + G LEQW+    G    L   + + +     KG+ Y+H     K++
Sbjct: 90  SKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLI 144
Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           +RD+K SNI +      K+ DFGL   L ++      R  GT  Y++PE  S+    +  
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RXRSKGTLRYMSPEQISSQDYGKEV 202
Query: 265 DVYSFGILIMEVI 277
           D+Y+ G+++ E++
Sbjct: 203 DLYALGLILAELL 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHG-----DVGPCSPL---TWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             +L       +  P   +   T   R  ++     A+G+++L        +HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+      K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GI
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 272 LIMEVIS 278
           L+ E+ S
Sbjct: 255 LLWEIFS 261

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 47  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 106 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S   + ++GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 155 VKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC+D + +
Sbjct: 214 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLDMDVE 259
Query: 341 KR 342
           KR
Sbjct: 260 KR 261

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 42  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 95
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 96  DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 147
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 148 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 205
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 206 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 244

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 36  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 95  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 147
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 148 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 205
Query: 282 PVD 284
           P +
Sbjct: 206 PYE 208

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
            P  + LG+G W      E+     +  K                    VA+K ++    
Sbjct: 8   APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
               +   +L   K +    E LE K  +HRD+ + N L++     KVSDFGL++ +  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 236 SSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD 284
               T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++P +
Sbjct: 174 E--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 6/167 (3%)
Query: 117 QAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPC 173
           +AE++  V EV  +  ++H N+VR      +  +  L  V EY   G+L   +       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEP--KVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L  E  + ++      L   H   +    V+HRD+K +N+ +D   N K+ DFGLA++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           L  +  +     +GT  Y++PE  +    NE+SD++S G L+ E+ +
Sbjct: 166 LNHDEDF-AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 102 DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           DN+ VAVK+         + +F  E   + +  H N+VRL+G C +     +V E V  G
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +   +L  +    + L  +  + ++   A G+ YL        +HRD+ + N L+ +   
Sbjct: 198 DFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNV 251
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEV 276
            K+SDFG+++    E+  +     G       + APE  + G  +  SDV+SFGIL+ E 
Sbjct: 252 LKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
Query: 277 IS 278
            S
Sbjct: 309 FS 310

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 42  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 101 LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 153
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 154 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 211
Query: 282 PVD 284
           P +
Sbjct: 212 PYE 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 470
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 471 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E 
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 587
Query: 298 LKKM 301
            ++M
Sbjct: 588 GERM 591

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 109
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 110 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 160
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 161 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 220
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 221 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 264
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 265 DSRPKFRELI 274

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 471
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 472 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E 
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 588
Query: 298 LKKM 301
            ++M
Sbjct: 589 GERM 592

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +G+   ++ EY+  G+    L    GP         +  
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKE 128
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           IL   KGL YLH     K +HRDIK++N+L+ +  + K++DFG+A  L +++       +
Sbjct: 129 IL---KGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV 181
Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           GT  ++APE       + ++D++S GI  +E+  G  P     P   + LI
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 64/123 (52%), Gaps = 7/123 (5%)
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+ + G LEQW+    G    L   + + +     KG+ Y+H     K++HRD+K SNI 
Sbjct: 114 EFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIF 168
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
           +      K+ DFGL   L ++     TR  GT  Y++PE  S+    +  D+Y+ G+++ 
Sbjct: 169 LVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 226
Query: 275 EVI 277
           E++
Sbjct: 227 ELL 229

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 15/185 (8%)
Query: 105 KVAVKNL-LNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-----MLVYEYV 157
           KVAVK + L+N  Q E  EF  E   +    H N++RLLG C E + +     M++  ++
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 158 NNGNLEQWL---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
             G+L  +L     + GP   +  +  +  ++  A G+ YL        +HRD+ + N +
Sbjct: 124 KYGDLHTYLLYSRLETGP-KHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCM 179
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FGYVAPEYASTGMLNERSDVYSFGILI 273
           +       V+DFGL+K + S   Y   R+      ++A E  +  +   +SDV++FG+ +
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 274 MEVIS 278
            E+ +
Sbjct: 240 WEIAT 244

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 17/187 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 163 EQWLHG---DVGPCSP-------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             +L     +  P  P       LT E  +      AKG+ +L      K +HRD+ + N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARN 178
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           IL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SFG+
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 272 LIMEVIS 278
           L+ E+ S
Sbjct: 239 LLWEIFS 245

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 45  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 104
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 105 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 161
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
             +  K+ DFG+ + +  ++      + +    ++APE    G+    SD++SFG+++ E
Sbjct: 162 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 221
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVALR 333
           + S       +  P +    E + K V +    G LD     PE+ T   L R+      
Sbjct: 222 ITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM------ 264
Query: 334 CVDPNAQKRPKMGHVVHMLEAQESPS 359
           C   N + RP    +V++L+    PS
Sbjct: 265 CWQFNPKMRPTFLEIVNLLKDDLHPS 290

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
             +  K+ DFG+ + +  ++      + +    ++APE    G+    SD++SFG+++ E
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVALR 333
           + S       +  P +    E + K V +    G LD     PE+ T   L R+      
Sbjct: 225 ITS------LAEQPYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTD--LMRM------ 267
Query: 334 CVDPNAQKRPKMGHVVHMLEAQESPS 359
           C   N + RP    +V++L+    PS
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 108 ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 161
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 162 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 219 SLVEMAVGRYPI----PPPDAKELELM 241

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 105 KVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           KVA+K +   + Q    E   E++A+ +  H N+V             LV + ++ G++ 
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 164 QWLHGDVGP----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
             +   V         L       I+    +GL YLH+  +   +HRD+K+ NIL+ +  
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTF----GYVAPEYA-STGMLNERSDVYSFGILIM 274
           + +++DFG++  L +       +V  TF     ++APE        + ++D++SFGI  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---GVLDPKLPEKPTSRLLKRILLVA 331
           E+ +G  P  +  PP +V ++      + N  P    GV D ++ +K      K I L  
Sbjct: 219 ELATGAAPY-HKYPPMKVLML-----TLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-- 270
Query: 332 LRCVDPNAQKRPKMGHVVHMLEAQESPSKE 361
             C+  + +KRP    ++     Q++ +KE
Sbjct: 271 --CLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 126
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 127 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 85/174 (48%), Gaps = 13/174 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +       +V   G         +  E+++ G+L+Q L         +  +I   +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKV 171
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
            +   KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G     +    +
Sbjct: 172 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV 226
Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  Y++PE       + +SD++S G+ ++E+  GR P+    PP +   +E +
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELM 276

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 128
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 129 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 128
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 129 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 93/184 (50%), Gaps = 16/184 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 36  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 95  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 147
Query: 225 DFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           DFGL++ +  +  Y ++R  G+     +  PE       + +SD+++FG+L+ E+ S G+
Sbjct: 148 DFGLSRYV-LDDEYTSSR--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204
Query: 281 IPVD 284
           +P +
Sbjct: 205 MPYE 208

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I ++ H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 179
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 180 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 240 FSLGYMP 246

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 89  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 148
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 149 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 205
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 206 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 266 FSLGYMP 272

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 163 EQWLHGDVGPCSP-----------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
             +L        P           LT E  +      AKG+ +L      K +HRD+ + 
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 177
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 271 ILIMEVIS 278
           +L+ E+ S
Sbjct: 238 VLLWEIFS 245

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I ++ H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 193
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 194 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 254 FSLGYMP 260

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 106
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 107 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 118
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 119 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 112
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 113 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 79  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 138
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 139 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 195
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 196 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 256 FSLGYMP 262

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 30/266 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
             +  K+ DFG+ + +  ++      + +    ++APE    G+    SD++SFG+++ E
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVALR 333
           + S       +  P +    E + K V +    G LD     PE+ T   L R+      
Sbjct: 225 ITS------LAEQPYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTD--LMRM------ 267
Query: 334 CVDPNAQKRPKMGHVVHMLEAQESPS 359
           C   N   RP    +V++L+    PS
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 108
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 109 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 121
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 239 FSLGYMP 245

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 179
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 180 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 240 FSLGYMP 246

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 69  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 128
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 129 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 185
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 186 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 246 FSLGYMP 252

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLS 193
           +N V+      + +   +  EY  N  L   +H + +       W +   I+    + LS
Sbjct: 75  RNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EALS 130
Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK---------LLGSE----SSYIT 240
           Y+H      ++HR++K  NI ID+  N K+ DFGLAK          L S+    SS   
Sbjct: 131 YIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 241 TRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  +GT  YVA E    TG  NE+ D YS GI+  E I       +S   E VN+++ L+
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI-----YPFSTGXERVNILKKLR 242
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +     P+   +    EK   RLL          +D +  KRP
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLL----------IDHDPNKRP 276

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRL------LGYCAEGAHRMLVYEYV 157
           +VA+K          RE + +E++ + ++ H N+V        L   A     +L  EY 
Sbjct: 42  QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 101
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID- 216
             G+L ++L+     C      IR  ++   +  L YLHE    +++HRD+K  NI++  
Sbjct: 102 EGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN---RIIHRDLKPENIVLQP 157
Query: 217 --KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
             +    K+ D G AK L  +   + T  +GT  Y+APE           D +SFG L  
Sbjct: 158 GPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 215
Query: 275 EVISGRIP 282
           E I+G  P
Sbjct: 216 ECITGFRP 223

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 121
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 239 FSLGYMP 245

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRL------LGYCAEGAHRMLVYEYV 157
           +VA+K          RE + +E++ + ++ H N+V        L   A     +L  EY 
Sbjct: 41  QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID- 216
             G+L ++L+     C      IR  ++   +  L YLHE    +++HRD+K  NI++  
Sbjct: 101 EGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN---RIIHRDLKPENIVLQP 156
Query: 217 --KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
             +    K+ D G AK L  +   + T  +GT  Y+APE           D +SFG L  
Sbjct: 157 GPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 275 EVISGRIP 282
           E I+G  P
Sbjct: 215 ECITGFRP 222

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 179
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 180 GRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 240 FSLGYMP 246

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 54  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 113
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 114 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 170
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 171 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 231 FSLGYMP 237

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 237 GVLLWEIFS 245

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 77  QVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 193
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 194 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 254 FSLGYMP 260

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           VAVK L  + G   R  +K E++ +  + H+++++  G C  A  A   LV EYV  G+L
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    +G    L +  ++       +G++YLH       +HRD+ + N+L+D     
Sbjct: 123 RDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA---QHYIHRDLAARNVLLDNDRLV 173
Query: 222 KVSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +  G E   +         + APE          SDV+SFG+ + E+++
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 121/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYEYVNNGNLEQWLHGDVGP 172
           RG  E+ ++ E+  + ++ H N+V+L+    +    H  +V+E VN G + +     V  
Sbjct: 77  RGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPT 130
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KL 231
             PL+ +          KG+ YLH     K++HRDIK SN+L+ +  + K++DFG++ + 
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRIPVDYSRP 288
            GS++  + +  +GT  ++APE  S        +  DV++ G+ +   + G+ P    R 
Sbjct: 188 KGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 289 --------------PEEVNLIEWLKKMVT---NRNPE 308
                         P++ ++ E LK ++T   ++NPE
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 136
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 193
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 194 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 254 FSLGYMP 260

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 121/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 123/267 (46%), Gaps = 32/267 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 49  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 108
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHR++ + N ++ 
Sbjct: 109 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVA 165
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 166 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 224
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 225 EITS------LAEQPYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTD--LMRM----- 268
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPS 359
            C   N   RP    +V++L+    PS
Sbjct: 269 -CWQFNPNMRPTFLEIVNLLKDDLHPS 294

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 56  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 116 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 173 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231
Query: 275 EVIS 278
           E+ +
Sbjct: 232 EIAT 235

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 123/267 (46%), Gaps = 32/267 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHR++ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 165 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 224 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 267
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPS 359
            C   N   RP    +V++L+    PS
Sbjct: 268 -CWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R Q  RE +V    +       +V   G         +  E+++ G+L+Q L        
Sbjct: 48  RNQIIRELQV----LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAG 99
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            +  +I   + +   KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G 
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQ 154
Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
               +    +GT  Y++PE       + +SD++S G+ ++E+  GR P+    PP +   
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKE 210
Query: 295 IEWL 298
           +E +
Sbjct: 211 LELM 214

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R Q  RE +V    +       +V   G         +  E+++ G+L+Q L        
Sbjct: 48  RNQIIRELQV----LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAG 99
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            +  +I   + +   KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G 
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQ 154
Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
               +    +GT  Y++PE       + +SD++S G+ ++E+  GR P+    PP +   
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKE 210
Query: 295 IEWL 298
           +E +
Sbjct: 211 LELM 214

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 92/185 (49%), Gaps = 15/185 (8%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 56  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 163 EQWLHGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           + +L   + P        +P +    + +    A G++YL+     K VHRD+ + N ++
Sbjct: 116 KSYLRS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILI 273
            + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++
Sbjct: 172 AEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 274 MEVIS 278
            E+ +
Sbjct: 231 WEIAT 235

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 48  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 107 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 155
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S   + ++GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 156 VKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC++ + +
Sbjct: 215 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLEMDVE 260
Query: 341 KR 342
           KR
Sbjct: 261 KR 262

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  EI   + +   +GL+YL E  + +++HRD+K S
Sbjct: 91  ICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPS 144
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y+APE       + +SD++S G+
Sbjct: 145 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGL 201
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 202 SLVELAVGRYPI----PPPDAKELEAI 224

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L  + G   R  +K E++ +  + H+++++  G C +   +   LV EYV  G+L
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    +G    L +  ++       +G++YLH       +HR++ + N+L+D     
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQI------CEGMAYLHS---QHYIHRNLAARNVLLDNDRLV 156
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 48  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HR+IKS NIL+    +
Sbjct: 107 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRNIKSDNILLGMDGS 155
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S  +T V GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 156 VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC++ + +
Sbjct: 215 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLEMDVE 260
Query: 341 KR 342
           KR
Sbjct: 261 KR 262

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 47  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 106
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 107 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 163
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 164 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 222
Query: 275 EVIS 278
           E+ +
Sbjct: 223 EIAT 226

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 47  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 106 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S   + ++GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 155 VKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC++ + +
Sbjct: 214 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLEMDVE 259
Query: 341 KR 342
           KR
Sbjct: 260 KR 261

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L  + G   R  +K E++ +  + H+++++  G C +   +   LV EYV  G+L
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    +G    L +  ++       +G++YLH       +HR++ + N+L+D     
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA---QHYIHRNLAARNVLLDNDRLV 156
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 57/285 (20%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC----SPL 176
           E + EV  +  ++H N+V+      E     +V +Y   G+L + ++   G        L
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W +++ +       L ++H+    K++HRDIKS NI + K    ++ DFG+A++L S +
Sbjct: 129 DWFVQICL------ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-T 178
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI-------------------LIMEVI 277
             +    +GT  Y++PE       N +SD+++ G                    L++++I
Sbjct: 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTN---RNPE------GVLDPKLPEKPTSRLLKRIL 328
           SG      S PP  ++    L+ +V+    RNP        +L+     K   + L   L
Sbjct: 239 SG------SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 329 LVALRCV--------DPNAQKRPKMGH-VVHMLEAQESPSKEDRY 364
           +    C+         P   KRP  G   + ++ AQ+      +Y
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKY 337

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 81  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 135 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 192 SLVEMAVGRYPI----PPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 81  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 135 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 192 SLVEMAVGRYPI----PPPDAKELELM 214

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 237 GVLLWEIFS 245

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 49  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 108
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 109 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 165
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 166 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 224
Query: 275 EVIS 278
           E+ +
Sbjct: 225 EIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 49  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 108
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 109 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 165
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 166 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 224
Query: 275 EVIS 278
           E+ +
Sbjct: 225 EIAT 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 43  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 102
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 103 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 159
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 160 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 218
Query: 275 EVIS 278
           E+ +
Sbjct: 219 EIAT 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 92/185 (49%), Gaps = 15/185 (8%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 46  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 105
Query: 163 EQWLHGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           + +L   + P        +P +    + +    A G++YL+     K VHRD+ + N ++
Sbjct: 106 KSYLRS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 161
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILI 273
            + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++
Sbjct: 162 AEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 220
Query: 274 MEVIS 278
            E+ +
Sbjct: 221 WEIAT 225

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 50  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 109
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 110 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 166
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 167 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 225
Query: 275 EVIS 278
           E+ +
Sbjct: 226 EIAT 229

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 179 VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 236
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 237 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 289
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 290 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 347
Query: 285 YSRPP 289
           ++ PP
Sbjct: 348 FNEPP 352

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 57  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 114
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 115 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 167
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 168 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 225
Query: 285 YSRPP 289
           ++ PP
Sbjct: 226 FNEPP 230

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 59  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 116
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 117 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 169
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 170 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 227
Query: 285 YSRPPEEV------NLIEWLKKM-VTNRNPEGVLDPKLPEKPTSR 322
           ++ PP +       NL   LK +   + + +G LD  L   P  R
Sbjct: 228 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 272

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 52  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 109
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 110 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 162
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 163 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 220
Query: 285 YSRPPEEV------NLIEWLKKM-VTNRNPEGVLDPKLPEKPTSR 322
           ++ PP +       NL   LK +   + + +G LD  L   P  R
Sbjct: 221 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 100 ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 153
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 154 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 210
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
            ++E+  GR P+        + + E L  +V N  P     PKLP
Sbjct: 211 SLVEMAVGRYPI--GSGSGSMAIFELLDYIV-NEPP-----PKLP 247

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 78  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 137
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 138 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 194
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 195 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 253
Query: 275 EVIS 278
           E+ +
Sbjct: 254 EIAT 257

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 48  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 105
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 106 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 159 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 216
Query: 285 YSRPPEEV------NLIEWLKKM-VTNRNPEGVLDPKLPEKPTSR 322
           ++ PP +       NL   LK +   + + +G LD  L   P  R
Sbjct: 217 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 261

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 80  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 139
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 140 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 196
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +     Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 197 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 257 FSLGYMP 263

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 162
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 219
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +     Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 280 FSLGYMP 286

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 102 VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 159
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 160 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 212
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 213 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 270
Query: 285 YSRPP 289
           ++ PP
Sbjct: 271 FNEPP 275

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +N K+++K+  +       +FK E++ I  ++++  +   G         ++YEY+ N +
Sbjct: 77  NNDKISIKSKYD-------DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 162 L----EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           +    E +   D      +  ++   II       SY+H   E  + HRD+K SNIL+DK
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVM----GTFGYVAPEYAS--TGMLNERSDVYSFGI 271
           +   K+SDFG       ES Y+  + +    GT+ ++ PE+ S  +     + D++S GI
Sbjct: 188 NGRVKLSDFG-------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
            +  +    +P        +++L+E    + T +N E  LD
Sbjct: 241 CLYVMFYNVVPFSL-----KISLVELFNNIRT-KNIEYPLD 275

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 117/258 (45%), Gaps = 26/258 (10%)
Query: 105 KVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           KVA+K +   + Q    E   E++A+ +  H N+V             LV + ++ G++ 
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 164 QWLHGDVGP----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
             +   V         L       I+    +GL YLH+  +   +HRD+K+ NIL+ +  
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTF----GYVAPEYA-STGMLNERSDVYSFGILIM 274
           + +++DFG++  L +       +V  TF     ++APE        + ++D++SFGI  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---GVLDPKLPEKPTSRLLKRILLVA 331
           E+ +G  P  +  PP +V ++      + N  P    GV D ++ +K      K I L  
Sbjct: 214 ELATGAAPY-HKYPPMKVLML-----TLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-- 265
Query: 332 LRCVDPNAQKRPKMGHVV 349
             C+  + +KRP    ++
Sbjct: 266 --CLQKDPEKRPTAAELL 281

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 41  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 100
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 101 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 157
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           + +  K+ DFG+ + +  ++      + +    +++PE    G+    SDV+SFG+++ E
Sbjct: 158 EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 217
Query: 276 VIS 278
           + +
Sbjct: 218 IAT 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 94/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C+ LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L    G Q    ++ E+E +  + H+++V+  G C +   +   LV EYV  G+L
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    VG    L +  ++       +G++YLH       +HR + + N+L+D     
Sbjct: 100 RDYLPRHCVGLAQLLLFAQQI------CEGMAYLHA---QHYIHRALAARNVLLDNDRLV 150
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L    G Q    ++ E+E +  + H+++V+  G C +   +   LV EYV  G+L
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    VG    L +  ++       +G++YLH       +HR + + N+L+D     
Sbjct: 101 RDYLPRHCVGLAQLLLFAQQI------CEGMAYLHA---QHYIHRALAARNVLLDNDRLV 151
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 48  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 102
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 103 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 159
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 160 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 214
Query: 276 VISGR 280
           +++GR
Sbjct: 215 LLTGR 219

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 43  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 102
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N  + 
Sbjct: 103 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVA 159
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 160 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 218
Query: 275 EVIS 278
           E+ +
Sbjct: 219 EIAT 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 59  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 113
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 114 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 170
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 171 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 225
Query: 276 VISGR 280
           +++GR
Sbjct: 226 LLTGR 230

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTA 189
           H  L  +        +   V EY+N G+L   +      D+   +    EI +       
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL------- 130
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTF 247
            GL +LH      +V+RD+K  NIL+DK  + K++DFG+ K  +LG      T    GT 
Sbjct: 131 -GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTP 183
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            Y+APE       N   D +SFG+L+ E++ G+ P 
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 50  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 109
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 110 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 166
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           + +  K+ DFG+ + +  ++      + +    +++PE    G+    SDV+SFG+++ E
Sbjct: 167 EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 226
Query: 276 VIS 278
           + +
Sbjct: 227 IAT 229

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK +++ R Q  RE    EV  +   +H N+V +      G    ++ E++  G L 
Sbjct: 72  QVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                D+     L  E    +     + L+YLH      V+HRDIKS +IL+      K+
Sbjct: 131 -----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           SDFG    +  +       ++GT  ++APE  S  +     D++S GI+++E++ G  P
Sbjct: 183 SDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 46  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 100
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 157
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 158 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 212
Query: 276 VISGR 280
           +++GR
Sbjct: 213 LLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 46  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 100
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 157
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 158 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 212
Query: 276 VISGR 280
           +++GR
Sbjct: 213 LLTGR 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 123
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 181 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 276 VISGR 280
           +++GR
Sbjct: 236 LLTGR 240

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 61  RVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 115
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 172
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 173 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 227
Query: 276 VISGR 280
           +++GR
Sbjct: 228 LLTGR 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 61  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 115
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 172
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 173 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 227
Query: 276 VISGR 280
           +++GR
Sbjct: 228 LLTGR 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 61  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 115
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 172
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 173 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 227
Query: 276 VISGR 280
           +++GR
Sbjct: 228 LLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 60  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 114
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 171
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 172 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 226
Query: 276 VISGR 280
           +++GR
Sbjct: 227 LLTGR 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 126
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 183
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 184 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 238
Query: 276 VISGR 280
           +++GR
Sbjct: 239 LLTGR 243

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTA 189
           H  L  +        +   V EY+N G+L   +      D+   +    EI +       
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL------- 129
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTF 247
            GL +LH      +V+RD+K  NIL+DK  + K++DFG+ K  +LG      T    GT 
Sbjct: 130 -GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTP 182
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            Y+APE       N   D +SFG+L+ E++ G+ P 
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 68  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 122
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 179
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 180 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 234
Query: 276 VISGR 280
           +++GR
Sbjct: 235 LLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 123
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 181 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 276 VISGR 280
           +++GR
Sbjct: 236 LLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 47  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 101
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 102 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 158
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 159 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 213
Query: 276 VISGR 280
           +++GR
Sbjct: 214 LLTGR 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 123
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXF 179
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 60  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 114
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 171
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 172 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 226
Query: 276 VISGR 280
           +++GR
Sbjct: 227 LLTGR 231

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 68  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 122
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 179
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 180 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 234
Query: 276 VISGR 280
           +++GR
Sbjct: 235 LLTGR 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 11/180 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K+ +   G  E + + E+E    + H N++RL  Y  +     L+ EY   G L +
Sbjct: 54  KVLFKSQIEKEG-VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYK 112
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            L      C+    +    I+   A  L Y H     KV+HRDIK  N+L+      K++
Sbjct: 113 ELQKS---CT-FDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIA 165
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +       S     + GT  Y+ PE     M NE+ D++  G+L  E++ G  P +
Sbjct: 166 DFGWSV---HAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL---HGDVGPCSPLTWEIR 181
           E+  +  ++HKN+VRL           LV+E+ +  +L+++    +GD+ P      EI 
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------EIV 103
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
            + +    KGL + H      V+HRD+K  N+LI+++   K++DFGLA+  G      + 
Sbjct: 104 KSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160
Query: 242 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
            V+ T  Y  P+      L   S D++S G +  E+ +   P+
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 112
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +   
Sbjct: 113 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 108
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 109 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXF 164
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 108
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 109 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTF 164
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           K+AVK L     +   A+R ++ E+  +  ++H+N++ LL             E  N+  
Sbjct: 78  KIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPATS----LEEFNDVY 132
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 189
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N   D++S G ++ E
Sbjct: 190 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNMTVDIWSVGCIMAE 244
Query: 276 VISGR 280
           +++GR
Sbjct: 245 LLTGR 249

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 24/247 (9%)
Query: 108 VKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL 166
           +K +  +R Q   E  + E+E +  + H N++++     +  +  +V E    G L + +
Sbjct: 52  IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI 111
Query: 167 HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKV 223
                    L+      ++      L+Y H      VVH+D+K  NIL      H   K+
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKI 168
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFGLA+L  S+    +T   GT  Y+APE      +  + D++S G+++  +++G +P 
Sbjct: 169 IDFGLAELFKSDEH--STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF 225
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
             +        +E +++  T + P   ++ +        LLK++L       DP  ++RP
Sbjct: 226 TGTS-------LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQML-----TKDP--ERRP 271
Query: 344 KMGHVVH 350
               V+H
Sbjct: 272 SAAQVLH 278

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 126
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 183
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E   Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 184 DCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 238
Query: 276 VISGR 280
           +++GR
Sbjct: 239 LLTGR 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLV-YEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           E + + R+ H   V+L  +C +   ++     Y  NG L +++   +G            
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA 144
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTR 242
            I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES       
Sbjct: 145 EIVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVYEYVNNG 160
           KVAVK       +A    + E+     +RH+N++  +    +G        L+ +Y  NG
Sbjct: 62  KVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILI 215
           +L  +L       + L  +  + +   +  GL +LH  +     +P + HRD+KS NIL+
Sbjct: 121 SLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 216 DKHWNPKVSDFGLAKLLGSESSYI----TTRVMGTFGYVAPEYASTGMLNER------SD 265
            K+    ++D GLA    S+++ +     TRV GT  Y+ PE     +          +D
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMAD 234
Query: 266 VYSFGILIMEV----ISGRIPVDYSRP 288
           +YSFG+++ EV    +SG I  +Y  P
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLP 261

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + ++ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + R  G   +     ++ EY+  G+       D+    PL       I
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATI 121
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    KGL YLH     + +HRDIK++N+L+ +  + K++DFG+A  L +++       +
Sbjct: 122 LREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFV 177
Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           GT  ++APE       + ++D++S GI  +E+  G  P
Sbjct: 178 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + ++ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 128
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 129 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTF 184
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +GT  ++APE       + ++D++S GI  +E+  G  P
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHG-DVGPCSPLTWEIRM 182
           E+  +  + H N+++L     +  +  LV E+   G L EQ ++      C         
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA------A 149
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKLLGSESSYI 239
           NI+     G+ YLH+     +VHRDIK  NIL++      N K+ DFGL+     +  Y 
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YK 204
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
               +GT  Y+APE       NE+ DV+S G+++  ++ G  P 
Sbjct: 205 LRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D+GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + ++ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 28  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 83
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 84  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 253
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 254 IPNRWQSCEALRVMAKIMRECWYANGAAR 282

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 29  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 84
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 85  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 139
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 140 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 199
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 200 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 254
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 255 IPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEV 276
               K+ DFGLA+    E     T  + T  Y APE     M  N+  D++S G ++ E+
Sbjct: 161 DCELKILDFGLARHTDDE----MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 277 ISGR 280
           ++GR
Sbjct: 217 LTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 7/129 (5%)
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           YV    +E  LH  +    PLT E     +    +GL Y+H     +V+HRD+K SN+L+
Sbjct: 135 YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV 191
Query: 216 DKHWNPKVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGI 271
           +++   K+ DFG+A+ L +   E  Y  T  + T  Y APE   S     +  D++S G 
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251
Query: 272 LIMEVISGR 280
           +  E+++ R
Sbjct: 252 IFGEMLARR 260

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 67  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 122
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 123 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 292
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 293 IPNRWQSCEALRVMAKIMRECWYANGAAR 321

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 31  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 86
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 87  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 141
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 142 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 201
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 202 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 256
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 257 IPNRWQSCEALRVMAKIMRECWYANGAAR 285

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 118
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 119 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 34  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 89
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 90  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 144
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 145 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 204
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 205 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 259
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 260 IPNRWQSCEALRVMAKIMRECWYANGAAR 288

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L  N   +A +E   E   +  V    + RLLG C     + LV + +  G L  
Sbjct: 49  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLD 107
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
            +    G +G    L W +++      AKG+SYL +    ++VHRD+ + N+L+    + 
Sbjct: 108 HVRENRGRLGSQDLLNWCMQI------AKGMSYLED---VRLVHRDLAARNVLVKSPNHV 158
Query: 222 KVSDFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLA+LL   E+ Y          ++A E         +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D     E  +L+E           +G    +LP+ P   +   + ++ ++C   ++
Sbjct: 219 AKPYDGIPAREIPDLLE-----------KG---ERLPQPPICTI--DVYMIMVKCWMIDS 262
Query: 340 QKRPKMGHVVHMLE-AQESPSK------EDRYRASPKNELIEKQVTESGD 382
           + RP+   +V         P +      ED   ASP +    + + E  D
Sbjct: 263 ECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDD 312

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 54  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 109
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 110 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 164
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 165 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 224
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 225 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 279
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 280 IPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 118 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +    ++ SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 7/129 (5%)
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           YV    +E  LH  +    PLT E     +    +GL Y+H     +V+HRD+K SN+L+
Sbjct: 136 YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV 192
Query: 216 DKHWNPKVSDFGLAKLLG---SESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGI 271
           +++   K+ DFG+A+ L    +E  Y  T  + T  Y APE   S     +  D++S G 
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252
Query: 272 LIMEVISGR 280
           +  E+++ R
Sbjct: 253 IFGEMLARR 261

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 52/311 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLG-YCAEGAHRM-----LVYEYV 157
           ++A   +++  G  E E K E+  + +   H+N+    G +  +    M     LV E+ 
Sbjct: 50  QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
             G++   +    G  + L  E    I     +GLS+LH+    KV+HRDIK  N+L+ +
Sbjct: 110 GAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE 164
Query: 218 HWNPKVSDFG----LAKLLGSESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYS 268
           +   K+ DFG    L + +G  +++I     GT  ++APE  +         + +SD++S
Sbjct: 165 NAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDFKSDLWS 219
Query: 269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL 328
            GI  +E+  G  P+    P   + LI         RNP     P+L  K  S+  +  +
Sbjct: 220 LGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPA----PRLKSKKWSKKFQSFI 267
Query: 329 LVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNET 388
                C+  N  +RP          A E   K    R  P    +  Q+ +  D +  + 
Sbjct: 268 ---ESCLVKNHSQRP----------ATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKR 314
Query: 389 GVHTNETRWQH 399
           G   +ET +++
Sbjct: 315 G-EKDETEYEY 324

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           +A K L    G  E E  V    + +++H N+V L      G H  L+ + V+ G     
Sbjct: 51  IAKKALEGKEGSMENEIAV----LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---- 102
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPK 222
           L   +      T      +I      + YLH   +  +VHRD+K  N+L   +D+     
Sbjct: 103 LFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +SDFGL+K+   +   + +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 160 ISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
Query: 283 V 283
Sbjct: 218 F 218

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GLS+ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP----CSPLTWEI 180
           E+  + +++H NLV LL          LV+EY ++  L +      G        +TW+ 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ- 110
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
                  T + +++ H+      +HRD+K  NILI KH   K+ DFG A+LL   S Y  
Sbjct: 111 -------TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160
Query: 241 TRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
             V  T  Y +PE            DV++ G +  E++SG
Sbjct: 161 DEV-ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 116
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 117 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 115
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 116 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 90/176 (51%), Gaps = 14/176 (7%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV----MFTEEDV 132
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A GL +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 133 KFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY- 188
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
                GT  Y+APE  +    +  +D +S+G+L+ E+++G +P       E + LI
Sbjct: 189 --SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 121
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +     V+ T  
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP--VVVTLW 176
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 141
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 142 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 141
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 142 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           +E   E+  + +    ++V+  G   +     +V EY   G++   +         LT +
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTED 125
Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
               I+  T KGL YLH     + +HRDIK+ NIL++   + K++DFG+A   G  +  +
Sbjct: 126 EIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDXM 179
Query: 240 TTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
             R  V+GT  ++APE       N  +D++S GI  +E+  G+ P     P   + +I
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 122
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 123 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 43/241 (17%)
Query: 53  VAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLL 112
           V++VV    H   GH + ++ +EV+                           +++ + L 
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAE-------------------------RLSPEQLE 140
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
             R    RE  +  +  G   H +++ L+      +   LV++ +  G L  +L   V  
Sbjct: 141 EVREATRRETHILRQVAG---HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA- 196
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              L+ +   +I+    + +S+LH      +VHRD+K  NIL+D +   ++SDFG +  L
Sbjct: 197 ---LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 233 GSESSYITTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPVDYS 286
             E       + GT GY+APE     M        +  D+++ G+++  +++G  P  + 
Sbjct: 251 --EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308
Query: 287 R 287
           R
Sbjct: 309 R 309

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 143
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 144 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 137
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 138 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 112
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 170 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 137
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 138 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VAVK L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +H ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 109 MD-ANLCQVIHMELD-------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 157
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+   + ++++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 158 KSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 276 VISGRI 281
           ++ G +
Sbjct: 216 LVKGSV 221

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DF LA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G+++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G+++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 121
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +     V+ T  
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--APVVVTLW 176
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 131
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 186
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+  FGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL---HGDVGPCSPLTWEIR 181
           E+  +  ++HKN+VRL           LV+E+ +  +L+++    +GD+ P      EI 
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------EIV 103
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
            + +    KGL + H      V+HRD+K  N+LI+++   K+++FGLA+  G      + 
Sbjct: 104 KSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 242 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
            V+ T  Y  P+      L   S D++S G +  E+ +   P+
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGXKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLH--GDVGPCSPLTWEI 180
           VE   +  +     +  L  C +   R+  V EYVN G+L   +   G       + +  
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 127
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            ++I      GL +LH+     +++RD+K  N+++D   + K++DFG+ K    +   +T
Sbjct: 128 EISI------GLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VT 176
Query: 241 TR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           TR   GT  Y+APE  +     +  D +++G+L+ E+++G+ P D
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 137
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 192
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 193 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 154
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 209
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 210 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 115
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 173 -TLWYRAPEILLGXKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLXQVIQMELD-------HERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++  +I
Sbjct: 218 MVRHKI 223

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE + ++ H N+++L     + +   +V E    G L      ++      +      I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARI 126
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           R+ GT  Y+APE    G  +E+ DV+S G+++  ++SG  P 
Sbjct: 183 RI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 155
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 210
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 211 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 115
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 173 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 121
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +     V+ T  
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--DPVVVTLW 176
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVM----FTEEDV 128
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A  L +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 129 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---- 295
                GT  Y+APE  +     + +D +SFG+L+ E+++G +P       E + +I    
Sbjct: 185 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 296 -----------EWLKKMVTNRNP 307
                      + L +M+  RNP
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNP 265

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQL 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           +A + L    G  E E  V    + +++H N+V L      G H  L+ + V+ G     
Sbjct: 51  IAKEALEGKEGSMENEIAV----LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---- 102
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPK 222
           L   +      T      +I      + YLH   +  +VHRD+K  N+L   +D+     
Sbjct: 103 LFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +SDFGL+K+   +   + +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 160 ISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
Query: 283 V 283
Sbjct: 218 F 218

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H N+V+L          +LV+E+++  +L++ L    G    +T +   + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SF 105
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L    G++Y H+    +V+HRD+K  N+LI++    K++DFGLA+  G      T  V+
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV 162
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
            T  Y AP+    +   +   D++S G +  E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV----MFTEEDV 129
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A  L +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 130 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 185
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---- 295
                GT  Y+APE  +     + +D +SFG+L+ E+++G +P       E + +I    
Sbjct: 186 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 243
Query: 296 -----------EWLKKMVTNRNP 307
                      + L +M+  RNP
Sbjct: 244 LGMPQFLSPEAQSLLRMLFKRNP 266

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV----MFTEEDV 128
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A  L +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 129 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---- 295
                GT  Y+APE  +     + +D +SFG+L+ E+++G +P       E + +I    
Sbjct: 185 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 296 -----------EWLKKMVTNRNP 307
                      + L +M+  RNP
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNP 265

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N + AVK +     +++R+   E+E + R  +H N++ L     +G +  +V E +  G 
Sbjct: 47  NMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102
Query: 162 L-EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHW 219
           L ++ L          +      ++    K + YLH      VVHRD+K SNIL +D+  
Sbjct: 103 LLDKILRQKF-----FSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESG 154
Query: 220 NP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           NP   ++ DFG AK L +E+  + T    T  +VAPE       +   D++S G+L+  +
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 277 ISGRIPVDYSRPPEE 291
           ++G  P  ++  P++
Sbjct: 214 LTGYTP--FANGPDD 226

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H N+V+L          +LV+E+++  +L++ L    G    +T +   + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SF 105
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L    G++Y H+    +V+HRD+K  N+LI++    K++DFGLA+  G      T  V+
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV 162
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
            T  Y AP+    +   +   D++S G +  E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+V+  +L+ ++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +++H N+V L      G H  L+ + V+ G     L   +      T      +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRL 121
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPKVSDFGLAKLLGSESSYITT 241
           I      + YLH   +  +VHRD+K  N+L   +D+     +SDFGL+K+   +   + +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
              GT GYVAPE  +    ++  D +S G++   ++ G  P 
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH     ++V+RD+K  NIL+D H + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 352
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APE           D ++ G L+ E+I+G+ P    +   +   +E L K V        
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------- 404
Query: 311 LDPKLPEKPTSRL--LKRILLVALRCVDP 337
                PE+ + R     R L   L C DP
Sbjct: 405 -----PEEYSERFSPQARSLCSQLLCKDP 428

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQL 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH     ++V+RD+K  NIL+D H + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 352
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APE           D ++ G L+ E+I+G+ P    +   +   +E L K V        
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------- 404
Query: 311 LDPKLPEKPTSRL--LKRILLVALRCVDP 337
                PE+ + R     R L   L C DP
Sbjct: 405 -----PEEYSERFSPQARSLCSQLLCKDP 428

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +++H N+V L      G H  L+ + V+ G     L   +      T      +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRL 121
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPKVSDFGLAKLLGSESSYITT 241
           I      + YLH   +  +VHRD+K  N+L   +D+     +SDFGL+K+   +   + +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
              GT GYVAPE  +    ++  D +S G++   ++ G  P 
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 40/277 (14%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHR--MLVYEYV 157
           D    A+K +L +  Q   E + E +      H N++RL+ YC    GA     L+  + 
Sbjct: 53  DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
             G L   +       + LT +  + ++LG  +GL  +H        HRD+K +NIL+  
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGD 169
Query: 218 HWNPKVSDFG-----LAKLLGSESSYITTRVMG---TFGYVAPEYAST---GMLNERSDV 266
              P + D G        + GS  +           T  Y APE  S     +++ER+DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229
Query: 267 YSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK----LPEKPTSR 322
           +S G ++  ++ G  P D                MV  +     L  +    +P+ P   
Sbjct: 230 WSLGCVLYAMMFGEGPYD----------------MVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 323 LLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
                LL ++  VDP+  +RP +  ++  LEA + P+
Sbjct: 274 SALWQLLNSMMTVDPH--QRPHIPLLLSQLEALQPPA 308

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQL 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 99/187 (52%), Gaps = 15/187 (8%)
Query: 103 NSKVAVKNL-LNNRGQAE----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           N  VA+K + L +R +A+    R    E++ +  + H N++ LL      ++  LV++++
Sbjct: 35  NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
              +LE  +  +    +P   +  M   L T +GL YLH+     ++HRD+K +N+L+D+
Sbjct: 95  ET-DLEVIIKDNSLVLTPSHIKAYM---LMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 147
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEV 276
           +   K++DFGLAK  GS +     +V+ T  Y APE      M     D+++ G ++ E+
Sbjct: 148 NGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 277 ISGRIPV 283
           +  R+P 
Sbjct: 207 LL-RVPF 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 125 EVEAIGR-------VRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
           +VEA  R       + H N++ L+G     EG   +L+  Y+ +G+L Q++     P   
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRS---PQRN 120
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            T +  ++  L  A+G+ YL E    K VHRD+ + N ++D+ +  KV+DFGLA+ +   
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177
Query: 236 SSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
             Y   +         + A E   T     +SDV+SFG+L+ E+++   P
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLXQVIQMELD-------HERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++  +I
Sbjct: 218 MVRHKI 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  +  +RH N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW-NPKVS--DFGL 228
              LT +     +     G+ YLH     ++ H D+K  NI L+DK+  NP++   DFG+
Sbjct: 109 KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  + + + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 166 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H N+V+L          +LV+E+++  +L++ L    G    +T +   + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SF 105
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L    G++Y H+    +V+HRD+K  N+LI++    K++DFGLA+  G      T  ++
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
            T  Y AP+    +   +   D++S G +  E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 123
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEV 276
               K+ DFGLA+    E        + T  Y APE     M  N+  D++S G ++ E+
Sbjct: 181 DCELKILDFGLARHTDDE----MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 277 ISGR 280
           ++GR
Sbjct: 237 LTGR 240

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE + ++ H N+++L     + +   +V E    G L      ++      +      I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARI 126
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           R+ GT  Y+APE    G  +E+ DV+S G+++  ++SG  P 
Sbjct: 183 RI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 24/189 (12%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 42  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
            E ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 101 MELMD-ANLXQVIQMELD-------HERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSN 149
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 150 IVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 208 MGEMVRHKI 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE + ++ H N+++L     + +   +V E    G L      ++      +      I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARI 126
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           R+ GT  Y+APE    G  +E+ DV+S G+++  ++SG  P 
Sbjct: 183 RI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  +  +RH N++ L          +L+ E V+ G L  +L      
Sbjct: 46  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 101
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW-NPKVS--DFGL 228
              LT +     +     G+ YLH     ++ H D+K  NI L+DK+  NP++   DFG+
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  + + + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 159 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++     LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           + S +A   +++ + + E E + VE++ +    H N+V+LL       +  ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  +   +    PLT      +   T   L+YLH+    K++HRD+K+ NIL     +
Sbjct: 120 AVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGD 173
Query: 221 PKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGMLNER-----SDVYSFGILI 273
            K++DFG++      +  I  R   +GT  ++APE        +R     +DV+S GI +
Sbjct: 174 IKLADFGVS---AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           +E+       +   P  E+N +  L K+  +  P
Sbjct: 231 IEM------AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 21/195 (10%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N + AVK +     +++R+   E+E + R  +H N++ L     +G +  +V E    G 
Sbjct: 47  NXEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGE 102
Query: 162 L-EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHW 219
           L ++ L          +      ++    K + YLH      VVHRD+K SNIL +D+  
Sbjct: 103 LLDKILRQKF-----FSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESG 154
Query: 220 NP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           NP   ++ DFG AK L +E+  + T    T  +VAPE       +   D++S G+L+   
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTX 213
Query: 277 ISGRIPVDYSRPPEE 291
           ++G  P  ++  P++
Sbjct: 214 LTGYTP--FANGPDD 226

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           + S +A   +++ + + E E + VE++ +    H N+V+LL       +  ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  +   +    PLT      +   T   L+YLH+    K++HRD+K+ NIL     +
Sbjct: 120 AVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGD 173
Query: 221 PKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGMLNER-----SDVYSFGILI 273
            K++DFG++      +  I  R   +GT  ++APE        +R     +DV+S GI +
Sbjct: 174 IKLADFGVS---AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           +E+       +   P  E+N +  L K+  +  P
Sbjct: 231 IEM------AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 214 IMGEMIKGGV 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 214 IMGEMIKGGV 223

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           + S +A   +++ + + E E + VE++ +    H N+V+LL       +  ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  +   +    PLT      +   T   L+YLH+    K++HRD+K+ NIL     +
Sbjct: 120 AVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGD 173
Query: 221 PKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGMLNER-----SDVYSFGILI 273
            K++DFG++      +  I  R   +GT  ++APE        +R     +DV+S GI +
Sbjct: 174 IKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           +E+       +   P  E+N +  L K+  +  P
Sbjct: 231 IEM------AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+ +L  +  +  +  LV E    G L      ++      +      I
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 131
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 132 IRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXK 186
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 99
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 156
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 157 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 215 IMGEMIKGGV 224

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 111 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 156
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 215 MGEMVRHKI 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLXQVIQMELD-------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++  +I
Sbjct: 218 MVRHKI 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 111 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 156
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 215 MGEMVRHKI 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 110 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 155
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 156 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 213
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 214 MGEMVRHKI 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++     LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 90/186 (48%), Gaps = 18/186 (9%)
Query: 104 SKVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           ++VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    
Sbjct: 69  TRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDL 127
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           +E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+LI+   + 
Sbjct: 128 METDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDL 183
Query: 222 KVSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIM 274
           K+ DFGLA++   E  +    T  + T  Y APE     MLN +      D++S G ++ 
Sbjct: 184 KICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILA 239
Query: 275 EVISGR 280
           E++S R
Sbjct: 240 EMLSNR 245

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 13/173 (7%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           RG +  E + EV  +  +RH N++ L          +L+ E V+ G L  +L        
Sbjct: 69  RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKE 124
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW-NPKVS--DFGLAK 230
            LT +     +     G+ YLH     ++ H D+K  NI L+DK+  NP++   DFG+A 
Sbjct: 125 SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            + + + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 182 KIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 112 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 157
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 158 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 216 MGEMVRHKI 224

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 111 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 156
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 157 IVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 215 MGEMVRHKI 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 43  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 101
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIK 209
            E +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K
Sbjct: 102 MELM-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 147
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
            SNI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S 
Sbjct: 148 PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 205
Query: 270 GILIMEVISGRI 281
           G ++ E++  +I
Sbjct: 206 GCIMGEMVRHKI 217

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 112 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 157
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 158 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 216 MGEMVRHKI 224

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGN 161
           VAVK + ++R +     + E+     +RH+N++  +       H      L+  Y   G+
Sbjct: 34  VAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92
Query: 162 LEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           L  +L     D   C        + I+L  A GL++LH  +     +P + HRD+KS NI
Sbjct: 93  LYDYLQLTTLDTVSC--------LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNE------R 263
           L+ K+    ++D GLA +    ++ +      RV GT  Y+APE     +  +      R
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPPEEV 292
            D+++FG+++ EV    +S  I  DY  P  +V
Sbjct: 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 149 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 253 MGEMVRHKI 261

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 149 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 253 MGEMVRHKI 261

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGN 161
           VAVK + ++R +     + E+     +RH+N++  +       H      L+  Y   G+
Sbjct: 34  VAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92
Query: 162 LEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           L  +L     D   C        + I+L  A GL++LH  +     +P + HRD+KS NI
Sbjct: 93  LYDYLQLTTLDTVSC--------LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNE------R 263
           L+ K+    ++D GLA +    ++ +      RV GT  Y+APE     +  +      R
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPPEEV 292
            D+++FG+++ EV    +S  I  DY  P  +V
Sbjct: 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 42  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIK 209
            E +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K
Sbjct: 101 MELM-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 146
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
            SNI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S 
Sbjct: 147 PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 270 GILIMEVISGRI 281
           G ++ E++  +I
Sbjct: 205 GCIMGEMVRHKI 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 43  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 101
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIK 209
            E +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K
Sbjct: 102 MELM-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 147
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
            SNI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S 
Sbjct: 148 PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 205
Query: 270 GILIMEVISGRI 281
           G ++ E++  +I
Sbjct: 206 GCIMGEMVRHKI 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+V+  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 214 IMGEMIKGGV 223

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           +I   I +   K L +LH  L   V+HRD+K SN+LI+     K+ DFG++  L    S 
Sbjct: 153 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSV 208
Query: 239 ITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
             T   G   Y+APE  +  +     + +SD++S GI ++E+   R P D    P     
Sbjct: 209 AKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----- 263
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + LK++V   +         P+ P  +     +    +C+  N+++RP
Sbjct: 264 FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERP 303

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 29/160 (18%)
Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           + L+G CAE               L++ + G      P+   I   + +   K L YL E
Sbjct: 103 MELMGTCAE--------------KLKKRMQG------PIPERILGKMTVAIVKALYYLKE 142
Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--- 254
             +  V+HRD+K SNIL+D+    K+ DFG++  L  + +    R  G   Y+APE    
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDP 198
Query: 255 --ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
              +    + R+DV+S GI ++E+ +G+ P    +   EV
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N   AVK +++ R +A  +   E+ A+     H N+V+L     +  H  LV E +N G 
Sbjct: 36  NQAFAVK-IISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKH 218
           L + +          +      I+      +S++H+     VVHRD+K  N+L    + +
Sbjct: 93  LFERIKKK----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDN 145
Query: 219 WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
              K+ DFG A+L   ++  + T    T  Y APE  +    +E  D++S G+++  ++S
Sbjct: 146 LEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204
Query: 279 GRIPV-DYSRPPEEVNLIEWLKKM 301
           G++P   + R     + +E +KK+
Sbjct: 205 GQVPFQSHDRSLTCTSAVEIMKKI 228

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 356
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGN 161
           VAVK + ++R +     + E+     +RH+N++  +       H      L+  Y   G+
Sbjct: 63  VAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 121
Query: 162 LEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           L  +L     D   C        + I+L  A GL++LH  +     +P + HRD+KS NI
Sbjct: 122 LYDYLQLTTLDTVSC--------LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 173
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNE------R 263
           L+ K+    ++D GLA +    ++ +      RV GT  Y+APE     +  +      R
Sbjct: 174 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKR 232
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPPEEV 292
            D+++FG+++ EV    +S  I  DY  P  +V
Sbjct: 233 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 265

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 34/203 (16%)
Query: 102 DNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLL-GYCAEGAHRML------V 153
           D+   A+K + L NR  A  +   EV+A+ ++ H  +VR    +  +     L      V
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 154 YEYVN-----NGNLEQWLHGDVGPCSPLTWE--IRMNIILGTAKGLSYLH-EGLEPKVVH 205
           Y Y+        NL+ W++G    C+    E  + ++I L  A+ + +LH +GL    +H
Sbjct: 89  YLYIQMQLCRKENLKDWMNGR---CTIEERERSVCLHIFLQIAEAVEFLHSKGL----MH 141
Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGS---ESSYIT--------TRVMGTFGYVAPEY 254
           RD+K SNI        KV DFGL   +     E + +T        T  +GT  Y++PE 
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 255 ASTGMLNERSDVYSFGILIMEVI 277
                 + + D++S G+++ E++
Sbjct: 202 IHGNSYSHKVDIFSLGLILFELL 224

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVAVK L     +   A R ++ E+  +  ++H+N++ LL             E      
Sbjct: 47  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L      ++  C  L+ E    ++    +GL Y+H      ++HRD+K SN+ +++    
Sbjct: 106 LMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCEL 162
Query: 222 KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           ++ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E++ G
Sbjct: 163 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217
Query: 280 R 280
           +
Sbjct: 218 K 218

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 112
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 170 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +  C  L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKCQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEIRMN 183
           E+  + +++H+N+V L        H  LV + V+ G L ++ L   V      T +    
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-----YTEKDASL 110
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNPKV--SDFGLAKLLGSESSYIT 240
           +I      + YLHE     +VHRD+K  N+L +    N K+  +DFGL+K+   E + I 
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIM 164
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +   GT GYVAPE  +    ++  D +S G++   ++ G  P 
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           +   +A   ++  + + E E + VE+E +    H  +V+LLG         ++ E+   G
Sbjct: 42  ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101
Query: 161 NLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
            ++   L  D G   P    +   ++    + L++LH     +++HRD+K+ N+L+    
Sbjct: 102 AVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RIIHRDLKAGNVLMTLEG 154
Query: 220 NPKVSDFGLA----KLLGSESSYITTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFG 270
           + +++DFG++    K L    S+I     GT  ++APE      + +     ++D++S G
Sbjct: 155 DIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
Query: 271 ILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLV 330
           I ++E+           P  E+N +  L K +   +P  +L P       S   +  L +
Sbjct: 210 ITLIEM------AQIEPPHHELNPMRVLLK-IAKSDPPTLLTP----SKWSVEFRDFLKI 258
Query: 331 ALRCVDPNAQKRPKMGHVV 349
           AL   D N + RP    ++
Sbjct: 259 AL---DKNPETRPSAAQLL 274

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           +   +A   ++  + + E E + VE+E +    H  +V+LLG         ++ E+   G
Sbjct: 34  ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 93
Query: 161 NLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
            ++   L  D G   P    +   ++    + L++LH     +++HRD+K+ N+L+    
Sbjct: 94  AVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RIIHRDLKAGNVLMTLEG 146
Query: 220 NPKVSDFGLA----KLLGSESSYITTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFG 270
           + +++DFG++    K L    S+I     GT  ++APE      + +     ++D++S G
Sbjct: 147 DIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLG 201
Query: 271 ILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLV 330
           I ++E+           P  E+N +  L K +   +P  +L P       S   +  L +
Sbjct: 202 ITLIEM------AQIEPPHHELNPMRVLLK-IAKSDPPTLLTP----SKWSVEFRDFLKI 250
Query: 331 ALRCVDPNAQKRPKMGHVV 349
           AL   D N + RP    ++
Sbjct: 251 AL---DKNPETRPSAAQLL 266

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 100
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 101 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 157
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++    + T  Y APE        E  D++S G 
Sbjct: 158 NIVVKSDCTLKILDFGLARTAG--TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGC 215
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 216 IMGEMIKGGV 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
             KVA+K +   L  +       + E+  +  +RH ++++L          ++V EY   
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG- 92
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
           G L  +    +     +T +            + Y H     K+VHRD+K  N+L+D + 
Sbjct: 93  GELFDY----IVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNL 145
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVIS 278
           N K++DFGL+ ++ ++ +++ T   G+  Y APE  +  +      DV+S GI++  ++ 
Sbjct: 146 NVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203
Query: 279 GRIPVD 284
           GR+P D
Sbjct: 204 GRLPFD 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
           P+T E  ++     A+G+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ +  
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 235 ESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE 290
              Y+    TR+     ++APE     + + +SDV+S+G+L+ E+ S G  P  Y     
Sbjct: 252 NPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP--YPGVQM 307
Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           + +    L++ +  R PE       PE         I  + L C   + ++RP+   +V 
Sbjct: 308 DEDFCSRLREGMRMRAPEY----STPE---------IYQIMLDCWHRDPKERPRFAELVE 354
Query: 351 ML 352
            L
Sbjct: 355 KL 356

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 19/183 (10%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVA+K L     +   A+R ++ E+  +  ++H+N++ LL      +     Y++     
Sbjct: 51  KVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL--- 106
Query: 162 LEQWLHGDVGPCSPLTW--EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
           +  ++  D+     L +  E    ++    KGL Y+H      VVHRD+K  N+ +++  
Sbjct: 107 VMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC 163
Query: 220 NPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVI 277
             K+ DFGLA+   +E + Y+ TR      Y APE   + M  N+  D++S G ++ E++
Sbjct: 164 ELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 278 SGR 280
           +G+
Sbjct: 219 TGK 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVAVK L     +   A R ++ E+  +  ++H+N++ LL             E      
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L      ++  C  L+ E    ++    +GL Y+H      ++HRD+K SN+ +++    
Sbjct: 114 LMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSEL 170
Query: 222 KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           ++ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E++ G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 280 R 280
           +
Sbjct: 226 K 226

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 92
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 93  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 149
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 150 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGC 207
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 208 IMGEMVCHKI 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 102 DNSKVAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 156
           D  K+     +N +   ER      FK E++ +  + H  LV L     +     +V + 
Sbjct: 38  DTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           +  G+L   L  +V        E     I      L YL      +++HRD+K  NIL+D
Sbjct: 97  LLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLD 149
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILI 273
           +H +  ++DF +A +L  E+  ITT + GT  Y+APE  S+      +   D +S G+  
Sbjct: 150 EHGHVHITDFNIAAMLPRETQ-ITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
Query: 274 MEVISGRIP 282
            E++ GR P
Sbjct: 208 YELLRGRRP 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++     LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGL +    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 103
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 104 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 160
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 161 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGC 218
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 219 IMGEMVCHKI 228

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM 182
           EV  +  + H N+V+L           L+ EY + G +  +L  HG +      + + R 
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-KFRQ 119
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    + Y H+    ++VHRD+K+ N+L+D   N K++DFG +          T  
Sbjct: 120 -----IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-- 169
Query: 243 VMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 170 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VAVK L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +H ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLCQVIHMELD-------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+   + ++++ T  + T  Y APE           D++S G ++ E
Sbjct: 160 KSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++ G +
Sbjct: 218 LVKGCV 223

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE-YVNNG 160
           KVA+K L     +   A+R ++ E+  +  ++H+N++ LL      +     Y+ Y+   
Sbjct: 69  KVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  L   +G     + E    ++    KGL Y+H      VVHRD+K  N+ +++   
Sbjct: 128 FMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCE 182
Query: 221 PKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVIS 278
            K+ DFGLA+   +E + Y+ TR      Y APE   + M  N+  D++S G ++ E+++
Sbjct: 183 LKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237
Query: 279 GR 280
           G+
Sbjct: 238 GK 239

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG    E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   R+   +  L  C +   R+  V E+VN G+L   +       S    E R 
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-----SRRFDEARA 126
Query: 183 NIILG-TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
                     L +LH+     +++RD+K  N+L+D   + K++DFG+ K  G  +   T 
Sbjct: 127 RFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTA 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--------EEVN 293
              GT  Y+APE     +     D ++ G+L+ E++ G  P +             +EV 
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 242
Query: 294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
              WL +  T     G+L   + + PT RL
Sbjct: 243 YPTWLHEDAT-----GILKSFMTKNPTMRL 267

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 98  LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLL 143
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 204 LWEMFT 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 98  LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLL 143
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 204 LWEMFT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 108 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 153
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 214 LWEMFT 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           V V    ++ G +  + K E      ++H ++V LL   +      +V+E+++  +L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--- 113
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-------KVVHRDIKSSNILIDKH 218
                  C  +        +   A    Y+ + LE         ++HRD+K  N+L+   
Sbjct: 114 -------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASK 166
Query: 219 WNP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
            N    K+ DFG+A  LG ES  +    +GT  ++APE        +  DV+  G+++  
Sbjct: 167 ENSAPVKLGDFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 276 VISGRIP 282
           ++SG +P
Sbjct: 226 LLSGCLP 232

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 102 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 147
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 148 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 208 LWEMFT 213

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 57  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 111
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T 
Sbjct: 112 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 167
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 227
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 228 PRTLSPEAKSLLAGLLKKDPKQRL 251

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG   
Sbjct: 46  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--- 101
Query: 172 PCSPLTW----EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
                 W    E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG
Sbjct: 102 ------WMKEKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFG 151
Query: 228 LAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            +      +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 152 FSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +        G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNK--LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 98  LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 143
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 204 LWEMFT 209

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T 
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 108 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 153
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 214 LWEMFT 219

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 319
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           APE           D +  G+++ E++ GR+P 
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           APE           D +  G+++ E++ GR+P 
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 97  FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 149
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 100 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RG 141
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFD 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 102 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 147
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 148 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 208 LWEMFT 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T 
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM 182
           EV  +  + H N+V+L           LV EY + G +  +L  HG            RM
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RM 111
Query: 183 NIILGTAK------GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
                 AK       + Y H+     +VHRD+K+ N+L+D   N K++DFG +      +
Sbjct: 112 KEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN 168
Query: 237 SYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
              T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 169 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 101
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 102 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 154
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 155 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           +I   I +   K L +LH  L   V+HRD+K SN+LI+     K+ DFG++  L  + + 
Sbjct: 109 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 239 ITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
                 G   Y+APE  +  +     + +SD++S GI ++E+   R P D    P     
Sbjct: 167 DIDA--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----- 219
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + LK++V   +         P+ P  +     +    +C+  N+++RP
Sbjct: 220 FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERP 259

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RG 173
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFD 254

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 100 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---G 130
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---G 126
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD 207

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 34/173 (19%)
Query: 132 VRHKNLVRLL----GYCAEG-AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           + H N+ R +       A+G    +LV EY  NG+L ++L           W     +  
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAH 118
Query: 187 GTAKGLSYLHEGL------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-------- 232
              +GL+YLH  L      +P + HRD+ S N+L+       +SDFGL+  L        
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 233 GSESSYITTRVMGTFGYVAPEYASTGMLNERS--------DVYSFGILIMEVI 277
           G E +   + V GT  Y+APE    G +N R         D+Y+ G++  E+ 
Sbjct: 179 GEEDNAAISEV-GTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG    
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF--- 159
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERS------DVYSFGILIMEVISGRIPVD 284
             S       ++    G  AP YA+  +   +       DV+S G+++  ++SG +P D
Sbjct: 160 --SNEFTFGNKLDAFCG--APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 102
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 103 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 155
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 156 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 8/137 (5%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 177
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--PE 308
           APE           D +  G+++ E++ GR+P  Y++  E++  +  ++++   R   PE
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLGPE 236
Query: 309 G--VLDPKLPEKPTSRL 323
              +L   L + P  RL
Sbjct: 237 AKSLLSGLLKKDPKQRL 253

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 127
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 128 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 180
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 181 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 178
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           APE           D +  G+++ E++ GR+P 
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 104
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 105 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 157
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 158 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 8/137 (5%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 176
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--PE 308
           APE           D +  G+++ E++ GR+P  Y++  E++  +  ++++   R   PE
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLGPE 235
Query: 309 G--VLDPKLPEKPTSRL 323
              +L   L + P  RL
Sbjct: 236 AKSLLSGLLKKDPKQRL 252

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 479
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 480 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 532
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK    +     +E F  E   +  + H ++V+L+G   E     ++ E    G L  
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGH 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  +      LT  +     L   K ++YL        VHRDI   NIL+      K+ 
Sbjct: 98  YLERNKNSLKVLTLVLYS---LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLG 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGL++ +  E  Y  +       +++PE  +       SDV+ F + + E++S      
Sbjct: 152 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------ 205
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL-RCVDPNAQKRP 343
           + + P       WL+    N++  GVL+ K    P   L   +L   + RC D +   RP
Sbjct: 206 FGKQP-----FFWLE----NKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 255
Query: 344 KMGHVVHML 352
           +   +V  L
Sbjct: 256 RFTELVCSL 264

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM 182
           EV  +  + H N+V+L           L+ EY + G +  +L  HG +      + + R 
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-KFRQ 122
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    + Y H+    ++VHRD+K+ N+L+D   N K++DFG      S    +  +
Sbjct: 123 -----IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVGGK 169
Query: 243 VMGTFGYVAPEYASTGMLNERS------DVYSFGILIMEVISGRIPVD 284
           +    G  AP YA+  +   +       DV+S G+++  ++SG +P D
Sbjct: 170 LDAFCG--APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-- 162
           KV  K ++    +     K E   +  V+H  +V L+     G    L+ EY++ G L  
Sbjct: 51  KVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
               + +  +   C  L  EI M         L +LH+     +++RD+K  NI+++   
Sbjct: 111 QLEREGIFMEDTACFYLA-EISM--------ALGHLHQ---KGIIYRDLKPENIMLNHQG 158
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           + K++DFGL K    + + +T    GT  Y+APE       N   D +S G L+ ++++G
Sbjct: 159 HVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 280 RIPV 283
             P 
Sbjct: 218 APPF 221

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 48  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 107 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 159
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGLA  +  +     T + GT  Y+APE  S    +   DV+S G ++  ++ G+ P +
Sbjct: 160 DFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218
Query: 285 YS 286
            S
Sbjct: 219 TS 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-- 162
           KV  K ++    +     K E   +  V+H  +V L+     G    L+ EY++ G L  
Sbjct: 51  KVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
               + +  +   C  L  EI M         L +LH+     +++RD+K  NI+++   
Sbjct: 111 QLEREGIFMEDTACFYLA-EISM--------ALGHLHQ---KGIIYRDLKPENIMLNHQG 158
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           + K++DFGL K    + + +T    GT  Y+APE       N   D +S G L+ ++++G
Sbjct: 159 HVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 280 RIPV 283
             P 
Sbjct: 218 APPF 221

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 52  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 110
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 111 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 163
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGLA  +  +     T + GT  Y+APE  S    +   DV+S G ++  ++ G+ P +
Sbjct: 164 DFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222
Query: 285 YS 286
            S
Sbjct: 223 TS 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 48  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 107 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 159
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGLA  +  +     T + GT  Y+APE  S    +   DV+S G ++  ++ G+ P +
Sbjct: 160 DFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218
Query: 285 YS 286
            S
Sbjct: 219 TS 220

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK    +     +E F  E   +  + H ++V+L+G   E     ++ E    G L  
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGH 113
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  +      LT  +     L   K ++YL        VHRDI   NIL+      K+ 
Sbjct: 114 YLERNKNSLKVLTLVLYS---LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLG 167
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGL++ +  E  Y  +       +++PE  +       SDV+ F + + E++S      
Sbjct: 168 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------ 221
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL-RCVDPNAQKRP 343
           + + P       WL+    N++  GVL+ K    P   L   +L   + RC D +   RP
Sbjct: 222 FGKQP-----FFWLE----NKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 271
Query: 344 KMGHVVHML 352
           +   +V  L
Sbjct: 272 RFTELVCSL 280

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+      K+
Sbjct: 100 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK    +     +E F  E   +  + H ++V+L+G   E     ++ E    G L  
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGH 101
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  +      LT  +     L   K ++YL        VHRDI   NIL+      K+ 
Sbjct: 102 YLERNKNSLKVLTLVLYS---LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLG 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGL++ +  E  Y  +       +++PE  +       SDV+ F + + E++S      
Sbjct: 156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------ 209
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL-RCVDPNAQKRP 343
           + + P       WL+    N++  GVL+ K    P   L   +L   + RC D +   RP
Sbjct: 210 FGKQP-----FFWLE----NKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 259
Query: 344 KMGHVVHML 352
           +   +V  L
Sbjct: 260 RFTELVCSL 268

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++    + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 214 IMGEMVCHKI 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY+  G++   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +++H+N+V L        H  LV + V+ G L       +      T +    +
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTL 125
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I      + YLH      +VHRD+K  N+L    D+     +SDFGL+K+ G     + +
Sbjct: 126 IRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMS 180
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
              GT GYVAPE  +    ++  D +S G++   ++ G  P 
Sbjct: 181 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 59  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 113
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 114 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 169
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 229
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 230 PRTLSPEAKSLLAGLLKKDPKQRL 253

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY+  G++   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 121 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 168
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 169 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 225
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 226 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 265

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 122 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 226
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 227 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 266

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 479
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+      K+
Sbjct: 480 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKL 532
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 122 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 226
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 227 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 128 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 175
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 176 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 232
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 233 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 272

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 122 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 226
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 227 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 266

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 117 QAERE-FKVEVEAIGRVRHKNLVRLLGY---CAEGAHRM-LVYEYVNNGNLEQWL-HGDV 170
           ++ER+ FK E E +  ++H N+VR         +G   + LV E   +G L+ +L    V
Sbjct: 66  KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV 125
Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLA 229
                L    R  +     KGL +LH    P ++HRD+K  NI I     + K+ D GLA
Sbjct: 126 XKIKVLRSWCRQIL-----KGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP 289
            L   + +     V+GT  + APE       +E  DVY+FG   +E  +   P  YS   
Sbjct: 180 TL---KRASFAKAVIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYP--YS--- 230
Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
           E  N  +  +++ +   P       +PE
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDKVAIPE 258

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ +         + YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 247 QMLL--------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 294
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 295 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 351
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 352 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 391

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 25/150 (16%)
Query: 144 CAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSP-----LTWEIRMNIILGTAKGLSYLHE 197
           C +   R+  V EYVN G+L   +   VG            EI + +    +KG      
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKG------ 141
Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-GTFGYVAPEY 254
                +++RD+K  N+++D   + K++DFG+ K    E+ +  +TT+   GT  Y+APE 
Sbjct: 142 -----IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPEI 192
Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            +     +  D ++FG+L+ E+++G+ P +
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 116/270 (42%), Gaps = 56/270 (20%)
Query: 102 DNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM--------- 151
           DN  VAVK +L      A+RE ++  E+     H N++R   +C E   +          
Sbjct: 47  DNRDVAVKRILPECFSFADREVQLLRESD---EHPNVIRY--FCTEKDRQFQYIAIELCA 101
Query: 152 -LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             + EYV   +   + H  + P         + ++  T  GL++LH      +VHRD+K 
Sbjct: 102 ATLQEYVEQKD---FAHLGLEP---------ITLLQQTTSGLAHLHS---LNIVHRDLKP 146
Query: 211 SNILI---DKHWNPK--VSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNER 263
            NILI   + H   K  +SDFGL K L  G  S    + V GT G++APE  S       
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 264 S---DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
           +   D++S G +   VIS G  P   S           L++          LD   PEK 
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKS-----------LQRQANILLGACSLDCLHPEKH 255
Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
              ++ R L+  +  +DP  QKRP   HV+
Sbjct: 256 ED-VIARELIEKMIAMDP--QKRPSAKHVL 282

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           +I   I +   K L +LH  L   V+HRD+K SN+LI+     K  DFG++  L  + + 
Sbjct: 136 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK 193
Query: 239 ITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
                 G   Y APE  +  +     + +SD++S GI  +E+   R P D    P     
Sbjct: 194 DID--AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP----- 246
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + LK++V   +         P+ P  +     +    +C+  N+++RP
Sbjct: 247 FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERP 286

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 144 CAEGAHRM-LVYEYVNNGNLEQWLHGDVG----PCSPL-TWEIRMNIILGTAKGLSYLHE 197
           C +   R+  V EYVN G+L   +   VG    P +     EI + +    +KG      
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKG------ 462
Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                +++RD+K  N+++D   + K++DFG+ K         T    GT  Y+APE  + 
Sbjct: 463 -----IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 258 GMLNERSDVYSFGILIMEVISGRIPVD 284
               +  D ++FG+L+ E+++G+ P +
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++    + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 214 IMGEMVCHKI 223

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ +         + YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 261 QMLL--------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 308
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 309 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 365
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 366 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 405

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 11/172 (6%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC 173
           N    ++ F+ EV     + H N+V+L           LV EY + G +  +L   V   
Sbjct: 53  NSSSLQKLFR-EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL---VAHG 108
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
                E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +    
Sbjct: 109 RXKEKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT 164
Query: 234 SESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +        G   Y APE +          DV+S G+++  ++SG +P D
Sbjct: 165 FGNK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 106 VAVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K +  +  Q+  +++    EV  + ++RH N ++  G         LV EY   G+ 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140
Query: 163 EQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
              L     P      E+ +  +  G  +GL+YLH      ++HRD+K+ NIL+ +    
Sbjct: 141 SDLLEVHKKPLQ----EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 193
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFG A ++   + ++     GT  ++APE       G  + + DV+S GI  +E+  
Sbjct: 194 KLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 279 GRIPV 283
            + P+
Sbjct: 249 RKPPL 253

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-------GAHRMLVYEYVN 158
           VAVK + ++R +     + E+     +RH N+   LG+ A             L+  Y  
Sbjct: 34  VAVK-IFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIASDMTSRNSSTQLWLITHYHE 89
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           +G+L  +L         L   + + + +  A GL++LH  +     +P + HRD KS N+
Sbjct: 90  HGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNV 144
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNER------ 263
           L+  +    ++D GLA +    S Y+      RV GT  Y+APE     +  +       
Sbjct: 145 LVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPEVLDEQIRTDCFESYKW 203
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPP 289
           +D+++FG+++ E+    I   I  DY RPP
Sbjct: 204 TDIWAFGLVLWEIARRTIVNGIVEDY-RPP 232

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 106 VAVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K +  +  Q+  +++    EV  + ++RH N ++  G         LV EY   G+ 
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
              L     P      E+ +  +  G  +GL+YLH      ++HRD+K+ NIL+ +    
Sbjct: 102 SDLLEVHKKPLQ----EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 154
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFG A ++   + ++     GT  ++APE       G  + + DV+S GI  +E+  
Sbjct: 155 KLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 279 GRIPV 283
            + P+
Sbjct: 210 RKPPL 214

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 153
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 154 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 206
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 106
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 72  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 130
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 131 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 183
Query: 225 DFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           DFGLA    ++  Y   R   + GT  Y+APE  S    +   DV+S G ++  ++ G+ 
Sbjct: 184 DFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 282 PVDYS 286
           P + S
Sbjct: 240 PFETS 244

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    KV+DFGLAK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 179
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA----TWTLCGTPEYLAPEIIL 232
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 70  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 128
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 129 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 181
Query: 225 DFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           DFGLA    ++  Y   R   + GT  Y+APE  S    +   DV+S G ++  ++ G+ 
Sbjct: 182 DFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 237
Query: 282 PVDYS 286
           P + S
Sbjct: 238 PFETS 242

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 10/180 (5%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
            A K ++      +   + E++ +  +RH  LV L     +    +++YE+++ G L + 
Sbjct: 79  FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 138
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNP-KV 223
           +  +    + ++ +  +  +    KGL ++HE      VH D+K  NI+   K  N  K+
Sbjct: 139 VADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 192
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFGL   L  + S   T   GT  + APE A    +   +D++S G+L   ++SG  P 
Sbjct: 193 IDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 58  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 116
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 117 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 172
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 173 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 228
Query: 276 VISGR 280
           ++S R
Sbjct: 229 MLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 179
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 232
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 151
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 204
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P     P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 106
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 145
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 146 S---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 198
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 107 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 162
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 163 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 218
Query: 276 VISGR 280
           ++S R
Sbjct: 219 MLSNR 223

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 179
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 232
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 114 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 169
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 170 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 225
Query: 276 VISGR 280
           ++S R
Sbjct: 226 MLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 56  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 114
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 115 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 170
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 171 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 226
Query: 276 VISGR 280
           ++S R
Sbjct: 227 MLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 47  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 105
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 106 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 161
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 162 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 217
Query: 276 VISGR 280
           ++S R
Sbjct: 218 MLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
           R+F  E   +    H N++ +LG C      H  L+  ++  G+L   LH         +
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS 111
Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
             ++    L  A+G+++LH  LEP +    + S +++ID+    ++S      +   + S
Sbjct: 112 QAVK--FALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARIS------MADVKFS 162
Query: 238 YITTRVMGTFGYVAPEYASTGM--LNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
           + +   M    +VAPE         N RS D++SF +L+ E+++  +P        +++ 
Sbjct: 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSN 216
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +E   K+      EG L P +P   +  + K + +    C++ +  KRPK   +V +LE 
Sbjct: 217 MEIGMKVAL----EG-LRPTIPPGISPHVSKLMKI----CMNEDPAKRPKFDMIVPILEK 267
Query: 355 QE 356
            +
Sbjct: 268 MQ 269

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 144
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIIL 197
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 107 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 162
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 163 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 218
Query: 276 VISGR 280
           ++S R
Sbjct: 219 MLSNR 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 125 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
            +L     L  L+      +VHRD+K  NIL+D   N K++DFG +  L          V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 244 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPV 283
            GT  Y+APE     M        +  D++S G+++  +++G  P 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 46  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 104
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 105 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 157
Query: 225 DFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           DFGLA    ++  Y   R   + GT  Y+APE  S    +   DV+S G ++  ++ G+ 
Sbjct: 158 DFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 282 PVDYS 286
           P + S
Sbjct: 214 PFETS 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 125 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 118
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
            +L     L  L+      +VHRD+K  NIL+D   N K++DFG +  L          V
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 244 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPV 283
            GT  Y+APE     M        +  D++S G+++  +++G  P 
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 111 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 166
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 167 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 222
Query: 276 VISGR 280
           ++S R
Sbjct: 223 MLSNR 227

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIII 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +     T + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTP 206
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 13/173 (7%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L        
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGLAK 230
            LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGLA 
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI ++ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 9/159 (5%)
Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           +  V+H  LV L            V +Y+N G L   L  +     P        I    
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI---- 148
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           A  L YLH      +V+RD+K  NIL+D   +  ++DFGL K    E +  T+   GT  
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR 287
           Y+APE       +   D +  G ++ E++ G +P  YSR
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSR 242

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 196 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 128
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 129 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 184
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 185 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 240
Query: 276 VISGR 280
           ++S R
Sbjct: 241 MLSNR 245

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 151
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 204
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 10/180 (5%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
            A K ++      +   + E++ +  +RH  LV L     +    +++YE+++ G L + 
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNP-KV 223
           +  +    + ++ +  +  +    KGL ++HE      VH D+K  NI+   K  N  K+
Sbjct: 245 VADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFGL   L  + S   T   GT  + APE A    +   +D++S G+L   ++SG  P 
Sbjct: 299 IDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 125 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
            +L     L  L+      +VHRD+K  NIL+D   N K++DFG +  L          V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSV 183
Query: 244 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPV 283
            GT  Y+APE     M        +  D++S G+++  +++G  P 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 194 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 IXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 100 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   +    ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 14/181 (7%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVAVK L     +   A R ++ E+  +  ++H+N++ LL             E      
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L      ++     L+ E    ++    +GL Y+H      ++HRD+K SN+ +++    
Sbjct: 114 LMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSEL 170
Query: 222 KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           ++ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E++ G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 280 R 280
           +
Sbjct: 226 K 226

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLE 163
           KV  K  +  + +     + E + +  +R    +  L Y  +   ++ L+ +Y+N G L 
Sbjct: 88  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147
Query: 164 QWLHGDVGPCSPLTWEIRMNIILG-TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             L            E  + I +G     L +LH+     +++RDIK  NIL+D + +  
Sbjct: 148 THL-----SQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVV 199
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML--NERSDVYSFGILIMEVISGR 280
           ++DFGL+K   ++ +       GT  Y+AP+    G    ++  D +S G+L+ E+++G 
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
Query: 281 IP 282
            P
Sbjct: 260 SP 261

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 212 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    +V+DFGLAK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           K+A K ++  RG  ++E  K E+  + ++ H NL++L          +LV EYV+ G L 
Sbjct: 116 KLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP- 221
             +  +    + L   + M  I    +G+ ++H+     ++H D+K  NIL +++     
Sbjct: 175 DRIIDESYNLTELDTILFMKQI---CEGIRHMHQMY---ILHLDLKPENILCVNRDAKQI 228
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           K+ DFGLA+              GT  ++APE  +   ++  +D++S G++   ++SG  
Sbjct: 229 KIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 282 PVDYSRPPEEVNLI 295
           P       E +N I
Sbjct: 287 PFLGDNDAETLNNI 300

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 194 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 27/169 (15%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEIRMN 183
           EV  +  + H N+++L  +  +  +  LV E    G L ++ +H            ++ N
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-----------RMKFN 134
Query: 184 ------IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGS 234
                 II     G++YLH+     +VHRD+K  N+L+   +K    K+ DFGL+ +   
Sbjct: 135 EVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-- 189
Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           E+       +GT  Y+APE       +E+ DV+S G+++  +++G  P 
Sbjct: 190 ENQKKMKERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPF 237

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+AP    
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +       + GT 
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTP 190
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +       + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTP 206
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +       + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTP 206
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN- 183
           EV  +  ++H N+V L           LV+EY++  +L+Q+L  D G        I M+ 
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNI------INMHN 101
Query: 184 ---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
               +    +GL+Y H     KV+HRD+K  N+LI++    K++DFGLA+     +    
Sbjct: 102 VKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 241 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
             V+ T  Y  P+    ST   + + D++  G +  E+ +GR     S   E+++ I
Sbjct: 159 NEVV-TLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 38  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 98  AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 143
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 144 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 278 SGRIP 282
            G  P
Sbjct: 202 VGYPP 206

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 17/191 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK +   RG A  E  V+ E I    +RH N+VR         H  ++ EY + G L 
Sbjct: 48  VAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-- 221
           + +  + G  S          +L    G+SY H     ++ HRD+K  N L+D    P  
Sbjct: 105 ERI-CNAGRFSEDEARFFFQQLLS---GVSYCHSM---QICHRDLKLENTLLDGSPAPRL 157
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGR 280
           K+ DFG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ G 
Sbjct: 158 KICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 281 IPVDYSRPPEE 291
            P +    P +
Sbjct: 216 YPFEDPEEPRD 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 38  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 98  AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 143
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 144 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 278 SGRIPV 283
            G  P 
Sbjct: 202 VGYPPF 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYAHAM---QVAHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAK--LLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEV 276
             K++DFG +K  +L S+        +GT  Y+APE       + + +DV+S G+ +  +
Sbjct: 155 RLKIADFGYSKASVLHSQPK----SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210
Query: 277 ISGRIPVDYSRPPEEVNLIEWLKKMV 302
           + G  P  +  P E  N  + + +++
Sbjct: 211 LVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 37  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 96
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 97  AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 142
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 143 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 200
Query: 278 SGRIP 282
            G  P
Sbjct: 201 VGYPP 205

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +       + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 114 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 169
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +       + T  Y APE     MLN +      D++S G ++ E
Sbjct: 170 ICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 225
Query: 276 VISGR 280
           ++S R
Sbjct: 226 MLSNR 230

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 43  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 100
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 101 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 153
Query: 222 --KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVIS 278
             K+ DFG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ 
Sbjct: 154 RLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 211
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMV 302
           G  P  +  P E  N  + + +++
Sbjct: 212 GAYP--FEDPEEPKNFRKTIHRIL 233

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V L+          LV+E++   +L++ L  +         +I +  
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L   +G+++ H+    +++HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 128 LL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y AP+    +   +   D++S G +  E+I+G+
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 121 AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 166
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 167 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
Query: 278 SGRIPV 283
            G  P 
Sbjct: 225 VGYPPF 230

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V L+          LV+E++   +L++ L  +         +I +  
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L   +G+++ H+    +++HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 128 LL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y AP+    +   +   D++S G +  E+I+G+
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 28/190 (14%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
            +KVA+K L     +   A+R ++ E+  +  +RH+N++ LL          +     LV
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-IILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             ++     +   H  +G       E R+  ++    KGL Y+H      ++HRD+K  N
Sbjct: 109 MPFMGTDLGKLMKHEKLG-------EDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGN 158
Query: 213 ILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFG 270
           + +++    K+ DFGLA+   SE    + TR      Y APE     M   +  D++S G
Sbjct: 159 LAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVG 213
Query: 271 ILIMEVISGR 280
            ++ E+I+G+
Sbjct: 214 CIMAEMITGK 223

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT   +APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 118 AEREFKVEVEAIGRVRHKNLVRLLG--YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
            E   K E++ + R+RHKN+++L+   Y  E     +V EY   G  E     D  P   
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKR 105
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
                          GL YLH      +VH+DIK  N+L+      K+S  G+A+ L   
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 236 SSYITTRV-MGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRIPVD 284
           ++  T R   G+  +  PE A+        + D++S G+ +  + +G  P +
Sbjct: 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           V V    ++ G +  + K E      ++H ++V LL   +      +V+E+++  +L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--- 113
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-------KVVHRDIKSSNILIDKH 218
                  C  +        +   A    Y+ + LE         ++HRD+K   +L+   
Sbjct: 114 -------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 166
Query: 219 WNP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
            N    K+  FG+A  LG ES  +    +GT  ++APE        +  DV+  G+++  
Sbjct: 167 ENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 276 VISGRIP 282
           ++SG +P
Sbjct: 226 LLSGCLP 232

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           V V    ++ G +  + K E      ++H ++V LL   +      +V+E+++  +L   
Sbjct: 59  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--- 115
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-------KVVHRDIKSSNILIDKH 218
                  C  +        +   A    Y+ + LE         ++HRD+K   +L+   
Sbjct: 116 -------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 168
Query: 219 WNP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
            N    K+  FG+A  LG ES  +    +GT  ++APE        +  DV+  G+++  
Sbjct: 169 ENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 227
Query: 276 VISGRIP 282
           ++SG +P
Sbjct: 228 LLSGCLP 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+      K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVIS 278
             K+ DFG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ 
Sbjct: 155 RLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMV 302
           G  P  +  P E  N  + + +++
Sbjct: 213 GAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
           ++HRD+K  N+L+DKH + K++DFG    +           +GT  Y++PE   +    G
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           + E+  + R+ H N+++L           LV E V  G L   +  + G  S       +
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADAV 154
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP------KVSDFGLAKLLGSES 236
             IL   + ++YLHE     +VHRD+K  N+L   +  P      K++DFGL+K++  E 
Sbjct: 155 KQIL---EAVAYLHEN---GIVHRDLKPENLL---YATPAPDAPLKIADFGLSKIV--EH 203
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
             +   V GT GY APE           D++S GI+   ++ G  P
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 106 VAVKNLLN---NRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR--MLVYEYVNN 159
           VAVK + +   N   A+R F+ E+  +  +  H+N+V LL        R   LV++Y   
Sbjct: 37  VAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY--- 92
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
             +E  LH  V   + L    +  ++    K + YLH G    ++HRD+K SNIL++   
Sbjct: 93  --METDLHA-VIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAEC 146
Query: 220 NPKVSDFGLAKLL--------------------GSESSYITTRVMGTFGYVAPE-YASTG 258
           + KV+DFGL++                        +   I T  + T  Y APE    + 
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 259 MLNERSDVYSFGILIMEVISGR 280
              +  D++S G ++ E++ G+
Sbjct: 207 KYTKGIDMWSLGCILGEILCGK 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 30/188 (15%)
Query: 110 NLLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL---- 162
            ++N +  + R+  K+E EA I R+ +H N+VRL    +E  H  L+++ V  G L    
Sbjct: 53  KIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI 112
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--- 216
              E +   D   C           I    + + + H   +  VVHRD+K  N+L+    
Sbjct: 113 VAREYYSEADASHC-----------IQQILEAVLHCH---QMGVVHRDLKPENLLLASKL 158
Query: 217 KHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           K    K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  
Sbjct: 159 KGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 216
Query: 276 VISGRIPV 283
           ++ G  P 
Sbjct: 217 LLVGYPPF 224

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNPKVSDFGLAK---LLGSESS 237
           NI+      L YLH      + HRDIK  N L   +K +  K+ DFGL+K    L +   
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 238 YITTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIMEVISGRIPVDYSRPPEEVN 293
           Y  T   GT  +VAPE  +T   NE    + D +S G+L+  ++ G +P       + ++
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS 286
Query: 294 LIEWLKKMVTNRNPE-GVLDPKLPEKPTSRLLKR 326
            +  L K +   NP   VL P L     S LL R
Sbjct: 287 QV--LNKKLCFENPNYNVLSP-LARDLLSNLLNR 317

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +   +H+N++ +       +       Y+    ++  LH  +     L+ +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDHIQYF 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL---GSESSYIT- 240
           I  T + +  LH      V+HRD+K SN+LI+ + + KV DFGLA+++    +++S  T 
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 241 -----TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 280
                T  + T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 111 LLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L     
Sbjct: 63  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 122
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---K 217
             E +   D   C           I    + ++++H+     +VHRD+K  N+L+    K
Sbjct: 123 AREYYSEADASHC-----------IHQILESVNHIHQH---DIVHRDLKPENLLLASKCK 168
Query: 218 HWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  +
Sbjct: 169 GAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYIL 226
Query: 277 ISGRIPV 283
           + G  P 
Sbjct: 227 LVGYPPF 233

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +   +H+N++ +       +       Y+    ++  LH  +     L+ +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDHIQYF 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL---GSESSYIT- 240
           I  T + +  LH      V+HRD+K SN+LI+ + + KV DFGLA+++    +++S  T 
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 241 -----TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 280
                T  + T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 30/187 (16%)
Query: 110 NLLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL---- 162
            ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L    
Sbjct: 35  KIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--- 216
              E +   D   C           I    + + + H   +  VVHRD+K  N+L+    
Sbjct: 95  VAREYYSEADASHC-----------IQQILEAVLHCH---QMGVVHRDLKPENLLLASKC 140
Query: 217 KHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           K    K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYI 198
Query: 276 VISGRIP 282
           ++ G  P
Sbjct: 199 LLVGYPP 205

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVIS 278
             K+  FG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ 
Sbjct: 155 RLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMV 302
           G  P  +  P E  N  + + +++
Sbjct: 213 GAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 18/168 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +   +H+N++ +       +       Y+    ++  LH  +     L+ +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDHIQYF 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-----------G 233
           I  T + +  LH      V+HRD+K SN+LI+ + + KV DFGLA+++           G
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 234 SESSYITTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 280
            +S  +    + T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 175 QQSGMV--EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 10/163 (6%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           K E+  + ++ H  L+ L     +    +L+ E+++ G L   +  +    S    E+ +
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA--EV-I 152
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDFGLAKLLGSESSYIT 240
           N +    +GL ++HE     +VH DIK  NI+ +  K  + K+ DFGLA  L  +   I 
Sbjct: 153 NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 207
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
                T  + APE      +   +D+++ G+L   ++SG  P 
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNER-SDVYSFGILIME 275
             K+  FG +K     SS + ++    +GT  Y+APE       + + +DV+S G+ +  
Sbjct: 155 RLKICAFGYSK-----SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMV 302
           ++ G  P  +  P E  N  + + +++
Sbjct: 210 MLVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
            +HRD+K  N+L+DK  + K++DFG    +  E        +GT  Y++PE   +    G
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
            +HRD+K  N+L+DK  + K++DFG    +  E        +GT  Y++PE   +    G
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
            +HRD+K  N+L+DK  + K++DFG    +  E        +GT  Y++PE   +    G
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/84 (40%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           VVHRDIK  NILID +    K+ DFG   LL  E     T   GT  Y  PE+ S    +
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYH 216
Query: 262 E-RSDVYSFGILIMEVISGRIPVD 284
              + V+S GIL+ +++ G IP +
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFE 240

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 103/254 (40%), Gaps = 49/254 (19%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-----DVGPCS 174
           + FK EV A  + RH+N+V  +G C    H  ++        L   +       DV    
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAKLL 232
            +  EI         KG+ YLH      ++H+D+KS N+  D   N KV  +DFGL  + 
Sbjct: 134 QIAQEI--------VKGMGYLH---AKGILHKDLKSKNVFYD---NGKVVITDFGLFSIS 179
Query: 233 G---SESSYITTRVM-GTFGYVAPEYASTGM---------LNERSDVYSFGILIMEVISG 279
           G   +       R+  G   ++APE                ++ SDV++ G +  E+ + 
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P   ++P E +     + +M T       + P L +    + +  ILL    C     
Sbjct: 240 EWPFK-TQPAEAI-----IWQMGTG------MKPNLSQIGMGKEISDILLF---CWAFEQ 284
Query: 340 QKRPKMGHVVHMLE 353
           ++RP    ++ MLE
Sbjct: 285 EERPTFTKLMDMLE 298

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 30/187 (16%)
Query: 111 LLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L     
Sbjct: 36  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 95
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + +++ H      +VHRD+K  N+L+    K
Sbjct: 96  AREYYSEADASHC-----------IQQILESVNHCHLN---GIVHRDLKPENLLLASKSK 141
Query: 218 HWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  +
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYIL 199
Query: 277 ISGRIPV 283
           + G  P 
Sbjct: 200 LVGYPPF 206

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 111 LLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+  K+E EA I R+ +H N+VRL    +E  H  L+++ V  G L     
Sbjct: 43  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---K 217
             E +   D   C           I    + + + H   +  VVHR++K  N+L+    K
Sbjct: 103 AREYYSEADASHC-----------IQQILEAVLHCH---QMGVVHRNLKPENLLLASKLK 148
Query: 218 HWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  +
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL 206
Query: 277 ISGRIPV 283
           + G  P 
Sbjct: 207 LVGYPPF 213

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 30/188 (15%)
Query: 110 NLLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL---- 162
            ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L    
Sbjct: 35  KIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---D 216
              E +   D   C           I    + +++ H      +VHRD+K  N+L+    
Sbjct: 95  VAREYYSEADASHC-----------IQQILESVNHCHLN---GIVHRDLKPENLLLASKS 140
Query: 217 KHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           K    K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 276 VISGRIPV 283
           ++ G  P 
Sbjct: 199 LLVGYPPF 206

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 37/79 (46%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
            HRD+K  NIL+       + DFG+A     E        +GT  Y APE  S      R
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 264 SDVYSFGILIMEVISGRIP 282
           +D+Y+   ++ E ++G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 42  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 96
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 97  DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 153
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPE-------YAST 257
              D+    +     +SDFGL K L S  S   T +    GT G+ APE         + 
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
             L    D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 260

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-----ASTG 258
           VHRDIK  NIL+D + + +++DFG    L  + +  ++  +GT  Y++PE         G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEH 251

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 239
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 240 GRSAAVWSLGILLYDMVCGDIPFEH 264

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 214
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 215 GRSAAVWSLGILLYDMVCGDIPFEH 239

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 191 GRSAAVWSLGILLYDMVCGDIPFEHD 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 17/171 (9%)
Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEI 180
           FK E+E +  + H N++RL     +     LV E    G L E+ +H  V   S      
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--- 109
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNP-KVSDFGLAKLLGSESS 237
              I+      ++Y H+     V HRD+K  N L   D   +P K+ DFGLA        
Sbjct: 110 --RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGK 163
Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
            + T+V GT  YV+P+    G+     D +S G+++  ++ G  P  +S P
Sbjct: 164 MMRTKV-GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP--FSAP 210

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/249 (21%), Positives = 112/249 (44%), Gaps = 30/249 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML-----VYEYV 157
           + +VA+K ++    Q+ +    E++ I R+ H N+V++         ++      + E  
Sbjct: 36  DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 158 NNGNLEQWLHGDVGPC---SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           +   +++++  D+       PL  E     +    +GL Y+H      V+HRD+K +N+ 
Sbjct: 96  SVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLF 152
Query: 215 ID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML------NERSDVY 267
           I+ +    K+ DFGLA+++    S+   +   + G V   Y S  +L       +  D++
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 209
Query: 268 SFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL---------DPKLPEK 318
           + G +  E+++G+     +   E++ LI     +V   + + +L         D   P K
Sbjct: 210 AAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHK 269
Query: 319 PTSRLLKRI 327
           P ++LL  I
Sbjct: 270 PLTQLLPGI 278

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           E E + ++ HKN+V+L     E    H++L+ E+   G+L   L  +      L     +
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFL 115
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSY 238
            ++     G+++L E     +VHR+IK  NI+     D     K++DFG A+ L  +  +
Sbjct: 116 IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 239 ITTRVMGTFGYVAPEYASTGMLNE--------RSDVYSFGILIMEVISGRIPVDYSRPPE 290
           ++  + GT  Y+ P+     +L +          D++S G+      +G +P      P 
Sbjct: 173 VS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 291 EVNLIEWLKKMVTNRNPEGVL 311
                E + K++T + P G +
Sbjct: 231 RNK--EVMYKIITGK-PSGAI 248

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----G 258
           VHRDIK  N+L+D + + +++DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEI 180
           FK E+E +  + H N++RL     +     LV E    G L E+ +H  V   S      
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--- 126
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNP-KVSDFGLAKLLGSESS 237
              I+      ++Y H   +  V HRD+K  N L   D   +P K+ DFGLA        
Sbjct: 127 --RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGK 180
Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
            + T+V GT  YV+P+    G+     D +S G+++  ++ G  P  +S P +
Sbjct: 181 MMRTKV-GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP--FSAPTD 229

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 60  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 114
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 115 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 171
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPEY---ASTGMLN 261
              D+    +     +SDFGL K L S        +    GT G+ APE    ++   L 
Sbjct: 172 FTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLT 231
Query: 262 ERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
              D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 232 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 274

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----G 258
           VHRDIK  N+L+D + + +++DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL--EQWLHGDVGPCSPLTWEIRM 182
           EV  + ++ H N+++L  +  +  +  LV E    G L  E  L       S +   + M
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF---SEVDAAVIM 110
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYI 239
             +L    G +YLH+     +VHRD+K  N+L++        K+ DFGL+     E    
Sbjct: 111 KQVLS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGK 162
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
               +GT  Y+APE       +E+ DV+S G+++  ++ G  P 
Sbjct: 163 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPF 205

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 122 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           F+VE + A   +    +V L G   EG    +  E +  G+L Q +   +G C P   E 
Sbjct: 112 FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMG-CLP---ED 166
Query: 181 RMNIILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSE 235
           R    LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G  
Sbjct: 167 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 236 SSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
            S +T   + GT  ++APE       + + D++S   +++ +++G  P   Y R P
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 279

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 60  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 114
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 115 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 171
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPEY---ASTGMLN 261
              D+    +     +SDFGL K L S        +    GT G+ APE    ++   L 
Sbjct: 172 FTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLT 231
Query: 262 ERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
              D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 232 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 274

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R  +E  F+     + ++ HK+LV   G C  G   +LV E+V  G+L+ +L  +   C 
Sbjct: 53  RNYSESFFEA-ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CI 110
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-- 232
            + W++ +   L  A     +H   E  ++H ++ + NIL+ +  + K  +    KL   
Sbjct: 111 NILWKLEVAKQLAAA-----MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
Query: 233 GSESSYITTRVMGT-FGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           G   + +   ++     +V PE       LN  +D +SFG  + E+ SG
Sbjct: 166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 37/237 (15%)
Query: 107 AVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCA-------EGAHRMLVYEYVN 158
           A+K LL+N  +  R    EV  + ++  H N+V+     +        G    L+   + 
Sbjct: 57  ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH 218
            G L ++L   +    PL+ +  + I   T + + ++H   +P ++HRD+K  N+L+   
Sbjct: 117 KGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQ 174
Query: 219 WNPKVSDFGLAKLLGSESSY---ITTRVM--------GTFGYVAPEYA---STGMLNERS 264
              K+ DFG A  +     Y      R +         T  Y  PE     S   + E+ 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 265 DVYSFGILIMEVISGRIPVD-----------YSRPPEEV--NLIEWLKKMVTNRNPE 308
           D+++ G ++  +   + P +           YS PP +    +   L + +   NPE
Sbjct: 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 122 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           F+VE + A   +    +V L G   EG    +  E +  G+L Q +   +G C P   E 
Sbjct: 110 FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMG-CLP---ED 164
Query: 181 RMNIILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSE 235
           R    LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G  
Sbjct: 165 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 236 SSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
            S +T   + GT  ++APE       + + D++S   +++ +++G  P   Y R P
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 277

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 122 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           F+VE + A   +    +V L G   EG    +  E +  G+L Q +   +G C P   E 
Sbjct: 96  FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMG-CLP---ED 150
Query: 181 RMNIILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSE 235
           R    LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G  
Sbjct: 151 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 236 SSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
            S +T   + GT  ++APE       + + D++S   +++ +++G  P   Y R P
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL--EQWLHGDVGPCSPLTWEIRM 182
           EV  + ++ H N+++L  +  +  +  LV E    G L  E  L       S +   + M
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF---SEVDAAVIM 127
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYI 239
             +L    G +YLH+     +VHRD+K  N+L++        K+ DFGL+     E    
Sbjct: 128 KQVLS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGK 179
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
               +GT  Y+APE       +E+ DV+S G+++  ++ G  P 
Sbjct: 180 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPF 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE--IR 181
           V++  +     KN V  L   +   +  +  +     NL+ W++     CS    E  + 
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR---CSLEDREHGVC 166
Query: 182 MNIILGTAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
           ++I +  A+ + +LH +GL    +HRD+K SNI        KV DFGL   +  +    T
Sbjct: 167 LHIFIQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 241 TRV-----------MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
                         +GT  Y++PE       + + D++S G+++ E++
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 125 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 176
Query: 250 V 250
           V
Sbjct: 177 V 177

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 178
Query: 250 V 250
           V
Sbjct: 179 V 179

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 178
Query: 250 V 250
           V
Sbjct: 179 V 179

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 180
Query: 250 V 250
           V
Sbjct: 181 V 181

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R  +E  F+     + ++ HK+LV   G C  G   +LV E+V  G+L+ +L  +   C 
Sbjct: 53  RNYSESFFEA-ASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKN-CI 110
Query: 175 PLTWEIRMNIILGTAKGLSY-LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL- 232
            + W++ +      AK L++ +H   E  ++H ++ + NIL+ +  + K  +    KL  
Sbjct: 111 NILWKLEV------AKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 233 -GSESSYITTRVMGT-FGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
            G   + +   ++     +V PE       LN  +D +SFG  + E+ SG
Sbjct: 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 12/132 (9%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP--CSPLTWEIR 181
           +E+  + RV H N++++L          LV E   +G L+ +   D  P    PL   I 
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIF 136
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
             ++  +A G   L +     ++HRDIK  NI+I + +  K+ DFG A  L  E   +  
Sbjct: 137 RQLV--SAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFY 187
Query: 242 RVMGTFGYVAPE 253
              GT  Y APE
Sbjct: 188 TFCGTIEYCAPE 199

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           E E + ++ HKN+V+L     E    H++L+ E+   G+L   L  +      L     +
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFL 115
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSY 238
            ++     G+++L E     +VHR+IK  NI+     D     K++DFG A+ L  +  +
Sbjct: 116 IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 239 ITTRVMGTFGYVAPEYASTGMLNE--------RSDVYSFGILIMEVISGRIPVDYSRPPE 290
           +   + GT  Y+ P+     +L +          D++S G+      +G +P      P 
Sbjct: 173 VX--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 291 EVNLIEWLKKMVTNRNPEGVL 311
                E + K++T + P G +
Sbjct: 231 RNK--EVMYKIITGK-PSGAI 248

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 66/140 (47%), Gaps = 20/140 (14%)
Query: 151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR-----MNIILGTAKGLSYLHEGLEPKVVH 205
           +L+ EY   G +          C P   E+      + +I    +G+ YLH+     +VH
Sbjct: 105 ILILEYAAGGEI-------FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVH 154
Query: 206 RDIKSSNILIDKHW---NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
            D+K  NIL+   +   + K+ DFG+++ +G         +MGT  Y+APE  +   +  
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITT 212
Query: 263 RSDVYSFGILIMEVISGRIP 282
            +D+++ GI+   +++   P
Sbjct: 213 ATDMWNIGIIAYMLLTHTSP 232

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 22/192 (11%)
Query: 107 AVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           AVK +    G +      EVE + + + +KN++ L+ +  +     LV+E +  G++   
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNP-K 222
           +                 ++   A  L +LH      + HRD+K  NIL +  +  +P K
Sbjct: 102 IQKQ----KHFNEREASRVVRDVAAALDFLHT---KGIAHRDLKPENILCESPEKVSPVK 154
Query: 223 VSDFGLAK--LLGSESSYITTRVM----GTFGYVAPEYA-----STGMLNERSDVYSFGI 271
           + DF L     L +  + ITT  +    G+  Y+APE            ++R D++S G+
Sbjct: 155 ICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGV 214
Query: 272 LIMEVISGRIPV 283
           ++  ++SG  P 
Sbjct: 215 VLYIMLSGYPPF 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           + + AVK +    G        EVE + + + H+N++ L+ +  E     LV+E +  G+
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +   +H           E+  ++++   A  L +LH      + HRD+K  NIL + H N
Sbjct: 98  ILSHIHK-----RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCE-HPN 148
Query: 221 P----KVSDFGLA---KLLGSESSYITTRVM---GTFGYVAPEYA-----STGMLNERSD 265
                K+ DFGL    KL G  S   T  ++   G+  Y+APE          + ++R D
Sbjct: 149 QVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 266 VYSFGILIMEVISGRIP 282
           ++S G+++  ++SG  P
Sbjct: 209 LWSLGVILYILLSGYPP 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+ A   +    +V L G   EG    +  E +  G+L Q L  + G C P   E R   
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQG-CLP---EDRALY 189
Query: 185 ILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSESSYI 239
            LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G   S +
Sbjct: 190 YLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 240 T-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T   + GT  ++APE       + + DV+S   +++ +++G  P
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 126 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/192 (21%), Positives = 89/192 (46%), Gaps = 19/192 (9%)
Query: 105 KVAVKNLLNNRGQAE--REFKVEVEAIGRVRHKNLVRLLGYCAEGAHR------MLVYEY 156
           KVAVK L  +   +    EF  E   +    H ++ +L+G       +      M++  +
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           + +G+L  +L       +P    ++  +  ++  A G+ YL        +HRD+ + N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCM 169
Query: 215 IDKHWNPKVSDFGLAKLLGSESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           + +     V+DFGL++ + S   Y     +++     ++A E  +  +    SDV++FG+
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGV 227
Query: 272 LIMEVIS-GRIP 282
            + E+++ G+ P
Sbjct: 228 TMWEIMTRGQTP 239

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 42  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 96
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 97  DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 153
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPE-------YAST 257
              D+    +     +SDFGL K L S        +    GT G+ APE         + 
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
             L    D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 260

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 127 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 182
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T     + YVAPE       ++  D++S G+++  ++ G  P 
Sbjct: 183 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 126 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 181
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T     + YVAPE       ++  D++S G+++  ++ G  P 
Sbjct: 182 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 175
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 176 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 177
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 178 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 128 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 183
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T     + YVAPE       ++  D++S G+++  ++ G  P 
Sbjct: 184 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 221
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 222 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 177
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 178 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 121 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 176
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T     + YVAPE       ++  D++S G+++  ++ G  P 
Sbjct: 177 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 172 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 227
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 228 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRM--LVYEYVN 158
           +N KV VK L   +   + + K E++ +  +R   N++ L     +   R   LV+E+VN
Sbjct: 61  NNEKVVVKIL---KPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 117
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-K 217
           N + +Q         +   ++IR   +    K L Y H      ++HRD+K  N++ID +
Sbjct: 118 NTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE 167
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV 276
           H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S G ++  +
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 277 ISGRIPV 283
           I  + P 
Sbjct: 226 IFRKEPF 232

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 126 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 136 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 191
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T     + YVAPE       ++  D++S G+++  ++ G  P 
Sbjct: 192 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 125 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 179 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 126 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV+E+VNN + +Q         +   ++IR   +    K L Y H      ++HRD+K  
Sbjct: 111 LVFEHVNNTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 212 NILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSF 269
           N+LID +H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S 
Sbjct: 161 NVLIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 270 GILIMEVISGRIPV 283
           G ++  +I  + P 
Sbjct: 219 GCMLASMIFRKEPF 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 188 TAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
           T   L++LH +GL    VH D+K +NI +      K+ DFGL   LG+  +       G 
Sbjct: 166 TLLALAHLHSQGL----VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GD 219
Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEV 276
             Y+APE    G     +DV+S G+ I+EV
Sbjct: 220 PRYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S   
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 174
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T    T  YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 175 TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 136 NLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGL 192
           N+++L+    +   +   LV+EY+NN + +Q           LT ++IR   +    K L
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY-------QILTDFDIRF-YMYELLKAL 150
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
            Y H      ++HRD+K  N++ID      ++ D+GLA+       Y   RV   + +  
Sbjct: 151 DYCHS---KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKG 205
Query: 252 PE-YASTGMLNERSDVYSFGILIMEVISGRIPV 283
           PE      M +   D++S G ++  +I  R P 
Sbjct: 206 PELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 136 NLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGL 192
           N+++L+    +   +   LV+EY+NN + +Q           LT ++IR   +    K L
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY-------QILTDFDIRF-YMYELLKAL 145
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
            Y H      ++HRD+K  N++ID      ++ D+GLA+       Y   RV   + +  
Sbjct: 146 DYCHS---KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKG 200
Query: 252 PE-YASTGMLNERSDVYSFGILIMEVISGRIPV 283
           PE      M +   D++S G ++  +I  R P 
Sbjct: 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L  +    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 48  VAIKKVLQGKAFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 159
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 213
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 214 AELLLGQ 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+ A   +    +V L G   EG    +  E +  G+L Q L  + G C P   E R   
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQG-CLP---EDRALY 170
Query: 185 ILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSESSYI 239
            LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G     +
Sbjct: 171 YLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 240 T-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
           T   + GT  ++APE       + + DV+S   +++ +++G  P   + R P
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP 279

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV+E+VNN + +Q         +   ++IR   +    K L Y H      ++HRD+K  
Sbjct: 111 LVFEHVNNTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 212 NILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSF 269
           N++ID +H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S 
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 270 GILIMEVISGRIPV 283
           G ++  +I  + P 
Sbjct: 219 GCMLASMIFRKEPF 232

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L  +    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 48  VAIKKVLQGKAFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 159
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 213
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 214 AELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L ++    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 82  VAIKKVLQDKRFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 193
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 194 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 247
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 248 AELLLGQ 254

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV+E+VNN + +Q         +   ++IR   +    K L Y H      ++HRD+K  
Sbjct: 111 LVFEHVNNTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 212 NILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSF 269
           N++ID +H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S 
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 270 GILIMEVISGRIPV 283
           G ++  +I  + P 
Sbjct: 219 GCMLASMIFRKEPF 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L ++    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 76  VAIKKVLQDKRFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 131
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 132 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 187
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 188 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 241
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 242 AELLLGQ 248

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV+E+VNN + +Q         +   ++IR   +    K L Y H      ++HRD+K  
Sbjct: 110 LVFEHVNNTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 159
Query: 212 NILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSF 269
           N++ID +H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S 
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 217
Query: 270 GILIMEVISGRIPV 283
           G ++  +I  + P 
Sbjct: 218 GCMLASMIFRKEPF 231
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	407
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-178
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-169
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-137
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-67
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-54
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-04
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  497 bits (1281), Expect = e-178
 Identities = 123/309 (39%), Positives = 194/309 (62%), Gaps = 4/309 (1%)

Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ 117
           PEV HLG    ++LREL+V+++ FS+  ++G GG+G VY G L D + VAVK L   R Q
Sbjct: 10  PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68

Query: 118 A-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L        PL
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W  R  I LG+A+GL+YLH+  +PK++HRD+K++NIL+D+ +   V DFGLAKL+  + 
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--VNL 294
           +++TT V GT G++APEY STG  +E++DV+ +G++++E+I+G+   D +R   +  V L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           ++W+K ++  +  E ++D  L        +++++ VAL C   +  +RPKM  VV MLE 
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

Query: 355 QESPSKEDR 363
                + + 
Sbjct: 309 DGLAERWEE 317

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  474 bits (1223), Expect = e-169
 Identities = 116/313 (37%), Positives = 181/313 (57%), Gaps = 4/313 (1%)

Query: 42  GNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE 101
           G+     +     A+          +   L +LE +TN F    +IG G +G VY G+L 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D +KVA+K       Q   EF+ E+E +   RH +LV L+G+C E    +L+Y+Y+ NGN
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L++ L+G   P   ++WE R+ I +G A+GL YLH      ++HRD+KS NIL+D+++ P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178

Query: 222 KVSDFGLAKL-LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           K++DFG++K     + ++++T V GT GY+ PEY   G L E+SDVYSFG+++ EV+  R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +  S P E VNL EW  +   N   E ++DP L +K     L++    A++C+  +++
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298

Query: 341 KRPKMGHVVHMLE 353
            RP MG V+  LE
Sbjct: 299 DRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  393 bits (1012), Expect = e-137
 Identities = 102/303 (33%), Positives = 173/303 (57%), Gaps = 21/303 (6%)

Query: 67  HWYTLRELEVSTNGFSDDK------VIGEGGYGIVYYGLLEDNSKVAVKNLLNNR----G 116
           H ++  EL+  TN F +         +GEGG+G+VY G + +N+ VAVK L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+ NG+L   L    G   PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           +W +R  I  G A G+++LH   E   +HRDIKS+NIL+D+ +  K+SDFGLA+     +
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 237 -SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            + +T+R++GT  Y+APE    G +  +SD+YSFG++++E+I+G   VD  R P+   L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLL 244

Query: 296 EWLKKMVTNRNP-EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +  +++       E  +D K+ +   S  ++ +  VA +C+     KRP +  V  +L+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 355 QES 357
             +
Sbjct: 304 MTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  285 bits (730), Expect = 3e-94
 Identities = 70/315 (22%), Positives = 130/315 (41%), Gaps = 38/315 (12%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAI 129
               L   +      +V   G +G V+   L  N  VAVK +   + +   + + EV ++
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSL 72

Query: 130 GRVRHKNLVRLLGYCAEGAH----RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
             ++H+N+++ +G    G        L+  +   G+L  +L       + ++W    +I 
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIA 127

Query: 186 LGTAKGLSYLHE-------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
              A+GL+YLHE       G +P + HRDIKS N+L+  +    ++DFGLA    +  S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 239 I-TTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
             T   +GT  Y+APE     +  +     R D+Y+ G+++ E+ S     D       +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 293 NLIEWL---------KKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKR 342
              E +         +++V ++       P L +       +  +      C D +A+ R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 343 PKMGHVVHMLEAQES 357
              G V   +   + 
Sbjct: 304 LSAGCVGERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (562), Expect = 5e-69
 Identities = 71/339 (20%), Positives = 121/339 (35%), Gaps = 53/339 (15%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE--AIG 130
           E  +  +     ++IG G YG VY G L D   VAVK          + F  E     + 
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62

Query: 131 RVRHKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
            + H N+ R +              +LV EY  NG+L ++L           W     + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLA 117

Query: 186 LGTAKGLSYLHE------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS----- 234
               +GL+YLH         +P + HRD+ S N+L+       +SDFGL+  L       
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 235 --ESSYITTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISGRIPVDY 285
             E        +GT  Y+APE     +         ++ D+Y+ G++  E+      +  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 286 SRPPEEVNL-----------IEWLKKMVTNRNPEGVLDPKLPE--KPTSRLLKRILLVAL 332
                E  +            E ++ +V+         PK PE  K  S  ++ +     
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIE 293

Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNE 371
            C D +A+ R         +       + ++  +   + 
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  215 bits (550), Expect = 1e-67
 Identities = 81/314 (25%), Positives = 147/314 (46%), Gaps = 29/314 (9%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR- 115
           +P   +L +       ++++     +  + IG G +G V+       S VAVK L+    
Sbjct: 15  IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF 73

Query: 116 -GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
             +   EF  EV  + R+RH N+V  +G   +  +  +V EY++ G+L + LH   G   
Sbjct: 74  HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGARE 132

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            L    R+++    AKG++YLH    P +VHR++KS N+L+DK +  KV DFGL++L  +
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-A 190

Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
            +   +    GT  ++APE       NE+SDVYSFG+++ E+ + + P  +      +N 
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP--W----GNLNP 244

Query: 295 IEWLKKMVTNRNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
            + +   V  +        ++P       + +++        C      KRP    ++ +
Sbjct: 245 AQVV-AAVGFKC----KRLEIPRNLNPQVAAIIE-------GCWTNEPWKRPSFATIMDL 292

Query: 352 LEA--QESPSKEDR 363
           L    + +    +R
Sbjct: 293 LRPLIKSAVPPPNR 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (522), Expect = 3e-63
 Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 31/283 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
            +       ++V+G G +G+V          VA+K + +      + F VE+  + RV H
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            N+V+L G C       LV EY   G+L   LHG   P    T    M+  L  ++G++Y
Sbjct: 61  PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           LH      ++HRD+K  N+L+       K+ DFG A  + +      T   G+  ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPE 173

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  +E+ DV+S+GI++ EVI+ R P  +    +E+    +      +        P
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP--F----DEIGGPAFRIMWAVHNG----TRP 223

Query: 314 KLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            L +   KP   L+        RC   +  +RP M  +V ++ 
Sbjct: 224 PLIKNLPKPIESLMT-------RCWSKDPSQRPSMEEIVKIMT 259

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  202 bits (517), Expect = 2e-62
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 34/283 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +V+G+G +G        +  + + +K L+    + +R F  EV+ +  + H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +      + EY+  G L   +       S   W  R++     A G++YLH      +
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-------------VMGTFGYV 250
           +HRD+ S N L+ ++ N  V+DFGLA+L+  E +                  V+G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APE  +    +E+ DV+SFGI++ E+I          P      +          N  G 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NVRGF 239

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           LD   P             + +RC D + +KRP    + H LE
Sbjct: 240 LDRYCPPNCPPSFFP----ITVRCCDLDPEKRPSFVKLEHWLE 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (514), Expect = 2e-62
 Identities = 79/302 (26%), Positives = 143/302 (47%), Gaps = 46/302 (15%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAE-------REFK 123
           R   ++ N    +K IG+GG+G+V+ G L++D S VA+K+L+    + E       +EF+
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            EV  +  + H N+V+L G         +V E+V  G+L   L        P+ W +++ 
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-----HWNPKVSDFGLAKLLGSESSY 238
           ++L  A G+ Y+     P +VHRD++S NI +           KV+DFGL++    +S +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH 181

Query: 239 ITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRIPVDYS-RPPEEVNLI 295
             + ++G F ++APE   A      E++D YSF +++  +++G  P  +      ++  I
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFI 239

Query: 296 EWLKKMVTNRNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
                M+        L P +PE        +++        C   + +KRP   ++V  L
Sbjct: 240 N----MIREEG----LRPTIPEDCPPRLRNVIE-------LCWSGDPKKRPHFSYIVKEL 284

Query: 353 EA 354
             
Sbjct: 285 SE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  200 bits (510), Expect = 6e-62
 Identities = 61/293 (20%), Positives = 120/293 (40%), Gaps = 38/293 (12%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAI 129
           +   +     +    + E   G ++ G     + + VK L       +  R+F  E   +
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 130 GRVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
               H N++ +LG C      H  L+  ++  G+L   LH   G    +     +   L 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            A+G+++LH  LEP +    + S +++ID+    ++S   +        S+ +   M   
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAP 172

Query: 248 GYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
            +VAPE             +D++SF +L+ E+++  +P  +     +++ +E   K+   
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP--F----ADLSNMEIGMKVALE 226

Query: 305 RNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
                 L P +P       S+L+K        C++ +  KRPK   +V +LE 
Sbjct: 227 G-----LRPTIPPGISPHVSKLMK-------ICMNEDPAKRPKFDMIVPILEK 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  198 bits (505), Expect = 3e-61
 Identities = 74/296 (25%), Positives = 138/296 (46%), Gaps = 42/296 (14%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL----NNRGQAEREFKVEVEAI 129
           LE+     + +++IG GG+G VY        +VAVK        +  Q     + E +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
             ++H N++ L G C +  +  LV E+   G L + L G       +  +I +N  +  A
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIA 115

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDK--------HWNPKVSDFGLAKLLGSESSYITT 241
           +G++YLH+     ++HRD+KSSNILI +        +   K++DFGLA+      +   +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
              G + ++APE     M ++ SDV+S+G+L+ E+++G +P  +      ++ +      
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F----RGIDGLAVA-YG 225

Query: 302 VTNRNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           V        L   +P    +P ++L++        C +P+   RP   +++  L  
Sbjct: 226 VAMNK----LALPIPSTCPEPFAKLME-------DCWNPDPHSRPSFTNILDQLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (503), Expect = 1e-60
 Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 30/293 (10%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVE 127
              + E+     +  + IG G +G VY G    +  VAVK L       Q  + FK EV 
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
            + + RH N++  +GY        +V ++    +L   LH      +    +  ++I   
Sbjct: 73  VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 128

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGT 246
           TA+G+ YLH      ++HRD+KS+NI + +    K+ DFGLA        S+   ++ G+
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

Query: 247 FGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
             ++APE      +   + +SDVY+FGI++ E+++G++P       +++       +MV 
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVG 239

Query: 304 NRNPEGVLDPKLPEKPTS--RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
                G L P L +  ++  + +KR++     C+     +RP    ++  +E 
Sbjct: 240 R----GSLSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  195 bits (498), Expect = 1e-59
 Identities = 66/301 (21%), Positives = 118/301 (39%), Gaps = 41/301 (13%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVE 127
            L+E ++        ++IG+G +G VY+G    + +VA++ +   R      + FK EV 
Sbjct: 24  FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
           A  + RH+N+V  +G C    H  ++        L   +         L       I   
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM--- 244
             KG+ YLH      ++H+D+KS N+  D +    ++DFGL  + G   +      +   
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 245 -GTFGYVAPEYASTGML---------NERSDVYSFGILIMEVISGRIPVDYSR-PPEEVN 293
            G   ++APE                ++ SDV++ G +  E+ +   P  +   P E + 
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAI- 251

Query: 294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                            + P L +    + +  IL   L C     ++RP    ++ MLE
Sbjct: 252 ------IWQMGTG----MKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298

Query: 354 A 354
            
Sbjct: 299 K 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  189 bits (481), Expect = 2e-57
 Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 44/299 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE--AIGRVRHKNLVRLLG 142
           + +G+G YG V+ G       VAVK       + E+ +  E E      +RH+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 143 YCAEGAHR----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                 H      L+  Y   G+L  +L       + L     + I+L  A GL++LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 199 LE-----PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGYV 250
           +      P + HRD+KS NIL+ K+    ++D GLA +    ++ +        GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 251 APE------YASTGMLNERSDVYSFGILIMEVISGRIPV----DYSRPPEEVN----LIE 296
           APE              +R D+++FG+++ EV    +      DY  P  +V       E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 297 WLKKMVTNRN--PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            ++K+V      P   +  +    PT   L +++     C   N   R     +   L 
Sbjct: 245 DMRKVVCVDQQRPN--IPNRWFSDPTLTSLAKLM---KECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (476), Expect = 3e-56
 Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 38/297 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
            K IG+G YG V+ G      KVAVK +     +A    + E+     +RH+N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 144 CAEGAHR----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-- 197
             +G        L+ +Y  NG+L  +L       + L  +  + +   +  GL +LH   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 198 ---GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVA 251
                +P + HRD+KS NIL+ K+    ++D GLA    S+++ +       +GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 252 PE------YASTGMLNERSDVYSFGILIMEVISGRIPV----DYSRPPEEVN----LIEW 297
           PE        +       +D+YSFG+++ EV    +      +Y  P  ++       E 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSR-LLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           ++++V  +     L P  P + +S   L+++  +   C   N   R     V   L 
Sbjct: 275 MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  181 bits (460), Expect = 8e-54
 Identities = 80/341 (23%), Positives = 136/341 (39%), Gaps = 66/341 (19%)

Query: 45  SGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS 104
           SG GSG  +                  R + +        + IG+G +G V+ G      
Sbjct: 26  SGSGSGLPLLV-----------QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGE 66

Query: 105 KVAVKNLLNNRGQAEREFKVEVE--AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVN 158
           +VAVK       + ER +  E E      +RH+N++  +              LV +Y  
Sbjct: 67  EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123

Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE-----PKVVHRDIKSSNI 213
           +G+L  +L+        +T E  + + L TA GL++LH  +      P + HRD+KS NI
Sbjct: 124 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPE------YASTGMLNERS 264
           L+ K+    ++D GLA    S +  I       +GT  Y+APE              +R+
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

Query: 265 DVYSFGILIMEVISGRIPV----DYSRPPEEVN----LIEWLKKMVTNRNPEGVLDPKLP 316
           D+Y+ G++  E+           DY  P  ++      +E ++K+V  +     L P +P
Sbjct: 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIP 294

Query: 317 EK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +       R++ +I+     C   N   R     +   L 
Sbjct: 295 NRWQSCEALRVMAKIM---RECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (376), Expect = 4e-41
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 85  KVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
           + IG G +G V+ G L  DN+ VAVK+         + +F  E   + +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
            C +     +V E V  G+   +L  +      L  +  + ++   A G+ YL       
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SKC 233

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGML 260
            +HRD+ + N L+ +    K+SDFG+++   ++  Y  +  +        APE  + G  
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 261 NERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
           +  SDV+SFGIL+ E  S G  P  Y     ++       ++ V      G   P     
Sbjct: 293 SSESDVWSFGILLWETFSLGASP--YPNLSNQQT------REFVEK----GGRLPCPELC 340

Query: 319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           P +  + R++    +C      +RP    +   L++
Sbjct: 341 PDA--VFRLM---EQCWAYEPGQRPSFSTIYQELQS 371

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  145 bits (368), Expect = 6e-41
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 35/270 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           D  IG G +  VY GL  E   +VA              + FK E E +  ++H N+VR 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 141 LGYCAEGAHRM----LVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSY 194
                          LV E + +G L+ +L           +  ++  +      KGL +
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQF 144

Query: 195 LHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           LH    P ++HRD+K  NI I     + K+ D GLA L  +  +     V+GT  ++APE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPE 200

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  +E  DVY+FG+ ++E+ +   P  YS   E  N  +  ++ VT+        P
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP--YS---ECQNAAQIYRR-VTSGVK-----P 248

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
              +K     +K I+     C+  N  +R 
Sbjct: 249 ASFDKVAIPEVKEII---EGCIRQNKDERY 275

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (366), Expect = 3e-40
 Identities = 69/305 (22%), Positives = 125/305 (40%), Gaps = 31/305 (10%)

Query: 85  KVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
             +G+G +G V             + VAVK L ++    +R+F+ E++ +  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             G       +   LV EY+ +G L  +L               +       KG+ YL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSSQICKGMEYLGS 145

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
               + VHRD+ + NIL++   + K++DFGLAKLL  +  Y   R  G     + APE  
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-- 312
           S  + + +SDV+SFG+++ E+ +        S   E + ++   + +        +L+  
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEEG 260

Query: 313 ---PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA---QESPSKEDRYRA 366
              P  P  P       +  +   C  P+ Q RP    +   L+         +   + A
Sbjct: 261 QRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA 315

Query: 367 SPKNE 371
            P+ +
Sbjct: 316 HPEGK 320

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (363), Expect = 5e-40
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 11/203 (5%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
              +G GG   VY       N KVA+K +      + +  + F+ EV    ++ H+N+V 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           ++    E     LV EY+    L +++        PL+ +  +N       G+ + H+  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             ++VHRDIK  NILID +   K+ DFG+AK L   S   T  V+GT  Y +PE A    
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 260 LNERSDVYSFGILIMEVISGRIP 282
            +E +D+YS GI++ E++ G  P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (356), Expect = 4e-39
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 18/228 (7%)

Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ 117
           P  + LG+G W      E+     +  K +G G +G+V YG       VA+K +      
Sbjct: 9   PSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSM 61

Query: 118 AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
           +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L           
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQ 118

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
            +  + +     + + YL      + +HRD+ + N L++     KVSDFGL++ +  +  
Sbjct: 119 TQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDE 174

Query: 238 YITTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           Y T+ V   F      PE       + +SD+++FG+L+ E+ S G++P
Sbjct: 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  139 bits (353), Expect = 1e-38
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLV 138
           DK +G G +G V  G  +       VAVK L N       + E   E   + ++ +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           R++G C   +  MLV E    G L ++L         +  +  + ++   + G+ YL E 
Sbjct: 82  RMIGICEAESW-MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE- 135

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYAS 256
                VHRD+ + N+L+      K+SDFGL+K L ++ +Y   +  G +   + APE  +
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 257 TGMLNERSDVYSFGILIMEVIS-GRIP 282
               + +SDV+SFG+L+ E  S G+ P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  143 bits (362), Expect = 1e-38
 Identities = 76/270 (28%), Positives = 129/270 (47%), Gaps = 24/270 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
             +G+G +G V+ G     ++VA+K L       E  F  E + + ++RH+ LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
           +E     +V EY++ G+L  +L G+ G    L     +++    A G++Y+        V
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYV 302

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD++++NIL+ ++   KV+DFGLA+L+                + APE A  G    +S
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
           DV+SFGIL+ E+ + GR+P       E ++ +E            G   P  PE P S  
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------RGYRMPCPPECPES-- 409

Query: 324 LKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           L  ++    +C     ++RP   ++   LE
Sbjct: 410 LHDLM---CQCWRKEPEERPTFEYLQAFLE 436

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 1e-38
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 12/201 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG G +G+V+ G   +  KVA+K +      +E +F  E E + ++ H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            E A   LV E++ +G L  +L    G       E  + + L   +G++YL    E  V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACVI 126

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLNE 262
           HRD+ + N L+ ++   KVSDFG+ + +       T+     F     +PE  S    + 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 263 RSDVYSFGILIMEVIS-GRIP 282
           +SDV+SFG+L+ EV S G+IP
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (348), Expect = 5e-38
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 14/206 (6%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK---VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           D  +G G +G V  G+     K   VA+K L          E   E + + ++ +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L+G C   A  MLV E    G L ++L G       +       ++   + G+ YL E  
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-- 128

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYAST 257
               VHRD+ + N+L+      K+SDFGL+K LG++ SY T R  G +   + APE  + 
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIP 282
              + RSDV+S+G+ + E +S G+ P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (353), Expect = 6e-38
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 30/288 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRGQAER-EFKVEVEAI 129
           E+     S DKV+G G +G V  G L    +    VA+K L     + +R +F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           G+  H N++RL G   +    M+V EY+ NG+L+ +L          T    + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIA 157

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
            G+ YL    +   VHRD+ + NILI+ +   KVSDFGL ++L  +     T   G    
Sbjct: 158 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 250 --VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
              +PE  +       SDV+S+GI++ EV+S G  P       + +  ++          
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------- 264

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            EG   P   + P       +  + L C   +   RPK   +V +L+ 
Sbjct: 265 -EGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (358), Expect = 7e-38
 Identities = 70/303 (23%), Positives = 126/303 (41%), Gaps = 40/303 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G G YG VY G+ +  S  VAVK L         EF  E   +  ++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           C       ++ E++  GNL  +L         ++  + + +    +  + YL    +   
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLN 261
           +HR++ + N L+ ++   KV+DFGL++L+       T      F     APE  +    +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 262 ERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
            +SDV++FG+L+ E+ + G  P       +   L+E   +M               E+P 
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------------ERPE 442

Query: 321 --SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVT 378
                +  ++     C   N   RP    +            E  ++ S  ++ +EK++ 
Sbjct: 443 GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF--------ETMFQESSISDEVEKELG 491

Query: 379 ESG 381
           + G
Sbjct: 492 KRG 494

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (349), Expect = 1e-37
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 14/207 (6%)

Query: 84  DKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           +K+IG G  G V YG L    + +  VA+K L     + +R +F  E   +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL G    G   M+V EY+ NG+L+ +L    G     T    + ++ G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLS-- 168

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYAS 256
            +   VHRD+ + N+L+D +   KVSDFGL+++L  +     T   G       APE  +
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 257 TGMLNERSDVYSFGILIMEVIS-GRIP 282
               +  SDV+SFG+++ EV++ G  P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (358), Expect = 1e-37
 Identities = 76/270 (28%), Positives = 129/270 (47%), Gaps = 24/270 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
             +G+G +G V+ G     ++VA+K L       E  F  E + + ++RH+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
           +E     +V EY++ G+L  +L G+ G    L     +++    A G++Y+        V
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD++++NIL+ ++   KV+DFGLA+L+                + APE A  G    +S
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
           DV+SFGIL+ E+ + GR+P       E ++ +E            G   P  PE P S  
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------RGYRMPCPPECPES-- 492

Query: 324 LKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           L  ++    +C     ++RP   ++   LE
Sbjct: 493 LHDLM---CQCWRKEPEERPTFEYLQAFLE 519

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (348), Expect = 1e-37
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            KV+G G +G VY GL     +     VA+K L          E   E   +  V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            RLLG C   +   L+ + +  G L  ++               +N  +  AKG++YL +
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEY 254
               ++VHRD+ + N+L+    + K++DFGLAKLLG+E         G      ++A E 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIP 282
               +   +SDV+S+G+ + E+++ G  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (344), Expect = 2e-37
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVE 125
           GH       E+     +  K +G G +G+V  G  +    VAVK +      +E EF  E
Sbjct: 1   GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
            + + ++ H  LV+  G C++     +V EY++NG L  +L         L     + + 
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMC 110

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
               +G+++L      + +HRD+ + N L+D+    KVSDFG+ + +  +  Y  + V  
Sbjct: 111 YDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQY-VSSVGT 165

Query: 246 TFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            F     APE       + +SDV++FGIL+ EV S G++P
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (344), Expect = 2e-37
 Identities = 65/291 (22%), Positives = 114/291 (39%), Gaps = 32/291 (10%)

Query: 84  DKVIGEGGYGIVYYGLL----EDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKN 136
            + +G+G +G+V  G           VAVK L   + ++ +A  +F  EV A+  + H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           L+RL G         +V E    G+L   L    G     T        +  A+G+ YL 
Sbjct: 83  LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT---LSRYAVQVAEGMGYLE 138

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEY 254
                + +HRD+ + N+L+      K+ DFGL + L     +   +      +   APE 
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
             T   +  SD + FG+ + E+ + G+ P       + ++ I+           EG   P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----------KEGERLP 245

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
           +  + P       I  V ++C     + RP    +   L   +       +
Sbjct: 246 RPEDCPQD-----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAEF 291

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (354), Expect = 2e-37
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 30/285 (10%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
             E+       +K +G G +G V+      ++KVAVK +      +   F  E   +  +
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTL 240

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H  LV+L     +     ++ E++  G+L  +L  D G  S       ++     A+G+
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGM 297

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--V 250
           +++ +      +HRD++++NIL+      K++DFGLA+++  ++ Y T R    F     
Sbjct: 298 AFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEY-TAREGAKFPIKWT 352

Query: 251 APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPE 308
           APE  + G    +SDV+SFGIL+ME+++ GRIP  Y      EV  I  L++        
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV--IRALER-------- 400

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           G   P+    P    L  I+   +RC     ++RP   ++  +L+
Sbjct: 401 GYRMPRPENCPEE--LYNIM---MRCWKNRPEERPTFEYIQSVLD 440

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (346), Expect = 2e-37
 Identities = 76/328 (23%), Positives = 144/328 (43%), Gaps = 43/328 (13%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-E 121
           Y   E EV+    +  + +G+G +G+VY G+       E  ++VA+K +       ER E
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL------HGDVGPCSP 175
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L        +    +P
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            +    + +    A G++YL+     K VHRD+ + N ++ + +  K+ DFG+ + +   
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

Query: 236 SSYITTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP 289
             Y      G  G +     +PE    G+    SDV+SFG+++ E+ +    P       
Sbjct: 192 DYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSN 246

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           E+V       + V      G+LD   P+     +L  ++     C   N + RP    ++
Sbjct: 247 EQV------LRFVMEG---GLLDK--PDN-CPDMLFELM---RMCWQYNPKMRPSFLEII 291

Query: 350 HMLEA-QESPSKEDRYRASPKNELIEKQ 376
             ++   E   +E  +  S +N+L E +
Sbjct: 292 SSIKEEMEPGFREVSFYYSEENKLPEPE 319

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  138 bits (349), Expect = 9e-37
 Identities = 80/302 (26%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           V          W       ++       + IG+G +G V  G     +KVAVK +     
Sbjct: 177 VAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KND 227

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVYEYVNNGNLEQWLHGDVGPCSP 175
              + F  E   + ++RH NLV+LLG   E      +V EY+  G+L  +L       S 
Sbjct: 228 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SV 285

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           L  +  +   L   + + YL        VHRD+ + N+L+ +    KVSDFGL K     
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 337

Query: 236 SSYITTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEE 291
               +T+  G       APE       + +SDV+SFGIL+ E+ S GR+P  Y R P ++
Sbjct: 338 -EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKD 394

Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           V  +  ++K        G         P +  +  ++     C   +A  RP    +   
Sbjct: 395 V--VPRVEK--------GYKMDAPDGCPPA--VYDVM---KNCWHLDAATRPTFLQLREQ 439

Query: 352 LE 353
           LE
Sbjct: 440 LE 441

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  135 bits (341), Expect = 1e-36
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
            +++G GG   V+    L D+  VAVK    +L  +     R F+ E +    + H  +V
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV 75

Query: 139 RLLGY-CAEGAHRMLVY---EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            +     AE     L Y   EYV+   L   +H +     P+T +  + +I    + L++
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNF 131

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT--RVMGTFGYVAP 252
            H+     ++HRD+K +NI+I      KV DFG+A+ +    + +T    V+GT  Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E A    ++ RSDVYS G ++ EV++G  P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (342), Expect = 1e-36
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 84  DKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            KVIG G +G VY G+L     +    VA+K L     + +R +F  E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +RL G  ++    M++ EY+ NG L+++L    G     +    + ++ G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLA- 164

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYA 255
                 VHRD+ + NIL++ +   KVSDFGL+++L  +     T   G       APE  
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIP 282
           S       SDV+SFGI++ EV++ G  P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (338), Expect = 1e-36
 Identities = 64/201 (31%), Positives = 111/201 (55%), Gaps = 12/201 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + +G G +G V+ G    ++KVAVK+L      +   F  E   + +++H+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +     ++ EY+ NG+L  +L    G    LT    +++    A+G++++ E      +
Sbjct: 78  TQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLNE 262
           HRD++++NIL+    + K++DFGLA+L+  ++ Y T R    F     APE  + G    
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 263 RSDVYSFGILIMEVIS-GRIP 282
           +SDV+SFGIL+ E+++ GRIP
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  134 bits (340), Expect = 2e-36
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 19/223 (8%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNL 137
            KV+G G +G V+ G+     +     V +K + +  G Q+ +     + AIG + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VRLLG C  G+   LV +Y+  G+L   +    G   P      +N  +  AKG+ YL E
Sbjct: 78  VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEY 254
                +VHR++ + N+L+      +V+DFG+A LL  +   +            ++A E 
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
              G    +SDV+S+G+ + E+++ G  P    R  E  +L+E
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  134 bits (339), Expect = 2e-36
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 19/207 (9%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK---VAVK----NLLNNRGQAEREFKVEVEAIGRVRHKN 136
            +++G GG G VY    ED  +   VA+K     L ++     R  + E    GR++  +
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPH 95

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V +  +        +    +N  +L   L        PL     + I+      L   H
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAH 151

Query: 197 E-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
             G      HRD+K  NIL+       + DFG+A     E        +GT  Y+APE  
Sbjct: 152 AAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 256 STGMLNERSDVYSFGILIMEVISGRIP 282
           S      R+D+Y+   ++ E ++G  P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (336), Expect = 2e-36
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           V          W       ++       + IG+G +G V  G     +KVAVK +     
Sbjct: 5   VAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KND 55

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVYEYVNNGNLEQWLHGDVGPCSP 175
              + F  E   + ++RH NLV+LLG   E      +V EY+  G+L  +L       S 
Sbjct: 56  ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SV 113

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           L  +  +   L   + + YL        VHRD+ + N+L+ +    KVSDFGL K     
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 165

Query: 236 SSYITTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
               +T+  G       APE       + +SDV+SFGIL+ E+ S GR+P
Sbjct: 166 -EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  133 bits (336), Expect = 3e-36
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 85  KVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G V     +         VAVK L ++  +  R+F+ E+E +  ++H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             G C     R   L+ EY+  G+L  +L         +     +       KG+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLGT 132

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
               + +HRD+ + NIL++     K+ DFGL K+L  +  +   +  G     + APE  
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 256 STGMLNERSDVYSFGILIMEVIS 278
           +    +  SDV+SFG+++ E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (337), Expect = 3e-36
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 34/296 (11%)

Query: 84  DKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           D+VIG+G +G+VY+G   D      + A+K+L       +   F  E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 139 RLLGYCAEGA-HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            L+G          ++  Y+ +G+L Q++          T +  ++  L  A+G+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLAE 142

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV---APEY 254
               K VHRD+ + N ++D+ +  KV+DFGLA+ +     Y   +       V   A E 
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLD 312
             T     +SDV+SFG+L+ E+++ G  P  Y    P ++    +L         +G   
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDPFDL--THFLA--------QGRRL 247

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASP 368
           P+    P       +  V  +C + +   RP    +V  +E   S    D Y   P
Sbjct: 248 PQPEYCP-----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (336), Expect = 3e-36
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 38/302 (12%)

Query: 85  KVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G G YG VY G+ +  +  VAVK L         EF  E   +  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           C       ++ E++  GNL  +L         ++  + + +    +  + YL    +   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNF 132

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLN 261
           +HRD+ + N L+ ++   KV+DFGL++L+       T      F     APE  +    +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 262 ERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            +SDV++FG+L+ E+ + G  P  Y      +V   E L+K             +    P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP--YPGIDLSQV--YELLEK--------DYRMERPEGCP 238

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRASPKNELIEKQVTE 379
                +++  +   C   N   RP    +            E  ++ S  ++ +EK++ +
Sbjct: 239 -----EKVYELMRACWQWNPSDRPSFAEIHQAF--------ETMFQESSISDEVEKELGK 285

Query: 380 SG 381
            G
Sbjct: 286 RG 287

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (336), Expect = 4e-36
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 17/218 (7%)

Query: 85  KVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           + +GEG +G V     +        +VAVK+L    G     + K E+E +  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 139 RLLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G C E       L+ E++ +G+L+++L  +    +      ++   +   KG+ YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMDYLG 143

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEY 254
                + VHRD+ + N+L++     K+ DFGL K + ++  Y T +        + APE 
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE 291
                    SDV+SFG+ + E+++             +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (336), Expect = 8e-36
 Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 42/289 (14%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
           + +G G +G VY G +          +VAVK L     + +  +F +E   I +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSY 194
           VR +G   +   R ++ E +  G+L+ +L          S L     +++    A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYITTRVMGTFGYV- 250
           L E      +HRDI + N L+         K+ DFG+A+ +   S Y      G    + 
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAMLP 208

Query: 251 ----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
                PE    G+   ++D +SFG+L+ E+ S G +P   S+  +EV       + VT+ 
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV------LEFVTSG 261

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
              G +DP  P+      + RI+    +C     + RP    ++  +E 
Sbjct: 262 ---GRMDP--PKN-CPGPVYRIM---TQCWQHQPEDRPNFAIILERIEY 301

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (333), Expect = 9e-36
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 52/297 (17%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
           + +GE  +G VY G L      E    VA+K L +      R EF+ E     R++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIRMNII 185
           V LLG   +     +++ Y ++G+L ++L              D    S L     ++++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT---- 241
              A G+ YL       VVH+D+ + N+L+    N K+SD GL + + +   Y       
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 242 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
              R M      APE    G  +  SD++S+G+++ EV S G  P       ++V     
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDV----- 239

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
             +M+ NR    VL    P+      +  ++   + C +    +RP+   +   L A
Sbjct: 240 -VEMIRNR---QVLPC--PDD-CPAWVYALM---IECWNEFPSRRPRFKDIHSRLRA 286

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 1e-35
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 40/295 (13%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           ++VIG G +G VY+G L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 139 RLLGYCAEGAH-RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS 146

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG------YVA 251
               K VHRD+ + N ++D+ +  KV+DFGLA+ +  +  Y    V    G      ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200

Query: 252 PEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEG 309
            E   T     +SDV+SFG+L+ E+++ G  P  Y      ++    +L +         
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDI--TVYLLQ-------GR 249

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
            L    PE      L  ++   L+C  P A+ RP    +V  + A  S    + Y
Sbjct: 250 RLLQ--PEY-CPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (345), Expect = 1e-35
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 14/206 (6%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK---VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           D  +G G +G V  G+     K   VA+K L          E   E + + ++ +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L+G C   A  MLV E    G L ++L G       +       ++   + G+ YL E  
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-- 454

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYAST 257
               VHR++ + N+L+      K+SDFGL+K LG++ SY T R  G +     APE  + 
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIP 282
              + RSDV+S+G+ + E +S G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (331), Expect = 2e-35
 Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 39/272 (14%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKV-EVEAIGRVRHKNLVRL 140
           K IG G +  VY    L D   VA+K   + +      R   + E++ + ++ H N+++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                E     +V E  + G+L + +         +         +     L ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------Y 254
            +V+HRDIK +N+ I      K+ D GL +   S+++   + V GT  Y++PE      Y
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP---EEVNLIEWLKKMVTNRNPEGVL 311
                 N +SD++S G L+ E+ +        + P   +++NL    KK+     P    
Sbjct: 214 ------NFKSDIWSLGCLLYEMAAL-------QSPFYGDKMNLYSLCKKIEQCDYPP--- 257

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
              LP    S  L++++     C++P+ +KRP
Sbjct: 258 ---LPSDHYSEELRQLV---NMCINPDPEKRP 283

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  131 bits (332), Expect = 2e-35
 Identities = 70/294 (23%), Positives = 123/294 (41%), Gaps = 48/294 (16%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
             +GEG +G V+          +D   VAVK L      A ++F+ E E +  ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL-----------HGDVGPCSPLTWEIRMNIILG 187
           R  G C EG   ++V+EY+ +G+L ++L            G+     PL     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            A G+ YL        VHRD+ + N L+ +    K+ DFG+++ + S   Y     +G  
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGGR 219

Query: 248 GYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKK 300
             +      PE          SDV+SFG+++ E+ + G+ P  +      E   I+ + +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTEA--IDCITQ 275

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
                     L+   P       +  I+     C     Q+R  +  V   L+A
Sbjct: 276 G-------RELER--PRA-CPPEVYAIM---RGCWQREPQQRHSIKDVHARLQA 316

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (331), Expect = 3e-35
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 85  KVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G V     +         VAVK L ++  +  R+F+ E+E +  ++H N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             G C     R   L+ EY+  G+L  +L         +     +       KG+ YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLGT 163

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
               + +HRD+ + NIL++     K+ DFGL K+L  +  Y   +  G     + APE  
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 256 STGMLNERSDVYSFGILIMEVIS 278
           +    +  SDV+SFG+++ E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (333), Expect = 4e-35
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 42/289 (14%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
           + +G G +G VY G +          +VAVK L     + +  +F +E   I +  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSY 194
           VR +G   +   R ++ E +  G+L+ +L          S L     +++    A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYITTRVMGTFGYV- 250
           L E      +HRDI + N L+         K+ DFG+A+ +     Y      G    + 
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249

Query: 251 ----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
                PE    G+   ++D +SFG+L+ E+ S G +P   S+  +EV       + VT+ 
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV------LEFVTSG 302

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
              G +DP  P+      + RI+    +C     + RP    ++  +E 
Sbjct: 303 ---GRMDP--PKN-CPGPVYRIM---TQCWQHQPEDRPNFAIILERIEY 342

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  130 bits (328), Expect = 5e-35
 Identities = 70/300 (23%), Positives = 130/300 (43%), Gaps = 49/300 (16%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + +GEG +G V+          +D   VAVK L +    A ++F+ E E +  ++H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIRMNIIL 186
           +  G C +G   ++V+EY+ +G+L ++L                     L     ++I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             A G+ YL        VHRD+ + N L+  +   K+ DFG+++ + S   Y     +G 
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193

Query: 247 FGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK 300
              +      PE          SDV+SFG+++ E+ + G+ P  +     EV  IE + +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNTEV--IECITQ 250

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA--QESP 358
                    VL+   P     + +  ++   L C     Q+R  +  +  +L A  + +P
Sbjct: 251 G-------RVLER--PRV-CPKEVYDVM---LGCWQREPQQRLNIKEIYKILHALGKATP 297

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (328), Expect = 5e-35
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 54/293 (18%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F +  V+G+G +G V       D+   A+K  + +  +       EV  +  + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 140 LLGYCAEGAHRM-------------LVYEYVNNGNLEQWLHGDVGPCSP-LTWEIRMNII 185
                 E  + +             +  EY  NG L   +H +         W +   I+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI------ 239
                 LSY+H      ++HRD+K  NI ID+  N K+ DFGLAK +      +      
Sbjct: 127 EA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 240 --------TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
                   T+ + GT  YVA E    TG  NE+ D+YS GI+  E+I             
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST 230

Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +  +  LKK+   R+      P        ++ K+I+      +D +  KRP
Sbjct: 231 GMERVNILKKL---RSVSIEFPPDFD-DNKMKVEKKII---RLLIDHDPNKRP 276

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 6e-35
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 19/223 (8%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            KV+G G +G VY GL     +     VA+K L          E   E   +  V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            RLLG C   +   L+ + +  G L  ++               +N  +  AKG++YL +
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEY 254
               ++VHRD+ + N+L+    + K++DFGLAKLLG+E         G      ++A E 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
               +   +SDV+S+G+ + E+++ G  P D     E  +++E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (328), Expect = 6e-35
 Identities = 75/308 (24%), Positives = 126/308 (40%), Gaps = 48/308 (15%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNL-LNNRGQAER-EF 122
             L ++ +  N     K++GEG +G V  G L+     + KVAVK + L+N  Q E  EF
Sbjct: 24  NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF 83

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWL--HGDVGPCSP 175
             E   +    H N++RLLG C E         M++  ++  G+L  +L           
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           +  +  +  ++  A G+ YL        +HRD+ + N ++       V+DFGL+K + S 
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200

Query: 236 SSYITTRV-------MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-S 286
             Y   R+       +      A E  +  +   +SDV++FG+ + E+ + G  P  Y  
Sbjct: 201 DYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPG 252

Query: 287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
               E+   ++L      + PE  LD           L  I+     C   +   RP   
Sbjct: 253 VQNHEM--YDYLLHGHRLKQPEDCLDE----------LYEIM---YSCWRTDPLDRPTFS 297

Query: 347 HVVHMLEA 354
            +   LE 
Sbjct: 298 VLRLQLEK 305

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (327), Expect = 9e-35
 Identities = 68/305 (22%), Positives = 120/305 (39%), Gaps = 37/305 (12%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
             + +    +   + +GEGG+  V     L D    A+K +L +  Q   E + E +   
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 131 RVRHKNLVRLLGYCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNII 185
              H N++RL+ YC           L+  +   G L   +       + LT  +I + ++
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLL 140

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM- 244
           LG  +GL  +H        HRD+K +NIL+     P + D G               +  
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 245 -------GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
                   T  Y APE     S  +++ER+DV+S G ++  ++ G  P D      +   
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-- 255

Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPT-SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
              +   V N+         +P+ P  S  L ++L      +  +  +RP +  ++  LE
Sbjct: 256 ---VALAVQNQ-------LSIPQSPRHSSALWQLL---NSMMTVDPHQRPHIPLLLSQLE 302

Query: 354 AQESP 358
           A + P
Sbjct: 303 ALQPP 307

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  130 bits (329), Expect = 2e-34
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 38/294 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           ++VIG G +G VY+G L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 139 RLLGYCAEGAH-RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ +L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV-----AP 252
               K VHRD+ + N ++D+ +  KV+DFGLA+ +  +  + +     T   +     A 
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMAL 265

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGV 310
           E   T     +SDV+SFG+L+ E+++ G  P  Y      ++    +L +          
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDI--TVYLLQ-------GRR 314

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
           L    PE     L +    V L+C  P A+ RP    +V  + A  S    + Y
Sbjct: 315 LLQ--PEYCPDPLYE----VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (328), Expect = 2e-34
 Identities = 58/262 (22%), Positives = 115/262 (43%), Gaps = 25/262 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREF-KVEVEAIGRVRHKNLVRLL 141
           + IGEG +G        ED  +  +K + ++     ERE  + EV  +  ++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
               E     +V +Y   G+L + ++   G       +  ++  +     L ++H+    
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---R 144

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           K++HRDIKS NI + K    ++ DFG+A++L S        + GT  Y++PE       N
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYN 203

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
            +SD+++ G ++ E+ +        +   E   ++ L   + + +      P +     S
Sbjct: 204 NKSDIWALGCVLYELCTL-------KHAFEAGSMKNLVLKIISGSF-----PPVSLH-YS 250

Query: 322 RLLKRILLVALRCVDPNAQKRP 343
             L+ ++    +    N + RP
Sbjct: 251 YDLRSLV---SQLFKRNPRDRP 269

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (323), Expect = 3e-34
 Identities = 56/267 (20%), Positives = 106/267 (39%), Gaps = 51/267 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + +G GG+G+V+      D+   A+K + L NR  A  +   EV+A+ ++ H  +VR   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 143 YCAEGAHRM------------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
              E                 +  +     NL+ W++G           + ++I L  A+
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAE 129

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM------ 244
            + +LH      ++HRD+K SNI        KV DFGL   +  +    T          
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 245 -----GTFGYVAPEYASTGMLNERSDVYSFGILIME-----------------VISGRIP 282
                GT  Y++PE       + + D++S G+++ E                 V + + P
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFP 246

Query: 283 VDYSR-PPEEVNLIEWLKKMVTNRNPE 308
             +++  P E  +++ +     + +P 
Sbjct: 247 PLFTQKYPCEYVMVQDM----LSPSPM 269

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (323), Expect = 4e-34
 Identities = 59/307 (19%), Positives = 123/307 (40%), Gaps = 45/307 (14%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS----KVAVKNL-LNNRGQAERE-F 122
             L ++ +    F+  +++G+G +G V    L+       KVAVK L  +    ++ E F
Sbjct: 13  EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEG------AHRMLVYEYVNNGNLEQWL--HGDVGPCS 174
             E   +    H ++ +L+G              M++  ++ +G+L  +L          
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            L  +  +  ++  A G+ YL        +HRD+ + N ++ +     V+DFGL++ + S
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

Query: 235 ESSYITTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SR 287
              Y      G    +     A E  +  +    SDV++FG+ + E+++ G+ P  Y   
Sbjct: 190 GDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGI 243

Query: 288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH 347
              E+    +L      + P   ++           +  ++    +C   + ++RP    
Sbjct: 244 ENAEI--YNYLIGGNRLKQPPECMEE----------VYDLM---YQCWSADPKQRPSFTC 288

Query: 348 VVHMLEA 354
           +   LE 
Sbjct: 289 LRMELEN 295

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 4e-34
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           + +GEG +G V     +  +      VAVK L  + G   R  +K E++ +  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 139 RLLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G C +       LV EYV  G+L  +L       + L     +       +G++YLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEY 254
                  +HRD+ + N+L+D     K+ DFGLAK +     Y   R  G     + APE 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 255 ASTGMLNERSDVYSFGILIMEVIS 278
                    SDV+SFG+ + E+++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (321), Expect = 4e-34
 Identities = 67/300 (22%), Positives = 123/300 (41%), Gaps = 50/300 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           ++IG GG+G V+      D     +K +  N  +AERE    V+A+ ++ H N+V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72

Query: 144 CAEGAHRM----------------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
                +                  +  E+ + G LEQW+    G    L   + + +   
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQ 130

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
             KG+ Y+H     K+++RD+K SNI +      K+ DFGL   L ++     TR  GT 
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTL 185

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE  S+    +  D+Y+ G+++ E++            E       L+        
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRD------- 233

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV-HMLEAQESPSKEDRYRA 366
                  + +    +  K +L    + +    + RP    ++  +   ++SP K +R+ A
Sbjct: 234 -----GIISDI-FDKKEKTLL---QKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTA 284

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (320), Expect = 5e-34
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 13/205 (6%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS----KVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           ++++GEG +G VY G+  ++      VAVK    +     + +F  E   +  + H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +L+G   E     ++ E    G L  +L  +      LT    +   L   K ++YL   
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES- 131

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
                VHRDI   NIL+      K+ DFGL++ +  E  Y  +       +++PE  +  
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 259 MLNERSDVYSFGILIMEVIS-GRIP 282
                SDV+ F + + E++S G+ P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (334), Expect = 6e-34
 Identities = 56/267 (20%), Positives = 99/267 (37%), Gaps = 49/267 (18%)

Query: 86  VIGEGGYGIVYYG--LLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLG 142
            I  GG G +Y       +   V +K L+++     +     E + +  V H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 143 YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +             +V EYV   +L++           L     +  +L     LSYLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS 200

Query: 198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
            GL    V+ D+K  NI++ +    K+ D G    + S        + GT G+ APE   
Sbjct: 201 IGL----VYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR 250

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
           TG     +D+Y+ G  +  +       +  R  + +              PE     K  
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLPTRN-GRYVDGL--------------PEDDPVLKTY 294

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRP 343
           +        R+L    R +DP+ ++R 
Sbjct: 295 DS-----YGRLL---RRAIDPDPRQRF 313

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (320), Expect = 6e-34
 Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 84  DKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK 135
           ++ +G+G +  ++ G+            ++V +K L          F      + ++ HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           +LV   G C  G   +LV E+V  G+L+ +L  +   C  + W++ +      A  + +L
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEV--AKQLAAAMHFL 129

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNP--------KVSDFGLAKLLGSESSYITTRVMGTF 247
               E  ++H ++ + NIL+ +  +         K+SD G++  +      +  R+    
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184

Query: 248 GYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRIP 282
               PE       LN  +D +SFG  + E+ S G  P
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (317), Expect = 1e-33
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 13/220 (5%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNL-LNNRGQAEREFK 123
            + R+ E+        + IGEG +G V+ G+          VA+K            +F 
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            E   + +  H ++V+L+G         ++ E    G L  +L          +    + 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LIL 120

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                +  L+YL      + VHRDI + N+L+  +   K+ DFGL++ +   + Y  ++ 
Sbjct: 121 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
                ++APE  +       SDV+ FG+ + E++  G  P
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (320), Expect = 1e-33
 Identities = 75/323 (23%), Positives = 138/323 (42%), Gaps = 57/323 (17%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAER-EFK 123
           + E   +  +  K +GEG +G V             ++   VAVK L ++  + +  +  
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88

Query: 124 VEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDV 170
            E+E +  + +HKN++ LLG C +     ++ EY + GNL ++L              + 
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148

Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK 230
            P   +T++  ++     A+G+ YL      K +HRD+ + N+L+ ++   K++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

Query: 231 LLGSESSYITTRV-------MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            + +   Y  T         M      APE     +   +SDV+SFG+L+ E+ + G  P
Sbjct: 206 DINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 283 VDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y   P EE+   + LK+      P    +           L  ++     C      +
Sbjct: 260 --YPGIPVEEL--FKLLKEGHRMDKPANCTNE----------LYMMM---RDCWHAVPSQ 302

Query: 342 RPKMGHVVHMLEAQESPSKEDRY 364
           RP    +V  L+   + +  + Y
Sbjct: 303 RPTFKQLVEDLDRILTLTTNEEY 325

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (315), Expect = 3e-33
 Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 24/266 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLL 141
             IG G YG         D   +  K L   +  +AE++  V EV  +  ++H N+VR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 142 GYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-- 197
               +  +  L  V EY   G+L   +         L  E  + ++      L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                V+HRD+K +N+ +D   N K+ DFGLA++L  ++S+  T V GT  Y++PE  + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
              NE+SD++S G L+ E+ +         PP      + L   +           ++P 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCAL-------MPPFTAFSQKELAGKIREGKF-----RRIPY 238

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRP 343
           +  S  L  I+    R ++     RP
Sbjct: 239 R-YSDELNEII---TRMLNLKDYHRP 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 3e-33
 Identities = 76/263 (28%), Positives = 121/263 (46%), Gaps = 23/263 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
            V+G+G YGIVY G  L +  ++A+K +     +  +    E+     ++HKN+V+ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
            +E     +  E V  G+L   L    GP       I         +GL YLH+    ++
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDN---QI 143

Query: 204 VHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--YASTGML 260
           VHRDIK  N+LI+ +    K+SDFG +K L   +    T   GT  Y+APE         
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
            + +D++S G  I+E+ +G+ P  +        L E    M   +     + P++PE   
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMF--KVGMFKVHPEIPES-M 251

Query: 321 SRLLKRILLVALRCVDPNAQKRP 343
           S   K  +   L+C +P+  KR 
Sbjct: 252 SAEAKAFI---LKCFEPDPDKRA 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (327), Expect = 5e-33
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 13/220 (5%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK----VAVKNL-LNNRGQAEREFK 123
            + R+ E+        + IGEG +G V+ G+          VA+K            +F 
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL 439

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            E   + +  H ++V+L+G   E     ++ E    G L  +L          +    + 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLAS---LIL 495

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                +  L+YL      + VHRDI + N+L+  +   K+ DFGL++ +   + Y  ++ 
Sbjct: 496 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
                ++APE  +       SDV+ FG+ + E++  G  P
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (315), Expect = 6e-33
 Identities = 76/329 (23%), Positives = 124/329 (37%), Gaps = 64/329 (19%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-E 121
           Y   + E   +     K +G G +G V                VAVK L      +E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76

Query: 122 FKVEVEAIGRV-RHKNLVRLLGYC-AEGAHRMLVYEYVNNGNLEQWL------------H 167
              E++ +  +  H N+V LLG C   G   M++ E+   GNL  +L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 168 GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
            +      LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 193

Query: 228 LAKLLGSESSYITT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           LA+ +  +  Y+         + M      APE     +   +SDV+SFG+L+ E+ S G
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247

Query: 280 RIPVDYSRPPEEVNLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRC 334
             P  Y     +      LK+   M                 P   +  + + +   L C
Sbjct: 248 ASP--YPGVKIDEEFCRRLKEGTRM---------------RAPDYTTPEMYQTM---LDC 287

Query: 335 VDPNAQKRPKMGHVVHMLEAQ-ESPSKED 362
                 +RP    +V  L    ++ +++D
Sbjct: 288 WHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 1e-32
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 72/311 (23%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKN 136
            K +GEG +G V              + VAVK L  N   +E  +   E   + +V H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--------------------HGDVGPCSPL 176
           +++L G C++    +L+ EY   G+L  +L                      D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           T    ++     ++G+ YL    E K+VHRD+ + NIL+ +    K+SDFGL++ +  E 
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 237 SYITT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SR 287
           SY+         + M      A E     +   +SDV+SFG+L+ E+++ G  P  Y   
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGI 256

Query: 288 PPEEVNLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKR 342
           PPE +     LK    M               E+P   S  + R++   L+C      KR
Sbjct: 257 PPERL--FNLLKTGHRM---------------ERPDNCSEEMYRLM---LQCWKQEPDKR 296

Query: 343 PKMGHVVHMLE 353
           P    +   LE
Sbjct: 297 PVFADISKDLE 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (315), Expect = 1e-32
 Identities = 74/327 (22%), Positives = 136/327 (41%), Gaps = 57/327 (17%)

Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL--------EDNSKVAVK 109
           P ++ +         + E   +  +  K +GEG +G V             ++   VAVK
Sbjct: 60  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 119

Query: 110 NLLNNRGQAER-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
            L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL     
Sbjct: 120 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 179

Query: 163 -------EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
                  E     +  P   +T++  ++     A+G+ YL      K +HRD+ + N+L+
Sbjct: 180 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236

Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRV-------MGTFGYVAPEYASTGMLNERSDVYS 268
            ++   K++DFGLA+ + +   Y  T         M      APE     +   +SDV+S
Sbjct: 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWS 290

Query: 269 FGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           FG+L+ E+ + G  P  Y   P EE+   + LK+      P    +              
Sbjct: 291 FGVLMWEIFTLGGSP--YPGIPVEEL--FKLLKEGHRMDKPANCTN-------------E 333

Query: 327 ILLVALRCVDPNAQKRPKMGHVVHMLE 353
           + ++   C      +RP    +V  L+
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLD 360

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (312), Expect = 3e-32
 Identities = 79/321 (24%), Positives = 135/321 (42%), Gaps = 69/321 (21%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHK 135
            KV+G G +G V             + +VAVK L      +ER     E++ + ++  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-------------------HGDVGPCSPL 176
           N+V LLG C       L++EY   G+L  +L                     +    + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           T+E  +      AKG+ +L        VHRD+ + N+L+      K+ DFGLA+ + S+S
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 237 SYITT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP 288
           +Y+         + M      APE    G+   +SDV+S+GIL+ E+ S G  P  Y   
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGI 278

Query: 289 PEEVNLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRP 343
           P + N  + ++    M               ++P   +  +  I+     C   +++KRP
Sbjct: 279 PVDANFYKLIQNGFKM---------------DQPFYATEEIYIIM---QSCWAFDSRKRP 320

Query: 344 KMGHVVHMLEAQESPSKEDRY 364
              ++   L  Q + ++E  Y
Sbjct: 321 SFPNLTSFLGCQLADAEEAMY 341

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  121 bits (307), Expect = 6e-32
 Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 64/313 (20%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHK 135
            K +G G +G V           +    VAVK L  +    ER     E++ +  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--------------HGDVGPCSPLTWEIR 181
           N+V LLG C  G   +++ EY   G+L  +L                       L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           ++     AKG+++L        +HRD+ + NIL+      K+ DFGLA+ + ++S+Y+  
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 242 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVN 293
                  + M      APE     +    SDV+S+GI + E+ S G  P  Y   P +  
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMPVDSK 256

Query: 294 LIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRPKMGHV 348
             + +K+   M                 P      +  I+     C D +  KRP    +
Sbjct: 257 FYKMIKEGFRM---------------LSPEHAPAEMYDIM---KTCWDADPLKRPTFKQI 298

Query: 349 VHMLEAQESPSKE 361
           V ++E Q S S  
Sbjct: 299 VQLIEKQISESTN 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (308), Expect = 7e-32
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 84  DKVIGEGGYGIVYYGLL---EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHKNLV 138
             VIGEG +G V    +         A+K +     + +  +F  E+E + ++  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIRMNIIL 186
            LLG C    +  L  EY  +GNL  +L                   S L+ +  ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             A+G+ YL    + + +HRD+ + NIL+ +++  K++DFGL++           + MG 
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 247 F--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
               ++A E  +  +    SDV+S+G+L+ E++S G  P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (309), Expect = 7e-32
 Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 58/318 (18%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFK 123
           L  LE   N     + IGEG +G V+          E  + VAVK L        + +F+
Sbjct: 39  LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----------------- 166
            E   +    + N+V+LLG CA G    L++EY+  G+L ++L                 
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 167 ---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                      PL+   ++ I    A G++YL E    K VHRD+ + N L+ ++   K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215

Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS 278
           +DFGL++ + S   Y           +      PE          SDV+++G+++ E+ S
Sbjct: 216 ADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

Query: 279 -GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD 336
            G  P  Y     EEV         V +     +L    PE      L  ++     C  
Sbjct: 272 YGLQP--YYGMAHEEV------IYYVRDG---NILAC--PEN-CPLELYNLM---RLCWS 314

Query: 337 PNAQKRPKMGHVVHMLEA 354
                RP    +  +L+ 
Sbjct: 315 KLPADRPSFCSIHRILQR 332

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (305), Expect = 1e-31
 Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 45/277 (16%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+GG+   +     +     A K    +LL    Q E+   +E+     + H+++V 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 79

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT-WEIRMNIILGTAKGLSYLH 196
             G+  +     +V E     +L +             LT  E R   +     G  YLH
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEAR-YYLRQIVLGCQYLH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                +V+HRD+K  N+ +++    K+ DFGLA  +  +       + GT  Y+APE  S
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 188

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKL 315
               +   DV+S G ++  ++ G       +PP E   L E   ++  N       +  +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKN-------EYSI 234

Query: 316 PE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           P+      + L++++L         +   RP +  ++
Sbjct: 235 PKHINPVAASLIQKML-------QTDPTARPTINELL 264

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (306), Expect = 2e-31
 Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 62/312 (19%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHK 135
            K +G G +G V           +   KVAVK L +     E+     E++ +  + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----------HGDVGPCSPLTWEIRMNII 185
           N+V LLG C  G   +++ EY   G+L  +L                 S  +    ++  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT---- 241
              A+G+++L        +HRD+ + N+L+      K+ DFGLA+ + ++S+YI      
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 242 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
              + M      APE     +   +SDV+S+GIL+ E+ S G  P  Y          + 
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGILVNSKFYKL 279

Query: 298 LKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
           +K    M                +P    + +  I+     C       RP    +   L
Sbjct: 280 VKDGYQM---------------AQPAFAPKNIYSIM---QACWALEPTHRPTFQQICSFL 321

Query: 353 EA--QESPSKED 362
           +   QE   + D
Sbjct: 322 QEQAQEDRRERD 333

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 2e-31
 Identities = 80/338 (23%), Positives = 142/338 (42%), Gaps = 69/338 (20%)

Query: 84  DKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-R 133
            K +GEG +G V                +KVAVK L ++  + +  +   E+E +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIR 181
           HKN++ LLG C +     ++ EY + GNL ++L            +    P   L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 242 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEV 292
                  + M      APE     +   +SDV+SFG+L+ E+ + G  P  Y   P EE+
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEEL 302

Query: 293 NLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRPKMGH 347
              + LK+   M               +KP+  +  L  ++     C      +RP    
Sbjct: 303 --FKLLKEGHRM---------------DKPSNCTNELYMMM---RDCWHAVPSQRPTFKQ 342

Query: 348 VVHMLEA--QESPSKEDRYRASPKNELIEKQVTESGDN 383
           +V  L+     + ++E  Y     +   +   TE+   
Sbjct: 343 LVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYF 380

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  119 bits (300), Expect = 4e-31
 Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 43/271 (15%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G VY     +    +A+K L    L   G   +  + EVE    +RH N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L GY  +     L+ EY   G + + L       S    +     I   A  LSY H   
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS-- 127

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTG 258
             +V+HRDIK  N+L+      K++DFG +    S         + GT  Y+ PE     
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGR 182

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
           M +E+ D++S G+L  E + G       +PP E     E  K++         ++   P+
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISR-------VEFTFPD 228

Query: 318 KPTS---RLLKRILLVALRCVDPNAQKRPKM 345
             T     L+ R+L         N  +RP +
Sbjct: 229 FVTEGARDLISRLL-------KHNPSQRPML 252

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (298), Expect = 6e-31
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 38/273 (13%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
            ++G+G +  VY    +    +VA+K      +   G  +R  + EV+   +++H +++ 
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILE 75

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  Y  +  +  LV E  +NG + ++L   V P S    E R + +     G+ YLH   
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE--NEAR-HFMHQIITGMLYLHS-- 130

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              ++HRD+  SN+L+ ++ N K++DFGLA  L        T + GT  Y++PE A+   
Sbjct: 131 -HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKLPE- 317
               SDV+S G +   ++ G       RPP +   +   L K+V         D ++P  
Sbjct: 189 HGLESDVWSLGCMFYTLLIG-------RPPFDTDTVKNTLNKVVLA-------DYEMPSF 234

Query: 318 --KPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
                  L+ ++L         N   R  +  V
Sbjct: 235 LSIEAKDLIHQLL-------RRNPADRLSLSSV 260

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (301), Expect = 8e-31
 Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 45/277 (16%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+GG+   +     +     A K    +LL    Q E+   +E+     + H+++V 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 105

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT-WEIRMNIILGTAKGLSYLH 196
             G+  +     +V E     +L +             LT  E R   +     G  YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEAR-YYLRQIVLGCQYLH 158

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                +V+HRD+K  N+ +++    K+ DFGLA  +  +       + GT  Y+APE  S
Sbjct: 159 R---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 214

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKL 315
               +   DV+S G ++  ++ G       +PP E   L E   ++  N       +  +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKN-------EYSI 260

Query: 316 PE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           P+      + L++++L         +   RP +  ++
Sbjct: 261 PKHINPVAASLIQKML-------QTDPTARPTINELL 290

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (296), Expect = 1e-30
 Identities = 59/292 (20%), Positives = 107/292 (36%), Gaps = 61/292 (20%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRV-RHKN 136
           F + + IG G +G V+  +   D    A+K       G  + +  + EV A   + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNP-------------------KVSDFGLAKLLGSESS 237
                 +VH DIK SNI I +   P                   K+ D G    + S   
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 238 YITTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEE 291
                  G   ++A E     +L E       +D+++  + ++              P  
Sbjct: 190 EE-----GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE------PLPRN 233

Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +      ++   R P       +P+   S+    +L      + P+ ++RP
Sbjct: 234 GDQW---HEIRQGRLPR------IPQV-LSQEFTELL---KVMIHPDPERRP 272

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (299), Expect = 2e-30
 Identities = 35/294 (11%), Positives = 70/294 (23%), Gaps = 49/294 (16%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVR 139
            + +  G   +V+    +E     A+K       N             A  R+  ++   
Sbjct: 67  VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 140 LLGYCAEGA--------------------------HRMLVYEYV--NNGNLEQWLHGDVG 171
                                              + +L+      +   L   L     
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                       +     +  + L       +VH      N+ I       + D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 232 LGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP 289
           +G+              Y   E+  AST       + +  G+ I  V    +P     P 
Sbjct: 244 VGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + +      ++    +        LP+     L+ R L       D   ++R 
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPD-FVKTLIGRFL-----NFDR--RRRL 345

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (300), Expect = 4e-30
 Identities = 69/279 (24%), Positives = 109/279 (39%), Gaps = 34/279 (12%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F    V+G G  G + Y  + DN  VAVK +L      A+RE ++  E+     H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIR 82

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
                 +   + +  E      L++++               + ++  T  GL++LH   
Sbjct: 83  YFCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 200 EPKVVHRDIKSSNILI-----DKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAP 252
              +VHRD+K  NILI            +SDFGL K L       + R  V GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 253 EY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
           E              D++S G +   VIS            + N+               
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----------LLGAC 245

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
            LD   PEK    + + ++    + +  + QKRP   HV
Sbjct: 246 SLDCLHPEKHEDVIARELI---EKMIAMDPQKRPSAKHV 281

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (293), Expect = 6e-30
 Identities = 69/272 (25%), Positives = 105/272 (38%), Gaps = 42/272 (15%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRV-RHKN 136
           F     +G G YG V+     ED    AVK      RG  +R  K+ EV +  +V +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            VRL     EG    L  E     +L+Q         + L        +  T   L++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLH 174

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--- 253
                 +VH D+K +NI +      K+ DFGL   LG+  +       G   Y+APE   
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ 229

Query: 254 --YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
             Y         +DV+S G+ I+EV            P      + L++        G L
Sbjct: 230 GSY------GTAADVFSLGLTILEVACNM------ELPHGGEGWQQLRQ--------GYL 269

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            P+      S  L+ +L   +  ++P+ + R 
Sbjct: 270 PPEFTAG-LSSELRSVL---VMMLEPDPKLRA 297

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  115 bits (289), Expect = 2e-29
 Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 26/252 (10%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
             ++G+G    V+ G   +     A+K  N ++     + + + E E + ++ HKN+V+L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKL 72

Query: 141 LGY--CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                     H++L+ E+   G+L   L  +      L     + ++     G+++L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 199 LEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
               +VHR+IK  NI+     D     K++DFG A+ L  +     +   GT  Y+ P+ 
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDM 186

Query: 255 ASTGML--------NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
               +L            D++S G+      +G +P      P      E + K++T + 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKP 244

Query: 307 PEGVLDPKLPEK 318
              +   +  E 
Sbjct: 245 SGAISGVQKAEN 256

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (291), Expect = 2e-29
 Identities = 66/340 (19%), Positives = 132/340 (38%), Gaps = 43/340 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--VRL 140
           K IG GG   V+  L E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 75  YDYEITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-- 127

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPE----- 253
             +VH D+K +N LI      K+ DFG+A  +   + S    ++V GT  Y+ PE     
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDM 184

Query: 254 ------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
                   S   ++ +SDV+S G ++  +  G+ P       + +N I  L  ++   + 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHE 239

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH--MLEAQESPSKEDRYR 365
                 + P+ P  + L+ +L     C+  + ++R  +  ++    ++ Q  P  +    
Sbjct: 240 -----IEFPDIP-EKDLQDVL---KCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

Query: 366 ASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKE 405
            + + + +  Q+      ++      T    +   E    
Sbjct: 291 TTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (288), Expect = 3e-29
 Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 45/278 (16%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--VRL 140
           K IG GG   V+  L E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-- 146

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-VMGTFGYVAPE------ 253
             +VH D+K +N LI      K+ DFG+A  +  +++ +     +GT  Y+ PE      
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
                  S   ++ +SDV+S G ++  +  G+ P       + +N I  L  ++   +  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHE- 258

Query: 309 GVLDPKLPEKPTS---RLLKRILLVALRCVDPNAQKRP 343
                + P+ P      +LK  L       DP   +R 
Sbjct: 259 ----IEFPDIPEKDLQDVLKCCL-----KRDPK--QRI 285

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 3e-29
 Identities = 64/358 (17%), Positives = 125/358 (34%), Gaps = 46/358 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
             ++G+G    V+ G   +     A+K  N ++     + + + E E + ++ HKN+V+L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKL 72

Query: 141 LGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                E   R   L+ E+   G+L   L  +      L     + ++     G+++L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 199 LEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
               +VHR+IK  NI+     D     K++DFG A+ L  +     +   GT  Y+ P+ 
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDM 186

Query: 255 ASTGML--------NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
               +L            D++S G+      +G +P      P      E + K++T + 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKP 244

Query: 307 PEGVLDPKLPEKPT-------------SRLLKRI---LLVALRCVDPNAQKRPKMGHVVH 350
              +   +  E                SR L+ +   +L  +   D   +K         
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--EKCWGFDQFFA 302

Query: 351 MLEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNETGVHT-NETRWQHQEFQKEKH 407
                          +  +    +  +      +     V+   +    +QE   E  
Sbjct: 303 ETSDILH-RMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGR 359

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  116 bits (291), Expect = 3e-28
 Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 36/286 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLL 141
            + +G GG+G V   +  +   +VA+K          RE + +E++ + ++ H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 142 ------GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT-WEIR--MNIILGTAKGL 192
                    A     +L  EY   G+L ++L+     C  L    IR  ++ I      L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SAL 134

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYITTRVMGTFGY 249
            YLHE    +++HRD+K  NI++         K+ D G AK L  +    T  V GT  Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQY 189

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI----------EWLK 299
           +APE           D +SFG L  E I+G  P   +  P + +             +  
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                +    +  P       +  L+R L   L       ++R   
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM-WHQ--RQRGTD 292

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (283), Expect = 3e-28
 Identities = 56/296 (18%), Positives = 109/296 (36%), Gaps = 56/296 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK-----------------NLLNNRGQAEREFKVEVE 127
           + + +G +  +     +DN   A+K                 N   +      +FK E++
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----HGDVGPCSPLTWEIRMN 183
            I  ++++  +   G         ++YEY+ N ++ ++       D      +  ++   
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II       SY+H      + HRD+K SNIL+DK+   K+SDFG ++        I    
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-S 210

Query: 244 MGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            GT+ ++ PE+ S        + D++S GI +  +    +P        +++L+E    +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFNNI 265

Query: 302 V-------TNRNPEGVLDPKLPEKPTSR--------LLKRILLVALRCVDPNAQKR 342
                    +RN             ++          LK  L         N  +R
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL-------RKNPAER 314

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (279), Expect = 4e-28
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 41/267 (15%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G VY     ++   +A+K L    L   G   +  + E+E    +RH N++R
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILR 78

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           +  Y  +     L+ E+   G L + L            +     +   A  L Y HE  
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE-- 132

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             KV+HRDIK  N+L+      K++DFG +    + S    T + GT  Y+ PE      
Sbjct: 133 -RKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT-MCGTLDYLPPEMIEGKT 188

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
            +E+ D++  G+L  E + G        PP +  +  E  +++V        +D K P  
Sbjct: 189 HDEKVDLWCAGVLCYEFLVG-------MPPFDSPSHTETHRRIVN-------VDLKFPPF 234

Query: 319 PTS---RLLKRILLVALRCVDPNAQKR 342
            +     L+ ++L         +  +R
Sbjct: 235 LSDGSKDLISKLL-------RYHPPQR 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (284), Expect = 4e-28
 Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 39/275 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--VRL 140
           K IG GG   V+  L E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             Y     +  +V E   N +L  WL        P  WE + +      + +  +H+   
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDP--WERK-SYWKNMLEAVHTIHQH-- 174

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-VMGTFGYVAPE------ 253
             +VH D+K +N LI      K+ DFG+A  +  +++ +     +G   Y+ PE      
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
                  S   ++ +SDV+S G ++  +  G+ P       + +N I  L  ++   +  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHE- 286

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                + P+ P  + L+ +L     C+  + ++R 
Sbjct: 287 ----IEFPDIP-EKDLQDVL---KCCLKRDPKQRI 313

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 4e-28
 Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 57/295 (19%)

Query: 45  SGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDN 103
            GG SG   +  V +   LG      +R            +V+ EGG+  VY    +   
Sbjct: 7   LGGASGRDQSDFVGQTVELG-ELRLRVR------------RVLAEGGFAFVYEAQDVGSG 53

Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM-------LVYE 155
            + A+K LL+N  +  R    EV  + ++  H N+V+     + G           L+  
Sbjct: 54  REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113

Query: 156 YVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
            +  G L ++L   +    PL+   +   I   T + + ++H   +P ++HRD+K  N+L
Sbjct: 114 ELCKGQLVEFLK-KMESRGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLL 170

Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVM-----------GTFGYVAPE---YASTGML 260
           +      K+ DFG A  +     Y  +               T  Y  PE     S   +
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230

Query: 261 NERSDVYSFGIL---------------IMEVISG--RIPVDYSRPPEEVNLIEWL 298
            E+ D+++ G +                + +++G   IP   ++     +LI  +
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAM 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  111 bits (280), Expect = 7e-28
 Identities = 52/283 (18%), Positives = 104/283 (36%), Gaps = 44/283 (15%)

Query: 67  HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVE 125
           HW T +              +G G +G V+     +   + AVK +     + E     E
Sbjct: 58  HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           + A   +    +V L G   EG    +  E +  G+L Q +         L  +  +  +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYL 156

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTR-- 242
               +GL YLH     +++H D+K+ N+L+    +   + DFG A  L  +    +    
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 243 --VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
             + GT  ++APE       + + D++S   +++ +++G        P  +        K
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLK 267

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
           + +   P      ++P    + L  + +      +      R 
Sbjct: 268 IASEPPPI----REIPPS-CAPLTAQAI---QEGLRKEPVHRA 302

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (273), Expect = 3e-27
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           ++  + IG+G  G VY  + +    +VA++ +   +   +     E+  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
            L     G    +V EY+  G+L      DV   + +  E ++  +     + L +LH  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMD-EGQIAAVCRECLQALEFLHSN 135

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              +V+HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +  
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
               + D++S GI+ +E+I G  P  Y    P        L  + TN        P+L  
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRA-----LYLIATN-GT-----PELQN 238

Query: 318 KPT-SRLLKRILLVALRCVDPNAQKRP 343
               S + +  L   L  +D   +KR 
Sbjct: 239 PEKLSAIFRDFLNRCL-EMDV--EKRG 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 3e-27
 Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 30/267 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
                 IGEG  GIV          +VAVK +   + Q       EV  +   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
           +      G    ++ E++  G L      D+     L  E ++  +     + L+YLH  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLN-EEQIATVCEAVLQALAYLHA- 159

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               V+HRDIKS +IL+      K+SDFG    +  +     + V GT  ++APE  S  
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
           +     D++S GI+++E++ G  P  Y    P +      +K++  +  P     PKL  
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP--YFSDSPVQA-----MKRLRDS-PP-----PKLKN 263

Query: 318 KPT-SRLLKRILLVALRCVDPNAQKRP 343
               S +L+  L   L   DP  Q+R 
Sbjct: 264 SHKVSPVLRDFLERML-VRDP--QERA 287

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 5e-27
 Identities = 40/302 (13%), Positives = 79/302 (26%), Gaps = 64/302 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVR--- 133
                V+G+            E      V            A ++ K EV  +  +R   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 134 ----------------------HKNLVRLLGYCAEGAHRMLV----YEYVNNGNLEQWLH 167
                                  K ++R+     +               N     + L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 168 GDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                   L    R+ + L   + L+ LH  G    +VH  ++  +I++D+     ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 227 GLAKLLGSESSYITTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRI 281
                 G+ +     R        A            ++    D ++ G+ I  +    +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P             EW+ +              +P+ P   LL+  L           + 
Sbjct: 316 PNTDDAALG---GSEWIFR----------SCKNIPQ-PVRALLEGFL-------RYPKED 354

Query: 342 RP 343
           R 
Sbjct: 355 RL 356

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (271), Expect = 5e-27
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 26/278 (9%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGR 131
           +EV  +       +G G YG+V     +     +AVK +      Q ++   ++++   R
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 132 -VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
            V     V   G         +  E ++  +L+++    +     +  +I   I +   K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L +LH   +  V+HRD+K SN+LI+     K+ DFG++  L            G   Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYM 176

Query: 251 APE----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           APE      +    + +SD++S GI ++E+   R P  Y          + LK++V    
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP--Y---DSWGTPFQQLKQVVEE-- 229

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
                 P+LP    S         + +C+  N+++RP 
Sbjct: 230 ----PSPQLPADKFSAEFVD--FTS-QCLKKNSKERPT 260

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  110 bits (276), Expect = 9e-27
 Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 45/292 (15%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +K++G G  G V +        VAVK +L +    A  E K+  E+     H N++R   
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRYYC 76

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM-NIILGTAKGLSYLHEGL 199
                    +  E   N NL+  +           L  E    +++   A G+++LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132

Query: 200 EPKVVHRDIKSSNILID-------------KHWNPKVSDFGLAKLLGSESSYITTRVM-- 244
             K++HRD+K  NIL+              ++    +SDFGL K L S  S   T +   
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 245 -GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
            GT G+ APE         +   L    D++S G +   ++S        +   E N+  
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-- 250

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
            ++ + +    + + D  L  + T  L+ +++       DP   KRP    V
Sbjct: 251 -IRGIFSLDEMKCLHDRSLIAEATD-LISQMI-----DHDPL--KRPTAMKV 293

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 3e-26
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 29/266 (10%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           F+  + IG+G +G V+ G+       VA+K +     + E E  + E+  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +  G   +     ++ EY+  G+       D+    PL       I+    KGL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              K +HRDIK++N+L+ +H   K++DFG+A  L        T  +GT  ++APE     
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
             + ++D++S GI  +E+  G  P  +S   P +V        ++   NP     P L E
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP--HSELHPMKVLF------LIPKNNP-----PTL-E 240

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRP 343
              S+ LK  +   L   +P    RP
Sbjct: 241 GNYSKPLKEFVEACL-NKEP--SFRP 263

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  106 bits (266), Expect = 5e-26
 Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 28/283 (9%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAI 129
           +  + +     D   IG G YG V   +       +AVK + +   + E++   ++++ +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 130 GR-VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
            R      +V+  G         +  E ++    + + +        +  EI   I L T
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            K L++L E    K++HRDIK SNIL+D+  N K+ DFG++  L    S   TR  G   
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRP 190

Query: 249 YVAPE----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           Y+APE     AS    + RSDV+S GI + E+ +GR P        +          V  
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVK 244

Query: 305 RNPEGVLDPKLPEKPT---SRLLKRILLVALRCVDPNAQKRPK 344
            +P     P+L        S        V   C+  +  KRPK
Sbjct: 245 GDP-----PQLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (265), Expect = 6e-26
 Identities = 37/201 (18%), Positives = 77/201 (38%), Gaps = 46/201 (22%)

Query: 143 YCAEGAHRMLVY---EYVNNGNLEQWLHGDVGPCSP---LTWEIRMNIILGTAKGLSYLH 196
                + ++ +Y   +     NL+ W++           +   I + I       + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH 181

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-----------TRVMG 245
                 ++HRD+K SNI        KV DFGL   +  +    T           T  +G
Sbjct: 182 S---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGI-----------------LIMEVISGRIPVDYS-R 287
           T  Y++PE       + + D++S G+                 +I +V + + P+ ++ +
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQK 298

Query: 288 PPEEVNLIEWLKKMVTNRNPE 308
            P+E  +++ +     + +P 
Sbjct: 299 YPQEHMMVQDM----LSPSPT 315

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 4/103 (3%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + +G GG+G+V+      D+   A+K + L NR  A  +   EV+A+ ++ H  +VR   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR--Y 69

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           + A        ++   +    +    D    SP   +     I
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (265), Expect = 9e-26
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 11/252 (4%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREF-KVEVEAI 129
           +  E+  + F     +G G  G+V+    + +  V A K +      A R     E++ +
Sbjct: 26  KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
                  +V   G         +  E+++ G+L+Q L         +  +I   + +   
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           KGL+YL E  + K++HRD+K SNIL++     K+ DFG++  L    S   + V GT  Y
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSY 196

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
           ++PE       + +SD++S G+ ++E+  GR P+      E   +     +      P  
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 310 VLDPKLPEKPTS 321
              P  P     
Sbjct: 257 PRTPGRPLNKFG 268

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (264), Expect = 1e-25
 Identities = 42/303 (13%), Positives = 86/303 (28%), Gaps = 73/303 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVR------- 133
            V+G+            E      V            A ++ K EV  +  +R       
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 134 ------------------HKNLVRLLGYCAEGAHRMLVYEY----VNNGNLEQWLHGDVG 171
                              K ++R+     +       + Y     N     + L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
               L    R+ + L   + L+ LH      +VH  ++  +I++D+     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 232 LGSESSYITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGR 280
            G+           + G+  PE  +             ++    D ++ G++I  +    
Sbjct: 256 DGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +P+        +   EW+ +   N  P+ V            LL+  L           +
Sbjct: 311 LPIT---KDAALGGSEWIFRSCKNI-PQPVRA----------LLEGFL-------RYPKE 349

Query: 341 KRP 343
            R 
Sbjct: 350 DRL 352

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (261), Expect = 3e-25
 Identities = 34/239 (14%), Positives = 80/239 (33%), Gaps = 40/239 (16%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS------KVAVKNLLNNRGQAEREFKVE 125
            E ++ +       ++GEG +  VY     D +      K  +K     +     EF + 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114

Query: 126 VEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-HGDVGPCSPLTWEIR 181
            + + R++       ++           +LV E  + G L   +      P   +   + 
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-----------KVSDFGLAK 230
           ++  +     +  +H+    +++H DIK  N ++   +              + D G + 
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 231 LLGS--ESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            +    + +  T +   T G+   E     ML+ +      D +     +  ++ G   
Sbjct: 232 DMKLFPKGTIFTAKC-ETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 4e-25
 Identities = 69/287 (24%), Positives = 109/287 (37%), Gaps = 75/287 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + +GEG YG V   +       VAVK       ++     ++E    +     + H+N+V
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IIL 186
           +  G+  EG  + L  EY + G L   +                 M           ++ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA 116

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL--LGSESSYITTRVM 244
           G    + YLH      + HRDIK  N+L+D+  N K+SDFGLA +    +    +     
Sbjct: 117 G----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168

Query: 245 GTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  YVAPE     +L  R       DV+S GI++  +++G +P D     +  +  +  
Sbjct: 169 GTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEY 218

Query: 299 KKMVTN---RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
                     NP   +D          LL +IL         N   R
Sbjct: 219 SDWKEKKTYLNPWKKIDSAP-----LALLHKIL-------VENPSAR 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 5e-25
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F   + +GEG YG VY  +  E    VA+K +        +E   E+  + +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
             G   +     +V EY   G++   +       +    E  +  IL  T KGL YLH  
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT----EDEIATILQSTLKGLEYLHFM 144

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              + +HRDIK+ NIL++   + K++DFG+A  L    +   T + GT  ++APE     
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200

Query: 259 MLNERSDVYSFGILIMEVISGRIP 282
             N  +D++S GI  +E+  G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (256), Expect = 7e-25
 Identities = 42/209 (20%), Positives = 95/209 (45%), Gaps = 15/209 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +     +G+G +G VY     E  +  A K +     +   ++ VE+E +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
           LLG         ++ E+   G ++  +       +    E ++ ++     + L++LH  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHSK 136

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              +++HRD+K+ N+L+    + +++DFG++           +  +GT  ++APE     
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192

Query: 259 ML-----NERSDVYSFGILIMEVISGRIP 282
            +     + ++D++S GI ++E+     P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 2e-24
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 31/282 (10%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAERE-FKVEVEAI 129
           +  +   N   +   +G G  G V+         V AVK +  +  + E +   ++++ +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 130 GR-VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
            +      +V+  G         +  E +     +           P+   I   + +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ----GPIPERILGKMTVAI 133

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            K L YL E  +  V+HRD+K SNIL+D+    K+ DFG++  L         R  G   
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAA 189

Query: 249 YVAPE-----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           Y+APE       +    + R+DV+S GI ++E+ +G+ P    +   EV     L K++ 
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQ 244

Query: 304 NRNPEGVLDPKLPEKPT-SRLLKRILLVALRCVDPNAQKRPK 344
              P     P LP     S   +    V   C+  + +KRPK
Sbjct: 245 E-EP-----PLLPGHMGFSGDFQS--FVK-DCLTKDHRKRPK 277

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  101 bits (253), Expect = 3e-24
 Identities = 69/287 (24%), Positives = 109/287 (37%), Gaps = 75/287 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + +GEG YG V   +       VAVK       ++     ++E    +     + H+N+V
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IIL 186
           +  G+  EG  + L  EY + G L   +                 M           ++ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA 116

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL--LGSESSYITTRVM 244
           G    + YLH      + HRDIK  N+L+D+  N K+SDFGLA +    +    +     
Sbjct: 117 G----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168

Query: 245 GTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  YVAPE     +L  R       DV+S GI++  +++G +P D     +  +  +  
Sbjct: 169 GTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEY 218

Query: 299 KKMVTN---RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
                     NP   +D          LL +IL         N   R
Sbjct: 219 SDWKEKKTYLNPWKKIDSAP-----LALLHKIL-------VENPSAR 253

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 8e-24
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 37/277 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLV 138
           F   +++G G YG VY G  ++     A+K +++  G  E E K E+  + +   H+N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84

Query: 139 RLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
              G +  +    M     LV E+   G++   +       + L  E    I     +GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGL 142

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           S+LH+    KV+HRDIK  N+L+ ++   K+ DFG++  L        T  +GT  ++AP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198

Query: 253 E-----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRN 306
           E            + +SD++S GI  +E+  G        PP  +++ +  L  +  N  
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG-------APPLCDMHPMRALFLIPRN-P 250

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 P+L  K  S+  +  +   L   +    +RP
Sbjct: 251 A-----PRLKSKKWSKKFQSFIESCL-VKNH--SQRP 279

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 99.6 bits (249), Expect = 8e-24
 Identities = 66/275 (24%), Positives = 106/275 (38%), Gaps = 47/275 (17%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
            ++GEG YG V   L  E   + AVK      L      E   K E++ + R+RHKN+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 140 LLG--YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR---MNIILGTAKGLSY 194
           L+   Y  E     +V EY   G  E               +       +I G    L Y
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV--CQAHGYFCQLIDG----LEY 124

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAP 252
           LH      +VH+DIK  N+L+      K+S  G+A+ L   +      T   G+  +  P
Sbjct: 125 LHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180

Query: 253 EYASTGMLNE--RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           E A+        + D++S G+ +  + +G  P +        N+ +  + +         
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKLFENIGKG------ 228

Query: 311 LDPKLPE---KPTSRLLKRILLVALRCVDPNAQKR 342
               +P     P S LLK +L       +    KR
Sbjct: 229 -SYAIPGDCGPPLSDLLKGML-------EYEPAKR 255

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  100 bits (251), Expect = 1e-23
 Identities = 64/256 (25%), Positives = 114/256 (44%), Gaps = 41/256 (16%)

Query: 41  PGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL 100
           P NG      D    V+  ++  G     T  + E++   +++ KVIG G +G+V+   L
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIA---YTNCKVIGNGSFGVVFQAKL 61

Query: 101 EDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRM------LV 153
            ++ +VA+K +L      ++ FK  E++ +  V+H N+V L  +      +       LV
Sbjct: 62  VESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI 213
            EYV    + +           +   +    +    + L+Y+H      + HRDIK  N+
Sbjct: 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNL 172

Query: 214 LIDKHWNP-KVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERS----- 264
           L+D      K+ DFG AK+L +     SYI +R      Y APE     +    +     
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPEL----IFGATNYTTNI 223

Query: 265 DVYSFGILIMEVISGR 280
           D++S G ++ E++ G+
Sbjct: 224 DIWSTGCVMAELMQGQ 239

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 70/283 (24%), Positives = 127/283 (44%), Gaps = 39/283 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           +   +VIG G   +V          KVA+K +   + Q   +    E++A+ +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 139 RLLGYCAEGAHRMLVYEYVNNG---NLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSY 194
                        LV + ++ G   ++ + +       S +  E  +  IL    +GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF-G---YV 250
           LH+      +HRD+K+ NIL+ +  + +++DFG++  L +       +V  TF G   ++
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 251 APE-------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMV 302
           APE       Y      + ++D++SFGI  +E+ +G  P  Y + PP +V     L   +
Sbjct: 194 APEVMEQVRGY------DFKADIWSFGITAIELATGAAP--YHKYPPMKV-----LMLTL 240

Query: 303 TNRNP--EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            N  P  E  +  K   K   +  ++++ + L   DP  +KRP
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCL-QKDP--EKRP 280

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 78  TNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
            + F  +++ G+G +G V  G        VA+K ++ +     RE +  ++ +  + H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 137 LVRLLGY-CAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           +V+L  Y    G          +V EYV +  L +               +    +    
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSES---SYITTRVMG 245
           + +  LH      V HRDIK  N+L+++     K+ DFG AK L       +YI +R   
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196

Query: 246 TFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
              Y APE     +   +      D++S G +  E++ G 
Sbjct: 197 ---YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 99.2 bits (247), Expect = 3e-23
 Identities = 43/225 (19%), Positives = 73/225 (32%), Gaps = 18/225 (8%)

Query: 71  LRELEVSTNGFSDDKVIGEG--GYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVE 125
           +         +    VIG+G      V           V V+  NL     +     + E
Sbjct: 17  MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           +       H N+V             +V  ++  G+ +  +         +       I+
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYIL 134

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
            G  K L Y+H       VHR +K+S+ILI       +S       + S           
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 246 TFGYV------APEYASTGML--NERSDVYSFGILIMEVISGRIP 282
               V      +PE     +   + +SD+YS GI   E+ +G +P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.9 bits (244), Expect = 7e-23
 Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 38/272 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           FSD + IG G +G VY+   + ++  VA+K +  +  Q+  +++    EV  + ++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYL 195
            ++  G         LV EY   G+    L     P      E+ +  +  G  +GL+YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYL 170

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-- 253
           H      ++HRD+K+ NIL+ +    K+ DFG A ++   +S++     GT  ++APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222

Query: 254 -YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVL 311
                G  + + DV+S GI  +E+          +PP   +N +  L  +  N       
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER-------KPPLFNMNAMSALYHIAQN-ES---- 270

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            P L     S   +  +   L    P  Q RP
Sbjct: 271 -PALQSGHWSEYFRNFVDSCL-QKIP--QDRP 298

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLV 138
           ++D KVIG G +G+VY   L +    VA+K +L      ++ FK  E++ + ++ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110

Query: 139 RLLGYCAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           RL  +      +       LV +YV    + +           L        +    + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSES---SYITTRVMGTFG 248
           +Y+H      + HRDIK  N+L+D      K+ DFG AK L       SYI +R      
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 221

Query: 249 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           Y APE     +          DV+S G ++ E++ G+
Sbjct: 222 YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLV 138
             IGEG YG+V+     +    VA+K         +    K     E+  + +++H NLV
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNLV 65

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL          LV+EY ++  +   L             ++ +I   T + +++ H+ 
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH--LVK-SITWQTLQAVNFCHKH 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE----- 253
                +HRD+K  NILI KH   K+ DFG A+LL   S Y    V  T  Y +PE     
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGD 177

Query: 254 --YASTGMLNERSDVYSFGILIMEVISGR 280
             Y    +     DV++ G +  E++SG 
Sbjct: 178 TQY-GPPV-----DVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLV 138
            ++GEG YG+V      +    VA+K         + +  K     E++ + ++RH+NLV
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL  C +     LV+E+V++  +   L             ++   +     G+ + H  
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ--VVQ-KYLFQIINGIGFCHSH 143

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
               ++HRDIK  NIL+ +    K+ DFG A+ L +        V  T  Y APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 88/309 (28%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVE------------- 125
             IG+G YG+V       DN+  A+K      L+   G   R                  
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 126 -VEAIGR-------VRHKNLVRLLGY----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPC 173
            +E + +       + H N+V+L            H  +V+E VN G +      +V   
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTL 131

Query: 174 SPLT----WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA 229
            PL+         ++I G    + YLH     K++HRDIK SN+L+ +  + K++DFG++
Sbjct: 132 KPLSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNER--------SDVYSFGILIMEVISGRI 281
                  + ++  V GT  ++APE      L+E          DV++ G+ +   + G+ 
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT-----SRLLKRILLVALRCVD 336
           P        +  ++    K+ +          + P++P        L+ R+L       D
Sbjct: 239 PFM------DERIMCLHSKIKSQ-------ALEFPDQPDIAEDLKDLITRML-------D 278

Query: 337 PNAQKRPKM 345
            N + R  +
Sbjct: 279 KNPESRIVV 287

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.2 bits (230), Expect = 2e-21
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 30/209 (14%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IGEG YG V+     E +  VA+K +   R   + E        E+  +  ++HKN+VRL
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                      LV+E+ +  +L+++     G   P   +  +  +L   KGL + H    
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR-- 120

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------- 253
             V+HRD+K  N+LI+++   K+++FGLA+  G      +  V+ T  Y  P+       
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIP 282
           Y ST +     D++S G +  E+ +   P
Sbjct: 179 Y-STSI-----DMWSAGCIFAELANAGRP 201

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.5 bits (235), Expect = 4e-21
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 32/231 (13%)

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREF 122
           W  L    +  + F D +V+G GG+G V+   ++   K+ A K L    L  R   +   
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA- 232

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
            VE + + +V  + +V L  Y  E    + LV   +N G++   ++           E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPR 290

Query: 182 MN-----IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
                  I+ G    L +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  
Sbjct: 291 AIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +       GT G++APE     +L         D ++ G+ + E+I+ R P
Sbjct: 344 TKTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.8 bits (229), Expect = 5e-21
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 29/206 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRLL 141
           +GEG YG+VY         VA+K +   R  AE E        E+  +  + H N+V L+
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                     LV+E++   +L++ L  +         +I +  +L   +G+++ H+    
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH--- 138

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-------Y 254
           +++HRD+K  N+LI+     K++DFGLA+  G      T  V+ T  Y AP+       Y
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197

Query: 255 ASTGMLNERSDVYSFGILIMEVISGR 280
            ST +     D++S G +  E+I+G+
Sbjct: 198 -STSV-----DIWSIGCIFAEMITGK 217

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 91.6 bits (228), Expect = 7e-21
 Identities = 66/283 (23%), Positives = 112/283 (39%), Gaps = 66/283 (23%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLL 141
           K IG+G +  V     +    +VA+K +   +       K+  EV  +  + H N+V+L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILGTA 189
                     L+ EY + G +  +L  HG            RM           I+    
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVSA-- 126

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
             + Y H+    ++VHRD+K+ N+L+D   N K++DFG +    +    +     G   Y
Sbjct: 127 --VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPY 179

Query: 250 VAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
            APE     +   +       DV+S G+++  ++SG +P D        NL E  ++++ 
Sbjct: 180 AAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVL- 227

Query: 304 NRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                G    P         LLKR L      ++P   KR  +
Sbjct: 228 ----RGKYRIPFYMSTDCENLLKRFL-----VLNP--IKRGTL 259

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 36/212 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE--------REFKVEVEAIGRVRHKNL 137
           +G G Y  VY GL       VA+K +   +  +E        RE  +  E    ++H+N+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKE----LKHENI 65

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           VRL           LV+E+++N +L++++           L   +         +GL++ 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-- 253
           HE    K++HRD+K  N+LI+K    K+ DFGLA+  G   +  ++ V+ T  Y AP+  
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGR 280
                Y ST +     D++S G ++ E+I+G+
Sbjct: 181 MGSRTY-STSI-----DIWSCGCILAEMITGK 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 29/206 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRLL 141
           IGEG YG+VY          A+K +   R + E E        E+  +  ++H N+V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                    +LV+E+++  +L++ L    G    +T +  +  +L    G++Y H+    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR--- 119

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-------Y 254
           +V+HRD+K  N+LI++    K++DFGLA+  G      T  ++ T  Y AP+       Y
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178

Query: 255 ASTGMLNERSDVYSFGILIMEVISGR 280
            ST +     D++S G +  E+++G 
Sbjct: 179 -STTI-----DIWSVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 27/207 (13%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV----EVEAIGRVRHKNLVRL 140
           +GEG +  VY       N  VA+K + L +R +A+         E++ +  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
           L      ++  LV++++   +LE  +  +    +P   +  M + L   +GL YLH+   
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLHQH-- 131

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------- 253
             ++HRD+K +N+L+D++   K++DFGLAK  GS +   T +V+ T  Y APE       
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARM 189

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
           Y   G+     D+++ G ++ E++   
Sbjct: 190 Y-GVGV-----DMWAVGCILAELLLRV 210

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 16/205 (7%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            K +G G YG V        + + A+K     +    +  +   EV  +  + H N+++L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             +  +  +  LV E    G L   +                 II     G++YLH+   
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-- 155

Query: 201 PKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
             +VHRD+K  N+L+   +K    K+ DFGL+ +       +  R+ GT  Y+APE    
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIAPE-VLR 211

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
              +E+ DV+S G+++  +++G  P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 69/256 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKV--EVEAIGRVRHK-- 135
            ++G GG+G VY G+ + DN  VA+K    + +++ G+     +V  EV  + +V     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNN-GNLEQWL--HGDVGPCSPLTWEIRMN--------- 183
            ++RLL +       +L+ E      +L  ++   G             +          
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------------ALQEELARSFFW 156

Query: 184 -IILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITT 241
            ++    + + + H      V+HRDIK  NILID      K+ DFG   LL  + +  T 
Sbjct: 157 QVL----EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD 207

Query: 242 RVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVD---------YS 286
              GT  Y  PE      +         + V+S GIL+ +++ G IP +           
Sbjct: 208 FD-GTRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 261

Query: 287 RP----PEEVNLIEWL 298
                  E  +LI W 
Sbjct: 262 FRQRVSSECQHLIRWC 277

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 63/254 (24%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
           LE S+  +S  K +G G +GIV     +E   + A+K +L +     RE  +    +  +
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI----MKVL 57

Query: 133 RHKNLVRLL------GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
            H N+++L+      G       +         G      +         +    +N+I+
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 187 G-------------------------------TAKGLSYLHEGLEPKVVHRDIKSSNILI 215
                                             + + ++H      + HRDIK  N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV 174

Query: 216 DKHWNP-KVSDFGLAKLLGSES---SYITTRVMGTFGYVAPEYASTGMLNERS-----DV 266
           +   N  K+ DFG AK L       +YI +R      Y APE     ML         D+
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSIDL 225

Query: 267 YSFGILIMEVISGR 280
           +S G +  E+I G+
Sbjct: 226 WSIGCVFGELILGK 239

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAE--------REFKVEVEAIGRVRHKN 136
           IG G YG VY          VA+K++ + N G           RE  +    +    H N
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR-LEAFEHPN 75

Query: 137 LVRLLGYCAEGAHR-----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           +VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++    +G
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRG 132

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L +LH      +VHRD+K  NIL+      K++DFGLA++   + +  T  V+ T  Y A
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TLWYRA 187

Query: 252 PE------YASTGMLNERSDVYSFGILIMEVISGR 280
           PE      Y +T +     D++S G +  E+   +
Sbjct: 188 PEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +V+G+G +G V          + AVK      +  +   E     EV+ + ++ H N+++
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIMK 90

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  +  +  +  LV E    G L   +          +      II     G++Y+H+  
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN- 145

Query: 200 EPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
             K+VHRD+K  N+L+    K  N ++ DFGL+      S  +  ++ GT  Y+APE   
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPE-VL 200

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
            G  +E+ DV+S G+++  ++SG  P
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPP 226

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 32/197 (16%)

Query: 72  RELEVSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEV 126
           ++L  ++  F+D     + IG G Y +    +    N + AVK +  ++     E    +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66

Query: 127 EAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-----CSPLTWEI 180
           E + R  +H N++ L     +G +  +V E +  G L   +            S + + I
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTI 125

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP---KVSDFGLAKLLGSES 236
                    K + YLH      VVHRD+K SNIL +D+  NP   ++ DFG AK L +E+
Sbjct: 126 --------TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 237 SYITTRVMGTFGYVAPE 253
             + T    T  +VAPE
Sbjct: 175 GLLMTPC-YTANFVAPE 190

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 63/253 (24%), Positives = 93/253 (36%), Gaps = 61/253 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKV--EVEAIGRVR---- 133
            ++G+GG+G V+ G  L D  +VA+K    N +              EV  + +V     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGN-LEQWL--HGDVGPCSPLTWEIRMN------- 183
           H  ++RLL +       MLV E       L  ++   G             +        
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG------------PLGEGPSRCF 144

Query: 184 ---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYI 239
              ++      + + H      VVHRDIK  NILID      K+ DFG   LL       
Sbjct: 145 FGQVVAA----IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPY 195

Query: 240 TTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVD---------YSRP- 288
           T    GT  Y  PE+ S        + V+S GIL+ +++ G IP +            P 
Sbjct: 196 TDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPA 254

Query: 289 ---PEEVNLIEWL 298
              P+   LI   
Sbjct: 255 HVSPDCCALIRRC 267

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 33/230 (14%)

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREF---K 123
           W  L    V+ N F   +V+G+GG+G V    +    K+ A K L   R +  +      
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E + + +V  + +V L  Y  E    + LV   +N G+L+  ++       P   E R 
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARA 288

Query: 183 -----NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
                 I  G    L  LH     ++V+RD+K  NIL+D H + ++SD GLA  +  E  
Sbjct: 289 VFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQ 340

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            I  RV GT GY+APE     ++         D ++ G L+ E+I+G+ P
Sbjct: 341 TIKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 36/212 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           +GEG YG VY  +    N  VA+K +   R + E E        EV  +  ++H+N++ L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                      L++EY      E  L   +     ++  +  + +     G+++ H    
Sbjct: 99  KSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS--- 150

Query: 201 PKVVHRDIKSSNILIDKHWNP-----KVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-- 253
            + +HRD+K  N+L+           K+ DFGLA+  G      T  ++ T  Y  PE  
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGR 280
                Y ST +     D++S   +  E++   
Sbjct: 210 LGSRHY-STSV-----DIWSIACIWAEMLMKT 235

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 46/200 (23%), Positives = 87/200 (43%), Gaps = 32/200 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +V+G G +  V+           A+K +  +    +   + E+  + +++H+N+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---------NIILGTAKGLSY 194
                H  LV + V+ G L   +             +            +I      + Y
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRI-------------LERGVYTEKDASLVIQQVLSAVKY 121

Query: 195 LHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           LHE     +VHRD+K  N+L    +++    ++DFGL+K+   ++  ++T   GT GYVA
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVA 175

Query: 252 PEYASTGMLNERSDVYSFGI 271
           PE  +    ++  D +S G+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGV 195

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 69/285 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
             +G G +G V  G       KVAVK      + +     +  K E++ +   RH ++++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIK 75

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILG 187
           L    +      +V EYV+ G L  ++  HG            R+           I+  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL-- 121

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
               + Y H      VVHRD+K  N+L+D H N K++DFGL+ ++       T+   G+ 
Sbjct: 122 --SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 174

Query: 248 GYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            Y APE     +++ R       D++S G+++  ++ G +P D      + ++    KK+
Sbjct: 175 NYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPTLFKKI 223

Query: 302 VTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                  GV   P+   +  + LL  +L         +  KR  +
Sbjct: 224 R-----GGVFYIPEYLNRSVATLLMHML-------QVDPLKRATI 256

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 13/197 (6%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +VIG+G + +V   +  E   + AVK        ++ G +  + K E      ++H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL   +      +V+E+++  +L   +          +  +  + +    + L Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 199 LEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
               ++HRD+K   +L+   +     K+  FG+A  LG        RV GT  ++APE  
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205

Query: 256 STGMLNERSDVYSFGIL 272
                 +  DV+  G++
Sbjct: 206 KREPYGKPVDVWGCGVI 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 37/210 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAE--------REFKVEVEAIGRVRHKNL 137
           +GEG Y  VY G  +     VA+K +   R + E        RE  +  +    ++H N+
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKD----LKHANI 62

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           V L           LV+EY++  +L+Q+L       +    ++ +  +L   +GL+Y H 
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR 118

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE---- 253
               KV+HRD+K  N+LI++    K++DFGLA+     +      V+ T  Y  P+    
Sbjct: 119 ---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLG 174

Query: 254 ---YASTGMLNERSDVYSFGILIMEVISGR 280
              Y ST +     D++  G +  E+ +GR
Sbjct: 175 STDY-STQI-----DMWGVGCIFYEMATGR 198

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 38/206 (18%)

Query: 70  TLRELEVSTNGFSDD----KVIGEGGYGIVYYGLLEDNS---KVAVK----NLLNNRGQA 118
           T+ +  V      D+    K +G G  G V   L  +     KVA++             
Sbjct: 122 TVDDQSVYPKALRDEYIMSKTLGSGACGEVK--LAFERKTCKKVAIRIISKRKFAIGSAR 179

Query: 119 ERE----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG- 171
           E +     + E+E + ++ H  ++++  +     +  +V E +  G L   +  +  +  
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKE 238

Query: 172 -PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFG 227
             C    +++           + YLHE     ++HRD+K  N+L+   ++    K++DFG
Sbjct: 239 ATCKLYFYQM--------LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287

Query: 228 LAKLLGSESSYITTRVMGTFGYVAPE 253
            +K+LG E+S + T   GT  Y+APE
Sbjct: 288 HSKILG-ETSLMRTLC-GTPTYLAPE 311

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 34/213 (15%)

Query: 87  IGEGGYGIVYYG--LLEDNSKVAVKNL-LNNRGQ-----AEREFKVEVEAIGRVRHKNLV 138
           IGEG YG V+    L      VA+K + +    +       RE  V    +    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETFEHPNVV 77

Query: 139 RLL----GYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           RL         +   ++ LV+E+V+  +L  +L  D  P   +  E   +++    +GL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           +LH     +VVHRD+K  NIL+      K++DFGLA++   + +  T+ V+ T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWYRAPE 189

Query: 254 ------YASTGMLNERSDVYSFGILIMEVISGR 280
                 Y +T +     D++S G +  E+   +
Sbjct: 190 VLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 40/217 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++GEG +  V        S+  A+K L    +    +       E + + R+ H   V+
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDHPFFVK 94

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-------------IIL 186
           L     +         Y  NG L +++              ++              I+ 
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVS 141

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-G 245
                L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES         G
Sbjct: 142 A----LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T  YV+PE  +     + SD+++ G +I ++++G  P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 49/226 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-------------NLLNNRGQAEREFKVEVEAIG 130
           + +G G YG V        +S+ A+K             +   N  +   E   E+  + 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWE 179
            + H N+++L     +  +  LV E+   G L           E     D          
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC----DAANI------ 151

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSES 236
             M  IL    G+ YLH+     +VHRDIK  NIL+   +   N K+ DFGL+     + 
Sbjct: 152 --MKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
                  +GT  Y+APE       NE+ DV+S G+++  ++ G  P
Sbjct: 204 KL--RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 11/193 (5%)

Query: 84  DKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLL 141
            + +G G +G V+         +  +K +  +R Q   E  + E+E +  + H N++++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
               +  +  +V E    G L + +         L+      ++      L+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 202 KVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
            VVH+D+K  NIL      H   K+ DFGLA+L      + T    GT  Y+APE     
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA-GTALYMAPEVFK-R 200

Query: 259 MLNERSDVYSFGI 271
            +  + D++S G+
Sbjct: 201 DVTFKCDIWSAGV 213

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 35/279 (12%), Positives = 81/279 (29%), Gaps = 60/279 (21%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKNL 137
               G       +     D +   +VA+  +       +   +E       + R+    +
Sbjct: 36  LIFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            R+L      A  ++V E++  G+L++       P         +  +   A      H 
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP------VGAIRAMQSLAAAADAAHR 147

Query: 198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
            G    V       S + +        S  G   L                  +      
Sbjct: 148 AG----VALSIDHPSRVRV--------SIDGDVVL-------------AYPATMPDA--- 179

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE-GVLDPKL 315
               N + D+   G  +  ++  R P+  +     +      ++    +  E   +D  +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQPIEPADIDRDI 232

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           P + ++        VA R V  +   R     ++++++ 
Sbjct: 233 PFQISA--------VAARSVQGDGGIRSA-STLLNLMQQ 262

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 66/288 (22%), Positives = 107/288 (37%), Gaps = 77/288 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLL 141
           K IG G +G+            VAVK +   RG A  E  V  E+     +RH N+VR  
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFK 82

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILGTA 189
                  H  ++ EY + G L + +   G            R +          ++    
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS--- 127

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
            G+SY H     ++ HRD+K  N L+D    P  K+ DFG +K      S   + V GT 
Sbjct: 128 -GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTP 181

Query: 248 GYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            Y+APE     +L  +      +DV+S G+ +  ++ G  P +      +       +K 
Sbjct: 182 AYIAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRDYRKT 230

Query: 302 VTNRNPEGVL--DPKLPEKP-----TSRLLKRILLVALRCVDPNAQKR 342
           +     + +L     +P+          L+ RI          +   R
Sbjct: 231 I-----QRILSVKYSIPDDIRISPECCHLISRIF-------VADPATR 266

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.4 bits (219), Expect = 5e-19
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 36/228 (15%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQ-----AERE 121
             + ++ N FS  ++IG GG+G VY     D  K+ A+K L    +  +        ER 
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
               +  +       +V +  Y      ++  + + +N G+L   L    G  S    E 
Sbjct: 242 M---LSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS----EA 292

Query: 181 RMN-----IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            M      IILG    L ++H      VV+RD+K +NIL+D+H + ++SD GLA     +
Sbjct: 293 DMRFYAAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345

Query: 236 SSYITTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIP 282
             +    V GT GY+APE    G+  + S D +S G ++ +++ G  P
Sbjct: 346 KPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 48/220 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
            ++G+G +G V          + AVK  N  + + +       EVE + ++ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               + +   +V E    G L           E     D            +  +     
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARI--------IKQVFS--- 132

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  R+ GT 
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTA 187

Query: 248 GYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRIP 282
            Y+APE     Y      +E+ DV+S G+++  ++SG  P
Sbjct: 188 YYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 64/340 (18%), Positives = 118/340 (34%), Gaps = 81/340 (23%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--------NLLNNRGQAEREFKVEVEAIGRVRHK 135
             +G G +G V+  +  E N +V VK                   +  +E+  + RV H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 136 NLVRLLGYCAEGAHRMLVYEY-----------VNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           N++++L          LV E              +  L++ L       S +  ++    
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------ASYIFRQL---- 139

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
                  + YL       ++HRDIK  NI+I + +  K+ DFG A  L     + T    
Sbjct: 140 ----VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--C 190

Query: 245 GTFGYVAPEYASTGMLNERS------DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  Y APE     +L          +++S G+ +  ++    P               L
Sbjct: 191 GTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------------L 233

Query: 299 KKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV------HM 351
           ++ V     E  +  P L  K    L+  +L        P  ++R  +  +V        
Sbjct: 234 EETV-----EAAIHPPYLVSKELMSLVSGLL-------QPVPERRTTLEKLVTDPWVTQP 281

Query: 352 LEAQESPSKEDRYRASPKNELIEKQVTESGDNSTNETGVH 391
           +   +   +E      P++ ++     E G+ S ++    
Sbjct: 282 VNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQA 321

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 50/207 (24%), Positives = 73/207 (35%), Gaps = 46/207 (22%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             IG G +G V   +      + A K +     +    FK E+E +  + H N++RL   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 144 CAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
             +     LV E    G L           E     D            M  +L     +
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARI--------MKDVL---SAV 119

Query: 193 SYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           +Y H+     V HRD+K  N L          K+ DFGLA         + T+V GT  Y
Sbjct: 120 AYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKV-GTPYY 174

Query: 250 VAPE-----YASTGMLNERSDVYSFGI 271
           V+P+     Y          D +S G+
Sbjct: 175 VSPQVLEGLY------GPECDEWSAGV 195

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 54/282 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + +G G Y  V+  + + +N KV VK L    + + +RE K+     G     N++ L  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG---GPNIITLAD 98

Query: 143 YCAEGAHRMLVY--EYVNNGNLEQWLHGDVGPCSPLT-WEIR--MNIILGTAKGLSYLHE 197
              +   R      E+VNN + +Q           LT ++IR  M  IL   K L Y H 
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHS 148

Query: 198 GLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                ++HRD+K  N++ID +H   ++ D+GLA+       Y   RV  +  +  PE   
Sbjct: 149 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGPEL-- 201

Query: 257 TGMLNERS-----DVYSFGILIMEVISGRIPV----DYSRPPEEVNLI----------EW 297
             +++ +      D++S G ++  +I  + P     D     +++  I          ++
Sbjct: 202 --LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVLGTEDLYDY 256

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           + K     +P    +  L      R  + +       V P A
Sbjct: 257 IDKYNIELDPR--FNDILGRHSRKRWERFVHSENQHLVSPEA 296

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 36/190 (18%)

Query: 87  IGEGGYGIVYYG---LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV------RHKNL 137
           +G G YG VY       +D+   A+K +            + + A   +      +H N+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80

Query: 138 VRLLGYCAEGAHR--MLVYEYVNNGNLEQWLH-----GDVGPCSPLTWEIRMNIILGTAK 190
           + L       A R   L+++Y  + +L   +              L   +  +++     
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSES---SYITTRV 243
           G+ YLH      V+HRD+K +NIL+          K++D G A+L  S     + +   V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 244 MGTFGYVAPE 253
           + TF Y APE
Sbjct: 197 V-TFWYRAPE 205

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 19/213 (8%)

Query: 69  YTLRELEVSTNGFSD----DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAERE 121
           Y  + +EV      D     + +G G +G+V+     + +       K +       +  
Sbjct: 37  YVPQPVEVKQGSVYDYYDILEELGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYT 94

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
            K E+  + ++ H  L+ L     +    +L+ E+++ G L   +         ++    
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEV 151

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYI 239
           +N +    +GL ++HE     +VH DIK  NI+ +       K+ DFGLA  L  +    
Sbjct: 152 INYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
                 T  + APE      +   +D+++ G+L
Sbjct: 209 V--TTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 69/282 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
             +G G +G V  G       KVAVK      + +     +  + E++ +   RH ++++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIK 80

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILG 187
           L    +  +   +V EYV+ G L  ++  +G            R++          I+  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQIL-- 126

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
              G+ Y H      VVHRD+K  N+L+D H N K++DFGL+ ++ S+  ++ T   G+ 
Sbjct: 127 --SGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSP 179

Query: 248 GYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            Y APE     +++ R       D++S G+++  ++ G +P D      + ++    KK+
Sbjct: 180 NYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHVPTLFKKI 228

Query: 302 VTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
                 +G+   P+        LLK +L         +  KR
Sbjct: 229 C-----DGIFYTPQYLNPSVISLLKHML-------QVDPMKR 258

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 42/217 (19%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLL 141
           DK +GEG + I    +  + N   AVK +        ++   E+ A+     H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               +  H  LV E +N G L           E               E    I+     
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--------------EAS-YIMRKLVS 117

Query: 191 GLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
            +S++H+     VVHRD+K  N+L  D++ N   K+ DFG A+L   ++  + T    T 
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 248 GYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRIP 282
            Y APE  +    +E  D++S G++   M  +SG++P
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVP 208

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 40/224 (17%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEA---------I 129
           ++  + I  G YG V  G+  +   VA+K + N  + G+                    +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 130 GRVRHKNLVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
               H N++ L   +       M    LV E +   +L Q +H        ++ +     
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD---QRIVISPQHIQYF 139

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITT 241
           +     GL  LHE     VVHRD+   NIL+  + +  + DF LA+   ++++   Y+T 
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 242 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           R      Y APE     ++  +      D++S G ++ E+ + +
Sbjct: 197 RW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 72  RELEVSTNGFSD----DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKV 124
           + +E+  +   D     + +G G +G+V+   + + +     A K ++      +   + 
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVH--RVTERATGNNFAAKFVMTPHESDKETVRK 203

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +  +RH  LV L     +    +++YE+++ G L + +  +      ++ +  +  
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEY 260

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNP-KVSDFGLAKLLGSESSYITTR 242
           +    KGL ++HE      VH D+K  NI+   K  N  K+ DFGL   L  + S     
Sbjct: 261 MRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KV 315

Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
             GT  + APE A    +   +D++S G+L
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 30/186 (16%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS---KVAVK----NLLNNRGQAERE----FKVEVEAIGRV 132
            K +G G  G V   L  +     KVA+K             E +     + E+E + ++
Sbjct: 15  SKTLGSGACGEVK--LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAK 190
            H  ++++  +     +  +V E +  G L   +  +        L              
Sbjct: 73  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLL 125

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            + YLHE     ++HRD+K  N+L+   ++    K++DFG +K+LG E+S + T   GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTP 180

Query: 248 GYVAPE 253
            Y+APE
Sbjct: 181 TYLAPE 186

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 54/248 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
             IG+G YG+V   +  +  +  A+K      +     +     K EV  + ++ H N+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNL----------------EQWLHGDVGPCSPLTWEIRM 182
           RL     +  +  LV E  + G+L                   +   + PC     E   
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 183 NIILGTAK--------------------GLSYLHEGLEPKVVHRDIKSSNILI--DKHWN 220
             I G  +                     L YLH      + HRDIK  N L   +K + 
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208

Query: 221 PKVSDFGLAKLLGS----ESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIM 274
            K+ DFGL+K        E   +TT+  GT  +VAPE    +      + D +S G+L+ 
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 275 EVISGRIP 282
            ++ G +P
Sbjct: 268 LLLMGAVP 275

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 37/222 (16%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIG 130
           E+    +     +G G YG V   +      KVA+K L     +   A+R ++ E+  + 
Sbjct: 21  ELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLK 78

Query: 131 RVRHKNLVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
            ++H+N++ LL  +    + R      LV  ++   +L++ +          + E    +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYL 131

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRV 243
           +    KGL Y+H      VVHRD+K  N+ +++    K+ DFGLA+   +E + Y+ TR 
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188

Query: 244 MGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
                Y APE     +L+        D++S G ++ E+++G+
Sbjct: 189 -----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 28/194 (14%)

Query: 77  STNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVK---------NLLNNRGQAEREF 122
           ST+GF ++    +++G G   +V   +      + AVK                +     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 123 KVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWE 179
             EV+ + +V  H N+++L           LV++ +  G L  +L           L+ +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEK 124

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
               I+    + +  LH+     +VHRD+K  NIL+D   N K++DFG +  L      +
Sbjct: 125 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKL 180

Query: 240 TTRVMGTFGYVAPE 253
                GT  Y+APE
Sbjct: 181 REVC-GTPSYLAPE 193

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + + K IG G  GIV        +  VA+K L     N+  A+R ++ E+  +  V HKN
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +  +          LV E ++  NL Q +         L  E    ++     
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 175

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITTRVMGTF 247
           G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G+      Y+ TR     
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228

Query: 248 GYVAPEYASTGMLNER----SDVYSFGILIMEVISGRI 281
            Y APE     +L        D++S G ++ E++  +I
Sbjct: 229 -YRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IG+G +G V+     +   KVA+K +     + E+E F +    E++ +  ++H+N+V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVNL 81

Query: 141 LGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +  C   A           LV+++  + +L   L          T      ++     GL
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGL 137

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG----SESSYITTRVMGTFG 248
            Y+H     K++HRD+K++N+LI +    K++DFGLA+       S+ +  T RV+ T  
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLW 193

Query: 249 YVAPE 253
           Y  PE
Sbjct: 194 YRPPE 198

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 40/199 (20%)

Query: 76  VSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEA 128
           ++   F+++    + +G+G + +V   + +    + A   +   +  A    K+  E   
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLT 177
              ++H N+VRL    +E  H  L+++ V  G L           E     D   C    
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHC---- 115

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGS 234
               +  IL     + + H+     VVHR++K  N+L+    K    K++DFGLA  +  
Sbjct: 116 ----IQQILE---AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165

Query: 235 ESSYITTRVMGTFGYVAPE 253
           E         GT GY++PE
Sbjct: 166 EQQAWFGFA-GTPGYLSPE 183

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 48/209 (22%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLL 141
            ++G+G +G V          + AVK +       +       EVE + ++ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               + +   +V E    G L           E     D            +  +     
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARI--------IKQVFS--- 132

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+      +     R+ GT 
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-GTA 187

Query: 248 GYVAPE-----YASTGMLNERSDVYSFGI 271
            Y+APE     Y      +E+ DV+S G+
Sbjct: 188 YYIAPEVLRGTY------DEKCDVWSAGV 210

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + + K IG G  GIV           VA+K L     N+  A+R ++ E+  +  V HKN
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +  + +        +V E ++  NL Q +         L  E    ++     
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 138

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITTRVMGTF 247
           G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G+      Y+ TR     
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 191

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            Y APE        E  D++S G ++ E+I G 
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 33/231 (14%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVE 125
           L+E+ +  + F   KVIG G +  V    ++   +V A+K +    +  RG+    F+ E
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREE 111

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTW------ 178
            + +     + + +L  +  +  + + LV EY   G+L   L    G   P         
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA 169

Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           EI M         +  +H       VHRDIK  NIL+D+  + +++DFG    L ++ + 
Sbjct: 170 EIVM--------AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 239 ITTRVMGTFGYVAPEYASTGMLNERSDVY-------SFGILIMEVISGRIP 282
            +   +GT  Y++PE          +  Y       + G+   E+  G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + IV      + S   + A K         +R    RE  + EV  + +V H 
Sbjct: 18  EELGSGQFAIVK--KCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-------EQWLHGDVGPCSPLTWEIRMNIILGT 188
           N++ L          +L+ E V+ G L       E     +            +  IL  
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQILD- 126

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYITTRVM 244
             G++YLH     K+ H D+K  NI++     P    K+ DFGLA  +     +    + 
Sbjct: 127 --GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IF 179

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGIL 272
           GT  +VAPE  +   L   +D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 35/216 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + D + +G G YG V   +     +KVA+K L     +   A+R ++ E+  +  +RH+N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +  +          LV  ++   +L + +         L  +    ++    K
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGY 249
           GL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   SE + Y+ TR      Y
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            APE     +LN        D++S G ++ E+I+G+
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 70/283 (24%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
            + +GEG +G V      +   KVA+K     LL       R  + E+  +  +RH +++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHII 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IIL 186
           +L          ++V EY   G L  ++                RM           II 
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYIVEKK------------RMTEDEGRRFFQQII- 118

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
                + Y H     K+VHRD+K  N+L+D + N K++DFGL+ ++   +   T+   G+
Sbjct: 119 ---CAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGS 170

Query: 247 FGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
             Y APE     ++N +       DV+S GI++  ++ GR+P D      +  +    KK
Sbjct: 171 PNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNLFKK 219

Query: 301 MVTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
           +        V   P         L++R++         +  +R
Sbjct: 220 VN-----SCVYVMPDFLSPGAQSLIRRMI-------VADPMQR 250

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 35/216 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + +   +G G YG V      +   +VAVK L     +   A+R ++ E+  +  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +    +        LV        +   L+ ++  C  LT +    +I    +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN-NIVKCQKLTDDHVQFLIYQILR 143

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGY 249
           GL Y+H      ++HRD+K SN+ +++    K+ DFGLA+    E + Y+ TR      Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            APE     MLN        D++S G ++ E+++GR
Sbjct: 196 RAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.5 bits (197), Expect = 6e-17
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 46/213 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + IV            + A K      L ++R    RE  + EV  +  +RH 
Sbjct: 11  EELGSGQFAIVR--KCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNI 184
           N++ L          +L+ E V+ G L           E     +            +  
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED----EATQF--------LKQ 116

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYIT 240
           IL    G+ YLH     ++ H D+K  NI++     P    K+ DFG+A  + + + +  
Sbjct: 117 ILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
             + GT  +VAPE  +   L   +D++S G++ 
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + IV      + S   + A K         +R    RE  + EV  + +V H 
Sbjct: 18  EELGSGQFAIVK--KCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-------EQWLHGDVGPCSPLTWEIRMNIILGT 188
           N++ L          +L+ E V+ G L       E     +            +  IL  
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQILD- 126

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYITTRVM 244
             G++YLH     K+ H D+K  NI++     P    K+ DFGLA  +     +    + 
Sbjct: 127 --GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IF 179

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGIL 272
           GT  +VAPE  +   L   +D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 37/205 (18%), Positives = 83/205 (40%), Gaps = 40/205 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           + +G G +GIV+     + S       K  +  +G  +   K E+  +   RH+N++ L 
Sbjct: 11  EDLGRGEFGIVH--RCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 142 GYCAEGAHRMLVYEYVNNGNL------------EQWLHGDVGPCSPLTWEIRMNIILGTA 189
                    ++++E+++  ++            E+    ++           ++ +    
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNER----EIVSY--------VHQVC--- 112

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
           + L +LH      + H DI+  NI+     +   K+ +FG A+ L    ++    +    
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAP 167

Query: 248 GYVAPEYASTGMLNERSDVYSFGIL 272
            Y APE     +++  +D++S G L
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTL 192

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 47/220 (21%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLL 141
           + V+GEG +  V   + L  + + AVK +    G        EVE + + + H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
            +  E     LV+E +  G++           E          S +  ++        A 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-------EASVVVQDV--------AS 122

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL--GSESSYITTRVM- 244
            L +LH      + HRD+K  NIL    ++    K+ DF L   +    + S I+T  + 
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 245 ---GTFGYVAPE-----YASTGMLNERSDVYSFG-IL-IM 274
              G+  Y+APE          + ++R D++S G IL I+
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 42/217 (19%)

Query: 78  TNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIG 130
           +  FSD+    + +G+G + +V   +      + A K +   +  A    K+  E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWE 179
           +++H N+VRL     E +   LV++ V  G L           E          S     
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-------DASHC--- 110

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSES 236
             +  IL   + ++Y H      +VHR++K  N+L   K      K++DFGLA  +  +S
Sbjct: 111 --IQQIL---ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DS 161

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFG-IL 272
                   GT GY++PE       ++  D+++ G IL
Sbjct: 162 EAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 33/200 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G G   IVY           A+K L   +   ++  + E+  + R+ H N+++L   
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---------NIILGTAKGLSY 194
                   LV E V  G L   +             +           + +    + ++Y
Sbjct: 117 FETPTEISLVLELVTGGELFDRI-------------VEKGYYSERDAADAVKQILEAVAY 163

Query: 195 LHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           LHE     +VHRD+K  N+L      +   K++DFGL+K++      + T   GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVC-GTPGYCA 218

Query: 252 PEYASTGMLNERSDVYSFGI 271
           PE           D++S GI
Sbjct: 219 PEILRGCAYGPEVDMWSVGI 238

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 45/192 (23%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--------NLLNNRGQAEREFKVEVEAIGRVR-H 134
            VIG G   +V   +      + AVK               +     + E   + +V  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIR-- 181
            +++ L+      +   LV++ +  G L           E+              E R  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK--------------ETRSI 205

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           M  +L   + +S+LH      +VHRD+K  NIL+D +   ++SDFG +  L      +  
Sbjct: 206 MRSLL---EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRE 258

Query: 242 RVMGTFGYVAPE 253
              GT GY+APE
Sbjct: 259 LC-GTPGYLAPE 269

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 40/226 (17%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGR 131
           +V    +++   IGEG YG+V       +  +VA+K +    ++   +R  + E++ + R
Sbjct: 24  DVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR 81

Query: 132 VRHKNLVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
            RH+N++ +     A    +M    +V +      +E  L+  +     L+ +     + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLY-KLLKTQHLSNDHICYFLY 135

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-------YI 239
              +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +         Y+
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 240 TTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            TR      Y APE     MLN +      D++S G ++ E++S R
Sbjct: 193 ATR-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 38/224 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + D K +G GG G+V+  +  + + +VA+K + L +    +   + E++ I R+ H N+V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71

Query: 139 RLLG-YCAEGAHRMLVYEYVNNGN--------LEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           ++       G+        +   N        +E  L  +V    PL  E     +    
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLLEEHARLFMYQLL 130

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSESS-------YITT 241
           +GL Y+H      V+HRD+K +N+ I+      K+ DFGLA+++    S        + T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 242 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           +      Y +P      +L+  +     D+++ G +  E+++G+
Sbjct: 188 K-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 46/212 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + +V      + S   + A K        ++R    RE  + EV  +  ++H 
Sbjct: 17  EELGSGQFAVVK--KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNI 184
           N++ L          +L+ E V  G L           E+    +            +  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEF--------LKQ 122

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYIT 240
           IL    G+ YLH     ++ H D+K  NI++     P    K+ DFGLA  +   + +  
Sbjct: 123 ILN---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
             + GT  +VAPE  +   L   +D++S G++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 36/230 (15%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVE 125
           +R+L +    +   KVIG G +G V     +   KV A+K L    +  R  +   F  E
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEE 119

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
            + +       +V+L  Y  +    + +V EY+  G+L   +                ++
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165

Query: 185 ILGTAK--------GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
               A+         L  +H       +HRD+K  N+L+DK  + K++DFG    +  E 
Sbjct: 166 PEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 237 SYITTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRIP 282
                  +GT  Y++PE        G      D +S G+ + E++ G  P
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 37/186 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLL 141
           + +G+G + +V   +      + A K +   +  A    K+  E     +++H N+VRL 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               E +   LV++ V  G L           E     D   C        +  IL   +
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA----DASHC--------IQQIL---E 139

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            ++Y H      +VHR++K  N+L+    K    K++DFGLA  +  +S        GT 
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTP 194

Query: 248 GYVAPE 253
           GY++PE
Sbjct: 195 GYLSPE 200

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 36/222 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL 137
           F    ++GEG YG+V           VA+K     +    A R  + E++ +   +H+N+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71

Query: 138 VRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           + +      +         ++ E      ++  LH  V     L+ +     I  T + +
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQEL-----MQTDLH-RVISTQMLSDDHIQYFIYQTLRAV 125

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF---GY 249
             LH      V+HRD+K SN+LI+ + + KV DFGLA+++   ++  +           +
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 250 V------APEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           V      APE     ML         DV+S G ++ E+   R
Sbjct: 183 VATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 51/238 (21%)

Query: 62  HLGWGHWYTLRELEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR 115
           H   G     +  E      +DD     +V+G G  G V          K A+K LL + 
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS 65

Query: 116 GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM----LVYEYVNNGNL--------- 162
            +A +E     +A G     ++V +L       H      ++ E +  G L         
Sbjct: 66  PKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122

Query: 163 ----EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDK 217
               E+         + +  +I           + +LH      + HRD+K  N+L   K
Sbjct: 123 QAFTER-------EAAEIMRDI--------GTAIQFLHSH---NIAHRDVKPENLLYTSK 164

Query: 218 HWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
             +   K++DFG AK     +  + T    T  YVAPE       ++  D++S G+++
Sbjct: 165 EKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 31/229 (13%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVE 125
           ++++ +    F   KVIG G +G V    L++  KV A+K L    +  R +    F+ E
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREE 124

Query: 126 VEAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR-- 181
            + +     K +  L  + A  +  +  LV +Y   G+L   L            E    
Sbjct: 125 RDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP----EEMAR 178

Query: 182 ---MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
                +++     +  +H+      VHRDIK  NIL+D + + +++DFG    L  + + 
Sbjct: 179 FYLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 239 ITTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRIP 282
            ++  +GT  Y++PE         G      D +S G+ + E++ G  P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 37/192 (19%), Positives = 74/192 (38%), Gaps = 18/192 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           +    +IG G YG V       +   VA+K +L    +    +R  + E+  + R+ H +
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113

Query: 137 LVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           +V++L     +   +     +V E       +            LT      ++     G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + Y+H      ++HRD+K +N L+++  + KV DFGLA+ +    +  +   +       
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 252 PEYASTGMLNER 263
                    N +
Sbjct: 226 NLVTFPHTKNLK 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKN 136
            S  +++G G +G V+    E+ +   K+A K ++  RG  ++E  K E+  + ++ H N
Sbjct: 91  VSKTEILGGGRFGQVH--KCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHAN 147

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT-WEIR--MNIILGTAKGLS 193
           L++L          +LV EYV+ G L   +   +     LT  +    M  I     G+ 
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIR 201

Query: 194 YLHEGLEPKVVHRDIKSSNIL-IDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           ++H+     ++H D+K  NIL +++     K+ DFGLA+              GT  ++A
Sbjct: 202 HMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLA 256

Query: 252 PEYASTGMLNERSDVYSFGIL 272
           PE  +   ++  +D++S G++
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVI 277

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 49/237 (20%), Positives = 91/237 (38%), Gaps = 48/237 (20%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           +    +IG G YG VY          VA+K +     +    +R  + E+  + R++   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86

Query: 137 LVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           ++RL      +   +     +V E       +  L         LT E    I+     G
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF---- 247
            +++HE     ++HRD+K +N L+++  + KV DFGLA+ + SE        +       
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 248 -----------GYV------APEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
                       +V      APE     +L + +     D++S G +  E+++    
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 30/205 (14%)

Query: 83  DDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKV--EVEAIGRVRH-KN 136
             K +G G + +V        S   + A K L   R   +   ++  E+  +   +    
Sbjct: 33  TSKELGRGKFAVVR--QCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP------CSPLTWEIRMNIILGTAK 190
           ++ L       +  +L+ EY   G +      ++           L     +  IL    
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE--- 142

Query: 191 GLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
           G+ YLH+     +VH D+K  NIL    +     K+ DFG+++ +G         +MGT 
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTP 197

Query: 248 GYVAPEYASTGMLNERSDVYSFGIL 272
            Y+APE  +   +   +D+++ GI+
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGII 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 50/232 (21%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAI 129
           +V+ + F   + IG+G +G V      D  K+ A+K +       R +    FK E++ +
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIM 69

Query: 130 GRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----- 183
             + H  LV L  Y  +    M +V + +  G+L    H        L   +        
Sbjct: 70  QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYH--------LQQNVHFKEETVK 118

Query: 184 -----IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
                +++     L YL      +++HRD+K  NIL+D+H +  ++DF +A +L  E+  
Sbjct: 119 LFICELVMA----LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170

Query: 239 ITTRVMGTFGYVAPEYASTGMLNERS--------DVYSFGILIMEVISGRIP 282
             T + GT  Y+APE     M + R         D +S G+   E++ GR P
Sbjct: 171 -ITTMAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 58/269 (21%), Positives = 100/269 (37%), Gaps = 24/269 (8%)

Query: 97  YGLLEDN--SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           +G L     SK         +G   R+ K  V AI     + L  +    +  +   +  
Sbjct: 111 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170

Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           + +++   E+           LT E  +      AKG+ +L      K +HRD+ + NIL
Sbjct: 171 KSLSDVEEEEAPEDL--YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 225

Query: 215 IDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
           + +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SFG+L+
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285

Query: 274 MEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
            E+ S G  P  Y     +      LK+    R P+                  +    L
Sbjct: 286 WEIFSLGASP--YPGVKIDEEFCRRLKEGTRMRAPDYTTPE-------------MYQTML 330

Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKE 361
            C      +RP    +V  L      + +
Sbjct: 331 DCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 48/220 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++G+G +G V     +   +  A+K L    +  + +       E   +   RH  L  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTA 69

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------IILGT 188
           L  Y  +   R+  V EY N G L  + H        L+ E              I+   
Sbjct: 70  LK-YAFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFTEERARFYGAEIVSA- 117

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTF 247
              L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ +  T +   GT 
Sbjct: 118 ---LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 169

Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            Y+APE     +L +       D +  G+++ E++ GR+P
Sbjct: 170 EYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 34/220 (15%)

Query: 74  LEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           L++  N   DD     +V+G G  G V          K A+K +L +  +A RE ++   
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 110

Query: 128 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVNNGNL----EQWLHGDVGPCSPLTWE 179
           A       ++VR++       A     ++V E ++ G L    +             T  
Sbjct: 111 ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD------QAFTER 161

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSES 236
               I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +
Sbjct: 162 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL--IM 274
           S  T     T  YVAPE       ++  D++S G++  I+
Sbjct: 219 SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 63/259 (24%), Positives = 103/259 (39%), Gaps = 40/259 (15%)

Query: 42  GNGSGGGSGDQ---VAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYG 98
           GN +    G +   V   + +        W T  +     + F   K +G G +G V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 99  LLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 153
             +++    A+K L    +    Q E     E   +  V    LV+L     + ++  +V
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------IILGTAKGLSYLHEGLEPKV 203
            EYV  G  E + H        L    R +          I+L       YLH      +
Sbjct: 120 MEYVAGG--EMFSH--------LRRIGRFSEPHARFYAAQIVLT----FEYLHSL---DL 162

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           ++RD+K  N+LID+    +V+DFG AK +       T  + GT   +APE   +   N+ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKA 218

Query: 264 SDVYSFGILIMEVISGRIP 282
            D ++ G+LI E+ +G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 46/232 (19%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVR-HK 135
           +   K +G+G YGIV+  +       VAVK + +   N   A+R F+ E+  +  +  H+
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHE 69

Query: 136 NLVRLLG-YCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           N+V LL    A+    + LV++Y+   +L   +  +      L    +  ++    K + 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIK 123

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF------ 247
           YLH G    ++HRD+K SNIL++   + KV+DFGL++   +         +         
Sbjct: 124 YLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 248 --------GYV------APEYASTGMLNERS-----DVYSFGILIMEVISGR 280
                    YV      APE     +L         D++S G ++ E++ G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCGK 228

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++G+G +G V     +   +  A+K L    +  + +       E   +   RH  L  
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTA 212

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAKGLS 193
           L  Y  +   R+  V EY N G L   L  +      +  E R       I+      L 
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSA----LD 262

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAP 252
           YLH      VV+RD+K  N+++DK  + K++DFGL K    + +  T +   GT  Y+AP
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAP 318

Query: 253 EYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           E     +L +       D +  G+++ E++ GR+P
Sbjct: 319 E-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 52/224 (23%)

Query: 85  KVIGEGGYGIVY---YGLLEDNSKV-AVK-----NLLNNRGQAEREFKVEVEAIGRVRHK 135
           +V+G+GGYG V+        +  K+ A+K      ++ N        K E   +  V+H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHP 81

Query: 136 NLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------I 184
            +V L+ Y  +   ++ L+ EY++ G L   L            E              I
Sbjct: 82  FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLER----------EGIFMEDTACFYLAEI 130

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
            +     L +LH+     +++RD+K  NI+++   + K++DFGL K    + +   T   
Sbjct: 131 SMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTF 181

Query: 245 -GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            GT  Y+APE     +L         D +S G L+ ++++G  P
Sbjct: 182 CGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           KVIG+G +G V     +      AVK L    +  + + +    E  V ++    V+H  
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHPF 100

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           LV L  +  + A ++  V +Y+N G L   L  +   C     E R       I      
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRER--CFL---EPRARFYAAEIASA--- 151

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L YLH      +V+RD+K  NIL+D   +  ++DFGL K     +S  TT    GT  Y
Sbjct: 152 -LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEY 205

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L+++      D +  G ++ E++ G  P
Sbjct: 206 LAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 33/213 (15%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
            V+G+G +G V     +   ++ AVK L    +      E    E +V        +   
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP---GKPPF 403

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           L +L   C +   R+  V EYVN G+L   +        P        I +G    L +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFL 458

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAPEY 254
                  +++RD+K  N+++D   + K++DFG+ K    +    TT+   GT  Y+APE 
Sbjct: 459 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPE- 512

Query: 255 ASTGMLNERS-----DVYSFGILIMEVISGRIP 282
               ++  +      D ++FG+L+ E+++G+ P
Sbjct: 513 ----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 3e-12
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 52/223 (23%)

Query: 85  KVIGEGGYGIVY---YGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKN 136
           KV+G+G +G V+        D  ++ A+K L    L  R +     K+E + +  V H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------II 185
           +V+L  Y  +   ++ L+ +++  G+L  +          L+ E+             + 
Sbjct: 88  IVKLH-YAFQTEGKLYLILDFLRGGDL--FTR--------LSKEVMFTEEDVKFYLAELA 136

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM- 244
           L     L +LH      +++RD+K  NIL+D+  + K++DFGL+K               
Sbjct: 137 LA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFC 187

Query: 245 GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           GT  Y+APE     ++N R      D +SFG+L+ E+++G +P
Sbjct: 188 GTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.0 bits (162), Expect = 3e-12
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 49/219 (22%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G G +G V+      N +  A+K L    +    Q E     E   +  V H  ++R
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVTHPFIIR 70

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------IILGTA 189
           + G   +     ++ +Y+  G L  +          L    R            + L   
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGEL--FSL--------LRKSQRFPNPVAKFYAAEVCLA-- 118

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFG 248
             L YLH      +++RD+K  NIL+DK+ + K++DFG AK +        T  + GT  
Sbjct: 119 --LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 168

Query: 249 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           Y+APE     +++ +      D +SFGILI E+++G  P
Sbjct: 169 YIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           K++G+G +G V+    +  ++  A+K L    +      E    E +V   A     H  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---WEHPF 79

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           L  +     +    +  V EY+N G+L   +      C       R       IILG   
Sbjct: 80  LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIILG--- 130

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L +LH      +V+RD+K  NIL+DK  + K++DFG+ K      +   T    GT  Y
Sbjct: 131 -LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDY 184

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L  +      D +SFG+L+ E++ G+ P
Sbjct: 185 IAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           +VIG G Y  V    L+   ++ A+K +    +N+    +    E  V  +A     H  
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPF 71

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           LV L   C +   R+  V EYVN G+L   +         L  E         I L    
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISLA--- 122

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L+YLHE     +++RD+K  N+L+D   + K++D+G+ K         TT    GT  Y
Sbjct: 123 -LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNY 176

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L         D ++ G+L+ E+++GR P
Sbjct: 177 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           +V+G+G +G V    +++   + AVK L    +      E    E ++   A     H  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA---RNHPF 85

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           L +L   C +   R+  V E+VN G+L   +            E R       II     
Sbjct: 86  LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD----EARARFYAAEIISA--- 136

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L +LH+     +++RD+K  N+L+D   + K++DFG+ K         TT    GT  Y
Sbjct: 137 -LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDY 190

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L E       D ++ G+L+ E++ G  P
Sbjct: 191 IAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.7 bits (154), Expect = 2e-11
 Identities = 48/320 (15%), Positives = 92/320 (28%), Gaps = 83/320 (25%)

Query: 76  VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVK--------NLLNNRGQAEREFKVEVE 127
           + T      + IGEG +G V+  +  D++ VA+K         +  +  +   E   E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 128 ---------AIGRVRHKNLVRLLG-YCAEGAH---------------------------- 149
                         R +  + L   +C +G++                            
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 150 -RMLVYEYVNNGN-LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD 207
              +V E+   G  LEQ            +     +I+      L+        +  HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187

Query: 208 IKSSNILIDKHWNPKVSDFGLAKLLGSESS--------YITTRVMGTFGYV-----APEY 254
           +   N+L+ K    K+      K     S         Y  +R+      V       E 
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN------LIEWLKKMVTNRNPE 308
             TG  + + D+Y         +       +       N      L + + K +T +   
Sbjct: 248 LFTGDGDYQFDIYRL-------MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300

Query: 309 GVLDPKLPEKPTSRLLKRIL 328
                K  ++      + +L
Sbjct: 301 NTPAMKQIKRKIQEFHRTML 320

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 52/226 (23%)

Query: 85  KVIGEGGYGIVY---YGLLEDNSKV-AVK-----NLLNNRGQAEREFKVEVEAIGRVRHK 135
           KV+G G YG V+        D  K+ A+K      ++      E   + E + +  +R  
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQS 118

Query: 136 N-LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN---------- 183
             LV L  Y  +   ++ L+ +Y+N G L  + H        L+   R            
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FTH--------LSQRERFTEHEVQIYVGE 167

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I+L     L +LH+     +++RDIK  NIL+D + +  ++DFGL+K   ++ +      
Sbjct: 168 IVLA----LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220

Query: 244 MGTFGYVAPEYASTGMLNERS-------DVYSFGILIMEVISGRIP 282
            GT  Y+AP+     ++           D +S G+L+ E+++G  P
Sbjct: 221 CGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           +VIG G Y  V    L+   ++ A++ +    +N+    +    E  V  +A     H  
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPF 114

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           LV L   C +   R+  V EYVN G+L   +         L  E         I L    
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISLA--- 165

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L+YLHE     +++RD+K  N+L+D   + K++D+G+ K         TT    GT  Y
Sbjct: 166 -LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNY 219

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L         D ++ G+L+ E+++GR P
Sbjct: 220 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 53/223 (23%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
            V+G+G +G V     +   ++ AVK L    +      E    E +V        +   
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP---GKPPF 82

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------II 185
           L +L   C +   R+  V EYVN G+L   +              R            I 
Sbjct: 83  LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIA 131

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM- 244
           +G    L +L       +++RD+K  N+++D   + K++DFG+ K    +    TT+   
Sbjct: 132 IG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFC 182

Query: 245 GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           GT  Y+APE     ++  +      D ++FG+L+ E+++G+ P
Sbjct: 183 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 51/248 (20%), Positives = 101/248 (40%), Gaps = 48/248 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN---RGQAEREFKV-------EVEAIGRVR 133
           + +G G +  V+    + +N+ VA+K +  +      AE E K+       +      + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 134 HKNLVRLLGY----CAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILG 187
             ++++LL +       G H ++V+E V   NL   +  +   G       +I   ++LG
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP------KVSDFGLAKLLGSE-SSYIT 240
               L Y+H      ++H DIK  N+L++   +P      K++D G A       ++ I 
Sbjct: 144 ----LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 241 TRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
           TR      Y +PE      +         +D++S   LI E+I+G    +          
Sbjct: 198 TRE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

Query: 295 IEWLKKMV 302
            + + +++
Sbjct: 247 DDHIAQII 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 35/233 (15%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN---RGQAERE 121
              Y ++  E   + +  D +IG+G +G V       +   VA+K + N      QA+ E
Sbjct: 42  YD-YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE 100

Query: 122 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT 177
            ++   +          +V L  +     H  LV+E ++  NL   L      G    LT
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLT 159

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNPKVSDFGLAKLLGSE 235
            +    +       L +L    E  ++H D+K  NIL+   K    K+ DFG +  LG  
Sbjct: 160 RKFAQQMCTA----LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 236 -SSYITTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRI 281
              YI +R    F Y +PE      Y      +   D++S G +++E+ +G  
Sbjct: 215 IYQYIQSR----F-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGEP 256

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 48/183 (26%)

Query: 74  LEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           L++  N   DD     +V+G G  G V          K A+K +L +  +A RE ++   
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 66

Query: 128 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVNNGNL-------------EQWLHGDV 170
           A       ++VR++       A     ++V E ++ G L             E+    + 
Sbjct: 67  ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EA 119

Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFG 227
                      M  I    + + YLH      + HRD+K  N+L   K  N   K++DFG
Sbjct: 120 SEI--------MKSIG---EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 228 LAK 230
            AK
Sbjct: 166 FAK 168

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 24/158 (15%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            K IG G +G +  G  L  N  VA+K   + +   Q   E++   +         + ++
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQV 70

Query: 141 LGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGT--AKGLSYLHE 197
             +   G +  +V E +  G +LE         C   T+ ++  +++       + Y+H 
Sbjct: 71  YYFGPCGKYNAMVLELL--GPSLEDLFDL----CDR-TFSLKTVLMIAIQLISRMEYVHS 123

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVS-----DFGLAK 230
                +++RD+K  N LI +  N         DF LAK
Sbjct: 124 ---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 6e-08
 Identities = 48/342 (14%), Positives = 102/342 (29%), Gaps = 96/342 (28%)

Query: 99  LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------- 151
           L  DN   A  N+  +R Q   + +   +A+  +R    V + G        +       
Sbjct: 119 LYNDNQVFAKYNV--SRLQPYLKLR---QALLELRPAKNVLIDG--------VLGSGKTW 165

Query: 152 LVYEYVNNGNLEQ-------WLHGDVGPC-SP---------------LTWEIRMNIILGT 188
           +  +   +  ++        WL  ++  C SP                 W  R +     
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWL--NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD-FGL-AKLLGSESSYITTRVMGT 246
              +  +   L   +  +  ++  +++    N K  + F L  K+L      +TTR    
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL------LTTRFKQV 277

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI-EWLKKMVTNR 305
             +++    +   L+  S   +                   P E  +L+ ++L       
Sbjct: 278 TDFLSAATTTHISLDHHSMTLT-------------------PDEVKSLLLKYL------- 311

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ-------KRPKMGHVVHM-LEAQES 357
                    LP +  +   +R+ ++A    D  A           K+  ++   L   E 
Sbjct: 312 ---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368

Query: 358 PSKEDRYRAS---PKNELIEKQVTES--GDNSTNETGVHTNE 394
                 +      P +  I   +      D   ++  V  N+
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 28/160 (17%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKN--LLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            + IGEG +G+++ G  L +N +VA+K     ++  Q   E++      G      +  +
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNV 71

Query: 141 LGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAK----GLSYL 195
             +  EG H +LV + +  G +LE  L       S  T       +   AK     +  +
Sbjct: 72  YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQSI 122

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPK-----VSDFGLAK 230
           HE     +V+RDIK  N LI +  +       V DFG+ K
Sbjct: 123 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 37/233 (15%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN---RGQAERE 121
           G  Y     +     +   KVIG+G +G V      + +  VA+K + N      QA  E
Sbjct: 85  GS-YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE 143

Query: 122 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT 177
            ++   +    +    N++ +L       H  + +E ++  NL + +  +   G   PL 
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLV 202

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSE 235
            +   +I+    + L  LH+    +++H D+K  NIL+ +      KV DFG +      
Sbjct: 203 RKFAHSIL----QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

Query: 236 -SSYITTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRI 281
             +YI +R    F Y APE      Y          D++S G ++ E+++G  
Sbjct: 256 VYTYIQSR----F-YRAPEVILGARY------GMPIDMWSLGCILAELLTGYP 297

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 33/169 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVA---VKNLLNNRGQAEREFKVE-----VEAIGRVRHK 135
           K IG GG+G++Y         K A   VK      G    E K        + I +   +
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 136 NLVRLLG-----YC-----AEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLT-WEIRMN 183
             +  LG               ++R +V E +  G +L++ + G  G     T  ++ + 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIR 159

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAK 230
           ++      L Y+HE    + VH DIK++N+L+      +V  +D+GL+ 
Sbjct: 160 ML----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 40/241 (16%), Positives = 72/241 (29%), Gaps = 64/241 (26%)

Query: 85  KVIGEGGYGIVYYGL---------LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK 135
                   GI+Y                 K ++K L    G+   E      A   ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 136 NLVRLLG----------YC--AEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRM 182
              +L                 +  +R LV   +  G +L+  L              R 
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALD----VSPKHVLSERS 160

Query: 183 NIILGT--AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAKLLGSESSY 238
            + +       L +LHE    + VH ++ + NI +D     +V  + +G A        Y
Sbjct: 161 VLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF------RY 211

Query: 239 ITTRV------------MGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRI 281
             +               G       E+ S  +        RSD+ S G  +++ + G +
Sbjct: 212 CPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266

Query: 282 P 282
           P
Sbjct: 267 P 267

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 47/257 (18%), Positives = 86/257 (33%), Gaps = 74/257 (28%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVR-----HKNL 137
           +G G +  V+    ++    VA+K   +  +    A  E ++  +++          + +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL-KSVRNSDPNDPNREMV 103

Query: 138 VRLLGY----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           V+LL         G H  +V+E V   +L +W+         L       II    +GL 
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 194 YLHEGLEPKVVHRDIKSSNILI-------------------------------------- 215
           YLH   + +++H DIK  NIL+                                      
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 216 -----------DKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNER 263
                       +    K++D G A  +    +  I TR      Y + E       N  
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273

Query: 264 SDVYSFGILIMEVISGR 280
           +D++S   +  E+ +G 
Sbjct: 274 ADIWSTACMAFELATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 64/241 (26%)

Query: 85  KVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAEREFKV-----EVEAIGRVR 133
             IG+GG+G +Y         +  ++   VK   ++ G    E K      + E I +  
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 134 HKNLVRLLG----------YCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPL--TWEI 180
               ++ LG               ++R ++ +    G +L++ ++             ++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAKRFSRKTVLQL 157

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAKLLGSESSY 238
            + I+      L Y+HE    + VH DIK+SN+L++     +V   D+GLA        Y
Sbjct: 158 SLRIL----DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY------RY 204

Query: 239 ITTRVM------------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRI 281
               V             GT      E+ S    N      R D+   G  +++ ++G +
Sbjct: 205 CPEGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259

Query: 282 P 282
           P
Sbjct: 260 P 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 34/162 (20%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--- 137
            + IG G +G +Y G  +    +VA+K   +     Q   E K+         +K +   
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---------YKMMQGG 64

Query: 138 ---VRLLGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGT--AKG 191
                +    AEG + ++V E +  G +LE     D+       + ++  ++L       
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLE-----DLFNFCSRKFSLKTVLLLADQMISR 117

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPK---VSDFGLAK 230
           + Y+H       +HRD+K  N L+          + DFGLAK
Sbjct: 118 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 20/155 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            + IG G +G +Y G  ++ N +VA+K  N+     Q   E K+     G      +  +
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNV 68

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT--AKGLSYLHEG 198
             +  EG + +LV + +   +LE   +      S     ++  ++L       + ++H  
Sbjct: 69  RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLS-----LKTVLMLADQMINRVEFVHS- 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPK---VSDFGLAK 230
                +HRDIK  N L+          + DFGLAK
Sbjct: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 49/251 (19%), Positives = 84/251 (33%), Gaps = 55/251 (21%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVY--YGLLEDNSKVAVKNLLNN---RGQAER 120
           GH    R  +     +     +GEG +G V          S+VA+K + N    R  A  
Sbjct: 7   GH-LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL 65

Query: 121 EFKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPL 176
           E  V  +++   +      V +  +     H  + +E +   N  ++L  +       P 
Sbjct: 66  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPH 124

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--------------- 221
              +   +       L +LHE    ++ H D+K  NIL                      
Sbjct: 125 VRHMAYQLC----HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 222 ----KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPE------YASTGMLNERSDVYSFG 270
               +V+DFG A       ++ + TR      Y  PE      +       +  DV+S G
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIG 226

Query: 271 ILIMEVISGRI 281
            ++ E   G  
Sbjct: 227 CILFEYYRGFT 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	407
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.21
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.64
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.2
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.19
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.9
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.7
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.66
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.63
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.53
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.48
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.38
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.05
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.03
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.63
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.58

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.5e-60  Score=447.57  Aligned_cols=263  Identities=26%  Similarity=0.444  Sum_probs=212.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      +..++|.+.+.||+|+||.||+|.+.      ++..||||++........+.|.+|+.+|++++|||||++++++.+.+.
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34567888899999999999999864      367899999987777777889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCC-----------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVG-----------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      ++||||||++|+|.++++....           ...++++.+++.|+.||+.||+|||++   +|+||||||+||||+.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            9999999999999999976431           124699999999999999999999999   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHH
Q 015395          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  296 (407)
                      +.+||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+      
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------  268 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------  268 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------
Confidence            99999999999876543322 2344679999999999999999999999999999999999 899998654322      


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .+..+.....      ...+    ..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       269 ~~~~i~~g~~------~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 AIDCITQGRE------LERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHTCC------CCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC------CCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            2222222211      1122    2345678999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-60  Score=443.07  Aligned_cols=262  Identities=25%  Similarity=0.448  Sum_probs=217.7

Q ss_pred             hcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||||++........+.|.+|+.+|++++|||||++++++.+++.+
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3567899999999999999999864      3677999999877777778899999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCC---------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          151 MLVYEYVNNGNLEQWLHGDV---------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                      +||||||++|+|.++|+...         .....+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence            99999999999999997532         2235799999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      ||+|||+|+......... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+      .+.
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~  241 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIE  241 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence            999999998765443322 233569999999999999999999999999999999999 899998654322      222


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .+.....      ...+    ..++.++.+||.+||+.||++|||+.+|.+.|+.+.+
T Consensus       242 ~i~~~~~------~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          242 CITQGRV------LQRP----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHTCC------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC------CCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222211      1111    2345679999999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-58  Score=434.22  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=212.9

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      |++..++|.+.+.||+|+||+||+|.+.  ..||||++...  .....+.|.+|+.+|++++|||||++++++.+ +.++
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            4667789999999999999999999865  36999988643  34455789999999999999999999998865 5689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ||||||++|+|.++|+...   ..+++..++.|+.||+.||+|||++   +||||||||+||||+.++++||+|||+|+.
T Consensus       108 iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            9999999999999997653   5799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc-eeeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          232 LGSESS-YITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ...... ......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||...+.....      .........
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~~~  255 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRGYA  255 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTTCC
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCC
Confidence            654322 23345679999999999853   46899999999999999999999999865543221      122222111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                          .+.++ .....++..+.+||.+||+.||++|||+.+|++.|+.++.+.
T Consensus       256 ----~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          256 ----SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             ----CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ----CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                11111 122345667999999999999999999999999999887654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-58  Score=439.81  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=214.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ..|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999975 68899999997655555567888999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      +||+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999975     3699999999999999999999999   999999999999999999999999999998754433


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+      .+..+.....      +.  .
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~------~~--~  290 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLP------PR--L  290 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSSC------CC--C
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCC------CC--C
Confidence             2445689999999999999999999999999999999999999997654322      2222222111      11  1


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .....++.++.+||.+||+.||++|||+.++++.-.
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~  326 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  326 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            123445677999999999999999999999987544

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.1e-59  Score=441.66  Aligned_cols=252  Identities=21%  Similarity=0.376  Sum_probs=206.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++++.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999965 6889999998654  3344567889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |||+||+|.++|.....  ..+++..++.|+.||+.||+|||++   +|+||||||+||||+.+|.+||+|||+|+....
T Consensus       103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999975432  4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+..      +.+.++......      .
T Consensus       178 ~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~~~------~  244 (350)
T 4b9d_A          178 TVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISGSFP------P  244 (350)
T ss_dssp             HHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC------C
T ss_pred             Ccc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCCCC------C
Confidence            221 234467999999999999999999999999999999999999999765432      223333332211      1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .    ...++.++.+||.+||+.||++|||+.++++.
T Consensus       245 ~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          245 V----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1    12345678999999999999999999999873

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-58  Score=434.99  Aligned_cols=260  Identities=25%  Similarity=0.381  Sum_probs=213.4

Q ss_pred             hcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ...++++.+.||+|+||.||+|.+.      +++.||||++.... ....+.|.+|+.+|++++|||||++++++.+.+.
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            3456788899999999999999863      45689999986543 3445789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  217 (407)
                      ++||||||++|+|.++|.....            ....+++..++.++.||+.||+|||++   +||||||||+||||++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999965421            124689999999999999999999999   9999999999999999


Q ss_pred             CCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHH
Q 015395          218 HWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       218 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~  295 (407)
                      ++++||+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+     
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-----  255 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----  255 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-----
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999987643322 22344579999999999999999999999999999999998 899998654322     


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                       .+..+.. ...     ...    +..++..+.+||.+||+.||++||||.+|++.|+..
T Consensus       256 -~~~~i~~-~~~-----~~~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 -VVEMIRN-RQV-----LPC----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHHHHT-TCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHHHHc-CCC-----CCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             1222222 111     111    223456789999999999999999999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.3e-59  Score=436.94  Aligned_cols=250  Identities=22%  Similarity=0.342  Sum_probs=212.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++++.||+|+||+||+|... +++.||||++...   .......+.+|+++|++++|||||++++++.+.+.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999965 6889999998643   223456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||||+||+|.++|...    +.+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+.
T Consensus       111 mEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            9999999999999765    5799999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .... ....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+..      +.+.++....       
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~-------  250 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKLE-------  250 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-------
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-------
Confidence            4432 3345678999999999999999999999999999999999999999765432      2223333221       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..++.    .++.++.+||.+||+.||++|||+++++..
T Consensus       251 ~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 YDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             CCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             CCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            11222    244578999999999999999999987543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.2e-58  Score=432.79  Aligned_cols=252  Identities=18%  Similarity=0.198  Sum_probs=208.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .+.|++.+.||+|+||.||+|.+. +++.||||++.....     ..+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456888899999999999999965 688999999865432     23599999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~  235 (407)
                      |+||+|.++|...    +.+++..++.++.||+.||+|||++   +|+||||||+||||+.+| .+||+|||+|+.+...
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999765    5799999999999999999999999   999999999999999987 5999999999987543


Q ss_pred             Cce----eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          236 SSY----ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       236 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ...    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||......+....      +.......   
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~~~~---  275 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEPPPI---  275 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HHHSCCGG---
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HHcCCCCc---
Confidence            221    12335799999999999999999999999999999999999999987655433222      22211100   


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                           ...+..++..+.++|.+||++||.+|||+.|+++.|...
T Consensus       276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                 011223456789999999999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-57  Score=442.19  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=213.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      +.|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46999999999999999999965 68899999997665555667889999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      +||+|.+++..     ..+++..+..++.||+.||+|||++   +||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999975     3599999999999999999999999   999999999999999999999999999998754432


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+      .+..+.....      +.+  
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~------~~~--  367 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLP------PRL--  367 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC------CCC--
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCC------CCC--
Confidence             2455689999999999999999999999999999999999999997554322      2222222211      111  


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .....++..+.+||.+||+.||++|||+.|+++.-.
T Consensus       368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~  403 (423)
T 4fie_A          368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  403 (423)
T ss_dssp             SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence            112234567899999999999999999999987433

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-57  Score=420.45  Aligned_cols=246  Identities=25%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec----CCeeEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV  153 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv  153 (407)
                      |++.+.||+|+||.||+|.+. ++..||+|++...  .......+.+|+.+|++++|||||++++++.+    ...+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            366778999999999999965 5788999998644  33445678999999999999999999999864    3568999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEeC-CCCcEEeecccce
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDK-HWNPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~-~~~~kl~DfGla~  230 (407)
                      ||||++|+|.+++...    ..+++..+..|+.||+.||+|||++   +  |+||||||+||||+. ++.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999865    5799999999999999999999998   7  999999999999974 7899999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .....   .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.......     ...... .....   
T Consensus       181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i-~~~~~---  247 (290)
T 3fpq_A          181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRV-TSGVK---  247 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHH-TTTCC---
T ss_pred             eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHH-HcCCC---
Confidence            65332   2345689999999999865 69999999999999999999999997544322     112222 22111   


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                           +.......+.++.+||.+||+.||++|||+.++++.
T Consensus       248 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 111122234468999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-57  Score=417.95  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=195.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||+||+|... +++.||||++....   ......+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999954 68999999986542   334567889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||| +|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 68999999765    5799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..  .....+||+.|||||++.+..+ +.++|||||||++|+|+||+.||...+..      ..+.......       .
T Consensus       165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~~~-------~  229 (275)
T 3hyh_A          165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISNGV-------Y  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-------C
T ss_pred             CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC-------C
Confidence            32  2345689999999999998876 57999999999999999999999754322      2222222221       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .++    ..++..+.+||.+||+.||++|||++++++.-.
T Consensus       230 ~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw  265 (275)
T 3hyh_A          230 TLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW  265 (275)
T ss_dssp             CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred             CCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence            112    124457899999999999999999999998543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8e-57  Score=430.25  Aligned_cols=270  Identities=26%  Similarity=0.389  Sum_probs=221.0

Q ss_pred             ccHHHHHHhcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCC-Ccccee
Q 015395           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRH-KNLVRL  140 (407)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h-pniv~~  140 (407)
                      ++...|++..++|++.+.||+|+||.||+|.+..      ++.||||.+..... ...+.+.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4567889999999999999999999999998543      24699999876543 345678999999999965 999999


Q ss_pred             eeeeec-CCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccC
Q 015395          141 LGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD  207 (407)
Q Consensus       141 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D  207 (407)
                      +++|.+ ++.++||||||++|+|.++|+....            ....+++..++.++.||+.||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            999865 4678999999999999999975321            124589999999999999999999999   999999


Q ss_pred             CCCccEEEeCCCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 015395          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY  285 (407)
Q Consensus       208 lkp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~  285 (407)
                      |||+|||++.++.+||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997754433 23445679999999999999999999999999999999998 9999987


Q ss_pred             CCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ....+..      ...+.....     ...|    ..++.++.++|.+||+.||++|||+.+|++.|+.+.
T Consensus       291 ~~~~~~~------~~~i~~g~~-----~~~p----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          291 VKIDEEF------CRRLKEGTR-----MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCCSHHH------HHHHHHTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHH------HHHHHcCCC-----CCCC----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            6543221      111221111     1122    223457899999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-57  Score=423.99  Aligned_cols=243  Identities=24%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++++.||+|+||+||+|+..    +++.||||++....  ......+.+|+.+|++++|||||++++++.+.+.+|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            367999999999999999999853    46789999986432  122335778999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ||||||+||+|.++|...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus       103 ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            999999999999999865    5799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ...... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+      .+..+....      
T Consensus       176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~------  242 (304)
T 3ubd_A          176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAK------  242 (304)
T ss_dssp             -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC------
T ss_pred             ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCC------
Confidence            543322 2345689999999999999999999999999999999999999998654322      222222221      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                       ..++    ..++.++.+||.+||+.||++|||+
T Consensus       243 -~~~p----~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 -LGMP----QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -CCCC----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -CCCC----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence             1122    2245678999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-55  Score=411.74  Aligned_cols=267  Identities=25%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----eeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~lv~  154 (407)
                      .+|.+.+.||+|+||.||+|.+. |+.||||++..... ....+..|+..+.+++|||||++++++.+.+    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            35788899999999999999985 88999998854432 2223345666777899999999999987653    579999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----CCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      |||++|+|.++|+..     .+++..+++++.|++.||+|||++.     .++|+||||||+||||+.++++||+|||+|
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999864     6899999999999999999999752     348999999999999999999999999999


Q ss_pred             eecCCCCcee---eeeeeccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--------h
Q 015395          230 KLLGSESSYI---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--------V  292 (407)
Q Consensus       230 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~--------~  292 (407)
                      +.........   ....+||+.|||||++.+.      .++.++|||||||+||||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8875544322   2345799999999999764      367899999999999999999887643321110        0


Q ss_pred             hHHHHHHHHhhcCCCCCcCCCCCCCCc-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          293 NLIEWLKKMVTNRNPEGVLDPKLPEKP-TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .....+.......    .+++.++... ....+..+.+||.+||+.||++||||.+|++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1112222322222    2233443322 3456778999999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.3e-54  Score=401.24  Aligned_cols=250  Identities=22%  Similarity=0.416  Sum_probs=191.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC--------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--------  148 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------  148 (407)
                      ++|++++.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35899999999999999999965 68899999986543 344567889999999999999999999986543        


Q ss_pred             ----eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          149 ----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       149 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                          .+|||||||++|+|.+++.... ......+..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                3799999999999999998652 123456777899999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCce-----------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh
Q 015395          225 DFGLAKLLGSESSY-----------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN  293 (407)
Q Consensus       225 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~  293 (407)
                      |||+|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||...     ..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence            99999877543221           1234579999999999999999999999999999999996   77521     11


Q ss_pred             HHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ....+......         .++. .....+..+.+||.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~---------~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVRTLTDVRNL---------KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHHTT---------CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcC---------CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12222222211         1111 12334455788999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=405.29  Aligned_cols=264  Identities=23%  Similarity=0.341  Sum_probs=205.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec------CCe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  149 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  149 (407)
                      ++|++++.||+|+||+||+|.+. +|+.||||++....  ......+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999965 68999999986543  3344577889999999999999999998753      467


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +|||||||+ |+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 6899999765    5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCC---ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          230 KLLGSES---SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       230 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      +.+....   .......+||+.|||||++.+. .++.++|||||||++|||++|+.||.+.+..+....+   .......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCC
Confidence            8764322   1223456899999999998775 5699999999999999999999999876543332222   2111111


Q ss_pred             CCCCc--------------CCCCCCCCc---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          306 NPEGV--------------LDPKLPEKP---TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       306 ~~~~~--------------~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .....              +....+...   ...++.++.+||.+||..||++|||+.++++.-.
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  347 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF  347 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence            00000              000000000   0123457889999999999999999999987544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-51  Score=419.53  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=216.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++..........+.+|+.+|+.++|||||++++++.+...+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            357999999999999999999965 6889999999877666677888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC--CCcEEeecccceecCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH--WNPKVSDFGLAKLLGS  234 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~DfGla~~~~~  234 (407)
                      |+||+|.++|....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999996543   4799999999999999999999999   99999999999999754  8999999999998765


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...  ....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+....+      .+..+....       ..
T Consensus       310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~-------~~  374 (573)
T 3uto_A          310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-------WN  374 (573)
T ss_dssp             TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC-------CC
T ss_pred             CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCC-------CC
Confidence            433  345689999999999999999999999999999999999999998654332      222222221       12


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ++......++..+.+||.+||+.||.+|||+.++++.-
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp  412 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  412 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            22222334567789999999999999999999998853

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-51  Score=394.42  Aligned_cols=260  Identities=20%  Similarity=0.281  Sum_probs=198.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||+||+|..+    +++.||||.+....  ....+.+|+.+|+.+ +||||+++++++.+.+.+||
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            467999999999999999999853    46789999886543  344677899999988 69999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEeeccccee
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKL  231 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~~  231 (407)
                      |||||++|+|.+++.       .+++.++..++.||+.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999983       489999999999999999999999   99999999999999877 7999999999986


Q ss_pred             cCCCCc---------------------------eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 015395          232 LGSESS---------------------------YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPV  283 (407)
Q Consensus       232 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf  283 (407)
                      ......                           ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            543211                           112345799999999999776 4899999999999999999999999


Q ss_pred             CCCCCchhhhHHHHHHHHhh----------------------------------c-CC-CCC----cCCCCCCCCccHHH
Q 015395          284 DYSRPPEEVNLIEWLKKMVT----------------------------------N-RN-PEG----VLDPKLPEKPTSRL  323 (407)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~----------------------------------~-~~-~~~----~~~~~~~~~~~~~~  323 (407)
                      ........  ....+.....                                  . .. ...    .............+
T Consensus       248 ~~~~~~~~--~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          248 YKASDDLT--ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCHHH--HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            65443211  1111110000                                  0 00 000    00000000112234


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          324 LKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       324 ~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      +.++.+||.+||+.||++|||++|+++.
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5678899999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.8e-51  Score=385.40  Aligned_cols=282  Identities=40%  Similarity=0.713  Sum_probs=246.1

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ++....++|.+.+.||+|+||.||+|.+.++..||||++..........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34456789999999999999999999988899999999877766677788999999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999999977654445799999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          233 GSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       233 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+......+.............+
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            43322 22334568999999999988899999999999999999999999998877776666676666666666666667


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ++.+........+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            7776666778889999999999999999999999999999997643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.7e-51  Score=414.81  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=205.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHH---HHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAER---EFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~---~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      +..++|+++++||+|+||.||+|+.. +++.||||++....   .....   ....++.+++.++|||||+++++|.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            35678999999999999999999965 68899999985431   11122   2234567788889999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+|||||||+||+|.++|...    +.+++..+..|+.||+.||+|||++   +||||||||+||||+.+|.+||+|||+
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999865    5799999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      |+......   ..+.+||+.|||||++.. ..|+.++|||||||+||||++|..||......+..   +.........  
T Consensus       339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~~--  410 (689)
T 3v5w_A          339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMA--  410 (689)
T ss_dssp             CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHCC--
T ss_pred             eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCCC--
Confidence            98775432   345689999999999964 57999999999999999999999999765433222   2222222211  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                           ..++    ..++.++.+||.+||+.||.+|++     +++|++
T Consensus       411 -----~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 -----VELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----CCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----CCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 1122    234567899999999999999998     677775

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-50  Score=384.46  Aligned_cols=292  Identities=40%  Similarity=0.763  Sum_probs=248.5

Q ss_pred             CCCccccHHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCccceeee
Q 015395           64 GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      +....+++.++.+..++|.+.+.||+|+||.||+|...++..||||++...... ....+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            334567889999999999999999999999999999878999999998654322 2236788999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      ++......++||||+.+++|.+++.........+++..++.++.|++.||+|||+....+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999988765556799999999999999999999998667899999999999999999999


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CchhhhHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR--PPEEVNLIEWLKK  300 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~  300 (407)
                      |+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|..||....  .........++..
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999999876555555555679999999999988889999999999999999999999996321  1122334555555


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .........+.+...........+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            5555555666666776777788899999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-48  Score=365.04  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=213.1

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45799999999999999999995 46889999998766656667788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...     .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999764     589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|..||........      +.........        .
T Consensus       171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~--------~  235 (297)
T 3fxz_A          171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP--------E  235 (297)
T ss_dssp             C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC--------C
T ss_pred             c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC--------C
Confidence            3 23345799999999999999999999999999999999999999975443221      1111111111        0


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ......++..+.++|.+||+.||++|||+.++++.-.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            1112345567899999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.2e-48  Score=367.51  Aligned_cols=266  Identities=29%  Similarity=0.461  Sum_probs=207.8

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ..+.+..++|++.+.||+|+||.||+|... +..||+|++....  ......+.+|+.++++++||||+++++++.+...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            344566778999999999999999999874 7889999986553  3444678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEeCCCCcEEeecc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      .++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999999986421 12389999999999999999999999   8  9999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.      ..........
T Consensus       185 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~  257 (309)
T 3p86_A          185 LSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFKCKR  257 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHSCCC
T ss_pred             CCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCC
Confidence            9986543321 23345689999999999999999999999999999999999999975543221      1111111111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                           ..+    ...++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       258 -----~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 -----LEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                 111    123445689999999999999999999999999987654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=365.78  Aligned_cols=258  Identities=26%  Similarity=0.445  Sum_probs=214.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ..++|.+.+.||+|+||.||+|.+. ++..||+|++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            3467999999999999999999975 588899999877777777889999999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        88 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999999998643   5699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Ccee-------------eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh---hHHHHHH
Q 015395          236 SSYI-------------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV---NLIEWLK  299 (407)
Q Consensus       236 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~~~  299 (407)
                      ....             .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........   .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            2211             11456999999999999999999999999999999999999998764433221   1111111


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .    .     ..+        .++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       242 ~----~-----~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          242 R----Y-----CPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             H----T-----CCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c----c-----CCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1    0     001        122348899999999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.6e-48  Score=358.96  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=217.2

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++..++|++.+.||+|+||.||+|...++..||+|++..... ....+.+|+.++++++||||+++++++.+....++||
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            345678999999999999999999988888899998865543 3456888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999999999997642   3589999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.      .........      .
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~------~  224 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVSQGHR------L  224 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHTTCC------C
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHHHcCCC------C
Confidence            54444444456788999999988889999999999999999999 9999975543221      122221111      0


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      ..+    ...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       225 ~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          225 YRP----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCC----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCC----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            111    11234688999999999999999999999999988654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.4e-48  Score=375.23  Aligned_cols=264  Identities=25%  Similarity=0.422  Sum_probs=214.7

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      .+..++|.+.+.||+|+||.||+|.+.        ++..||||++.... ......+.+|+.+|+.+ +||||+++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            445678999999999999999999852        34569999986653 33456788999999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      .+.+.+++||||+++|+|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999976431            123589999999999999999999999   99999999999


Q ss_pred             EEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCch
Q 015395          213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (407)
Q Consensus       213 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~  290 (407)
                      |||+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999999876543321 1223356889999999999999999999999999999999 999998654332


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ..   .   ...... .     ...    +..++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       314 ~~---~---~~~~~~-~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 LF---K---LLKEGH-R-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             HH---H---HHHTTC-C-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---H---HHhcCC-C-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            21   1   111111 0     111    12344578999999999999999999999999998643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-48  Score=360.09  Aligned_cols=259  Identities=27%  Similarity=0.449  Sum_probs=215.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .+..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            345578999999999999999999988888999999875543 3457888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             ECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999997653   4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+      ..........      .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~~~------~  226 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFR------L  226 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC------C
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcCcc------C
Confidence            33222333456788999999998999999999999999999999 999997544322      1222222111      1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ..    ....+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       227 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          227 YK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC----CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            11    1123456899999999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=367.45  Aligned_cols=260  Identities=28%  Similarity=0.466  Sum_probs=212.0

Q ss_pred             hcCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||.+... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3567999999999999999999974    3445999998765 3445567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       127 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            9999999999999997543   4699999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          232 LGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       232 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ........  .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.      .........  
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~~~~~~~~~--  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV------ISSVEEGYR--  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HHHHHTTCC--
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH------HHHHHcCCC--
Confidence            75433221  222346788999999998899999999999999999999 9999975543221      222221111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                          ..    ....++..+.++|.+||+.||.+|||+.+|++.|+.+...
T Consensus       273 ----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          273 ----LP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ----CC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                11    1123445789999999999999999999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.7e-48  Score=368.11  Aligned_cols=250  Identities=21%  Similarity=0.337  Sum_probs=209.4

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++...  .......+.+|+.+|+.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            56899999999999999999997 57899999998654  3344567888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999765    5699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...  ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......+      ..........       
T Consensus       167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~-------  231 (328)
T 3fe3_A          167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRGKY-------  231 (328)
T ss_dssp             SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------
T ss_pred             CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-------
Confidence            332  3345799999999999888765 79999999999999999999997654322      2222222211       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..+.    .++..+.+|+.+||..||.+|||+.++++.-.
T Consensus       232 ~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          232 RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence            1111    23456889999999999999999999987533

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.2e-48  Score=361.32  Aligned_cols=262  Identities=27%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999965 6889999988543   234456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    .++++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999999765    5799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.      ..........      
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~------  230 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDSVP------  230 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSCCC------
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhccCC------
Confidence            4443334455799999999999999999999999999999999999999976543211      1122221111      


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHhccCC
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQESP  358 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~~~  358 (407)
                      ..+......++..+.++|.+||+.||.+|| +++++.+.|+.+...
T Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            000011223456799999999999999999 999999999987553

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.9e-48  Score=358.56  Aligned_cols=260  Identities=22%  Similarity=0.396  Sum_probs=212.3

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +++..++|++.+.||+|+||.||+|.+.++..||+|++..... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            3455678999999999999999999998888999998875543 345688899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           98 TEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             ECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            99999999999997632   4699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+.      .........      
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~~~~~------  239 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLR------  239 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHTTCC------
T ss_pred             ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HHHHhcccC------
Confidence            433222233346788999999998899999999999999999998 9999975543221      122221110      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ...+    ...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       240 ~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 LYRP----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            1111    122356889999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.8e-47  Score=366.28  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=209.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh------hHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .+.|.+.+.||+|+||.||+|... ++..||+|.+......      ....+.+|+.+|+.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            357999999999999999999965 6889999998654322      356788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC----CcEEeec
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDF  226 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df  226 (407)
                      ++||||+++|+|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999765    5799999999999999999999999   999999999999998776    7999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |++........  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .+..+.... 
T Consensus       164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~-  234 (361)
T 2yab_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVS-  234 (361)
T ss_dssp             SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC-
T ss_pred             CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-
Confidence            99987754322  334579999999999999999999999999999999999999997654322      222222211 


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                            ..++......++..+.+||.+||..||.+|||+.++++.
T Consensus       235 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          235 ------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  111111122345678999999999999999999999863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.9e-47  Score=365.11  Aligned_cols=249  Identities=24%  Similarity=0.302  Sum_probs=208.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++...   .......+..|+.+|+.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999965 6889999998653   223445678899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999999765    4699999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... .....+||+.|+|||++.+..++.++|||||||++|||++|..||......+      ....+....       .
T Consensus       157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-------~  222 (337)
T 1o6l_A          157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-------I  222 (337)
T ss_dssp             CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-------C
T ss_pred             cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-------C
Confidence            3222 2345679999999999999999999999999999999999999997543221      122222221       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      .++    ..++..+.++|.+||+.||.+||     ++.++++.
T Consensus       223 ~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 RFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            111    12445789999999999999999     89999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-46  Score=356.05  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=212.1

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      |...+.||+|+||.||+|... +++.||||++..........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            677789999999999999976 6899999999776666677888999999999999999999999999999999999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      ++|.+++..     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus       127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  197 (321)
T 2c30_A          127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K  197 (321)
T ss_dssp             CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred             CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence            999999865     3699999999999999999999999   999999999999999999999999999987654332 2


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCc
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (407)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      .+........      +.+  ..
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~------~~~--~~  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRLRDSPP------PKL--KN  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSSC------CCC--TT
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCC------CCc--Cc
Confidence            334579999999999999999999999999999999999999997543321      1222222111      111  11


Q ss_pred             cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ...++..+.+++.+||+.||++|||+.++++......
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            2334567899999999999999999999998655443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-47  Score=369.27  Aligned_cols=255  Identities=19%  Similarity=0.312  Sum_probs=206.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ++|++.+.||+|+||.||+|... +++.||||++....     ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46999999999999999999965 68899999885321     2245678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC---cEEeecccc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLA  229 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGla  229 (407)
                      |||||++++|.+++.........+++..++.++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            9999999999988865322224689999999999999999999999   9999999999999986654   999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....       ............   
T Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~---  249 (351)
T 3c0i_A          181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKY---  249 (351)
T ss_dssp             EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCC---
T ss_pred             eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCC---
Confidence            88765432 2334579999999999999999999999999999999999999997532       111222222211   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          .........++..+.+||.+||+.||++|||+.++++.
T Consensus       250 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 ----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                01101112345678999999999999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.5e-48  Score=373.48  Aligned_cols=262  Identities=24%  Similarity=0.389  Sum_probs=213.9

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .+.+..++|.+.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+|+.++||||+++++++...+..
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            34556678999999999999999999976 68899999886543 33345688899999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++|+|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999997542   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceee-eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......... ....++..|+|||++....++.++|||||||++|||++ |..||......+..       ........ 
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~-  333 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKGGR-  333 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTTCC-
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC-
Confidence            7543321111 11235778999999988899999999999999999998 99999765432211       11111110 


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                          ...+    ..++..+.++|.+||+.||++|||+.++++.|+.+.
T Consensus       334 ----~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 ----LPCP----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                1111    223456899999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-47  Score=364.05  Aligned_cols=271  Identities=25%  Similarity=0.378  Sum_probs=211.7

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----eeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~  151 (407)
                      +..++|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.++++++||||+++++++....    .++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            44578999999999999999999876 7899999886543 23344556899999999999999999987643    479


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-------CCCceeccCCCCccEEEeCCCCcEEe
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG-------LEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                      +||||+++|+|.+++...     .+++..++.++.|++.||+|||+.       +..+|+||||||+|||++.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999999764     599999999999999999999975       23389999999999999999999999


Q ss_pred             ecccceecCCCCce-eeeeeeccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhH----
Q 015395          225 DFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL----  294 (407)
Q Consensus       225 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~----  294 (407)
                      |||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||...........    
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876544332 22335689999999999763     466788999999999999999999976543221111    


Q ss_pred             -----HHHHHHHhhcCCCCCcCCCCCCCC-ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          295 -----IEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       295 -----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           ...+.........    .+.++.. .....+..+.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 1111112211111    1121111 223456779999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-47  Score=360.07  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=207.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999966 688999998865432 334567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999765    5699999999999999999999999   9999999999999999999999999999876433


Q ss_pred             Cc-eeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          236 SS-YITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       236 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..    ......        
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~----~~~~~~--------  225 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS----DWKEKK--------  225 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH----HHHTTC--------
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH----HHhccc--------
Confidence            22 12334579999999999987765 77899999999999999999999765432211 11    111111        


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                       ........++..+.+||.+||+.||++|||+.++++....
T Consensus       226 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             -ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence             1111123455678899999999999999999999875543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-47  Score=354.33  Aligned_cols=259  Identities=21%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ++..++|++.+.||+|+||.||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            4456789999999999999999998643    346999988654 3344567889999999999999999999985 457


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence            899999999999999997653   4689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+..   .   .+.....  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~---~i~~~~~--  235 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G---RIENGER--  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H---HHHTTCC--
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H---HHHcCCC--
Confidence            8775543333334457889999999988899999999999999999997 99999865543322   1   1111111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                          ...    ...++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       236 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          236 ----LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                111    1234456899999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.3e-48  Score=382.48  Aligned_cols=264  Identities=24%  Similarity=0.440  Sum_probs=217.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ...+++..++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+|+.++||||+++++++. ....
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            345677788999999999999999999999888899999987644 34668889999999999999999999986 5678


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+.+|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            999999999999999975321  2588999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..............+|..|+|||++....++.++|||||||++|||++ |+.||......+..      ..+.....   
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~------~~i~~~~~---  403 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------RALERGYR---  403 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH------HHHHHTCC---
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCCC---
Confidence            764322221223346788999999988899999999999999999999 99999865433221      12222111   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         ...    +..++..+.++|.+||+.||++|||+.+|++.|+.+..
T Consensus       404 ---~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 ---MPR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---CCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence               011    12345678999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=364.24  Aligned_cols=255  Identities=19%  Similarity=0.254  Sum_probs=212.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999965 6788999998776666667888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC--CCCcEEeecccceecCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~  234 (407)
                      +.+++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||++.....
T Consensus       130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999997542   4689999999999999999999999   9999999999999974  47799999999998765


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      +.+..+.....       .
T Consensus       204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~~-------~  268 (387)
T 1kob_A          204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDW-------E  268 (387)
T ss_dssp             TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCC-------C
T ss_pred             Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------C
Confidence            433  23346999999999999999999999999999999999999999764322      22222222211       1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ++......++..+.++|.+||+.||.+|||+.++++.-.
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence            111122234567899999999999999999999998543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=361.58  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=193.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++....  ....+.+|+.++++++||||+++++++.+....++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467999999999999999999976 57789999886543  345677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeecccceecC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGLAKLLG  233 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~~~~  233 (407)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||++....
T Consensus       130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999765    5699999999999999999999999   9999999999999975   8899999999998764


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........     .+........       
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~-------  268 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEY-------  268 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCC-------
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCC-------
Confidence            332  22345689999999999999999999999999999999999999975543221     1222222111       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..+......++..+.+||.+||+.||++|||+.++++.-.
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  308 (349)
T 2w4o_A          269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW  308 (349)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            1111112334567899999999999999999999987443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-46  Score=355.64  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=206.8

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++....  ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36799999999999999999999889999999986542  2234577889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |++ ++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       100 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            997 48888887643   4699999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC---
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL---  311 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  311 (407)
                      ... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....   +.............   
T Consensus       173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGT
T ss_pred             ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhh
Confidence            322 233468999999999876 5689999999999999999999999987665443322   22222211111000   


Q ss_pred             ---------CCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 ---------DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ---------~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                               ...+....    ...++.++.+||.+||+.||++|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     00000000    11234578899999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.1e-47  Score=368.02  Aligned_cols=260  Identities=29%  Similarity=0.457  Sum_probs=201.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      +..++|.+.+.||+|+||.||+|...    ++..||||.+... .....+.+.+|+.++++++||||+++++++.+....
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            34568999999999999999999854    4667999998655 334556789999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            99999999999999997653   4699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ..........  ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.      ......... 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~------~~~i~~~~~-  268 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV------IKAVDEGYR-  268 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH------HHHHHTTEE-
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCC-
Confidence            7654322211  12235778999999999999999999999999999998 9999975543221      111111100 


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           ..    ....++..+.++|.+||+.||.+||++.+|++.|+.+..
T Consensus       269 -----~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 -----LP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -----CC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                 01    112344568999999999999999999999999988754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-47  Score=367.38  Aligned_cols=270  Identities=26%  Similarity=0.391  Sum_probs=217.7

Q ss_pred             ccHHHHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCcccee
Q 015395           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRL  140 (407)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~  140 (407)
                      +....+++..++|++.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            356778888999999999999999999999842      35689999987643 34456788999999999 79999999


Q ss_pred             eeeeecCC-eeEEEEEeccCCChHHhhhCCCCC-----------------------------------------------
Q 015395          141 LGYCAEGA-HRMLVYEYVNNGNLEQWLHGDVGP-----------------------------------------------  172 (407)
Q Consensus       141 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------  172 (407)
                      ++++.+.+ ..++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987754 589999999999999999765321                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          173 ---------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       173 ---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                                     ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12289999999999999999999999   999999999999999999999999999987644332


Q ss_pred             -eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          238 -YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       238 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                       .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+..  .   ........      ...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~---~~~~~~~~------~~~  317 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C---RRLKEGTR------MRA  317 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H---HHHHHTCC------CCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H---HHHHcCCC------CCC
Confidence             23344568999999999999999999999999999999998 99999865543321  1   11111111      111


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      +    ..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       318 ~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          318 P----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1    123456899999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-47  Score=362.99  Aligned_cols=269  Identities=25%  Similarity=0.372  Sum_probs=217.0

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeee
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGY  143 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~  143 (407)
                      +..+.+..++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445567789999999999999999999964      24789999987653 3445678899999999999999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCce
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGP--------------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKV  203 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  203 (407)
                      +.+.+..++||||+++++|.+++......                    ...+++..++.++.||+.||.|||++   +|
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            99999999999999999999999764211                    15689999999999999999999999   99


Q ss_pred             eccCCCCccEEEeCCCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 015395          204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI  281 (407)
Q Consensus       204 vH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~  281 (407)
                      +||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999986643322 12233467899999999988899999999999999999999 999


Q ss_pred             CCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       282 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      ||......+      ........ ..     ...    ...++..+.++|.+||+.||++||++.++++.|+.+...
T Consensus       276 p~~~~~~~~------~~~~~~~~-~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          276 PYYGMAHEE------VIYYVRDG-NI-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTTTSCHHH------HHHHHHTT-CC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             cCCCCChHH------HHHHHhCC-Cc-----CCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            997544321      12222211 11     111    123345789999999999999999999999999987653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.9e-47  Score=357.64  Aligned_cols=265  Identities=27%  Similarity=0.418  Sum_probs=216.4

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  145 (407)
                      .+++..++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            34556788999999999999999999852      34679999986543 344567889999999999999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceec
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVG--------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH  205 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH  205 (407)
                      +.+..++||||+++++|.+++.....                    ....+++..++.++.||+.||.|||++   +|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence            99999999999999999999976432                    113489999999999999999999999   9999


Q ss_pred             cCCCCccEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 015395          206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV  283 (407)
Q Consensus       206 ~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf  283 (407)
                      |||||+|||++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998775543322 223457889999999998899999999999999999999 99999


Q ss_pred             CCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ...........       ......     ...    ...++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       254 ~~~~~~~~~~~-------~~~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          254 PGIPPERLFNL-------LKTGHR-----MER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TTCCGGGHHHH-------HHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHH-------hhcCCc-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            86654332211       111110     111    1234457899999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-47  Score=351.04  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=214.2

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .+..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            345578999999999999999999988888999999876543 3467888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            9999999999997653   4689999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..........++..|+|||++.+..++.++||||||+++|+|++ |+.||......+      ..........      .
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~~------~  224 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFR------L  224 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC------C
T ss_pred             ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCCc------C
Confidence            22222223356788999999988899999999999999999999 899997544322      1222222111      1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ..    ...++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       225 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          225 YK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11    1123456899999999999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-45  Score=346.39  Aligned_cols=282  Identities=36%  Similarity=0.664  Sum_probs=225.5

Q ss_pred             ccccHHHHHHhcCCCCcc------ceecccCceEEEEEEECCCCEEEEEEeccC----ChhhHHHHHHHHHHHhcCCCCc
Q 015395           67 HWYTLRELEVSTNGFSDD------KVIGEGGYGIVYYGLLEDNSKVAVKNLLNN----RGQAEREFKVEVEAIGRVRHKN  136 (407)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~hpn  136 (407)
                      ..|+..++.-..++|...      +.||+|+||.||+|.. ++..||+|++...    .......+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            446777787777777766      8999999999999986 4789999988643    2344567889999999999999


Q ss_pred             cceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe
Q 015395          137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID  216 (407)
Q Consensus       137 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~  216 (407)
                      |+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.   +|+||||||+||+++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            99999999999999999999999999999974321 24699999999999999999999999   999999999999999


Q ss_pred             CCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH
Q 015395          217 KHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       217 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~  295 (407)
                      .++.+||+|||++......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            9999999999999876543322 2234568999999998865 5889999999999999999999999876544332222


Q ss_pred             HHHHHHhhc-CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          296 EWLKKMVTN-RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       296 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                        ....... ......++..+ .......+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       247 --~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          247 --KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             --HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             --HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence              1111111 11112223332 23356678889999999999999999999999999998743

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=357.26  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=209.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.....      .....+.+|+.+|+.++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46999999999999999999975 588999998865432      23567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC----CcEEeecc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDFG  227 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfG  227 (407)
                      +||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999764    5799999999999999999999999   999999999999998887    79999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.      +.......  
T Consensus       164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~--  233 (326)
T 2y0a_A          164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN--  233 (326)
T ss_dssp             TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHTC--
T ss_pred             CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHhcC--
Confidence            9988754332  2345699999999999999999999999999999999999999975543221      11211111  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                           ..++......++..+.++|.+||+.||.+|||+.++++.-.
T Consensus       234 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          234 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             -----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                 11111111234567899999999999999999999998543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=366.86  Aligned_cols=250  Identities=20%  Similarity=0.314  Sum_probs=202.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      +..++|++.+.||+|+||.||+|... +++.||||++...   .......+..|..+++.+ +||||+++++++.+.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            45678999999999999999999965 5889999998653   223445677899999988 699999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |+||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus       100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence            9999999999999999765    5699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+      ....+....     
T Consensus       173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~-----  240 (353)
T 3txo_A          173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDE-----  240 (353)
T ss_dssp             CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-----
T ss_pred             ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-----
Confidence            643322 22345679999999999998889999999999999999999999997654322      222222221     


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM------GHVVH  350 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~  350 (407)
                        ..++    ..++..+.++|.+||+.||.+||++      .++++
T Consensus       241 --~~~p----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 --VVYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CCCC----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCC----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              1111    1234568899999999999999998      67765

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.4e-47  Score=353.53  Aligned_cols=266  Identities=22%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             hcCCCCccceecccCceEEEEEEE-----CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~  149 (407)
                      ..++|++.+.||+|+||.||+|.+     .++..||||++..........+.+|+.++++++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            456899999999999999999984     2578899999987777777789999999999999999999999854  356


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            899999999999999997653   3599999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---------hhhhHHHHH
Q 015395          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP---------EEVNLIEWL  298 (407)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~---------~~~~~~~~~  298 (407)
                      .........  ......++..|+|||++.+..++.++|||||||++|+|++|..||......         ........+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            876543321  122334677899999999999999999999999999999999998632110         000011111


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .........     ..    ....++..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       242 ~~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          242 IELLKNNGR-----LP----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHTTCC-----CC----CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhccCc-----CC----CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            111111110     11    122345679999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=355.08  Aligned_cols=255  Identities=16%  Similarity=0.246  Sum_probs=211.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367999999999999999999966 57789999886543 3455688899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC--CCCcEEeecccceecCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~  234 (407)
                      +++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.  ++.+||+|||++.....
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999997642   4699999999999999999999999   9999999999999987  78999999999988765


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .+........       .
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-------~  221 (321)
T 1tki_A          157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY-------T  221 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-------C
T ss_pred             CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCC-------C
Confidence            433  344579999999999999889999999999999999999999997644322      2222222211       1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ++......++..+.++|.+||..||.+|||+.++++.-..
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  261 (321)
T 1tki_A          222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence            1111122345678999999999999999999999985543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.5e-47  Score=353.61  Aligned_cols=264  Identities=23%  Similarity=0.404  Sum_probs=220.0

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ..+++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++.+....
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            3456677889999999999999999999764 7789999886543 3456788899999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence            999999999999999976422  4699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........   +.   ...    
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~---~~~----  229 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LE---KDY----  229 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HH---TTC----
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---Hh---ccC----
Confidence            776555444445567889999999998899999999999999999999 9999976554332211   11   110    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                        ...    ....++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       230 --~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 --RME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             --CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence              011    112334578999999999999999999999999987643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-47  Score=367.03  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=215.6

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~  143 (407)
                      +++..++|.+.+.||+|+||.||+|.+.        .+..||+|++.... ......+.+|+.+++++ +||||++++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            3456678999999999999999999853        23469999986653 34456788999999999 89999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCc
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~  211 (407)
                      +...+..++||||+++++|.+++.....            ....+++..++.++.||+.||+|||+.   +|+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            9999999999999999999999976531            124599999999999999999999999   9999999999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~  289 (407)
                      ||||+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654332 12233457889999999999999999999999999999999 99999755432


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      +      ..........      ...    ...++..+.++|.+||+.||++|||+.+|++.|+.+..
T Consensus       301 ~------~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          301 E------LFKLLKEGHR------MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             H------HHHHHHTTCC------CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H------HHHHHHcCCC------CCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2      1222221111      111    12234568999999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.7e-47  Score=381.54  Aligned_cols=264  Identities=23%  Similarity=0.394  Sum_probs=218.7

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ..+++..++|.+.+.||+|+||.||+|.+.. +..||||.+.... .....+.+|+.+|++++||||+++++++.....+
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3455667789999999999999999999764 7889999986554 3456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +|||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence            999999999999999975421  4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..............++..|+|||++....++.++|||||||++|||++ |..||......+..   ..+    ....   
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~---  436 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELL----EKDY---  436 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHH----HTTC---
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC---
Confidence            775443332333446789999999998899999999999999999999 99999866543322   111    1111   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                        ....    +..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       437 --~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 --RMER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             --CCCC----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence              0111    22345678999999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-46  Score=350.28  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=204.2

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCccceeeeeeec----CCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAE----GAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~----~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+ +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 5889999988543   23344455565555  799999999998643    35689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhh--------hcCCCceeccCCCCccEEEeCCCCcEE
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH--------EGLEPKVVHRDIKSSNILIDKHWNPKV  223 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~~kl  223 (407)
                      +||||+++|+|.+++..     ..+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++.+||
T Consensus        83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred             EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence            99999999999999964     36999999999999999999999        77   9999999999999999999999


Q ss_pred             eecccceecCCCCcee---eeeeeccccccCccccCCC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 015395          224 SDFGLAKLLGSESSYI---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISG----------RIPVD  284 (407)
Q Consensus       224 ~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDiwslG~il~elltg----------~~Pf~  284 (407)
                      +|||++..........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998765443332   2234799999999999876      455799999999999999999          88886


Q ss_pred             CCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC-CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ........  ...+........    ..+..+. ......+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPS--FEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcc--hhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            54432221  111222222111    1122221 12345778899999999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-46  Score=362.21  Aligned_cols=252  Identities=18%  Similarity=0.301  Sum_probs=209.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999965 68899999986543  334467889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC---CCcEEeeccccee
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKL  231 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~~  231 (407)
                      ||+.+++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.+   +.+||+|||++..
T Consensus       108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999999765    5699999999999999999999999   99999999999999765   4599999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ..........      
T Consensus       181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~------  246 (362)
T 2bdw_A          181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGA------  246 (362)
T ss_dssp             CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC------
T ss_pred             ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC------
Confidence            654322  23457999999999999999999999999999999999999999754322      1122222211      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       ..++......++..+.+||.+||+.||++|||+.++++.
T Consensus       247 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 -YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             112222234456779999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.8e-47  Score=350.42  Aligned_cols=262  Identities=27%  Similarity=0.458  Sum_probs=215.5

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +++++..++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++||||+++++++.+ +..+
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            35667778999999999999999999998888899999886543 335678889999999999999999999864 5689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            99999999999999965311  2589999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||......+      ..........    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~----  228 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYR----  228 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC----
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhcccC----
Confidence            76544333333456889999999988889999999999999999999 999997554322      1222221110    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                        ...    ...++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       229 --~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          229 --MVR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCC----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              111    1233457899999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=363.41  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=207.6

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+|+.++||||+++++++.+....++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567999999999999999999965 57889999885432   2334577889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+.+|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||++...
T Consensus        93 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            99999999999999865    5799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....  .....+||+.|+|||++..   ..++.++|||||||++|+|++|..||.............   ......    
T Consensus       166 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~----  236 (384)
T 4fr4_A          166 PRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFETTV----  236 (384)
T ss_dssp             CTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHHCC----
T ss_pred             cCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhhcc----
Confidence            5432  2345679999999999964   458999999999999999999999997655433322222   222111    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVH  350 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~  350 (407)
                         ..++    ..++..+.+||.+||+.||.+||+ +++++.
T Consensus       237 ---~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ---VTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               1111    223457899999999999999998 777765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-46  Score=348.38  Aligned_cols=252  Identities=27%  Similarity=0.491  Sum_probs=197.7

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh----hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG----QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|++.+.||+|+||.||+|.+. +..||+|++.....    ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            4578999999999999999999976 78899998865432    234678889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc---eeccCCCCccEEEeC--------CCCc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK---VVHRDIKSSNILIDK--------HWNP  221 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---ivH~Dlkp~Nill~~--------~~~~  221 (407)
                      ||||+++++|.+++..     ..+++..++.++.|++.||.|||++   +   |+||||||+|||++.        ++.+
T Consensus        84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999964     4699999999999999999999999   7   999999999999986        6789


Q ss_pred             EEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      ||+|||++........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .....
T Consensus       156 kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~  226 (271)
T 3dtc_A          156 KITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGV  226 (271)
T ss_dssp             EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHH
T ss_pred             EEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhh
Confidence            9999999986643322   23468999999999998899999999999999999999999997544221      11122


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ......     ...    ...++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       227 ~~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNKLA-----LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSCCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCCCC-----CCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            211111     111    223445789999999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-47  Score=376.93  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=211.4

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..+++..++|++.+.||+|+||.||+|.+.++..||||++.... .....+.+|+.+|++++||||+++++++.+ ...+
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            44566778899999999999999999999887889999987654 335678899999999999999999999876 6789


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       255 iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            99999999999999964311  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .............++..|+|||++....++.++|||||||++|||++ |+.||......+.      +........    
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~~i~~~~~----  399 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYR----  399 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTCC----
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCC----
Confidence            65433222333457889999999988899999999999999999999 9999976543221      222221111    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                        ...    +..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus       400 --~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 --MPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence              111    123456789999999999999999999999999987543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=356.24  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|+.+++.++||||+++++++.+...+++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999965 68899999986532   23345677899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||++....
T Consensus        85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            9999999999999865    5699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....+....       .
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-------~  220 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAE-------L  220 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCC-------C
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------C
Confidence            32    23457999999999999999999999999999999999999999754322      2222232221       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      .++    ..++..+.++|.+||..||.+||     +++++++.
T Consensus       221 ~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            111    12345689999999999999999     88888864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=369.59  Aligned_cols=253  Identities=19%  Similarity=0.269  Sum_probs=207.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++.+.||+|+||.||+|... ++..+|+|++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            356999999999999999999965 67889999886553  234456889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe---CCCCcEEeeccccee
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKL  231 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~  231 (407)
                      ||+.+|+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999865    5799999999999999999999999   999999999999998   467899999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+      ..........     
T Consensus       163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~-----  230 (444)
T 3soa_A          163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQIKAGAY-----  230 (444)
T ss_dssp             CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC-----
T ss_pred             ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhCCC-----
Confidence            654432 2234579999999999999999999999999999999999999997543221      1222222211     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        .++......++..+.+||.+||+.||.+|||+.++++.
T Consensus       231 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 --DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              11112223445679999999999999999999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=349.56  Aligned_cols=272  Identities=21%  Similarity=0.291  Sum_probs=215.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC--eeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357999999999999999999976 58899999986543 234566778999999999999999999987654  78999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE----eCCCCcEEeecccc
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGla  229 (407)
                      |||+++++|.+++..... ...+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999976432 13499999999999999999999999   99999999999999    77778999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYAS--------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      ........  .....||+.|+|||++.        +..++.++|||||||++|+|++|+.||.........  .+.+...
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~  239 (319)
T 4euu_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (319)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred             eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence            88755433  23456899999999885        577899999999999999999999999765443222  1222222


Q ss_pred             hhcCCCC---Cc---------C--CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          302 VTNRNPE---GV---------L--DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       302 ~~~~~~~---~~---------~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .......   .+         .  ...........+...+.+++.+||+.||++|||+.++++...+...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            2221110   00         0  0111223456788899999999999999999999999999886543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.4e-47  Score=360.78  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999996 468899999885432   22235678899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+ +|+|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 78999988765    5699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......+....               +..
T Consensus       160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~  222 (336)
T 3h4j_B          160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNS  222 (336)
T ss_dssp             TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCS
T ss_pred             CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHc
Confidence            4322  234579999999999988776 7899999999999999999999976443221110               000


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ..  ...+..++..+.+||.+||+.||.+|||+.++++.-..
T Consensus       223 ~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          223 CV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             SC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred             CC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence            00  01122345568999999999999999999999985543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=360.88  Aligned_cols=270  Identities=27%  Similarity=0.413  Sum_probs=214.6

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      ++++..++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            45667789999999999999999999952      34579999986542 23445788899999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceec
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVGP-------------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH  205 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH  205 (407)
                      ...+..++||||+++|+|.+++......                   ...+++..++.++.||+.||.|||++   +|+|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            9999999999999999999999765321                   12489999999999999999999999   9999


Q ss_pred             cCCCCccEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 015395          206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV  283 (407)
Q Consensus       206 ~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf  283 (407)
                      |||||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999999876544332 2334567889999999988899999999999999999998 99999


Q ss_pred             CCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCCc
Q 015395          284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (407)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  360 (407)
                      .........      .........     ...    ...++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus       276 ~~~~~~~~~------~~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          276 PGIPVDANF------YKLIQNGFK-----MDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TTCCCSHHH------HHHHHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             ccCCcHHHH------HHHHhcCCC-----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            866543221      111211110     111    12234578999999999999999999999999998866543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.7e-46  Score=345.82  Aligned_cols=253  Identities=28%  Similarity=0.527  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhh-------HHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA-------EREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......       ...+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            468999999999999999999964 68899999886543221       157888999999999999999999987655 


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEeCCCC-----cE
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWN-----PK  222 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----~k  222 (407)
                       ++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +  |+||||||+|||++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             79999999999999887653   4799999999999999999999999   8  999999999999988776     99


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCcccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      |+|||++......    .....||+.|+|||++  ....++.++|||||||++|+|++|+.||........    .....
T Consensus       170 l~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~  241 (287)
T 4f0f_A          170 VADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINM  241 (287)
T ss_dssp             ECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHH
T ss_pred             eCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHH
Confidence            9999999754332    3345689999999998  455688999999999999999999999976554322    11222


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .......     +..    ...++..+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       242 ~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 IREEGLR-----PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHSCCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HhccCCC-----CCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            2221111     111    223445789999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-46  Score=348.90  Aligned_cols=262  Identities=21%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||+|+||.||+|...+++.||+|++.....  .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999998899999999865432  2235677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++ +|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            965 9999987643   4689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC---C---
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---G---  309 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~---  309 (407)
                      . ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+..   ..+..........   .   
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhc
Confidence            2 12334689999999998764 5899999999999999999999999765432221   1122211111000   0   


Q ss_pred             --cCCCCCCC-------CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 --VLDPKLPE-------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 --~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ..++.+..       .....++..+.+||.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              00111100       0112345678899999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.7e-46  Score=350.56  Aligned_cols=263  Identities=17%  Similarity=0.211  Sum_probs=214.1

Q ss_pred             hcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....  ....+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            356799999999999999999996 468889999885442  233567799999999 7999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC-----cEEeecccc
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-----PKVSDFGLA  229 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~DfGla  229 (407)
                      ||+ +++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.     +||+|||++
T Consensus        86 e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999 999999998642   4699999999999999999999999   9999999999999987766     999999999


Q ss_pred             eecCCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          230 KLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       230 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      .........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            877544321      12345699999999999999999999999999999999999999987654443333333322211


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ......         ....++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       239 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          239 STPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            111000         011234579999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=367.11  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=210.5

Q ss_pred             hcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4567999999999999999999843      3567999998654 34455678889999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCC---CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC---CcEE
Q 015395          150 RMLVYEYVNNGNLEQWLHGDV---GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKV  223 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl  223 (407)
                      .++||||+++|+|.+++....   .....+++..++.++.||+.||+|||++   +|+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999997542   1224589999999999999999999999   999999999999998554   5999


Q ss_pred             eecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHH
Q 015395          224 SDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       224 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      +|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+      .+...
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~i  299 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFV  299 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence            99999975422111 11233457899999999999999999999999999999998 999997654322      12222


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ......      ..    ...++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       300 ~~~~~~------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          300 TSGGRM------DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HTTCCC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCC------CC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            221110      11    12334568899999999999999999999999987644

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-46  Score=355.24  Aligned_cols=266  Identities=21%  Similarity=0.380  Sum_probs=198.8

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECC-CC---EEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NS---KVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  146 (407)
                      ++.+..++|++.+.||+|+||.||+|.+.. +.   .||||.+...  .....+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            344566789999999999999999999553 32   7999988654  33456678899999999999999999999987


Q ss_pred             CCee------EEEEEeccCCChHHhhhCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          147 GAHR------MLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       147 ~~~~------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      ....      ++||||+.+++|.+++....  .....+++..++.++.|++.||+|||++   +|+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            6654      99999999999999986432  1123689999999999999999999999   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHH
Q 015395          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  296 (407)
                      +.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+...   
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---  250 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---  250 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---
Confidence            99999999999876443322 1223356789999999999999999999999999999999 999998655433221   


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         .......      ...    ...++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       251 ---~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 ---YLIGGNR------LKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             ---HHHTTCC------CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHhcCCC------CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               1111111      011    12334568999999999999999999999999998744

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-47  Score=371.10  Aligned_cols=263  Identities=20%  Similarity=0.280  Sum_probs=213.3

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  146 (407)
                      +.++++..++|++.+.||+|+||.||+|... ++..||+|++....   ......+..|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445567789999999999999999999976 57889999885421   1122346789999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ...+|+||||+++|+|.+++...     .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999753     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |+++.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+..+..      ..+.
T Consensus       213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~  286 (410)
T 3v8s_A          213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIM  286 (410)
T ss_dssp             TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH
T ss_pred             ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HHHH
Confidence            999887665544445678999999999997665    789999999999999999999999865433222      1111


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHHh
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLEA  354 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L~~  354 (407)
                      .....     ..++.  ...++..+.+||.+||..+|.+  ||++++|++.-..
T Consensus       287 ~~~~~-----~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          287 NHKNS-----LTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             THHHH-----CCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             hcccc-----ccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence            11000     01111  1123456899999999999988  9999999986543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-46  Score=356.41  Aligned_cols=260  Identities=17%  Similarity=0.194  Sum_probs=211.7

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||||.+.....  ...+..|+.+++.+ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999996 4688899998865432  23577899999999 89999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC-----cEEeecccce
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-----PKVSDFGLAK  230 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~DfGla~  230 (407)
                      |+ +++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||++.
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 999999997642   4799999999999999999999999   9999999999999998877     9999999998


Q ss_pred             ecCCCCcee------eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          231 LLGSESSYI------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       231 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      .........      .....||+.|+|||++.+..++.++|||||||++|||++|..||......+.......+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            765433211      23457999999999999999999999999999999999999999876554443333333222111


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ... ..+        ...++ .+.+++..||+.||.+||++.+|++.|+.+.
T Consensus       239 ~~~-~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          239 TPI-EVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             SCH-HHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCH-HHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            100 000        01123 6999999999999999999999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-46  Score=369.78  Aligned_cols=265  Identities=21%  Similarity=0.263  Sum_probs=213.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECC-CCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  146 (407)
                      +.++.+..++|++.++||+|+||.||+|.... ++.||+|++.....   .....+..|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34455677899999999999999999999764 67899998854321   112237789999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ...+++|||||++|+|.+++....   ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999998632   5699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+   ...
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~  296 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNH  296 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhc
Confidence            999877655554445568999999999986     567999999999999999999999999865433322211   110


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLE  353 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L~  353 (407)
                      ....        .++.. ...++..+.+||.+||..+|++  ||+++++++.-.
T Consensus       297 ~~~~--------~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf  341 (437)
T 4aw2_A          297 KERF--------QFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF  341 (437)
T ss_dssp             HHHC--------CCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred             cccc--------cCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence            0000        11110 1123456899999999888888  999999997543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=349.18  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=199.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh--------------------------hHHHHHHHHHHHh
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--------------------------AEREFKVEVEAIG  130 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------------------------~~~~~~~E~~~l~  130 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++......                          ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999965 5788999988654311                          1245788999999


Q ss_pred             cCCCCccceeeeeeec--CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCC
Q 015395          131 RVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI  208 (407)
Q Consensus       131 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl  208 (407)
                      +++||||+++++++.+  ....++||||+++++|.+++..     ..+++..++.++.||+.||+|||++   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999876  5688999999999999887643     4699999999999999999999999   9999999


Q ss_pred             CCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 015395          209 KSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDY  285 (407)
Q Consensus       209 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~elltg~~Pf~~  285 (407)
                      ||+|||++.++.+||+|||++......... .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999999877544332 33457999999999997765   47889999999999999999999975


Q ss_pred             CCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ....      ...........       .++  ....++..+.++|.+||+.||++|||+.++++.
T Consensus       243 ~~~~------~~~~~~~~~~~-------~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          243 ERIM------CLHSKIKSQAL-------EFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSHH------HHHHHHHHCCC-------CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ccHH------HHHHHHhcccC-------CCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            4321      11222222111       001  112234568999999999999999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-46  Score=371.17  Aligned_cols=255  Identities=29%  Similarity=0.405  Sum_probs=210.5

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC-eeEE
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRML  152 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~l  152 (407)
                      +++..++|++.+.||+|+||.||+|.+. +..||||.+....  ....+.+|+.+|++++||||+++++++.+.. ..++
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            3456778999999999999999999986 7799999986553  4567889999999999999999999976654 7999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       265 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            9999999999999976421  3479999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ....    ....++..|+|||++.+..++.++|||||||++|||++ |..||......+....      ......     
T Consensus       340 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~------i~~~~~-----  404 (450)
T 1k9a_A          340 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------VEKGYK-----  404 (450)
T ss_dssp             C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH------HHTTCC-----
T ss_pred             cccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCC-----
Confidence            3321    22357889999999999999999999999999999998 9999987654432221      111110     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                       ...    +..++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       405 -~~~----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          405 -MDA----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             111    1234567899999999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.6e-47  Score=362.43  Aligned_cols=252  Identities=24%  Similarity=0.354  Sum_probs=206.2

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCC
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA  148 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  148 (407)
                      ..+..++|.+.+.||+|+||.||+|... +++.||||++....   ......+..|..++..+ +||||+++++++.+..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3456789999999999999999999975 57889999986532   23345667788888876 8999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence            999999999999999999764    4699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+      ....+....   
T Consensus       165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~---  234 (345)
T 1xjd_A          165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN---  234 (345)
T ss_dssp             CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC---
T ss_pred             hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC---
Confidence            986433222 2345679999999999999999999999999999999999999997554322      222222221   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG-HVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~  350 (407)
                          ..++    ..++..+.+||.+||..||.+||++. +|++
T Consensus       235 ----~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ----PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                1121    12445789999999999999999997 6664

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.6e-46  Score=364.10  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  150 (407)
                      +..++|++.++||+|+||.||+|... +++.||+|++....   ......+..|..+|.++ +||||+++++++.+...+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            45678999999999999999999976 56789999986542   22234577799998877 899999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++|+|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus       129 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence            9999999999999999765    5799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--VNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~  308 (407)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  ......+...+....  
T Consensus       202 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  278 (396)
T 4dc2_A          202 EGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  278 (396)
T ss_dssp             CCCCTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred             ecccCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence            6332222 24456799999999999999999999999999999999999999975432211  111122222222211  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM------GHVVH  350 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~  350 (407)
                          ..++    ..++..+.+||.+||+.||.+||++      .+|++
T Consensus       279 ----~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 ----IRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ----CCCC----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ----cCCC----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                1122    1244568999999999999999985      56655

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.3e-46  Score=342.47  Aligned_cols=254  Identities=20%  Similarity=0.330  Sum_probs=208.6

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--CeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l  152 (407)
                      ..++|.+.+.||+|+||.||+|.+. +..||+|++....  ......+.+|+.++++++||||+++++++.+.  ...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            4567999999999999999999986 8889999986543  34456788999999999999999999999877  78899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEeCCCCcEEeecccce
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   +  |+||||||+||+++.++.++|+|||++.
T Consensus        87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999999999987532  3589999999999999999999998   8  9999999999999999999999998875


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .....      ...||+.|+|||++.+..++.   ++|||||||++|+|++|+.||......+      ...........
T Consensus       162 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~  229 (271)
T 3kmu_A          162 SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR  229 (271)
T ss_dssp             TTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC
T ss_pred             eeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC
Confidence            43322      236899999999998766554   7999999999999999999997544322      12222222111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           +..    ...++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       230 -----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 -----PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                 111    12344568999999999999999999999999998753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-46  Score=358.35  Aligned_cols=248  Identities=23%  Similarity=0.286  Sum_probs=208.4

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|+.+|+.++||||+++++++.+....++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3467999999999999999999965 68899999985432   2334567889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       119 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence            99999999999999765    4699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      +....+....       
T Consensus       192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-------  254 (350)
T 1rdq_E          192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-------  254 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------
T ss_pred             cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHcCC-------
Confidence            543    23457999999999999999999999999999999999999999754322      2222222221       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHML  352 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~L  352 (407)
                      ..++    ..++..+.++|.+||+.||.+||+     +++|++.-
T Consensus       255 ~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          255 VRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             CCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            1111    123456899999999999999998     78887643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-46  Score=355.57  Aligned_cols=257  Identities=26%  Similarity=0.434  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+. ++.    +||+|.+... .......+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            467999999999999999999964 343    3688877543 2345567889999999999999999999998754 78


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +++||+.+|+|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            9999999999999997653   5699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........ .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+....       ......  
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~~--  237 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGER--  237 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTCC--
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcCCC--
Confidence            75443322 223456889999999999999999999999999999999 9999986554332211       111110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         ...    ...++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       238 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 ---LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---CCC----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---CCC----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               011    12234568899999999999999999999999987754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=369.01  Aligned_cols=264  Identities=21%  Similarity=0.248  Sum_probs=211.8

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  145 (407)
                      .+.+..+..++|++.+.||+|+||.||+|... +++.||||++....   ......+..|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34555677889999999999999999999975 68899999986432   122234778999999999999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      +.+.+|+||||+++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            9999999999999999999997642   3699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYAS-------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  298 (407)
                      ||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..+....+   
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---  282 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI---  282 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence            9999887655444344567999999999986       457899999999999999999999999765433222111   


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCC---CCHHHHHHHH
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR---PKMGHVVHML  352 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~~L  352 (407)
                      .........     +..    ...++.++.+||.+||. +|.+|   |+++++++.-
T Consensus       283 ~~~~~~~~~-----p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          283 VHYKEHLSL-----PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HTHHHHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             HhcccCcCC-----Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            110000000     100    12345578999999999 99998   5899988743

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.3e-46  Score=357.85  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=205.8

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  149 (407)
                      .+..++|++.+.||+|+||.||+|... +++.||||++....   ......+..|..+|..+ +||||+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            345678999999999999999999976 46789999986532   23345677899999988 79999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .|+||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||++
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            99999999999999999764    4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....+....    
T Consensus       169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~----  237 (353)
T 2i0e_A          169 KENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN----  237 (353)
T ss_dssp             BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC----
T ss_pred             cccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC----
Confidence            86432222 234567999999999999999999999999999999999999999754432      2222222221    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                         ..++    ..++..+.+||.+||..||.+||+     +.+|++
T Consensus       238 ---~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 ---VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---CCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               1111    234557899999999999999995     467665

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-45  Score=360.04  Aligned_cols=255  Identities=20%  Similarity=0.266  Sum_probs=195.9

Q ss_pred             CCCCcc-ceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHh-cCCCCccceeeeeeec----CCeeE
Q 015395           79 NGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIG-RVRHKNLVRLLGYCAE----GAHRM  151 (407)
Q Consensus        79 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~----~~~~~  151 (407)
                      ++|.+. ++||+|+||.||+|... ++..||||++...     ..+.+|+.++. ..+||||+++++++..    ...+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            457766 78999999999999965 6888999988532     34556777764 4589999999998865    56789


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeeccc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGL  228 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGl  228 (407)
                      ||||||++|+|.+++.....  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999986421  4699999999999999999999999   9999999999999987   78899999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh-HHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN-LIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~  307 (407)
                      ++.......  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ....+   ....  
T Consensus       211 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~--  283 (400)
T 1nxk_A          211 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQ--  283 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTC--
T ss_pred             ccccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCc--
Confidence            987653322  334578999999999999999999999999999999999999997655432211 11111   1111  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                           ..++......++..+.+||.+||+.||++|||+.++++.....
T Consensus       284 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          284 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             -----CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             -----ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence                 0111111234556799999999999999999999999865543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.3e-46  Score=347.08  Aligned_cols=263  Identities=29%  Similarity=0.488  Sum_probs=200.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ++..++|++.+.||+|+||.||+|.+.  ..||+|++....  ......+.+|+.+++.++||||++++++. .....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            445678999999999999999999864  359999886543  34456788999999999999999999965 4566899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            999999999999996543   5699999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCC-ceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          233 GSES-SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       233 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .... ........||+.|+|||++.   ...++.++|||||||++|+|++|+.||......+.  ...    ........
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~~  244 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSLS  244 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSCC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----HhcccccC
Confidence            4322 12223456899999999986   56788999999999999999999999976544322  111    11111111


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                          +. .......++..+.++|.+||+.||.+|||+.++++.|+.+.+
T Consensus       245 ----~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 ----PD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----CC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----cc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                11 111122345679999999999999999999999999998753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.4e-46  Score=355.00  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++...   .......+..|..+++++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467999999999999999999976 5788999998654   233455678899999887 89999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999765    4699999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--hHHHHHHHHhhcCCCCCc
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  310 (407)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .....+...+....    
T Consensus       161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          161 LRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             cCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            33222 234467999999999999999999999999999999999999999753322110  11112222222211    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM------GHVVH  350 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~  350 (407)
                        ..++    ..++..+.+||.+||+.||.+||++      .++++
T Consensus       236 --~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 --IRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --CCCC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence              1122    1244568999999999999999986      56654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-46  Score=353.13  Aligned_cols=260  Identities=28%  Similarity=0.455  Sum_probs=205.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEECC-----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      +..++|.+.+.||+|+||.||+|....     +..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            345678999999999999999998542     2359999986543 3345578899999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++||||+++++|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             cEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence            999999999999999997643   4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          230 KLLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       230 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ..........  .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+      .+........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~~  268 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFR  268 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHCCCc
Confidence            8765432211  122346789999999998999999999999999999999 999997544321      1222221111


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                            ...    ...++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       269 ------~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 ------LPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ------CCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  111    12344568999999999999999999999999988754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.9e-46  Score=355.09  Aligned_cols=266  Identities=26%  Similarity=0.432  Sum_probs=215.3

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLG  142 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~  142 (407)
                      .+.+..++|.+.+.||+|+||.||+|.+.        ++..||+|++.... ......+.+|+.+++++ +||||+++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            34566788999999999999999999863        46679999986553 34456788899999999 8999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCCC------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCC
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGP------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  210 (407)
                      ++.+.+..++||||+++++|.+++......            ...+++..++.++.||+.||.|||+.   +|+||||||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence            999999999999999999999999765321            13489999999999999999999999   999999999


Q ss_pred             ccEEEeCCCCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~  288 (407)
                      +|||++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            99999999999999999998776543322 223457889999999988889999999999999999999 9999975543


Q ss_pred             chhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .+      ..........      ...    ...++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       266 ~~------~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 EE------LFKLLKEGHR------MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HH------HHHHHHHTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH------HHHHHhcCCC------CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22      1112221111      111    12234568999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-46  Score=352.80  Aligned_cols=267  Identities=26%  Similarity=0.406  Sum_probs=217.3

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEE------CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      .+++..++|.+.+.||+|+||.||+|.+      .++..||+|.+..... .....+.+|+.+++++ +||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            4556678899999999999999999985      2456799999875543 3456788999999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCCC--------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCC
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVGP--------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  210 (407)
                      ...+..++||||+++++|.+++......              ...+++..++.++.|++.||.|||++   +|+||||||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence            9999999999999999999999765321              12589999999999999999999999   999999999


Q ss_pred             ccEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~  288 (407)
                      +||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999999877554332 2233457889999999988999999999999999999999 9999976554


Q ss_pred             chhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ....  ...+.    ....     ...    ...++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       254 ~~~~--~~~~~----~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          254 DSKF--YKMIK----EGFR-----MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             SHHH--HHHHH----HTCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHH--HHHhc----cCCC-----CCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            3221  11111    1100     111    12234568999999999999999999999999987643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-45  Score=345.34  Aligned_cols=264  Identities=21%  Similarity=0.303  Sum_probs=203.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999975 58889999986543  3344677889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++ +|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 6666554432   5799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC---cC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG---VL  311 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  311 (407)
                      .. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......  .....+...........   ..
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhc
Confidence            22 233456899999999997766 8999999999999999999888864333221  12222222211111000   00


Q ss_pred             ---C---------CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          312 ---D---------PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       312 ---~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                         +         ..........++..+.+|+.+||+.||++|||++++++.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  284 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence               0         0000011223456789999999999999999999998743

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=351.93  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=203.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+. ++.    +||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            468999999999999999999964 344    3577776543 3445678889999999999999999999998754 78


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ++++|+.+|+|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            9999999999999997653   4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+       .....  
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~~~~--  237 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGER--  237 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTCC--
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCCC--
Confidence            6543322 1223456889999999999999999999999999999999 99999866543322111       11110  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                         ...    ...++..+.++|.+||+.||.+||++.++++.|+.+...
T Consensus       238 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 ---LPQ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence               111    122345688999999999999999999999999987653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=359.07  Aligned_cols=247  Identities=21%  Similarity=0.291  Sum_probs=201.6

Q ss_pred             cceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      .+.||+|+||.||+|... ++..||+|++..........+.+|+.+|++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            578999999999999964 6889999999877666777899999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE--eCCCCcEEeecccceecCCCCceee
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNPKVSDFGLAKLLGSESSYIT  240 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~DfGla~~~~~~~~~~~  240 (407)
                      .+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||++........  .
T Consensus       174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~  245 (373)
T 2x4f_A          174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L  245 (373)
T ss_dssp             HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred             HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence            99886542   4689999999999999999999999   99999999999999  4567899999999988754432  2


Q ss_pred             eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCcc
Q 015395          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (407)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (407)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .+..+.....       .++....
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~-------~~~~~~~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRW-------DLEDEEF  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-------CSCSGGG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccC-------CCChhhh
Confidence            33469999999999999999999999999999999999999997654322      2222222211       1111112


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          321 SRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..++..+.+||.+||+.||.+|||+.++++.
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            3345679999999999999999999999983

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.9e-46  Score=354.86  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             hcCCCCccceecccCceEEEEEEE----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      ..++|++.+.||+|+||.||+|..    .+++.||+|++....    ......+..|+.+|+.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            356799999999999999999996    468899999986542    233446778999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            999999999999999999765    4689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .+..+....   
T Consensus       168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~---  237 (327)
T 3a62_A          168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILKCK---  237 (327)
T ss_dssp             C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTC---
T ss_pred             ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC---
Confidence            876433222 2234569999999999999999999999999999999999999997544322      222222221   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L  352 (407)
                          ..++    ..++..+.++|.+||+.||.+||     ++.++++.-
T Consensus       238 ----~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          238 ----LNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             ----CCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             ----CCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence                1111    12345689999999999999999     677877643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.5e-46  Score=358.56  Aligned_cols=255  Identities=21%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++..... ....+.+|+.+++.++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999976 688999998865433 235677899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC--cEEeecccceecCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--PKVSDFGLAKLLGS  234 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla~~~~~  234 (407)
                      +++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999764    4699999999999999999999999   9999999999999987765  99999999975432


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..  ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........  ...+........       
T Consensus       171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~-------  239 (361)
T 3uc3_A          171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKY-------  239 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCC-------
T ss_pred             cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCC-------
Confidence            22  2234569999999999988887665 89999999999999999999865443322  222233222211       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .++  ....++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       240 ~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          240 SIP--DDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             CCC--TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CCC--CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            111  11123456889999999999999999999998544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-45  Score=348.92  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=202.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999965 67889999886542   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999765    4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||......       .+..........     
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~-----  253 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR-----  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC-----
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC-----
Confidence            44333334456899999999999999999999999999999999999999753221       122222221110     


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHhccCCC
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQESPS  359 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~~~~  359 (407)
                        +......++..+.++|.+||+.||++|| +++++++.|+......
T Consensus       254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence              0011123344689999999999999999 9999999999876543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.4e-46  Score=346.14  Aligned_cols=254  Identities=20%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             hcCCCCccceecccCceEEEEEEECC-C-------CEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED-N-------SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      ..++|.+.+.||+|+||.||+|.... +       ..||+|.+..........+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            34679999999999999999998553 3       469999987766677788999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC--------
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--------  220 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------  220 (407)
                      ..++||||+++++|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            9999999999999999997652   3489999999999999999999999   9999999999999998887        


Q ss_pred             cEEeecccceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCchhhhHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGR-IPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~-~Pf~~~~~~~~~~~~~~~  298 (407)
                      +||+|||++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|. .||.......   .   .
T Consensus       160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~---~  228 (289)
T 4fvq_A          160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---K---L  228 (289)
T ss_dssp             EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H---H
T ss_pred             eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---H---H
Confidence            999999998654322     22357899999999987 67999999999999999999955 4444322111   1   1


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      .........    ....        +..+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus       229 ~~~~~~~~~----~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          229 QFYEDRHQL----PAPK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHHHTTCCC----CCCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             HHhhccCCC----CCCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            111111111    1111        224889999999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-45  Score=358.35  Aligned_cols=267  Identities=17%  Similarity=0.202  Sum_probs=206.4

Q ss_pred             cCCCCccceeccc--CceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEG--GYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|  +||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999976 68899999986543  3445678889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999976432  4699999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCce------eeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          233 GSESSY------ITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       233 ~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ......      ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||............  +......
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hcCCCCc
Confidence            322111      1122368999999999987  57999999999999999999999999865543322110  0000000


Q ss_pred             C----C------------------CCCc---------CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          305 R----N------------------PEGV---------LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       305 ~----~------------------~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .    .                  ....         ............++..+.+||.+||+.||++|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0    0                  0000         00000001223345679999999999999999999999975

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.8e-46  Score=345.22  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             hcCCCCccceecccCceEEEEEEECC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|.+.+.||+|+||.||+|.+..    +..||+|.+... .......+.+|+.+++.++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            45689999999999999999998543    235999988665 33455678899999999999999999999865 4568


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            9999999999999997642   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+..   ..+.   ....    
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~---~~~~----  232 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLE---KGDR----  232 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHH---HTCC----
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHh---cCCC----
Confidence            65543333334457889999999988899999999999999999998 99999765443322   1111   1111    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                        ...    ...++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       233 --~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          233 --LPK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence              011    1123456899999999999999999999999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-45  Score=366.41  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=208.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+++.++||||+++++++......++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3568999999999999999999975 78899999986432   2234578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        94 v~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999765    5799999999999999999999999   9999999999999999999999999999886


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .....  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........      ...+.....     
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~-----  233 (476)
T 2y94_A          167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------FKKICDGIF-----  233 (476)
T ss_dssp             CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------HHHHHTTCC-----
T ss_pred             ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcCCc-----
Confidence            54332  334579999999999988775 6899999999999999999999986543322      222222110     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ..+    ..++..+.+||.+||+.||.+|||+.++++.
T Consensus       234 --~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 --YTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --CCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --CCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence              111    1234568899999999999999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=344.91  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=210.9

Q ss_pred             hcCCCCccc-eecccCceEEEEEEEC---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDK-VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|.+.+ .||+|+||.||+|.+.   ++..||+|++.... ......+.+|+.+++.++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            345677776 9999999999999853   56779999987653 34566788999999999999999999999 456789


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            9999999999999996542   4699999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          232 LGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       232 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .........  ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+..      ....... . 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~i~~~~-~-  231 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGK-R-  231 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH------HHHHTTC-C-
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHhcCC-c-
Confidence            754433222  22346889999999988889999999999999999998 99999865543221      1111111 1 


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                          ...    ...++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       232 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          232 ----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             ----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                111    12344579999999999999999999999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-45  Score=350.24  Aligned_cols=267  Identities=22%  Similarity=0.376  Sum_probs=193.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999954 688999999865432 334567789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          156 YVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |++ ++|.+++....  .....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 59999886432  1123589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC---C
Q 015395          234 SESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---G  309 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~  309 (407)
                      ..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..   ..+..........   .
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGG
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhh
Confidence            43221 233468999999999976 46899999999999999999999999865543222   2222221111000   0


Q ss_pred             -----cCCCCC----CCC--------ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          310 -----VLDPKL----PEK--------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       310 -----~~~~~~----~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                           ...+..    +..        ....++..+.+||.+||+.||++|||+.++++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp  295 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP  295 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence                 000000    000        0012345789999999999999999999998743

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=381.60  Aligned_cols=265  Identities=26%  Similarity=0.432  Sum_probs=216.2

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ...+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ ...
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            344567778899999999999999999999888889999987654 335678899999999999999999999876 678


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +|||||+.+|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             eEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            999999999999999964311  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ..............++..|+|||++....++.++|||||||+||||++ |+.||......+.      +..+.....   
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~~~i~~~~~---  482 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYR---  482 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------HHHHHTTCC---
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCC---
Confidence            664322111222346788999999988899999999999999999999 9999976543221      222221111   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                         ...    ...++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       483 ---~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          483 ---MPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ---CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence               011    123455789999999999999999999999999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-45  Score=346.94  Aligned_cols=264  Identities=22%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             cCCCCccceecccCceEEEEEEE-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecC--Ce
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~  149 (407)
                      .+.|++.+.||+|+||.||+|.+     .+++.||+|++.... ......+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45689999999999999999983     357889999986543 33456788999999999999999999999876  67


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            899999999999999995543   4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CchhhhHHHHHH
Q 015395          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR--------PPEEVNLIEWLK  299 (407)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~  299 (407)
                      .........  ......||..|+|||++.+..++.++|||||||++|+|++|..|+....        +.........+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            887654432  2233457888999999999999999999999999999999999864221        001111111122


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ........     ..    ....++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       254 ~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGKR-----LP----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTCC-----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCC-----CC----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22221111     11    12234467999999999999999999999999998763

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-46  Score=353.43  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----e
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----H  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~  149 (407)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++....   ......+.+|+.++++++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 468889999986543   333457888999999999999999999987554    3


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            49999999999999999765    4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence            876543221  2233568999999999999999999999999999999999999997654322      11222221111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHH-HHHHhc
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV-HMLEAQ  355 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl-~~L~~~  355 (407)
                             .+......++..+.++|.+||+.||.+||++.+++ ..|...
T Consensus       238 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                   00011122456789999999999999999666555 455444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.3e-46  Score=353.70  Aligned_cols=268  Identities=24%  Similarity=0.341  Sum_probs=214.0

Q ss_pred             hcCCCCccceecccCceEEEEEEE-----CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee--cCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~  149 (407)
                      ..++|++.+.||+|+||.||+|.+     .++..||+|++........+.+.+|+.++++++||||+++++++.  +...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            346799999999999999999984     357789999998777777778999999999999999999999876  4567


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            899999999999999997632   3599999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch--------hhhHHHHHH
Q 015395          230 KLLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE--------EVNLIEWLK  299 (407)
Q Consensus       230 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~  299 (407)
                      ..........  .....||..|+|||++.+..++.++|||||||++|+|++|..||.......        .......+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            8875443322  223457888999999998899999999999999999999999986422110        001111111


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      .......         .......++..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus       255 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          255 ELLEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHhhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            2221111         11112234567899999999999999999999999999886543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.8e-45  Score=348.50  Aligned_cols=251  Identities=20%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC--------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--------  148 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------  148 (407)
                      ++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|+.+|++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46899999999999999999976 78899999986543 345567889999999999999999999885543        


Q ss_pred             -------------------------------------------------eeEEEEEeccCCChHHhhhCCCCCCCCCCHH
Q 015395          149 -------------------------------------------------HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE  179 (407)
Q Consensus       149 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~  179 (407)
                                                                       ..++|||||++++|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                             37999999999999999986532 2346777


Q ss_pred             HHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce-----------eeeeeecccc
Q 015395          180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-----------ITTRVMGTFG  248 (407)
Q Consensus       180 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-----------~~~~~~gt~~  248 (407)
                      .++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.........           ......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            8999999999999999999   9999999999999999999999999999887654321           1233469999


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHH
Q 015395          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (407)
Q Consensus       249 y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (407)
                      |+|||++.+..++.++|||||||++|+|++|..|+.        ............         .. ..........+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~~---------~~-~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRNL---------KF-PLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHTT---------CC-CHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhcc---------CC-CcccccCChhHH
Confidence            999999999999999999999999999999877652        111111211111         11 112344556789


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHH
Q 015395          329 LVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       329 ~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ++|.+||+.||.+|||+.++++.
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.9e-46  Score=351.78  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=185.2

Q ss_pred             cceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEeccCCC
Q 015395           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      .+.||+|+||.||+|... +++.||||++...   ....+..|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 6889999998543   3456678999999997 9999999999999999999999999999


Q ss_pred             hHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC---CcEEeecccceecCCCCce
Q 015395          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKVSDFGLAKLLGSESSY  238 (407)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~~~~~~~~  238 (407)
                      |.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++   .+||+|||++........ 
T Consensus        93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            99999875    5799999999999999999999999   999999999999998765   799999999987654332 


Q ss_pred             eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh-hhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE-VNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+.+.......       ..++.
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-------~~~~~  237 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-------FSFEG  237 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-------CCCCS
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-------CCCCc
Confidence            23345689999999999999999999999999999999999999976543211 11222233322211       11122


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .....++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence            222345678999999999999999999999986543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.6e-46  Score=351.22  Aligned_cols=270  Identities=21%  Similarity=0.408  Sum_probs=217.2

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      ...++++..++|.+.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            34455677789999999999999999999854      36779999986543 334457889999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCC------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDV------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID  216 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~  216 (407)
                      ++.+.+..++||||+++++|.+++....      .....+++..++.++.|++.||.|||++   +|+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence            9999999999999999999999986421      1124579999999999999999999999   999999999999999


Q ss_pred             CCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhH
Q 015395          217 KHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNL  294 (407)
Q Consensus       217 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~  294 (407)
                      .++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+    
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  248 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----  248 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH----
Confidence            9999999999999865433221 1223457889999999988899999999999999999999 899997543221    


Q ss_pred             HHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                        ...........      ..    ...++..+.++|.+||+.||.+|||+.++++.|+.....
T Consensus       249 --~~~~~~~~~~~------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          249 --VLRFVMEGGLL------DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             --HHHHHHTTCCC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             --HHHHHHcCCcC------CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence              12222221110      11    123445689999999999999999999999999987554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-45  Score=341.97  Aligned_cols=250  Identities=21%  Similarity=0.286  Sum_probs=207.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            46999999999999999999966 46789999987765566778899999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccceecCC
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~~  234 (407)
                      ++++|.+++...    ..+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+|||++.....
T Consensus        89 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           89 TGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998765    4699999999999999999999999   99999999999999   7888999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...  .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+      ..........       .
T Consensus       162 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~-------~  225 (277)
T 3f3z_A          162 GKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREGTF-------T  225 (277)
T ss_dssp             TSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------C
T ss_pred             ccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCC-------C
Confidence            432  3344689999999998654 8999999999999999999999997544322      1222222111       1


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .+......++..+.++|.+||+.||.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111111345679999999999999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-45  Score=348.72  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=208.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh------hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|.+......      ....+.+|+.+++.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46999999999999999999965 6889999988654321      3567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC----CcEEeecc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDFG  227 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfG  227 (407)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999765    5789999999999999999999999   999999999999999887    79999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .+.......  
T Consensus       165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~--  234 (321)
T 2a2a_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVS--  234 (321)
T ss_dssp             TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC--
T ss_pred             cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc--
Confidence            9987654332  234468999999999999999999999999999999999999997544322      122222111  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                           ..++......++..+.++|.+||+.||++|||+.++++.-
T Consensus       235 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          235 -----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             -----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             -----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence                 0111111123445689999999999999999999998743

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-45  Score=346.83  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=201.9

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|.. .++..||+|++...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999996 46889999998653   344556788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864222225689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... ......|++.|+|||++.+..++.++|||||||++|+|++|..||......    ............ .      
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~------  255 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCD-Y------  255 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHTTC-S------
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhccc-C------
Confidence            4322 123346899999999999999999999999999999999999999754321    122222222211 1      


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                        +......++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       256 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          256 --PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             --CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence              111112345578999999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.5e-46  Score=354.04  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCE----EEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSK----VAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+. ++..    ||+|.+.... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            467999999999999999999965 3443    7888774432 2233456679999999999999999999864 5689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+.+|+|.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            9999999999999997643   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          232 LGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....... ......||..|+|||++.+..++.++|||||||++|+|++ |..||......+....+      .....   
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~~---  235 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL------EKGER---  235 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH------HTTCB---
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH------HcCCC---
Confidence            7544332 2334567889999999998999999999999999999999 99999876543322211      11110   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                         ...+    ..++..+.++|.+||+.||.+||++.++++.|+.+...
T Consensus       236 ---~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          236 ---LAQP----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ---CCCC----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ---CCCC----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               0111    11223478899999999999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=353.55  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCC--CccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~  151 (407)
                      +..++|++.+.||+|+||.||+|...++..||||++...  .......+.+|+.+|+.++|  |||+++++++......+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            345679999999999999999999888999999988654  33445678899999999976  99999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +|||+ .+++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||++..
T Consensus        86 lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99995 588999999875    5799999999999999999999999   999999999999997 56899999999987


Q ss_pred             cCCCCce-eeeeeeccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          232 LGSESSY-ITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      ....... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....     ....+.
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~  231 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH  231 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH
Confidence            6543322 2334579999999999854           6789999999999999999999999975332     122222


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .......     ...++..    .+..+.++|.+||+.||.+|||+.++++....
T Consensus       232 ~~~~~~~-----~~~~~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          232 AIIDPNH-----EIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             HHHCTTS-----CCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHhcCCc-----ccCCccc----CCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence            2222111     1111111    23468899999999999999999999986554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=349.57  Aligned_cols=268  Identities=23%  Similarity=0.332  Sum_probs=210.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee----cCCee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA----EGAHR  150 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~  150 (407)
                      +..++|++.+.||+|+||.||+|.. .+++.||||++..........+.+|+.+++.++||||+++++++.    .....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            3456899999999999999999996 578899999987776677778899999999999999999999986    34578


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+.+++|.+++.........+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999976332336799999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCcee--------eeeeeccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          231 LLGSESSYI--------TTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       231 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      .........        .....||+.|+|||++....   ++.++|||||||++|+|++|+.||........ ...    
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----  257 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA----  257 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH----
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh----
Confidence            653211100        01234799999999987654   68999999999999999999999953111000 011    


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCCc
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  360 (407)
                      .......       ..  .....++..+.++|.+||+.||.+|||+.++++.|+.+....+
T Consensus       258 ~~~~~~~-------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          258 LAVQNQL-------SI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HHHHCC---------C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             HHhhccC-------CC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            1111110       00  0112334569999999999999999999999999998876543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.9e-45  Score=352.38  Aligned_cols=268  Identities=17%  Similarity=0.229  Sum_probs=204.6

Q ss_pred             hcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCChhhHH-----------HHHHHHHHHhcCCCCccce
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQAER-----------EFKVEVEAIGRVRHKNLVR  139 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~-----------~~~~E~~~l~~l~hpniv~  139 (407)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++.........           .+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999999764      367999988665432221           2334666778889999999


Q ss_pred             eeeeeecC----CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE
Q 015395          140 LLGYCAEG----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI  215 (407)
Q Consensus       140 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill  215 (407)
                      +++++...    ...++||||+ +++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99998754    5589999999 999999997642   4699999999999999999999999   99999999999999


Q ss_pred             e--CCCCcEEeecccceecCCCCcee------eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 015395          216 D--KHWNPKVSDFGLAKLLGSESSYI------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR  287 (407)
Q Consensus       216 ~--~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~  287 (407)
                      +  .++.+||+|||+++.+.......      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998765332211      123459999999999999999999999999999999999999998543


Q ss_pred             CchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ......  ......... ....+++..++   ...++..+.+++..||..||.+||++.+|++.|+.+..
T Consensus       266 ~~~~~~--~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          266 KDPKYV--RDSKIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             TCHHHH--HHHHHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCHHHH--HHHHHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            322211  111111000 00001111000   01224568999999999999999999999999987643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-45  Score=349.08  Aligned_cols=269  Identities=26%  Similarity=0.388  Sum_probs=217.0

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEE------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLL  141 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~  141 (407)
                      ....+.+..++|++.+.||+|+||.||+|.+      .+++.||||.+.... ....+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            4566777888999999999999999999984      245789999986653 33456788999999999 699999999


Q ss_pred             eeeecC-CeeEEEEEeccCCChHHhhhCCCCC------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCC
Q 015395          142 GYCAEG-AHRMLVYEYVNNGNLEQWLHGDVGP------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI  208 (407)
Q Consensus       142 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl  208 (407)
                      +++... ..+++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.   +|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            998765 4589999999999999999875321            12389999999999999999999999   9999999


Q ss_pred             CCccEEEeCCCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 015395          209 KSSNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYS  286 (407)
Q Consensus       209 kp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~  286 (407)
                      ||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433 22334568899999999999999999999999999999998 99999765


Q ss_pred             CCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ...+..  .   ........      ...+    ..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       255 ~~~~~~--~---~~~~~~~~------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDEEF--C---RRLKEGTR------MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSHHH--H---HHHHHTCC------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHH--H---HHhccCcc------CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            543221  1   11111111      1111    123456899999999999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=344.52  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=201.9

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .++|++.+.||+|+||.||+|.+. ++.||+|.+...  .....+.+|+.++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            467999999999999999999886 788999988543  445678899999999999999999998874  479999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC-cEEeecccceecCCCC
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSES  236 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~DfGla~~~~~~~  236 (407)
                      ++++|.+++.... ....+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            9999999997642 1234789999999999999999999932229999999999999998887 799999999765432 


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........    ......... ..     +.. 
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~-~~-----~~~-  225 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHNG-TR-----PPL-  225 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHTT-CC-----CCC-
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhcC-CC-----CCc-
Confidence               2234589999999999999999999999999999999999999975443221    111111111 11     111 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                         ...++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence               1233456899999999999999999999999999876543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.7e-45  Score=339.28  Aligned_cols=254  Identities=18%  Similarity=0.290  Sum_probs=208.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|++...  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            368999999999999999999965 5889999988654  3344567888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC---cEEeeccccee
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAKL  231 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGla~~  231 (407)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999988765    4699999999999999999999999   9999999999999976655   99999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ..........     
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~-----  224 (284)
T 3kk8_A          158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGAY-----  224 (284)
T ss_dssp             CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-----
T ss_pred             cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHHHhccc-----
Confidence            654332  233568999999999999999999999999999999999999997543221      1112221111     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                        ..+......++..+.+++.+||+.||++|||+.++++.-.
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (284)
T 3kk8_A          225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  264 (284)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred             --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence              1111112234556899999999999999999999998544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-45  Score=353.79  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=206.9

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----CCccceeeeeee
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----HKNLVRLLGYCA  145 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~  145 (407)
                      ....+..++|.+.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.+.     ||||+++++++.
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            344455689999999999999999999974 6788999988643 344556677999999886     999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC--------
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--------  217 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------  217 (407)
                      ..+..++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.        
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence            999999999999 8999999976532  3589999999999999999999999   9999999999999975        


Q ss_pred             -----------------CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 015395          218 -----------------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  280 (407)
Q Consensus       218 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~  280 (407)
                                       ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence                             789999999999875443    23456899999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhhHHHHHHHHhhcCC-----------CCCc-----CCCCCCCCcc-H---------------HHHHHHH
Q 015395          281 IPVDYSRPPEEVNLIEWLKKMVTNRN-----------PEGV-----LDPKLPEKPT-S---------------RLLKRIL  328 (407)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-----~~~~~~~~~~-~---------------~~~~~l~  328 (407)
                      .||......+....   +........           ....     .....+.... .               .....+.
T Consensus       257 ~pf~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  333 (360)
T 3llt_A          257 LLFRTHEHMEHLAM---MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC  333 (360)
T ss_dssp             CSCCCSSHHHHHHH---HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred             CCCCCCcHHHHHHH---HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence            99986543322222   111110000           0000     0000000000 0               0115577


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHH
Q 015395          329 LVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       329 ~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      +||.+||+.||++|||+.++++.
T Consensus       334 ~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          334 DFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHhcCChhhCCCHHHHhcC
Confidence            99999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.3e-46  Score=369.43  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=199.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +..++|++.+.||+|+||.||+|... ++..||||++...   .......+..|+.+++.++||||+++++++...+.++
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            44578999999999999999999965 6889999998643   2233456678999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +||||+++++|.+++...    ..+++..++.++.||+.||+|||+ .   +|+||||||+||||+.++.+||+|||+++
T Consensus       225 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            999999999999999765    479999999999999999999998 8   99999999999999999999999999997


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .........     
T Consensus       298 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-----  365 (446)
T 4ejn_A          298 EGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE-----  365 (446)
T ss_dssp             TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-----
T ss_pred             eccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-----
Confidence            6433222 2344679999999999999999999999999999999999999997544322      122222211     


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L  352 (407)
                        ..++    ..++..+.+||.+||+.||.+||     ++.++++.-
T Consensus       366 --~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          366 --IRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             --CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             --CCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence              1111    12345689999999999999999     999998743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.5e-45  Score=341.39  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             cCCCCccceecccCceEEEEEEECC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeee-ecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~  151 (407)
                      ..+|++.+.||+|+||.||+|...+    ...+|+|.+.... ......+.+|+.++++++||||+++++++ ...+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3468899999999999999998542    2258999886543 34456788999999999999999999985 4566889


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus       104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            9999999999999997643   5689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCce---eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          232 LGSESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       232 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .......   ......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....      ...... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~------~~~~~~-  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LLQGRR-  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH------HHTTCC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH------HhcCCC-
Confidence            6543321   1233457889999999999999999999999999999999 6667765443322111      111110 


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           ...    ...++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       251 -----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          251 -----LLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 011    11234568999999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.1e-46  Score=359.31  Aligned_cols=246  Identities=24%  Similarity=0.298  Sum_probs=194.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHH-HhcCCCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|... ++..||||++....   ......+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999976 57789999986543   2233445567666 577899999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999999765    4689999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||......      +....+.....      
T Consensus       190 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~------  256 (373)
T 2r5t_A          190 IEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL------  256 (373)
T ss_dssp             BCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSCC------
T ss_pred             ccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhccc------
Confidence            33222 234467999999999999999999999999999999999999999754322      22222222211      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV  348 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev  348 (407)
                       .++    ..++..+.+||.+||+.||.+||++.+.
T Consensus       257 -~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          257 -QLK----PNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             -CCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             -CCC----CCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence             111    1234568999999999999999998543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=359.97  Aligned_cols=258  Identities=22%  Similarity=0.305  Sum_probs=207.3

Q ss_pred             hcCCCCccceecccCceEEEEEEE----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCccceeeeeeecC
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG  147 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  147 (407)
                      ..++|++.+.||+|+||.||+|..    .+++.||||++....    ......+..|+.+|+.+ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            456899999999999999999997    368899999885432    22334566789999999 699999999999999


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ...++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999999765    4699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      +++..............||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.........  ...........
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~  282 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE  282 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC
Confidence            998765443333444579999999999975  34789999999999999999999999765433222  12222222211


Q ss_pred             CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHHh
Q 015395          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLEA  354 (407)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L~~  354 (407)
                             +.++    ..++..+.+||.+||..||.+||     ++.++++....
T Consensus       283 -------~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          283 -------PPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             -------CCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             -------CCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence                   1111    22345688999999999999999     89999886654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=344.63  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=203.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++.....  .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999975 588999998865432  334567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999988765    5699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc----------
Q 015395          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN----------  304 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----------  304 (407)
                      ... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+   ......          
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI---RKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHHHHH
T ss_pred             ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhcccccccccccc
Confidence            322 234468999999999876 66899999999999999999999999865543322221   111110          


Q ss_pred             --CCCC--CcCCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          305 --RNPE--GVLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       305 --~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                        ....  ...++.....   ....++..+.++|.+||+.||.+|||++++++.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  286 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP  286 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence              0000  0000000000   0123455689999999999999999999999743

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-45  Score=347.82  Aligned_cols=267  Identities=24%  Similarity=0.388  Sum_probs=203.7

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeee
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  145 (407)
                      .++.+..++|.+.+.||+|+||.||+|...    .+..||+|.+...  .......+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344566788999999999999999999854    2347999988654  3344567889999999999999999999987


Q ss_pred             cCC-----eeEEEEEeccCCChHHhhhCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          146 EGA-----HRMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       146 ~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      +..     ..++||||+++++|.+++....  .....+++..++.++.|++.||.|||++   +|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            654     3599999999999999984322  1225699999999999999999999999   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHH
Q 015395          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  296 (407)
                      +.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+...   
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD---  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---
Confidence            99999999999876443322 1223457889999999999999999999999999999999 899997655432211   


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         .......      ..    ....++..+.++|.+||..||.+|||+.++++.|+.+..
T Consensus       261 ---~~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          261 ---YLLHGHR------LK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             ---HHHTTCC------CC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHcCCC------CC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1111111      11    122344578999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=339.44  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=186.1

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            45799999999999999999996 468899999885432   12346788899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999998653   4689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+...      ....       .+.
T Consensus       164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-------~~~  229 (278)
T 3cok_A          164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVL-------ADY  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-------SCC
T ss_pred             CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhh-------ccc
Confidence            33221 223468999999999999899999999999999999999999997654332111      0000       011


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..+    ..++..+.++|.+||+.||++|||+.++++.
T Consensus       230 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 EMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            111    2244578999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-45  Score=343.73  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=209.5

Q ss_pred             HHHhcCCCCccc-eecccCceEEEEEEEC---CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecC
Q 015395           74 LEVSTNGFSDDK-VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (407)
Q Consensus        74 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  147 (407)
                      +.+..++|.+.+ .||+|+||.||+|.+.   ++..||||++....  ......+.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            344566788888 9999999999999642   46779999886543  23356788999999999999999999999 56


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      +..++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence            6789999999999999999865    4699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          228 LAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       228 la~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ++...........  ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+.      .... ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~-~~  235 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAML-EK  235 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHH-HT
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHH-Hc
Confidence            9988765443322  22346788999999988889999999999999999999 9999976543221      1111 11


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ...     ...    ...++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       236 ~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          236 GER-----MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             TCC-----CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111     111    12345579999999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=354.46  Aligned_cols=259  Identities=27%  Similarity=0.398  Sum_probs=198.4

Q ss_pred             CCCccceecccCceEEEEEEEC--CC--CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeee-cCCeeEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE--DN--SKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv  153 (407)
                      .|.+.+.||+|+||.||+|.+.  ++  ..||+|.+... .......+.+|+.++++++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677899999999999999853  22  35899988654 3345567889999999999999999999865 45678999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999997653   4689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCce---eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          234 SESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       234 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      .....   ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+....      ......   
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~------~~~~~~---  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LLQGRR---  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH------HHTTCC---
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH------HHcCCC---
Confidence            33221   1223457889999999999999999999999999999999 7888876554332211      111110   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCCc
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  360 (407)
                         ...    +..++..+.++|.+||+.||++|||+.++++.|+.+.....
T Consensus       315 ---~~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 ---LLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ---CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence               011    12234568999999999999999999999999998765443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=350.54  Aligned_cols=266  Identities=18%  Similarity=0.266  Sum_probs=201.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccCChhh-----------HHHHHHHHHHHhcCCCCccceeee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQA-----------EREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      .++|.+.+.||+|+||.||+|...    ++..||+|++.......           ...+..|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999975    46789999886654221           123556888899999999999999


Q ss_pred             eeec----CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          143 YCAE----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       143 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      ++..    ....++||||+ +++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9877    78899999999 99999999765    3799999999999999999999999   99999999999999988


Q ss_pred             C--CcEEeecccceecCCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          219 W--NPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       219 ~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                      +  .+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876432211      1133468999999999999999999999999999999999999996432221


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .  ................+. ...+   ...++..+.++|.+||+.||++||++.+|++.|+....
T Consensus       268 ~--~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 V--AVQTAKTNLLDELPQSVL-KWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             H--HHHHHHHHHHHTTTHHHH-HHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             H--HHHHHHHhhcccccHHHH-hhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1  111111111111100000 0000   01344579999999999999999999999999997654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.2e-45  Score=340.77  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=207.0

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeee-ecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+..|+.+++.++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            46799999999999999999996 4688899998654422  23467799999999988777766655 67788899999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~  232 (407)
                      |+ +++|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||++...
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99 999999997432   4699999999999999999999999   99999999999999   78899999999999877


Q ss_pred             CCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          233 GSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       233 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ......      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            554331      12345689999999999999999999999999999999999999987665444444333322211110


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .. .        ....++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       239 ~~-~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          239 IE-V--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HH-H--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hh-h--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            00 0        001224579999999999999999999999999988753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-45  Score=351.98  Aligned_cols=263  Identities=19%  Similarity=0.282  Sum_probs=196.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  .....+.+|+.++++++||||+++++++.+....++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            467999999999999999999955 678899999865432  22446778999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-----CCCCcEEeecccc
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-----KHWNPKVSDFGLA  229 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~~kl~DfGla  229 (407)
                      ||++ ++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++     ..+.+||+|||++
T Consensus       113 e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             ECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             ecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9996 5999999775    4699999999999999999999999   999999999999995     4455999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+...   .+..........
T Consensus       185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~~~  260 (329)
T 3gbz_A          185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF---KIFEVLGLPDDT  260 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTT
T ss_pred             cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH---HHHHHhCCCchh
Confidence            87653322 22334689999999999774 48999999999999999999999997654322211   111111111000


Q ss_pred             Cc-----------CCCCCCCCc-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          309 GV-----------LDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       309 ~~-----------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ..           ..+......     ...++..+.+||.+||+.||.+|||+.++++.-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  320 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP  320 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence            00           000000000     111346788999999999999999999998743

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-45  Score=340.08  Aligned_cols=262  Identities=19%  Similarity=0.250  Sum_probs=209.4

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeee-ecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  ..+..|+.+++.++|++++..+.++ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999996 56889999988654322  3577899999999988876666554 66778899999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~  232 (407)
                      |+ +++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||++...
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 899999997432   4699999999999999999999999   99999999999999   48889999999999877


Q ss_pred             CCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          233 GSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       233 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ......      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            654331      12345699999999999999999999999999999999999999987554433333333222111110


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .. .        ....++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       239 ~~-~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          239 IE-V--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HH-H--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hH-H--------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            00 0        011234568999999999999999999999999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-45  Score=343.53  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46999999999999999999965 67889999886543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccceecC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~  233 (407)
                      +++++|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999998854322225699999999999999999999999   99999999999999   456789999999998764


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....  .....||+.|+|||++. ..++.++|||||||++|+|++|+.||......+..      ............   
T Consensus       179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~~~---  246 (285)
T 3is5_A          179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKATYKEPNYAV---  246 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCCCCC---
T ss_pred             Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhhccCCccccc---
Confidence            4322  33456899999999985 56899999999999999999999999765432211      111111111000   


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                           ....++..+.+++.+||+.||++|||+.++++.
T Consensus       247 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          247 -----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 001134568899999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3e-45  Score=346.50  Aligned_cols=261  Identities=20%  Similarity=0.289  Sum_probs=202.3

Q ss_pred             CCCCcc-ceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      +.|.+. +.||+|+||.||+|... +++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467774 78999999999999954 6889999999776666677888999999885 79999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC---cEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGla~~~  232 (407)
                      |+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++...
T Consensus        92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999765    4689999999999999999999999   9999999999999988766   999999998765


Q ss_pred             CCCCc------eeeeeeeccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--------h
Q 015395          233 GSESS------YITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--------N  293 (407)
Q Consensus       233 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~--------~  293 (407)
                      .....      .......||+.|+|||++..     ..++.++|||||||++|+|++|+.||......+..        .
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211      11223458999999999865     55889999999999999999999999865432200        0


Q ss_pred             -HHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          294 -LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                       ............ .      .++......++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       245 ~~~~~~~~i~~~~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          245 CQNMLFESIQEGK-Y------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             HHHHHHHHHHHCC-C------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             HHHHHHHHHhccC-c------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence             011112221111 0      1111111234567899999999999999999999988543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.8e-45  Score=352.35  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=204.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++......    ...|++++.++ +||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            356999999999999999999975 5788999998665433    23577778777 79999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC----CCcEEeeccccee
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVSDFGLAKL  231 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~~  231 (407)
                      |+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||+.+.    +.+||+|||++..
T Consensus        97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999765    5699999999999999999999999   99999999999999543    3499999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........   +.+..+.....     
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~~~~~-----  240 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILARIGSGKF-----  240 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHHHHHCCC-----
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHHHccCCc-----
Confidence            654432 233457899999999998888999999999999999999999999754322222   22222222211     


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                        .++......++..+.+||.+||..||++|||+.++++.-.
T Consensus       241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence              1112222345567999999999999999999999997443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-45  Score=341.25  Aligned_cols=250  Identities=27%  Similarity=0.431  Sum_probs=204.8

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|++.+.||+|+||.||+|... ++..||+|++....   ......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3567999999999999999999966 56789999885432   2234578889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999765    4699999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+.      ........       
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-------  223 (279)
T 3fdn_A          160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVE-------  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-------
T ss_pred             Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHHHhCC-------
Confidence            3322   2344689999999999999999999999999999999999999975443222      12221111       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ..++    ..++..+.+||.+||+.||.+|||+.++++...
T Consensus       224 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          224 FTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             CCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             CCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            1111    123456889999999999999999999998554

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.6e-45  Score=356.42  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCC--CCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.||+|+||.||+|...++..||||++...  .......+.+|+.+|+.++  ||||+++++++...+.+++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3459999999999999999999888899999988654  3345567889999999996  59999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      || +.+++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||++....
T Consensus       135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 5588999999875    4789999999999999999999999   999999999999995 5799999999998765


Q ss_pred             CCCce-eeeeeeccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          234 SESSY-ITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       234 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      ..... .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||......     ...+...
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~  280 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI  280 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHH
Confidence            43322 2334579999999999865           46899999999999999999999999754321     1222222


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .....     ...++..    .+..+.+||.+||+.||.+|||+.++++...
T Consensus       281 ~~~~~-----~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          281 IDPNH-----EIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             HCTTS-----CCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             hCccc-----cCCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence            22111     1111211    1346889999999999999999999997544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-44  Score=335.48  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=207.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            56999999999999999999975 68899999886443 34456788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999764    5699999999999999999999999   99999999999999999999999999998764332


Q ss_pred             c-eeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          237 S-YITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       237 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      . .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... .    ........        
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~----~~~~~~~~--------  226 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y----SDWKEKKT--------  226 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-H----HHHHTTCT--------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-H----HHhhhccc--------
Confidence            2 12234568999999999987765 77899999999999999999999765432211 1    11111110        


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                       .......++..+.++|.+||+.||.+|||+.++++..
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (276)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence             0111234456789999999999999999999998743

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.1e-45  Score=349.50  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=204.4

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +.|.+.+.||+|+||.||+|.. .++..||||++....   ......+.+|+.++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3589999999999999999996 468889999986543   233457888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+. |+|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9996 68888875432   4799999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCceeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          235 ESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .     ....||+.|+|||++.   ...++.++|||||||++|||++|+.||......      ..+.........    
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~~----  271 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP----  271 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC----
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCC----
Confidence            2     2346899999999884   567899999999999999999999999754322      222222222211    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                        .   .....++..+.++|.+||+.||++|||+.++++.....
T Consensus       272 --~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          272 --A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             --C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             --C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence              1   11122345688999999999999999999999865543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=339.33  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=203.5

Q ss_pred             CCCccceecccCceEEEEEEECC-CC---EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee-EEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLED-NS---KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLV  153 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~-~~---~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~lv  153 (407)
                      .|.+.+.||+|+||.||+|.+.+ +.   .||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667999999999999998532 22   69999886543 34456788999999999999999999999766555 999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+.+++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999997643   5689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCc---eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          234 SESS---YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       234 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....   .......+|+.|+|||.+.+..++.++|||||||++|+|++|..| |......+   ....+   .....   
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~---~~~~~---  246 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFL---AQGRR---  246 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHH---HTTCC---
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHh---hcCCC---
Confidence            3221   112234578899999999999999999999999999999995555 44333222   11111   11110   


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                         ...    ...++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       247 ---~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 ---LPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               011    122345689999999999999999999999999987543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=348.59  Aligned_cols=273  Identities=25%  Similarity=0.385  Sum_probs=203.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHH--HHHHHhcCCCCccceeeeeee-----cCC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLLGYCA-----EGA  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--E~~~l~~l~hpniv~~~~~~~-----~~~  148 (407)
                      +..++|++.+.||+|+||.||+|.. +++.||||++....   ...+..  |+..+..++||||+++++.+.     ...
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            4467899999999999999999977 47899999886443   223333  444455689999999997543     334


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC------CCceeccCCCCccEEEeCCCCcE
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL------EPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      .+++||||+++|+|.+++...     ..++..++.++.||+.||.|||+..      ..+|+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            679999999999999999764     4689999999999999999999763      23899999999999999999999


Q ss_pred             EeecccceecCCCCc-------eeeeeeeccccccCccccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015395          223 VSDFGLAKLLGSESS-------YITTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (407)
Q Consensus       223 l~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~elltg~~Pf~~~~~  288 (407)
                      |+|||++........       .......||+.|+|||++.+       ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653321       11223469999999999977       4567789999999999999999777643322


Q ss_pred             chhh-h----------HHHHHHHHhhcCCCCCcCCCCCCC--CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          289 PEEV-N----------LIEWLKKMVTNRNPEGVLDPKLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       289 ~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .... .          ....+.........    .+.++.  .....++..+.+||.+||+.||++|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            1110 0          01111112221111    122221  12345777899999999999999999999999999988


Q ss_pred             cCCCcc
Q 015395          356 ESPSKE  361 (407)
Q Consensus       356 ~~~~~~  361 (407)
                      ......
T Consensus       317 l~~~~~  322 (336)
T 3g2f_A          317 MMIWER  322 (336)
T ss_dssp             HHCCCC
T ss_pred             HHHHHh
Confidence            765433

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-45  Score=351.56  Aligned_cols=259  Identities=23%  Similarity=0.293  Sum_probs=203.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|++...     .......+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            467999999999999999999965 6778999988543     2345567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCC------------------------------------CCCCCHHHHHHHHHHHHHHHHhh
Q 015395          152 LVYEYVNNGNLEQWLHGDVGP------------------------------------CSPLTWEIRMNIILGTAKGLSYL  195 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~~L~~L  195 (407)
                      +||||+++|+|.+++......                                    ...+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998521100                                    11246778889999999999999


Q ss_pred             hhcCCCceeccCCCCccEEEeCCC--CcEEeecccceecCCCCc---eeeeeeeccccccCccccCC--CCCCcchhHHH
Q 015395          196 HEGLEPKVVHRDIKSSNILIDKHW--NPKVSDFGLAKLLGSESS---YITTRVMGTFGYVAPEYAST--GMLNERSDVYS  268 (407)
Q Consensus       196 H~~~~~~ivH~Dlkp~Nill~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiws  268 (407)
                      |+.   +|+||||||+|||++.++  .+||+|||++........   .......||+.|+|||++.+  ..++.++||||
T Consensus       185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999   999999999999998776  899999999987643221   12334569999999999865  67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 015395          269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV  348 (407)
Q Consensus       269 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev  348 (407)
                      |||++|+|++|+.||......+      .+........       .++......++..+.++|.+||+.||.+||++.++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            9999999999999997554322      2222222211       11111223355679999999999999999999999


Q ss_pred             HHHH
Q 015395          349 VHML  352 (407)
Q Consensus       349 l~~L  352 (407)
                      ++.-
T Consensus       329 l~hp  332 (345)
T 3hko_A          329 LQHP  332 (345)
T ss_dssp             HHSH
T ss_pred             hcCh
Confidence            9843

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-44  Score=358.59  Aligned_cols=263  Identities=24%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999965 5788999998654  344456788899999999999999999998654      4


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+|+||||+++ +|.+.+..      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            67999999965 57777643      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH-----------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW-----------  297 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-----------  297 (407)
                      ++......  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..           
T Consensus       211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98765432  23445799999999999999999999999999999999999999986553322211110           


Q ss_pred             -----HHHHhhcCCC-CC-----cCCC-CCCC--CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          298 -----LKKMVTNRNP-EG-----VLDP-KLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       298 -----~~~~~~~~~~-~~-----~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                           .......... ..     .... .++.  ......+..+.+||.+||..||++|||++++++.-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                 0000000000 00     0000 0000  01112356789999999999999999999999843

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=350.03  Aligned_cols=264  Identities=23%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhH-HHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|.+.+.||+|+||.||+|... ++..||+|++........ ..+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999976 688999998865432211 2345699999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      ++ ++|.+++....   ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            96 59999887643   4689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             ceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC---CcCC
Q 015395          237 SYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---GVLD  312 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  312 (407)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..   ..+..........   ....
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhc
Confidence            2 2233468999999999876 56899999999999999999999999865543322   2222222111110   0000


Q ss_pred             ---------CCCCCC----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 ---------PKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ---------~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                               +.....    ....++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence                     000000    01123456889999999999999999999998443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.1e-45  Score=349.16  Aligned_cols=266  Identities=26%  Similarity=0.413  Sum_probs=214.5

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECC-C-----CEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED-N-----SKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      .+++..++|.+.+.||+|+||.||+|.... +     ..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            456677899999999999999999999643 2     379999886653 34456788999999999 899999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC----------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEE
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG----------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil  214 (407)
                      .+.+..++||||+++|+|.+++.....          ....+++..++.++.|++.||.|||++   +|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999864210          124689999999999999999999999   9999999999999


Q ss_pred             EeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhh
Q 015395          215 IDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEV  292 (407)
Q Consensus       215 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~  292 (407)
                      ++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999999999876443322 2233457889999999988899999999999999999998 99999765443221


Q ss_pred             hHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                        .    ........     ...+    ...+..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       277 --~----~~~~~~~~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          277 --Y----KLVKDGYQ-----MAQP----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             --H----HHHHHTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --H----HHHhcCCC-----CCCC----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence              1    11111110     1111    122456899999999999999999999999998764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.2e-45  Score=348.29  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=206.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCE--EEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSK--VAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|... ++..  +|+|.+... .......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            467999999999999999999954 4554  489988653 233445788899999999 89999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC
Q 015395          153 VYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN  220 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  220 (407)
                      ||||+++++|.+++....            .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999997653            2224799999999999999999999999   9999999999999999999


Q ss_pred             cEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      +||+|||++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+      ...
T Consensus       181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE  252 (327)
T ss_dssp             EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred             EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence            9999999987432211  1222356889999999988889999999999999999998 999997554321      122


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      .......      ...    ...++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       253 ~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          253 KLPQGYR------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HGGGTCC------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhhcCCC------CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            2211110      111    123445789999999999999999999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-45  Score=370.45  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=210.9

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +..++|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+|+.++||||+++++++.+.+.++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            45678999999999999999999975 68899999985432   233456788999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||++||+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||+.+|.+||+|||++..
T Consensus       261 lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence            99999999999999976531  3599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ......  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+  ........      
T Consensus       336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i~~~~------  405 (576)
T 2acx_A          336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLVKEVP------  405 (576)
T ss_dssp             CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHHHHCC------
T ss_pred             cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHhhccc------
Confidence            754432  33457999999999999999999999999999999999999999865432221111  11111111      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                       ..+    ...++..+.+||.+||+.||.+||     ++.+|++.
T Consensus       406 -~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 -EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             111    123445789999999999999999     77888764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8e-45  Score=338.11  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=204.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....      .....+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999976 688999998865421      23567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC----CcEEeecc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDFG  227 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfG  227 (407)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999764    4699999999999999999999999   999999999999998877    79999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+      .+.......  
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~--  227 (283)
T 3bhy_A          158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVN--  227 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC--
T ss_pred             cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhcc--
Confidence            9987654322  233468999999999999999999999999999999999999997654322      122221111  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                           ...+......++..+.+++.+||+.||++|||+.++++
T Consensus       228 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 -----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                 01111111233456899999999999999999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=345.62  Aligned_cols=246  Identities=24%  Similarity=0.283  Sum_probs=194.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||+||+|... +++.||||++....  .........|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357999999999999999999976 68899999876542  23333444555555554 899999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+ +++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 779999887643   4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|||++|..||....      .   ...+...         
T Consensus       209 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~---~~~~~~~---------  267 (311)
T 3p1a_A          209 TAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G---WQQLRQG---------  267 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H---HHHHTTT---------
T ss_pred             cCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H---HHHHhcc---------
Confidence            4322  333468999999999876 78999999999999999999976664211      1   1111111         


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..+......++..+.++|.+||+.||++|||+.++++.
T Consensus       268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            11111122345679999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-44  Score=342.41  Aligned_cols=259  Identities=23%  Similarity=0.373  Sum_probs=207.6

Q ss_pred             CCccceecccCceEEEEEEEC-----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRML  152 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l  152 (407)
                      |++++.||+|+||.||++.+.     +++.||||++.... ......+.+|+.++++++||||+++++++.+  ...+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999998643     57789999987653 3445678899999999999999999999987  467899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++...     .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999764     489999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch--------hhhHHHHHHHHh
Q 015395          233 GSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE--------EVNLIEWLKKMV  302 (407)
Q Consensus       233 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~~~~  302 (407)
                      ......  ......+|..|+|||++.+..++.++|||||||++|+|++|..||.......        .......+....
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            654332  1233457889999999998899999999999999999999999986421110        000111112222


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .....         ......++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       265 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          265 ERGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            21111         1112234467999999999999999999999999998764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-45  Score=350.65  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=208.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.||+|+||.||++... ++..||+|++...   .......+..|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            457999999999999999999976 4778999988544   334556788899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999998764    4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      .........       .
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-------~  258 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-------Y  258 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-------C
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCC-------C
Confidence            3322 2233568999999999999899999999999999999999999997543222      111221111       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .++.    .++..+.++|.+||+.||++|||+.++++.-.
T Consensus       259 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          259 SIPK----HINPVAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            1111    23346889999999999999999999997443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-45  Score=373.18  Aligned_cols=257  Identities=25%  Similarity=0.410  Sum_probs=205.0

Q ss_pred             hcCCCCccc-eecccCceEEEEEEEC---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDK-VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..+++.+.+ .||+|+||.||+|.+.   ++..||||++.... ......+.+|+.+|+.++||||+++++++.. +..+
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            344555555 7999999999999864   45579999987643 3456788999999999999999999999876 5689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+.+|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.
T Consensus       412 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            9999999999999997543   5699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          232 LGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       232 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .........  ....+++.|+|||++.+..++.++|||||||+||||++ |+.||......+...      .+.....  
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------~i~~~~~--  557 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------FIEQGKR--  557 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH------HHHTTCC--
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHcCCC--
Confidence            654332211  22345689999999998999999999999999999998 999998766543221      1111111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                          ...    +..++..+.++|.+||+.||++||++.+|++.|+.+.
T Consensus       558 ----~~~----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          558 ----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ----CCC----CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                111    1234567999999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.7e-45  Score=354.42  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCC-CCccceeeeeeecC--CeeE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRM  151 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~  151 (407)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+|+.+. ||||+++++++...  ..+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            578999999999999999999965 6889999988543  3444556778999999997 99999999998754  4789


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +|||||+ ++|.+++...     .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        88 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            9999996 6999999763     689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC--------------------ceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          232 LGSES--------------------SYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       232 ~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                      .....                    .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            64311                    112234579999999999976 678999999999999999999999998665433


Q ss_pred             hhhHHHHHHHHhhcCCCCCc---------------------CCCCCCCCc------------cHHHHHHHHHHHHHccCc
Q 015395          291 EVNLIEWLKKMVTNRNPEGV---------------------LDPKLPEKP------------TSRLLKRILLVALRCVDP  337 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~~l~~li~~cl~~  337 (407)
                      ....+   ...........+                     .........            ...++..+.+|+.+||+.
T Consensus       239 ~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            22211   111110000000                     000000000            002345688999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 015395          338 NAQKRPKMGHVVHM  351 (407)
Q Consensus       338 dp~~RPt~~evl~~  351 (407)
                      ||++|||+.++++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=350.21  Aligned_cols=244  Identities=22%  Similarity=0.345  Sum_probs=203.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      .++|++.+.||+|+||.||+|... ++..||||++.....        .....+..|+.++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            357999999999999999999964 678899998865431        12335667999999999999999999999999


Q ss_pred             eeEEEEEeccCC-ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          149 HRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       149 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ..++||||+.+| +|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999776 999999875    5799999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ++........  .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......            .    
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~----  237 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V----  237 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T----
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H----
Confidence            9988755432  334569999999999988876 78999999999999999999999642110            0    


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                       .....  .    ...++..+.+||.+||+.||++|||+.++++.-.
T Consensus       238 -~~~~~--~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          238 -EAAIH--P----PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             -TTCCC--C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             -hhccC--C----CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence             00000  0    1123456899999999999999999999998644

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=344.88  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=200.8

Q ss_pred             hcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcC---CCCccceeeeeeecC
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRV---RHKNLVRLLGYCAEG  147 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~  147 (407)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999995 468899999886432     11223455677766666   599999999998765


Q ss_pred             C-----eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          148 A-----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       148 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      .     ..++||||+. ++|.+++.....  ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            4     5799999996 699999986532  3499999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |+|||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+..   ..+....
T Consensus       161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~  235 (308)
T 3g33_A          161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLI  235 (308)
T ss_dssp             ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHH
T ss_pred             EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHh
Confidence            999999986643322  23457899999999999999999999999999999999999999765433222   2222221


Q ss_pred             hcCCCCCc----------CCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          303 TNRNPEGV----------LDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       303 ~~~~~~~~----------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ........          +.+..+..   ....++..+.+||.+||+.||++|||+.++++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            11110000          00000000   0113456789999999999999999999998743

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-44  Score=358.43  Aligned_cols=267  Identities=20%  Similarity=0.242  Sum_probs=189.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec-----CCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  149 (407)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+|+.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999965 6889999998653  33445678899999999999999999999843     357


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +|+||||+ +++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 67999999765    5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCc--------------------------eeeeeeeccccccCcccc-CCCCCCcchhHHHHHHHHHHHHh----
Q 015395          230 KLLGSESS--------------------------YITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVIS----  278 (407)
Q Consensus       230 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~ellt----  278 (407)
                      +.......                          ......+||+.|+|||++ ....++.++|||||||+||||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            87643221                          122345789999999976 56679999999999999999999    


Q ss_pred             -------CCCCCCCCCCch-----------------hhhHHHHHHHHhhcCC------------------CCCcCCCCCC
Q 015395          279 -------GRIPVDYSRPPE-----------------EVNLIEWLKKMVTNRN------------------PEGVLDPKLP  316 (407)
Q Consensus       279 -------g~~Pf~~~~~~~-----------------~~~~~~~~~~~~~~~~------------------~~~~~~~~~~  316 (407)
                             |+++|.+.....                 ....+..+........                  ........+ 
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  362 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL-  362 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG-
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH-
Confidence                   677776543210                 0111111111111000                  000000000 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .......+..+.+||.+||..||++|||++++++.-.
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~  399 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF  399 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence            0011223566899999999999999999999998543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.7e-45  Score=342.08  Aligned_cols=253  Identities=20%  Similarity=0.299  Sum_probs=206.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357999999999999999999965 6889999998766555556788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccceecC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~  233 (407)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998764    4689999999999999999999999   99999999999999   778899999999987653


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....+.....       
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~-------  224 (304)
T 2jam_A          161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYY-------  224 (304)
T ss_dssp             CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCC-------
T ss_pred             CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCC-------
Confidence            321   22346899999999999999999999999999999999999999754322      11222222211       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .++......++..+.++|.+||+.||++|||+.++++...
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            1111112234567899999999999999999999997443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=348.60  Aligned_cols=259  Identities=22%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeee-------
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCA-------  145 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~-------  145 (407)
                      ++...+|++.+.||+|+||.||+|.+. +++.||||++..........+.+|+.+++++. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            344567999999999999999999965 68899999987777777778889999999996 999999999983       


Q ss_pred             -cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEeCCCCcE
Q 015395          146 -EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~k  222 (407)
                       ....++++|||+. |+|.+++.... ....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence             3456899999995 79998886421 114699999999999999999999999   8  99999999999999999999


Q ss_pred             EeecccceecCCCCcee-----------eeeeeccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015395          223 VSDFGLAKLLGSESSYI-----------TTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~  288 (407)
                      |+|||++..........           .....||+.|+|||++   .+..++.++|||||||++|+|++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432211           1134589999999998   567789999999999999999999999974332


Q ss_pred             chhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ..      .+...         ....    .....+..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       259 ~~------~~~~~---------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          259 LR------IVNGK---------YSIP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------------------CCCC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH------hhcCc---------ccCC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11      01100         0000    011122347889999999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-44  Score=341.14  Aligned_cols=268  Identities=26%  Similarity=0.450  Sum_probs=205.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCccceeeeeeecC----Ce
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEG----AH  149 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~----~~  149 (407)
                      ...++|++.+.||+|+||.||+|... +..||||++....   ...+..|.+++..  ++||||+++++++...    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            34568999999999999999999986 8899999885432   2333445555554  4899999999998876    78


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----CCceeccCCCCccEEEeCCCCcEEe
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                      .++||||+++|+|.+++...     .+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            89999999999999999763     5999999999999999999999752     3389999999999999999999999


Q ss_pred             ecccceecCCCCcee---eeeeeccccccCccccCCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCC
Q 015395          225 DFGLAKLLGSESSYI---TTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISG----------RIPVDY  285 (407)
Q Consensus       225 DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDiwslG~il~elltg----------~~Pf~~  285 (407)
                      |||++..........   .....||+.|+|||++.+..++..      +|||||||++|||++|          ..||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999998765433221   123469999999999988776665      9999999999999999          677765


Q ss_pred             CCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC-ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      .......  ...+........    ..+.++.. ....++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       265 ~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          265 LVPSDPS--YEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hcCCCCc--hhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            4332211  111222222111    12222221 2347888899999999999999999999999999987543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=353.29  Aligned_cols=272  Identities=21%  Similarity=0.281  Sum_probs=215.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC--eeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv  153 (407)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357999999999999999999976 58899999986543 234566778999999999999999999987654  78999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE----eCCCCcEEeecccc
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGla  229 (407)
                      |||+++++|.+++..... ...+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999976432 13499999999999999999999999   99999999999999    67778999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      +.......  .....||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.........  .+.+...
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~  239 (396)
T 4eut_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (396)
T ss_dssp             EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred             eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence            87654332  233568999999998864        56788999999999999999999999754432221  2223333


Q ss_pred             hhcCCCCCc------C--------CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          302 VTNRNPEGV------L--------DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       302 ~~~~~~~~~------~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .........      .        +..........+...+.+++.+||+.||++||++.++++.++.+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            332211000      0        0111223346788889999999999999999999999999987654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.2e-45  Score=350.09  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=208.0

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            3567999999999999999999976 6888999988765 3444567889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||++....
T Consensus       111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999765    469999999999999999999998 5   79999999999999999999999999987543


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH------------------
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI------------------  295 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~------------------  295 (407)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.....                  
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            21   123356899999999999999999999999999999999999999764432211110                  


Q ss_pred             ------------------HHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          296 ------------------EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       296 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                                        +.+......         ..+......++..+.+||.+||+.||++|||+.++++.-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNE---------PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             -------------CCCHHHHHHHHHHS---------CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhcc---------CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                              011111111         0111112234557899999999999999999999997443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.4e-44  Score=341.55  Aligned_cols=267  Identities=27%  Similarity=0.419  Sum_probs=211.8

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCccceeeeeeecCC--
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEGA--  148 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~--  148 (407)
                      ......++|.+.+.||+|+||.||+|... ++.||||++...   ....+..|++++..  ++||||+++++++....  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            33445678999999999999999999985 889999988543   34556678888876  78999999999998765  


Q ss_pred             --eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhh--------hcCCCceeccCCCCccEEEeCC
Q 015395          149 --HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH--------EGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       149 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                        ..++||||+++++|.+++...     .+++..++.++.|++.||.|||        +.   +|+||||||+|||++.+
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence              789999999999999999763     5899999999999999999999        77   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCcee---eeeeeccccccCccccCCCC------CCcchhHHHHHHHHHHHHhC----------
Q 015395          219 WNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISG----------  279 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~sDiwslG~il~elltg----------  279 (407)
                      +.+||+|||++..........   .....||+.|+|||++.+..      ++.++|||||||++|+|++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999999998776544321   23446899999999997753      34689999999999999999          


Q ss_pred             CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCC-ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       280 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ..||........ .... +.......    .+.+.++.. .....+..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       264 ~~p~~~~~~~~~-~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          264 QLPYYDLVPSDP-SVEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCTTTTTSCSSC-CHHH-HHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCccccCcCcc-cHHH-HHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            788875543221 1111 22222211    112222221 234677889999999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.3e-45  Score=365.81  Aligned_cols=257  Identities=22%  Similarity=0.292  Sum_probs=210.5

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|.+.++||+|+||.||+|... +++.||+|++....   ......+..|+.+|++++||||+++++++.....+|+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            4578999999999999999999975 68899999985432   2334567889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||++||+|.+++.........+++..++.++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999976543345799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........  ............       
T Consensus       340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-------  409 (543)
T 3c4z_A          340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-------  409 (543)
T ss_dssp             CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC-------
T ss_pred             cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc-------
Confidence            54432 23345799999999999999999999999999999999999999986543221  112222222211       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~  350 (407)
                      ..++    ..++..+.+||.+||+.||.+||++     .+|+.
T Consensus       410 ~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 VTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1111    2345578999999999999999975     56654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-45  Score=340.30  Aligned_cols=254  Identities=29%  Similarity=0.417  Sum_probs=201.0

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-CeeEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-AHRMLV  153 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  153 (407)
                      .+..++|++.+.||+|+||.||+|... +..||+|.+....  ....+.+|+.++++++||||+++++++.+. +..++|
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             cCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            344678999999999999999999875 7899999886543  456788899999999999999999986544 578999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            999999999999975411  2378999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...    ....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+..      ...... .     .
T Consensus       169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~-~-----~  232 (278)
T 1byg_A          169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKG-Y-----K  232 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HHHTTT-C-----C
T ss_pred             ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHhcC-C-----C
Confidence            322    22357889999999988899999999999999999998 99999765432211      111111 0     0


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ...    ...++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       233 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          233 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            111    2234557899999999999999999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-44  Score=343.02  Aligned_cols=256  Identities=20%  Similarity=0.299  Sum_probs=204.6

Q ss_pred             cCCCCcc-ceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l  152 (407)
                      .+.|.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.+. ||||+++++++.+....++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4567776 89999999999999966 58899999886542  334567888999999995 6999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeecccc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGLA  229 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla  229 (407)
                      ||||+.+++|.+++.....  ..+++..++.++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999999999865422  5699999999999999999999999   9999999999999987   789999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+..      .......    
T Consensus       182 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~----  249 (327)
T 3lm5_A          182 RKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY------LNISQVN----  249 (327)
T ss_dssp             EEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTC----
T ss_pred             cccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------HHHHhcc----
Confidence            87654322  23456999999999999999999999999999999999999999765432221      1111111    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         ...+......++..+.++|.+||+.||.+|||+.++++.-.
T Consensus       250 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          250 ---VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             ---cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence               11111122234566899999999999999999999987544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-44  Score=338.51  Aligned_cols=252  Identities=19%  Similarity=0.327  Sum_probs=209.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+...   .......+..|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            457999999999999999999976 5778999988544   234556788899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998764    4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.      ........       .
T Consensus       167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-------~  232 (294)
T 2rku_A          167 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE-------Y  232 (294)
T ss_dssp             STTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTC-------C
T ss_pred             cCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhhcc-------C
Confidence            33222 2335689999999999999999999999999999999999999975443221      11221111       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .++    ..++..+.+++.+||+.||++|||+.++++....
T Consensus       233 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          233 SIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             CCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence            111    1233568899999999999999999999985443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.8e-45  Score=341.73  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=206.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeee--cCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357999999999999999999975 68889999986543  344567889999999999999999999874  4678999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc-----eeccCCCCccEEEeCCCCcEEeecc
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-----VVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999975432334699999999999999999999999   8     9999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      ......... .
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~~~-~  233 (279)
T 2w5a_A          162 LARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGK-F  233 (279)
T ss_dssp             HHHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-C
T ss_pred             hheeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHHHHhhcc-c
Confidence            99876543221 223468999999999998899999999999999999999999997553221      112222211 1


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                           +.++    ..++..+.++|.+||+.||.+||++.++++.+...
T Consensus       234 -----~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          234 -----RRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             -----CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             -----ccCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                 1111    13445789999999999999999999999877644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.9e-45  Score=347.14  Aligned_cols=267  Identities=24%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            457999999999999999999976 58899999886543  333456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            999999998887654    4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH--------HHH-hhc
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL--------KKM-VTN  304 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--------~~~-~~~  304 (407)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+...        ... ...
T Consensus       177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            322 22334689999999999775 7899999999999999999999999865543222111100        000 000


Q ss_pred             CCCCCcCCCCCCCC-----ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          305 RNPEGVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       305 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ........+.....     ....++..+.+||.+||+.||++|||+.++++.-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            00000111111111     1123456799999999999999999999998743

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=345.29  Aligned_cols=265  Identities=22%  Similarity=0.383  Sum_probs=211.5

Q ss_pred             hcCCCCccceecccCceEEEEEEE-----CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecC--Ce
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~  149 (407)
                      ..++|++.+.||+|+||.||+|.+     .++..||+|++..........+.+|+.++++++||||+++++++...  ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            346799999999999999999984     35788999999877666777899999999999999999999988654  37


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence            899999999999999997653   4689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---------chhhhHHHHH
Q 015395          230 KLLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP---------PEEVNLIEWL  298 (407)
Q Consensus       230 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~---------~~~~~~~~~~  298 (407)
                      ..........  .....++..|+|||++.+..++.++|||||||++|+|++|..||.....         .........+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            8876543321  1223467789999999888899999999999999999999999863210         0000011111


Q ss_pred             HHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .........     ...    ...++..+.++|.+||+.||++|||+.++++.|+.+.
T Consensus       273 ~~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          273 IELLKNNGR-----LPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHTTCC-----CCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhcCCC-----CCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            122221111     011    2234567999999999999999999999999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.9e-45  Score=338.20  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=207.1

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|.+.+.||+|+||.||+|... ++..||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            4568999999999999999999976 56789999885432   2234678889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999765    4689999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....   .....|++.|+|||++.+..++.++||||||+++|+|++|..||......+      .........       
T Consensus       165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-------  228 (284)
T 2vgo_A          165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNVD-------  228 (284)
T ss_dssp             SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------
T ss_pred             cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhccc-------
Confidence            4322   233568999999999999999999999999999999999999997543221      112222111       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..++    ..++..+.++|.+||+.||.+||++.++++.
T Consensus       229 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          229 LKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             cCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            1111    1234568899999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-44  Score=361.45  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=202.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999975 67889999986543  3335678889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC---CCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~~~  232 (407)
                      ||.+|+|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++..   +.+||+|||++...
T Consensus       117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999988765    5699999999999999999999999   99999999999999764   55999999999877


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....  .....||+.|+|||++. ..++.++|||||||++|+|++|..||......+      .+........      
T Consensus       190 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~------  254 (494)
T 3lij_A          190 ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKGKY------  254 (494)
T ss_dssp             BTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC------
T ss_pred             CCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC------
Confidence            54432  33457999999999986 569999999999999999999999998654322      2222222211      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       .++......++..+.+||.+||+.||.+|||+.++++.
T Consensus       255 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 -TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence             11111123455678999999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.6e-45  Score=363.42  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=209.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|... ++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356999999999999999999976 68899999985432   34566788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccce
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~  230 (407)
                      |||+.+++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||++.
T Consensus       105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999999765    5799999999999999999999999   99999999999999   567899999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      .......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+      .+..+.....    
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~----  244 (484)
T 3nyv_A          178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGKY----  244 (484)
T ss_dssp             HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC----
T ss_pred             Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC----
Confidence            7654332  233469999999999865 68999999999999999999999998654322      2222222211    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         .++......++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       245 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          245 ---TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             ---CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             ---CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence               1111223345677999999999999999999999997443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-44  Score=334.56  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=200.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec----CCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~  151 (407)
                      ..|.+.+.||+|+||.||+|... ++..||+|.+...  .......+..|+.+++.++||||+++++++..    ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45888899999999999999965 5778999988654  34455678899999999999999999998764    45689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEe-CCCCcEEeeccc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILID-KHWNPKVSDFGL  228 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~DfGl  228 (407)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +  |+||||||+|||++ .++.+||+|||+
T Consensus       106 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            999999999999999764    4689999999999999999999999   8  99999999999997 789999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +.......   .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.......     ...........  
T Consensus       179 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~--  247 (290)
T 1t4h_A          179 ATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVK--  247 (290)
T ss_dssp             GGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCC--
T ss_pred             cccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHHHhccCC--
Confidence            97654332   23456899999999886 458999999999999999999999997544322     11222221111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                             +.......+..+.++|.+||+.||.+|||+.++++.
T Consensus       248 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 -------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   111112223468999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-44  Score=335.28  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      +..++|.+.+.||+|+||.||+|... +++.||||.+....   ......+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            34578999999999999999999976 68899999885432   233457888999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++..
T Consensus        88 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             EEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccc
Confidence            999999999999999765    4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ......  .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......      ..........    
T Consensus       161 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~----  228 (276)
T 2h6d_A          161 MSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKIRGGVF----  228 (276)
T ss_dssp             CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC----
T ss_pred             cCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhhcCcc----
Confidence            654322  233468999999999988765 689999999999999999999997543221      1222222110    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                         .++    ..++..+.++|.+||+.||.+|||+.++++.-
T Consensus       229 ---~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~  263 (276)
T 2h6d_A          229 ---YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHE  263 (276)
T ss_dssp             ---CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             ---cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence               111    12345688999999999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-44  Score=361.61  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=206.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+|++++||||+++++++.+...+++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46999999999999999999975 6889999998543  22345678889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe---CCCCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~  232 (407)
                      ||.+++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++...
T Consensus       102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999998765    4699999999999999999999999   999999999999995   4567999999999866


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+      .+........      
T Consensus       175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~------  239 (486)
T 3mwu_A          175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKY------  239 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC------
T ss_pred             CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC------
Confidence            44322  334579999999999875 58999999999999999999999997654322      2222222211      


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                       .+.......++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence             1111223345677999999999999999999999998543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-44  Score=354.29  Aligned_cols=198  Identities=25%  Similarity=0.371  Sum_probs=166.9

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----Ce
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  149 (407)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+|+.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            367999999999999999999965 5778999998653  334456788999999999999999999998765     57


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .|+||||+. ++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999995 6999999865    5699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCce---------------------eeeeeeccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015395          230 KLLGSESSY---------------------ITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPV  283 (407)
Q Consensus       230 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~elltg~~Pf  283 (407)
                      +........                     .....+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876543221                     12456799999999986 5667999999999999999999854443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.1e-45  Score=345.18  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=206.7

Q ss_pred             hcCCCCccceecccCceEEEEEEE------CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ..++|.+.+.||+|+||.||+|.+      .++..||||.+... .......+.+|+.++++++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            356899999999999999999983      24678999998654 34455678889999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCC---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEE
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKV  223 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl  223 (407)
                      .++||||+++++|.+++.....   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999976532   123589999999999999999999999   9999999999999984   456999


Q ss_pred             eecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHH
Q 015395          224 SDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       224 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      +|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+      .....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFV  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHHH
Confidence            999999765332221 2233457889999999988899999999999999999998 999997543221      12222


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .....      ...    ...++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       259 ~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 TSGGR------MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCC------CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            21111      111    12234568999999999999999999999999987643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-44  Score=334.68  Aligned_cols=249  Identities=23%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec-----------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----------  146 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----------  146 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....    .+.+|+.++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            46999999999999999999976 788999999876542    45579999999999999999998754           


Q ss_pred             -----CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCc
Q 015395          147 -----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (407)
Q Consensus       147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  221 (407)
                           ....++||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                 4557999999999999999965321  4689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      ||+|||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||..     .   .......
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~---~~~~~~~  231 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----T---SKFFTDL  231 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----H---HHHHHHH
T ss_pred             EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----H---HHHHHHh
Confidence            9999999987755432  2334689999999999999999999999999999999999988741     1   1111111


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCCC
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  359 (407)
                      . ...        ++    ..++..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus       232 ~-~~~--------~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          232 R-DGI--------IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             H-TTC--------CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             h-ccc--------cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1 111        11    112345889999999999999999999999999886543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-44  Score=355.56  Aligned_cols=255  Identities=20%  Similarity=0.344  Sum_probs=195.5

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcCCCCccceeeeeeecC
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  147 (407)
                      ..++|.+.+.||+|+||.||+|... ++..||||++....        ......+.+|+.+|++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3578999999999999999999965 57899999986532        1112247789999999999999999999754 


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC---CCcEEe
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVS  224 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~  224 (407)
                      ...++||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.+   +.+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            5689999999999999998765    5799999999999999999999999   99999999999999654   459999


Q ss_pred             ecccceecCCCCceeeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       225 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |||+++......  ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.........  ..    .
T Consensus       285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~----~  356 (419)
T 3i6u_A          285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KD----Q  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HH----H
T ss_pred             ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HH----H
Confidence            999998765432  2344579999999999853   56888999999999999999999999765433221  11    1


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ......      .........++..+.++|.+||+.||++|||+.++++.-.
T Consensus       357 i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          357 ITSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             HHTTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HhcCCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence            111110      0111111234567899999999999999999999987543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.6e-44  Score=337.28  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      +.|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46999999999999999999864 68899999886543 34456788999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++..     ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999965     4699999999999999999999999   99999999999999999999999999998765433


Q ss_pred             ceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|..||........      ........ .     +.++
T Consensus       174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~-----~~~~  240 (303)
T 3a7i_A          174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LFLIPKNN-P-----PTLE  240 (303)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C-----CCCC
T ss_pred             c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HHHhhcCC-C-----CCCc
Confidence            2 22345689999999999999999999999999999999999999975432211      11111111 1     1111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ..++..+.+++.+||+.||.+|||+.++++....
T Consensus       241 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  274 (303)
T 3a7i_A          241 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI  274 (303)
T ss_dssp             ----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred             ----cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence                1234568999999999999999999999985543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-45  Score=358.07  Aligned_cols=243  Identities=13%  Similarity=0.193  Sum_probs=190.1

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccC---ChhhHHHHHHHH---HHHhcCCCCccceee-------ee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN---RGQAEREFKVEV---EAIGRVRHKNLVRLL-------GY  143 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~~~-------~~  143 (407)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++...   .....+.+.+|+   .+|+.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688999999999999999995 56899999998632   344567788899   555566899999998       55


Q ss_pred             eecCC-----------------eeEEEEEeccCCChHHhhhCCCC---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCce
Q 015395          144 CAEGA-----------------HRMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV  203 (407)
Q Consensus       144 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  203 (407)
                      +...+                 ..++||||+ +|+|.+++.....   ....+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 378999999 6899999975310   011234588889999999999999999   99


Q ss_pred             eccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCC-----------CCCcchhHHHHHHH
Q 015395          204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-----------MLNERSDVYSFGIL  272 (407)
Q Consensus       204 vH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwslG~i  272 (407)
                      +||||||+||||+.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986432    2344567 999999999877           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       273 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +|||++|+.||...........               +.. ..     ..++..+.+||.+||+.||++|||+.++++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~---------------~~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEW---------------IFR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCSGG---------------GGS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccchhh---------------hhh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999975443221111               000 00     123456899999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=349.80  Aligned_cols=263  Identities=17%  Similarity=0.214  Sum_probs=205.9

Q ss_pred             cCCCCccceecccCceEEEEEEECC---------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccce---------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED---------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR---------  139 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------  139 (407)
                      .++|.+.+.||+|+||.||+|....         +..||+|.+...     ..+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999999763         778999988654     35677999999999999998         


Q ss_pred             ------eeeeeec-CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          140 ------LLGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       140 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                            +++++.. ....++||||+ +++|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  4556654 67889999999 999999997642  14699999999999999999999999   99999999999


Q ss_pred             EEEeCCC--CcEEeecccceecCCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015395          213 ILIDKHW--NPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD  284 (407)
Q Consensus       213 ill~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~  284 (407)
                      ||++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876533211      1123468999999999999999999999999999999999999998


Q ss_pred             CCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      ....... ............  ...+.+..   .....++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       270 ~~~~~~~-~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          270 NCLPNTE-DIMKQKQKFVDK--PGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             GGTTCHH-HHHHHHHHHHHS--CCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCCcCHH-HHHHHHHhccCC--hhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            6542221 112222222111  11111111   0112234679999999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-44  Score=361.51  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-------------hhHHHHHHHHHHHhcCCCCccceeeee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-------------QAEREFKVEVEAIGRVRHKNLVRLLGY  143 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~~~  143 (407)
                      .++|.+++.||+|+||.||+|... ++..||+|++.....             ...+.+.+|+.+|++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467999999999999999999965 578899999865421             334678889999999999999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC---C
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---N  220 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~  220 (407)
                      +.+...+++|||||++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999998765    5699999999999999999999999   999999999999998776   6


Q ss_pred             cEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      +||+|||++........  .....||+.|+|||++. ..++.++|||||||++|+|++|..||......+      .+..
T Consensus       188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~  258 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKK  258 (504)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH
T ss_pred             EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence            99999999987754432  33456999999999986 468999999999999999999999998654322      2222


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      +.....       .++......++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       259 i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          259 VEKGKY-------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW  304 (504)
T ss_dssp             HHHCCC-------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HHcCCC-------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence            222211       1111111234567999999999999999999999997543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-44  Score=344.28  Aligned_cols=268  Identities=23%  Similarity=0.296  Sum_probs=202.1

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ..++|++.+.||+|+||.||+|... +++.||||++......     ....+.+|+.+++.++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3568999999999999999999965 5889999988653221     123577899999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+++ +|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999975 8998887643   4688899999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC-
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE-  308 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  308 (407)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+..   ..+.......... 
T Consensus       161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTT
T ss_pred             eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCChhh
Confidence            7654332 23345689999999998664 5899999999999999999999999765432221   1111111111000 


Q ss_pred             --Cc-------CCCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          309 --GV-------LDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       309 --~~-------~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                        ..       .....+..+    ...++..+.+||.+||+.||++|||+.++++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence              00       000111111    123346799999999999999999999999865543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4e-44  Score=345.43  Aligned_cols=270  Identities=21%  Similarity=0.282  Sum_probs=202.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh-----------hhHHHHHHHHHHHhcCCCCccce
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-----------QAEREFKVEVEAIGRVRHKNLVR  139 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~  139 (407)
                      +.++....++|.+.+.||+|+||.||+|...++..||||++.....           .....+.+|+.+++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4567778899999999999999999999988899999998854321           22367889999999999999999


Q ss_pred             eeeeeec-----CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEE
Q 015395          140 LLGYCAE-----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (407)
Q Consensus       140 ~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil  214 (407)
                      +++++..     ....++||||+. ++|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+|||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            9999843     346899999996 68888887543   4699999999999999999999999   9999999999999


Q ss_pred             EeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh
Q 015395          215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN  293 (407)
Q Consensus       215 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~  293 (407)
                      ++.++.+||+|||++........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999975443322  234568999999999877 678999999999999999999999998654332222


Q ss_pred             HHHHHHHHhhcCCC---------------CCcCCCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          294 LIEWLKKMVTNRNP---------------EGVLDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       294 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .+   .........               ...+ ...+...    ....+..+.+||.+||+.||.+|||+.++++.-.
T Consensus       245 ~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          245 KI---VEVVGTPKIEDVVMFSSPSARDYLRNSL-SNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HH---HHHHCCCCHHHHHHTSCHHHHHHTTTCC-CCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HH---HHHcCCCChHHhhhccchhhhHHHHhhc-ccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            11   111100000               0000 0011111    1123456899999999999999999999997543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.7e-44  Score=346.32  Aligned_cols=254  Identities=20%  Similarity=0.337  Sum_probs=206.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  145 (407)
                      .-.++|.+.+.||+|+||.||+|... +|+.||||++.....        .....+..|+.+++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            33467999999999999999999975 689999998865431        1244677899999999 7999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      .....++||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999764    4699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      ||++........  .....||+.|+|||++.      ...++.++|||||||++|+|++|..||......      ..+.
T Consensus       244 fG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~  315 (365)
T 2y7j_A          244 FGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------LMLR  315 (365)
T ss_dssp             CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred             cCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence            999987754432  23457999999999885      335889999999999999999999999754322      1122


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .......       .........++..+.++|.+||+.||++|||+.++++.
T Consensus       316 ~i~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 MIMEGQY-------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHTCC-------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhCCC-------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2222111       00000011234568999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-44  Score=370.54  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=199.5

Q ss_pred             ceecccCceEEEEEEEC---CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|.+.   .+..||||++....  ......+.+|+.+|++++||||+++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   45679999986543  3446788999999999999999999999865 558899999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCce-
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-  238 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-  238 (407)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999765    5799999999999999999999999   9999999999999999999999999999876544322 


Q ss_pred             -eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          239 -ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       239 -~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..      ..+. ....     ... 
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------~~i~-~~~~-----~~~-  593 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLE-KGER-----MGC-  593 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHH-TTCC-----CCC-
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHH-cCCC-----CCC-
Confidence             1223346789999999999999999999999999999998 99999865543221      1111 1111     111 


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         ...++..+.+||.+||+.||++||++.+|++.|+.+
T Consensus       594 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          594 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               123456799999999999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.2e-44  Score=343.32  Aligned_cols=265  Identities=20%  Similarity=0.285  Sum_probs=203.7

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec--------C
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------G  147 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~  147 (407)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999997 468899999885543  2234567789999999999999999999876        4


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      +..++||||+++ +|.+.+....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            568999999965 7877776543   4699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCc---eeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          228 LAKLLGSESS---YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       228 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      ++........   .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........   +.....
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~  246 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCG  246 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhC
Confidence            9987653222   12234568999999999876 4589999999999999999999999986554332222   222221


Q ss_pred             cCCCCCcCCC--------------CCCCCccHH-----HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          304 NRNPEGVLDP--------------KLPEKPTSR-----LLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       304 ~~~~~~~~~~--------------~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      .... .....              .........     ....+.+||.+||+.||++|||+.++++.-..
T Consensus       247 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  315 (351)
T 3mi9_A          247 SITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  315 (351)
T ss_dssp             CCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence            1110 00000              000000011     13458899999999999999999999986554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-44  Score=373.74  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=207.1

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  149 (407)
                      .+..++|++++.||+|+||.||+|... +++.||||++...   .......+..|..+|..+ +||||+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            345678999999999999999999965 5778999998643   123345667799999988 69999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +||||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence            99999999999999999865    4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||...+..      +.+..+....    
T Consensus       490 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~----  558 (674)
T 3pfq_A          490 KENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN----  558 (674)
T ss_dssp             EECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSSC----
T ss_pred             eccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC----
Confidence            86433322 244567999999999999999999999999999999999999999764432      2222332221    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVH  350 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~  350 (407)
                         ..++    ..++.++.+||.+||+.||++||++     ++|++
T Consensus       559 ---~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 ---VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---CCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---CCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               1122    2345678999999999999999987     66665

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=331.92  Aligned_cols=255  Identities=28%  Similarity=0.447  Sum_probs=202.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|....+||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            456677779999999999999964 6788999998776666667888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecccceecCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~~  235 (407)
                      +++++|.+++..... ...+++..++.++.|++.||.|||+.   +|+|+||||+||+++. ++.+||+|||++......
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999999976432 23567999999999999999999999   9999999999999987 899999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .. ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........    ..........      .+
T Consensus       177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~------~~  245 (295)
T 2clq_A          177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMFKV------HP  245 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHHHCC------CC
T ss_pred             CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhccccc------cc
Confidence            22 123446899999999986643  88999999999999999999999964332211    1111111110      11


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .++    ..++..+.++|.+||+.||++||++.++++.
T Consensus       246 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          246 EIP----ESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            121    2334568899999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-45  Score=352.66  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=197.8

Q ss_pred             HHhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec-------
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-------  146 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------  146 (407)
                      +...++|++.+.||+|+||.||+|.. .++..||||++.......    .+|+.+++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~----~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK----NRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC----CHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH----HHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999996 468899999886553322    359999999999999999999843       


Q ss_pred             -------------------------------CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 015395          147 -------------------------------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL  195 (407)
Q Consensus       147 -------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L  195 (407)
                                                     ....++||||++ ++|.+.+.........+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 587777654222225799999999999999999999


Q ss_pred             hhcCCCceeccCCCCccEEEe-CCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHH
Q 015395          196 HEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILI  273 (407)
Q Consensus       196 H~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il  273 (407)
                      |+.   +|+||||||+|||++ .++.+||+|||++........  .....||+.|+|||++.+. .++.++|||||||++
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            999   999999999999998 688999999999987654432  2334689999999998775 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCchhhhHHHHHHHHhh----------cCCCCCcCCCCCCCC-----ccHHHHHHHHHHHHHccCcC
Q 015395          274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVT----------NRNPEGVLDPKLPEK-----PTSRLLKRILLVALRCVDPN  338 (407)
Q Consensus       274 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~d  338 (407)
                      |+|++|+.||......+....+   .+...          ........-+.....     .....+..+.+||.+||+.|
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i---~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRI---IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCCCChHHHHHHH---HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999865543322211   11100          000011100111111     11124456899999999999


Q ss_pred             CCCCCCHHHHHH
Q 015395          339 AQKRPKMGHVVH  350 (407)
Q Consensus       339 p~~RPt~~evl~  350 (407)
                      |.+|||+.++++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=349.05  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=197.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+|+.++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            367999999999999999999964 6889999998543  333456788899999999999999999998765      3


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+++||||+ +++|.+++..     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 8899999976     3689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC-
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (407)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+   ........ 
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~~~~  247 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPA  247 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCH
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCH
Confidence            9876432    234568999999999876 67999999999999999999999999865433222111   11100000 


Q ss_pred             -----------------CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          307 -----------------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       307 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                                       ........+. ......+..+.+|+.+||..||.+|||+.++++.-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp  309 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  309 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence                             0000000000 01122345689999999999999999999999843

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.4e-44  Score=372.00  Aligned_cols=263  Identities=21%  Similarity=0.363  Sum_probs=210.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeee
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  145 (407)
                      ...+++..++|++.+.||+|+||.||+|.+..    +..||+|.+... .......+.+|+.++++++||||+++++++.
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34556667889999999999999999998642    456999988654 3344567889999999999999999999985


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      + +..++||||+++|+|.+++....   ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence            4 56899999999999999997643   4689999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ||+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+      .+......
T Consensus       535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~  608 (656)
T 2j0j_A          535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENG  608 (656)
T ss_dssp             CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHT
T ss_pred             cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcC
Confidence            99998775544333334457889999999988899999999999999999997 999997654322      12222222


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ...      ..    +..++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       609 ~~~------~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 ERL------PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             CCC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC------CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111      11    1233457899999999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=342.72  Aligned_cols=257  Identities=15%  Similarity=0.160  Sum_probs=205.2

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEE------ECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCccceeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGY  143 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~  143 (407)
                      ++.+..++|.+.+.||+|+||.||+|.      ..+++.||||++....   ...+..|+.++++++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            344566789999999999999999994      4468889999986543   345666777777776   9999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCC-CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-----
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG-PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-----  217 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----  217 (407)
                      +...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++   +|+||||||+||||+.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            9999999999999999999999974211 125699999999999999999999999   9999999999999998     


Q ss_pred             ------CCCcEEeecccceecCC-CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          218 ------HWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       218 ------~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                            ++.+||+|||+++.+.. .........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999986542 22233455679999999999999999999999999999999999999996432211


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHHhcc
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR-PKMGHVVHMLEAQE  356 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~~~~  356 (407)
                      .                  .+...+....   ..+.+.+++..||+.+|.+| |++.++.+.|+...
T Consensus       293 ~------------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          293 C------------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             E------------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             e------------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            0                  0111111111   23457789999999999999 47888888887654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-43  Score=342.68  Aligned_cols=264  Identities=24%  Similarity=0.295  Sum_probs=195.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  148 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999965 5788999998653  3344567888999999999999999999987654      


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||++ ++|.+++..      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            7899999996 588888863      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH------------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE------------  296 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~------------  296 (407)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.            
T Consensus       174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98764322  2334578999999999999999999999999999999999999998654322111110            


Q ss_pred             ----HHHHHhhcCC-CCC-----cCC-CCCCC--CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          297 ----WLKKMVTNRN-PEG-----VLD-PKLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       297 ----~~~~~~~~~~-~~~-----~~~-~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                          .+........ ...     .+. ..++.  ......+..+.+||.+||+.||.+|||+.++++.-.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence                0000000000 000     000 00000  012234678999999999999999999999998544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-44  Score=338.53  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=200.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC--CCC--EEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE--DNS--KVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||+|.+...   .......+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            457999999999999999999853  233  5899987643   2345567889999999999999999999998765 8


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+.+++|.+++....   ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            99999999999999997542   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .........  .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......      +.+.........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC
Confidence            875443321  223457889999999988889999999999999999999 99999755432      222222222111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                           ..    ....++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       244 -----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          244 -----LP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----CC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 01    112345679999999999999999999999999998754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-43  Score=354.01  Aligned_cols=260  Identities=19%  Similarity=0.257  Sum_probs=209.1

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++.+.||+|+||.||+|.+ .++..||||++......  ..+..|+.+++.++| ++|..+..++......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999996 46889999987544322  346779999999986 556666666778889999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE---eCCCCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~  232 (407)
                      |+ +++|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+||||   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 999999997532   4699999999999999999999999   99999999999999   68899999999999877


Q ss_pred             CCCCcee------eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          233 GSESSYI------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       233 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      .......      .....||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            6543221      2245799999999999999999999999999999999999999987665444433333322221111


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      ...+         ...++.++.++|..||+.||++||++.+|++.|+.+
T Consensus       237 ~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1000         112345799999999999999999999999998876

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9e-44  Score=333.48  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---------hhhHHHHHHHHHHHhcCC-CCccceeeeeeec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---------GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAE  146 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  146 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++....         ......+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999975 57889999986543         123456778999999995 9999999999999


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ....++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   +|+|+||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999764    4699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      |++........  .....||+.|+|||++.      ...++.++|||||||++|+|++|..||.......      ....
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~  240 (298)
T 1phk_A          169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRM  240 (298)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH
T ss_pred             cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHH
Confidence            99987654332  23356899999999884      4568899999999999999999999997543221      1222


Q ss_pred             HhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ......       ..+......++..+.+++.+||+.||.+|||+.++++.
T Consensus       241 ~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 IMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            222111       11112223456679999999999999999999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=332.51  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCccceeeeee--ecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~  150 (407)
                      .++|.+.+.||+|+||.||+|... ++..||+|++....    ......+.+|+.+++.++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999964 67899999886532    23456788999999999999999999998  445688


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+.++ |.+++.....  ..+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999776 7777765322  5699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCC-ceeeeeeeccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSES-SYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ...... ........||+.|+|||++.+..  ++.++|||||||++|+|++|..||......      ..........  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~~--  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGKGS--  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCC--
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhcCC--
Confidence            765432 22233456899999999997644  478999999999999999999999754322      1122222211  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                           ..++    ..++..+.++|.+||+.||.+|||+.++++....
T Consensus       230 -----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          230 -----YAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             -----CCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             -----CCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                 1111    1234568899999999999999999999975443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=335.68  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+....  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3567999999999999999999976 58899999886543  34567889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+++++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999996322   5699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........      .........      +.+
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~------~~~  245 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPTNPP------PTF  245 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC------CCC
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC------ccc
Confidence            22 22334689999999999999999999999999999999999999975432211      111111111      011


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                        .....++..+.++|.+||+.||.+|||+.++++.-.
T Consensus       246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence              112334567899999999999999999999987443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.4e-44  Score=342.48  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChh-----------------hHHHHHHHHHHHhcCCCCcccee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-----------------AEREFKVEVEAIGRVRHKNLVRL  140 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpniv~~  140 (407)
                      .++|.+.+.||+|+||.||+|.. ++..||+|.+......                 ....+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999999999 7999999988543211                 11678899999999999999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChHHh------hhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccE
Q 015395          141 LGYCAEGAHRMLVYEYVNNGNLEQW------LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNI  213 (407)
Q Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Ni  213 (407)
                      ++++.+.+..++||||+++++|.++      +...  ....+++..++.++.|++.||.|||+ .   +|+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999999      5432  12679999999999999999999999 8   999999999999


Q ss_pred             EEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCCchh
Q 015395          214 LIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNE-RSDVYSFGILIMEVISGRIPVDYSRPPEE  291 (407)
Q Consensus       214 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDiwslG~il~elltg~~Pf~~~~~~~~  291 (407)
                      +++.++.+||+|||++......   ......||..|+|||++.+. .++. ++|||||||++|+|++|..||....... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence            9999999999999999876443   23445689999999999887 6666 9999999999999999999998655421 


Q ss_pred             hhHHHHHHHHhhcCCCCCc-----CCCCC---CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          292 VNLIEWLKKMVTNRNPEGV-----LDPKL---PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                          +..............     ..+..   .......++..+.++|.+||+.||.+|||+.++++.-
T Consensus       260 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          260 ----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             ----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             ----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                112222211110000     00000   0000133456789999999999999999999998743

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.4e-43  Score=337.08  Aligned_cols=259  Identities=20%  Similarity=0.285  Sum_probs=202.6

Q ss_pred             cCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeec--CCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ...+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46799999999999999999986 468899999986433   456788999999997 9999999999987  6678999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~  232 (407)
                      |||+.+++|.+++.       .+++..++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++...
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999984       488999999999999999999999   999999999999999776 8999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH--------HHhh
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK--------KMVT  303 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~  303 (407)
                      .....  .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ......        ....
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHH
Confidence            54432  233468999999999877 67999999999999999999999999644332111 100000        0000


Q ss_pred             cCC--------------CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          304 NRN--------------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       304 ~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ...              ................++..+.+||.+||+.||.+|||+.++++.-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence            000              0000001111122233567799999999999999999999998743

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-44  Score=339.40  Aligned_cols=269  Identities=21%  Similarity=0.352  Sum_probs=189.6

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .+.+..++|++.+.||+|+||.||+|.. .++..||||.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3456678999999999999999999985 468899999875443 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCC----CCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          151 MLVYEYVNNGNLEQWLHGD----VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ++||||+++++|.+++...    ......+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            9999999999999998631    11125689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCc----eeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          227 GLAKLLGSESS----YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       227 Gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |++........    .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........      ...
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~  239 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLT  239 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHH
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHH
Confidence            99876643321    11233468999999999865 56899999999999999999999999765433221      111


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .... ................++..+.++|.+||+.||.+|||+.++++.
T Consensus       240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          240 LQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            1111 111100000001112234568999999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-44  Score=337.78  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=190.7

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-h-hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-Q-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      +..++|++.+.||+|+||.||+|... +++.||+|++..... . ..+.+..+...++.++||||+++++++.+.+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            44678999999999999999999964 688899999865432 2 22334445556888899999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||++ ++|.+++.........+++..++.++.|++.||+|||++.  +|+||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999996 5888777542222257999999999999999999999842  8999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .....  .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.......     ..+......... 
T Consensus       161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~-  232 (290)
T 3fme_A          161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPSP-  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCCC-
T ss_pred             ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCCC-
Confidence            54322  2234689999999996    56678999999999999999999999997543321     112222222111 


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                              ......++..+.+++.+||+.||++|||+.++++.
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          233 --------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                    11122345578999999999999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.9e-44  Score=334.46  Aligned_cols=247  Identities=22%  Similarity=0.320  Sum_probs=199.7

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56999999999999999999976 7889999998654  234456777899999999 8999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC----------------
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----------------  218 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----------------  218 (407)
                      ||+++++|.+++.........+++..++.++.||+.||.|||++   +|+||||||+|||++.+                
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999999975422224689999999999999999999999   99999999999999844                


Q ss_pred             ---CCcEEeecccceecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhH
Q 015395          219 ---WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL  294 (407)
Q Consensus       219 ---~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~  294 (407)
                         ..+||+|||++........     ..||+.|+|||++.+. .++.++|||||||++|+|++|..|+....      .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H
T ss_pred             CCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H
Confidence               4799999999987754322     3589999999999776 56789999999999999999988764221      1


Q ss_pred             HHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      .   ..... ...     +.++    ..++..+.++|.+||+.||++|||+.++++.-
T Consensus       237 ~---~~~~~-~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          237 W---HEIRQ-GRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             H---HHHHT-TCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             H---HHHHc-CCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            1   11111 111     1111    12345689999999999999999999998743

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-44  Score=338.64  Aligned_cols=253  Identities=20%  Similarity=0.304  Sum_probs=202.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999976 5788999998776666677888999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +++++|.+++....   ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999986532   4699999999999999999999999   99999999999999999999999999875432111


Q ss_pred             ceeeeeeeccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          237 SYITTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                       .......||+.|+|||++     ....++.++|||||||++|+|++|..||.......      .+.........    
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~----  240 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDPP----  240 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCC----
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCCc----
Confidence             112234689999999988     46778999999999999999999999997544321      12222222111    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                          .......++..+.++|.+||+.||.+|||+.++++.
T Consensus       241 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 ----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                011123445678999999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=339.63  Aligned_cols=256  Identities=25%  Similarity=0.374  Sum_probs=199.1

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeec------
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE------  146 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------  146 (407)
                      ....++|++.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++++ +||||+++++++..      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            345678999999999999999999974 68899999886543 3345778899999998 79999999999876      


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      ....++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence            468899999999999999997642  14689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      |++........ ......||+.|+|||++.     ...++.++|||||||++|+|++|..||........      +...
T Consensus       174 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~  246 (326)
T 2x7f_A          174 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLI  246 (326)
T ss_dssp             TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH
T ss_pred             cCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHh
Confidence            99987643322 123346899999999986     56789999999999999999999999975443211      1112


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ..... ...        ....++..+.++|.+||..||.+||++.++++.-
T Consensus       247 ~~~~~-~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          247 PRNPA-PRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             HHSCC-CCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             hcCcc-ccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence            22111 111        1122345689999999999999999999999843

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-44  Score=350.57  Aligned_cols=262  Identities=23%  Similarity=0.288  Sum_probs=196.1

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC------eeEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRML  152 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~l  152 (407)
                      .+|.+.+.||+|+||.||+|....+..||+|++.......    .+|+.+++.++||||+++++++....      .+++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC----CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH----HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            4699999999999999999998877789999886543322    25899999999999999999985433      3789


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCCcEEeeccccee
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKL  231 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~~  231 (407)
                      ||||++++ +.+.+.........+++..++.++.||+.||+|||++   +|+||||||+||||+ .++.+||+|||+++.
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999764 4433321111125799999999999999999999999   999999999999999 789999999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH---------HHH
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL---------KKM  301 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~---------~~~  301 (407)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+...         ..+
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            654332  2345689999999998765 5899999999999999999999999866543322211110         000


Q ss_pred             hhcCCCCCcCCCCCCCCc-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      ...  .....-+......     ....+..+.+||.+||+.||.+|||+.++++.-
T Consensus       270 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          270 NPN--YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             CGG--GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             Chh--hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence            000  0000001111111     112445799999999999999999999999743

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=342.58  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=204.9

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      +.++++..++|++.+.||+|+||.||+|....  .+|+|++....  ......+.+|+.++++++||||+++++++.+..
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            45566778899999999999999999998763  59999886432  222345667999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++ ++.+||+|||+
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999997643   4689999999999999999999999   999999999999998 67999999999


Q ss_pred             ceecCCCCc----eeeeeeeccccccCccccCC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH
Q 015395          229 AKLLGSESS----YITTRVMGTFGYVAPEYAST---------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       229 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~  295 (407)
                      +........    .......||+.|+|||++..         ..++.++|||||||++|+|++|..||.......     
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----  250 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----  250 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            876532211    11223458999999999864         457899999999999999999999997544221     


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                       ......... ......        ..++..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus       251 -~~~~~~~~~-~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          251 -IIWQMGTGM-KPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -HHHHHHTTC-CCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -HHHHhccCC-CCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             122222211 111111        11233588999999999999999999999999988654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.3e-43  Score=346.81  Aligned_cols=201  Identities=21%  Similarity=0.280  Sum_probs=173.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC------CCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV------RHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~  150 (407)
                      .++|++.+.||+|+||.||+|... ++..||||++... ......+..|+.+++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 5788999988654 33345666788777766      578999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC--cEEeeccc
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--PKVSDFGL  228 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfGl  228 (407)
                      ++||||+. ++|.+++.....  ..+++..++.++.||+.||+|||+.   +|+||||||+||||+.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999995 699999876532  4589999999999999999999999   9999999999999999887  99999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~  289 (407)
                      +......    .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            9875433    23357899999999999999999999999999999999999999866543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-43  Score=347.39  Aligned_cols=262  Identities=24%  Similarity=0.296  Sum_probs=196.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------CeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------AHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~  151 (407)
                      .+|++.+.||+|+||.||+|.+. +++.||||++......    ..+|+.+|+.++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46999999999999999999975 5889999988654322    23599999999999999999988432      2467


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-CCcEEeecccce
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAK  230 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~  230 (407)
                      +||||+++ +|.+.+.........+++..++.++.||+.||.|||++   +|+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999965 66666543211225799999999999999999999999   99999999999999965 568999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH-------h
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM-------V  302 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------~  302 (407)
                      .......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+  +...       +
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i--~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI--IKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCHHHH
Confidence            7654332  2335689999999998765 7999999999999999999999999865533222111  1110       0


Q ss_pred             --hcCCCCCcCCCCCCCCcc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          303 --TNRNPEGVLDPKLPEKPT-----SRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       303 --~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                        ..........+.......     ...+..+.+||.+||+.||.+|||+.++++.-
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence              011111111111111111     12346789999999999999999999999743

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.9e-44  Score=344.58  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=186.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecC------C
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  148 (407)
                      .++|++.+.||+|+||.||+|... ++..||||++...  .......+.+|+.+|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            368999999999999999999954 6888999998653  334456778899999999999999999998653      5


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..++||||+ +++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 7899998865     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....   +.+...... 
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~-  250 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPG-  250 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCC-
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCC-
Confidence            9875432    234578999999999877 6789999999999999999999999986553322221   111111100 


Q ss_pred             CCcCC--------------CCCCCCcc----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          308 EGVLD--------------PKLPEKPT----SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       308 ~~~~~--------------~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...+.              +..+....    ...+..+.+||.+||..||.+|||+.++++.-.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence            00000              00011111    112456889999999999999999999997543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.4e-44  Score=345.94  Aligned_cols=252  Identities=11%  Similarity=0.043  Sum_probs=182.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHH---HHHhcCCCCccceee-------eee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEV---EAIGRVRHKNLVRLL-------GYC  144 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~---~~l~~l~hpniv~~~-------~~~  144 (407)
                      .+|.+.+.||+|+||.||+|.+. +++.||||++.....   .....+..|+   .+|+. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            35899999999999999999965 688899999977542   3344566774   55555 799988855       333


Q ss_pred             ecC-----------------CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHH------HHHHHHHHHHHHhhhhcCCC
Q 015395          145 AEG-----------------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR------MNIILGTAKGLSYLHEGLEP  201 (407)
Q Consensus       145 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~  201 (407)
                      ...                 ..+++||||++ ++|.+++....   ..+.+..+      +.++.||+.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            322                 34799999998 89999997532   23444555      67789999999999999   


Q ss_pred             ceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhC
Q 015395          202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISG  279 (407)
Q Consensus       202 ~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg  279 (407)
                      +|+||||||+||||+.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||++|+|++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999876432    223457799999999987  6799999999999999999999


Q ss_pred             CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       280 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +.||....+......        ....................++..+.+||.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999986643211100        000000001111111112245667999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.5e-44  Score=338.59  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCccceeeeeeecCC
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  148 (407)
                      .++|.+.+.||+|+||.||+|... +++.||||.+.....        .....+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357999999999999999999965 578899998864321        12235778999999999999999999987655


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC---cEEee
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSD  225 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~D  225 (407)
                       .++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             89999999999999999765    5799999999999999999999999   9999999999999987654   99999


Q ss_pred             cccceecCCCCceeeeeeeccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      ||++........  .....||+.|+|||++   ....++.++|||||||++|+|++|..||.........  ...+..  
T Consensus       161 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~--  234 (322)
T 2ycf_A          161 FGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS--  234 (322)
T ss_dssp             CTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHHH--
T ss_pred             Cccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHHh--
Confidence            999987654321  2234689999999987   3567899999999999999999999999765443221  111111  


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        ...      .........++..+.++|.+||+.||++||++.++++.
T Consensus       235 --~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          235 --GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --Ccc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              100      00000112345678999999999999999999999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.5e-43  Score=340.38  Aligned_cols=264  Identities=22%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----Cee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (407)
                      .++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357999999999999999999965 67789999986543 33446788999999999999999999998654     468


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+. ++|.+++...     .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999996 5999998763     599999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcee--eeeeeccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSESSYI--TTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .........  .....||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+   .........
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence            765432211  23457999999999864 455899999999999999999999999876544333222   111110000


Q ss_pred             C---------------CcCC-CCCC-CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          308 E---------------GVLD-PKLP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       308 ~---------------~~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .               .... ...+ ......++..+.+||.+||+.||.+|||+.++++.-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            0               0000 0000 0001123456899999999999999999999997544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.4e-44  Score=336.03  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=202.9

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCC--CCccceeeeeeecC
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEG  147 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~  147 (407)
                      ..+.+..++|++.+.||+|+||.||+|...+++.||+|++...  .......+.+|+.++++++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3344566789999999999999999999888999999998654  3345567889999999997  59999999999999


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      ...++||| +.+++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++ +.+||+|||
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999 5588999999865    4789999999999999999999999   9999999999999975 799999999


Q ss_pred             cceecCCCCce-eeeeeeccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH
Q 015395          228 LAKLLGSESSY-ITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       228 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~  295 (407)
                      ++......... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||......     .
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~  246 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I  246 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence            99876543322 2234568999999999865           46888999999999999999999999754322     1


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ..+........     ...++..    .+..+.++|.+||+.||.+||++.++++....
T Consensus       247 ~~~~~~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          247 SKLHAIIDPNH-----EIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             HHHHHHHCTTS-----CCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHHhccc-----ccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            22222222111     1111111    23468899999999999999999999985543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-42  Score=330.57  Aligned_cols=259  Identities=20%  Similarity=0.292  Sum_probs=204.3

Q ss_pred             cCCCCccceecccCceEEEEEEE-C-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC------ccceeeeeeecCCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL-E-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK------NLVRLLGYCAEGAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~~  149 (407)
                      .++|++.+.||+|+||.||+|.. . +++.||+|++... ......+..|+.+++.++|+      +|+++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986 3 5788999988643 34456677899999888655      49999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC------------
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK------------  217 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~------------  217 (407)
                      .++||||+ +++|.+++.....  .++++..++.++.||+.||+|||++   +|+||||||+|||++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 8899999976532  3689999999999999999999999   9999999999999987            


Q ss_pred             -------CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          218 -------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       218 -------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                             ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   678999999999875433    233468999999999999999999999999999999999999998655433


Q ss_pred             hhhHHHHHHHHhhcCCCCC---------cC---------------------CC-CCCCCccHHHHHHHHHHHHHccCcCC
Q 015395          291 EVNLIEWLKKMVTNRNPEG---------VL---------------------DP-KLPEKPTSRLLKRILLVALRCVDPNA  339 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~---------~~---------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp  339 (407)
                      ....+   ...... .+..         ..                     .+ ..........+..+.+||.+||+.||
T Consensus       242 ~~~~~---~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 HLAMM---ERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             HHHHH---HHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HHHHH---HHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            22221   111110 0000         00                     00 00001123456789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 015395          340 QKRPKMGHVVHM  351 (407)
Q Consensus       340 ~~RPt~~evl~~  351 (407)
                      .+|||+.++++.
T Consensus       318 ~~Rpt~~ell~h  329 (339)
T 1z57_A          318 AKRITLREALKH  329 (339)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             ccccCHHHHhcC
Confidence            999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=331.90  Aligned_cols=264  Identities=21%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee-----------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----------  145 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----------  145 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999976 48889999998777677778899999999999999999998873           


Q ss_pred             ---cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCCc
Q 015395          146 ---EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNP  221 (407)
Q Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~  221 (407)
                         +....++||||++ ++|.+++..     ..+++..++.++.|++.||+|||++   +|+||||||+|||++ .++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               4467899999997 699999964     4689999999999999999999999   999999999999997 56789


Q ss_pred             EEeecccceecCCCCce--eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHH
Q 015395          222 KVSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  298 (407)
                      ||+|||++.........  ......+|..|+|||++.. ..++.++|||||||++|+|++|+.||......+....   +
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL---I  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---H
Confidence            99999999876432211  1223457899999998765 6789999999999999999999999986543222111   1


Q ss_pred             HHHhhc----------CCCCC-----cCCCCCC-CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          299 KKMVTN----------RNPEG-----VLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       299 ~~~~~~----------~~~~~-----~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ......          .....     ...+..+ ......++..+.++|.+||+.||++|||+.++++.-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            110000          00000     0000000 0001124567999999999999999999999987433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=341.64  Aligned_cols=271  Identities=18%  Similarity=0.243  Sum_probs=186.2

Q ss_pred             CCCc-cceecccCceEEEEEEEC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeee--cCCeeEEE
Q 015395           80 GFSD-DKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLV  153 (407)
Q Consensus        80 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv  153 (407)
                      .|.+ .++||+|+||.||+|...   ++..||||++....  ....+.+|+.+|+.++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3665 568999999999999965   47789999886543  2345778999999999999999999994  46789999


Q ss_pred             EEeccCCChHHhhhCCC-----CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE----eCCCCcEEe
Q 015395          154 YEYVNNGNLEQWLHGDV-----GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVS  224 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~  224 (407)
                      |||+. ++|.+++....     .....+++..++.++.||+.||.|||+.   +|+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99995 58888775221     1123599999999999999999999999   99999999999999    677899999


Q ss_pred             ecccceecCCCCc--eeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCch------hhhHH
Q 015395          225 DFGLAKLLGSESS--YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPE------EVNLI  295 (407)
Q Consensus       225 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~------~~~~~  295 (407)
                      |||+++.......  ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......      ....+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999987654322  123345789999999999874 58999999999999999999999997654310      01111


Q ss_pred             HHHHHHhhcCCCCCcC----------------CCCCCCCccHH--------HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          296 EWLKKMVTNRNPEGVL----------------DPKLPEKPTSR--------LLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~--------~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..+.............                ...........        ....+.+||.+||+.||.+|||+.++++.
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1121111111000000                00000000000        03457899999999999999999999986


Q ss_pred             HHhcc
Q 015395          352 LEAQE  356 (407)
Q Consensus       352 L~~~~  356 (407)
                      -....
T Consensus       335 p~f~~  339 (405)
T 3rgf_A          335 PYFLE  339 (405)
T ss_dssp             GGGTS
T ss_pred             hhhcc
Confidence            65543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.9e-43  Score=340.88  Aligned_cols=264  Identities=19%  Similarity=0.240  Sum_probs=203.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC--------CCccceeeeeee---
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR--------HKNLVRLLGYCA---  145 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~~~~~~~---  145 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999965 5778999988643 344567788999999885        788999999987   


Q ss_pred             -cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-----
Q 015395          146 -EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-----  219 (407)
Q Consensus       146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----  219 (407)
                       .....++||||+ +++|.+++....  ...+++..++.++.||+.||.|||++.  +|+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence             566899999999 567766665432  146999999999999999999999852  899999999999998775     


Q ss_pred             --------------------------------------------CcEEeecccceecCCCCceeeeeeeccccccCcccc
Q 015395          220 --------------------------------------------NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA  255 (407)
Q Consensus       220 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~  255 (407)
                                                                  .+||+|||++......    .....||+.|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999876533    2334689999999999


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH---HHHHhhcC---------CCCCcCC---------CC
Q 015395          256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW---LKKMVTNR---------NPEGVLD---------PK  314 (407)
Q Consensus       256 ~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~---------~~~~~~~---------~~  314 (407)
                      .+..++.++|||||||++|+|++|+.||......+.......   +.......         .......         ..
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999987665432222221   21111110         0000000         00


Q ss_pred             CC----------CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LP----------EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .+          .......+..+.+||.+||+.||++|||+.++++.
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00          01235667789999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.4e-43  Score=327.79  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=195.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec-----------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----------  146 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----------  146 (407)
                      ++|++.+.||+|+||.||+|... +++.||||.+... ......+.+|+.+++.++||||+++++++.+           
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            46999999999999999999965 6889999988543 3445678889999999999999999998754           


Q ss_pred             --CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEe
Q 015395          147 --GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (407)
Q Consensus       147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  224 (407)
                        ....++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence              356799999999999999997542   4678899999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCC-------------ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          225 DFGLAKLLGSES-------------SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       225 DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                      |||++.......             ........||+.|+|||++.+. .++.++|||||||++|+|++   ||...    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----  231 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----  231 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence            999998664321             1112345689999999999765 68999999999999999998   55421    


Q ss_pred             hhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                       ..............       ..++.......+..+.++|.+||+.||.+|||+.++++..
T Consensus       232 -~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          232 -MERVNILKKLRSVS-------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             -HHHHHHHHHHHSTT-------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             -hhHHHHHHhccccc-------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence             11122222222111       1122222334455688999999999999999999998743

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.6e-43  Score=327.20  Aligned_cols=251  Identities=21%  Similarity=0.320  Sum_probs=204.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            457999999999999999999975 6889999988543  2344567888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC---CCcEEeeccccee
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKL  231 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~~  231 (407)
                      ||+.+++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.+   +.+||+|||++..
T Consensus       101 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999988754    4689999999999999999999999   99999999999999654   4699999999986


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......      ............    
T Consensus       174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----  240 (287)
T 2wei_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA----  240 (287)
T ss_dssp             BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC----
T ss_pred             ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCC----
Confidence            644322  223458999999999865 4899999999999999999999999754422      122222222110    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         .+......++..+.++|.+||..||++|||+.++++.
T Consensus       241 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ---CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence               1111112345678999999999999999999999983

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-43  Score=337.05  Aligned_cols=274  Identities=19%  Similarity=0.234  Sum_probs=191.4

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC---
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA---  148 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---  148 (407)
                      ......++|.+.+.||+|+||.||+|... ++..||||++...... ......++..++.++||||+++++++....   
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            44566789999999999999999999975 6889999988654332 234456788888899999999999986533   


Q ss_pred             ----eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhh--hcCCCceeccCCCCccEEEeC-CCCc
Q 015395          149 ----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH--EGLEPKVVHRDIKSSNILIDK-HWNP  221 (407)
Q Consensus       149 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~Nill~~-~~~~  221 (407)
                          ..++||||+.+ +|.+.+.........+++..++.++.|++.||.|||  +.   +|+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence                27899999976 555444322122257899999999999999999999  88   9999999999999997 8999


Q ss_pred             EEeecccceecCCCCceeeeeeeccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHH---
Q 015395          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW---  297 (407)
Q Consensus       222 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---  297 (407)
                      ||+|||++........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+..   
T Consensus       172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            9999999987654432  23346899999999986654 89999999999999999999999986543322211110   


Q ss_pred             ------HHHHhhcCCCCCcCCCC-C-----CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          298 ------LKKMVTNRNPEGVLDPK-L-----PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       298 ------~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                            +.............+.. .     ........+..+.+||.+||+.||.+|||+.++++.-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence                  00000000000000000 0     00011124567999999999999999999999997443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-42  Score=335.25  Aligned_cols=258  Identities=22%  Similarity=0.333  Sum_probs=198.7

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee----
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~----  150 (407)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999965 6888999998654  333456788899999999999999999999876654    


Q ss_pred             --EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          151 --MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       151 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                        ++||||+. ++|.+++..      .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999996 689888743      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+   ....... .
T Consensus       191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~-~  262 (371)
T 4exu_A          191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVP-G  262 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCC-C
T ss_pred             ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCC-c
Confidence            9865432    233568999999999877 67999999999999999999999999865432221111   1110000 0


Q ss_pred             CCcCC--------------CCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          308 EGVLD--------------PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       308 ~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .....              +..+...    ...++..+.+||.+||+.||++|||+.++++.-.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            00000              0000000    1123567899999999999999999999987544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.4e-42  Score=333.83  Aligned_cols=205  Identities=22%  Similarity=0.280  Sum_probs=172.2

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CC-----ccceeeeeeecCC
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HK-----NLVRLLGYCAEGA  148 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~~~~~  148 (407)
                      ...++|++.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999965 5778999988643 334456677888888774 44     5999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe--CCCCcEEeec
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDF  226 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df  226 (407)
                      ..++||||+. ++|.+++.....  ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999995 599999976532  4589999999999999999999952 22899999999999995  4778999999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~  289 (407)
                      |++......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999887543    23356899999999999999999999999999999999999999865543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.7e-43  Score=332.78  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=200.1

Q ss_pred             cCCCCccceecccCceEEEEEEE--CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCccceeeeeee-----
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLL--EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCA-----  145 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~-----  145 (407)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            46899999999999999999997  3577899998854321  1122444566666655   8999999999986     


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                      .....++||||+. ++|.+++.....  ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence            5567899999997 699999976432  3589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ||++.......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+.   ...+.......
T Consensus       164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~  238 (326)
T 1blx_A          164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP  238 (326)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred             CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCC
Confidence            99998664322  12345689999999999999999999999999999999999999986543222   11122111110


Q ss_pred             CCCC----------cCCC---CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 NPEG----------VLDP---KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 ~~~~----------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ....          .+..   .........++..+.+||.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000          0000   00001112345678999999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.8e-43  Score=336.00  Aligned_cols=264  Identities=21%  Similarity=0.302  Sum_probs=202.3

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecC-----Cee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (407)
                      .++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999976 67889999986543 34455778899999999999999999987653     678


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++||||+. ++|.+++..     ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999996 699999876     3689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCce---------eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHH
Q 015395          231 LLGSESSY---------ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (407)
Q Consensus       231 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (407)
                      ........         ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.........   ..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHH
Confidence            76533211         1123468999999998754 77899999999999999999999999865432211   11111


Q ss_pred             HhhcCCCCCcCC--------------CCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          301 MVTNRNPEGVLD--------------PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       301 ~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ............              +..+...    ...++..+.+||.+||+.||++|||+.++++.-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY  308 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            111110000000              0000000    1234567899999999999999999999997443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.8e-42  Score=342.10  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=190.2

Q ss_pred             CCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEEEecc
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      .|.+.+.||+|+||+||.+...+++.||||++....   ...+..|+.+|+++ +||||+++++++.+....++|||||.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            455678899999999987777789999999886532   34567799999876 89999999999999999999999995


Q ss_pred             CCChHHhhhCCCCCCCC---CCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC-------------CCcE
Q 015395          159 NGNLEQWLHGDVGPCSP---LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-------------WNPK  222 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~k  222 (407)
                       |+|.+++.........   .++..++.++.||+.||+|||++   +|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999765321111   13345678999999999999999   99999999999999754             4799


Q ss_pred             EeecccceecCCCCce---eeeeeeccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 015395          223 VSDFGLAKLLGSESSY---ITTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE  291 (407)
Q Consensus       223 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~  291 (407)
                      |+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||......+ 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            9999999987654322   1234579999999999965       668999999999999999999 999997543322 


Q ss_pred             hhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                         ..    .......    .+.........++..+.++|.+||+.||.+|||+.++++
T Consensus       248 ---~~----i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---SN----IIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---HH----HHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HH----HhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               11    1111110    011122234567788999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-42  Score=331.93  Aligned_cols=255  Identities=18%  Similarity=0.234  Sum_probs=175.9

Q ss_pred             cCCCCcc-ceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec----CCeeE
Q 015395           78 TNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM  151 (407)
Q Consensus        78 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~  151 (407)
                      .++|.+. ++||+|+||.||+|... +++.||||++.... ....   .....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            3578885 46999999999999976 68899999886532 2222   22334566789999999999875    45689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeeccc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGL  228 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGl  228 (407)
                      +||||+++|+|.+++.....  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.   ++.+||+|||+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999986532  4699999999999999999999999   9999999999999976   45599999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||............   .......   
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~---  248 (336)
T 3fhr_A          178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG---  248 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc---
Confidence            98764322   23346899999999998889999999999999999999999999755432211100   0000000   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                         ...++......++..+.+||.+||+.||.+|||+.++++...
T Consensus       249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence               011111222345567899999999999999999999998544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.5e-43  Score=334.83  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=198.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe-----
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  149 (407)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367999999999999999999965 6888999998654  23345678889999999999999999999977654     


Q ss_pred             -eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          150 -RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       150 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                       +++||||+. ++|.+++..      .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999996 689888743      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC--
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--  305 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--  305 (407)
                      +......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....   +.......  
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~  245 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTGVPGT  245 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH---HHHHHCBCCH
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCH
Confidence            9765432    233468999999999877 6789999999999999999999999986543222111   11110000  


Q ss_pred             ----------------CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          306 ----------------NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       306 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                                      .........+. .....++..+.+||.+||+.||++|||+.++++.-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                            00000001111 112234567999999999999999999999987543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.1e-42  Score=327.68  Aligned_cols=260  Identities=21%  Similarity=0.285  Sum_probs=201.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CC-CEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc------cceeeeeeecCCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DN-SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN------LVRLLGYCAEGAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~~  149 (407)
                      .++|++.+.||+|+||.||+|... ++ ..||+|++... ......+..|+.+++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999965 34 57999988643 344567778999999887665      8999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEE--------------
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--------------  215 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill--------------  215 (407)
                      .++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 6677777765421  4699999999999999999999999   99999999999999              


Q ss_pred             -----eCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 015395          216 -----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (407)
Q Consensus       216 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~  290 (407)
                           +.++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 678899999999998754332    33568999999999999999999999999999999999999998654332


Q ss_pred             hhhHHHHHHHHhhcCCCCCc----------CCC---------------------CCCCCccHHHHHHHHHHHHHccCcCC
Q 015395          291 EVNLIEWLKKMVTNRNPEGV----------LDP---------------------KLPEKPTSRLLKRILLVALRCVDPNA  339 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~----------~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dp  339 (407)
                      ....   +...... .+...          ...                     ..........+..+.+||.+||+.||
T Consensus       247 ~~~~---~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 HLVM---MEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             HHHH---HHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HHHH---HHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            2221   2221110 00000          000                     00001122345678999999999999


Q ss_pred             CCCCCHHHHHHHH
Q 015395          340 QKRPKMGHVVHML  352 (407)
Q Consensus       340 ~~RPt~~evl~~L  352 (407)
                      ++|||+.++++.-
T Consensus       323 ~~Rpt~~e~l~hp  335 (355)
T 2eu9_A          323 AQRITLAEALLHP  335 (355)
T ss_dssp             TTSCCHHHHTTSG
T ss_pred             hhCcCHHHHhcCh
Confidence            9999999998643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-42  Score=329.18  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=182.2

Q ss_pred             HHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHH-HHhcCCCCccceeeeeeecCCeeE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      .+..++|++.+.||+|+||.||+|... +++.||||++.... ......+..|+. +++.++||||+++++++...+..+
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            345678999999999999999999975 68889999986653 233344555555 778889999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCC-CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          152 LVYEYVNNGNLEQWLHGDV-GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +||||+.+ +|.+++.... .....+++..++.++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++.
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            99999975 8877775210 01157899999999999999999999842  89999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      .......  .....||+.|+|||++    .+..++.++|||||||++|+|++|..||.......     +.+...     
T Consensus       175 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~-----  242 (327)
T 3aln_A          175 QLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQV-----  242 (327)
T ss_dssp             C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCC-----
T ss_pred             ecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHH-----
Confidence            7643322  2233689999999998    45678999999999999999999999997533210     000000     


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       .....+.++......++..+.++|.+||+.||++|||+.++++.
T Consensus       243 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 -VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence             00011112222223345679999999999999999999999873

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.8e-42  Score=331.95  Aligned_cols=266  Identities=20%  Similarity=0.247  Sum_probs=200.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----------CCccceeeeeee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----------HKNLVRLLGYCA  145 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~  145 (407)
                      .++|.+.+.||+|+||.||+|... +++.||||++... ......+..|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999964 6788999988643 334556778999988876           899999999987


Q ss_pred             cCC----eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC----
Q 015395          146 EGA----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK----  217 (407)
Q Consensus       146 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----  217 (407)
                      ..+    .+++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++.  +|+||||||+|||++.    
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            543    789999999 8899999976432  45899999999999999999999842  8999999999999953    


Q ss_pred             --CCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHH
Q 015395          218 --HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (407)
Q Consensus       218 --~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~  295 (407)
                        .+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              347999999999876533    22346899999999999999999999999999999999999999865432211111


Q ss_pred             HHHHHHhhc-CCCC-----------------CcCCC----CC---------CCCccHHHHHHHHHHHHHccCcCCCCCCC
Q 015395          296 EWLKKMVTN-RNPE-----------------GVLDP----KL---------PEKPTSRLLKRILLVALRCVDPNAQKRPK  344 (407)
Q Consensus       296 ~~~~~~~~~-~~~~-----------------~~~~~----~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt  344 (407)
                      ..+..+... ...+                 ..+..    ..         ........+..+.+||.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            111111100 0000                 00000    00         01123567788999999999999999999


Q ss_pred             HHHHHHHHH
Q 015395          345 MGHVVHMLE  353 (407)
Q Consensus       345 ~~evl~~L~  353 (407)
                      +.++++.-.
T Consensus       328 ~~ell~hp~  336 (373)
T 1q8y_A          328 AGGLVNHPW  336 (373)
T ss_dssp             HHHHHTCGG
T ss_pred             HHHHhhChh
Confidence            999988544

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-42  Score=360.20  Aligned_cols=240  Identities=22%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             hcCCCCccceecccCceEEEEEEEC--CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe----
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH----  149 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----  149 (407)
                      ..++|++.+.||+|+||.||+|.+.  +++.||||++... .......+..|+.++++++||||+++++++...+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3478999999999999999999975  5788999988654 33455678889999999999999999999987654    


Q ss_pred             -eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          150 -RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       150 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                       .||||||+++++|.+++..      .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence             7999999999999987753      589999999999999999999999   99999999999999986 899999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +......     ....||+.|+|||++.+.. +.++|||||||++|+|++|..||......                   
T Consensus       228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------  282 (681)
T 2pzi_A          228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------  282 (681)
T ss_dssp             CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------
T ss_pred             chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------------
Confidence            9876543     3346999999999987654 88999999999999999999888632110                   


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHHHHhc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHMLEAQ  355 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L~~~  355 (407)
                          ...........+..+.++|.+||+.||.+||+ ++++...|...
T Consensus       283 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 ----GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ----SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                00011123344567899999999999999995 55666655543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=338.55  Aligned_cols=251  Identities=27%  Similarity=0.344  Sum_probs=189.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      +...+|.+.++||+|+||.||.....+++.||||++......   .+.+|+.+|+.+ +||||+++++++.+....++||
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            344569999999999999977666677999999998654322   245699999999 7999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---C--CCcEEeecccc
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---H--WNPKVSDFGLA  229 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~DfGla  229 (407)
                      |||. |+|.+++....   ..+.+..++.++.||+.||.|||++   +|+||||||+|||++.   +  ..+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9995 69999997654   2345556688999999999999999   9999999999999953   2  35779999999


Q ss_pred             eecCCCCc--eeeeeeeccccccCccccC---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhh
Q 015395          230 KLLGSESS--YITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT  303 (407)
Q Consensus       230 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  303 (407)
                      ........  .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||.......       ......
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~  243 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLG  243 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhc
Confidence            87654322  1233457999999999997   4567889999999999999999 999996433211       111111


Q ss_pred             cCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      ....    +   ...........+.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~----~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ACSL----D---CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCC----T---TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCc----c---ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111    0   01112345566889999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=325.89  Aligned_cols=244  Identities=28%  Similarity=0.430  Sum_probs=192.3

Q ss_pred             hcCCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChh------hHHHHHHHHHHHhcC----CCCccceeeeeee
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRV----RHKNLVRLLGYCA  145 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l----~hpniv~~~~~~~  145 (407)
                      -.++|++.+.||+|+||.||+|.. .+++.||||++......      ....+..|+.++.++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            357899999999999999999985 46889999998654321      222345688888888    8999999999999


Q ss_pred             cCCeeEEEEEe-ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCCcEE
Q 015395          146 EGAHRMLVYEY-VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKV  223 (407)
Q Consensus       146 ~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl  223 (407)
                      ..+..++|||| +.+++|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+||+++ .++.+||
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999 7899999999765    4699999999999999999999999   999999999999999 8899999


Q ss_pred             eecccceecCCCCceeeeeeeccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       224 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      +|||++.......   .....||..|+|||++.+..+. .++|||||||++|+|++|+.||....        .    ..
T Consensus       182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~~  246 (312)
T 2iwi_A          182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----IL  246 (312)
T ss_dssp             CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HH
T ss_pred             EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----Hh
Confidence            9999998775432   2345689999999998776664 58999999999999999999996321        0    11


Q ss_pred             hcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      ...       ..++    ..++..+.++|.+||+.||++|||+.++++...
T Consensus       247 ~~~-------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          247 EAE-------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             HTC-------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             hhc-------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            110       0111    123456889999999999999999999987443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9e-43  Score=330.60  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChh------hHHHHHHHHHHHhcCC--CCccceeee
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVR--HKNLVRLLG  142 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~~~~  142 (407)
                      ...+...++|++.+.||+|+||.||+|... ++..||||.+......      ....+..|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344455678999999999999999999964 6788999998654221      2234566899999986  599999999


Q ss_pred             eeecCCeeEEEEEeccC-CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe-CCCC
Q 015395          143 YCAEGAHRMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWN  220 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~  220 (407)
                      ++...+..++|||++.+ ++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++ +++.
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence            99999999999999976 8999999764    5799999999999999999999999   999999999999999 7889


Q ss_pred             cEEeecccceecCCCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  299 (407)
                      +||+|||++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....            
T Consensus       189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------  253 (320)
T 3a99_A          189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------  253 (320)
T ss_dssp             EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred             EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------
Confidence            9999999998765432   233468999999999877665 688999999999999999999996321            


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .......       ..+    ..++..+.++|.+||+.||++|||+.++++...
T Consensus       254 ~~~~~~~-------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          254 EIIRGQV-------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             HHHHCCC-------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             hhhcccc-------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence            0111110       011    123456899999999999999999999987543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=320.01  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=183.7

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-hh-HHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ..++|++.+.||+|+||.||+|... +++.||||++..... .. .+.+..+..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            4567999999999999999999975 688999999865532 22 23444455678888999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |||+ ++.+..+.....   ..+++..++.++.|++.||.|||+ .   +|+||||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 556665554322   468999999999999999999998 6   8999999999999999999999999999765


Q ss_pred             CCCCceeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .....  .....||+.|+|||++.     ...++.++|||||||++|+|++|+.||......     ...+.........
T Consensus       176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~  248 (318)
T 2dyl_A          176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPP  248 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCC
T ss_pred             cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCC
Confidence            44322  23346899999999984     456889999999999999999999999754322     1222222222111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                            .++.  ...++..+.++|.+||+.||.+||++.++++.
T Consensus       249 ------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 ------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                  1111  11234568999999999999999999999873

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.1e-41  Score=312.16  Aligned_cols=231  Identities=13%  Similarity=0.087  Sum_probs=186.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999976 48889999986553   23346788899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++...      ....++..++.|++.||+|||++   +|+||||||+|||++.++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999542      35567889999999999999999   99999999999999999999997443      


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                                     |++|       ++.++|||||||++|+|++|+.||......+.....            ......
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~  220 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAG  220 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTS
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhcc
Confidence                           3443       689999999999999999999999865543211000            000000


Q ss_pred             CCC--CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          314 KLP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       314 ~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      ..+  ......++..+.++|.+||+.||++| |+.++++.|+.....
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            000  01112345679999999999999999 999999999987554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.5e-41  Score=343.96  Aligned_cols=265  Identities=23%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeec------CCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  149 (407)
                      .++|++.+.||+|+||.||+|.+. ++..||||++... .......+..|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999964 6888999988654 34455678899999999999999999998765      677


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC---cEEeec
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDF  226 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Df  226 (407)
                      .++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999986432 23689999999999999999999999   9999999999999997765   899999


Q ss_pred             ccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhH-H-H-HHHHHhh
Q 015395          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL-I-E-WLKKMVT  303 (407)
Q Consensus       227 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~-~-~-~~~~~~~  303 (407)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||........... . . .......
T Consensus       169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99987654432  2345789999999999999999999999999999999999999975321110000 0 0 0000000


Q ss_pred             cCCCCCc--CC--CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 015395          304 NRNPEGV--LD--PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV  348 (407)
Q Consensus       304 ~~~~~~~--~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev  348 (407)
                      .......  ..  ...+......++..+.++|.+||..||++|||+.++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0000000  00  111223345578889999999999999999999873

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5e-41  Score=320.65  Aligned_cols=243  Identities=15%  Similarity=0.146  Sum_probs=186.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcCC--------------
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--------GQAEREFKVEVEAIGRVR--------------  133 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~--------------  133 (407)
                      +..++|++.+.||+|+||.||+|.+ +++.||||++....        ......+.+|+.+++.++              
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3456799999999999999999998 57899999986542        223367778888888875              


Q ss_pred             ------------CCccceeeeeeec-------------CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHH
Q 015395          134 ------------HKNLVRLLGYCAE-------------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT  188 (407)
Q Consensus       134 ------------hpniv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi  188 (407)
                                  ||||+++++++.+             ....++||||+++|++.+.+..     ..+++..++.++.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence                        4555555555544             6889999999999977776643     358999999999999


Q ss_pred             HHHHHhhh-hcCCCceeccCCCCccEEEeCCC--------------------CcEEeecccceecCCCCceeeeeeeccc
Q 015395          189 AKGLSYLH-EGLEPKVVHRDIKSSNILIDKHW--------------------NPKVSDFGLAKLLGSESSYITTRVMGTF  247 (407)
Q Consensus       189 ~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~  247 (407)
                      +.||+||| ++   +|+||||||+||||+.++                    .+||+|||+++.....      ..+||+
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~  241 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence            99999999 89   999999999999999887                    8999999999876532      347999


Q ss_pred             cccCccccCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCchhhhHHH-HHHHHhhcCCCCCcCCCCCCCCccHHHHH
Q 015395          248 GYVAPEYASTGMLNERSDVYSFGIL-IMEVISGRIPVDYSRPPEEVNLIE-WLKKMVTNRNPEGVLDPKLPEKPTSRLLK  325 (407)
Q Consensus       248 ~y~aPE~~~~~~~~~~sDiwslG~i-l~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (407)
                      .|+|||++.+.. +.++|||||+++ .+++++|..||..      ..... ...........    ...........++.
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTF----KTKCNTPAMKQIKR  310 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCC----SSCCCSHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhcc----CcccchhhhhhcCH
Confidence            999999998776 899999998777 7778889999841      11111 11122211111    11112223456888


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHH
Q 015395          326 RILLVALRCVDPNAQKRPKMGHVV  349 (407)
Q Consensus       326 ~l~~li~~cl~~dp~~RPt~~evl  349 (407)
                      ++.+||.+||+.|     |+.+++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999977     898888

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-40  Score=308.18  Aligned_cols=231  Identities=19%  Similarity=0.262  Sum_probs=180.3

Q ss_pred             CCCCcc-ceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHH-hcCCCCccceeeeeeec----CCeeE
Q 015395           79 NGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHRM  151 (407)
Q Consensus        79 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~~  151 (407)
                      ++|.+. +.||+|+||.||+|... ++..||+|.+...     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            457776 78999999999999964 6889999988542     3455688877 55689999999999876    67889


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeeccc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGL  228 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGl  228 (407)
                      +||||+++++|.+++.....  ..+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999976532  4699999999999999999999999   9999999999999988   78899999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +....                       +..++.++|||||||++|+|++|..||.........           .....
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~  212 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT  212 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence            86532                       245678999999999999999999999754322110           00001


Q ss_pred             CcCCCCC--CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 015395          309 GVLDPKL--PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (407)
Q Consensus       309 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~  353 (407)
                      .+.....  +......++..+.++|.+||+.||.+|||+.++++...
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence            1111111  11111235677999999999999999999999998443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-40  Score=327.45  Aligned_cols=242  Identities=14%  Similarity=0.165  Sum_probs=181.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCC-Cccceee------------
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRH-KNLVRLL------------  141 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-pniv~~~------------  141 (407)
                      ..|...++||+|+||.||+|.+. +++.||||++.....   ...+.+.+|+.+++.++| +|...+.            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            35778899999999999999954 688999998874332   234678889999999976 3221111            


Q ss_pred             ---------eeeec-----CCeeEEEEEeccCCChHHhhhCC---CCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCcee
Q 015395          142 ---------GYCAE-----GAHRMLVYEYVNNGNLEQWLHGD---VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV  204 (407)
Q Consensus       142 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv  204 (407)
                               .++..     ...++++|+++ +++|.+++...   ......+++..++.++.||+.||+|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                     11111     22457777766 67999888411   11124588889999999999999999999   999


Q ss_pred             ccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCcccc----------CCCCCCcchhHHHHHHHHH
Q 015395          205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA----------STGMLNERSDVYSFGILIM  274 (407)
Q Consensus       205 H~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDiwslG~il~  274 (407)
                      ||||||+||||+.++.+||+|||+++.....    ....+| +.|+|||++          ....++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999999875432    344567 999999999          6667889999999999999


Q ss_pred             HHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       275 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                      +|++|+.||......+....               ++...      ..++..+.+||.+||+.||++||++.++++
T Consensus       309 elltg~~Pf~~~~~~~~~~~---------------~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEW---------------IFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGG---------------GGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHCCCCCCCcchhhhHHH---------------HHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999975443221111               11100      122356999999999999999999887764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2e-33  Score=285.51  Aligned_cols=184  Identities=14%  Similarity=0.074  Sum_probs=129.9

Q ss_pred             ecccCceEEEEEE-ECCCCEEEEEEeccCC----------hhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEEEE
Q 015395           87 IGEGGYGIVYYGL-LEDNSKVAVKNLLNNR----------GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        87 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++.|++|.+..++ .-.|..+|+|.+....          ....+++.+|+++|+++ .|+||+++++++++.+..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5566676666554 3347889999886431          22335688999999999 6999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||++|++|.++|...    ++++..   .|+.||+.||+|||++   |||||||||+||||+.+|.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999875    567664   4789999999999999   999999999999999999999999999987654


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP  282 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~P  282 (407)
                      ... .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            332 2344679999999999965 467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.6e-29  Score=253.77  Aligned_cols=184  Identities=16%  Similarity=0.210  Sum_probs=144.9

Q ss_pred             CccceecccCceEEEEEEECCCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ...++||+|+||.||+|.. .+..+++|+......        ...+.+.+|+++|++++||||+++..++......+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 478899997644321        1134578999999999999999666666677778999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++++|.+++..            ++.++.|++.||+|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999864            468999999999999999   9999999999999998  99999999999875


Q ss_pred             CCCcee------eeeeeccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 015395          234 SESSYI------TTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPV  283 (407)
Q Consensus       234 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~elltg~~Pf  283 (407)
                      ......      .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++-+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            532211      134679999999999977  56788899999999888888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=9.5e-26  Score=209.43  Aligned_cols=151  Identities=17%  Similarity=0.105  Sum_probs=121.5

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh------------------hhHHHHHHHHHHHhcCCC
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG------------------QAEREFKVEVEAIGRVRH  134 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  134 (407)
                      .+......|.+.+.||+|+||.||+|.+.++..||||.+.....                  .....+.+|+.+|++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34445556777899999999999999997788999998854321                  13456888999999999 


Q ss_pred             CccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEE
Q 015395          135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (407)
Q Consensus       135 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil  214 (407)
                       | +++.+++.. +..++||||++|++|.+ +..          .....++.|++.||.|||+.   +|+||||||+|||
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL  225 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  225 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence             5 666665544 56799999999999998 421          12357999999999999999   9999999999999


Q ss_pred             EeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccC
Q 015395          215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS  256 (407)
Q Consensus       215 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  256 (407)
                      ++ ++.+||+|||+++.              +..++|||.+.
T Consensus       226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            99 99999999999863              45678999774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.2e-21  Score=179.45  Aligned_cols=136  Identities=21%  Similarity=0.189  Sum_probs=106.6

Q ss_pred             CCccceecccCceEEEEEEE-CCCCE--EEEEEeccCChh------------------------hHHHHHHHHHHHhcCC
Q 015395           81 FSDDKVIGEGGYGIVYYGLL-EDNSK--VAVKNLLNNRGQ------------------------AEREFKVEVEAIGRVR  133 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  133 (407)
                      |.+.+.||+|+||.||+|.. .+|..  ||||++......                        ....+..|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999997 67888  999986443111                        1235778999999998


Q ss_pred             CCcc--ceeeeeeecCCeeEEEEEeccC-C----ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCceec
Q 015395          134 HKNL--VRLLGYCAEGAHRMLVYEYVNN-G----NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH-EGLEPKVVH  205 (407)
Q Consensus       134 hpni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH  205 (407)
                      |+++  +.++++    ...+|||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8764  344432    356899999942 3    67766532       234456789999999999999 88   9999


Q ss_pred             cCCCCccEEEeCCCCcEEeecccceec
Q 015395          206 RDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       206 ~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=2.3e-18  Score=164.55  Aligned_cols=139  Identities=14%  Similarity=0.089  Sum_probs=99.9

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh--------------hhH--------HHHHHHHHHHhcCCC
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--------------QAE--------REFKVEVEAIGRVRH  134 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~h  134 (407)
                      ...-|.+.+.||.|+||.||+|...+|+.||||++.....              ...        .....|...|.++.+
T Consensus        93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            3334999999999999999999988899999998643210              000        112345556666644


Q ss_pred             Cccc--eeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCcc
Q 015395          135 KNLV--RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (407)
Q Consensus       135 pniv--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  212 (407)
                      .++.  ..+++    ...+|||||++|++|.++...          .....++.|++.+|.+||+.   |||||||||.|
T Consensus       173 ~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N  235 (397)
T 4gyi_A          173 EGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFN  235 (397)
T ss_dssp             TTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             cCCCCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence            3332  12221    123799999999888765421          12356889999999999999   99999999999


Q ss_pred             EEEeCCCC----------cEEeecccceec
Q 015395          213 ILIDKHWN----------PKVSDFGLAKLL  232 (407)
Q Consensus       213 ill~~~~~----------~kl~DfGla~~~  232 (407)
                      |||++++.          +.|+||+-+...
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99988763          789999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.4e-13  Score=125.82  Aligned_cols=144  Identities=15%  Similarity=0.047  Sum_probs=112.0

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ....|.+...++.|+.+.||++... ++.+++|............+..|+.+++.+. +..++++++++...+..|+|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            4467888899999999999998754 6889999876432122335778899888884 6778899999988889999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC------------------------------------
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL------------------------------------  199 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------  199 (407)
                      |++|.+|.+.+..         ......++.+++++|..||+..                                    
T Consensus        91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999876421         1123467889999999999810                                    


Q ss_pred             --------------------CCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          200 --------------------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       200 --------------------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                                          +..++|+|++|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                1358999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=2.5e-12  Score=116.88  Aligned_cols=137  Identities=18%  Similarity=0.119  Sum_probs=98.9

Q ss_pred             CCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc--cceeeeeeecCCeeEEEEEec
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++.+..+.+.|..+.||++...++..+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44444444456679999998777788999986543   2234667888888875434  566888888778899999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--------------------------------------
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--------------------------------------  199 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------  199 (407)
                      +|.+|.  ..       ....   ..++.++++.|..||+..                                      
T Consensus        98 ~G~~l~--~~-------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           98 PGQDLL--SS-------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             SSEETT--TS-------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CCcccC--cC-------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            998884  21       1221   256777788888888641                                      


Q ss_pred             -----------------CCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          200 -----------------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       200 -----------------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                                       +..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             11399999999999998876667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=3e-11  Score=115.51  Aligned_cols=145  Identities=12%  Similarity=0.128  Sum_probs=108.0

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEec--cCC-hhhHHHHHHHHHHHhcCC--CCccceeeeeeecC---CeeEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL--NNR-GQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEG---AHRML  152 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~---~~~~l  152 (407)
                      ...++.|+.|.++.||++... +..+++|+..  ... ......+..|+.+++.+.  +..+++++.++.+.   +..++
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            445678999999999998865 4678888665  322 123446778999998886  45678888888766   45899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC---------------------------------
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL---------------------------------  199 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------  199 (407)
                      ||||++|..+.+...      ..++......++.++++.|..||+..                                 
T Consensus       119 vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            999999987754221      34778888899999999999999731                                 


Q ss_pred             ----------------------CCceeccCCCCccEEEeCCCC--cEEeecccceec
Q 015395          200 ----------------------EPKVVHRDIKSSNILIDKHWN--PKVSDFGLAKLL  232 (407)
Q Consensus       200 ----------------------~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla~~~  232 (407)
                                            ...++|+|+++.|||++.++.  +.|+||+.+..-
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                  247999999999999987753  589999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.21  E-value=1e-11  Score=116.02  Aligned_cols=184  Identities=19%  Similarity=0.191  Sum_probs=122.9

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCc--cceeeeeeecCC---eeEEEEEe
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKN--LVRLLGYCAEGA---HRMLVYEY  156 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~e~  156 (407)
                      .++.++.|....||++.    ..+++|....  ......+..|+.+|+.+. +..  +.+++.......   ..|+||++
T Consensus        24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           24 TIEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eeEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            34669999999999763    5688997532  244567888999998773 332  445555443332   34889999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc--------------------------------------
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG--------------------------------------  198 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------------------  198 (407)
                      ++|.+|.+...      ..++..+...++.++++.|..||+.                                      
T Consensus        98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99988875433      2467777788888888888888861                                      


Q ss_pred             -----------------CCCceeccCCCCccEEEeC--CCCcEEeecccceecCCCCceeeeeeeccccc---cCccccC
Q 015395          199 -----------------LEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGSESSYITTRVMGTFGY---VAPEYAS  256 (407)
Q Consensus       199 -----------------~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~  256 (407)
                                       ....++|+|++|.||++++  +..+.|+||+.+..-.......     ....+   ..|+...
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHH
Confidence                             1235899999999999998  4567899999987643321100     00011   1222110


Q ss_pred             C-----CC---------CCcchhHHHHHHHHHHHHhCCCCC
Q 015395          257 T-----GM---------LNERSDVYSFGILIMEVISGRIPV  283 (407)
Q Consensus       257 ~-----~~---------~~~~sDiwslG~il~elltg~~Pf  283 (407)
                      .     ..         .....+.|+++.++|.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0     00         112368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=8.9e-08  Score=89.24  Aligned_cols=138  Identities=17%  Similarity=0.160  Sum_probs=97.5

Q ss_pred             ccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC---ccceeeeeee-cCCeeEEEEEecc
Q 015395           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK---NLVRLLGYCA-EGAHRMLVYEYVN  158 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~~~  158 (407)
                      .++.++.|....||+.    +..+++|+.  ........+..|+.+|+.+.+.   .+.+++.+.. ..+..++||||++
T Consensus        23 ~v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             CEEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            3567888999999987    567888874  2334456788899999988642   3566666663 4456789999999


Q ss_pred             CCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc----------------------------------------
Q 015395          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG----------------------------------------  198 (407)
Q Consensus       159 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------------  198 (407)
                      |.+|.+...      ..++......++.++++.|..||+.                                        
T Consensus        97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            988876432      1245555556666666666666642                                        


Q ss_pred             -----------------CCCceeccCCCCccEEEeC---CCCc-EEeecccceec
Q 015395          199 -----------------LEPKVVHRDIKSSNILIDK---HWNP-KVSDFGLAKLL  232 (407)
Q Consensus       199 -----------------~~~~ivH~Dlkp~Nill~~---~~~~-kl~DfGla~~~  232 (407)
                                       .+..++|+|+++.|||++.   ++.+ .|+||+.+..-
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             2235799999999999987   4554 89999987654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.58  E-value=2.9e-07  Score=83.81  Aligned_cols=135  Identities=16%  Similarity=0.102  Sum_probs=94.3

Q ss_pred             eecccCce-EEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEEEeccCCCh
Q 015395           86 VIGEGGYG-IVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        86 ~lg~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      .+..|..+ .||+.... ++..+++|.....   ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445444 68987754 4567899975432   3456778998888774 33367888888888999999999999888


Q ss_pred             HHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc--------------------------------------------
Q 015395          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG--------------------------------------------  198 (407)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------------------------  198 (407)
                      .+.....        ......+..+++..|.-||..                                            
T Consensus       108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            7655321        112234556666666666642                                            


Q ss_pred             -----------CCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          199 -----------LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       199 -----------~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                                 ....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       012379999999999999877677999997754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=1.7e-07  Score=89.05  Aligned_cols=81  Identities=11%  Similarity=0.030  Sum_probs=54.4

Q ss_pred             ccee-cccCceEEEEEEEC-------CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-C--CccceeeeeeecC--
Q 015395           84 DKVI-GEGGYGIVYYGLLE-------DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVR-H--KNLVRLLGYCAEG--  147 (407)
Q Consensus        84 ~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~--  147 (407)
                      .+.| +.|....+|+....       ++..+++|......   ......+..|+.+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999988754       25678888654322   001234566888887774 2  3567788776654  


Q ss_pred             -CeeEEEEEeccCCChHH
Q 015395          148 -AHRMLVYEYVNNGNLEQ  164 (407)
Q Consensus       148 -~~~~lv~e~~~~g~L~~  164 (407)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999998877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=5.2e-06  Score=78.02  Aligned_cols=143  Identities=17%  Similarity=0.238  Sum_probs=79.1

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC--CCccceeee------eeecCCeeEEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR--HKNLVRLLG------YCAEGAHRMLVYE  155 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~------~~~~~~~~~lv~e  155 (407)
                      .+.|+.|..+.||++...++ .+++|......    ..+..|..+++.+.  .-.+++++.      +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566677899999987644 58999876521    22333445444442  112344433      1234567899999


Q ss_pred             eccCCChH--------------HhhhC---CCC-CC------CCCCHHHH------------------------------
Q 015395          156 YVNNGNLE--------------QWLHG---DVG-PC------SPLTWEIR------------------------------  181 (407)
Q Consensus       156 ~~~~g~L~--------------~~l~~---~~~-~~------~~l~~~~~------------------------------  181 (407)
                      |++|..+.              ..+|.   ... +.      ..-.|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              11121   000 00      01122211                              


Q ss_pred             -HHHHHHHHHHHHhhhh----------cCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          182 -MNIILGTAKGLSYLHE----------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       182 -~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                       ..+...+..++.+|+.          ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             0111223345666653          1245899999999999998888999999997653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.20  E-value=5.4e-06  Score=79.95  Aligned_cols=76  Identities=14%  Similarity=0.138  Sum_probs=48.8

Q ss_pred             ccceecccCceEEEEEEEC-CCCEEEEEEeccCCh-------hhHHHHHHHHHHHhcCCC--C-ccceeeeeeecCCeeE
Q 015395           83 DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-------QAEREFKVEVEAIGRVRH--K-NLVRLLGYCAEGAHRM  151 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-niv~~~~~~~~~~~~~  151 (407)
                      ..+.||.|.++.||++... +++.+++|.......       .....+..|.++|+.+..  + .+++++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3567999999999999743 467899997643211       122345668888877632  3 34456544  344568


Q ss_pred             EEEEeccCC
Q 015395          152 LVYEYVNNG  160 (407)
Q Consensus       152 lv~e~~~~g  160 (407)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.19  E-value=8.1e-06  Score=75.06  Aligned_cols=82  Identities=17%  Similarity=0.210  Sum_probs=59.0

Q ss_pred             hcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC---CccceeeeeeecCCeeEEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH---KNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~~~~~lv  153 (407)
                      ......-++.+|.|..+.||+....+|+.|++|+...........+..|+..|+.|.-   --+++++++.    ..++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3445666788999999999999999999999997655444444567778888887742   1345555542    34789


Q ss_pred             EEeccCCCh
Q 015395          154 YEYVNNGNL  162 (407)
Q Consensus       154 ~e~~~~g~L  162 (407)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=3e-05  Score=72.15  Aligned_cols=141  Identities=16%  Similarity=0.144  Sum_probs=91.6

Q ss_pred             CccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCccceeeeeeecCCeeEEEEEecc
Q 015395           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYVN  158 (407)
Q Consensus        82 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~  158 (407)
                      .-.+.|+.|....+|+... ++..+++|.....   ....+..|+..|+.|.   ...+++++.+....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456799999999999875 4678889976432   3456778888888773   3568888888877788999999999


Q ss_pred             CCChH-----------HhhhCCCC--CC----------------CCCCHHHHH---HHHH----------------HHHH
Q 015395          159 NGNLE-----------QWLHGDVG--PC----------------SPLTWEIRM---NIIL----------------GTAK  190 (407)
Q Consensus       159 ~g~L~-----------~~l~~~~~--~~----------------~~l~~~~~~---~i~~----------------qi~~  190 (407)
                      +..+.           ..||....  ..                ..-+|....   ++..                .++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87652           12232211  00                012344322   1111                1111


Q ss_pred             HH-Hhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          191 GL-SYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       191 ~L-~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      .+ ..|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 23321 2256899999999999999887 8899974

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.95  E-value=6.6e-05  Score=65.02  Aligned_cols=103  Identities=17%  Similarity=0.095  Sum_probs=67.5

Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      -+|.+.|....   .++++.++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|+|.+.+ +.+.         
T Consensus        33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            37888887664   68999999999999999987762210  111233457899999999988764 1110         


Q ss_pred             eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 015395          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP  282 (407)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~P  282 (407)
                          .....+.+||... ...+.+.=|||||++||..+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1133567888763 4456788999999999998874443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.90  E-value=4.5e-05  Score=74.10  Aligned_cols=79  Identities=8%  Similarity=-0.009  Sum_probs=47.7

Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCC---CCcchhHHHHHHHHHHH
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEV  276 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~el  276 (407)
                      ...++|+|+++.|||++.++ ++|+||+.+..-............-...|++|+......   -....++..+...+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            34899999999999998876 999999988764322110000000123466666553211   12234556777777777


Q ss_pred             HhC
Q 015395          277 ISG  279 (407)
Q Consensus       277 ltg  279 (407)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.76  E-value=9.6e-05  Score=71.94  Aligned_cols=73  Identities=19%  Similarity=0.256  Sum_probs=48.8

Q ss_pred             cceecccCceEEEEEEECC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~  154 (407)
                      ++.|+.|....||++...+        +..+++|+.....  ....+..|..+++.+...++ +++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888899999998653        4788999774321  11344468888887743333 567766543    3899


Q ss_pred             EeccCCCh
Q 015395          155 EYVNNGNL  162 (407)
Q Consensus       155 e~~~~g~L  162 (407)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.70  E-value=0.00012  Score=67.55  Aligned_cols=140  Identities=14%  Similarity=0.093  Sum_probs=75.1

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEEEec-cCCC
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYV-NNGN  161 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~-~~g~  161 (407)
                      ++.|+.|....+|++     ..+++|+........ .....|+.+++.+...++ .+++++.  ...-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678999999999988     568888765432111 122346666666532222 4666543  33347899999 6655


Q ss_pred             hHH------------------hhhCCCCCCC-CCC-HHHHHHHHHH--------------HHHHHH----hhhh-cCCCc
Q 015395          162 LEQ------------------WLHGDVGPCS-PLT-WEIRMNIILG--------------TAKGLS----YLHE-GLEPK  202 (407)
Q Consensus       162 L~~------------------~l~~~~~~~~-~l~-~~~~~~i~~q--------------i~~~L~----~LH~-~~~~~  202 (407)
                      |..                  .+|....... ... +..+..+...              +...+.    .|.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            431                  1122110000 011 1111111111              111111    1111 12345


Q ss_pred             eeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       203 ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 56678899999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.66  E-value=0.00017  Score=68.90  Aligned_cols=143  Identities=15%  Similarity=0.125  Sum_probs=83.4

Q ss_pred             cceecccCceEEEEEEEC--------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++.|..|-...+|++...        ++..+++|+.-.. ......+.+|..+++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456777888999998864        2468899975222 223445567888888774 2223667766654    2999


Q ss_pred             EeccCCChHHh-----------------hhCCCCCC-CCC--CHHHHHHHHHHHHH-------------------HHHhh
Q 015395          155 EYVNNGNLEQW-----------------LHGDVGPC-SPL--TWEIRMNIILGTAK-------------------GLSYL  195 (407)
Q Consensus       155 e~~~~g~L~~~-----------------l~~~~~~~-~~l--~~~~~~~i~~qi~~-------------------~L~~L  195 (407)
                      ||++|.+|..-                 ||....+. ...  -+.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988665311                 12211111 112  24555556554422                   12222


Q ss_pred             h----hc-CCCceeccCCCCccEEEeCC----CCcEEeeccccee
Q 015395          196 H----EG-LEPKVVHRDIKSSNILIDKH----WNPKVSDFGLAKL  231 (407)
Q Consensus       196 H----~~-~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~~  231 (407)
                      .    .. .+..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    11 13468999999999999876    7899999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.63  E-value=0.00031  Score=65.69  Aligned_cols=143  Identities=15%  Similarity=0.080  Sum_probs=71.4

Q ss_pred             ceecccCceE-EEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC--CccceeeeeeecCCeeEEEEEeccCCC
Q 015395           85 KVIGEGGYGI-VYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        85 ~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      +.|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565565544 6666554467777775433221   222345555555531  23566666543333  78999997766


Q ss_pred             hHHhhhCC---------------------CCC-CCCCCHHHHH-------HHH-------------HHHHHHHHhhh---
Q 015395          162 LEQWLHGD---------------------VGP-CSPLTWEIRM-------NII-------------LGTAKGLSYLH---  196 (407)
Q Consensus       162 L~~~l~~~---------------------~~~-~~~l~~~~~~-------~i~-------------~qi~~~L~~LH---  196 (407)
                      +.+++...                     ... ...+......       .+.             ..+...+..+-   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65443211                     000 1112221100       000             01111122221   


Q ss_pred             hcCCCceeccCCCCccEEEeCC----CCcEEeecccceec
Q 015395          197 EGLEPKVVHRDIKSSNILIDKH----WNPKVSDFGLAKLL  232 (407)
Q Consensus       197 ~~~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~~~  232 (407)
                      ...+..++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1123479999999999999874    67899999988754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.54  E-value=0.0035  Score=58.01  Aligned_cols=145  Identities=14%  Similarity=0.097  Sum_probs=76.9

Q ss_pred             cceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc--cceeeee------eecCCeeEEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE  155 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~------~~~~~~~~lv~e  155 (407)
                      .+.|+.|....+|+....++ .+++|......  ....+..|+.+++.+...+  +.+++..      ....+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            34577788899999987655 68899775521  1123445666665553111  3333321      122356789999


Q ss_pred             eccCCChHH--------------hhhCC----CCCC-CCCC---HHHHHHH------------HHHHHHHHHhhhhc---
Q 015395          156 YVNNGNLEQ--------------WLHGD----VGPC-SPLT---WEIRMNI------------ILGTAKGLSYLHEG---  198 (407)
Q Consensus       156 ~~~~g~L~~--------------~l~~~----~~~~-~~l~---~~~~~~i------------~~qi~~~L~~LH~~---  198 (407)
                      |++|..+..              .++..    .... ....   |...+.-            ...+...++.+...   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            998865421              11211    0000 0011   2211100            01123344444422   


Q ss_pred             -CCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          199 -LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       199 -~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                       .+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             234799999999999999876568999987653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.53  E-value=0.0009  Score=62.24  Aligned_cols=143  Identities=15%  Similarity=0.134  Sum_probs=79.6

Q ss_pred             ceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ccceeeee-----eecCCeeEEEEEec
Q 015395           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGY-----CAEGAHRMLVYEYV  157 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~-----~~~~~~~~lv~e~~  157 (407)
                      ..|+ |....||++...+|+.+++|...... .....+..|..+++.+...  .+++++..     ....+..+++|+|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4577 88899998877667789999875331 1234555677777666321  23444443     12245668899999


Q ss_pred             cCCChH-----Hh---------hhC----CCC-CCCCCCHHHH----HHHH---------------HHHHHHHHhhhh--
Q 015395          158 NNGNLE-----QW---------LHG----DVG-PCSPLTWEIR----MNII---------------LGTAKGLSYLHE--  197 (407)
Q Consensus       158 ~~g~L~-----~~---------l~~----~~~-~~~~l~~~~~----~~i~---------------~qi~~~L~~LH~--  197 (407)
                      +|..+.     .+         +|.    ... ......+...    ..++               ..+...++.+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     00         111    000 0011222111    0000               011111222221  


Q ss_pred             --cCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          198 --GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       198 --~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                        ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1234789999999999999 4 899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.48  E-value=0.00021  Score=67.92  Aligned_cols=74  Identities=15%  Similarity=0.058  Sum_probs=43.2

Q ss_pred             cceecccCceEEEEEEECC---------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc-cceeeeeeecCCeeEEE
Q 015395           84 DKVIGEGGYGIVYYGLLED---------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv  153 (407)
                      .+.|+.|....+|++...+         +..+++|+....... ......|..+++.+...+ +.++++...    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            4567888889999998654         267888876443221 112345777777664223 446665442    2689


Q ss_pred             EEeccCCCh
Q 015395          154 YEYVNNGNL  162 (407)
Q Consensus       154 ~e~~~~g~L  162 (407)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.39  E-value=0.0015  Score=61.30  Aligned_cols=32  Identities=22%  Similarity=0.308  Sum_probs=28.0

Q ss_pred             CceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       201 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999877643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.38  E-value=0.00092  Score=65.44  Aligned_cols=74  Identities=12%  Similarity=0.060  Sum_probs=46.5

Q ss_pred             cceecccCceEEEEEEECC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc-ceeeeeeecCCeeEEEEEeccCCC
Q 015395           84 DKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNNGN  161 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~  161 (407)
                      ++.|+.|-...+|++...+ +..+++|+........ .....|..+++.|...++ +++++++. +   .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            4568888899999998764 4678888764322111 112468888887764444 56777663 2   35999998755


Q ss_pred             h
Q 015395          162 L  162 (407)
Q Consensus       162 L  162 (407)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.75  E-value=0.004  Score=60.18  Aligned_cols=142  Identities=13%  Similarity=0.142  Sum_probs=83.0

Q ss_pred             cceecccCceEEEEEEECC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++.|..|-...+|++...+        +..+++++..... .......+|..+++.+. +.-..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567778899999998653        5788998754332 11112345777777764 222456665432    27899


Q ss_pred             EeccCCChHHh-----------------hhCC-------CC--CCCCCCHHHHHHHHHHHH-------------------
Q 015395          155 EYVNNGNLEQW-----------------LHGD-------VG--PCSPLTWEIRMNIILGTA-------------------  189 (407)
Q Consensus       155 e~~~~g~L~~~-----------------l~~~-------~~--~~~~l~~~~~~~i~~qi~-------------------  189 (407)
                      ||++|.+|..-                 +|..       ..  ...+.-+..+.++..++-                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998664210                 1110       00  111223444444443321                   


Q ss_pred             HHHHhhhh---------------------cCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          190 KGLSYLHE---------------------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       190 ~~L~~LH~---------------------~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ..+..|..                     ..+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            12222221                     11336899999999999 7888999999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.03  E-value=0.13  Score=49.10  Aligned_cols=30  Identities=23%  Similarity=0.377  Sum_probs=24.9

Q ss_pred             ceeccCCCCccEEE------eCCCCcEEeeccccee
Q 015395          202 KVVHRDIKSSNILI------DKHWNPKVSDFGLAKL  231 (407)
Q Consensus       202 ~ivH~Dlkp~Nill------~~~~~~kl~DfGla~~  231 (407)
                      .++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      3456799999988754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.63  E-value=0.56  Score=40.36  Aligned_cols=115  Identities=10%  Similarity=0.145  Sum_probs=79.2

Q ss_pred             CCCccceeeeeeecCCeeEEEEEeccCC-ChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCc
Q 015395          133 RHKNLVRLLGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       133 ~hpniv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~  211 (407)
                      .||+++.. .+-.+.+.+.|.++.-+.+ ++.. +       ..++...+++++.+|+....+++.     -+|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence            57888866 4555666666666654322 2222 3       357889999999999998877664     367789999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD  284 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~  284 (407)
                      ||+++.++.+++.-.|+...                  ++|.     .++...=+-.+=|++..+++++..|+
T Consensus       109 NL~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987665322                  2222     12233334477888999999998884

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.58  E-value=1.6  Score=37.56  Aligned_cols=115  Identities=8%  Similarity=0.047  Sum_probs=77.7

Q ss_pred             CCCccceeeeeeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHH-hhhhcCCCceeccCCCCc
Q 015395          133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS-YLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       133 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~ivH~Dlkp~  211 (407)
                      .||++  -..+-.+.+.+.|.++.-+++.=...+.       .++...+++++.+|+.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57877  3334466677777777653332233342       4788999999999988777 6654     467778999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD  284 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~  284 (407)
                      ||+++.++.+++.-.|+-.                  -++|.-+     +..-=+-.+=|++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKE------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETT------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcc------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999998766532                  2333321     222223477788889999888874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	407
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 9e-72
 Identities = 70/285 (24%), Positives = 128/285 (44%), Gaps = 22/285 (7%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
           + E+     +  + IG G +G VY G    +  V + N+     Q  + FK EV  + + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           RH N++  +GY        +V ++    +L   LH              ++I   TA+G+
Sbjct: 62  RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGM 117

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-SYITTRVMGTFGYVA 251
            YLH      ++HRD+KS+NI + +    K+ DFGLA +    S S+   ++ G+  ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 252 PEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           PE          + +SDVY+FGI++ E+++G++P       +++  +             
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------R 224

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           G L P L +   S   K +  +   C+     +RP    ++  +E
Sbjct: 225 GYLSPDLSKVR-SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 1e-68
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 22/281 (7%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
           E EV        + +G G +G V+ G    ++KVAVK  L     +   F  E   + ++
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQL 65

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H+ LVRL     +     ++ EY+ NG+L  +L    G    LT    +++    A+G+
Sbjct: 66  QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           +++ E      +HRD++++NIL+    + K++DFGLA+L+                + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
           E  + G    +SDV+SFGIL+ E+++         P   +   E ++ +   R    V  
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLE--RGYRMVRP 232

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
              PE         +  +   C     + RP   ++  +LE
Sbjct: 233 DNCPE--------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-65
 Identities = 69/269 (25%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG G +G+V+ G   +  KVA+K  +     +E +F  E E + ++ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            E A   LV+E++ +G L  +L    G  +    E  + + L   +G++YL E     V+
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE---ACVI 123

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD+ + N L+ ++   KVSDFG+ + +  +    +T       + +PE  S    + +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           DV+SFG+L+ EV S       +R   E  ++E +                 P   ++ + 
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTG---------FRLYKPRLASTHVY 232

Query: 325 KRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +    +   C     + RP    ++  L 
Sbjct: 233 Q----IMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-65
 Identities = 58/269 (21%), Positives = 110/269 (40%), Gaps = 22/269 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V YG       VA+K ++     +E EF  E + +  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +     ++ EY+ NG L  +L            +  + +     + + YL      + +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFL 122

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD+ + N L++     KVSDFGL++ +  +    +        +  PE       + +S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           D+++FG+L+ E+ S         P E     E  + +         L    P   + ++ 
Sbjct: 183 DIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQG------LRLYRPHLASEKVY 231

Query: 325 KRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                +   C    A +RP    ++  + 
Sbjct: 232 T----IMYSCWHEKADERPTFKILLSNIL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 7e-65
 Identities = 70/292 (23%), Positives = 127/292 (43%), Gaps = 30/292 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG+G +G V+ G      +VAVK + ++R +     + E+     +RH+N++  +   
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 145 AEG----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL- 199
            +         LV +Y  +G+L  +L+        +T E  + + L TA GL++LH  + 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 200 ----EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVAP 252
               +P + HRD+KS NIL+ K+    ++D GLA    S +  I       +GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 253 EYASTGM------LNERSDVYSFGILIMEVISGRIP----VDYSRPPEEVNLIEWLKKMV 302
           E     +        +R+D+Y+ G++  E+           DY  P  ++   +   + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 303 TNRNPEGVLDPKLPEKPTSR-LLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                E  L P +P +  S   L+ +  +   C   N   R     +   L 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (524), Expect = 2e-64
 Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 39/303 (12%)

Query: 69  YTLRELEVSTNGFSD---------DKVIGEGGYGIVYYGLLEDNSK----VAVKNL-LNN 114
           +T  +   +   F+          ++VIG G +G V  G L+   K    VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
             +  R+F  E   +G+  H N++ L G   +    M++ E++ NG+L+ +L  + G   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
             T    + ++ G A G+ YL +      VHRD+ + NIL++ +   KVSDFGL++ L  
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 235 ESSYITTR----VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
           ++S  T            + APE          SDV+S+GI++ EV+S         P  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235

Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           ++   + +  +  +              P       +  + L C   +   RPK G +V+
Sbjct: 236 DMTNQDVINAIEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 351 MLE 353
            L+
Sbjct: 286 TLD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 6e-63
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 22/281 (7%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
             E+       +  +G+G +G V+ G     ++VA+K  L     +   F  E + + ++
Sbjct: 11  AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKL 69

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           RH+ LV+L    +E     +V EY++ G+L  +L G+ G    L     +++    A G+
Sbjct: 70  RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGM 126

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           +Y+        VHRD++++NIL+ ++   KV+DFGLA+L+                + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
           E A  G    +SDV+SFGIL+ E+ +            EV     L ++           
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRMP--CP 236

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           P+ PE         +  +  +C     ++RP   ++   LE
Sbjct: 237 PECPE--------SLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 1e-62
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 29/290 (10%)

Query: 72  RELEVSTNGFS-DDKVIGEGGYGIVYYGLLEDNSK---VAVKNLLNNRGQAERE-FKVEV 126
           ++L +  +     D  +G G +G V  G+     K   VA+K L     +A+ E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           + + ++ +  +VRL+G C +    MLV E    G L ++L G       +       ++ 
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VM 244
             + G+ YL E      VHRD+ + N+L+      K+SDFGL+K LG++ SY T R    
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
               + APE  +    + RSDV+S+G+ + E +S         P +++   E +  +   
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQG 228

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +  E    P+ P +     L  ++     C     + RP    V   + A
Sbjct: 229 KRME--CPPECPPE-----LYALM---SDCWIYKWEDRPDFLTVEQRMRA 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 44/304 (14%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGR 131
           +E+  + F     +G G  G+V+          +A K + L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
                +V   G         +  E+++ G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L+YL E  + K++HRD+K SNIL++     K+ DFG++  L      +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 171

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVD-------------------YSRPPEEV 292
           PE       + +SD++S G+ ++E+  GR P+                       PP   
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 293 NLIEWLKKMVTNRNPEGVL-----------DPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
                L     +  P   +            PKLP    S   +  +    +C+  N  +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV---NKCLIKNPAE 288

Query: 342 RPKM 345
           R  +
Sbjct: 289 RADL 292

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (508), Expect = 5e-62
 Identities = 73/311 (23%), Positives = 121/311 (38%), Gaps = 46/311 (14%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNL-LNNRGQAEREFK 123
           L  LE   N     + IGEG +G V+          E  + VAVK L        + +F+
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG--------------- 168
            E   +    + N+V+LLG CA G    L++EY+  G+L ++L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 169 -----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                      PL+   ++ I    A G++YL E    K VHRD+ + N L+ ++   K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181

Query: 224 SDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +DFGL++ + S   Y           ++ PE          SDV+++G+++ E+ S  + 
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
             Y    EEV                 V D  +   P       +  +   C       R
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADR 286

Query: 343 PKMGHVVHMLE 353
           P    +  +L+
Sbjct: 287 PSFCSIHRILQ 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-61
 Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 45/309 (14%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK------VAVKNLLNNRGQAERE-FKVEVE 127
           E         KV+G G +G V        SK      VAVK L      +ERE    E++
Sbjct: 33  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92

Query: 128 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS------------ 174
            + ++  H+N+V LLG C       L++EY   G+L  +L       S            
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 175 -------PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
                   LT+E  +      AKG+ +L        VHRD+ + N+L+      K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 228 LAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
           LA+ + S+S+Y+          ++APE    G+   +SDV+S+GIL+ E+ S  +     
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---- 265

Query: 287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
            P   + +     K++ N           P   T  +      +   C   +++KRP   
Sbjct: 266 -PYPGIPVDANFYKLIQNG-----FKMDQPFYATEEIYI----IMQSCWAFDSRKRPSFP 315

Query: 347 HVVHMLEAQ 355
           ++   L  Q
Sbjct: 316 NLTSFLGCQ 324

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  197 bits (501), Expect = 4e-61
 Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 24/293 (8%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGR 131
           + E+     +    +G G YG VY G+ +  S  VAVK L  +  + E EF  E   +  
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           ++H NLV+LLG C       ++ E++  GNL  +L         ++  + + +    +  
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + YL +      +HRD+ + N L+ ++   KV+DFGL++L+  ++            + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           PE  +    + +SDV++FG+L+ E+ +  +         +V  +               L
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------------L 229

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA--QESPSKED 362
           +     +      +++  +   C   N   RP    +    E   QES   ++
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-61
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 29/287 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRGQAER-EFKVEVEA 128
           E+  +  +  KVIG G +G VY G+L+ +S      VA+K L     + +R +F  E   
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           +G+  H N++RL G  ++    M++ EY+ NG L+++L          +    + ++ G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGT 246
           A G+ YL        VHRD+ + NIL++ +   KVSDFGL+++L    E++Y T+     
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
             + APE  S       SDV+SFGI++ EV++      +     EV              
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            + + D      P       I  + ++C      +RPK   +V +L+
Sbjct: 223 MKAINDGFRLPTP-MDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 2e-60
 Identities = 71/280 (25%), Positives = 114/280 (40%), Gaps = 28/280 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
            ++       + IG+G +G V  G     +KVAVK +        + F  E   + ++RH
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
            NLV+LLG   E    + +V EY+  G+L  +L       S L  +  +   L   + + 
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YL        VHRD+ + N+L+ +    KVSDFGL K   S              + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPE 170

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  + +SDV+SFGIL+ E+ S         P   + L + + ++      +     
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMD----- 220

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
             P+     + +    V   C   +A  RP    +   LE
Sbjct: 221 -APDGCPPAVYE----VMKNCWHLDAAMRPSFLQLREQLE 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 6e-60
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 30/290 (10%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLV 138
           ++VIG G +G VY+G L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 139 RLLGYCAEG-AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ +L  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 148

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEY 254
               K VHRD+ + N ++D+ +  KV+DFGLA+ +  +   S +  T       ++A E 
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
             T     +SDV+SFG+L+ E+++   P     P  +VN  +    ++  R         
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL------ 254

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEDRY 364
            PE     L +    V L+C  P A+ RP    +V  + A  S    + Y
Sbjct: 255 QPEYCPDPLYE----VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 4e-59
 Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 40/311 (12%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAERE-FKV 124
            + E   N  S  K +G G +G V           +    VAVK L  +    ERE    
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 125 EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS--------- 174
           E++ +  +  H N+V LLG C  G   +++ EY   G+L  +L                 
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 175 -----PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA 229
                 L  E  ++     AKG+++L        +HRD+ + NIL+      K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 230 KLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           + + ++S+Y +         ++APE     +    SDV+S+GI + E+ S         P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
            +         KM+             PE   + +      +   C D +  KRP    +
Sbjct: 253 VD-----SKFYKMIKEG-----FRMLSPEHAPAEMYD----IMKTCWDADPLKRPTFKQI 298

Query: 349 VHMLEAQESPS 359
           V ++E Q S S
Sbjct: 299 VQLIEKQISES 309

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 6e-59
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 32/279 (11%)

Query: 83  DDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLN--NRGQAEREFKVEVEAIGRVRHKNL 137
           +DK +G G +G V  G  +       VAVK L N  N    + E   E   + ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VR++G C E    MLV E    G L ++L         +  +  + ++   + G+ YL E
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYA 255
                 VHRD+ + N+L+      K+SDFGL+K L ++ +Y   +        + APE  
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E  ++              
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------MG 230

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            P      +      +   C   + + RP    V   L 
Sbjct: 231 CPAGCPREMYD----LMNLCWTYDVENRPGFAAVELRLR 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 8e-59
 Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 24/272 (8%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
             IG G YG         D   +  K  +  +     ++    EV  +  ++H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 142 GYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
               +  +  L  V EY   G+L   +         L  E  + ++      L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 200 E--PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
           +    V+HRD+K +N+ +D   N K+ DFGLA++L  ++S+     +GT  Y++PE  + 
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
              NE+SD++S G L+ E+ +   P          +  E   K+   +     +  +  +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKFRR--IPYRYSD 240

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           +     L  I+    R ++     RP +  ++
Sbjct: 241 E-----LNEII---TRMLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 2e-58
 Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 34/272 (12%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKN 136
           FSD + IG G +G VY+   + ++  VA+K +        +  ++   EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            ++  G         LV EY      +           PL       +  G  +GL+YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 ++HRD+K+ NIL+ +    K+ DFG A ++           +GT  ++APE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 257 T---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
               G  + + DV+S GI  +E+   +       P   +N +  L  +  N        P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE------SP 232

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
            L     S   +  +     C+    Q RP  
Sbjct: 233 ALQSGHWSEYFRNFV---DSCLQKIPQDRPTS 261

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 64/296 (21%), Positives = 119/296 (40%), Gaps = 37/296 (12%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK---VAVKNL-LNNRGQAEREFKVEVEAIG 130
            +  N      VIGEG +G V    ++ +      A+K +         R+F  E+E + 
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 131 RV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG------------DVGPCSPLT 177
           ++  H N++ LLG C    +  L  EY  +GNL  +L                   S L+
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
            +  ++     A+G+ YL +    + +HRD+ + NIL+ +++  K++DFGL++       
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW 297
              T       ++A E  +  +    SDV+S+G+L+ E++S         P   +   E 
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAEL 235

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +K+      E       P      +      +  +C      +RP    ++  L 
Sbjct: 236 YEKLPQGYRLE------KPLNCDDEVYD----LMRQCWREKPYERPSFAQILVSLN 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-56
 Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 38/285 (13%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLN---NRGQAEREFKV 124
           + L + E+        + +G+G +G VY     +    +A+K L      +   E + + 
Sbjct: 3   WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE    +RH N++RL GY  +     L+ EY   G + + L       S    +     
Sbjct: 56  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           I   A  LSY H     +V+HRDIK  N+L+      K++DFG +    S      T + 
Sbjct: 112 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLC 165

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           GT  Y+ PE     M +E+ D++S G+L  E + G+ P + +   E    I         
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------- 218

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
                 ++   P+   +   + ++    R +  N  +RP +  V+
Sbjct: 219 ------VEFTFPDF-VTEGARDLI---SRLLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-56
 Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 29/280 (10%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNS-----KVAVKNL-LNNRGQAEREFKVEVEAIGRVRH 134
           F   KV+G G +G VY GL           VA+K L      +A +E   E   +  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            ++ RLLG C       L+ + +  G L  ++            +  +N  +  AKG++Y
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPE 253
           L +    ++VHRD+ + N+L+    + K++DFGLAKLLG+ E  Y          ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                +   +SDV+S+G+ + E+++         P + +   E    +           P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLP--QPP 236

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                        + ++ ++C   +A  RPK   ++    
Sbjct: 237 ICTID--------VYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 31/275 (11%)

Query: 84  DKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRL 140
           D  IG G +  VY GL  E   +VA   L + +      + FK E E +  ++H N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 141 LGYCAEGA----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
                         +LV E + +G L+ +L         +  ++  +      KGL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129

Query: 197 EGLEPKVVHRDIKSSNILI-DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
               P ++HRD+K  NI I     + K+ D GLA L  +        V+GT  ++APE  
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMY 185

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL 315
                +E  DVY+FG+ ++E+ +   P  YS       +   +   V          P  
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGV---------KPAS 233

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
            +K     +K I+     C+  N  +R  +  +++
Sbjct: 234 FDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 27/287 (9%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS----KVAVKNLLNNRGQAERE-FKVEVE 127
           + E+        + IGEG +G V+ G+          VA+K   N    + RE F  E  
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
            + +  H ++V+L+G   E     ++ E    G L  +L         L     +     
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQ 116

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            +  L+YL      + VHRDI + N+L+  +   K+ DFGL++ +   + Y  ++     
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            ++APE  +       SDV+ FG+ + E++   +      P + V   + + ++      
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERL 228

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
              + P  P       L  ++    +C   +  +RP+   +   L  
Sbjct: 229 P--MPPNCPPT-----LYSLM---TKCWAYDPSRRPRFTELKAQLST 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 9e-56
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 27/267 (10%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G+G +G VY     E +   A K +     +   ++ VE++ +    H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                +  ++ E+   G ++  +        PLT      +   T   L+YLH   + K+
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML--- 260
           +HRD+K+ NIL     + K++DFG++           + + GT  ++APE          
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190

Query: 261 --NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
             + ++DV+S GI ++E+     P        E+N +  L K+  +  P      +    
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 319 PTSRLLKRILLVALRCVDPNAQKRPKM 345
                 K  L    +C++ N   R   
Sbjct: 245 -----FKDFL---KKCLEKNVDARWTT 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-55
 Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 31/281 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK----VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNL 137
           + +G+G +G+V  G  +  S     VAVK L   + ++ +A  +F  EV A+  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +RL G       +M V E    G+L   L    G              +  A+G+ YL  
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYA 255
               + +HRD+ + N+L+      K+ DFGL + L     +  +       F + APE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL 315
            T   +  SD + FG+ + E+ +         P   +N  + L K+              
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGER-----LPR 236

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML-EAQ 355
           PE     +      V ++C     + RP    +   L EAQ
Sbjct: 237 PEDCPQDIYN----VMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 69/317 (21%), Positives = 142/317 (44%), Gaps = 33/317 (10%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-E 121
           Y   E EV+    +  + +G+G +G+VY G+       E  ++VA+K +       ER E
Sbjct: 10  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------GDVGPCSP 175
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L        +    +P
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            +    + +    A G++YL+     K VHRD+ + N ++ + +  K+ DFG+ + +   
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 236 SSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
             Y    + +    +++PE    G+    SDV+SFG+++ E+ +         P + ++ 
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSN 241

Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            + L+          V++  L +KP       +  +   C   N + RP    ++  ++ 
Sbjct: 242 EQVLRF---------VMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291

Query: 355 QESPS-KEDRYRASPKN 370
           +  P  +E  +  S +N
Sbjct: 292 EMEPGFREVSFYYSEEN 308

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-54
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 24/262 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + IG+G  G VY  + +    +VA++ +   +   +     E+  +   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
              G    +V EY+  G+L   +       + +       +     + L +LH     +V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +      +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196

Query: 264 SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D++S GI+ +E+I G  P          N +  L  + TN  PE     KL       +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSA-----I 245

Query: 324 LKRILLVALRCVDPNAQKRPKM 345
            +  L    RC+D + +KR   
Sbjct: 246 FRDFL---NRCLDMDVEKRGSA 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 29/276 (10%)

Query: 81  FSDD----KVIGEGGYGIVYYG-LLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRH 134
           F +D    + +GEG YG V           VAVK + +          K E+     + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           +N+V+  G+  EG  + L  EY + G L   +  D+G    +              G+ Y
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVY 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPE 253
           LH      + HRDIK  N+L+D+  N K+SDFGLA +    +   +  ++ GT  YVAPE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 254 YASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                  + E  DV+S GI++  +++G +P D      +       KK   N        
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-------- 227

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
              P K        +L    + +  N   R  +  +
Sbjct: 228 ---PWKKIDSAPLALL---HKILVENPSARITIPDI 257

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 39/307 (12%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAE-RE 121
           Y   + E   +     K +G G +G V                VAVK L      +E R 
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62

Query: 122 FKVEVEAIGR-VRHKNLVRLLGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVGPCSP---- 175
              E++ +     H N+V LLG C + G   M++ E+   GNL  +L        P    
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 176 --------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
                   LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 228 LAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
           LA+ +  +  Y+          ++APE     +   +SDV+SFG+L+ E+ S        
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---- 235

Query: 287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
            P   V + E   + +           + P+  T  + +      L C      +RP   
Sbjct: 236 -PYPGVKIDEEFCRRLKEGTR-----MRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFS 285

Query: 347 HVVHMLE 353
            +V  L 
Sbjct: 286 ELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 8e-52
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 41/302 (13%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAE-REFKVE 125
           E+  +     K +GEG +G V                +KVAVK L ++  + +  +   E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68

Query: 126 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------------GDVGP 172
           +E +  + +HKN++ LLG C +     ++ EY + GNL ++L                 P
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              L+ +  ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 233 GSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE 291
                Y  T        ++APE     +   +SDV+SFG+L+ E+ +          P  
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYP 239

Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
              +E L K++   +         P   T+ L      +   C      +RP    +V  
Sbjct: 240 GVPVEELFKLLKEGHR-----MDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQLVED 290

Query: 352 LE 353
           L+
Sbjct: 291 LD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  172 bits (438), Expect = 5e-51
 Identities = 53/264 (20%), Positives = 108/264 (40%), Gaps = 24/264 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + +G G +G+V+        +  A K ++      +   + E++ +  +RH  LV L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +    +++YE+++ G L + +  +      ++ +  +  +    KGL ++HE      
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NY 145

Query: 204 VHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           VH D+K  NI+     +   K+ DFGL   L  + S   T   GT  + APE A    + 
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVG 203

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
             +D++S G+L   ++SG  P       E +  +         ++ +  +D        S
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---------KSCDWNMDDSAFSG-IS 253

Query: 322 RLLKRILLVALRCVDPNAQKRPKM 345
              K  +    + +  +   R  +
Sbjct: 254 EDGKDFI---RKLLLADPNTRMTI 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 9e-49
 Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 29/279 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKNLVRL 140
           K++GEG +  V     L  + + A+K L       E        E + + R+ H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                +         Y  NG L +++                         L YLH    
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG--- 126

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGM 259
             ++HRD+K  NIL+++  + +++DFG AK+L  ES        +GT  YV+PE  +   
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
             + SD+++ G +I ++++G        P    N     +K++        L+   PEK 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIK-------LEYDFPEK- 232

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP 358
                + ++    + +  +A KR     +      +  P
Sbjct: 233 FFPKARDLV---EKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  165 bits (419), Expect = 3e-48
 Identities = 54/285 (18%), Positives = 106/285 (37%), Gaps = 28/285 (9%)

Query: 68  WYTLRELEVSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREF 122
            Y  + +EV      D     + +G G +G+V+  +          K +       +   
Sbjct: 14  KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 73

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           K E+  + ++ H  L+ L     +    +L+ E+++ G L   +  +      ++    +
Sbjct: 74  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVI 130

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYIT 240
           N +    +GL ++HE     +VH DIK  NI+ +       K+ DFGLA  L  +   I 
Sbjct: 131 NYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 185

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
                T  + APE      +   +D+++ G+L   ++SG  P       E +  +     
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV----- 240

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
               +  +   D        S   K  +      +    +KR  +
Sbjct: 241 ----KRCDWEFDEDAFSS-VSPEAKDFI---KNLLQKEPRKRLTV 277

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  161 bits (408), Expect = 2e-47
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 31/287 (10%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVR 133
           ++ +   +++G GG   V+    L  +  VAVK L   L         F+ E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 134 HKNLVRLLGYCAE----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           H  +V +          G    +V EYV+   L   +H       P+T +  + +I    
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI--TTRVMGTF 247
           + L++ H+     ++HRD+K +NI+I      KV DFG+A+ +    + +  T  V+GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE A    ++ RSDVYS G ++ EV++G  P     P            +  +  P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDPIP 233

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHMLE 353
                  L        L  ++   L+ +  N + R +    +   L 
Sbjct: 234 PSARHEGLSAD-----LDAVV---LKALAKNPENRYQTAAEMRADLV 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (411), Expect = 5e-47
 Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 32/279 (11%)

Query: 77  STNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV 132
           + N FS  ++IG GG+G VY     +     A+K L   R    Q E     E   +  V
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 133 R---HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
                  +V +            + + +N G+L   L                 I     
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI----I 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
            GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +        +GT GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGY 171

Query: 250 VAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           +APE    G+  +  +D +S G ++ +++ G  P    +  ++  +      M       
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH 347
                +LP+   S  L+ +L      +  +  +R     
Sbjct: 225 ---AVELPDS-FSPELRSLL---EGLLQRDVNRRLGCLG 256

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 46/264 (17%), Positives = 102/264 (38%), Gaps = 25/264 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + +G G +GIV+  +          K  +  +G  +   K E+  +   RH+N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                  ++++E+++  ++ + ++        L     ++ +    + L +LH      +
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNI 123

Query: 204 VHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            H DI+  NI+     +   K+ +FG A+ L    ++          Y APE     +++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVS 181

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
             +D++S G L+  ++SG  P       + +  I          N E   D +  ++  S
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---------MNAEYTFDEEAFKE-IS 231

Query: 322 RLLKRILLVALRCVDPNAQKRPKM 345
                 +    R +    + R   
Sbjct: 232 IEAMDFV---DRLLVKERKSRMTA 252

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 30/264 (11%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGRV-RHKNLVR 139
           K++G+G +G V+     + N   A+K L  +    + +     VE   +     H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           +        +   V EY+N G+L   +      C                 GL +LH   
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-- 121

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +V+RD+K  NIL+DK  + K++DFG+ K      +   T   GT  Y+APE      
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQK 179

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            N   D +SFG+L+ E++ G+ P       E   L   ++            +P  P   
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMD----------NPFYPRW- 225

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
             +  K +L   ++      +KR 
Sbjct: 226 LEKEAKDLL---VKLFVREPEKRL 246

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (391), Expect = 8e-45
 Identities = 52/275 (18%), Positives = 106/275 (38%), Gaps = 21/275 (7%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + IGEG YG+VY          A+K   L             E+  +  ++H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                   +LV+E+++    +     +      L      + +L    G++Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RR 120

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           V+HRD+K  N+LI++    K++DFGLA+  G      T  ++  +         +   + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--------PK 314
             D++S G +  E+++G          +++  I  +     ++N   V +          
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 315 LPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
               P    LK +    +    + +  +  +R   
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 8e-45
 Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 27/279 (9%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAI 129
           ++ E   + +    V+G G +  V           VA+K +     + +    + E+  +
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
            +++H N+V L      G H  L+ + V+ G L   +          T      +I    
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVL 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             + YLH   +  +VHRD+K  N+L    D+     +SDFGL+K+    S  + +   GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGT 172

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
            GYVAPE  +    ++  D +S G++   ++ G  P       +    I           
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI---------LK 223

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
            E   D    +   S   K  +      ++ + +KR   
Sbjct: 224 AEYEFDSPYWDD-ISDSAKDFI---RHLMEKDPEKRFTC 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 8e-45
 Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 45/287 (15%)

Query: 81  FSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNL---------LNNRGQAEREFKVEV 126
           F ++    +++G G   +V   +      + AVK +              +       EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 127 EAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           + + +V  H N+++L           LV++ +  G L  +L   V     L+ +    I+
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIM 116

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
               + +  LH+     +VHRD+K  NIL+D   N K++DFG +  L          V G
Sbjct: 117 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCG 171

Query: 246 TFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  Y+APE     M +         D++S G+++  +++G  P  + +    + +I    
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--- 228

Query: 300 KMVTNRNPEGVLDPKLPEKPT-SRLLKRILLVALRCVDPNAQKRPKM 345
                    G      PE    S  +K ++    R +    QKR   
Sbjct: 229 --------SGNYQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTA 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 62/279 (22%), Positives = 118/279 (42%), Gaps = 39/279 (13%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNL---LNNRGQAEREFKV 124
           Y+L++ ++        + +G G +G V+      +    A+K L   +  R +       
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E   +  V H  ++R+ G   +     ++ +Y+  G L   L       +P+       +
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
                     L       +++RD+K  NIL+DK+ + K++DFG AK +       T  + 
Sbjct: 114 -------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLC 162

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           GT  Y+APE  ST   N+  D +SFGILI E+++G        P  + N ++  +K++  
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNA 216

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                  + + P    +  +K +L    R +  +  +R 
Sbjct: 217 -------ELRFPPF-FNEDVKDLL---SRLITRDLSQRL 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 4e-43
 Identities = 49/280 (17%), Positives = 97/280 (34%), Gaps = 29/280 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + IG G +G +Y G  +    +VA+K           +  +E +    ++    +  + +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 144 C-AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C AEG + ++V E +     + +           + +  + +       + Y+H      
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KN 123

Query: 203 VVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYI------TTRVMGTFGYVAPE 253
            +HRD+K  N L+    K     + DFGLAK      ++          + GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  + R D+ S G ++M    G +P    +   +    E + +      P  VL  
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMSTPIEVLCK 242

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
             P +         L     C       +P   ++  +  
Sbjct: 243 GYPSE-----FATYL---NFCRSLRFDDKPDYSYLRQLFR 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-43
 Identities = 56/280 (20%), Positives = 105/280 (37%), Gaps = 21/280 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL 137
           F   + IGEG YG+VY          VA+K   L             E+  +  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           V+LL          LV+E+++    +     D    + +   +  + +    +GL++ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+  +          
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD----- 312
              +   D++S G +  E+++ R         +++  I             GV       
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 313 ---PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
              PK   +  S+++  +         + +  +  KR   
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 33/285 (11%)

Query: 74  LEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           L++  N   DD     +V+G G  G V          K A+K +L +  +A RE ++   
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 60

Query: 128 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           A    +  ++VR++       A     ++V E ++ G L   +          T      
Sbjct: 61  AS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASE 115

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L          K++DFG AK   S +S  T
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
                T  YVAPE       ++  D++S G+++  ++ G  P   +       +   +K 
Sbjct: 173 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKT 227

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
            +     E    P       S  +K ++      +     +R  +
Sbjct: 228 RIRMGQYE---FPNPEWSEVSEEVKMLI---RNLLKTEPTQRMTI 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 61/287 (21%), Positives = 121/287 (42%), Gaps = 23/287 (8%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHK 135
              +++   IGEG YG+V       +  +VA+K +     Q   +    E++ + R RH+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N++ +           +   Y+    +   L+  +     L+ +     +    +GL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPE 253
           H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 254 YASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                    +S D++S G ++ E++S R         +++N I  +    +  +   +++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 313 ----------PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
                     P   + P +RL       AL    + +  N  KR ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 65/306 (21%), Positives = 116/306 (37%), Gaps = 32/306 (10%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
             +GEG +  VY       N  VA+K     +    +    R    E++ +  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL      ++  LV++++                  LT       +L T +GL YLH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               ++HRD+K +N+L+D++   K++DFGLAK  GS +   T +V  T  Y APE     
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 259 ML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-------NRNPEGV 310
            +     D+++ G ++ E++     +      +++  I       T          P+ V
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 311 LDPKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKMGHVVHMLEAQESPSKEDRYRA 366
                P  P   +        L         N   R          +A +     +R   
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT------ATQALKMKYFSNRPGP 289

Query: 367 SPKNEL 372
           +P  +L
Sbjct: 290 TPGCQL 295

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-42
 Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 29/283 (10%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           ++D KVIG G +G+VY   L +    VA+K +L ++    RE    ++ + ++ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 77

Query: 140 LLGYCAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           L  +      +       LV +YV         H        L        +    + L+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLA 136

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           Y+H      + HRDIK  N+L+D      K+ DFG AK L        + +   +     
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 192

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-------NR 305
                       DV+S G ++ E++ G+         +++  I  +    T       N 
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 306 NPEGVLDPKLPEKPTSRLLKRIL---LVAL--RCVDPNAQKRP 343
           N      P++   P +++ +       +AL  R ++     R 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 33/272 (12%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL------LNNRGQAEREFKVEVEAIGRVRHKNL 137
           + +G G + +V          + A K +       + RG +  + + EV  +  ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           + L          +L+ E V  G L  +L         LT E     +     G+ YLH 
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH- 130

Query: 198 GLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
               ++ H D+K  NI++     P    K+ DFGLA  +   + +    + GT  +VAPE
Sbjct: 131 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 186

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
             +   L   +D++S G++   ++SG  P       E +  +  +     +         
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT--- 243

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                  S L K  +    R +  + +KR  +
Sbjct: 244 -------SALAKDFI---RRLLVKDPKKRMTI 265

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-41
 Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 24/280 (8%)

Query: 85  KVIGEGGYGIVYYG--LLEDNSKVAVKNLLNNRGQAEREFKVEVEA-----IGRVRHKNL 137
             IGEG YG V+    L      VA+K +    G+         E      +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQW--LHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           VRL   C            +   +++Q    + D  P   +  E   +++    +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           H     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  Y APE  
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI----------EWLKKMVTNR 305
                    D++S G +  E+   +     S   +++  I          +W + +   R
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                   +  EK  + + +    + L+C+  N  KR   
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 1e-40
 Identities = 47/282 (16%), Positives = 95/282 (33%), Gaps = 31/282 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLG 142
           + IGEG +G+++ G  L +N +VA+K     R     + + E      +     +  +  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           +  EG H +LV + +     +             + +            +  +HE     
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 203 VVHRDIKSSNILIDKHWNP-----KVSDFGLAKLLGSESS------YITTRVMGTFGYVA 251
           +V+RDIK  N LI +  +       V DFG+ K      +           + GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
                    + R D+ + G + M  + G +P    +        E + +   +      L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-EL 240

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
               PE+       + +       +      P   ++  +  
Sbjct: 241 CAGFPEE-----FYKYM---HYARNLAFDATPDYDYLQGLFS 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 7e-40
 Identities = 65/275 (23%), Positives = 100/275 (36%), Gaps = 29/275 (10%)

Query: 76  VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGR 131
           V+ N F   K++G+G +G V            A+K L      A+ E      E   +  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
            RH  L  L            V EY N G L   L          T E            
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSA 117

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ +       GT  Y+A
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           PE           D +  G+++ E++ GR       P    +     + ++         
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME------- 220

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
           + + P    S   K +L      +  + ++R   G
Sbjct: 221 EIRFPRT-LSPEAKSLL---AGLLKKDPKQRLGGG 251

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 55/277 (19%), Positives = 104/277 (37%), Gaps = 23/277 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           + IGEG YG V+     E +  VA+K   L ++          E+  +  ++HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                     LV+E+ +    + +   +         EI  + +    KGL + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            V+HRD+K  N+LI+++   K+++FGLA+  G      +  V+  +           + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIEWLKKMVTNRNPEGVLDPKLPEKP 319
              D++S G +  E+ +   P+      ++    +   L      + P     P     P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 320 TSRLLKRILLVA-----------LRCVDPNAQKRPKM 345
                  ++ V               +  N  +R   
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 4e-37
 Identities = 57/291 (19%), Positives = 112/291 (38%), Gaps = 37/291 (12%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNLL--NNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
             IG+G +G V+     +   KVA+K +L  N +         E++ +  ++H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 142 GYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
             C   A           LV+++  +       +  V         +   +       L+
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-------LN 128

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITTRVMGTFGYV 250
            L+     K++HRD+K++N+LI +    K++DFGLA+      +      T  + T  Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 251 APEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
            PE            D++  G ++ E+ +    +  +    ++ LI  L   +T      
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 310 VLDPKLPE-----KPTSRLLKRILLVAL----------RCVDPNAQKRPKM 345
           V + +L E     K   R +K  L   +          + +  +  +R   
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-36
 Identities = 53/298 (17%), Positives = 114/298 (38%), Gaps = 27/298 (9%)

Query: 69  YTLRELEVSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAERE 121
           +  +E+  +           + +G G YG V   +     +KVA+K            + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
              E+  +  +RH+N++ LL             ++           G +     L  +  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
             ++    KGL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   SE   +T 
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTG 177

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            V+  +        +     +  D++S G ++ E+I+G+     S   +++  I  +   
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 302 VTNRNPEGVLD----------PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
                 + +            P+L +K  + +L     +A+    + +  +A++R   
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 43/272 (15%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVR--HK 135
            ++G GG+G VY G+ + DN  VA+K++  +R     E        +EV  + +V     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
            ++RLL +       +L+ E             + G    L  E+  +      + + + 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHC 126

Query: 196 HEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           H      V+HRDIK  NILID +    K+ DFG   LL      + T   GT  Y  PE+
Sbjct: 127 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEW 180

Query: 255 ASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                 + RS  V+S GIL+ +++ G IP ++        +                   
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF---------------FRQ 225

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
           ++  +      + ++     C+      RP  
Sbjct: 226 RVSSE-----CQHLI---RWCLALRPSDRPTF 249

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-34
 Identities = 64/283 (22%), Positives = 120/283 (42%), Gaps = 31/283 (10%)

Query: 76  VSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNL----LNNRGQAEREFKVEVE 127
           V    F   KV+G G YG V+        +     A+K L    +  + +     + E +
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 128 AIGRVRHK-NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
            +  +R    LV L           L+ +Y+N G L   L          T       + 
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVG 136

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
                L +LH+     +++RDIK  NIL+D + +  ++DFGL+K   ++ +       GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193

Query: 247 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
             Y+AP+    G    ++  D +S G+L+ E+++G  P  ++   E+ +  E  ++++ +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH 347
                  +P  P++  S L K ++    R +  + +KR   G 
Sbjct: 252 -------EPPYPQE-MSALAKDLI---QRLLMKDPKKRLGCGP 283

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 8e-34
 Identities = 63/281 (22%), Positives = 103/281 (36%), Gaps = 32/281 (11%)

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE---FK 123
           W T  +     + F   K +G G +G V      E  +  A+K L   +    ++     
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            E   +  V    LV+L     + ++  +V EYV  G +   L          +      
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARF 145

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                     YLH      +++RD+K  N+LID+    +V+DFG AK         T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTL 198

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
            GT   +APE   +   N+  D ++ G+LI E+ +G  P    +P +    I   K    
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---- 254

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
                     + P    S  LK +L      +  +  KR  
Sbjct: 255 ---------VRFPSH-FSSDLKDLL---RNLLQVDLTKRFG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 52/276 (18%), Positives = 109/276 (39%), Gaps = 23/276 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
             +G G YG V      +   +VAVK  +         +    E+  +  ++H+N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                        +     +L      ++  C  LT +    +I    +GL Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            ++HRD+K SN+ +++    K+ DFGLA+    E   +T  V   +        +    N
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYN 197

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--------- 312
           +  D++S G ++ E+++GR     +   +++ LI  L         + +           
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257

Query: 313 -PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRP 343
             ++P+   + +      +A+    + +  ++ KR 
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 25/261 (9%)

Query: 68  WYTLRELEVSTNGFSD---DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK 123
           ++      V      D    + +G G Y  V+  + + +N KV VK L   +   +++ K
Sbjct: 21  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 77

Query: 124 VEVEAIGRVR-HKNLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
            E++ +  +R   N++ L     +   R   LV+E+VNN + +Q           LT   
Sbjct: 78  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYD 130

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYI 239
               +    K L Y H      ++HRD+K  N++ID +H   ++ D+GLA+       Y 
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 240 TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
               + +  +  PE      M +   D++S G ++  +I  + P  +     +  L+   
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIA 244

Query: 299 KKMVTNRNPEGVLDPKLPEKP 319
           K + T    + +    +   P
Sbjct: 245 KVLGTEDLYDYIDKYNIELDP 265

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 8e-29
 Identities = 67/294 (22%), Positives = 110/294 (37%), Gaps = 48/294 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           K IG G  GIV        +  VA+K L     N+  A+R    E+  +  V HKN++ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVNHKNIISL 81

Query: 141 LGYCA------EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           L          E     LV E ++    +               E    ++     G+ +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKH 134

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LH      ++HRD+K SNI++      K+ DFGLA+  G+  S++ T  + T  Y APE 
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---------EWLKKMVTNR 305
                  E  D++S G ++ E++  +I        ++ N +         E++KK+    
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVAL----------------RCVDPNAQKRP 343
                  PK       +L    L  A                 + +  +  KR 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 8e-26
 Identities = 39/233 (16%), Positives = 82/233 (35%), Gaps = 18/233 (7%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + +G G +  V+    + +N+ VA+K +  ++   E   + E++ + RV   +  +    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSM 77

Query: 144 CAEGAHRMLVYEYVNNGNLEQW------------LHGDVGPCSPLTWEIRMNIILGTAKG 191
            A    ++L +      N                          +       I      G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYIT-TRVMGTFGY 249
           L Y+H      ++H DIK  N+L++       +    +A L  +       T  + T  Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV 302
            +PE          +D++S   LI E+I+G    +           + + +++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.5 bits (216), Expect = 6e-21
 Identities = 28/163 (17%), Positives = 54/163 (33%), Gaps = 21/163 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK----------NLLNNRGQAEREFKVEVEAIGRVRH 134
           K++GEG    V+    E   +  VK           +   R   +  F V      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           + L +L G          VY +  N  L + +         +       ++    + ++ 
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
            +      +VH D+   N+L+ +     + DF  +  +G E  
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	407
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.34
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.8
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.76

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=419.76  Aligned_cols=265  Identities=28%  Similarity=0.451  Sum_probs=210.4

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      |++..++|++.+.||+|+||.||+|.++  ..||||++...  .....+.+.+|+.+|++++||||+++++++.+ ..++
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            4566789999999999999999999864  36999998643  34456788999999999999999999998765 5689


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +|||||++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.
T Consensus        80 lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence            9999999999999997653   4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc-eeeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          232 LGSESS-YITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ...... .......||+.|||||++.+   ..++.++|||||||+||||+||+.||.........      .........
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~~  227 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYL  227 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTSC
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCC
Confidence            654332 23345679999999999864   35899999999999999999999999866543321      111111111


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                          .+.+ ......+++.+.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus       228 ----~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         228 ----SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             ----CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                1111 111233456799999999999999999999999999987643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=415.13  Aligned_cols=256  Identities=27%  Similarity=0.456  Sum_probs=203.1

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .++|++.+.||+|+||.||+|.+.++..||||++.... ...+++.+|+.++++++||||+++++++.+.+..++|||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46899999999999999999999888899999986543 44567899999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++++||+|||+++.......
T Consensus        83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            9999999987653   5689999999999999999999999   999999999999999999999999999987765544


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||......      +.+........      ...+
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~------~~~p  224 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFR------LYKP  224 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH------HHHHHHHHTCC------CCCC
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH------HHHHHHHhcCC------CCCc
Confidence            444456789999999999999999999999999999999995 5555433221      12222222211      1111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                          ..++.++.+||.+||+.||++|||+++|++.|+.+.
T Consensus       225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                123456899999999999999999999999998763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=414.73  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++++.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..||||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999975 68899999986543 23445688999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      |++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999999765    5799999999999999999999999   99999999999999999999999999999775433


Q ss_pred             c-eeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          237 S-YITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       237 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      . ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........     ........         
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~~~~---------  223 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEKK---------  223 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHHTTC---------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----HHHHhcCC---------
Confidence            2 22345679999999999988776 57899999999999999999999765432211     11111111         


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ........++.++.+||.+||+.||++|||++++++.
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111233455678899999999999999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=416.57  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=212.6

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.+|+.++||||+++++++.+.+.+|||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999995 468899999987665556678899999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++...     .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999999988753     699999999999999999999999   999999999999999999999999999998754432


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (407)
                       .....+||+.|||||++.+..++.++|||||||++|+|++|+.||......+      .+.........        ..
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~--------~~  236 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP--------EL  236 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC--------CC
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC--------CC
Confidence             2344579999999999999999999999999999999999999997544322      12222222111        11


Q ss_pred             CccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..+..++..+.+||.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1233456779999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-57  Score=419.73  Aligned_cols=266  Identities=22%  Similarity=0.372  Sum_probs=220.4

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      +++|++..++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            3456777889999999999999999999976 57889999886544 345678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      ++||||||++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||++
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999975422  5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +..............||+.|+|||++.+..++.++|||||||++|||++|..||........      +...+.....  
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~~~--  234 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR--  234 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTCC--
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcCCC--
Confidence            98765554444555689999999999999999999999999999999997776643332211      1122222111  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         +..    +..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       235 ---~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 ---MER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ---CCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               111    22345679999999999999999999999999987643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=410.93  Aligned_cols=246  Identities=28%  Similarity=0.445  Sum_probs=209.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 6889999988543   2334567888999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|.....
T Consensus        86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999765    5799999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ..   .....||+.|||||++.+..++.++|||||||++|+|++|+.||...+..+      .+.......       ..
T Consensus       159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~  222 (263)
T d2j4za1         159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-------FT  222 (263)
T ss_dssp             CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------CC
T ss_pred             Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-------CC
Confidence            32   334579999999999999999999999999999999999999997654322      222222211       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ++    ..++.++.+||.+||+.||++|||++++++.
T Consensus       223 ~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         223 FP----DFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            22    2245678999999999999999999999873

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=415.07  Aligned_cols=262  Identities=25%  Similarity=0.418  Sum_probs=214.7

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ++|++..++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++|||||++++++.+ +..+
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            34567778999999999999999999999888899999986543 345678999999999999999999998765 5679


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +|||||++|+|.+++.....  ..+++..++.++.||++||.|||++   +|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEE
Confidence            99999999999998865421  3589999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .............||+.|||||++.+..++.++|||||||++|||+||..|+......     .+.+.......      
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i~~~~------  227 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGY------  227 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC------
T ss_pred             ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcC------
Confidence            8665544445567899999999999899999999999999999999965554322221     11222222211      


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .+..+    ..++.++.+||.+||+.||++|||+++|++.|+..
T Consensus       228 ~~~~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         228 RMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            11111    23455789999999999999999999999999865

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=405.33  Aligned_cols=254  Identities=22%  Similarity=0.401  Sum_probs=216.2

Q ss_pred             cCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      .++|++.+.||+|+||.||+|.++++..||||++..... ..+++.+|+.++++++||||+++++++.+.+.+++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            478999999999999999999998888999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++....   ..+++..+++++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999999976653   4689999999999999999999999   999999999999999999999999999987765544


Q ss_pred             eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.      .........      ...+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------~~~i~~~~~------~~~p  223 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLR------LYRP  223 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HHHHHTTCC------CCCC
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------HHHHHhCCC------CCCc
Confidence            44445678999999999999999999999999999999998 8999986653322      222222111      1111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                          ..++..+.+||.+||+.||++|||+++|++.|.+
T Consensus       224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                2334578999999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-56  Score=414.29  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=202.9

Q ss_pred             hcCCCCccceecccCceEEEEEEECC-CC---EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLED-NS---KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ..++|++.++||+|+||+||+|.+.. ++   .||||.+... .....+.|.+|+.+|++++|||||++++++.+.+.++
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            34678889999999999999999653 22   5889987654 3445567999999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      +|||||++|+|.+++....   ..+++..++.++.||++||+|||++   +|+||||||+||||+.++.+||+|||+++.
T Consensus       104 iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence            9999999999999987653   4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcee----eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          232 LGSESSYI----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       232 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ........    .....||+.|||||++.+..++.++|||||||++|||+| |+.||......+      .+..+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~~~~  251 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDYR  251 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC
Confidence            65433221    122457899999999999999999999999999999998 899997654332      2222222111


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                            ...    +..++..+.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus       252 ------~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 ------LPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ------CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                  111    22345678999999999999999999999999987643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=411.73  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec--CCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv  153 (407)
                      ++|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|+.+|++++||||+++++++.+  .+.+|||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999965 68899999986543  3345578899999999999999999999864  4568999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--CCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      ||||++|+|.+++.........+++..++.++.||+.||+|||+..  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643222257999999999999999999999871  01399999999999999999999999999988


Q ss_pred             cCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcC
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ...... ......||+.|||||++.+..++.++|||||||++|||+||+.||...+..+      ......... .    
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~~-~----  231 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGK-F----  231 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTC-C----
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC-C----
Confidence            754332 2345679999999999999999999999999999999999999997654322      122222221 1    


Q ss_pred             CCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                       +.++    ..+++++.+||.+||+.||.+|||+.++++
T Consensus       232 -~~~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -RRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             1111    234567999999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=412.53  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=210.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      +.|++++.||+|+||.||+|.+. ++..||||++........+.+.+|+++|++++|||||++++++.+.+.+++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999965 68889999997766666678889999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++....   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|........
T Consensus        92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            9999999976532   4699999999999999999999999   999999999999999999999999999976533211


Q ss_pred             eeeeeeeccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          238 YITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                       ......||+.|||||++.     ...|+.++|||||||++|||+||+.||...+..+..      .........     
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~~~~~-----  233 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKSEPP-----  233 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHHSCCC-----
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCC-----
Confidence             123457999999999984     456899999999999999999999999866543322      222222110     


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         .......++.++.+||.+||+.||++|||+.++++.
T Consensus       234 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 ---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               111233456779999999999999999999999774

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.5e-55  Score=415.88  Aligned_cols=253  Identities=20%  Similarity=0.316  Sum_probs=215.2

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999965 6889999999877666677889999999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC--CCCcEEeecccceecCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~  234 (407)
                      |++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++.+..
T Consensus       105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999996543   4699999999999999999999999   9999999999999964  57899999999998765


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...  .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+      .+..+....       ..
T Consensus       179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~  243 (350)
T d1koaa2         179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-------WN  243 (350)
T ss_dssp             TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-------CC
T ss_pred             ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            443  344579999999999999999999999999999999999999997654322      222222221       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ++......+++.+.+||.+||+.||++|||++++++.
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222234456779999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-54  Score=413.58  Aligned_cols=252  Identities=20%  Similarity=0.271  Sum_probs=214.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  157 (407)
                      ++|++++.||+|+||.||+|... +++.||||++..........+.+|+.+|++++||||+++++++.+++.+|||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            56999999999999999999965 68899999997776666678889999999999999999999999999999999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe--CCCCcEEeecccceecCCC
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~~~~~~  235 (407)
                      ++|+|.+++....   .++++.+++.++.||+.||+|||++   +|+||||||+||||+  .++.+||+|||+|......
T Consensus       109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999999886542   4699999999999999999999999   999999999999997  5789999999999987654


Q ss_pred             CceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCC
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (407)
                      ..  .....||+.|||||++.+..++.++|||||||++|+|+||+.||.+.+..+      .+..+....       ..+
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~-------~~~  247 (352)
T d1koba_         183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCD-------WEF  247 (352)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCC-------CCC
T ss_pred             Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CCC
Confidence            33  344579999999999999999999999999999999999999997554322      222222221       112


Q ss_pred             CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      +......++.++.+||.+||+.||.+|||+.++++.
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222233455678999999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-56  Score=410.75  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=207.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++++.||+|+||+||+|... +++.||||++....   ......+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 68899999985432   234457889999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      |||++|+|.+++...    +.+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999998765    5799999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          235 ESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ... ......+||+.|||||++.+..++.++|||||||++|+|++|+.||...+..+      .+..+....       .
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-------~  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLE-------Y  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC-------C
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCC-------C
Confidence            432 23345679999999999999999999999999999999999999998654322      222222221       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                      .++    ..++..+.+||.+||+.||++|||++|++...
T Consensus       228 ~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         228 DFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             CCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             CCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence            122    12445689999999999999999999986543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=416.76  Aligned_cols=266  Identities=21%  Similarity=0.339  Sum_probs=208.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      +..++|++++.||+|+||+||+|... ++..||+|++... .......+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            34578999999999999999999965 6788999998654 334456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      ||||++|+|.+++.+.    ..+++..++.++.|++.||.|||+ +   +|+||||||+||||+.++.+||+|||+|+..
T Consensus        83 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            9999999999999765    569999999999999999999996 6   8999999999999999999999999999865


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH-HHHHHhhcC------
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE-WLKKMVTNR------  305 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~------  305 (407)
                      ...   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+...... .........      
T Consensus       156 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         156 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             CCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            432   2334689999999999999999999999999999999999999998655432211000 000000000      


Q ss_pred             ---C-CCC----------------cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 ---N-PEG----------------VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 ---~-~~~----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                         . ...                ......+..+...++.++.+||.+||+.||.+|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               0 000                000001111122234678999999999999999999999983

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=399.74  Aligned_cols=245  Identities=25%  Similarity=0.413  Sum_probs=199.5

Q ss_pred             CCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec----CCeeEEE
Q 015395           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV  153 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv  153 (407)
                      |++.+.||+|+||+||+|.+. ++..||+|++...  .....+.+.+|+++|++++||||+++++++.+    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356778999999999999965 5788999988654  33445678899999999999999999999864    4568999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc--eeccCCCCccEEEe-CCCCcEEeecccce
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILID-KHWNPKVSDFGLAK  230 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~DfGla~  230 (407)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +  |+||||||+||||+ .++.+||+|||+++
T Consensus        91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            9999999999999765    5799999999999999999999998   7  99999999999996 57899999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ......   ....+||+.|||||++.+ .++.++|||||||++|||++|+.||........     ....+... ..   
T Consensus       164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~~~-~~---  230 (270)
T d1t4ha_         164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSG-VK---  230 (270)
T ss_dssp             GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTT-CC---
T ss_pred             eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHHcC-CC---
Confidence            654332   345679999999999865 599999999999999999999999975443221     12222211 11   


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                           +.......+.++.+||.+||+.||++|||+.|+++
T Consensus       231 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 11112223456899999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=402.86  Aligned_cols=255  Identities=26%  Similarity=0.431  Sum_probs=209.6

Q ss_pred             cCCCCccce-ecccCceEEEEEEEC---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKV-IGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|.+.+. ||+|+||.||+|.++   ++..||||++.... ....+.+.+|+++|++++|||||++++++.. +.++|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            456777775 999999999999854   34469999986553 3445688999999999999999999999865 46899


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |||||++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus        86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            999999999999986543   5799999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCceee--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          233 GSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       233 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........  ....||+.|||||++.+..++.++|||||||++|||+| |+.||......+..   .   .+. ....  
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~---~i~-~~~~--  230 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A---FIE-QGKR--  230 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H---HHH-TTCC--
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH---H---HHH-cCCC--
Confidence            65443322  23468999999999999999999999999999999998 99999876543322   1   111 1111  


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                         +..+    ..++.++.+||.+||+.||++|||+.+|++.|+..
T Consensus       231 ---~~~p----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 ---MECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---CCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCC----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               1111    23456789999999999999999999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-55  Score=408.69  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=194.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .+.|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+.+|+.++||||+++++++.+.+.+|||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356999999999999999999975 68899999986543 2334567789999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe---CCCCcEEeecccceec
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLL  232 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~  232 (407)
                      ||+||+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||+.   +++.+||+|||+++..
T Consensus        88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999765    5799999999999999999999999   999999999999994   5789999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....  ....+||+.|||||++.+..++.++|||||||++|+|++|+.||......+      .........       
T Consensus       161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-------  225 (307)
T d1a06a_         161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAE-------  225 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTC-------
T ss_pred             cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccC-------
Confidence            54332  334579999999999999999999999999999999999999997544322      122222221       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..++......++..+.+||.+||+.||++|||+.++++.
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            111112223455679999999999999999999999884

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=412.98  Aligned_cols=263  Identities=27%  Similarity=0.423  Sum_probs=212.4

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECC-C-----CEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLED-N-----SKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  145 (407)
                      |++..++|++.+.||+|+||+||+|.+.. +     ..||+|.+.... ......+.+|+.+|.++ +|||||++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            45677899999999999999999998643 2     258999886543 33445788899999998 8999999999999


Q ss_pred             cCCeeEEEEEeccCCChHHhhhCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceecc
Q 015395          146 EGAHRMLVYEYVNNGNLEQWLHGDVG-------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (407)
Q Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~  206 (407)
                      +.+..++|||||++|+|.++|.....                   ....+++..++.++.||+.||+|||++   +|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999976532                   123589999999999999999999999   99999


Q ss_pred             CCCCccEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 015395          207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD  284 (407)
Q Consensus       207 Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~  284 (407)
                      ||||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876544332 3345678999999999999999999999999999999998 899998


Q ss_pred             CCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      +.......      .+.......     ...    +..++.++.+||.+||+.||++|||+++|++.|..
T Consensus       269 ~~~~~~~~------~~~~~~~~~-----~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         269 GIPVDANF------YKLIQNGFK-----MDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TCCCSHHH------HHHHHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHHH------HHHHhcCCC-----CCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            65543321      122222111     111    22345679999999999999999999999999964

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=397.57  Aligned_cols=247  Identities=27%  Similarity=0.428  Sum_probs=201.2

Q ss_pred             ceecccCceEEEEEEECC---CCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEeccC
Q 015395           85 KVIGEGGYGIVYYGLLED---NSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (407)
Q Consensus        85 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  159 (407)
                      +.||+|+||.||+|.++.   ++.||||++...  .....+.+.+|+.+|++++|||||++++++.. +..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   457999998643  23345678999999999999999999999865 457899999999


Q ss_pred             CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCcee
Q 015395          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (407)
Q Consensus       160 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  239 (407)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.........
T Consensus        92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999865    5799999999999999999999999   99999999999999999999999999999876544332


Q ss_pred             e--eeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCC
Q 015395          240 T--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (407)
Q Consensus       240 ~--~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (407)
                      .  ....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+   ..   ..+. ....     +..+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~---~~i~-~~~~-----~~~p  232 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT---AMLE-KGER-----MGCP  232 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH---HHHH-TTCC-----CCCC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HH---HHHH-cCCC-----CCCC
Confidence            2  23468999999999999999999999999999999998 899998654322   11   1111 1111     1111


Q ss_pred             CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                          ..++.++.+||.+||+.||++|||+++|++.|+..
T Consensus       233 ----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                23456789999999999999999999999988764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=400.03  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=203.9

Q ss_pred             hcCCCCccceecccCceEEEEEEECCC-----CEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLEDN-----SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      ..+.|+..++||+|+||.||+|.++..     ..||||++.... ......+.+|+.+|++++|||||++++++.+....
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            346789999999999999999986532     369999986543 33445788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++|||||.+++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999999886553   5799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCce--eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ........  ......||+.|||||++.+..++.++|||||||++|||++|..||.......     +.+..+. ...  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~-~~~--  230 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAIN-DGF--  230 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH-TTC--
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-----HHHHHHh-ccC--
Confidence            76543222  2233468999999999999999999999999999999999766654333221     1122222 111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                         .+..    +..++..+.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus       231 ---~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 ---RLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---CCCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---CCCC----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence               1111    22345678999999999999999999999999987654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-54  Score=403.89  Aligned_cols=245  Identities=25%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      .|+.++.||+|+||.||+|... ++..||||++....   ......+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4899999999999999999965 67889999986543   2334568889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ||.+|+|..++...    ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+|......
T Consensus        96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999998777654    5799999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CceeeeeeeccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          236 SSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                           ....||+.|||||++.+   ..|+.++|||||||++|||++|..||......      +.+.........     
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~~-----  232 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-----  232 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC-----
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-----
Confidence                 33579999999999864   45899999999999999999999999754332      222233322211     


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                       .   .....++..+.+||.+||+.||.+|||+.++++.
T Consensus       233 -~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         233 -A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -C---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -C---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             1   1122345679999999999999999999999873

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=399.51  Aligned_cols=259  Identities=21%  Similarity=0.362  Sum_probs=202.0

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCe
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  149 (407)
                      ++..++|++.+.||+|+||.||+|.+..    +..||||.+.... ......+.+|+.+|++++||||+++++++.+ +.
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~   81 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP   81 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence            4556789999999999999999998643    3468999886543 3445678899999999999999999999864 67


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      +++||||+++|+|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence            899999999999999876543   5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +..............||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+..      ........  
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~------~~i~~~~~--  227 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------GRIENGER--  227 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------HHHHTTCC--
T ss_pred             eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH------HHHHcCCC--
Confidence            8876554444455678999999999999999999999999999999998 89999866544322      12222111  


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                          ...    +..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       228 ----~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         228 ----LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                111    2234567999999999999999999999999998763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-55  Score=402.76  Aligned_cols=263  Identities=25%  Similarity=0.397  Sum_probs=207.7

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      |++..++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            345567899999999999999999999888889999986543 345678999999999999999999999865 568999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||||++|+|..++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++++||+|||+++...
T Consensus        90 ~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence            999999999998865321  4699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...........||+.|+|||++....++.++|||||||++|||++|..||......     .+.+..+.....      .
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~~~~~------~  233 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYR------M  233 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC------C
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCC------C
Confidence            54444444567899999999999999999999999999999999976665433221     112222222111      1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      ..    ...+++++.++|.+||+.||++||++++|++.|+.....
T Consensus       234 ~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         234 PC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            11    223456799999999999999999999999999876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-54  Score=399.23  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=209.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  151 (407)
                      ++|++++.||+|+||+||+|... +|+.||||++....      ......+.+|+.+|++++|||||++++++.+.+.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999975 68899999985432      223567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC----CcEEeecc
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDFG  227 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfG  227 (407)
                      ||||||++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++    .+||+|||
T Consensus        90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999765    5799999999999999999999999   999999999999998776    49999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.      +..+....  
T Consensus       163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~--  232 (293)
T d1jksa_         163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN--  232 (293)
T ss_dssp             TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTC--
T ss_pred             hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHhcC--
Confidence            9988754432  3345689999999999999999999999999999999999999986543222      22222211  


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                           ..++......++..+.+||.+||+.||++|||++++++.
T Consensus       233 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 111111122345678999999999999999999999873

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-54  Score=405.50  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=210.3

Q ss_pred             hcCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ..++|++++.||+|+||.||+|... +++.||||++....   ......+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            3568999999999999999999964 78899999986432   2345667889999999999999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      |||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        83 v~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             ceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence            99999999999999876    5799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+      .........       
T Consensus       156 ~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~~~-------  221 (337)
T d1o6la_         156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-------  221 (337)
T ss_dssp             CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-------
T ss_pred             ccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhcCC-------
Confidence            54332 2445689999999999999999999999999999999999999998654322      222222221       


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                      ..++    ..++.++.+||.+||++||.+|++     +.++++
T Consensus       222 ~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1122    224456899999999999999995     778876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-53  Score=398.36  Aligned_cols=246  Identities=25%  Similarity=0.361  Sum_probs=208.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      .++|++++.||+|+||+||+|+.. +++.||||++...   .....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            357999999999999999999965 6889999998543   223456788899999999999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||||.||+|..++...    ..+++..+..++.||+.||+|||++   +|+||||||+||||+.+|.+||+|||+|+...
T Consensus        83 mE~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence            9999999999999876    5789999999999999999999999   99999999999999999999999999998875


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ..    ....+||+.|||||++.+..++.++|||||||++|+|++|+.||...+..      +.+........       
T Consensus       156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~-------  218 (316)
T d1fota_         156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAEL-------  218 (316)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCCC-------
T ss_pred             cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCCC-------
Confidence            43    23467999999999999999999999999999999999999999765432      22223322211       


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~  351 (407)
                      .++    ..++..+.+++.+||+.||.+|+     |++++++.
T Consensus       219 ~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            111    12345688999999999999996     88998863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-53  Score=398.32  Aligned_cols=268  Identities=26%  Similarity=0.383  Sum_probs=217.1

Q ss_pred             cHHHHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCccceeee
Q 015395           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      .+.++++..++|++++.||+|+||.||+|++.      ++..||||++..... .....+.+|+.+|++++||||+++++
T Consensus         4 ~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             chhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            45667778899999999999999999999864      346799999866543 34567899999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCc
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDV--------------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK  202 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  202 (407)
                      ++......+++|||+.+|+|.+++....                    .....+++..++.++.|++.||+|||++   +
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence            9999999999999999999999996432                    1123589999999999999999999999   9


Q ss_pred             eeccCCCCccEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-
Q 015395          203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-  280 (407)
Q Consensus       203 ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~-  280 (407)
                      |+||||||+||||+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            999999999999999999999999999876443322 233456899999999999999999999999999999999985 


Q ss_pred             CCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .||......+.      +..... ...     +..+    ..++.++.+||.+||+.||++||||.+|+++|+.+.
T Consensus       241 ~p~~~~~~~e~------~~~v~~-~~~-----~~~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         241 QPYYGMAHEEV------IYYVRD-GNI-----LACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CTTTTSCHHHH------HHHHHT-TCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCHHHH------HHHHHc-CCC-----CCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            57765443322      222222 111     1111    233456899999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-52  Score=388.23  Aligned_cols=258  Identities=25%  Similarity=0.372  Sum_probs=205.3

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----ee
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HR  150 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~  150 (407)
                      ++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+|+.++||||+++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            67999999999999999999964 68899999986543   334557889999999999999999999987543    47


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |||||||+|++|.+++...    ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.++|+|||.+.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            9999999999999998765    5799999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCc--eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          231 LLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......  ......+||+.|||||++.+..++.++|||||||++|+|+||+.||...+..+      .+......... 
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~-  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI-  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC-
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCC-
Confidence            6543322  22344679999999999999999999999999999999999999997654322      22233332211 


Q ss_pred             CcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHhcc
Q 015395          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQE  356 (407)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~  356 (407)
                            .+......++..+.++|.+||+.||++|| |+++++..|.++.
T Consensus       233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                  11111223456799999999999999999 8999999888764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-52  Score=385.41  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=208.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh---------hhHHHHHHHHHHHhcCC-CCccceeeeeeecC
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---------QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEG  147 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  147 (407)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.....         .....+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57999999999999999999964 688899999865421         12345778999999997 99999999999999


Q ss_pred             CeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecc
Q 015395          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (407)
Q Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG  227 (407)
                      +..|||||||++|+|.++|...    ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999765    5799999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHH
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (407)
                      +++.......  .....||+.|+|||.+.      ...++.++||||+||++|+|++|+.||......+.      ....
T Consensus       156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~~i  227 (277)
T d1phka_         156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMI  227 (277)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred             heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HHHH
Confidence            9998765432  34457999999999884      34578899999999999999999999986543221      2222


Q ss_pred             hhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ....       ..++......+++++.+|+.+||+.||++|||+++|++.
T Consensus       228 ~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGN-------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTC-------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCC-------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2221       112222334566789999999999999999999999763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=389.10  Aligned_cols=254  Identities=29%  Similarity=0.425  Sum_probs=201.6

Q ss_pred             HHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec-CCeeEEE
Q 015395           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLV  153 (407)
Q Consensus        75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  153 (407)
                      ++..++|++.+.||+|+||.||+|.++ +..||||++...  ...+.+.+|+.++++++||||+++++++.+ .+.+++|
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            455678999999999999999999986 778999998554  345678899999999999999999998854 4678999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            999999999999965321  3589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..    .....+|..|+|||++.+..++.++|||||||++|||+| |++||......+.   ...   . ....     .
T Consensus       155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~---i-~~~~-----~  218 (262)
T d1byga_         155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR---V-EKGY-----K  218 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH---H-TTTC-----C
T ss_pred             CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHH---H-HcCC-----C
Confidence            33    223457899999999999999999999999999999998 7888876544322   211   1 1111     1


Q ss_pred             CCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      +..+.    .++.++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       219 ~~~~~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 MDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCc----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            12222    23457899999999999999999999999998763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=398.97  Aligned_cols=244  Identities=23%  Similarity=0.297  Sum_probs=207.5

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++|++++.||+|+||.||+|.+. +|+.||||++....   ......+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 68899999885432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCC
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~  234 (407)
                      ||+.+|+|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999999765    5799999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      .    .....||+.|||||++.+..++.++|||||||++|+|+||+.||.+.+..      ..+..+....       ..
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~-------~~  256 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-------VR  256 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------CC
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcCC-------CC
Confidence            3    23457999999999999999999999999999999999999999754322      2222332221       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVH  350 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~  350 (407)
                      .+    ..++.++.+||.+||+.||.+|+     |++++++
T Consensus       257 ~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            11    23455789999999999999994     8999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=392.32  Aligned_cols=252  Identities=16%  Similarity=0.258  Sum_probs=210.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .++|++.+.||+|+||+||+|.+. +++.||||.+.... .....+.+|+.+|+.++||||+++++++.+.+.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999975 67889999986654 3345678899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC--CCcEEeecccceecCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH--WNPKVSDFGLAKLLGS  234 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~DfGla~~~~~  234 (407)
                      |+||+|.+++....   ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++....
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999997653   4699999999999999999999999   99999999999999754  5799999999988754


Q ss_pred             CCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ...  .....||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+      .+..+....       ..
T Consensus       157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~-------~~  221 (321)
T d1tkia_         157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAE-------YT  221 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-------CC
T ss_pred             CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            432  344578999999999999999999999999999999999999998654322      222222221       11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ++......++.++.+||.+||..||.+|||+.++++.
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111122345678999999999999999999999984

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=393.35  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=204.6

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  152 (407)
                      ++|+++++||+|+||+||+|.+. +++    +||+|++... .....+.+.+|+.+|++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            57999999999999999999865 333    5899988643 344567899999999999999999999999875 5678


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +|||+.+++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            889999999999887653   5799999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc
Q 015395          233 GSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (407)
Q Consensus       233 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ....... .....||+.|||||++.+..++.++|||||||++|||+| |..||......+..   ..+..   ...    
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i~~---~~~----  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK---GER----  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHHHH---TCC----
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc---CCC----
Confidence            6543322 233468999999999999999999999999999999998 89999766543322   11111   111    


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                        ...    +..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       232 --~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         232 --LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             --CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence              111    1234457899999999999999999999999988653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.7e-52  Score=398.57  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHH---HHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREF---KVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .++|++.++||+|+||.||+|... +++.||||++....   ......+   ..++.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            578999999999999999999965 68899999885332   1122223   3457788888999999999999999999


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      |||||||++|+|.++|...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            9999999999999999765    5789999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          231 LLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ......   .....||+.|||||++.. ..++.++|||||||+||||+||+.||......+...    +.......    
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~----  224 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM----  224 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSC----
T ss_pred             ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccC----
Confidence            775432   334579999999999864 568999999999999999999999998655433221    11111111    


Q ss_pred             cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                        ...+    +..++.++.+||.+||+.||++|||     ++++++
T Consensus       225 --~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 --AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              0111    1234567899999999999999999     688876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=390.09  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=200.5

Q ss_pred             cCCCCccceecccCceEEEEEEECC--C--CEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCCee
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLED--N--SKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  150 (407)
                      .++|++.+.||+|+||.||+|.+..  +  ..||||++...   .....+.+.+|+.+|++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4579999999999999999998532  2  36899987543   33445678999999999999999999999976 467


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      ++|||||++|+|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            89999999999998887543   4699999999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCcee--eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          231 LLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       231 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .........  .....|+..|+|||++.+..++.++|||||||++|||+| |..||...+..+      .+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~  233 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGER  233 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCC
Confidence            875543322  233457889999999999999999999999999999998 899997554322      22333322211


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                           +..    ...++..+.+||.+||+.||++|||+.+|++.|++.
T Consensus       234 -----~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 -----LPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 111    223445789999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=393.01  Aligned_cols=270  Identities=26%  Similarity=0.388  Sum_probs=206.3

Q ss_pred             ccHHHHHHhcCCCCccceecccCceEEEEEEECC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCcccee
Q 015395           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRL  140 (407)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~  140 (407)
                      ++...|++..++|++.+.||+|+||.||+|.+..      ++.||||++.... ....+.+..|...+.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            3567788888999999999999999999998542      3579999986543 34455677788877776 68999999


Q ss_pred             eeeeec-CCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccC
Q 015395          141 LGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD  207 (407)
Q Consensus       141 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D  207 (407)
                      ++++.+ ...+++|||||++|+|.+++.....            ....+++..++.++.||+.||+|||++   +|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence            998765 4578999999999999999975421            123589999999999999999999999   999999


Q ss_pred             CCCccEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 015395          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDY  285 (407)
Q Consensus       208 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg-~~Pf~~  285 (407)
                      |||+||||+.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+|| ..||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332 23345799999999999999999999999999999999996 567865


Q ss_pred             CCCchhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      ....+..      .........     +..+    ..++.++.++|.+||+.||++|||+.+|++.|+.+.
T Consensus       240 ~~~~~~~------~~~~~~~~~-----~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         240 VKIDEEF------CRRLKEGTR-----MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CCCSHHH------HHHHHHTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHH------HHHHhcCCC-----CCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            5433221      111111111     1111    223456899999999999999999999999998763

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=390.96  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=202.7

Q ss_pred             cCCCCccc-eecccCceEEEEEEE-CCCCEEEEEEeccCChhhHHHHHHHHHHHhc-CCCCccceeeeeeec----CCee
Q 015395           78 TNGFSDDK-VIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGR-VRHKNLVRLLGYCAE----GAHR  150 (407)
Q Consensus        78 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~~  150 (407)
                      .++|.+.+ +||+|+||+||+|.+ .+++.||||++...     ..+.+|+.++.+ ++||||+++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788864 699999999999996 46889999988543     345678888655 489999999999865    4678


Q ss_pred             EEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC---CCCcEEeecc
Q 015395          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFG  227 (407)
Q Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfG  227 (407)
                      |||||||+||+|.++|.....  ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.   .+.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999976422  4699999999999999999999999   9999999999999975   5679999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +|+.......  .....||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+..+....+   ..   ... 
T Consensus       160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~---~i~-  230 (335)
T d2ozaa1         160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT---RIR-  230 (335)
T ss_dssp             TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCC-
T ss_pred             eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HH---HHh-
Confidence            9987755433  34457999999999999999999999999999999999999999765443221111   10   000 


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                        .....++......++.++.+||.+||+.||++|||+.++++.
T Consensus       231 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 --MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              011223333445677889999999999999999999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=393.02  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=204.4

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHh-cCCCCccceeeeeeecCCeeEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIG-RVRHKNLVRLLGYCAEGAHRMLV  153 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv  153 (407)
                      ++|++++.||+|+||+||+|.+. +++.||||++....   ....+.+..|..++. .++||||+++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999965 68889999986432   223345556666654 68999999999999999999999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecC
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~  233 (407)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999765    5799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCC
Q 015395          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (407)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.      +.......       +
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~-------~  220 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDN-------P  220 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-------C
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC-------C
Confidence            4333 23445799999999999999999999999999999999999999986543322      22222211       1


Q ss_pred             CCCCCccHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 015395          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG-HVVH  350 (407)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~  350 (407)
                      .++    ..++.++.+||.+||+.||++||++. ++++
T Consensus       221 ~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            222    12355689999999999999999995 6764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=388.24  Aligned_cols=264  Identities=27%  Similarity=0.437  Sum_probs=210.0

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEECC--------CCEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCccceeeee
Q 015395           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (407)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~  143 (407)
                      |++..++|++.+.||+|+||.||+|+...        +..||||++..... .....+..|...+.++ +||||++++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            55677899999999999999999998532        23699999866543 3446788898888888 79999999999


Q ss_pred             eecCCeeEEEEEeccCCChHHhhhCCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCc
Q 015395          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (407)
Q Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~  211 (407)
                      +.+++..++|||||++|+|.++|.....            ....+++..++.++.||+.||+|||++   +|+||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            9999999999999999999999976531            124689999999999999999999999   9999999999


Q ss_pred             cEEEeCCCCcEEeecccceecCCCCce-eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 015395          212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (407)
Q Consensus       212 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~~  289 (407)
                      |||++.++.+||+|||+++........ ......||+.|+|||.+.+..|+.++|||||||++|||++ |..||......
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999999999999999999877543322 2334568999999999999999999999999999999998 78888754432


Q ss_pred             hhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .       +...+.....     +..+    ..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       245 ~-------~~~~i~~~~~-----~~~p----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 E-------LFKLLKEGHR-----MDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H-------HHHHHHTTCC-----CCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H-------HHHHHHcCCC-----CCCC----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            2       1122222111     1111    224457899999999999999999999999998764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=388.85  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=206.6

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCccceeeeeeecCCeeEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS--KVAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  152 (407)
                      .++|++.+.||+|+||.||+|.+. ++.  .||||++... .....+.+.+|+.+|.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            468999999999999999999965 344  4788887543 333455789999999999 79999999999999999999


Q ss_pred             EEEeccCCChHHhhhCCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCC
Q 015395          153 VYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN  220 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  220 (407)
                      ||||+++|+|.++|+...            .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence            999999999999997542            2235799999999999999999999999   9999999999999999999


Q ss_pred             cEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCchhhhHHHHHH
Q 015395          221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-IPVDYSRPPEEVNLIEWLK  299 (407)
Q Consensus       221 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~-~Pf~~~~~~~~~~~~~~~~  299 (407)
                      +||+|||+++.......  .....||..|+|||.+.+..++.++|||||||++|||++|. +||...+..      +.+.
T Consensus       166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~~~~  237 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE  237 (309)
T ss_dssp             EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH
T ss_pred             eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------HHHH
Confidence            99999999986543222  22345899999999999999999999999999999999965 567644322      2222


Q ss_pred             HHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .+.....      +..    +..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       238 ~i~~~~~------~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         238 KLPQGYR------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HGGGTCC------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCC------CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222111      111    12345679999999999999999999999999988753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=388.80  Aligned_cols=265  Identities=26%  Similarity=0.391  Sum_probs=215.5

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCccceeeeee
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  144 (407)
                      .|++..++|++.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.+++++ +|||||++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            45667789999999999999999999852      34579999997644 34455788999999999 699999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCCC--------------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCC
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG--------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  210 (407)
                      .+....++|||||++|+|.+++.....              ....+++..+..++.||+.||+|||++   +++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence            999999999999999999999975431              224689999999999999999999999   999999999


Q ss_pred             ccEEEeCCCCcEEeecccceecCCCCc-eeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 015395          211 SNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (407)
Q Consensus       211 ~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~ellt-g~~Pf~~~~~  288 (407)
                      +|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998765433 33344679999999999999999999999999999999999 5666655443


Q ss_pred             chhhhHHHHHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .+..      ...+....     .+..    ...++..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       254 ~~~~------~~~i~~~~-----~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 DSKF------YKMIKEGF-----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SHHH------HHHHHHTC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH------HHHHhcCC-----CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            3221      11222111     1111    122345789999999999999999999999999865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=383.14  Aligned_cols=258  Identities=23%  Similarity=0.272  Sum_probs=199.0

Q ss_pred             ccceecccCceEEEEEEEC-CCCEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           83 DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        83 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      .+++||+|+||+||+|.+. +++.||||++......     ....+.+|+.+|++++||||+++++++.+.+.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999964 6889999988544321     124678899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.++++..++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9888777766544    5689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc-----
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV-----  310 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  310 (407)
                      .. ....+||+.|+|||++... .++.++|||||||++|||++|..||......+..   ..+.+..........     
T Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTS
T ss_pred             cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhc
Confidence            22 2345799999999998654 5799999999999999999999999865543322   222222111110000     


Q ss_pred             -----CCCCCCCCcc----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          311 -----LDPKLPEKPT----SRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       311 -----~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                           .....+....    ...++.+.+||.+||+.||++|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                 0011111111    1234678999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=387.14  Aligned_cols=267  Identities=21%  Similarity=0.399  Sum_probs=216.8

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEEC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeee
Q 015395           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~  144 (407)
                      ++|++..++|.+.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.++++++||||+++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            356777889999999999999999999853      24679999986543 34445688999999999999999999999


Q ss_pred             ecCCeeEEEEEeccCCChHHhhhCCC------CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCC
Q 015395          145 AEGAHRMLVYEYVNNGNLEQWLHGDV------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (407)
Q Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  218 (407)
                      ......++|||||++|+|.+++....      .....+++..+..++.|+++||.|||++   +|+||||||+||||+.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence            99999999999999999999985421      1224579999999999999999999999   99999999999999999


Q ss_pred             CCcEEeecccceecCCCCcee-eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhHHH
Q 015395          219 WNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       219 ~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg-~~Pf~~~~~~~~~~~~~  296 (407)
                      +++||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+|| ..||...+..+      
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------  243 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------  243 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------
Confidence            999999999998765433322 2334689999999999999999999999999999999998 57776543322      


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccC
Q 015395          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~  357 (407)
                      .+..+.....      ...    +..++..+.++|.+||+.||++|||+.+|++.|+....
T Consensus       244 ~~~~i~~~~~------~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         244 VLRFVMEGGL------LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHHHTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHhCCC------CCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2222222111      111    12234579999999999999999999999999987644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=377.07  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=204.0

Q ss_pred             cceecccCceEEEEEEECCC----CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCccceeeeeeec-CCeeEEEEEec
Q 015395           84 DKVIGEGGYGIVYYGLLEDN----SKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYEYV  157 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~  157 (407)
                      .++||+|+||+||+|.+.++    ..||||++... ......++.+|+++|++++||||+++++++.+ .+..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999996532    25899998643 44455789999999999999999999999765 56899999999


Q ss_pred             cCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCCc
Q 015395          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (407)
Q Consensus       158 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~  237 (407)
                      ++|+|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+||||++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999998654   4678899999999999999999999   999999999999999999999999999987654432


Q ss_pred             ee---eeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCcCCCC
Q 015395          238 YI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (407)
Q Consensus       238 ~~---~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (407)
                      ..   .....||+.|+|||.+....++.++|||||||++|||+||..||.......     +..........      +.
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~------~~  254 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRR------LL  254 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC------CC
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCC------CC
Confidence            21   223468999999999999999999999999999999999888876432211     11222222211      11


Q ss_pred             CCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhccCC
Q 015395          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (407)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  358 (407)
                      .+    ..++..+.+||.+||+.||++||++.+|++.|+.+...
T Consensus       255 ~p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         255 QP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             Cc----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            11    22345789999999999999999999999999988543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-51  Score=379.37  Aligned_cols=269  Identities=21%  Similarity=0.347  Sum_probs=203.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++++.||+|+||+||+|.+. +++.||||++.....  .....+.+|+++|++++||||+++++++.+++.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999964 688999999854432  234578889999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      |+.+ ++.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9965 4444443221  15699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CceeeeeeeccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC---CCc-
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EGV-  310 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~-  310 (407)
                      ... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....   +.........   ... 
T Consensus       156 ~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR---IFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             SBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGG
T ss_pred             ccc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH---HHHhcCCCchhhccccc
Confidence            332 33346999999999887665 57899999999999999999999986543322111   1111111000   000 


Q ss_pred             ----CCCCC---CCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHhccC
Q 015395          311 ----LDPKL---PEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM--LEAQES  357 (407)
Q Consensus       311 ----~~~~~---~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~  357 (407)
                          .....   ....    ...++..+.+|+.+||+.||++|||+.++++.  ++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                00000   0000    11234678999999999999999999999984  444433

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=381.69  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----eeEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVY  154 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~lv~  154 (407)
                      .+|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++||||+++++++.+.+    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            35778899999999999999874 78999998854422 2222334555666789999999999987543    679999


Q ss_pred             EeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----CCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       155 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      |||++|+|.+++++.     .+++..++.++.|++.||+|||+..     ..+|+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999864     6899999999999999999999631     239999999999999999999999999999


Q ss_pred             eecCCCCcee---eeeeeccccccCccccCCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--------h
Q 015395          230 KLLGSESSYI---TTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPVDYSRPPEE--------V  292 (407)
Q Consensus       230 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~sDiwslG~il~elltg~~Pf~~~~~~~~--------~  292 (407)
                      +.........   .....||+.|+|||++.+..      ++.++|||||||+||||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8875543322   23467999999999987643      56789999999999999999988754321110        0


Q ss_pred             hHHHHHHHHhhcCCCCCcCCCCCCCCc-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          293 NLIEWLKKMVTNRNPEGVLDPKLPEKP-TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .....+.......    .+++.++... .......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1122223332222    2233333322 3456677999999999999999999999999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-50  Score=376.29  Aligned_cols=261  Identities=20%  Similarity=0.304  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEECCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++++.||+|+||+||+|.+.+++.||||++.....  .....+.+|+.+|++++||||+++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            68999999999999999999999899999999865432  2346788899999999999999999999999999999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCCC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~  236 (407)
                      +.++.+..+....    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9877776666544    5799999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCCc-----
Q 015395          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV-----  310 (407)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  310 (407)
                      .. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....   +............     
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGG
T ss_pred             cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCChhhccchhh
Confidence            32 3334689999999998654 578999999999999999999999986543322211   1111111100000     


Q ss_pred             ----------CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 015395          311 ----------LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH  350 (407)
Q Consensus       311 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~  350 (407)
                                ..+.........++..+.+||.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      0000000112234567889999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=374.84  Aligned_cols=240  Identities=25%  Similarity=0.416  Sum_probs=196.8

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCC--CCccceeeeeeecCCe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVR--HKNLVRLLGYCAEGAH  149 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~  149 (407)
                      ++|++.+.||+|+||.||+|... +++.||||++.....      .....+.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999965 688999998864321      11233567999999986  8999999999999999


Q ss_pred             eEEEEEeccC-CChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-CCCcEEeecc
Q 015395          150 RMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFG  227 (407)
Q Consensus       150 ~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfG  227 (407)
                      .++||||+.+ +++.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++. ++.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 5788888665    5799999999999999999999999   9999999999999985 4789999999


Q ss_pred             cceecCCCCceeeeeeeccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       228 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      +|......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....            .......
T Consensus       157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~  221 (273)
T d1xwsa_         157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV  221 (273)
T ss_dssp             TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC
T ss_pred             cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc
Confidence            99876433   2345679999999999987665 567899999999999999999996321            1111110


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                             .++    ..++.++.+||.+||+.||++|||++++++.
T Consensus       222 -------~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 -------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------CCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                   111    1234578999999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=374.51  Aligned_cols=263  Identities=24%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-C-CCEEEEEEeccCC--hhhHHHHHHHHHHHhcC---CCCccceeeeeeec----
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-D-NSKVAVKNLLNNR--GQAEREFKVEVEAIGRV---RHKNLVRLLGYCAE----  146 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~----  146 (407)
                      .++|++++.||+|+||+||+|.+. + ++.||||++....  ......+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            368999999999999999999974 4 5568999885432  11222344566666555   89999999999852    


Q ss_pred             -CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEee
Q 015395          147 -GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (407)
Q Consensus       147 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  225 (407)
                       ....+++|||+.++.+........   ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             357899999998877765554432   5689999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC
Q 015395          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (407)
Q Consensus       226 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ||++.......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....   +.......
T Consensus       160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCC
T ss_pred             hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCC
Confidence            99988654332  23446799999999999999999999999999999999999999986654332222   11111110


Q ss_pred             CCC----------CcCCCCC---CCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 NPE----------GVLDPKL---PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 ~~~----------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ...          .......   .......++..+.+||.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000          0000000   001122345668899999999999999999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=366.97  Aligned_cols=267  Identities=19%  Similarity=0.254  Sum_probs=200.1

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeec--------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------  146 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------  146 (407)
                      .++|++++.||+|+||+||+|.+. +++.||||++...  .......+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367999999999999999999964 7889999988543  23344567889999999999999999998754        


Q ss_pred             CCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeec
Q 015395          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (407)
Q Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  226 (407)
                      .+..++||||+.++.+..+....    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            35689999999877666555433    5789999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCce---eeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh
Q 015395          227 GLAKLLGSESSY---ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (407)
Q Consensus       227 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (407)
                      |++.........   .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....   +....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH---HHHhc
Confidence            999876543321   12335699999999998765 689999999999999999999999986543332222   22222


Q ss_pred             hcCCCCCc--CC----------CCCCCCccH------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHh
Q 015395          303 TNRNPEGV--LD----------PKLPEKPTS------RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (407)
Q Consensus       303 ~~~~~~~~--~~----------~~~~~~~~~------~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~  354 (407)
                      ........  ..          .........      .....+.+||.+||+.||++|||++|+++.-..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            11111000  00          000000011      113456789999999999999999999986543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-48  Score=362.16  Aligned_cols=259  Identities=18%  Similarity=0.221  Sum_probs=199.2

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccc-eeeeeeecCCeeEEEEEe
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEY  156 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~  156 (407)
                      ++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+..|+++++.++|+|++ .+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999964 688999998765432  23467799999999876654 555666788899999999


Q ss_pred             ccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEe---CCCCcEEeecccceecC
Q 015395          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLG  233 (407)
Q Consensus       157 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~~  233 (407)
                      + +++|.+.+....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+...
T Consensus        85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             c-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9 567766665432   5799999999999999999999999   999999999999985   45679999999999875


Q ss_pred             CCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCC
Q 015395          234 SESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (407)
Q Consensus       234 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .....      ......||+.|||||++.+..++.++|||||||++|||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            43321      223457999999999999999999999999999999999999999876554433322222111111000


Q ss_pred             CCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhc
Q 015395          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (407)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~  355 (407)
                      .         .....++.++.++|..||+.||++||++.++.+.|+.+
T Consensus       238 ~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             H---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             h---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0         00112345689999999999999999999998888765

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-48  Score=360.43  Aligned_cols=261  Identities=17%  Similarity=0.216  Sum_probs=209.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CccceeeeeeecCCeeEEEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e  155 (407)
                      .++|++++.||+|+||+||+|.+. +++.||||++....  ....+..|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999965 67889999875442  22345678888988865 899999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeC-----CCCcEEeecccce
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-----HWNPKVSDFGLAK  230 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~DfGla~  230 (407)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+
T Consensus        82 ~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 789999987653   4699999999999999999999999   9999999999999964     5789999999999


Q ss_pred             ecCCCCce------eeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhc
Q 015395          231 LLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (407)
Q Consensus       231 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ........      .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+............+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            86543221      223457999999999999999999999999999999999999999876655444333333222211


Q ss_pred             CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHhcc
Q 015395          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (407)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~  356 (407)
                      .....+         ...+++++.+++..|+..+|++||+++.+.+.|+.+.
T Consensus       235 ~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         235 TPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             SCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111000         1123456899999999999999999999988887653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=370.70  Aligned_cols=266  Identities=23%  Similarity=0.261  Sum_probs=196.3

Q ss_pred             CCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCccceeeeeeec------CCeeEE
Q 015395           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAHRML  152 (407)
Q Consensus        80 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~~l  152 (407)
                      +|...++||+|+||+||+|.+. +++.||||++......    +.+|+.+|++++||||+++++++..      ..+++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999975 6889999998665432    2359999999999999999999853      235789


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeeccccee
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKL  231 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~  231 (407)
                      |||||+++.+..+.. .......+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999997654333322 111125799999999999999999999999   999999999999999775 899999999987


Q ss_pred             cCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH---------HHHHH
Q 015395          232 LGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE---------WLKKM  301 (407)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~  301 (407)
                      ......  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.         .....
T Consensus       173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            754432  234579999999998765 568999999999999999999999997654332221110         00111


Q ss_pred             hhc---CCCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHhc
Q 015395          302 VTN---RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM--LEAQ  355 (407)
Q Consensus       302 ~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~  355 (407)
                      ...   ...................+..+.+|+.+||+.||++|||+.|+++.  ++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            000   00000000000011122345678999999999999999999999973  4444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=369.62  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=206.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC----CCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCC-CccceeeeeeecCC
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGA  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~  148 (407)
                      .++|++++.||+|+||+||+|...    +|+.||||++....    ......+.+|+.+|++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            467999999999999999999852    47889999885432    2234567789999999976 89999999999999


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      ..+++|||+.+|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999999776    4688999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCC
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ++..............|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||......+....+  ........ 
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~~-  252 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE-  252 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC-
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccCC-
Confidence            988765544444556799999999999764  4788999999999999999999999876654433322  22222111 


Q ss_pred             CCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 015395          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVH  350 (407)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~  350 (407)
                            +..    +..++.++.+|+.+||+.||++|||     ++|+++
T Consensus       253 ------~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  111    1234567999999999999999995     778875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=367.62  Aligned_cols=262  Identities=22%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             CCCCccceecccCceEEEEEEE-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCccceeeeeeecCC----eeEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRML  152 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l  152 (407)
                      ++|++++.||+|+||+||+|.. .+++.||||++.... ......+.+|+.+|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4699999999999999999996 478999999986543 344567888999999999999999999986543    2345


Q ss_pred             EEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceec
Q 015395          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (407)
Q Consensus       153 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~  232 (407)
                      +++|+.+|+|.+++...     .+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||++...
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667799999999753     599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCce--eeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC
Q 015395          233 GSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (407)
Q Consensus       233 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ......  .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+.....   ...........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhh
Confidence            443221  1234579999999999844 56789999999999999999999999765432222111   11100000000


Q ss_pred             --------------cCCCCCCCC---ccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 --------------VLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 --------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                    .........   ....++.++.+|+.+||+.||.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                          000000000   011233568899999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-48  Score=366.56  Aligned_cols=257  Identities=22%  Similarity=0.321  Sum_probs=195.8

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCccceeeeeeecCC------
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  148 (407)
                      .++|++++.||+|+||+||+|.+. +++.||||++...  .......+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999965 6889999998653  3334557888999999999999999999987654      


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+|+||||+ +.+|..++..     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            579999999 6688887765     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcC--
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--  305 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--  305 (407)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........   .......  
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPA  240 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCH
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH---HhccCCCcH
Confidence            9876543    234578999999999866 45789999999999999999999999765432221111   1110000  


Q ss_pred             ----------------CCCCcCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          306 ----------------NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       306 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                      .........+ .......+..+.+||.+||..||.+|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            0000000000 00112234568899999999999999999999984

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.3e-47  Score=361.16  Aligned_cols=257  Identities=20%  Similarity=0.272  Sum_probs=200.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeec--CCeeEEE
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV  153 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv  153 (407)
                      .++|++++.||+|+||+||+|+.. +++.||||++....   ...+.+|+.+|+.++ ||||+++++++..  ....++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            357999999999999999999964 68889999986443   456788999999995 9999999999874  4568999


Q ss_pred             EEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCC-CcEEeecccceec
Q 015395          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLL  232 (407)
Q Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~  232 (407)
                      ||||.+++|..+.       ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++ .+||+|||+|+..
T Consensus       111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999998764       3589999999999999999999999   999999999999998765 5899999999877


Q ss_pred             CCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHh---------
Q 015395          233 GSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV---------  302 (407)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  302 (407)
                      .....  .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||..........  ..+....         
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHH
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH--HHHHHHHCCchhhhhh
Confidence            54432  3345689999999998765 47999999999999999999999997655432211  1111100         


Q ss_pred             hcCCC---CC---c--------CCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          303 TNRNP---EG---V--------LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       303 ~~~~~---~~---~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      .....   ..   .        ............++.++.+||.+||+.||.+|||++++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000   00   0        00111112233455678999999999999999999999873

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=352.78  Aligned_cols=263  Identities=20%  Similarity=0.276  Sum_probs=207.9

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeecCCeeEEEEE
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  155 (407)
                      ++|++++.||+|+||+||+|.+. +++.||||++....  ......+.+|+.+|+.++||||+++++++.+....+++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999965 67889999985443  3445678899999999999999999999999999999999


Q ss_pred             eccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccceecCCC
Q 015395          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (407)
Q Consensus       156 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~  235 (407)
                      ++.+++|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+......
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999998888765    5789999999999999999999999   9999999999999999999999999999887554


Q ss_pred             CceeeeeeeccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCCC-----
Q 015395          236 SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG-----  309 (407)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  309 (407)
                      ... .....++..|+|||++.... ++.++|||||||++|||++|+.||.......  .....+...........     
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence            332 23345788999999987665 6899999999999999999999975443322  12222222222111000     


Q ss_pred             ----------cCCCCCCCCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          310 ----------VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       310 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                                ..............+..+.+|+.+||+.||.+|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      000001111223345668899999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-46  Score=354.96  Aligned_cols=263  Identities=24%  Similarity=0.281  Sum_probs=193.4

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec------CC
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GA  148 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~  148 (407)
                      .++|+++++||+|+||+||+|.+. +++.||||++....  ......+.+|+.+|++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999976 68899999986542  3444578899999999999999999999853      46


Q ss_pred             eeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeeccc
Q 015395          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (407)
Q Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl  228 (407)
                      .+|+|||||.++ +.+.+.      ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            889999999665 444443      3589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH------------
Q 015395          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE------------  296 (407)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~------------  296 (407)
                      ++......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.            
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            88765433  2344578999999999999999999999999999999999999997654322111110            


Q ss_pred             ----HHHHHhhcCCCCC------cC-CCCCC--CCccHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 015395          297 ----WLKKMVTNRNPEG------VL-DPKLP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (407)
Q Consensus       297 ----~~~~~~~~~~~~~------~~-~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L  352 (407)
                          .............      .. ....+  .......+..+.+||.+||..||++|||++|+++.-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence                0011111110000      00 00001  112334677899999999999999999999998753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=355.99  Aligned_cols=258  Identities=21%  Similarity=0.310  Sum_probs=196.5

Q ss_pred             cCCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCccceeeeeeec-----CCe
Q 015395           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH  149 (407)
Q Consensus        78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  149 (407)
                      .++|++++.||+|+||+||+|.+. +++.||||++....  ......+.+|+.+|+.++||||+++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999964 68899999986543  3344567889999999999999999999853     234


Q ss_pred             eEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcEEeecccc
Q 015395          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (407)
Q Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla  229 (407)
                      .+++|+|+.+|+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            4667778889999999965     3699999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCceeeeeeeccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHHHHHHHhhcCCCC
Q 015395          230 KLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (407)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ......    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+   ......... 
T Consensus       169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~-  240 (348)
T d2gfsa1         169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGA-  240 (348)
T ss_dssp             -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCH-
T ss_pred             cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCh-
Confidence            765332    2345689999999987665 4689999999999999999999999865433222111   111110000 


Q ss_pred             Cc--------------CCCCCCCCc----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 015395          309 GV--------------LDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (407)
Q Consensus       309 ~~--------------~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~  351 (407)
                      ..              .....+...    ....+..+.+||.+||+.||.+|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00              000011110    11234568899999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-40  Score=318.73  Aligned_cols=263  Identities=19%  Similarity=0.206  Sum_probs=189.1

Q ss_pred             CCCCccceecccCceEEEEEEEC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----------CCccceeeeeeec
Q 015395           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----------HKNLVRLLGYCAE  146 (407)
Q Consensus        79 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~~  146 (407)
                      ++|++++.||+|+||+||+|... +++.||||++.... .....+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            45999999999999999999964 68899999986543 33456677888887764           5789999988754


Q ss_pred             --CCeeEEEEEeccCCChH-HhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCceeccCCCCccEEEeCCCC--
Q 015395          147 --GAHRMLVYEYVNNGNLE-QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWN--  220 (407)
Q Consensus       147 --~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~--  220 (407)
                        ....+++|+++..+... ......  ....+++..+..++.||+.||+|||+ .   +|+||||||+||||+.++.  
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence              35566777776554332 222221  12578999999999999999999998 6   9999999999999986654  


Q ss_pred             ----cEEeecccceecCCCCceeeeeeeccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhHHH
Q 015395          221 ----PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (407)
Q Consensus       221 ----~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~elltg~~Pf~~~~~~~~~~~~~  296 (407)
                          ++++|||.+......    ....+||+.|+|||++....++.++|||||||++++|++|+.||.............
T Consensus       167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                899999999865432    234569999999999999999999999999999999999999997544322211111


Q ss_pred             HHHHHhh---c------------------CCCCCcCCCC----------CCCCccHHHHHHHHHHHHHccCcCCCCCCCH
Q 015395          297 WLKKMVT---N------------------RNPEGVLDPK----------LPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (407)
Q Consensus       297 ~~~~~~~---~------------------~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  345 (407)
                      .+.....   .                  ......+...          .........+..+.+|+.+||+.||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            1111100   0                  0000000000          0112235677889999999999999999999


Q ss_pred             HHHHHH
Q 015395          346 GHVVHM  351 (407)
Q Consensus       346 ~evl~~  351 (407)
                      +|+++.
T Consensus       323 ~e~L~H  328 (362)
T d1q8ya_         323 GGLVNH  328 (362)
T ss_dssp             HHHHTC
T ss_pred             HHHhcC
Confidence            999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=9.3e-26  Score=195.31  Aligned_cols=165  Identities=16%  Similarity=0.160  Sum_probs=121.1

Q ss_pred             CCccceecccCceEEEEEEECCCCEEEEEEeccCCh------------------hhHHHHHHHHHHHhcCCCCccceeee
Q 015395           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG------------------QAEREFKVEVEAIGRVRHKNLVRLLG  142 (407)
Q Consensus        81 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpniv~~~~  142 (407)
                      +.+.+.||+|+||.||+|...+|+.||||++.....                  ........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999998643211                  11223456888899999999998876


Q ss_pred             eeecCCeeEEEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCceeccCCCCccEEEeCCCCcE
Q 015395          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (407)
Q Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  222 (407)
                      +..    .+++|||+++..+.+           ++...+..++.|++.+|+|||++   +|+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence            532    379999998766543           23334567899999999999999   99999999999999976 489


Q ss_pred             EeecccceecCCCCceeeeeeeccccccCcc-----ccCCCCCCcchhHHHHHHHH
Q 015395          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILI  273 (407)
Q Consensus       223 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~sDiwslG~il  273 (407)
                      |+|||+|.........         .|....     .+....|+.++|+||+.--+
T Consensus       143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999999876533221         111100     01135678899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=1.5e-08  Score=89.80  Aligned_cols=149  Identities=15%  Similarity=0.070  Sum_probs=100.5

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeE
Q 015395           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  151 (407)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  151 (407)
                      ++.--...|++.+..+.++.+.||+... ++..+++|+...........+..|...++.+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4444456777777666566789998764 46678888775544333445566777776663 333677888888888999


Q ss_pred             EEEEeccCCChHHhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--------------------------------
Q 015395          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--------------------------------  199 (407)
Q Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------  199 (407)
                      +||++++|.++.+.....      ..   ...++.++++.+..||+..                                
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999998886654221      11   1234455555555555320                                


Q ss_pred             ------------------------CCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          200 ------------------------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       200 ------------------------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                                              ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                    12379999999999999876667999997653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.34  E-value=1.1e-06  Score=76.88  Aligned_cols=130  Identities=18%  Similarity=0.111  Sum_probs=83.5

Q ss_pred             ecccC-ceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC--CCccceeeeeeecCCeeEEEEEeccCCChH
Q 015395           87 IGEGG-YGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEGAHRMLVYEYVNNGNLE  163 (407)
Q Consensus        87 lg~G~-~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  163 (407)
                      +..|. .+.||+....++..+++|.......   ..+..|+..|+.+.  .-.+.+++.+..+.+..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            44444 4689999887787889997654432   23455677666553  233677888888888899999999887653


Q ss_pred             HhhhCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh----------------------------------------------
Q 015395          164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE----------------------------------------------  197 (407)
Q Consensus       164 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------------------  197 (407)
                      +..         ....   .++.++...|.-||+                                              
T Consensus        95 ~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          95 SSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            311         1111   112223333333332                                              


Q ss_pred             -----c----CCCceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          198 -----G----LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       198 -----~----~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                           .    .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                 1    122489999999999999876677999987643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.80  E-value=4.5e-05  Score=71.10  Aligned_cols=77  Identities=14%  Similarity=0.144  Sum_probs=47.3

Q ss_pred             cceecccCceEEEEEEEC-CCCEEEEEEeccC-------ChhhHHHHHHHHHHHhcCC---CCccceeeeeeecCCeeEE
Q 015395           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-------RGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML  152 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-------~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~l  152 (407)
                      .+.||.|....||++... +++.+++|.-...       ......+...|...|+.+.   ...+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999854 4677899964321       1112223445777776552   2345666654  4455689


Q ss_pred             EEEeccCCCh
Q 015395          153 VYEYVNNGNL  162 (407)
Q Consensus       153 v~e~~~~g~L  162 (407)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.49  E-value=0.00025  Score=64.07  Aligned_cols=139  Identities=15%  Similarity=0.096  Sum_probs=76.8

Q ss_pred             cCceEEEEEEECCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCcc--ceee-----eeeecCCeeEEEEEeccCCCh
Q 015395           90 GGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL--VRLL-----GYCAEGAHRMLVYEYVNNGNL  162 (407)
Q Consensus        90 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~~~-----~~~~~~~~~~lv~e~~~~g~L  162 (407)
                      +.--.||++...+|..+++|+..... .....+..|...+..|...+|  +..+     ..+...+..+.+++++.|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            34568999998889999999765442 234556678777766632222  1111     122445677889999876433


Q ss_pred             H-----Hh---------h----hCCC-CCCCCCCHH----------------------HHHHHHHHHHHHHHhh-hhcCC
Q 015395          163 E-----QW---------L----HGDV-GPCSPLTWE----------------------IRMNIILGTAKGLSYL-HEGLE  200 (407)
Q Consensus       163 ~-----~~---------l----~~~~-~~~~~l~~~----------------------~~~~i~~qi~~~L~~L-H~~~~  200 (407)
                      .     .+         +    .... .....++..                      .....+..+...+.-+ ....+
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            1     00         0    1100 000111111                      1112222222222211 12234


Q ss_pred             CceeccCCCCccEEEeCCCCcEEeeccccee
Q 015395          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (407)
Q Consensus       201 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~  231 (407)
                      .++||+|+.+.|||++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            579999999999999744  45899997754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.32  E-value=0.00052  Score=63.62  Aligned_cols=73  Identities=18%  Similarity=0.196  Sum_probs=49.0

Q ss_pred             cceecccCceEEEEEEECC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCccceeeeeeecCCeeEEEE
Q 015395           84 DKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  154 (407)
Q Consensus        84 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  154 (407)
                      ++.|+.|-.-.+|++...+        ...|.+++.-..  .......+|..+++.+. +.-..++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4568889999999998653        245666655422  23344567888888775 3334577777653    6899


Q ss_pred             EeccCCCh
Q 015395          155 EYVNNGNL  162 (407)
Q Consensus       155 e~~~~g~L  162 (407)
                      ||++|.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.76  E-value=0.017  Score=50.97  Aligned_cols=31  Identities=23%  Similarity=0.238  Sum_probs=27.2

Q ss_pred             CCceeccCCCCccEEEeCCCCcEEeecccce
Q 015395          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (407)
Q Consensus       200 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~  230 (407)
                      +.++||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999988777899999775